"","pmid","doi","title","abstract","year","month","day","jabbrv","journal","keywords","lastname","firstname","address","email"
"1","34184738","10.1093/bib/bbab244","DeepIPs: comprehensive assessment and computational identification of phosphorylation sites of SARS-CoV-2 infection using a deep learning-based approach.","The rapid spread of SARS-CoV-2 infection around the globe has caused a massive health and socioeconomic crisis. Identification of phosphorylation sites is an important step for understanding the molecular mechanisms of SARS-CoV-2 infection and the changes within the host cells pathways. In this study, we present DeepIPs, a first specific deep-learning architecture to identify phosphorylation sites in host cells infected with SARS-CoV-2. DeepIPs consists of the most popular word embedding method ","2021","06","29","Brief Bioinform","Briefings in bioinformatics","CNN; LSTM; SARS-CoV-2; phosphorylation; word embedding","Lv","Hao","Center for Informational Biology at the University of Electronic Science and Technology of China, Chengdu 610054, China",NA
"2","34184738","10.1093/bib/bbab244","DeepIPs: comprehensive assessment and computational identification of phosphorylation sites of SARS-CoV-2 infection using a deep learning-based approach.","The rapid spread of SARS-CoV-2 infection around the globe has caused a massive health and socioeconomic crisis. Identification of phosphorylation sites is an important step for understanding the molecular mechanisms of SARS-CoV-2 infection and the changes within the host cells pathways. In this study, we present DeepIPs, a first specific deep-learning architecture to identify phosphorylation sites in host cells infected with SARS-CoV-2. DeepIPs consists of the most popular word embedding method ","2021","06","29","Brief Bioinform","Briefings in bioinformatics","CNN; LSTM; SARS-CoV-2; phosphorylation; word embedding","Dao","Fu-Ying","Center for Informational Biology at the University of Electronic Science and Technology of China, Chengdu 610054, China",NA
"3","34184738","10.1093/bib/bbab244","DeepIPs: comprehensive assessment and computational identification of phosphorylation sites of SARS-CoV-2 infection using a deep learning-based approach.","The rapid spread of SARS-CoV-2 infection around the globe has caused a massive health and socioeconomic crisis. Identification of phosphorylation sites is an important step for understanding the molecular mechanisms of SARS-CoV-2 infection and the changes within the host cells pathways. In this study, we present DeepIPs, a first specific deep-learning architecture to identify phosphorylation sites in host cells infected with SARS-CoV-2. DeepIPs consists of the most popular word embedding method ","2021","06","29","Brief Bioinform","Briefings in bioinformatics","CNN; LSTM; SARS-CoV-2; phosphorylation; word embedding","Zulfiqar","Hasan","Center for Informational Biology at the University of Electronic Science and Technology of China, Chengdu 610054, China",NA
"4","34184738","10.1093/bib/bbab244","DeepIPs: comprehensive assessment and computational identification of phosphorylation sites of SARS-CoV-2 infection using a deep learning-based approach.","The rapid spread of SARS-CoV-2 infection around the globe has caused a massive health and socioeconomic crisis. Identification of phosphorylation sites is an important step for understanding the molecular mechanisms of SARS-CoV-2 infection and the changes within the host cells pathways. In this study, we present DeepIPs, a first specific deep-learning architecture to identify phosphorylation sites in host cells infected with SARS-CoV-2. DeepIPs consists of the most popular word embedding method ","2021","06","29","Brief Bioinform","Briefings in bioinformatics","CNN; LSTM; SARS-CoV-2; phosphorylation; word embedding","Lin","Hao","Center for Informational Biology at the University of Electronic Science and Technology of China, Chengdu 610054, China",NA
"5","34184737","10.1093/fampra/cmab068","Facial paralysis and vaccinations: a vaccine adverse event reporting system review.","Vaccinations are a cornerstone of preventative medicine in the USA. However, growing concerns regarding facial nerve palsy following vaccination exist. This study aims to assess the occurrence of facial palsy as reported by the Vaccine Adverse Event Reporting System (VAERS) database. A retrospective analysis of the VAERS database was performed for cases of 'Facial Palsy', 'Bell's Palsy', 'Facial Paralysis' and 'Ramsay Hunt Syndrome' between 2009 and 2018. Subgroup analysis was performed to deter","2021","06","29","Fam Pract","Family practice","Adverse drug reaction reporting systems; Bell palsy; facial nerve; facial paralysis; iatrogenic disease; vaccination","Ahsanuddin","Salma","Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA",NA
"6","34184737","10.1093/fampra/cmab068","Facial paralysis and vaccinations: a vaccine adverse event reporting system review.","Vaccinations are a cornerstone of preventative medicine in the USA. However, growing concerns regarding facial nerve palsy following vaccination exist. This study aims to assess the occurrence of facial palsy as reported by the Vaccine Adverse Event Reporting System (VAERS) database. A retrospective analysis of the VAERS database was performed for cases of 'Facial Palsy', 'Bell's Palsy', 'Facial Paralysis' and 'Ramsay Hunt Syndrome' between 2009 and 2018. Subgroup analysis was performed to deter","2021","06","29","Fam Pract","Family practice","Adverse drug reaction reporting systems; Bell palsy; facial nerve; facial paralysis; iatrogenic disease; vaccination","Nasser","Wissam","Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA",NA
"7","34184737","10.1093/fampra/cmab068","Facial paralysis and vaccinations: a vaccine adverse event reporting system review.","Vaccinations are a cornerstone of preventative medicine in the USA. However, growing concerns regarding facial nerve palsy following vaccination exist. This study aims to assess the occurrence of facial palsy as reported by the Vaccine Adverse Event Reporting System (VAERS) database. A retrospective analysis of the VAERS database was performed for cases of 'Facial Palsy', 'Bell's Palsy', 'Facial Paralysis' and 'Ramsay Hunt Syndrome' between 2009 and 2018. Subgroup analysis was performed to deter","2021","06","29","Fam Pract","Family practice","Adverse drug reaction reporting systems; Bell palsy; facial nerve; facial paralysis; iatrogenic disease; vaccination","Roy","Savannah C","Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA",NA
"8","34184737","10.1093/fampra/cmab068","Facial paralysis and vaccinations: a vaccine adverse event reporting system review.","Vaccinations are a cornerstone of preventative medicine in the USA. However, growing concerns regarding facial nerve palsy following vaccination exist. This study aims to assess the occurrence of facial palsy as reported by the Vaccine Adverse Event Reporting System (VAERS) database. A retrospective analysis of the VAERS database was performed for cases of 'Facial Palsy', 'Bell's Palsy', 'Facial Paralysis' and 'Ramsay Hunt Syndrome' between 2009 and 2018. Subgroup analysis was performed to deter","2021","06","29","Fam Pract","Family practice","Adverse drug reaction reporting systems; Bell palsy; facial nerve; facial paralysis; iatrogenic disease; vaccination","Povolotskiy","Roman","Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA",NA
"9","34184737","10.1093/fampra/cmab068","Facial paralysis and vaccinations: a vaccine adverse event reporting system review.","Vaccinations are a cornerstone of preventative medicine in the USA. However, growing concerns regarding facial nerve palsy following vaccination exist. This study aims to assess the occurrence of facial palsy as reported by the Vaccine Adverse Event Reporting System (VAERS) database. A retrospective analysis of the VAERS database was performed for cases of 'Facial Palsy', 'Bell's Palsy', 'Facial Paralysis' and 'Ramsay Hunt Syndrome' between 2009 and 2018. Subgroup analysis was performed to deter","2021","06","29","Fam Pract","Family practice","Adverse drug reaction reporting systems; Bell palsy; facial nerve; facial paralysis; iatrogenic disease; vaccination","Paskhover","Boris","Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA",NA
"10","34184726","10.4067/S0716-10182021000200306","[SARS-CoV-2: A leap from feces to aquatic ecosystems].",NA,"2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Ecosystem; Feces; Humans; SARS-CoV-2","Godin","Bárbara","Escuela de Medicina, Facultad de Medicina, Universidad del Sinú, Cartagena, Colombia",NA
"11","34184726","10.4067/S0716-10182021000200306","[SARS-CoV-2: A leap from feces to aquatic ecosystems].",NA,"2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Ecosystem; Feces; Humans; SARS-CoV-2","Tejeda","Lesly","Grupo de Investigación en Ciencias Biomédicas, Toxicológicas y Ambientales, Universidad de Cartagena, Colombia",NA
"12","34184726","10.4067/S0716-10182021000200306","[SARS-CoV-2: A leap from feces to aquatic ecosystems].",NA,"2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Ecosystem; Feces; Humans; SARS-CoV-2","Arroyo","Bárbara","Grupo de Investigación en Ciencias Biomédicas, Toxicológicas y Ambientales, Universidad de Cartagena, Colombia",NA
"13","34184718","10.4067/S0716-10182021000200271","[Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?]","Excessive release of cytokines in severe COVID-19 resembles secondary hemophagocytic lymphohistiocytosis (sHLH). To compare the clinical and laboratory characteristics between sHLH and cytokine release syndrome (CRS) in COVID-19. A review of articles in the PubMed database was performed, using the following keywords ""HLH and COVID"", ""HScore in COVID"". Articles available until July 16, 2020 were included. A comparative table was prepared based on the diagnostic criteria of the HLH 2004 protocol, ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Cytokine Release Syndrome; Humans; Lymphohistiocytosis, Hemophagocytic; SARS-CoV-2","Alfaro-Murillo","Alberto","Medicina Interna e Inmunología Clínica, Caja Costarricense del Seguro Social, San José, Costa Rica",NA
"14","34184718","10.4067/S0716-10182021000200271","[Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?]","Excessive release of cytokines in severe COVID-19 resembles secondary hemophagocytic lymphohistiocytosis (sHLH). To compare the clinical and laboratory characteristics between sHLH and cytokine release syndrome (CRS) in COVID-19. A review of articles in the PubMed database was performed, using the following keywords ""HLH and COVID"", ""HScore in COVID"". Articles available until July 16, 2020 were included. A comparative table was prepared based on the diagnostic criteria of the HLH 2004 protocol, ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Cytokine Release Syndrome; Humans; Lymphohistiocytosis, Hemophagocytic; SARS-CoV-2","Lazo-Paéz","Gustavo","Servicio de Inmunología y Reumatología Pediátrica, Hospital Nacional de Niños ""Dr. Carlos Sáenz-Herrera"", San José, Costa Rica",NA
"15","34184708","10.4067/S0716-10182021000200185","[Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].","COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","Advisory Committees; COVID-19; COVID-19 Vaccines; Humans; Immunization; SARS-CoV-2; Vaccination; Vaccines","Dabanch","Jeannette","Comité Asesor de Vacunas y Estrategias de Inmunización, Ministerio de Salud de Chile, Chile",NA
"16","34184708","10.4067/S0716-10182021000200185","[Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].","COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","Advisory Committees; COVID-19; COVID-19 Vaccines; Humans; Immunization; SARS-CoV-2; Vaccination; Vaccines","Bastías","Magdalena","Comité Asesor de Vacunas y Estrategias de Inmunización, Ministerio de Salud de Chile, Chile",NA
"17","34184708","10.4067/S0716-10182021000200185","[Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].","COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","Advisory Committees; COVID-19; COVID-19 Vaccines; Humans; Immunization; SARS-CoV-2; Vaccination; Vaccines","Endeiza","María L","Comité Asesor de Vacunas y Estrategias de Inmunización, Ministerio de Salud de Chile, Chile",NA
"18","34184708","10.4067/S0716-10182021000200185","[Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].","COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","Advisory Committees; COVID-19; COVID-19 Vaccines; Humans; Immunization; SARS-CoV-2; Vaccination; Vaccines","Díaz","Eduardo","Comité Asesor de Vacunas y Estrategias de Inmunización, Ministerio de Salud de Chile, Chile",NA
"19","34184708","10.4067/S0716-10182021000200185","[Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].","COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","Advisory Committees; COVID-19; COVID-19 Vaccines; Humans; Immunization; SARS-CoV-2; Vaccination; Vaccines","Inostroza","Jaime","Comité Asesor de Vacunas y Estrategias de Inmunización, Ministerio de Salud de Chile, Chile",NA
"20","34184708","10.4067/S0716-10182021000200185","[Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].","COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","Advisory Committees; COVID-19; COVID-19 Vaccines; Humans; Immunization; SARS-CoV-2; Vaccination; Vaccines","Cerda","Jaime","Comité Asesor de Vacunas y Estrategias de Inmunización, Ministerio de Salud de Chile, Chile",NA
"21","34184708","10.4067/S0716-10182021000200185","[Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].","COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","Advisory Committees; COVID-19; COVID-19 Vaccines; Humans; Immunization; SARS-CoV-2; Vaccination; Vaccines","Santillana","Solange","Comité Asesor de Vacunas y Estrategias de Inmunización, Ministerio de Salud de Chile, Chile",NA
"22","34184708","10.4067/S0716-10182021000200185","[Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].","COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","Advisory Committees; COVID-19; COVID-19 Vaccines; Humans; Immunization; SARS-CoV-2; Vaccination; Vaccines","Rodríguez","Jaime","Comité Asesor de Vacunas y Estrategias de Inmunización, Ministerio de Salud de Chile, Chile",NA
"23","34184708","10.4067/S0716-10182021000200185","[Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].","COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","Advisory Committees; COVID-19; COVID-19 Vaccines; Humans; Immunization; SARS-CoV-2; Vaccination; Vaccines","González","Cecilia","Comité Asesor de Vacunas y Estrategias de Inmunización, Ministerio de Salud de Chile, Chile",NA
"24","34184708","10.4067/S0716-10182021000200185","[Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].","COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","Advisory Committees; COVID-19; COVID-19 Vaccines; Humans; Immunization; SARS-CoV-2; Vaccination; Vaccines","Rodríguez","María","Comité Asesor de Vacunas y Estrategias de Inmunización, Ministerio de Salud de Chile, Chile",NA
"25","34184708","10.4067/S0716-10182021000200185","[Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].","COVID-19 is a global public health issue due to its epidemic nature that, to date, lacks pharmacological treatment. However, some COVID-19 vaccines have been authorized for emergency use, although the duration of their protection, their ability to interrupt viral transmission, and their efficacy against emerging variants of SARS-CoV-2 are being studied. Chile's SARS-CoV-2 vaccination campaign required design and planning, like any other campaign. This process included the prioritization of risk ","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","Advisory Committees; COVID-19; COVID-19 Vaccines; Humans; Immunization; SARS-CoV-2; Vaccination; Vaccines","Pizarro","Alejandra","Comité Asesor de Vacunas y Estrategias de Inmunización, Ministerio de Salud de Chile, Chile",NA
"26","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","Bastías","Magdalena","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"27","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","Avendaño","Marcela","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"28","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","Muñoz","Felipe","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"29","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","Brstilo","Iván","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"30","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","Álvarez","Andrés","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"31","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","Burgos","Pamela","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"32","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","Espinoza","Daniela","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"33","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","Núñez","Marcia","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"34","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","Rodríguez","Juan","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"35","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","Rivas","Marcela","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"36","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","Solar","Rosa","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"37","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","Soto","Leslie","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"38","34184707","10.4067/S0716-10182021000200178","[Seasonal influenza campaign 2020 in the context of SARS-CoV-2 pandemic: an unprecedented public health experience in Chile].","In Chile, the Immunization Department of the Ministry of Health has carried out the seasonal influenza vaccination campaign annually since 1982 in collaboration with the national health services, regional health offices, and primary health care centres. With the aim of preventing deaths and serious morbidity in high-risk groups and preserving the integrity of health services, the seasonal influenza campaign had been the largest implemented in Chile until 2020, since in 2021 the vaccination campa","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Humans; Influenza Vaccines; Influenza, Human; Pandemics; Public Health; SARS-CoV-2; Seasons; Vaccination","González","Cecilia","Departamento de Inmunizaciones, Ministerio de Salud de Chile, Chile",NA
"39","34184703","10.4067/S0716-10182021000200144","[Epidemiological characterization of infection by SARS-CoV-2 of the healthcare workers of a university hospital in Santiago de Chile].","The SARS-CoV-2 outbreak originated in the Hubei province in China spread rapidly throughout the world during the first months of 2020. On March 3, the first case was reported in Chile; at 17 days the first case of COVID-19 healthcare worker (HCW) was notified in our institution. To describe the demographic characteristics and the incidence of SARS-CoV-2 infection in the HCW of a university hospital in Chile. Retrospective study of SARS-CoV-2 infection on HCW in a university hospital between Marc","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Health Personnel; Hospitals, University; Humans; Retrospective Studies; SARS-CoV-2","Saint-Pierre-Contreras","Gustavo","Servicio de Laboratorio Clínico, Hospital Clínico, Universidad de Chile, Santiago, Chile",NA
"40","34184703","10.4067/S0716-10182021000200144","[Epidemiological characterization of infection by SARS-CoV-2 of the healthcare workers of a university hospital in Santiago de Chile].","The SARS-CoV-2 outbreak originated in the Hubei province in China spread rapidly throughout the world during the first months of 2020. On March 3, the first case was reported in Chile; at 17 days the first case of COVID-19 healthcare worker (HCW) was notified in our institution. To describe the demographic characteristics and the incidence of SARS-CoV-2 infection in the HCW of a university hospital in Chile. Retrospective study of SARS-CoV-2 infection on HCW in a university hospital between Marc","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Health Personnel; Hospitals, University; Humans; Retrospective Studies; SARS-CoV-2","Silva-Ojeda","Francisco","Servicio de Laboratorio Clínico, Hospital Clínico, Universidad de Chile, Santiago, Chile",NA
"41","34184703","10.4067/S0716-10182021000200144","[Epidemiological characterization of infection by SARS-CoV-2 of the healthcare workers of a university hospital in Santiago de Chile].","The SARS-CoV-2 outbreak originated in the Hubei province in China spread rapidly throughout the world during the first months of 2020. On March 3, the first case was reported in Chile; at 17 days the first case of COVID-19 healthcare worker (HCW) was notified in our institution. To describe the demographic characteristics and the incidence of SARS-CoV-2 infection in the HCW of a university hospital in Chile. Retrospective study of SARS-CoV-2 infection on HCW in a university hospital between Marc","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Health Personnel; Hospitals, University; Humans; Retrospective Studies; SARS-CoV-2","Conei-Valencia","Daniel","Programa de Doctorado en Ciencias Morfológicas, Universidad de La Frontera, Temuco, Chile",NA
"42","34184703","10.4067/S0716-10182021000200144","[Epidemiological characterization of infection by SARS-CoV-2 of the healthcare workers of a university hospital in Santiago de Chile].","The SARS-CoV-2 outbreak originated in the Hubei province in China spread rapidly throughout the world during the first months of 2020. On March 3, the first case was reported in Chile; at 17 days the first case of COVID-19 healthcare worker (HCW) was notified in our institution. To describe the demographic characteristics and the incidence of SARS-CoV-2 infection in the HCW of a university hospital in Chile. Retrospective study of SARS-CoV-2 infection on HCW in a university hospital between Marc","2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; Chile; Health Personnel; Hospitals, University; Humans; Retrospective Studies; SARS-CoV-2","Cifuentes-Díaz","Marcela","Comité de Prevención y Control de Infecciones Asociadas a la Atención de Salud y Epidemiología Hospitalaria, Hospital Clínico, Universidad de Chile, Santiago, Chile",NA
"43","34184702","10.4067/S0716-10182021000200135","[Role of public laboratories in the SARS-CoV-2 diagnosis in the COVID-19 pandemic: experience, challenges and opportunities. March 2021].",NA,"2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; COVID-19 Testing; Humans; Laboratories; Pandemics; SARS-CoV-2","Acevedo-Muñoz","William","Hospital de Enfermedades Infecciosas Dr. Lucio Córdova, Santiago, Chile",NA
"44","34184702","10.4067/S0716-10182021000200135","[Role of public laboratories in the SARS-CoV-2 diagnosis in the COVID-19 pandemic: experience, challenges and opportunities. March 2021].",NA,"2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; COVID-19 Testing; Humans; Laboratories; Pandemics; SARS-CoV-2","Benadof-Fuentes","Dona","Hospital de Niños Dr. Roberto del Río, Santiago, Chile",NA
"45","34184702","10.4067/S0716-10182021000200135","[Role of public laboratories in the SARS-CoV-2 diagnosis in the COVID-19 pandemic: experience, challenges and opportunities. March 2021].",NA,"2021","07","02","Rev Chilena Infectol","Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia","COVID-19; COVID-19 Testing; Humans; Laboratories; Pandemics; SARS-CoV-2","Farfán-Urzúa","Mauricio J","Departamento de Pediatría Infantil Campus Oriente, Facultad de Medicina, Universidad de Chile, Santiago, Chile",NA
"46","34184663","10.1097/JOM.0000000000002238","SARS-CoV-2 Transmission Risk to Household and Family Contacts by Vaccinated Healthcare Workers.",NA,"2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","Asymptomatic Infections; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; COVID-19 Vaccines; Contact Tracing; Family Characteristics; Female; Health Personnel; Humans; Male; Pandemics; SARS-CoV-2","Pratò","Simone","School of Medicine and Surgery University of Milano-Bicocca Monza, Italy",NA
"47","34184663","10.1097/JOM.0000000000002238","SARS-CoV-2 Transmission Risk to Household and Family Contacts by Vaccinated Healthcare Workers.",NA,"2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","Asymptomatic Infections; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; COVID-19 Vaccines; Contact Tracing; Family Characteristics; Female; Health Personnel; Humans; Male; Pandemics; SARS-CoV-2","Paladino","Maria Emilia","School of Medicine and Surgery University of Milano-Bicocca Monza, Italy",NA
"48","34184663","10.1097/JOM.0000000000002238","SARS-CoV-2 Transmission Risk to Household and Family Contacts by Vaccinated Healthcare Workers.",NA,"2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","Asymptomatic Infections; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; COVID-19 Vaccines; Contact Tracing; Family Characteristics; Female; Health Personnel; Humans; Male; Pandemics; SARS-CoV-2","Riva","Michele Augusto","School of Medicine and Surgery University of Milano-Bicocca Monza, Italy",NA
"49","34184663","10.1097/JOM.0000000000002238","SARS-CoV-2 Transmission Risk to Household and Family Contacts by Vaccinated Healthcare Workers.",NA,"2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","Asymptomatic Infections; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; COVID-19 Vaccines; Contact Tracing; Family Characteristics; Female; Health Personnel; Humans; Male; Pandemics; SARS-CoV-2","Deni","Matteo","School of Medicine and Surgery University of Milano-Bicocca Monza, Italy",NA
"50","34184663","10.1097/JOM.0000000000002238","SARS-CoV-2 Transmission Risk to Household and Family Contacts by Vaccinated Healthcare Workers.",NA,"2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","Asymptomatic Infections; COVID-19; COVID-19 Nucleic Acid Testing; COVID-19 Testing; COVID-19 Vaccines; Contact Tracing; Family Characteristics; Female; Health Personnel; Humans; Male; Pandemics; SARS-CoV-2","Belingheri","Michael","School of Medicine and Surgery University of Milano-Bicocca Monza, Italy",NA
"51","34184657","10.1097/JOM.0000000000002230","Variation in Employment in Healthcare Occupations and County-Level Differences in COVID-19 Cases in the United States of America.","To study how county-level differences in employment in healthcare occupations contributes to county-level differences in COVID-19 cases. The number of active COVID-19 cases were gathered from the Johns Hopkins University Coronavirus Resource Center weekly between April 22, 2020 and July 1, 2020. Data for the number of workers employed in healthcare occupations were collected at the county-level from the American Community Survey. These data were combined to explore the association between employ","2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","COVID-19; Delivery of Health Care; Employment; Health Occupations; Health Personnel; Humans; Local Government; Occupations; Risk Factors; SARS-CoV-2; United States","Le","Dong","Premedical and Health Studies Program, School of Arts and Sciences, MCPHS University, Boston, Massachusetts, USA (Mr Le)",NA
"52","34184657","10.1097/JOM.0000000000002230","Variation in Employment in Healthcare Occupations and County-Level Differences in COVID-19 Cases in the United States of America.","To study how county-level differences in employment in healthcare occupations contributes to county-level differences in COVID-19 cases. The number of active COVID-19 cases were gathered from the Johns Hopkins University Coronavirus Resource Center weekly between April 22, 2020 and July 1, 2020. Data for the number of workers employed in healthcare occupations were collected at the county-level from the American Community Survey. These data were combined to explore the association between employ","2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","COVID-19; Delivery of Health Care; Employment; Health Occupations; Health Personnel; Humans; Local Government; Occupations; Risk Factors; SARS-CoV-2; United States","Hawkins","Devan","Premedical and Health Studies Program, School of Arts and Sciences, MCPHS University, Boston, Massachusetts, USA (Mr Le)",NA
"53","34184650","10.1097/JOM.0000000000002218","Frequency of Workplace Controls and Associations With Safety Perceptions Among a National Sample of US Food Retail Workers During the COVID-19 Pandemic.","Explore workplace control frequencies and factors associated with US food retail workers' safety perceptions during COVID-19. An online, cross-sectional survey captured working conditions and safety perceptions among a large, national sample of US food retail workers from July to October 2020. Overall, 40.3% reported feeling ""not so"" or ""not protected"" by COVID-19 controls. Administrative controls were more commonly reported (56.8% reported =5 controls) than engineering (19.5% reported =3). Fomi","2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","Adolescent; Adult; Aged; COVID-19; Commerce; Cross-Sectional Studies; Female; Food Industry; Humans; Male; Middle Aged; Occupational Health; Occupational Stress; Pandemics; Perception; SARS-CoV-2; Safety; Workplace; Young Adult","Ceryes","Caitlin","Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (Ceryes, Barnett, Neff)",NA
"54","34184650","10.1097/JOM.0000000000002218","Frequency of Workplace Controls and Associations With Safety Perceptions Among a National Sample of US Food Retail Workers During the COVID-19 Pandemic.","Explore workplace control frequencies and factors associated with US food retail workers' safety perceptions during COVID-19. An online, cross-sectional survey captured working conditions and safety perceptions among a large, national sample of US food retail workers from July to October 2020. Overall, 40.3% reported feeling ""not so"" or ""not protected"" by COVID-19 controls. Administrative controls were more commonly reported (56.8% reported =5 controls) than engineering (19.5% reported =3). Fomi","2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","Adolescent; Adult; Aged; COVID-19; Commerce; Cross-Sectional Studies; Female; Food Industry; Humans; Male; Middle Aged; Occupational Health; Occupational Stress; Pandemics; Perception; SARS-CoV-2; Safety; Workplace; Young Adult","Robinson","Joelle","Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (Ceryes, Barnett, Neff)",NA
"55","34184650","10.1097/JOM.0000000000002218","Frequency of Workplace Controls and Associations With Safety Perceptions Among a National Sample of US Food Retail Workers During the COVID-19 Pandemic.","Explore workplace control frequencies and factors associated with US food retail workers' safety perceptions during COVID-19. An online, cross-sectional survey captured working conditions and safety perceptions among a large, national sample of US food retail workers from July to October 2020. Overall, 40.3% reported feeling ""not so"" or ""not protected"" by COVID-19 controls. Administrative controls were more commonly reported (56.8% reported =5 controls) than engineering (19.5% reported =3). Fomi","2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","Adolescent; Adult; Aged; COVID-19; Commerce; Cross-Sectional Studies; Female; Food Industry; Humans; Male; Middle Aged; Occupational Health; Occupational Stress; Pandemics; Perception; SARS-CoV-2; Safety; Workplace; Young Adult","Biehl","Erin","Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (Ceryes, Barnett, Neff)",NA
"56","34184650","10.1097/JOM.0000000000002218","Frequency of Workplace Controls and Associations With Safety Perceptions Among a National Sample of US Food Retail Workers During the COVID-19 Pandemic.","Explore workplace control frequencies and factors associated with US food retail workers' safety perceptions during COVID-19. An online, cross-sectional survey captured working conditions and safety perceptions among a large, national sample of US food retail workers from July to October 2020. Overall, 40.3% reported feeling ""not so"" or ""not protected"" by COVID-19 controls. Administrative controls were more commonly reported (56.8% reported =5 controls) than engineering (19.5% reported =3). Fomi","2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","Adolescent; Adult; Aged; COVID-19; Commerce; Cross-Sectional Studies; Female; Food Industry; Humans; Male; Middle Aged; Occupational Health; Occupational Stress; Pandemics; Perception; SARS-CoV-2; Safety; Workplace; Young Adult","Wirtz","Andrea L","Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (Ceryes, Barnett, Neff)",NA
"57","34184650","10.1097/JOM.0000000000002218","Frequency of Workplace Controls and Associations With Safety Perceptions Among a National Sample of US Food Retail Workers During the COVID-19 Pandemic.","Explore workplace control frequencies and factors associated with US food retail workers' safety perceptions during COVID-19. An online, cross-sectional survey captured working conditions and safety perceptions among a large, national sample of US food retail workers from July to October 2020. Overall, 40.3% reported feeling ""not so"" or ""not protected"" by COVID-19 controls. Administrative controls were more commonly reported (56.8% reported =5 controls) than engineering (19.5% reported =3). Fomi","2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","Adolescent; Adult; Aged; COVID-19; Commerce; Cross-Sectional Studies; Female; Food Industry; Humans; Male; Middle Aged; Occupational Health; Occupational Stress; Pandemics; Perception; SARS-CoV-2; Safety; Workplace; Young Adult","Barnett","Daniel J","Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (Ceryes, Barnett, Neff)",NA
"58","34184650","10.1097/JOM.0000000000002218","Frequency of Workplace Controls and Associations With Safety Perceptions Among a National Sample of US Food Retail Workers During the COVID-19 Pandemic.","Explore workplace control frequencies and factors associated with US food retail workers' safety perceptions during COVID-19. An online, cross-sectional survey captured working conditions and safety perceptions among a large, national sample of US food retail workers from July to October 2020. Overall, 40.3% reported feeling ""not so"" or ""not protected"" by COVID-19 controls. Administrative controls were more commonly reported (56.8% reported =5 controls) than engineering (19.5% reported =3). Fomi","2021","07","20","J Occup Environ Med","Journal of occupational and environmental medicine","Adolescent; Adult; Aged; COVID-19; Commerce; Cross-Sectional Studies; Female; Food Industry; Humans; Male; Middle Aged; Occupational Health; Occupational Stress; Pandemics; Perception; SARS-CoV-2; Safety; Workplace; Young Adult","Neff","Roni","Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (Ceryes, Barnett, Neff)",NA
"59","34184648","10.1097/MCC.0000000000000849","Vitamin D in critical care: where are we now and what is next?","To summarize the recent evidence on the role of vitamin D deficiency in critically ill patients and emerging data claiming a role of vitamin D in COVID-19. Vitamin D is a strong predictor for worse outcomes in critically ill patients, and as well in COVID-19. The vitamin D content in typical nutrition regimes is lower than what is recommended for the general population. Although its supplementation has been shown to reduce respiratory tract infections, asthma exacerbations and mortality risk in ","2021","07","01","Curr Opin Crit Care","Current opinion in critical care","Aged; COVID-19; Critical Care; Dietary Supplements; Humans; SARS-CoV-2; Vitamin D; Vitamins","Amrein","Karin","Division of Endocrinology and Diabetology",NA
"60","34184648","10.1097/MCC.0000000000000849","Vitamin D in critical care: where are we now and what is next?","To summarize the recent evidence on the role of vitamin D deficiency in critically ill patients and emerging data claiming a role of vitamin D in COVID-19. Vitamin D is a strong predictor for worse outcomes in critically ill patients, and as well in COVID-19. The vitamin D content in typical nutrition regimes is lower than what is recommended for the general population. Although its supplementation has been shown to reduce respiratory tract infections, asthma exacerbations and mortality risk in ","2021","07","01","Curr Opin Crit Care","Current opinion in critical care","Aged; COVID-19; Critical Care; Dietary Supplements; Humans; SARS-CoV-2; Vitamin D; Vitamins","Hoffmann","Magdalena","Division of Endocrinology and Diabetology",NA
"61","34184648","10.1097/MCC.0000000000000849","Vitamin D in critical care: where are we now and what is next?","To summarize the recent evidence on the role of vitamin D deficiency in critically ill patients and emerging data claiming a role of vitamin D in COVID-19. Vitamin D is a strong predictor for worse outcomes in critically ill patients, and as well in COVID-19. The vitamin D content in typical nutrition regimes is lower than what is recommended for the general population. Although its supplementation has been shown to reduce respiratory tract infections, asthma exacerbations and mortality risk in ","2021","07","01","Curr Opin Crit Care","Current opinion in critical care","Aged; COVID-19; Critical Care; Dietary Supplements; Humans; SARS-CoV-2; Vitamin D; Vitamins","Lobmeyr","Elisabeth","Intensive Care Unit 13i2, Department of Medicine I, Medical University of Vienna, Vienna, Austria",NA
"62","34184648","10.1097/MCC.0000000000000849","Vitamin D in critical care: where are we now and what is next?","To summarize the recent evidence on the role of vitamin D deficiency in critically ill patients and emerging data claiming a role of vitamin D in COVID-19. Vitamin D is a strong predictor for worse outcomes in critically ill patients, and as well in COVID-19. The vitamin D content in typical nutrition regimes is lower than what is recommended for the general population. Although its supplementation has been shown to reduce respiratory tract infections, asthma exacerbations and mortality risk in ","2021","07","01","Curr Opin Crit Care","Current opinion in critical care","Aged; COVID-19; Critical Care; Dietary Supplements; Humans; SARS-CoV-2; Vitamin D; Vitamins","Martucci","Gennaro","Department of Anesthesia and Intensive Care, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione) Palermo, Italy",NA
"63","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Stirrup","Oliver","Institute for Global Health, University College London, London, United Kingdom",NA
"64","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Hughes","Joseph","MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom",NA
"65","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Parker","Matthew","Sheffield Bioinformatics Core, The University of Sheffield, Sheffield, United Kingdom",NA
"66","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Partridge","David G","Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom",NA
"67","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Shepherd","James G","MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom",NA
"68","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Blackstone","James","The Comprehensive Clinical Trials Unit at UCL , University College London, London, United Kingdom",NA
"69","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Coll","Francesc","Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene &amp",NA
"70","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Keeley","Alexander","Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom",NA
"71","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Lindsey","Benjamin B","Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom",NA
"72","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Marek","Aleksandra","Clinical Microbiology, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom",NA
"73","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Peters","Christine","Clinical Microbiology, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom",NA
"74","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Singer","Joshua B","MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom",NA
"75","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Tamuri","Asif","Research Computing, University College London, London, United Kingdom",NA
"76","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","de Silva","Thushan I","Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom",NA
"77","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Thomson","Emma C","MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom",NA
"78","34184637","10.7554/eLife.65828","Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data.","Rapid identification and investigation of healthcare-associated infections (HCAIs) is important for suppression of SARS-CoV-2, but the infection source for hospital onset COVID-19 infections (HOCIs) cannot always be readily identified based only on epidemiological data. Viral sequencing data provides additional information regarding potential transmission clusters, but the low mutation rate of SARS-CoV-2 can make interpretation using standard phylogenetic methods difficult. We developed a novel ","2021","07","21","Elife","eLife","COVID-19; SARS-CoV-2; epidemiology; global health; healthcare associated; human; infectious disease; microbiology; nosocomial; outbreak; whole genome sequencing; COVID-19; Cross Infection; Disease Outbreaks; Genome, Viral; Hospitals; Humans; Population Surveillance; Probability; Retrospective Studies; SARS-CoV-2; United Kingdom; Whole Genome Sequencing","Breuer","Judith","Division of Infection and Immunity, University College London, London, United Kingdom",NA
"79","34184628","10.1017/ice.2021.253","Emergence of NDM-producing <i>Pseudomonas aeruginosa</i> among hospitalized patients and impact on antimicrobial therapy during the coronavirus disease 2019 (COVID-19) pandemic.",NA,"2021","06","29","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Perez","Leandro Reus Rodrigues","Federal University of Health Sciences of Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil",NA
"80","34184628","10.1017/ice.2021.253","Emergence of NDM-producing <i>Pseudomonas aeruginosa</i> among hospitalized patients and impact on antimicrobial therapy during the coronavirus disease 2019 (COVID-19) pandemic.",NA,"2021","06","29","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Carniel","Eliana","Feevale University, Novo Hamburgo, Rio Grande do Sul, Brazil",NA
"81","34184628","10.1017/ice.2021.253","Emergence of NDM-producing <i>Pseudomonas aeruginosa</i> among hospitalized patients and impact on antimicrobial therapy during the coronavirus disease 2019 (COVID-19) pandemic.",NA,"2021","06","29","Infect Control Hosp Epidemiol","Infection control and hospital epidemiology",NA,"Narvaez","Gabriel Azambuja","Mãe de Deus Hospital, Porto Alegre, Rio Grande do Sul, Brazil",NA
"82","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Vaira","L A","Maxillofacial Surgery Operative Unit, University Hospital of Sassari, Sassari, Italy",NA
"83","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","De Vito","A","Infectious and Tropical Diseases Unit, University Hospital of Sassari, Sassari, Italy",NA
"84","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Deiana","G","Biomedical Science PhD School, Biomedical Science Department, University of Sassari, Sassari, Italy",NA
"85","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Pes","C","Internal Medicine Department, University Hospital of Sassari, Sassari, Italy",NA
"86","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Giovanditto","F","Maxillofacial Surgery Operative Unit, University Hospital of Sassari, Sassari, Italy",NA
"87","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Fiore","V","Infectious and Tropical Diseases Unit, University Hospital of Sassari, Sassari, Italy",NA
"88","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Lechien","J R","COVID-19 Task Force of the Young-Otolaryngologists of the International Federation of Oto-rhino-laryngological Societies ('YO-IFOS'), Paris, France",NA
"89","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Saussez","S","COVID-19 Task Force of the Young-Otolaryngologists of the International Federation of Oto-rhino-laryngological Societies ('YO-IFOS'), Paris, France",NA
"90","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Policicchio","D","Neurosurgery Operative Unit, University Hospital of Sassari, Sassari, Italy",NA
"91","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Boccaletti","R","Neurosurgery Operative Unit, University Hospital of Sassari, Sassari, Italy",NA
"92","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Madeddu","G","Infectious and Tropical Diseases Unit, University Hospital of Sassari, Sassari, Italy",NA
"93","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Babudieri","S","Infectious and Tropical Diseases Unit, University Hospital of Sassari, Sassari, Italy",NA
"94","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Pazzola","A","Onco-COVID Department, University Hospital of Sassari, Sassari, Italy",NA
"95","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Bandiera","F","Internal Medicine Department, University Hospital of Sassari, Sassari, Italy",NA
"96","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Fois","A G","Respiratory Diseases Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy",NA
"97","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Piana","A F","Biomedical Science PhD School, Biomedical Science Department, University of Sassari, Sassari, Italy",NA
"98","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","Hopkins","C","King's College, London, UK",NA
"99","34184623","10.1017/S0022215121001651","Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?","To analyse the correlations between olfactory psychophysical scores and the serum levels of D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcitonin and neutrophil-to-lymphocyte ratio in coronavirus disease 2019 patients. Patients underwent psychophysical olfactory assessment with the Connecticut Chemosensory Clinical Research Center test, and determination of blood serum levels of the inflammatory markers D-dimer, C-reactive protein, ferritin, lactate dehydrogenase, procalcit","2021","07","10","J Laryngol Otol","The Journal of laryngology and otology","Anosmia; C-Reactive Protein; COVID-19; Coronavirus; Ferritins; Fibrin Fragment D; Lactate Dehydrogenases; Procalcitonin; SARS-CoV; Smell","De Riu","G","Maxillofacial Surgery Operative Unit, University Hospital of Sassari, Sassari, Italy",NA
"100","34184616","10.1080/07481187.2021.1944401","Validating the Coronavirus Anxiety Scale in a Colombian sample.","The present instrumental study evaluated the psychometric properties of the Coronavirus Anxiety Scale with 421 Colombian adults in full lockdown of coronavirus. The reliability was excellent, obtained through the Cronbach's Alpha coefficient (a = 0.83). The results of the confirmatory factor analysis identified satisfactory indicators for the scale's one-dimensional model. The correlations obtained in the discriminant analysis of the items have a moderate level of correlation with ","2021","06","29","Death Stud","Death studies",NA,"Vinaccia","Stefano","Psychology Program, Research Group I-flor. Universidad del Sinú, Montería, Colombia",NA
"101","34184616","10.1080/07481187.2021.1944401","Validating the Coronavirus Anxiety Scale in a Colombian sample.","The present instrumental study evaluated the psychometric properties of the Coronavirus Anxiety Scale with 421 Colombian adults in full lockdown of coronavirus. The reliability was excellent, obtained through the Cronbach's Alpha coefficient (a = 0.83). The results of the confirmatory factor analysis identified satisfactory indicators for the scale's one-dimensional model. The correlations obtained in the discriminant analysis of the items have a moderate level of correlation with ","2021","06","29","Death Stud","Death studies",NA,"Bahamón","Marly J","Department of Social and Human Sciences, Universidad Simón Bolívar, Barranquilla, Colombia",NA
"102","34184616","10.1080/07481187.2021.1944401","Validating the Coronavirus Anxiety Scale in a Colombian sample.","The present instrumental study evaluated the psychometric properties of the Coronavirus Anxiety Scale with 421 Colombian adults in full lockdown of coronavirus. The reliability was excellent, obtained through the Cronbach's Alpha coefficient (a = 0.83). The results of the confirmatory factor analysis identified satisfactory indicators for the scale's one-dimensional model. The correlations obtained in the discriminant analysis of the items have a moderate level of correlation with ","2021","06","29","Death Stud","Death studies",NA,"Trejos-Herrera","Ana M","Department of Psychology, Universidad del Norte, Barranquilla, Colombia",NA
"103","34184616","10.1080/07481187.2021.1944401","Validating the Coronavirus Anxiety Scale in a Colombian sample.","The present instrumental study evaluated the psychometric properties of the Coronavirus Anxiety Scale with 421 Colombian adults in full lockdown of coronavirus. The reliability was excellent, obtained through the Cronbach's Alpha coefficient (a = 0.83). The results of the confirmatory factor analysis identified satisfactory indicators for the scale's one-dimensional model. The correlations obtained in the discriminant analysis of the items have a moderate level of correlation with ","2021","06","29","Death Stud","Death studies",NA,"Lee","Sherman A","Department of Psychology, Christopher Newport University, Newport News, Virginia, USA",NA
"104","34184616","10.1080/07481187.2021.1944401","Validating the Coronavirus Anxiety Scale in a Colombian sample.","The present instrumental study evaluated the psychometric properties of the Coronavirus Anxiety Scale with 421 Colombian adults in full lockdown of coronavirus. The reliability was excellent, obtained through the Cronbach's Alpha coefficient (a = 0.83). The results of the confirmatory factor analysis identified satisfactory indicators for the scale's one-dimensional model. The correlations obtained in the discriminant analysis of the items have a moderate level of correlation with ","2021","06","29","Death Stud","Death studies",NA,"Quiceno","Japcy Margarita","Department of Psychology, Universidad de Medellín, Medellin, Colombia",NA
"105","34184616","10.1080/07481187.2021.1944401","Validating the Coronavirus Anxiety Scale in a Colombian sample.","The present instrumental study evaluated the psychometric properties of the Coronavirus Anxiety Scale with 421 Colombian adults in full lockdown of coronavirus. The reliability was excellent, obtained through the Cronbach's Alpha coefficient (a = 0.83). The results of the confirmatory factor analysis identified satisfactory indicators for the scale's one-dimensional model. The correlations obtained in the discriminant analysis of the items have a moderate level of correlation with ","2021","06","29","Death Stud","Death studies",NA,"Gómez","Cesar Andrés","Department of Psychology, Universidad Sanitas, Barranquilla, Colombia",NA
"106","34184616","10.1080/07481187.2021.1944401","Validating the Coronavirus Anxiety Scale in a Colombian sample.","The present instrumental study evaluated the psychometric properties of the Coronavirus Anxiety Scale with 421 Colombian adults in full lockdown of coronavirus. The reliability was excellent, obtained through the Cronbach's Alpha coefficient (a = 0.83). The results of the confirmatory factor analysis identified satisfactory indicators for the scale's one-dimensional model. The correlations obtained in the discriminant analysis of the items have a moderate level of correlation with ","2021","06","29","Death Stud","Death studies",NA,"Vega DoLugar","Samuel","Department of Social and Human Sciences, Universidad Simón Bolívar Graduate, Barranquilla, Colombia",NA
"107","34184616","10.1080/07481187.2021.1944401","Validating the Coronavirus Anxiety Scale in a Colombian sample.","The present instrumental study evaluated the psychometric properties of the Coronavirus Anxiety Scale with 421 Colombian adults in full lockdown of coronavirus. The reliability was excellent, obtained through the Cronbach's Alpha coefficient (a = 0.83). The results of the confirmatory factor analysis identified satisfactory indicators for the scale's one-dimensional model. The correlations obtained in the discriminant analysis of the items have a moderate level of correlation with ","2021","06","29","Death Stud","Death studies",NA,"Pelaez","Edgar Camilo","Department of Social and Human Sciences, Student at Universidad Simón Bolívar, Barranquilla, Colombia",NA
"108","34184612","10.1080/02699052.2021.1934731","Management of neurotrauma during COVID-19: a single centre experience and lessons for the future.","Introduction: Traumatic brain injury (TBI) is amongst the leading causes of morbidity and mortality worldwide. The unprecedented emergence of COVID-19 has mandated neurosurgeons to limit viral spread and spare hospital resources whilst trying to adapt management plans for TBI. We aimed to characterize how this affects decision-making on TBI management and drive strategies to cope with future expected waves.Methods: Retrospective TBI data collection from a single tertiary referral u","2021","06","29","Brain Inj","Brain injury","COVID-19; neurosurgery; traumatic brain injury","Manivannan","S","Department of Neurosurgery, Southampton General Hospital, Southampton, UK",NA
"109","34184612","10.1080/02699052.2021.1934731","Management of neurotrauma during COVID-19: a single centre experience and lessons for the future.","Introduction: Traumatic brain injury (TBI) is amongst the leading causes of morbidity and mortality worldwide. The unprecedented emergence of COVID-19 has mandated neurosurgeons to limit viral spread and spare hospital resources whilst trying to adapt management plans for TBI. We aimed to characterize how this affects decision-making on TBI management and drive strategies to cope with future expected waves.Methods: Retrospective TBI data collection from a single tertiary referral u","2021","06","29","Brain Inj","Brain injury","COVID-19; neurosurgery; traumatic brain injury","Sharouf","F","Department of Neurosurgery, University Hospital of Wales, Cardiff, UK",NA
"110","34184612","10.1080/02699052.2021.1934731","Management of neurotrauma during COVID-19: a single centre experience and lessons for the future.","Introduction: Traumatic brain injury (TBI) is amongst the leading causes of morbidity and mortality worldwide. The unprecedented emergence of COVID-19 has mandated neurosurgeons to limit viral spread and spare hospital resources whilst trying to adapt management plans for TBI. We aimed to characterize how this affects decision-making on TBI management and drive strategies to cope with future expected waves.Methods: Retrospective TBI data collection from a single tertiary referral u","2021","06","29","Brain Inj","Brain injury","COVID-19; neurosurgery; traumatic brain injury","Mayo","I","Department of Neurosurgery, University Hospital of Wales, Cardiff, UK",NA
"111","34184612","10.1080/02699052.2021.1934731","Management of neurotrauma during COVID-19: a single centre experience and lessons for the future.","Introduction: Traumatic brain injury (TBI) is amongst the leading causes of morbidity and mortality worldwide. The unprecedented emergence of COVID-19 has mandated neurosurgeons to limit viral spread and spare hospital resources whilst trying to adapt management plans for TBI. We aimed to characterize how this affects decision-making on TBI management and drive strategies to cope with future expected waves.Methods: Retrospective TBI data collection from a single tertiary referral u","2021","06","29","Brain Inj","Brain injury","COVID-19; neurosurgery; traumatic brain injury","Albaqer","H","Department of Neurosurgery, University Hospital of Wales, Cardiff, UK",NA
"112","34184612","10.1080/02699052.2021.1934731","Management of neurotrauma during COVID-19: a single centre experience and lessons for the future.","Introduction: Traumatic brain injury (TBI) is amongst the leading causes of morbidity and mortality worldwide. The unprecedented emergence of COVID-19 has mandated neurosurgeons to limit viral spread and spare hospital resources whilst trying to adapt management plans for TBI. We aimed to characterize how this affects decision-making on TBI management and drive strategies to cope with future expected waves.Methods: Retrospective TBI data collection from a single tertiary referral u","2021","06","29","Brain Inj","Brain injury","COVID-19; neurosurgery; traumatic brain injury","Mehrez","M","Department of Neurosurgery, University Hospital of Wales, Cardiff, UK",NA
"113","34184612","10.1080/02699052.2021.1934731","Management of neurotrauma during COVID-19: a single centre experience and lessons for the future.","Introduction: Traumatic brain injury (TBI) is amongst the leading causes of morbidity and mortality worldwide. The unprecedented emergence of COVID-19 has mandated neurosurgeons to limit viral spread and spare hospital resources whilst trying to adapt management plans for TBI. We aimed to characterize how this affects decision-making on TBI management and drive strategies to cope with future expected waves.Methods: Retrospective TBI data collection from a single tertiary referral u","2021","06","29","Brain Inj","Brain injury","COVID-19; neurosurgery; traumatic brain injury","Jaber","H","Department of Radiology, University Hospital of Wales, Cardiff, UK",NA
"114","34184612","10.1080/02699052.2021.1934731","Management of neurotrauma during COVID-19: a single centre experience and lessons for the future.","Introduction: Traumatic brain injury (TBI) is amongst the leading causes of morbidity and mortality worldwide. The unprecedented emergence of COVID-19 has mandated neurosurgeons to limit viral spread and spare hospital resources whilst trying to adapt management plans for TBI. We aimed to characterize how this affects decision-making on TBI management and drive strategies to cope with future expected waves.Methods: Retrospective TBI data collection from a single tertiary referral u","2021","06","29","Brain Inj","Brain injury","COVID-19; neurosurgery; traumatic brain injury","Nicholls","Z","Department of Radiology, University Hospital of Wales, Cardiff, UK",NA
"115","34184612","10.1080/02699052.2021.1934731","Management of neurotrauma during COVID-19: a single centre experience and lessons for the future.","Introduction: Traumatic brain injury (TBI) is amongst the leading causes of morbidity and mortality worldwide. The unprecedented emergence of COVID-19 has mandated neurosurgeons to limit viral spread and spare hospital resources whilst trying to adapt management plans for TBI. We aimed to characterize how this affects decision-making on TBI management and drive strategies to cope with future expected waves.Methods: Retrospective TBI data collection from a single tertiary referral u","2021","06","29","Brain Inj","Brain injury","COVID-19; neurosurgery; traumatic brain injury","Woodward","B O","Department of Radiology, University Hospital of Wales, Cardiff, UK",NA
"116","34184612","10.1080/02699052.2021.1934731","Management of neurotrauma during COVID-19: a single centre experience and lessons for the future.","Introduction: Traumatic brain injury (TBI) is amongst the leading causes of morbidity and mortality worldwide. The unprecedented emergence of COVID-19 has mandated neurosurgeons to limit viral spread and spare hospital resources whilst trying to adapt management plans for TBI. We aimed to characterize how this affects decision-making on TBI management and drive strategies to cope with future expected waves.Methods: Retrospective TBI data collection from a single tertiary referral u","2021","06","29","Brain Inj","Brain injury","COVID-19; neurosurgery; traumatic brain injury","Watkins","W J","Department of Infection &amp",NA
"117","34184612","10.1080/02699052.2021.1934731","Management of neurotrauma during COVID-19: a single centre experience and lessons for the future.","Introduction: Traumatic brain injury (TBI) is amongst the leading causes of morbidity and mortality worldwide. The unprecedented emergence of COVID-19 has mandated neurosurgeons to limit viral spread and spare hospital resources whilst trying to adapt management plans for TBI. We aimed to characterize how this affects decision-making on TBI management and drive strategies to cope with future expected waves.Methods: Retrospective TBI data collection from a single tertiary referral u","2021","06","29","Brain Inj","Brain injury","COVID-19; neurosurgery; traumatic brain injury","Zaben","M","Department of Neurosurgery, University Hospital of Wales, Cardiff, UK",NA
"118","34184575","10.1177/10499091211028849","Covid-19 Mortality in an Acute Care Hospital: Association of Patient Factors With Decision to Forego the Intensive Care Unit.","Public awareness of the large mortality toll of COVID-19 particularly among elderly and frail persons is high. This public awareness represents an enhanced opportunity for early and urgent goals-of-care discussions to reduce medically ineffective care. To assess the end-of-life experiences of hospitalized patients dying of COVID-19 with respect to identifying the clinical factors associated with utilization or non-utilization of the ICU. Retrospective cohort study of hospital outcomes using elec","2021","06","29","Am J Hosp Palliat Care","The American journal of hospice &amp; palliative care","COVID-19; ICU utilization; POLST; advanced directives; goals of care; palliative medicine","Meisenberg","Barry R","Department of Medicine, Annapolis, MD, USA",NA
"119","34184575","10.1177/10499091211028849","Covid-19 Mortality in an Acute Care Hospital: Association of Patient Factors With Decision to Forego the Intensive Care Unit.","Public awareness of the large mortality toll of COVID-19 particularly among elderly and frail persons is high. This public awareness represents an enhanced opportunity for early and urgent goals-of-care discussions to reduce medically ineffective care. To assess the end-of-life experiences of hospitalized patients dying of COVID-19 with respect to identifying the clinical factors associated with utilization or non-utilization of the ICU. Retrospective cohort study of hospital outcomes using elec","2021","06","29","Am J Hosp Palliat Care","The American journal of hospice &amp; palliative care","COVID-19; ICU utilization; POLST; advanced directives; goals of care; palliative medicine","Qureshi","Sadaf","9981Luminis Health Research Institute, Luminis Health, Annapolis, MD, USA",NA
"120","34184575","10.1177/10499091211028849","Covid-19 Mortality in an Acute Care Hospital: Association of Patient Factors With Decision to Forego the Intensive Care Unit.","Public awareness of the large mortality toll of COVID-19 particularly among elderly and frail persons is high. This public awareness represents an enhanced opportunity for early and urgent goals-of-care discussions to reduce medically ineffective care. To assess the end-of-life experiences of hospitalized patients dying of COVID-19 with respect to identifying the clinical factors associated with utilization or non-utilization of the ICU. Retrospective cohort study of hospital outcomes using elec","2021","06","29","Am J Hosp Palliat Care","The American journal of hospice &amp; palliative care","COVID-19; ICU utilization; POLST; advanced directives; goals of care; palliative medicine","Somasekar","Monika Thandalam","Department of Medicine, Annapolis, MD, USA",NA
"121","34184575","10.1177/10499091211028849","Covid-19 Mortality in an Acute Care Hospital: Association of Patient Factors With Decision to Forego the Intensive Care Unit.","Public awareness of the large mortality toll of COVID-19 particularly among elderly and frail persons is high. This public awareness represents an enhanced opportunity for early and urgent goals-of-care discussions to reduce medically ineffective care. To assess the end-of-life experiences of hospitalized patients dying of COVID-19 with respect to identifying the clinical factors associated with utilization or non-utilization of the ICU. Retrospective cohort study of hospital outcomes using elec","2021","06","29","Am J Hosp Palliat Care","The American journal of hospice &amp; palliative care","COVID-19; ICU utilization; POLST; advanced directives; goals of care; palliative medicine","Ali","Qurat","9981Luminis Health Research Institute, Luminis Health, Annapolis, MD, USA",NA
"122","34184575","10.1177/10499091211028849","Covid-19 Mortality in an Acute Care Hospital: Association of Patient Factors With Decision to Forego the Intensive Care Unit.","Public awareness of the large mortality toll of COVID-19 particularly among elderly and frail persons is high. This public awareness represents an enhanced opportunity for early and urgent goals-of-care discussions to reduce medically ineffective care. To assess the end-of-life experiences of hospitalized patients dying of COVID-19 with respect to identifying the clinical factors associated with utilization or non-utilization of the ICU. Retrospective cohort study of hospital outcomes using elec","2021","06","29","Am J Hosp Palliat Care","The American journal of hospice &amp; palliative care","COVID-19; ICU utilization; POLST; advanced directives; goals of care; palliative medicine","Karpman","Mitchell","9981Luminis Health Research Institute, Luminis Health, Annapolis, MD, USA",NA
"123","34184575","10.1177/10499091211028849","Covid-19 Mortality in an Acute Care Hospital: Association of Patient Factors With Decision to Forego the Intensive Care Unit.","Public awareness of the large mortality toll of COVID-19 particularly among elderly and frail persons is high. This public awareness represents an enhanced opportunity for early and urgent goals-of-care discussions to reduce medically ineffective care. To assess the end-of-life experiences of hospitalized patients dying of COVID-19 with respect to identifying the clinical factors associated with utilization or non-utilization of the ICU. Retrospective cohort study of hospital outcomes using elec","2021","06","29","Am J Hosp Palliat Care","The American journal of hospice &amp; palliative care","COVID-19; ICU utilization; POLST; advanced directives; goals of care; palliative medicine","Rhule","Jane","9981Luminis Health Research Institute, Luminis Health, Annapolis, MD, USA",NA
"124","34184570","10.1080/10615806.2021.1946518","The moderating effects of reported pre-pandemic social anxiety, symptom impairment, and current stressors on mental health and affiliative adjustment during the first wave of the COVID-19 pandemic.","Individuals with social anxiety (SA) have well-established fears of being negatively evaluated and exposing self-perceived flaws to others. However, the unique impacts of pre-existing SA on well-being and interpersonal outcomes within the stressful context of the pandemic are currently unknown. In a study that took place in May 2020, we surveyed 488 North American community participants online. We used multiple linear regression to analyze whether retrospective reports of pre-pandemic SA symptom","2021","06","29","Anxiety Stress Coping","Anxiety, stress, and coping","COVID-19; Social anxiety; impairment; pandemic; social support; stressors","Ho","Jolie T K","Department of Psychology and Centre for Mental Health Research and Treatment, University of Waterloo, Waterloo, ON, Canada",NA
"125","34184570","10.1080/10615806.2021.1946518","The moderating effects of reported pre-pandemic social anxiety, symptom impairment, and current stressors on mental health and affiliative adjustment during the first wave of the COVID-19 pandemic.","Individuals with social anxiety (SA) have well-established fears of being negatively evaluated and exposing self-perceived flaws to others. However, the unique impacts of pre-existing SA on well-being and interpersonal outcomes within the stressful context of the pandemic are currently unknown. In a study that took place in May 2020, we surveyed 488 North American community participants online. We used multiple linear regression to analyze whether retrospective reports of pre-pandemic SA symptom","2021","06","29","Anxiety Stress Coping","Anxiety, stress, and coping","COVID-19; Social anxiety; impairment; pandemic; social support; stressors","Moscovitch","David A","Department of Psychology and Centre for Mental Health Research and Treatment, University of Waterloo, Waterloo, ON, Canada",NA
"126","34184563","10.1177/10760296211027653","Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity.","Identifying a hypercoagulable state in patients with COVID-19 may help identify those at risk for virus-induced thromboembolic events and improve clinical outcomes using personalized therapeutic approaches. Herein, we aimed to perform a global assessment of the patients' hemostatic system with COVID-19 using rotational thromboelastometry (ROTEM) and to describe whether patients with different disease severities present different coagulation profiles. Together with 37 healthy volunteers, a total ","2021","07","02","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID-19; coagulopathy; thromboelastometry; Adult; Blood Cell Count; Blood Coagulation Tests; Blood Proteins; COVID-19; Case-Control Studies; Female; Humans; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Thrombelastography; Thrombophilia","Gönenli","Mehmet Gökhan","Internal Medicine Department, Koç University School of Medicine, Istanbul, Turkey",NA
"127","34184563","10.1177/10760296211027653","Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity.","Identifying a hypercoagulable state in patients with COVID-19 may help identify those at risk for virus-induced thromboembolic events and improve clinical outcomes using personalized therapeutic approaches. Herein, we aimed to perform a global assessment of the patients' hemostatic system with COVID-19 using rotational thromboelastometry (ROTEM) and to describe whether patients with different disease severities present different coagulation profiles. Together with 37 healthy volunteers, a total ","2021","07","02","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID-19; coagulopathy; thromboelastometry; Adult; Blood Cell Count; Blood Coagulation Tests; Blood Proteins; COVID-19; Case-Control Studies; Female; Humans; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Thrombelastography; Thrombophilia","Komesli","Zeynep","Internal Medicine Department, Koç University Hospital, Istanbul, Turkey",NA
"128","34184563","10.1177/10760296211027653","Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity.","Identifying a hypercoagulable state in patients with COVID-19 may help identify those at risk for virus-induced thromboembolic events and improve clinical outcomes using personalized therapeutic approaches. Herein, we aimed to perform a global assessment of the patients' hemostatic system with COVID-19 using rotational thromboelastometry (ROTEM) and to describe whether patients with different disease severities present different coagulation profiles. Together with 37 healthy volunteers, a total ","2021","07","02","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID-19; coagulopathy; thromboelastometry; Adult; Blood Cell Count; Blood Coagulation Tests; Blood Proteins; COVID-19; Case-Control Studies; Female; Humans; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Thrombelastography; Thrombophilia","Incir","Said","Medical Biochemistry Department, Koç University School of Medicine, Istanbul, Turkey",NA
"129","34184563","10.1177/10760296211027653","Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity.","Identifying a hypercoagulable state in patients with COVID-19 may help identify those at risk for virus-induced thromboembolic events and improve clinical outcomes using personalized therapeutic approaches. Herein, we aimed to perform a global assessment of the patients' hemostatic system with COVID-19 using rotational thromboelastometry (ROTEM) and to describe whether patients with different disease severities present different coagulation profiles. Together with 37 healthy volunteers, a total ","2021","07","02","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID-19; coagulopathy; thromboelastometry; Adult; Blood Cell Count; Blood Coagulation Tests; Blood Proteins; COVID-19; Case-Control Studies; Female; Humans; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Thrombelastography; Thrombophilia","Yalçin","Özlem","Physiology Department, Koç University School of Medicine, Istanbul, Turkey",NA
"130","34184563","10.1177/10760296211027653","Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity.","Identifying a hypercoagulable state in patients with COVID-19 may help identify those at risk for virus-induced thromboembolic events and improve clinical outcomes using personalized therapeutic approaches. Herein, we aimed to perform a global assessment of the patients' hemostatic system with COVID-19 using rotational thromboelastometry (ROTEM) and to describe whether patients with different disease severities present different coagulation profiles. Together with 37 healthy volunteers, a total ","2021","07","02","Clin Appl Thromb Hemost","Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","COVID-19; coagulopathy; thromboelastometry; Adult; Blood Cell Count; Blood Coagulation Tests; Blood Proteins; COVID-19; Case-Control Studies; Female; Humans; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Thrombelastography; Thrombophilia","Akay","Olga Meltem","Division of Hematology, Internal Medicine Department, Koç University School of Medicine, Istanbul, Turkey",NA
"131","34184540","10.2217/cer-2021-0144","R WE ready for reimbursement? A round up of developments in RWE relating to health technology assessment: part 2.","In this round up, we cover how COVID-19 has been beneficial for improved access to real-world data, as well as how real-world data can be used to address health inequity, an area of increasing interest for health technology assessment.","2021","06","29","J Comp Eff Res","Journal of comparative effectiveness research","COVID-19; HTA; RWE; health technology assessment; real-world evidence; reimbursement","Simpson","Alex","Global Access, F Hoffmann-La Roche, Basel, Switzerland",NA
"132","34184540","10.2217/cer-2021-0144","R WE ready for reimbursement? A round up of developments in RWE relating to health technology assessment: part 2.","In this round up, we cover how COVID-19 has been beneficial for improved access to real-world data, as well as how real-world data can be used to address health inequity, an area of increasing interest for health technology assessment.","2021","06","29","J Comp Eff Res","Journal of comparative effectiveness research","COVID-19; HTA; RWE; health technology assessment; real-world evidence; reimbursement","Ramagopalan","Sreeram V","Global Access, F Hoffmann-La Roche, Basel, Switzerland",NA
"133","34184523","10.26444/aaem/136572","Is job seniority a protective factor against anxiety among midwives during the SARS-CoV-2 pandemic?","Introduction. The pandemic SARS-Cov-2 outbreak necessitated the implementation of changes in everyday obstetric attendance, which demands continuity of care. Employment of sudden changes in obstetric attendance could have increased anxiety among medical personnel. The aim of the Communication was to analyse the influence of professional experience on the level of anxiety in a group of midwives during the SARS-CoV-2 pandemic. The analysis included 100 midwives: average professional experience: 11","2021","07","05","Ann Agric Environ Med","Annals of agricultural and environmental medicine : AAEM","COVID-19; SARS-CoV-2; anxiety; midwifery; obstetrics; pandemic; perinatal care; prenatal care; Anxiety; COVID-19; Humans; Midwifery; Protective Factors; SARS-CoV-2; Severity of Illness Index","Gotlib","Joanna","Medical University, Warsaw, Poland",NA
"134","34184523","10.26444/aaem/136572","Is job seniority a protective factor against anxiety among midwives during the SARS-CoV-2 pandemic?","Introduction. The pandemic SARS-Cov-2 outbreak necessitated the implementation of changes in everyday obstetric attendance, which demands continuity of care. Employment of sudden changes in obstetric attendance could have increased anxiety among medical personnel. The aim of the Communication was to analyse the influence of professional experience on the level of anxiety in a group of midwives during the SARS-CoV-2 pandemic. The analysis included 100 midwives: average professional experience: 11","2021","07","05","Ann Agric Environ Med","Annals of agricultural and environmental medicine : AAEM","COVID-19; SARS-CoV-2; anxiety; midwifery; obstetrics; pandemic; perinatal care; prenatal care; Anxiety; COVID-19; Humans; Midwifery; Protective Factors; SARS-CoV-2; Severity of Illness Index","Rzonca","Ewa","Medical University, Warsaw, Poland",NA
"135","34184523","10.26444/aaem/136572","Is job seniority a protective factor against anxiety among midwives during the SARS-CoV-2 pandemic?","Introduction. The pandemic SARS-Cov-2 outbreak necessitated the implementation of changes in everyday obstetric attendance, which demands continuity of care. Employment of sudden changes in obstetric attendance could have increased anxiety among medical personnel. The aim of the Communication was to analyse the influence of professional experience on the level of anxiety in a group of midwives during the SARS-CoV-2 pandemic. The analysis included 100 midwives: average professional experience: 11","2021","07","05","Ann Agric Environ Med","Annals of agricultural and environmental medicine : AAEM","COVID-19; SARS-CoV-2; anxiety; midwifery; obstetrics; pandemic; perinatal care; prenatal care; Anxiety; COVID-19; Humans; Midwifery; Protective Factors; SARS-CoV-2; Severity of Illness Index","Baranowska","Barbara","Department of Obstetrics, Centre for Postgraduate Medical Education, Warsaw, Poland",NA
"136","34184523","10.26444/aaem/136572","Is job seniority a protective factor against anxiety among midwives during the SARS-CoV-2 pandemic?","Introduction. The pandemic SARS-Cov-2 outbreak necessitated the implementation of changes in everyday obstetric attendance, which demands continuity of care. Employment of sudden changes in obstetric attendance could have increased anxiety among medical personnel. The aim of the Communication was to analyse the influence of professional experience on the level of anxiety in a group of midwives during the SARS-CoV-2 pandemic. The analysis included 100 midwives: average professional experience: 11","2021","07","05","Ann Agric Environ Med","Annals of agricultural and environmental medicine : AAEM","COVID-19; SARS-CoV-2; anxiety; midwifery; obstetrics; pandemic; perinatal care; prenatal care; Anxiety; COVID-19; Humans; Midwifery; Protective Factors; SARS-CoV-2; Severity of Illness Index","Tataj-Puzyna","Urszula","Department of Obstetrics, Centre for Postgraduate Medical Education, Warsaw, Poland",NA
"137","34184523","10.26444/aaem/136572","Is job seniority a protective factor against anxiety among midwives during the SARS-CoV-2 pandemic?","Introduction. The pandemic SARS-Cov-2 outbreak necessitated the implementation of changes in everyday obstetric attendance, which demands continuity of care. Employment of sudden changes in obstetric attendance could have increased anxiety among medical personnel. The aim of the Communication was to analyse the influence of professional experience on the level of anxiety in a group of midwives during the SARS-CoV-2 pandemic. The analysis included 100 midwives: average professional experience: 11","2021","07","05","Ann Agric Environ Med","Annals of agricultural and environmental medicine : AAEM","COVID-19; SARS-CoV-2; anxiety; midwifery; obstetrics; pandemic; perinatal care; prenatal care; Anxiety; COVID-19; Humans; Midwifery; Protective Factors; SARS-CoV-2; Severity of Illness Index","Pawlicka","Paulina","Institute of Psychology, University of Gdansk, Poland",NA
"138","34184523","10.26444/aaem/136572","Is job seniority a protective factor against anxiety among midwives during the SARS-CoV-2 pandemic?","Introduction. The pandemic SARS-Cov-2 outbreak necessitated the implementation of changes in everyday obstetric attendance, which demands continuity of care. Employment of sudden changes in obstetric attendance could have increased anxiety among medical personnel. The aim of the Communication was to analyse the influence of professional experience on the level of anxiety in a group of midwives during the SARS-CoV-2 pandemic. The analysis included 100 midwives: average professional experience: 11","2021","07","05","Ann Agric Environ Med","Annals of agricultural and environmental medicine : AAEM","COVID-19; SARS-CoV-2; anxiety; midwifery; obstetrics; pandemic; perinatal care; prenatal care; Anxiety; COVID-19; Humans; Midwifery; Protective Factors; SARS-CoV-2; Severity of Illness Index","Jaworski","Mariusz","Medical University, Warsaw, Poland",NA
"139","34184523","10.26444/aaem/136572","Is job seniority a protective factor against anxiety among midwives during the SARS-CoV-2 pandemic?","Introduction. The pandemic SARS-Cov-2 outbreak necessitated the implementation of changes in everyday obstetric attendance, which demands continuity of care. Employment of sudden changes in obstetric attendance could have increased anxiety among medical personnel. The aim of the Communication was to analyse the influence of professional experience on the level of anxiety in a group of midwives during the SARS-CoV-2 pandemic. The analysis included 100 midwives: average professional experience: 11","2021","07","05","Ann Agric Environ Med","Annals of agricultural and environmental medicine : AAEM","COVID-19; SARS-CoV-2; anxiety; midwifery; obstetrics; pandemic; perinatal care; prenatal care; Anxiety; COVID-19; Humans; Midwifery; Protective Factors; SARS-CoV-2; Severity of Illness Index","Wójcik-Fatla","Angelina","Institute of Rural Health, Lublin, Poland",NA
"140","34184523","10.26444/aaem/136572","Is job seniority a protective factor against anxiety among midwives during the SARS-CoV-2 pandemic?","Introduction. The pandemic SARS-Cov-2 outbreak necessitated the implementation of changes in everyday obstetric attendance, which demands continuity of care. Employment of sudden changes in obstetric attendance could have increased anxiety among medical personnel. The aim of the Communication was to analyse the influence of professional experience on the level of anxiety in a group of midwives during the SARS-CoV-2 pandemic. The analysis included 100 midwives: average professional experience: 11","2021","07","05","Ann Agric Environ Med","Annals of agricultural and environmental medicine : AAEM","COVID-19; SARS-CoV-2; anxiety; midwifery; obstetrics; pandemic; perinatal care; prenatal care; Anxiety; COVID-19; Humans; Midwifery; Protective Factors; SARS-CoV-2; Severity of Illness Index","Panczyk","Mariusz","Medical University, Warsaw, Poland",NA
"141","34184491","10.17116/jnevro2021121051144","[Prospects for pharmacological adaptation of neurovascular unit in conditions of neurotropic viral infection].","The article discusses the prospects for pharmacological conditioning as a method for adaptation of neurovascular unit in conditions of neurotropic viral infection. A step-by-step mechanism for development of preconditioning and postconditioning is presented with a detailed description of it's main stages (trigger, signal and effector). The role of neuroinflammation as the leading mechanism of damage and the possibility of influencing the brain neurotrophic factor are considered. It is shown that","2021","06","30","Zh Nevrol Psikhiatr Im S S Korsakova","Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","COVID-19; SARS-CoV-2; brain neurotrophic factor; cerebrolysin; neuroinflammation; neurotrophic drugs; neurotropic viruses; neurovascular unit; pharmacological adaptation; pharmacological conditioning; postconditioning; preconditioning; Brain; Humans; Virus Diseases","Putilina","M V","Pirogov Russian National Research Medical University, Moscow, Russia",NA
"142","34184491","10.17116/jnevro2021121051144","[Prospects for pharmacological adaptation of neurovascular unit in conditions of neurotropic viral infection].","The article discusses the prospects for pharmacological conditioning as a method for adaptation of neurovascular unit in conditions of neurotropic viral infection. A step-by-step mechanism for development of preconditioning and postconditioning is presented with a detailed description of it's main stages (trigger, signal and effector). The role of neuroinflammation as the leading mechanism of damage and the possibility of influencing the brain neurotrophic factor are considered. It is shown that","2021","06","30","Zh Nevrol Psikhiatr Im S S Korsakova","Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","COVID-19; SARS-CoV-2; brain neurotrophic factor; cerebrolysin; neuroinflammation; neurotrophic drugs; neurotropic viruses; neurovascular unit; pharmacological adaptation; pharmacological conditioning; postconditioning; preconditioning; Brain; Humans; Virus Diseases","Teplova","N V","Pirogov Russian National Research Medical University, Moscow, Russia",NA
"143","34184491","10.17116/jnevro2021121051144","[Prospects for pharmacological adaptation of neurovascular unit in conditions of neurotropic viral infection].","The article discusses the prospects for pharmacological conditioning as a method for adaptation of neurovascular unit in conditions of neurotropic viral infection. A step-by-step mechanism for development of preconditioning and postconditioning is presented with a detailed description of it's main stages (trigger, signal and effector). The role of neuroinflammation as the leading mechanism of damage and the possibility of influencing the brain neurotrophic factor are considered. It is shown that","2021","06","30","Zh Nevrol Psikhiatr Im S S Korsakova","Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","COVID-19; SARS-CoV-2; brain neurotrophic factor; cerebrolysin; neuroinflammation; neurotrophic drugs; neurotropic viruses; neurovascular unit; pharmacological adaptation; pharmacological conditioning; postconditioning; preconditioning; Brain; Humans; Virus Diseases","Poryadin","G V","Pirogov Russian National Research Medical University, Moscow, Russia",NA
"144","34184490","10.17116/jnevro2021121051138","[Polyneuropathies during COVID-19 epidemics].","Our review article aimed for analysis of pathogenesis, diagnostyics and treatment of polyneuropathies manifesting in the course of COVID-19. The reasons for hyposmia and taste disturbances are considered in the subjects with this coronavirus infection as well as relationship between these clinical manifestations and severity of the viral infection. Special attention is given to description of autoimmune mechanisms of Guillain-Barré syndrome and polyneuropathies of critical conditions associated ","2021","06","30","Zh Nevrol Psikhiatr Im S S Korsakova","Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","Guillain-Barré syndrome; Neuromultivit; SARS-CoV-2; alcoholic neuropathy; diabetic neuropathy; COVID-19; Epidemics; Guillain-Barre Syndrome; Humans; Quality of Life; SARS-CoV-2","Chukhlovina","M L","Almazov National Medical Research Center, St. Petersburg, Russia",NA
"145","34184468","10.23736/S2724-5276.20.06050-8","Organization of a pediatric acupuncture clinic for pain and enuresis during Covid-19 pandemic in a third level Italian Pediatric Hospital: experience of Ospedale Pediatrico Bambino Gesù.",NA,"2021","06","29","Minerva Pediatr (Torino)","Minerva pediatrics",NA,"Vittori","Alessandro","ARCO Roma, Department of Anesthesia and Critical Care, Ospedale Pediatrico Bambino Gesù IRCCS, Rome, Italy - alexvittori82@gmail","alexvittori82@gmail.com"
"146","34184468","10.23736/S2724-5276.20.06050-8","Organization of a pediatric acupuncture clinic for pain and enuresis during Covid-19 pandemic in a third level Italian Pediatric Hospital: experience of Ospedale Pediatrico Bambino Gesù.",NA,"2021","06","29","Minerva Pediatr (Torino)","Minerva pediatrics",NA,"Marchetti","Giuliano","ARCO Roma, Department of Anesthesia and Critical Care, Ospedale Pediatrico Bambino Gesù IRCCS, Rome, Italy",NA
"147","34184468","10.23736/S2724-5276.20.06050-8","Organization of a pediatric acupuncture clinic for pain and enuresis during Covid-19 pandemic in a third level Italian Pediatric Hospital: experience of Ospedale Pediatrico Bambino Gesù.",NA,"2021","06","29","Minerva Pediatr (Torino)","Minerva pediatrics",NA,"Francia","Elisa","ARCO Roma, Department of Anesthesia and Critical Care, Ospedale Pediatrico Bambino Gesù IRCCS, Rome, Italy",NA
"148","34184468","10.23736/S2724-5276.20.06050-8","Organization of a pediatric acupuncture clinic for pain and enuresis during Covid-19 pandemic in a third level Italian Pediatric Hospital: experience of Ospedale Pediatrico Bambino Gesù.",NA,"2021","06","29","Minerva Pediatr (Torino)","Minerva pediatrics",NA,"Mascilini","Ilaria","ARCO Roma, Department of Anesthesia and Critical Care, Ospedale Pediatrico Bambino Gesù IRCCS, Rome, Italy",NA
"149","34184468","10.23736/S2724-5276.20.06050-8","Organization of a pediatric acupuncture clinic for pain and enuresis during Covid-19 pandemic in a third level Italian Pediatric Hospital: experience of Ospedale Pediatrico Bambino Gesù.",NA,"2021","06","29","Minerva Pediatr (Torino)","Minerva pediatrics",NA,"Picardo","Sergio G","ARCO Roma, Department of Anesthesia and Critical Care, Ospedale Pediatrico Bambino Gesù IRCCS, Rome, Italy",NA
"150","34184463","10.3988/jcn.2021.17.3.490","Acute Encephalitis Associated with SARS-CoV-2 Confirmed in Cerebrospinal Fluid: First Case in Malaysia.",NA,"2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)",NA,"Tee","Tze Yuan","Department of Medicine, Tawau Hospital, Sabah, Malaysia. tzeyuan28@gmail","tzeyuan28@gmail.com"
"151","34184463","10.3988/jcn.2021.17.3.490","Acute Encephalitis Associated with SARS-CoV-2 Confirmed in Cerebrospinal Fluid: First Case in Malaysia.",NA,"2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)",NA,"Thabit","Alif Adlan Mohd","Infectious Diseases Unit, Department of Medicine, Sungai Buloh Hospital, Selangor, Malaysia",NA
"152","34184463","10.3988/jcn.2021.17.3.490","Acute Encephalitis Associated with SARS-CoV-2 Confirmed in Cerebrospinal Fluid: First Case in Malaysia.",NA,"2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)",NA,"Khoo","Ching Soong","Neurology Unit, Department of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia",NA
"153","34184463","10.3988/jcn.2021.17.3.490","Acute Encephalitis Associated with SARS-CoV-2 Confirmed in Cerebrospinal Fluid: First Case in Malaysia.",NA,"2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)",NA,"Shahrom","Hisham Md","Department of Medicine, Tawau Hospital, Sabah, Malaysia",NA
"154","34184463","10.3988/jcn.2021.17.3.490","Acute Encephalitis Associated with SARS-CoV-2 Confirmed in Cerebrospinal Fluid: First Case in Malaysia.",NA,"2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)",NA,"Chan","En Ze","Department of Medicine, Tawau Hospital, Sabah, Malaysia",NA
"155","34184463","10.3988/jcn.2021.17.3.490","Acute Encephalitis Associated with SARS-CoV-2 Confirmed in Cerebrospinal Fluid: First Case in Malaysia.",NA,"2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)",NA,"Marzukie","Marsilla Mariaty","Department of Medicine, Tawau Hospital, Sabah, Malaysia",NA
"156","34184463","10.3988/jcn.2021.17.3.490","Acute Encephalitis Associated with SARS-CoV-2 Confirmed in Cerebrospinal Fluid: First Case in Malaysia.",NA,"2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)",NA,"Kamaruddin","Zul Amali Che","Department of Medicine, Tawau Hospital, Sabah, Malaysia",NA
"157","34184463","10.3988/jcn.2021.17.3.490","Acute Encephalitis Associated with SARS-CoV-2 Confirmed in Cerebrospinal Fluid: First Case in Malaysia.",NA,"2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)",NA,"Thayan","Ravindran","Virology Unit, Institute for Medical Research, Kuala Lumpur, Malaysia",NA
"158","34184463","10.3988/jcn.2021.17.3.490","Acute Encephalitis Associated with SARS-CoV-2 Confirmed in Cerebrospinal Fluid: First Case in Malaysia.",NA,"2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)",NA,"Chidambaram","Suresh Kumar","Infectious Diseases Unit, Department of Medicine, Sungai Buloh Hospital, Selangor, Malaysia",NA
"159","34184452","10.3988/jcn.2021.17.3.435","Neurological Manifestations in Patients with COVID-19: Experiences from the Central Infectious Diseases Hospital in South Korea.","To investigate the incidence and characteristics of neurological manifestations associated with coronavirus disease 2019 (COVID-19). We reviewed the medical records of the consecutive patients with COVID-19 who were admitted to the central infectious diseases hospital designated for the treatment of COVID-19 in South Korea between March 2020 and September 2020. Newly developed neurological manifestations associated with COVID-19 were investigated. The frequency and clinical features of the neuro","2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)","COVID-19; Korea; neurological manifestations","Kim","Hyun Kyung","Department of Neurology, National Medical Center, Seoul, Korea",NA
"160","34184452","10.3988/jcn.2021.17.3.435","Neurological Manifestations in Patients with COVID-19: Experiences from the Central Infectious Diseases Hospital in South Korea.","To investigate the incidence and characteristics of neurological manifestations associated with coronavirus disease 2019 (COVID-19). We reviewed the medical records of the consecutive patients with COVID-19 who were admitted to the central infectious diseases hospital designated for the treatment of COVID-19 in South Korea between March 2020 and September 2020. Newly developed neurological manifestations associated with COVID-19 were investigated. The frequency and clinical features of the neuro","2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)","COVID-19; Korea; neurological manifestations","Cho","Yeo Jeong","Department of Neurology, National Medical Center, Seoul, Korea",NA
"161","34184452","10.3988/jcn.2021.17.3.435","Neurological Manifestations in Patients with COVID-19: Experiences from the Central Infectious Diseases Hospital in South Korea.","To investigate the incidence and characteristics of neurological manifestations associated with coronavirus disease 2019 (COVID-19). We reviewed the medical records of the consecutive patients with COVID-19 who were admitted to the central infectious diseases hospital designated for the treatment of COVID-19 in South Korea between March 2020 and September 2020. Newly developed neurological manifestations associated with COVID-19 were investigated. The frequency and clinical features of the neuro","2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)","COVID-19; Korea; neurological manifestations","Lee","Seo Young","Department of Neurology, School of Medicine, Interdisciplinary Graduate Program in Medical Bigdata Convergence, Kangwon National University, Chuncheon, Korea. leeseoyoung@kangwon.ac","leeseoyoung@kangwon.ac.kr"
"162","34184443","10.3988/jcn.2021.17.3.363","Acute Confusion as an Initial Presentation of SARS-CoV-2 Infection.","The respiratory manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been extensively documented. There is emerging evidence that coronavirus disease 2019 (COVID-19) has number of other presenting features which might not be related to the severity of the respiratory disease. We have previously described a case of hypoactive delirium as the first manifestation of COVID-19 without profound lung disease. Here we present five cases of elderly patients, witho","2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)","COVID-19; SARS-CoV-2; delirium; neuropathology","Butt","Isabel","University of Southampton School of Medicine, Southampton, UK. imab1g18@soton.ac","imab1g18@soton.ac.uk"
"163","34184443","10.3988/jcn.2021.17.3.363","Acute Confusion as an Initial Presentation of SARS-CoV-2 Infection.","The respiratory manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been extensively documented. There is emerging evidence that coronavirus disease 2019 (COVID-19) has number of other presenting features which might not be related to the severity of the respiratory disease. We have previously described a case of hypoactive delirium as the first manifestation of COVID-19 without profound lung disease. Here we present five cases of elderly patients, witho","2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)","COVID-19; SARS-CoV-2; delirium; neuropathology","Ochoa-Ferraro","Antonio","Department of Diabetes, Endocrinology and Metabolism, Queen Elizabeth Hospital, Birmingham, UK",NA
"164","34184443","10.3988/jcn.2021.17.3.363","Acute Confusion as an Initial Presentation of SARS-CoV-2 Infection.","The respiratory manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been extensively documented. There is emerging evidence that coronavirus disease 2019 (COVID-19) has number of other presenting features which might not be related to the severity of the respiratory disease. We have previously described a case of hypoactive delirium as the first manifestation of COVID-19 without profound lung disease. Here we present five cases of elderly patients, witho","2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)","COVID-19; SARS-CoV-2; delirium; neuropathology","Dawson","Charlotte","Department of Diabetes, Endocrinology and Metabolism, Queen Elizabeth Hospital, Birmingham, UK",NA
"165","34184443","10.3988/jcn.2021.17.3.363","Acute Confusion as an Initial Presentation of SARS-CoV-2 Infection.","The respiratory manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been extensively documented. There is emerging evidence that coronavirus disease 2019 (COVID-19) has number of other presenting features which might not be related to the severity of the respiratory disease. We have previously described a case of hypoactive delirium as the first manifestation of COVID-19 without profound lung disease. Here we present five cases of elderly patients, witho","2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)","COVID-19; SARS-CoV-2; delirium; neuropathology","Madathil","Shyam","Department of Respiratory Medicine, Queen Elizabeth Hospital, Birmingham, UK",NA
"166","34184443","10.3988/jcn.2021.17.3.363","Acute Confusion as an Initial Presentation of SARS-CoV-2 Infection.","The respiratory manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been extensively documented. There is emerging evidence that coronavirus disease 2019 (COVID-19) has number of other presenting features which might not be related to the severity of the respiratory disease. We have previously described a case of hypoactive delirium as the first manifestation of COVID-19 without profound lung disease. Here we present five cases of elderly patients, witho","2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)","COVID-19; SARS-CoV-2; delirium; neuropathology","Gautam","Nandan","Institute of Clinical Sciences, University of Birmingham, Birmingham, UK",NA
"167","34184443","10.3988/jcn.2021.17.3.363","Acute Confusion as an Initial Presentation of SARS-CoV-2 Infection.","The respiratory manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been extensively documented. There is emerging evidence that coronavirus disease 2019 (COVID-19) has number of other presenting features which might not be related to the severity of the respiratory disease. We have previously described a case of hypoactive delirium as the first manifestation of COVID-19 without profound lung disease. Here we present five cases of elderly patients, witho","2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)","COVID-19; SARS-CoV-2; delirium; neuropathology","Sawlani","Vijay","Department of Radiology, Queen Elizabeth Hospital, University of Birmingham, Birmingham, UK",NA
"168","34184443","10.3988/jcn.2021.17.3.363","Acute Confusion as an Initial Presentation of SARS-CoV-2 Infection.","The respiratory manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been extensively documented. There is emerging evidence that coronavirus disease 2019 (COVID-19) has number of other presenting features which might not be related to the severity of the respiratory disease. We have previously described a case of hypoactive delirium as the first manifestation of COVID-19 without profound lung disease. Here we present five cases of elderly patients, witho","2021","07","07","J Clin Neurol","Journal of clinical neurology (Seoul, Korea)","COVID-19; SARS-CoV-2; delirium; neuropathology","Geberhiwot","Tarekegn","Department of Diabetes, Endocrinology and Metabolism, Queen Elizabeth Hospital, Birmingham, UK",NA
"169","34184439","10.3346/jkms.2021.36.e184","Parental Mental Health and Children's Behaviors and Media Usage during COVID-19-Related School Closures.","Coronavirus disease 2019 (COVID-19) is different from previous disasters in that it continues to the present and has affected all aspects of family life. During epidemics, psychosocial support is not less important than infection control. During COVID-19-related school closures, prolonged partial closures of schools could have detrimental social and health consequences for children and may increase the burden on the family. Based on a community sample in Korea, this study identified parental con","2021","07","05","J Korean Med Sci","Journal of Korean medical science","COVID-19; Media Usage; Parental Mental Health, Children's Behaviors; School Closure; Adult; Body Mass Index; COVID-19; Child; Child Behavior Disorders; Child Care; Depression; Education, Distance; Exercise; Female; Humans; Income; Leisure Activities; Male; Mass Media; Mental Health Services; Pandemics; Parent-Child Relations; Parents; Procedures and Techniques Utilization; Psychology, Child; Quarantine; Republic of Korea; SARS-CoV-2; Schools; Sedentary Behavior; Sleep Wake Disorders; Social Isolation; Social Support; Stress, Psychological; Surveys and Questionnaires","Kim","Seong Ju","Department of Psychiatry, Ajou University School of Medicine, Suwon, Korea",NA
"170","34184439","10.3346/jkms.2021.36.e184","Parental Mental Health and Children's Behaviors and Media Usage during COVID-19-Related School Closures.","Coronavirus disease 2019 (COVID-19) is different from previous disasters in that it continues to the present and has affected all aspects of family life. During epidemics, psychosocial support is not less important than infection control. During COVID-19-related school closures, prolonged partial closures of schools could have detrimental social and health consequences for children and may increase the burden on the family. Based on a community sample in Korea, this study identified parental con","2021","07","05","J Korean Med Sci","Journal of Korean medical science","COVID-19; Media Usage; Parental Mental Health, Children's Behaviors; School Closure; Adult; Body Mass Index; COVID-19; Child; Child Behavior Disorders; Child Care; Depression; Education, Distance; Exercise; Female; Humans; Income; Leisure Activities; Male; Mass Media; Mental Health Services; Pandemics; Parent-Child Relations; Parents; Procedures and Techniques Utilization; Psychology, Child; Quarantine; Republic of Korea; SARS-CoV-2; Schools; Sedentary Behavior; Sleep Wake Disorders; Social Isolation; Social Support; Stress, Psychological; Surveys and Questionnaires","Lee","Sangha","Department of Psychiatry, Ajou University School of Medicine, Suwon, Korea",NA
"171","34184439","10.3346/jkms.2021.36.e184","Parental Mental Health and Children's Behaviors and Media Usage during COVID-19-Related School Closures.","Coronavirus disease 2019 (COVID-19) is different from previous disasters in that it continues to the present and has affected all aspects of family life. During epidemics, psychosocial support is not less important than infection control. During COVID-19-related school closures, prolonged partial closures of schools could have detrimental social and health consequences for children and may increase the burden on the family. Based on a community sample in Korea, this study identified parental con","2021","07","05","J Korean Med Sci","Journal of Korean medical science","COVID-19; Media Usage; Parental Mental Health, Children's Behaviors; School Closure; Adult; Body Mass Index; COVID-19; Child; Child Behavior Disorders; Child Care; Depression; Education, Distance; Exercise; Female; Humans; Income; Leisure Activities; Male; Mass Media; Mental Health Services; Pandemics; Parent-Child Relations; Parents; Procedures and Techniques Utilization; Psychology, Child; Quarantine; Republic of Korea; SARS-CoV-2; Schools; Sedentary Behavior; Sleep Wake Disorders; Social Isolation; Social Support; Stress, Psychological; Surveys and Questionnaires","Han","Hyojin","Department of Psychiatry, Ajou University School of Medicine, Suwon, Korea",NA
"172","34184439","10.3346/jkms.2021.36.e184","Parental Mental Health and Children's Behaviors and Media Usage during COVID-19-Related School Closures.","Coronavirus disease 2019 (COVID-19) is different from previous disasters in that it continues to the present and has affected all aspects of family life. During epidemics, psychosocial support is not less important than infection control. During COVID-19-related school closures, prolonged partial closures of schools could have detrimental social and health consequences for children and may increase the burden on the family. Based on a community sample in Korea, this study identified parental con","2021","07","05","J Korean Med Sci","Journal of Korean medical science","COVID-19; Media Usage; Parental Mental Health, Children's Behaviors; School Closure; Adult; Body Mass Index; COVID-19; Child; Child Behavior Disorders; Child Care; Depression; Education, Distance; Exercise; Female; Humans; Income; Leisure Activities; Male; Mass Media; Mental Health Services; Pandemics; Parent-Child Relations; Parents; Procedures and Techniques Utilization; Psychology, Child; Quarantine; Republic of Korea; SARS-CoV-2; Schools; Sedentary Behavior; Sleep Wake Disorders; Social Isolation; Social Support; Stress, Psychological; Surveys and Questionnaires","Jung","Jaeoh","Department of Psychiatry, Ajou University School of Medicine, Suwon, Korea",NA
"173","34184439","10.3346/jkms.2021.36.e184","Parental Mental Health and Children's Behaviors and Media Usage during COVID-19-Related School Closures.","Coronavirus disease 2019 (COVID-19) is different from previous disasters in that it continues to the present and has affected all aspects of family life. During epidemics, psychosocial support is not less important than infection control. During COVID-19-related school closures, prolonged partial closures of schools could have detrimental social and health consequences for children and may increase the burden on the family. Based on a community sample in Korea, this study identified parental con","2021","07","05","J Korean Med Sci","Journal of Korean medical science","COVID-19; Media Usage; Parental Mental Health, Children's Behaviors; School Closure; Adult; Body Mass Index; COVID-19; Child; Child Behavior Disorders; Child Care; Depression; Education, Distance; Exercise; Female; Humans; Income; Leisure Activities; Male; Mass Media; Mental Health Services; Pandemics; Parent-Child Relations; Parents; Procedures and Techniques Utilization; Psychology, Child; Quarantine; Republic of Korea; SARS-CoV-2; Schools; Sedentary Behavior; Sleep Wake Disorders; Social Isolation; Social Support; Stress, Psychological; Surveys and Questionnaires","Yang","Su Jin","Institute of Future Convergence, Yonsei University, Seoul, Korea",NA
"174","34184439","10.3346/jkms.2021.36.e184","Parental Mental Health and Children's Behaviors and Media Usage during COVID-19-Related School Closures.","Coronavirus disease 2019 (COVID-19) is different from previous disasters in that it continues to the present and has affected all aspects of family life. During epidemics, psychosocial support is not less important than infection control. During COVID-19-related school closures, prolonged partial closures of schools could have detrimental social and health consequences for children and may increase the burden on the family. Based on a community sample in Korea, this study identified parental con","2021","07","05","J Korean Med Sci","Journal of Korean medical science","COVID-19; Media Usage; Parental Mental Health, Children's Behaviors; School Closure; Adult; Body Mass Index; COVID-19; Child; Child Behavior Disorders; Child Care; Depression; Education, Distance; Exercise; Female; Humans; Income; Leisure Activities; Male; Mass Media; Mental Health Services; Pandemics; Parent-Child Relations; Parents; Procedures and Techniques Utilization; Psychology, Child; Quarantine; Republic of Korea; SARS-CoV-2; Schools; Sedentary Behavior; Sleep Wake Disorders; Social Isolation; Social Support; Stress, Psychological; Surveys and Questionnaires","Shin","Yunmi","Department of Psychiatry, Ajou University School of Medicine, Suwon, Korea. ymshin@ajou.ac","ymshin@ajou.ac.kr"
"175","34184438","10.3346/jkms.2021.36.e181","The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.","Multisystem inflammatory disease in children is a Kawasaki disease like illness occurring after severe acute respiratory syndrome coronavirus 2 infection in children. As the pandemic progresses, similar syndromes were also reported in adult with a decreased incidence. Multisystem inflammatory syndrome in adults (MIS-A) can be characterized with shock, heart failure, and gastrointestinal symptoms with elevated inflammatory markers after coronavirus disease 2019 (COVID-19) infection. Herein, we de","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Adult; COVID-19; Multisystem Inflammatory Syndrome; Abdominal Pain; Adrenal Cortex Hormones; Adult; COVID-19; Fever; Humans; Immunoglobulins, Intravenous; Male; Republic of Korea; SARS-CoV-2; Shock; Systemic Inflammatory Response Syndrome","Chung","Hyemin","Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"176","34184438","10.3346/jkms.2021.36.e181","The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.","Multisystem inflammatory disease in children is a Kawasaki disease like illness occurring after severe acute respiratory syndrome coronavirus 2 infection in children. As the pandemic progresses, similar syndromes were also reported in adult with a decreased incidence. Multisystem inflammatory syndrome in adults (MIS-A) can be characterized with shock, heart failure, and gastrointestinal symptoms with elevated inflammatory markers after coronavirus disease 2019 (COVID-19) infection. Herein, we de","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Adult; COVID-19; Multisystem Inflammatory Syndrome; Abdominal Pain; Adrenal Cortex Hormones; Adult; COVID-19; Fever; Humans; Immunoglobulins, Intravenous; Male; Republic of Korea; SARS-CoV-2; Shock; Systemic Inflammatory Response Syndrome","Seo","Hyeonji","Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"177","34184438","10.3346/jkms.2021.36.e181","The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.","Multisystem inflammatory disease in children is a Kawasaki disease like illness occurring after severe acute respiratory syndrome coronavirus 2 infection in children. As the pandemic progresses, similar syndromes were also reported in adult with a decreased incidence. Multisystem inflammatory syndrome in adults (MIS-A) can be characterized with shock, heart failure, and gastrointestinal symptoms with elevated inflammatory markers after coronavirus disease 2019 (COVID-19) infection. Herein, we de","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Adult; COVID-19; Multisystem Inflammatory Syndrome; Abdominal Pain; Adrenal Cortex Hormones; Adult; COVID-19; Fever; Humans; Immunoglobulins, Intravenous; Male; Republic of Korea; SARS-CoV-2; Shock; Systemic Inflammatory Response Syndrome","Park","Sunghee","Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"178","34184438","10.3346/jkms.2021.36.e181","The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.","Multisystem inflammatory disease in children is a Kawasaki disease like illness occurring after severe acute respiratory syndrome coronavirus 2 infection in children. As the pandemic progresses, similar syndromes were also reported in adult with a decreased incidence. Multisystem inflammatory syndrome in adults (MIS-A) can be characterized with shock, heart failure, and gastrointestinal symptoms with elevated inflammatory markers after coronavirus disease 2019 (COVID-19) infection. Herein, we de","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Adult; COVID-19; Multisystem Inflammatory Syndrome; Abdominal Pain; Adrenal Cortex Hormones; Adult; COVID-19; Fever; Humans; Immunoglobulins, Intravenous; Male; Republic of Korea; SARS-CoV-2; Shock; Systemic Inflammatory Response Syndrome","Kim","Haein","Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"179","34184438","10.3346/jkms.2021.36.e181","The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.","Multisystem inflammatory disease in children is a Kawasaki disease like illness occurring after severe acute respiratory syndrome coronavirus 2 infection in children. As the pandemic progresses, similar syndromes were also reported in adult with a decreased incidence. Multisystem inflammatory syndrome in adults (MIS-A) can be characterized with shock, heart failure, and gastrointestinal symptoms with elevated inflammatory markers after coronavirus disease 2019 (COVID-19) infection. Herein, we de","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Adult; COVID-19; Multisystem Inflammatory Syndrome; Abdominal Pain; Adrenal Cortex Hormones; Adult; COVID-19; Fever; Humans; Immunoglobulins, Intravenous; Male; Republic of Korea; SARS-CoV-2; Shock; Systemic Inflammatory Response Syndrome","Jung","Jiwon","Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"180","34184438","10.3346/jkms.2021.36.e181","The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.","Multisystem inflammatory disease in children is a Kawasaki disease like illness occurring after severe acute respiratory syndrome coronavirus 2 infection in children. As the pandemic progresses, similar syndromes were also reported in adult with a decreased incidence. Multisystem inflammatory syndrome in adults (MIS-A) can be characterized with shock, heart failure, and gastrointestinal symptoms with elevated inflammatory markers after coronavirus disease 2019 (COVID-19) infection. Herein, we de","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Adult; COVID-19; Multisystem Inflammatory Syndrome; Abdominal Pain; Adrenal Cortex Hormones; Adult; COVID-19; Fever; Humans; Immunoglobulins, Intravenous; Male; Republic of Korea; SARS-CoV-2; Shock; Systemic Inflammatory Response Syndrome","Chong","Yong Pil","Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"181","34184438","10.3346/jkms.2021.36.e181","The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.","Multisystem inflammatory disease in children is a Kawasaki disease like illness occurring after severe acute respiratory syndrome coronavirus 2 infection in children. As the pandemic progresses, similar syndromes were also reported in adult with a decreased incidence. Multisystem inflammatory syndrome in adults (MIS-A) can be characterized with shock, heart failure, and gastrointestinal symptoms with elevated inflammatory markers after coronavirus disease 2019 (COVID-19) infection. Herein, we de","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Adult; COVID-19; Multisystem Inflammatory Syndrome; Abdominal Pain; Adrenal Cortex Hormones; Adult; COVID-19; Fever; Humans; Immunoglobulins, Intravenous; Male; Republic of Korea; SARS-CoV-2; Shock; Systemic Inflammatory Response Syndrome","Kim","Sung Han","Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"182","34184438","10.3346/jkms.2021.36.e181","The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.","Multisystem inflammatory disease in children is a Kawasaki disease like illness occurring after severe acute respiratory syndrome coronavirus 2 infection in children. As the pandemic progresses, similar syndromes were also reported in adult with a decreased incidence. Multisystem inflammatory syndrome in adults (MIS-A) can be characterized with shock, heart failure, and gastrointestinal symptoms with elevated inflammatory markers after coronavirus disease 2019 (COVID-19) infection. Herein, we de","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Adult; COVID-19; Multisystem Inflammatory Syndrome; Abdominal Pain; Adrenal Cortex Hormones; Adult; COVID-19; Fever; Humans; Immunoglobulins, Intravenous; Male; Republic of Korea; SARS-CoV-2; Shock; Systemic Inflammatory Response Syndrome","Lee","Sang Oh","Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"183","34184438","10.3346/jkms.2021.36.e181","The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.","Multisystem inflammatory disease in children is a Kawasaki disease like illness occurring after severe acute respiratory syndrome coronavirus 2 infection in children. As the pandemic progresses, similar syndromes were also reported in adult with a decreased incidence. Multisystem inflammatory syndrome in adults (MIS-A) can be characterized with shock, heart failure, and gastrointestinal symptoms with elevated inflammatory markers after coronavirus disease 2019 (COVID-19) infection. Herein, we de","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Adult; COVID-19; Multisystem Inflammatory Syndrome; Abdominal Pain; Adrenal Cortex Hormones; Adult; COVID-19; Fever; Humans; Immunoglobulins, Intravenous; Male; Republic of Korea; SARS-CoV-2; Shock; Systemic Inflammatory Response Syndrome","Choi","Sang Ho","Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"184","34184438","10.3346/jkms.2021.36.e181","The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.","Multisystem inflammatory disease in children is a Kawasaki disease like illness occurring after severe acute respiratory syndrome coronavirus 2 infection in children. As the pandemic progresses, similar syndromes were also reported in adult with a decreased incidence. Multisystem inflammatory syndrome in adults (MIS-A) can be characterized with shock, heart failure, and gastrointestinal symptoms with elevated inflammatory markers after coronavirus disease 2019 (COVID-19) infection. Herein, we de","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Adult; COVID-19; Multisystem Inflammatory Syndrome; Abdominal Pain; Adrenal Cortex Hormones; Adult; COVID-19; Fever; Humans; Immunoglobulins, Intravenous; Male; Republic of Korea; SARS-CoV-2; Shock; Systemic Inflammatory Response Syndrome","Kim","Yang Soo","Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"185","34184438","10.3346/jkms.2021.36.e181","The First Case of Multisystem Inflammatory Syndrome in Adult after COVID-19 in Korea.","Multisystem inflammatory disease in children is a Kawasaki disease like illness occurring after severe acute respiratory syndrome coronavirus 2 infection in children. As the pandemic progresses, similar syndromes were also reported in adult with a decreased incidence. Multisystem inflammatory syndrome in adults (MIS-A) can be characterized with shock, heart failure, and gastrointestinal symptoms with elevated inflammatory markers after coronavirus disease 2019 (COVID-19) infection. Herein, we de","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Adult; COVID-19; Multisystem Inflammatory Syndrome; Abdominal Pain; Adrenal Cortex Hormones; Adult; COVID-19; Fever; Humans; Immunoglobulins, Intravenous; Male; Republic of Korea; SARS-CoV-2; Shock; Systemic Inflammatory Response Syndrome","Kim","Min Jae","Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. nahani99@gmail","nahani99@gmail.com"
"186","34184434","10.3346/jkms.2021.36.e168","Factorial Validity of the Arabic Version of the Stress and Anxiety to Viral Epidemics-6 Items (SAVE-6) Scale among the General Population in Lebanon.","This study explored the psychometric properties of the Arabic version of the Stress and Anxiety to Viral Epidemics-6 items (SAVE-6) scale for assessing people's anxiety in response to the viral epidemic in Lebanon. The 406 participants responded voluntarily to the online survey that included the SAVE-6, Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9) tools. The single-structure SAVE-6 model showed good internal consistency (Cronbach's a = 0.773). The SAVE-6 sca","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Anxiety; Arabic; COVID-19; SAVE-6; Adolescent; Adult; Aged; Anxiety; Anxiety Disorders; Area Under Curve; COVID-19; Depression; Depressive Disorder; Diagnostic Self Evaluation; Factor Analysis, Statistical; Female; Humans; Lebanon; Male; Middle Aged; Pandemics; Patient Health Questionnaire; Psychiatric Status Rating Scales; Psychometrics; Quarantine; ROC Curve; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Stress, Psychological; Surveys and Questionnaires; Translations; Young Adult","Hong","Youjin","Department of Psychiatry, GangNeung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea",NA
"187","34184434","10.3346/jkms.2021.36.e168","Factorial Validity of the Arabic Version of the Stress and Anxiety to Viral Epidemics-6 Items (SAVE-6) Scale among the General Population in Lebanon.","This study explored the psychometric properties of the Arabic version of the Stress and Anxiety to Viral Epidemics-6 items (SAVE-6) scale for assessing people's anxiety in response to the viral epidemic in Lebanon. The 406 participants responded voluntarily to the online survey that included the SAVE-6, Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9) tools. The single-structure SAVE-6 model showed good internal consistency (Cronbach's a = 0.773). The SAVE-6 sca","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Anxiety; Arabic; COVID-19; SAVE-6; Adolescent; Adult; Aged; Anxiety; Anxiety Disorders; Area Under Curve; COVID-19; Depression; Depressive Disorder; Diagnostic Self Evaluation; Factor Analysis, Statistical; Female; Humans; Lebanon; Male; Middle Aged; Pandemics; Patient Health Questionnaire; Psychiatric Status Rating Scales; Psychometrics; Quarantine; ROC Curve; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Stress, Psychological; Surveys and Questionnaires; Translations; Young Adult","Yoo","Soyoung","Department of Convergence Medicine, University of Ulsan College of Medicine, Korea",NA
"188","34184434","10.3346/jkms.2021.36.e168","Factorial Validity of the Arabic Version of the Stress and Anxiety to Viral Epidemics-6 Items (SAVE-6) Scale among the General Population in Lebanon.","This study explored the psychometric properties of the Arabic version of the Stress and Anxiety to Viral Epidemics-6 items (SAVE-6) scale for assessing people's anxiety in response to the viral epidemic in Lebanon. The 406 participants responded voluntarily to the online survey that included the SAVE-6, Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9) tools. The single-structure SAVE-6 model showed good internal consistency (Cronbach's a = 0.773). The SAVE-6 sca","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Anxiety; Arabic; COVID-19; SAVE-6; Adolescent; Adult; Aged; Anxiety; Anxiety Disorders; Area Under Curve; COVID-19; Depression; Depressive Disorder; Diagnostic Self Evaluation; Factor Analysis, Statistical; Female; Humans; Lebanon; Male; Middle Aged; Pandemics; Patient Health Questionnaire; Psychiatric Status Rating Scales; Psychometrics; Quarantine; ROC Curve; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Stress, Psychological; Surveys and Questionnaires; Translations; Young Adult","Mreydem","Hussein Walid","Faculty of Medical Sciences, Lebanese University",NA
"189","34184434","10.3346/jkms.2021.36.e168","Factorial Validity of the Arabic Version of the Stress and Anxiety to Viral Epidemics-6 Items (SAVE-6) Scale among the General Population in Lebanon.","This study explored the psychometric properties of the Arabic version of the Stress and Anxiety to Viral Epidemics-6 items (SAVE-6) scale for assessing people's anxiety in response to the viral epidemic in Lebanon. The 406 participants responded voluntarily to the online survey that included the SAVE-6, Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9) tools. The single-structure SAVE-6 model showed good internal consistency (Cronbach's a = 0.773). The SAVE-6 sca","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Anxiety; Arabic; COVID-19; SAVE-6; Adolescent; Adult; Aged; Anxiety; Anxiety Disorders; Area Under Curve; COVID-19; Depression; Depressive Disorder; Diagnostic Self Evaluation; Factor Analysis, Statistical; Female; Humans; Lebanon; Male; Middle Aged; Pandemics; Patient Health Questionnaire; Psychiatric Status Rating Scales; Psychometrics; Quarantine; ROC Curve; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Stress, Psychological; Surveys and Questionnaires; Translations; Young Adult","Abou Ali","Bayan Tarek","Faculty of Medical Sciences, Lebanese University",NA
"190","34184434","10.3346/jkms.2021.36.e168","Factorial Validity of the Arabic Version of the Stress and Anxiety to Viral Epidemics-6 Items (SAVE-6) Scale among the General Population in Lebanon.","This study explored the psychometric properties of the Arabic version of the Stress and Anxiety to Viral Epidemics-6 items (SAVE-6) scale for assessing people's anxiety in response to the viral epidemic in Lebanon. The 406 participants responded voluntarily to the online survey that included the SAVE-6, Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9) tools. The single-structure SAVE-6 model showed good internal consistency (Cronbach's a = 0.773). The SAVE-6 sca","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Anxiety; Arabic; COVID-19; SAVE-6; Adolescent; Adult; Aged; Anxiety; Anxiety Disorders; Area Under Curve; COVID-19; Depression; Depressive Disorder; Diagnostic Self Evaluation; Factor Analysis, Statistical; Female; Humans; Lebanon; Male; Middle Aged; Pandemics; Patient Health Questionnaire; Psychiatric Status Rating Scales; Psychometrics; Quarantine; ROC Curve; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Stress, Psychological; Surveys and Questionnaires; Translations; Young Adult","Saleh","Nada Omar","Faculty of Medical Sciences, Lebanese University",NA
"191","34184434","10.3346/jkms.2021.36.e168","Factorial Validity of the Arabic Version of the Stress and Anxiety to Viral Epidemics-6 Items (SAVE-6) Scale among the General Population in Lebanon.","This study explored the psychometric properties of the Arabic version of the Stress and Anxiety to Viral Epidemics-6 items (SAVE-6) scale for assessing people's anxiety in response to the viral epidemic in Lebanon. The 406 participants responded voluntarily to the online survey that included the SAVE-6, Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9) tools. The single-structure SAVE-6 model showed good internal consistency (Cronbach's a = 0.773). The SAVE-6 sca","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Anxiety; Arabic; COVID-19; SAVE-6; Adolescent; Adult; Aged; Anxiety; Anxiety Disorders; Area Under Curve; COVID-19; Depression; Depressive Disorder; Diagnostic Self Evaluation; Factor Analysis, Statistical; Female; Humans; Lebanon; Male; Middle Aged; Pandemics; Patient Health Questionnaire; Psychiatric Status Rating Scales; Psychometrics; Quarantine; ROC Curve; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Stress, Psychological; Surveys and Questionnaires; Translations; Young Adult","Hammoudi","Sajida Fawaz","Faculty of Medical Sciences, Lebanese University",NA
"192","34184434","10.3346/jkms.2021.36.e168","Factorial Validity of the Arabic Version of the Stress and Anxiety to Viral Epidemics-6 Items (SAVE-6) Scale among the General Population in Lebanon.","This study explored the psychometric properties of the Arabic version of the Stress and Anxiety to Viral Epidemics-6 items (SAVE-6) scale for assessing people's anxiety in response to the viral epidemic in Lebanon. The 406 participants responded voluntarily to the online survey that included the SAVE-6, Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9) tools. The single-structure SAVE-6 model showed good internal consistency (Cronbach's a = 0.773). The SAVE-6 sca","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Anxiety; Arabic; COVID-19; SAVE-6; Adolescent; Adult; Aged; Anxiety; Anxiety Disorders; Area Under Curve; COVID-19; Depression; Depressive Disorder; Diagnostic Self Evaluation; Factor Analysis, Statistical; Female; Humans; Lebanon; Male; Middle Aged; Pandemics; Patient Health Questionnaire; Psychiatric Status Rating Scales; Psychometrics; Quarantine; ROC Curve; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Stress, Psychological; Surveys and Questionnaires; Translations; Young Adult","Lee","Joohee","Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",NA
"193","34184434","10.3346/jkms.2021.36.e168","Factorial Validity of the Arabic Version of the Stress and Anxiety to Viral Epidemics-6 Items (SAVE-6) Scale among the General Population in Lebanon.","This study explored the psychometric properties of the Arabic version of the Stress and Anxiety to Viral Epidemics-6 items (SAVE-6) scale for assessing people's anxiety in response to the viral epidemic in Lebanon. The 406 participants responded voluntarily to the online survey that included the SAVE-6, Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9) tools. The single-structure SAVE-6 model showed good internal consistency (Cronbach's a = 0.773). The SAVE-6 sca","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Anxiety; Arabic; COVID-19; SAVE-6; Adolescent; Adult; Aged; Anxiety; Anxiety Disorders; Area Under Curve; COVID-19; Depression; Depressive Disorder; Diagnostic Self Evaluation; Factor Analysis, Statistical; Female; Humans; Lebanon; Male; Middle Aged; Pandemics; Patient Health Questionnaire; Psychiatric Status Rating Scales; Psychometrics; Quarantine; ROC Curve; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Stress, Psychological; Surveys and Questionnaires; Translations; Young Adult","Suh","Sooyeon","Department of Psychology, Sungshin Women's University, Seoul, Korea",NA
"194","34184434","10.3346/jkms.2021.36.e168","Factorial Validity of the Arabic Version of the Stress and Anxiety to Viral Epidemics-6 Items (SAVE-6) Scale among the General Population in Lebanon.","This study explored the psychometric properties of the Arabic version of the Stress and Anxiety to Viral Epidemics-6 items (SAVE-6) scale for assessing people's anxiety in response to the viral epidemic in Lebanon. The 406 participants responded voluntarily to the online survey that included the SAVE-6, Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9) tools. The single-structure SAVE-6 model showed good internal consistency (Cronbach's a = 0.773). The SAVE-6 sca","2021","07","05","J Korean Med Sci","Journal of Korean medical science","Anxiety; Arabic; COVID-19; SAVE-6; Adolescent; Adult; Aged; Anxiety; Anxiety Disorders; Area Under Curve; COVID-19; Depression; Depressive Disorder; Diagnostic Self Evaluation; Factor Analysis, Statistical; Female; Humans; Lebanon; Male; Middle Aged; Pandemics; Patient Health Questionnaire; Psychiatric Status Rating Scales; Psychometrics; Quarantine; ROC Curve; Reproducibility of Results; SARS-CoV-2; Sensitivity and Specificity; Stress, Psychological; Surveys and Questionnaires; Translations; Young Adult","Chung","Seockhoon","Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. schung@amc.seoul","schung@amc.seoul.kr"
"195","34184433","10.5534/wjmh.210081","COVID-19 and Erectile Dysfunction: Endothelial Dysfunction and Beyond.",NA,"2021","06","29","World J Mens Health","The world journal of men's health",NA,"Sansone","Andrea","Chair of Endocrinology and Medical Sexology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy",NA
"196","34184433","10.5534/wjmh.210081","COVID-19 and Erectile Dysfunction: Endothelial Dysfunction and Beyond.",NA,"2021","06","29","World J Mens Health","The world journal of men's health",NA,"Jannini","Emmanuele A","Chair of Endocrinology and Medical Sexology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. eajannini@gmail","eajannini@gmail.com"
"197","34184428","10.1002/ehf2.13500","Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS-CoV-2 infection.","Implantable device-based sensor measurements including heart sounds, markers of ventilation, and thoracic impedance have been shown to predict heart failure (HF) hospitalizations. We sought to assess how these parameters changed prior to COVID-19 (Cov-19) and how these compared with those presenting with decompensated HF or pneumonia. This retrospective analysis explores patterns of changes in daily measurements by implantable sensors in 10 patients with Cov-19 and compares these findings with t","2021","06","29","ESC Heart Fail","ESC heart failure","Ambulatory monitoring; COVID-19; CRT; Heart failure; ICD; SARS-Cov-2","Gardner","Roy S","Golden Jubilee National Hospital, Clydebank, Glasgow, UK",NA
"198","34184428","10.1002/ehf2.13500","Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS-CoV-2 infection.","Implantable device-based sensor measurements including heart sounds, markers of ventilation, and thoracic impedance have been shown to predict heart failure (HF) hospitalizations. We sought to assess how these parameters changed prior to COVID-19 (Cov-19) and how these compared with those presenting with decompensated HF or pneumonia. This retrospective analysis explores patterns of changes in daily measurements by implantable sensors in 10 patients with Cov-19 and compares these findings with t","2021","06","29","ESC Heart Fail","ESC heart failure","Ambulatory monitoring; COVID-19; CRT; Heart failure; ICD; SARS-Cov-2","Capodilupo","Robert C","New England Heart and Vascular Institute, Catholic Medical Center, Manchester, NH, USA",NA
"199","34184428","10.1002/ehf2.13500","Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS-CoV-2 infection.","Implantable device-based sensor measurements including heart sounds, markers of ventilation, and thoracic impedance have been shown to predict heart failure (HF) hospitalizations. We sought to assess how these parameters changed prior to COVID-19 (Cov-19) and how these compared with those presenting with decompensated HF or pneumonia. This retrospective analysis explores patterns of changes in daily measurements by implantable sensors in 10 patients with Cov-19 and compares these findings with t","2021","06","29","ESC Heart Fail","ESC heart failure","Ambulatory monitoring; COVID-19; CRT; Heart failure; ICD; SARS-Cov-2","Ahmed","Rezwan","Boston Scientific, Arden Hills, MN, USA",NA
"200","34184428","10.1002/ehf2.13500","Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS-CoV-2 infection.","Implantable device-based sensor measurements including heart sounds, markers of ventilation, and thoracic impedance have been shown to predict heart failure (HF) hospitalizations. We sought to assess how these parameters changed prior to COVID-19 (Cov-19) and how these compared with those presenting with decompensated HF or pneumonia. This retrospective analysis explores patterns of changes in daily measurements by implantable sensors in 10 patients with Cov-19 and compares these findings with t","2021","06","29","ESC Heart Fail","ESC heart failure","Ambulatory monitoring; COVID-19; CRT; Heart failure; ICD; SARS-Cov-2","Stolen","Craig M","Boston Scientific, Arden Hills, MN, USA",NA
"201","34184428","10.1002/ehf2.13500","Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS-CoV-2 infection.","Implantable device-based sensor measurements including heart sounds, markers of ventilation, and thoracic impedance have been shown to predict heart failure (HF) hospitalizations. We sought to assess how these parameters changed prior to COVID-19 (Cov-19) and how these compared with those presenting with decompensated HF or pneumonia. This retrospective analysis explores patterns of changes in daily measurements by implantable sensors in 10 patients with Cov-19 and compares these findings with t","2021","06","29","ESC Heart Fail","ESC heart failure","Ambulatory monitoring; COVID-19; CRT; Heart failure; ICD; SARS-Cov-2","An","Qi","Boston Scientific, Arden Hills, MN, USA",NA
"202","34184428","10.1002/ehf2.13500","Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS-CoV-2 infection.","Implantable device-based sensor measurements including heart sounds, markers of ventilation, and thoracic impedance have been shown to predict heart failure (HF) hospitalizations. We sought to assess how these parameters changed prior to COVID-19 (Cov-19) and how these compared with those presenting with decompensated HF or pneumonia. This retrospective analysis explores patterns of changes in daily measurements by implantable sensors in 10 patients with Cov-19 and compares these findings with t","2021","06","29","ESC Heart Fail","ESC heart failure","Ambulatory monitoring; COVID-19; CRT; Heart failure; ICD; SARS-Cov-2","Averina","Viktoria","Boston Scientific, Arden Hills, MN, USA",NA
"203","34184428","10.1002/ehf2.13500","Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS-CoV-2 infection.","Implantable device-based sensor measurements including heart sounds, markers of ventilation, and thoracic impedance have been shown to predict heart failure (HF) hospitalizations. We sought to assess how these parameters changed prior to COVID-19 (Cov-19) and how these compared with those presenting with decompensated HF or pneumonia. This retrospective analysis explores patterns of changes in daily measurements by implantable sensors in 10 patients with Cov-19 and compares these findings with t","2021","06","29","ESC Heart Fail","ESC heart failure","Ambulatory monitoring; COVID-19; CRT; Heart failure; ICD; SARS-Cov-2","Hernandez","Adrian F","Duke University School of Medicine, Durham, NC, USA",NA
"204","34184428","10.1002/ehf2.13500","Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS-CoV-2 infection.","Implantable device-based sensor measurements including heart sounds, markers of ventilation, and thoracic impedance have been shown to predict heart failure (HF) hospitalizations. We sought to assess how these parameters changed prior to COVID-19 (Cov-19) and how these compared with those presenting with decompensated HF or pneumonia. This retrospective analysis explores patterns of changes in daily measurements by implantable sensors in 10 patients with Cov-19 and compares these findings with t","2021","06","29","ESC Heart Fail","ESC heart failure","Ambulatory monitoring; COVID-19; CRT; Heart failure; ICD; SARS-Cov-2","Boehmer","John P","Penn State Milton S Hershey Medical Center, Hershey, PA, USA",NA
"205","34184392","10.1111/obr.13222","Effects of the coronavirus disease 2019 pandemic and the policy response on childhood obesity risk factors: Gender and sex differences and recommendations for research.","Childhood obesity is a public health concern globally, with generally higher prevalence rates in boys compared to girls. Although biological sex is an important determinant, gender roles and norms influence the exposure and vulnerability to risk factors for noncommunicable diseases. Norms and roles might be reinforced or change due to coronavirus disease 2019 (COVID-19) related measures as well as the exposure to risk factors for childhood obesity. COVID-19 related changes, such as home confinem","2021","07","10","Obes Rev","Obesity reviews : an official journal of the International Association for the Study of Obesity","COVID-19; children; gender; overweight","Knebusch","Veronika","Gender and Human Rights, WHO European Office for Investment for Health and Development, Venice, Italy",NA
"206","34184392","10.1111/obr.13222","Effects of the coronavirus disease 2019 pandemic and the policy response on childhood obesity risk factors: Gender and sex differences and recommendations for research.","Childhood obesity is a public health concern globally, with generally higher prevalence rates in boys compared to girls. Although biological sex is an important determinant, gender roles and norms influence the exposure and vulnerability to risk factors for noncommunicable diseases. Norms and roles might be reinforced or change due to coronavirus disease 2019 (COVID-19) related measures as well as the exposure to risk factors for childhood obesity. COVID-19 related changes, such as home confinem","2021","07","10","Obes Rev","Obesity reviews : an official journal of the International Association for the Study of Obesity","COVID-19; children; gender; overweight","Williams","Julianne","World Health Organization (WHO) European Office for the Prevention and Control of Noncommunicable Diseases, Division of Country Health Programmes, WHO Regional Office for Europe, Moscow, Russian Federation",NA
"207","34184392","10.1111/obr.13222","Effects of the coronavirus disease 2019 pandemic and the policy response on childhood obesity risk factors: Gender and sex differences and recommendations for research.","Childhood obesity is a public health concern globally, with generally higher prevalence rates in boys compared to girls. Although biological sex is an important determinant, gender roles and norms influence the exposure and vulnerability to risk factors for noncommunicable diseases. Norms and roles might be reinforced or change due to coronavirus disease 2019 (COVID-19) related measures as well as the exposure to risk factors for childhood obesity. COVID-19 related changes, such as home confinem","2021","07","10","Obes Rev","Obesity reviews : an official journal of the International Association for the Study of Obesity","COVID-19; children; gender; overweight","Yordi Aguirre","Isabel","Gender and Human Rights, WHO European Office for Investment for Health and Development, Venice, Italy",NA
"208","34184392","10.1111/obr.13222","Effects of the coronavirus disease 2019 pandemic and the policy response on childhood obesity risk factors: Gender and sex differences and recommendations for research.","Childhood obesity is a public health concern globally, with generally higher prevalence rates in boys compared to girls. Although biological sex is an important determinant, gender roles and norms influence the exposure and vulnerability to risk factors for noncommunicable diseases. Norms and roles might be reinforced or change due to coronavirus disease 2019 (COVID-19) related measures as well as the exposure to risk factors for childhood obesity. COVID-19 related changes, such as home confinem","2021","07","10","Obes Rev","Obesity reviews : an official journal of the International Association for the Study of Obesity","COVID-19; children; gender; overweight","Weber","Martin W","World Health Organization (WHO) Child and Adolescent Health and Development, WHO Regional Office for Europe, Copenhagen, Denmark",NA
"209","34184392","10.1111/obr.13222","Effects of the coronavirus disease 2019 pandemic and the policy response on childhood obesity risk factors: Gender and sex differences and recommendations for research.","Childhood obesity is a public health concern globally, with generally higher prevalence rates in boys compared to girls. Although biological sex is an important determinant, gender roles and norms influence the exposure and vulnerability to risk factors for noncommunicable diseases. Norms and roles might be reinforced or change due to coronavirus disease 2019 (COVID-19) related measures as well as the exposure to risk factors for childhood obesity. COVID-19 related changes, such as home confinem","2021","07","10","Obes Rev","Obesity reviews : an official journal of the International Association for the Study of Obesity","COVID-19; children; gender; overweight","Rakovac","Ivo","World Health Organization (WHO) European Office for the Prevention and Control of Noncommunicable Diseases, Division of Country Health Programmes, WHO Regional Office for Europe, Moscow, Russian Federation",NA
"210","34184392","10.1111/obr.13222","Effects of the coronavirus disease 2019 pandemic and the policy response on childhood obesity risk factors: Gender and sex differences and recommendations for research.","Childhood obesity is a public health concern globally, with generally higher prevalence rates in boys compared to girls. Although biological sex is an important determinant, gender roles and norms influence the exposure and vulnerability to risk factors for noncommunicable diseases. Norms and roles might be reinforced or change due to coronavirus disease 2019 (COVID-19) related measures as well as the exposure to risk factors for childhood obesity. COVID-19 related changes, such as home confinem","2021","07","10","Obes Rev","Obesity reviews : an official journal of the International Association for the Study of Obesity","COVID-19; children; gender; overweight","Breda","João","World Health Organization (WHO) European Office for the Prevention and Control of Noncommunicable Diseases, Division of Country Health Programmes, WHO Regional Office for Europe, Moscow, Russian Federation",NA
"211","34184361","10.1002/pon.5759","Psychooncological care for patients with cancer during 12 months of the Covid-19 pandemic: Views and experiences of senior psychooncologists at German Comprehensive Cancer Centers.",NA,"2021","07","14","Psychooncology","Psycho-oncology","Covid-19; Psycho-Oncology; SARS-CoV-2; cancer; coronavirus; oncology; psychooncological care","Dinkel","Andreas","Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany",NA
"212","34184361","10.1002/pon.5759","Psychooncological care for patients with cancer during 12 months of the Covid-19 pandemic: Views and experiences of senior psychooncologists at German Comprehensive Cancer Centers.",NA,"2021","07","14","Psychooncology","Psycho-oncology","Covid-19; Psycho-Oncology; SARS-CoV-2; cancer; coronavirus; oncology; psychooncological care","Goerling","Ute","Charité Comprehensive Cancer Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany",NA
"213","34184361","10.1002/pon.5759","Psychooncological care for patients with cancer during 12 months of the Covid-19 pandemic: Views and experiences of senior psychooncologists at German Comprehensive Cancer Centers.",NA,"2021","07","14","Psychooncology","Psycho-oncology","Covid-19; Psycho-Oncology; SARS-CoV-2; cancer; coronavirus; oncology; psychooncological care","Hönig","Klaus","Department of Psychosomatic Medicine and Psychotherapy, University Ulm Medical Center, Ulm, Germany",NA
"214","34184361","10.1002/pon.5759","Psychooncological care for patients with cancer during 12 months of the Covid-19 pandemic: Views and experiences of senior psychooncologists at German Comprehensive Cancer Centers.",NA,"2021","07","14","Psychooncology","Psycho-oncology","Covid-19; Psycho-Oncology; SARS-CoV-2; cancer; coronavirus; oncology; psychooncological care","Karger","André","Center of Integrated Oncology, University Hospital Duesseldorf, Duesseldorf, Germany",NA
"215","34184361","10.1002/pon.5759","Psychooncological care for patients with cancer during 12 months of the Covid-19 pandemic: Views and experiences of senior psychooncologists at German Comprehensive Cancer Centers.",NA,"2021","07","14","Psychooncology","Psycho-oncology","Covid-19; Psycho-Oncology; SARS-CoV-2; cancer; coronavirus; oncology; psychooncological care","Maatouk","Imad","Psycho-oncology Service, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany",NA
"216","34184361","10.1002/pon.5759","Psychooncological care for patients with cancer during 12 months of the Covid-19 pandemic: Views and experiences of senior psychooncologists at German Comprehensive Cancer Centers.",NA,"2021","07","14","Psychooncology","Psycho-oncology","Covid-19; Psycho-Oncology; SARS-CoV-2; cancer; coronavirus; oncology; psychooncological care","Petermann-Meyer","Andrea","Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Section Psychooncology, Center for Integrated Oncology - Aachen, Medical Faculty, RWTH Aachen University, Aachen, Germany",NA
"217","34184361","10.1002/pon.5759","Psychooncological care for patients with cancer during 12 months of the Covid-19 pandemic: Views and experiences of senior psychooncologists at German Comprehensive Cancer Centers.",NA,"2021","07","14","Psychooncology","Psycho-oncology","Covid-19; Psycho-Oncology; SARS-CoV-2; cancer; coronavirus; oncology; psychooncological care","Senf","Bianca","Department of Psycho-Oncology, University Cancer Center, Johann Wolfgang Goethe University, Frankfurt, Germany",NA
"218","34184361","10.1002/pon.5759","Psychooncological care for patients with cancer during 12 months of the Covid-19 pandemic: Views and experiences of senior psychooncologists at German Comprehensive Cancer Centers.",NA,"2021","07","14","Psychooncology","Psycho-oncology","Covid-19; Psycho-Oncology; SARS-CoV-2; cancer; coronavirus; oncology; psychooncological care","Woellert","Katharina","Institute for History and Ethics of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"219","34184361","10.1002/pon.5759","Psychooncological care for patients with cancer during 12 months of the Covid-19 pandemic: Views and experiences of senior psychooncologists at German Comprehensive Cancer Centers.",NA,"2021","07","14","Psychooncology","Psycho-oncology","Covid-19; Psycho-Oncology; SARS-CoV-2; cancer; coronavirus; oncology; psychooncological care","Wünsch","Alexander","Psychosocial Counselling for Cancer Outpatients, Comprehensive Cancer Center, Medical Center-University of Freiburg, Freiburg im Breisgau, Germany",NA
"220","34184361","10.1002/pon.5759","Psychooncological care for patients with cancer during 12 months of the Covid-19 pandemic: Views and experiences of senior psychooncologists at German Comprehensive Cancer Centers.",NA,"2021","07","14","Psychooncology","Psycho-oncology","Covid-19; Psycho-Oncology; SARS-CoV-2; cancer; coronavirus; oncology; psychooncological care","Zimmermann","Tanja","Department of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hannover, Germany",NA
"221","34184361","10.1002/pon.5759","Psychooncological care for patients with cancer during 12 months of the Covid-19 pandemic: Views and experiences of senior psychooncologists at German Comprehensive Cancer Centers.",NA,"2021","07","14","Psychooncology","Psycho-oncology","Covid-19; Psycho-Oncology; SARS-CoV-2; cancer; coronavirus; oncology; psychooncological care","Schulz-Kindermann","Frank","Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"222","34184349","10.1111/jocn.15916","Workforce management and patient outcomes in the intensive care unit during the COVID-19 pandemic and beyond: a discursive paper.","To highlight the need for the development of effective and realistic workforce strategies for critical care nurses, in both a steady state and pandemic. In acute care settings, there is an inverse relationship between nurse staffing and iatrogenesis, including mortality. Despite this, there remains a lack of consensus on how to determine safe staffing levels. Intensive care units (ICU) provide highly specialised complex healthcare treatments. In developed countries, mortality rates in the ICU se","2021","06","29","J Clin Nurs","Journal of clinical nursing","COVID-19; critical care; intensive care unit; mortality; nurse staffing; workforce","Wynne","Rochelle","Western Sydney Nursing &amp",NA
"223","34184349","10.1111/jocn.15916","Workforce management and patient outcomes in the intensive care unit during the COVID-19 pandemic and beyond: a discursive paper.","To highlight the need for the development of effective and realistic workforce strategies for critical care nurses, in both a steady state and pandemic. In acute care settings, there is an inverse relationship between nurse staffing and iatrogenesis, including mortality. Despite this, there remains a lack of consensus on how to determine safe staffing levels. Intensive care units (ICU) provide highly specialised complex healthcare treatments. In developed countries, mortality rates in the ICU se","2021","06","29","J Clin Nurs","Journal of clinical nursing","COVID-19; critical care; intensive care unit; mortality; nurse staffing; workforce","Davidson","Patricia M","Johns Hopkins University School of Nursing, Baltimore, Maryland, USA",NA
"224","34184349","10.1111/jocn.15916","Workforce management and patient outcomes in the intensive care unit during the COVID-19 pandemic and beyond: a discursive paper.","To highlight the need for the development of effective and realistic workforce strategies for critical care nurses, in both a steady state and pandemic. In acute care settings, there is an inverse relationship between nurse staffing and iatrogenesis, including mortality. Despite this, there remains a lack of consensus on how to determine safe staffing levels. Intensive care units (ICU) provide highly specialised complex healthcare treatments. In developed countries, mortality rates in the ICU se","2021","06","29","J Clin Nurs","Journal of clinical nursing","COVID-19; critical care; intensive care unit; mortality; nurse staffing; workforce","Duffield","Christine","Faculty of Health, University of Technology (UTS, Sydney, New South Wales, Australia",NA
"225","34184349","10.1111/jocn.15916","Workforce management and patient outcomes in the intensive care unit during the COVID-19 pandemic and beyond: a discursive paper.","To highlight the need for the development of effective and realistic workforce strategies for critical care nurses, in both a steady state and pandemic. In acute care settings, there is an inverse relationship between nurse staffing and iatrogenesis, including mortality. Despite this, there remains a lack of consensus on how to determine safe staffing levels. Intensive care units (ICU) provide highly specialised complex healthcare treatments. In developed countries, mortality rates in the ICU se","2021","06","29","J Clin Nurs","Journal of clinical nursing","COVID-19; critical care; intensive care unit; mortality; nurse staffing; workforce","Jackson","Debra","Susan Wakil School of Nursing, The University of Sydney, Sydney, New South Wales, Australia",NA
"226","34184349","10.1111/jocn.15916","Workforce management and patient outcomes in the intensive care unit during the COVID-19 pandemic and beyond: a discursive paper.","To highlight the need for the development of effective and realistic workforce strategies for critical care nurses, in both a steady state and pandemic. In acute care settings, there is an inverse relationship between nurse staffing and iatrogenesis, including mortality. Despite this, there remains a lack of consensus on how to determine safe staffing levels. Intensive care units (ICU) provide highly specialised complex healthcare treatments. In developed countries, mortality rates in the ICU se","2021","06","29","J Clin Nurs","Journal of clinical nursing","COVID-19; critical care; intensive care unit; mortality; nurse staffing; workforce","Ferguson","Caleb","Western Sydney Nursing &amp",NA
"227","34184343","10.1111/ejn.15373","Potential neurobiological links between social isolation and Alzheimer's disease risk.","It is estimated that 40% of dementia cases could be prevented by modification of lifestyle factors that associate with disease risk. One of these potentially modifiable lifestyle factors is social isolation. In this review, we discuss what is known about associations between social isolation and Alzheimer's disease, the most common cause of dementia. This is particularly relevant in the time of the COVID-19 pandemic when social isolation has been enforced with potential emerging negative impacts","2021","07","08","Eur J Neurosci","The European journal of neuroscience","Alzheimer's disease; COVID-19; social isolation; synapse","Drinkwater","Elizabeth","Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK",NA
"228","34184343","10.1111/ejn.15373","Potential neurobiological links between social isolation and Alzheimer's disease risk.","It is estimated that 40% of dementia cases could be prevented by modification of lifestyle factors that associate with disease risk. One of these potentially modifiable lifestyle factors is social isolation. In this review, we discuss what is known about associations between social isolation and Alzheimer's disease, the most common cause of dementia. This is particularly relevant in the time of the COVID-19 pandemic when social isolation has been enforced with potential emerging negative impacts","2021","07","08","Eur J Neurosci","The European journal of neuroscience","Alzheimer's disease; COVID-19; social isolation; synapse","Davies","Caitlin","Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK",NA
"229","34184343","10.1111/ejn.15373","Potential neurobiological links between social isolation and Alzheimer's disease risk.","It is estimated that 40% of dementia cases could be prevented by modification of lifestyle factors that associate with disease risk. One of these potentially modifiable lifestyle factors is social isolation. In this review, we discuss what is known about associations between social isolation and Alzheimer's disease, the most common cause of dementia. This is particularly relevant in the time of the COVID-19 pandemic when social isolation has been enforced with potential emerging negative impacts","2021","07","08","Eur J Neurosci","The European journal of neuroscience","Alzheimer's disease; COVID-19; social isolation; synapse","Spires-Jones","Tara L","Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK",NA
"230","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Sun","Wei","Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"231","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Zhang","Yanting","Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"232","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Wu","Chun","Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"233","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Xie","Yuji","Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"234","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Peng","Li","Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"235","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Nie","Xiu","Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"236","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Yu","Cheng","Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"237","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Zheng","Yi","Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"238","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Li","Yuman","Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"239","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Wang","Jing","Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"240","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Yang","Yali","Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"241","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Lv","Qing","Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"242","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Zhang","Li","Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"243","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Taub","Cynthia C","Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA",NA
"244","34184314","10.1111/echo.15133","Incremental prognostic value of biventricular longitudinal strain and high-sensitivity troponin I in COVID-19 patients.","Whether the combination of ventricular strain with high-sensitivity troponin I (hs-TNI) has an incremental prognostic value in coronavirus disease 2019 (COVID-19) patients has not been evaluated. The study aimed to evaluate the prognostic value of biventricular longitudinal strain and its combination with hs-TNI in COVID-19 patients. A total of 160 COVID-19 patients who underwent both echocardiography and hs-TNI testing were enrolled in our study. COVID-19 patients were divided into two groups (","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","COVID-19; biventricular strain; high-sensitivity troponin I; speckle-tracking echocardiography","Xie","Mingxing","Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"245","34184313","10.1111/echo.15146","Effects of SARS-COV-2 infection on fetal pulmonary artery Doppler parameters.","To determine the effect of SARS-CoV-2 infection on the fetal pulmonary system using the acceleration time (AT), ejection time (ET), and acceleration/ejection time ratio (PATET) of the fetal main pulmonary artery Doppler waveform. We prospectively studied pregnant women attending our hospital with confirmed SARS-CoV-2 infection by RT-PCR test and an age-matched control group who admitted for routine prenatal care. An ultrasound examination that included measurements of the AT, ET, and AT/ET ratio","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","color Doppler; fetal echocardiography; pulmonary artery","Sule","Goncu Ayhan","Department of Obstetrics and Gynecology, Ministry of Health Ankara City Hospital, Ankara, Turkey",NA
"246","34184313","10.1111/echo.15146","Effects of SARS-COV-2 infection on fetal pulmonary artery Doppler parameters.","To determine the effect of SARS-CoV-2 infection on the fetal pulmonary system using the acceleration time (AT), ejection time (ET), and acceleration/ejection time ratio (PATET) of the fetal main pulmonary artery Doppler waveform. We prospectively studied pregnant women attending our hospital with confirmed SARS-CoV-2 infection by RT-PCR test and an age-matched control group who admitted for routine prenatal care. An ultrasound examination that included measurements of the AT, ET, and AT/ET ratio","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","color Doppler; fetal echocardiography; pulmonary artery","Aysegul","Atalay","Department of Obstetrics and Gynecology, Ministry of Health Ankara City Hospital, Ankara, Turkey",NA
"247","34184313","10.1111/echo.15146","Effects of SARS-COV-2 infection on fetal pulmonary artery Doppler parameters.","To determine the effect of SARS-CoV-2 infection on the fetal pulmonary system using the acceleration time (AT), ejection time (ET), and acceleration/ejection time ratio (PATET) of the fetal main pulmonary artery Doppler waveform. We prospectively studied pregnant women attending our hospital with confirmed SARS-CoV-2 infection by RT-PCR test and an age-matched control group who admitted for routine prenatal care. An ultrasound examination that included measurements of the AT, ET, and AT/ET ratio","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","color Doppler; fetal echocardiography; pulmonary artery","Selcan","Sinaci","Department of Obstetrics and Gynecology, Ministry of Health Ankara City Hospital, Ankara, Turkey",NA
"248","34184313","10.1111/echo.15146","Effects of SARS-COV-2 infection on fetal pulmonary artery Doppler parameters.","To determine the effect of SARS-CoV-2 infection on the fetal pulmonary system using the acceleration time (AT), ejection time (ET), and acceleration/ejection time ratio (PATET) of the fetal main pulmonary artery Doppler waveform. We prospectively studied pregnant women attending our hospital with confirmed SARS-CoV-2 infection by RT-PCR test and an age-matched control group who admitted for routine prenatal care. An ultrasound examination that included measurements of the AT, ET, and AT/ET ratio","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","color Doppler; fetal echocardiography; pulmonary artery","Atakan","Tanacan","Department of Obstetrics and Gynecology, Ministry of Health Ankara City Hospital, Ankara, Turkey",NA
"249","34184313","10.1111/echo.15146","Effects of SARS-COV-2 infection on fetal pulmonary artery Doppler parameters.","To determine the effect of SARS-CoV-2 infection on the fetal pulmonary system using the acceleration time (AT), ejection time (ET), and acceleration/ejection time ratio (PATET) of the fetal main pulmonary artery Doppler waveform. We prospectively studied pregnant women attending our hospital with confirmed SARS-CoV-2 infection by RT-PCR test and an age-matched control group who admitted for routine prenatal care. An ultrasound examination that included measurements of the AT, ET, and AT/ET ratio","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","color Doppler; fetal echocardiography; pulmonary artery","Eda","Ozden Tokalioglu","Department of Obstetrics and Gynecology, Ministry of Health Ankara City Hospital, Ankara, Turkey",NA
"250","34184313","10.1111/echo.15146","Effects of SARS-COV-2 infection on fetal pulmonary artery Doppler parameters.","To determine the effect of SARS-CoV-2 infection on the fetal pulmonary system using the acceleration time (AT), ejection time (ET), and acceleration/ejection time ratio (PATET) of the fetal main pulmonary artery Doppler waveform. We prospectively studied pregnant women attending our hospital with confirmed SARS-CoV-2 infection by RT-PCR test and an age-matched control group who admitted for routine prenatal care. An ultrasound examination that included measurements of the AT, ET, and AT/ET ratio","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","color Doppler; fetal echocardiography; pulmonary artery","Deniz","Oluklu","Department of Obstetrics and Gynecology, Ministry of Health Ankara City Hospital, Ankara, Turkey",NA
"251","34184313","10.1111/echo.15146","Effects of SARS-COV-2 infection on fetal pulmonary artery Doppler parameters.","To determine the effect of SARS-CoV-2 infection on the fetal pulmonary system using the acceleration time (AT), ejection time (ET), and acceleration/ejection time ratio (PATET) of the fetal main pulmonary artery Doppler waveform. We prospectively studied pregnant women attending our hospital with confirmed SARS-CoV-2 infection by RT-PCR test and an age-matched control group who admitted for routine prenatal care. An ultrasound examination that included measurements of the AT, ET, and AT/ET ratio","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","color Doppler; fetal echocardiography; pulmonary artery","Filiz","Halici Ozturk","Department of Obstetrics and Gynecology, Ministry of Health Ankara City Hospital, Ankara, Turkey",NA
"252","34184313","10.1111/echo.15146","Effects of SARS-COV-2 infection on fetal pulmonary artery Doppler parameters.","To determine the effect of SARS-CoV-2 infection on the fetal pulmonary system using the acceleration time (AT), ejection time (ET), and acceleration/ejection time ratio (PATET) of the fetal main pulmonary artery Doppler waveform. We prospectively studied pregnant women attending our hospital with confirmed SARS-CoV-2 infection by RT-PCR test and an age-matched control group who admitted for routine prenatal care. An ultrasound examination that included measurements of the AT, ET, and AT/ET ratio","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","color Doppler; fetal echocardiography; pulmonary artery","Ozlem","Moraloglu Tekin","Department of Obstetrics and Gynecology, Ministry of Health Ankara City Hospital, Ankara, Turkey",NA
"253","34184313","10.1111/echo.15146","Effects of SARS-COV-2 infection on fetal pulmonary artery Doppler parameters.","To determine the effect of SARS-CoV-2 infection on the fetal pulmonary system using the acceleration time (AT), ejection time (ET), and acceleration/ejection time ratio (PATET) of the fetal main pulmonary artery Doppler waveform. We prospectively studied pregnant women attending our hospital with confirmed SARS-CoV-2 infection by RT-PCR test and an age-matched control group who admitted for routine prenatal care. An ultrasound examination that included measurements of the AT, ET, and AT/ET ratio","2021","06","29","Echocardiography","Echocardiography (Mount Kisco, N.Y.)","color Doppler; fetal echocardiography; pulmonary artery","Dilek","Sahin","Department of Obstetrics and Gynecology, Ministry of Health Ankara City Hospital, Ankara, Turkey",NA
"254","34184290","10.1111/sltb.12782","A prospective examination of COVID-19-related social distancing practices on suicidal ideation.","The COVID-19 pandemic has spurred the implementation of several public safety measures to contain virus spread, most notably socially distancing policies. Prior research has linked similar public safety measures (i.e., quarantine) with suicide risk, in addition to supporting the role of social connection in suicidal thoughts and behaviors; consequently, there is a need to better understand the relationship between widespread social distancing policies and suicide risk. The current study aimed to","2021","06","29","Suicide Life Threat Behav","Suicide &amp; life-threatening behavior","COVID-19; coronavirus; lockdown; social distancing; suicidal ideation; suicide risk","Ammerman","Brooke A","Department of Psychology, University of Notre Dame, Notre Dame, IN, USA",NA
"255","34184290","10.1111/sltb.12782","A prospective examination of COVID-19-related social distancing practices on suicidal ideation.","The COVID-19 pandemic has spurred the implementation of several public safety measures to contain virus spread, most notably socially distancing policies. Prior research has linked similar public safety measures (i.e., quarantine) with suicide risk, in addition to supporting the role of social connection in suicidal thoughts and behaviors; consequently, there is a need to better understand the relationship between widespread social distancing policies and suicide risk. The current study aimed to","2021","06","29","Suicide Life Threat Behav","Suicide &amp; life-threatening behavior","COVID-19; coronavirus; lockdown; social distancing; suicidal ideation; suicide risk","Burke","Taylor A","Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA",NA
"256","34184290","10.1111/sltb.12782","A prospective examination of COVID-19-related social distancing practices on suicidal ideation.","The COVID-19 pandemic has spurred the implementation of several public safety measures to contain virus spread, most notably socially distancing policies. Prior research has linked similar public safety measures (i.e., quarantine) with suicide risk, in addition to supporting the role of social connection in suicidal thoughts and behaviors; consequently, there is a need to better understand the relationship between widespread social distancing policies and suicide risk. The current study aimed to","2021","06","29","Suicide Life Threat Behav","Suicide &amp; life-threatening behavior","COVID-19; coronavirus; lockdown; social distancing; suicidal ideation; suicide risk","McClure","Kenneth","Department of Psychology, University of Notre Dame, Notre Dame, IN, USA",NA
"257","34184290","10.1111/sltb.12782","A prospective examination of COVID-19-related social distancing practices on suicidal ideation.","The COVID-19 pandemic has spurred the implementation of several public safety measures to contain virus spread, most notably socially distancing policies. Prior research has linked similar public safety measures (i.e., quarantine) with suicide risk, in addition to supporting the role of social connection in suicidal thoughts and behaviors; consequently, there is a need to better understand the relationship between widespread social distancing policies and suicide risk. The current study aimed to","2021","06","29","Suicide Life Threat Behav","Suicide &amp; life-threatening behavior","COVID-19; coronavirus; lockdown; social distancing; suicidal ideation; suicide risk","Jacobucci","Ross","Department of Psychology, University of Notre Dame, Notre Dame, IN, USA",NA
"258","34184290","10.1111/sltb.12782","A prospective examination of COVID-19-related social distancing practices on suicidal ideation.","The COVID-19 pandemic has spurred the implementation of several public safety measures to contain virus spread, most notably socially distancing policies. Prior research has linked similar public safety measures (i.e., quarantine) with suicide risk, in addition to supporting the role of social connection in suicidal thoughts and behaviors; consequently, there is a need to better understand the relationship between widespread social distancing policies and suicide risk. The current study aimed to","2021","06","29","Suicide Life Threat Behav","Suicide &amp; life-threatening behavior","COVID-19; coronavirus; lockdown; social distancing; suicidal ideation; suicide risk","Liu","Richard T","Harvard Medical School, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA",NA
"259","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Ruscica","Massimiliano","Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy",NA
"260","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Macchi","Chiara","Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy",NA
"261","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Iodice","Simona","EPIGET Lab, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy",NA
"262","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Tersalvi","Gregorio","Division of Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland",NA
"263","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Rota","Irene","Cardiovascular Disease Unit, Internal Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"264","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Ghidini","Simone","Dyspnea Lab, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy",NA
"265","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Terranova","Leonardo","Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"266","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Valenti","Luca","Translational Medicine, Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico IRCCS, Milan, Italy",NA
"267","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Amati","Francesco","Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"268","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Aliberti","Stefano","Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"269","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Corsini","Alberto","Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy",NA
"270","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Blasi","Francesco","Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"271","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Carugo","Stefano","Cardiovascular Disease Unit, Internal Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"272","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Bollati","Valentina","EPIGET Lab, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy",NA
"273","34184268","10.1111/eci.13629","Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.","Background During COVID-19 outbreak, Italy was the first country in Europe to be heavily affected with an intensive care unit mortality of 26%. In order to reduce this percentage, physicians should establish clear and objective criteria to stratify COVID-19 patients at high risk of in-hospital death. Thus, the aim has been to test a large spectrum of variables ranging from clinical evaluation to laboratory biomarkers to identify which parameter would best predict all-cause in-hospital mortality ","2021","06","29","Eur J Clin Invest","European journal of clinical investigation","COVID-19; NT-proBNP; PCSK9; Tn-T; in-hospital mortality; interleukin 6; lactate dehydrogenase","Vicenzi","Marco","Cardiovascular Disease Unit, Internal Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"274","34184250","10.1111/avj.13101","A survey of enteric organisms detected by real-time PCR assay in faeces of dogs in Western Australia.","This retrospective observational study reports the enteric organisms detected in dogs in Western Australia that had a faecal PCR (fPCR) submitted to a commercial veterinary laboratory. Of 2025 fPCR results, Clostridium perfringens alpha toxin gene was most frequently detected (87.2%), followed by Campylobacter spp. (37.8%), canine parvovirus (10.5%), Giardia spp. (9.7%), Salmonella spp. (7.0%), canine enteric coronavirus (2.3%), and canine distemper virus (0.3%). C.perfringens alpha toxin gene a","2021","06","29","Aust Vet J","Australian veterinary journal","Campylobacter; Clostridium; Salmonella; canine distemper virus; canine parvovirus; diarrhoea","Kim","M W","School of Veterinary Medicine, Murdoch University, Murdoch, Western Australia, 6150, Australia",NA
"275","34184250","10.1111/avj.13101","A survey of enteric organisms detected by real-time PCR assay in faeces of dogs in Western Australia.","This retrospective observational study reports the enteric organisms detected in dogs in Western Australia that had a faecal PCR (fPCR) submitted to a commercial veterinary laboratory. Of 2025 fPCR results, Clostridium perfringens alpha toxin gene was most frequently detected (87.2%), followed by Campylobacter spp. (37.8%), canine parvovirus (10.5%), Giardia spp. (9.7%), Salmonella spp. (7.0%), canine enteric coronavirus (2.3%), and canine distemper virus (0.3%). C.perfringens alpha toxin gene a","2021","06","29","Aust Vet J","Australian veterinary journal","Campylobacter; Clostridium; Salmonella; canine distemper virus; canine parvovirus; diarrhoea","Sharp","C R","School of Veterinary Medicine, Murdoch University, Murdoch, Western Australia, 6150, Australia",NA
"276","34184250","10.1111/avj.13101","A survey of enteric organisms detected by real-time PCR assay in faeces of dogs in Western Australia.","This retrospective observational study reports the enteric organisms detected in dogs in Western Australia that had a faecal PCR (fPCR) submitted to a commercial veterinary laboratory. Of 2025 fPCR results, Clostridium perfringens alpha toxin gene was most frequently detected (87.2%), followed by Campylobacter spp. (37.8%), canine parvovirus (10.5%), Giardia spp. (9.7%), Salmonella spp. (7.0%), canine enteric coronavirus (2.3%), and canine distemper virus (0.3%). C.perfringens alpha toxin gene a","2021","06","29","Aust Vet J","Australian veterinary journal","Campylobacter; Clostridium; Salmonella; canine distemper virus; canine parvovirus; diarrhoea","Boyd","C J","School of Veterinary Medicine, Murdoch University, Murdoch, Western Australia, 6150, Australia",NA
"277","34184250","10.1111/avj.13101","A survey of enteric organisms detected by real-time PCR assay in faeces of dogs in Western Australia.","This retrospective observational study reports the enteric organisms detected in dogs in Western Australia that had a faecal PCR (fPCR) submitted to a commercial veterinary laboratory. Of 2025 fPCR results, Clostridium perfringens alpha toxin gene was most frequently detected (87.2%), followed by Campylobacter spp. (37.8%), canine parvovirus (10.5%), Giardia spp. (9.7%), Salmonella spp. (7.0%), canine enteric coronavirus (2.3%), and canine distemper virus (0.3%). C.perfringens alpha toxin gene a","2021","06","29","Aust Vet J","Australian veterinary journal","Campylobacter; Clostridium; Salmonella; canine distemper virus; canine parvovirus; diarrhoea","Twomey","L N","Vetpath Laboratory Services, Jandakot, Western Australia, 6164, Australia",NA
"278","34184228","10.1007/s11356-021-14980-6","Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study.","We conducted the current analysis to determine the potential role of measles vaccination in the context of the spread of COVID-19. Data were extracted from the World Health Organization's (WHO) Global Health Observatory data repository about the measles immunization coverage estimates and correlated to overall morbidity and mortality for COVID-19 among different countries. Data were statistically analyzed to calculate the Spearman rank correlation coefficient (rho). There was a significant posit","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Correlation; Immunization; Measles","Altulayhi","Raed Ibrahim","Department of Pathology, Microbiology Unit, King Saud University, Riyadh, Saudi Arabia. rayden185@hotmail","rayden185@hotmail.com"
"279","34184228","10.1007/s11356-021-14980-6","Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study.","We conducted the current analysis to determine the potential role of measles vaccination in the context of the spread of COVID-19. Data were extracted from the World Health Organization's (WHO) Global Health Observatory data repository about the measles immunization coverage estimates and correlated to overall morbidity and mortality for COVID-19 among different countries. Data were statistically analyzed to calculate the Spearman rank correlation coefficient (rho). There was a significant posit","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Correlation; Immunization; Measles","Alqahtani","Rakan M","Department of Critical Care Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"280","34184228","10.1007/s11356-021-14980-6","Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study.","We conducted the current analysis to determine the potential role of measles vaccination in the context of the spread of COVID-19. Data were extracted from the World Health Organization's (WHO) Global Health Observatory data repository about the measles immunization coverage estimates and correlated to overall morbidity and mortality for COVID-19 among different countries. Data were statistically analyzed to calculate the Spearman rank correlation coefficient (rho). There was a significant posit","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Correlation; Immunization; Measles","Alakeel","Reem Abdullah","Family Medicine Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia",NA
"281","34184228","10.1007/s11356-021-14980-6","Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study.","We conducted the current analysis to determine the potential role of measles vaccination in the context of the spread of COVID-19. Data were extracted from the World Health Organization's (WHO) Global Health Observatory data repository about the measles immunization coverage estimates and correlated to overall morbidity and mortality for COVID-19 among different countries. Data were statistically analyzed to calculate the Spearman rank correlation coefficient (rho). There was a significant posit","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Correlation; Immunization; Measles","Khorshid","Faten Abdulrahman","Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia",NA
"282","34184228","10.1007/s11356-021-14980-6","Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study.","We conducted the current analysis to determine the potential role of measles vaccination in the context of the spread of COVID-19. Data were extracted from the World Health Organization's (WHO) Global Health Observatory data repository about the measles immunization coverage estimates and correlated to overall morbidity and mortality for COVID-19 among different countries. Data were statistically analyzed to calculate the Spearman rank correlation coefficient (rho). There was a significant posit","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Correlation; Immunization; Measles","Alshammari","Rehab Hamoud","Maternity and Children Hospital in Dammam, Dammam, Saudi Arabia",NA
"283","34184228","10.1007/s11356-021-14980-6","Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study.","We conducted the current analysis to determine the potential role of measles vaccination in the context of the spread of COVID-19. Data were extracted from the World Health Organization's (WHO) Global Health Observatory data repository about the measles immunization coverage estimates and correlated to overall morbidity and mortality for COVID-19 among different countries. Data were statistically analyzed to calculate the Spearman rank correlation coefficient (rho). There was a significant posit","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Correlation; Immunization; Measles","Alattas","Sana Ghazi","Biological Sciences Department, King Abdulaziz University, Jeddah, Saudi Arabia",NA
"284","34184228","10.1007/s11356-021-14980-6","Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study.","We conducted the current analysis to determine the potential role of measles vaccination in the context of the spread of COVID-19. Data were extracted from the World Health Organization's (WHO) Global Health Observatory data repository about the measles immunization coverage estimates and correlated to overall morbidity and mortality for COVID-19 among different countries. Data were statistically analyzed to calculate the Spearman rank correlation coefficient (rho). There was a significant posit","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Correlation; Immunization; Measles","Alshammari","Fahad Abdullah M","Department of Adult Emergency Medicine, Department of Emergency Medical Services, King Khalid Hospital, Hail, Saudi Arabia",NA
"285","34184228","10.1007/s11356-021-14980-6","Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study.","We conducted the current analysis to determine the potential role of measles vaccination in the context of the spread of COVID-19. Data were extracted from the World Health Organization's (WHO) Global Health Observatory data repository about the measles immunization coverage estimates and correlated to overall morbidity and mortality for COVID-19 among different countries. Data were statistically analyzed to calculate the Spearman rank correlation coefficient (rho). There was a significant posit","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Correlation; Immunization; Measles","Bin-Jumah","May","Biology Department, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia",NA
"286","34184228","10.1007/s11356-021-14980-6","Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study.","We conducted the current analysis to determine the potential role of measles vaccination in the context of the spread of COVID-19. Data were extracted from the World Health Organization's (WHO) Global Health Observatory data repository about the measles immunization coverage estimates and correlated to overall morbidity and mortality for COVID-19 among different countries. Data were statistically analyzed to calculate the Spearman rank correlation coefficient (rho). There was a significant posit","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Correlation; Immunization; Measles","Abdel-Daim","Mohamed M","Department of Zoology, Science College, King Saud University, Riyadh, 11451, Saudi Arabia. abdeldaim.m@vet.suez.edu","abdeldaim.m@vet.suez.edu.eg"
"287","34184228","10.1007/s11356-021-14980-6","Correlation between measles immunization coverage and overall morbidity and mortality for COVID-19: an epidemiological study.","We conducted the current analysis to determine the potential role of measles vaccination in the context of the spread of COVID-19. Data were extracted from the World Health Organization's (WHO) Global Health Observatory data repository about the measles immunization coverage estimates and correlated to overall morbidity and mortality for COVID-19 among different countries. Data were statistically analyzed to calculate the Spearman rank correlation coefficient (rho). There was a significant posit","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19; Correlation; Immunization; Measles","Almohideb","Mohammad","College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia",NA
"288","34184210","10.1007/s11524-021-00552-z","Hyper Focusing Local Geospatial Data to Improve COVID-19 Vaccine Equity and Distribution.",NA,"2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Aging; COVID-19; Coronavirus; Geospatial mapping; Geriatrics; SARS-CoV-2; Vaccines","Lei","Yuxiao","The Center for Healthy Aging, The New York Academy of Medicine, New York, NY, USA. ylei@nyam","ylei@nyam.org"
"289","34184207","10.1007/s11845-021-02687-z","Impact of COVID-19 pandemic on hip fractures: the central London experience COVID-related urgent geriatric hip trauma (COUGH) study COVERT ( COVid Emergency-Related Trauma and orthopaedics) collaborative.","COVID-19 has been recognized as the unprecedented global health crisis in modern times. The purpose of this study was to assess the impact of COVID-19 on treatment of neck of femur fractures (NOFF) against the current guidelines and meeting best practice key performance indicators (KPIs) according to the National Hip Fracture Database (NHFD) in two large central London hospitals. A multi-center, longitudinal, retrospective, observational study of NOFF patients was performed for the first 'golden","2021","07","01","Ir J Med Sci","Irish journal of medical science","Best practice tariff; COVID-19; Epidemiology; Hip fracture; Mortality; National hip fracture database; Neck of femur fracture; Surgery","Park","Chang","Imperial College Healthcare NHS Trust, London, UK",NA
"290","34184207","10.1007/s11845-021-02687-z","Impact of COVID-19 pandemic on hip fractures: the central London experience COVID-related urgent geriatric hip trauma (COUGH) study COVERT ( COVid Emergency-Related Trauma and orthopaedics) collaborative.","COVID-19 has been recognized as the unprecedented global health crisis in modern times. The purpose of this study was to assess the impact of COVID-19 on treatment of neck of femur fractures (NOFF) against the current guidelines and meeting best practice key performance indicators (KPIs) according to the National Hip Fracture Database (NHFD) in two large central London hospitals. A multi-center, longitudinal, retrospective, observational study of NOFF patients was performed for the first 'golden","2021","07","01","Ir J Med Sci","Irish journal of medical science","Best practice tariff; COVID-19; Epidemiology; Hip fracture; Mortality; National hip fracture database; Neck of femur fracture; Surgery","Sugand","Kapil","Imperial College Healthcare NHS Trust, London, UK. ks704@ic.ac","ks704@ic.ac.uk"
"291","34184207","10.1007/s11845-021-02687-z","Impact of COVID-19 pandemic on hip fractures: the central London experience COVID-related urgent geriatric hip trauma (COUGH) study COVERT ( COVid Emergency-Related Trauma and orthopaedics) collaborative.","COVID-19 has been recognized as the unprecedented global health crisis in modern times. The purpose of this study was to assess the impact of COVID-19 on treatment of neck of femur fractures (NOFF) against the current guidelines and meeting best practice key performance indicators (KPIs) according to the National Hip Fracture Database (NHFD) in two large central London hospitals. A multi-center, longitudinal, retrospective, observational study of NOFF patients was performed for the first 'golden","2021","07","01","Ir J Med Sci","Irish journal of medical science","Best practice tariff; COVID-19; Epidemiology; Hip fracture; Mortality; National hip fracture database; Neck of femur fracture; Surgery","Aframian","Arash","Chelsea &amp",NA
"292","34184207","10.1007/s11845-021-02687-z","Impact of COVID-19 pandemic on hip fractures: the central London experience COVID-related urgent geriatric hip trauma (COUGH) study COVERT ( COVid Emergency-Related Trauma and orthopaedics) collaborative.","COVID-19 has been recognized as the unprecedented global health crisis in modern times. The purpose of this study was to assess the impact of COVID-19 on treatment of neck of femur fractures (NOFF) against the current guidelines and meeting best practice key performance indicators (KPIs) according to the National Hip Fracture Database (NHFD) in two large central London hospitals. A multi-center, longitudinal, retrospective, observational study of NOFF patients was performed for the first 'golden","2021","07","01","Ir J Med Sci","Irish journal of medical science","Best practice tariff; COVID-19; Epidemiology; Hip fracture; Mortality; National hip fracture database; Neck of femur fracture; Surgery","Morgan","Catrin","Chelsea &amp",NA
"293","34184207","10.1007/s11845-021-02687-z","Impact of COVID-19 pandemic on hip fractures: the central London experience COVID-related urgent geriatric hip trauma (COUGH) study COVERT ( COVid Emergency-Related Trauma and orthopaedics) collaborative.","COVID-19 has been recognized as the unprecedented global health crisis in modern times. The purpose of this study was to assess the impact of COVID-19 on treatment of neck of femur fractures (NOFF) against the current guidelines and meeting best practice key performance indicators (KPIs) according to the National Hip Fracture Database (NHFD) in two large central London hospitals. A multi-center, longitudinal, retrospective, observational study of NOFF patients was performed for the first 'golden","2021","07","01","Ir J Med Sci","Irish journal of medical science","Best practice tariff; COVID-19; Epidemiology; Hip fracture; Mortality; National hip fracture database; Neck of femur fracture; Surgery","Pakroo","Nadia","Chelsea &amp",NA
"294","34184207","10.1007/s11845-021-02687-z","Impact of COVID-19 pandemic on hip fractures: the central London experience COVID-related urgent geriatric hip trauma (COUGH) study COVERT ( COVid Emergency-Related Trauma and orthopaedics) collaborative.","COVID-19 has been recognized as the unprecedented global health crisis in modern times. The purpose of this study was to assess the impact of COVID-19 on treatment of neck of femur fractures (NOFF) against the current guidelines and meeting best practice key performance indicators (KPIs) according to the National Hip Fracture Database (NHFD) in two large central London hospitals. A multi-center, longitudinal, retrospective, observational study of NOFF patients was performed for the first 'golden","2021","07","01","Ir J Med Sci","Irish journal of medical science","Best practice tariff; COVID-19; Epidemiology; Hip fracture; Mortality; National hip fracture database; Neck of femur fracture; Surgery","Gibbons","Charles","Chelsea &amp",NA
"295","34184207","10.1007/s11845-021-02687-z","Impact of COVID-19 pandemic on hip fractures: the central London experience COVID-related urgent geriatric hip trauma (COUGH) study COVERT ( COVid Emergency-Related Trauma and orthopaedics) collaborative.","COVID-19 has been recognized as the unprecedented global health crisis in modern times. The purpose of this study was to assess the impact of COVID-19 on treatment of neck of femur fractures (NOFF) against the current guidelines and meeting best practice key performance indicators (KPIs) according to the National Hip Fracture Database (NHFD) in two large central London hospitals. A multi-center, longitudinal, retrospective, observational study of NOFF patients was performed for the first 'golden","2021","07","01","Ir J Med Sci","Irish journal of medical science","Best practice tariff; COVID-19; Epidemiology; Hip fracture; Mortality; National hip fracture database; Neck of femur fracture; Surgery","Fertleman","Michael","Imperial College Healthcare NHS Trust, London, UK",NA
"296","34184207","10.1007/s11845-021-02687-z","Impact of COVID-19 pandemic on hip fractures: the central London experience COVID-related urgent geriatric hip trauma (COUGH) study COVERT ( COVid Emergency-Related Trauma and orthopaedics) collaborative.","COVID-19 has been recognized as the unprecedented global health crisis in modern times. The purpose of this study was to assess the impact of COVID-19 on treatment of neck of femur fractures (NOFF) against the current guidelines and meeting best practice key performance indicators (KPIs) according to the National Hip Fracture Database (NHFD) in two large central London hospitals. A multi-center, longitudinal, retrospective, observational study of NOFF patients was performed for the first 'golden","2021","07","01","Ir J Med Sci","Irish journal of medical science","Best practice tariff; COVID-19; Epidemiology; Hip fracture; Mortality; National hip fracture database; Neck of femur fracture; Surgery","Nathwani","Dinesh","Imperial College Healthcare NHS Trust, London, UK",NA
"297","34184207","10.1007/s11845-021-02687-z","Impact of COVID-19 pandemic on hip fractures: the central London experience COVID-related urgent geriatric hip trauma (COUGH) study COVERT ( COVid Emergency-Related Trauma and orthopaedics) collaborative.","COVID-19 has been recognized as the unprecedented global health crisis in modern times. The purpose of this study was to assess the impact of COVID-19 on treatment of neck of femur fractures (NOFF) against the current guidelines and meeting best practice key performance indicators (KPIs) according to the National Hip Fracture Database (NHFD) in two large central London hospitals. A multi-center, longitudinal, retrospective, observational study of NOFF patients was performed for the first 'golden","2021","07","01","Ir J Med Sci","Irish journal of medical science","Best practice tariff; COVID-19; Epidemiology; Hip fracture; Mortality; National hip fracture database; Neck of femur fracture; Surgery","Bhattacharya","Rajarshi","Imperial College Healthcare NHS Trust, London, UK",NA
"298","34184207","10.1007/s11845-021-02687-z","Impact of COVID-19 pandemic on hip fractures: the central London experience COVID-related urgent geriatric hip trauma (COUGH) study COVERT ( COVid Emergency-Related Trauma and orthopaedics) collaborative.","COVID-19 has been recognized as the unprecedented global health crisis in modern times. The purpose of this study was to assess the impact of COVID-19 on treatment of neck of femur fractures (NOFF) against the current guidelines and meeting best practice key performance indicators (KPIs) according to the National Hip Fracture Database (NHFD) in two large central London hospitals. A multi-center, longitudinal, retrospective, observational study of NOFF patients was performed for the first 'golden","2021","07","01","Ir J Med Sci","Irish journal of medical science","Best practice tariff; COVID-19; Epidemiology; Hip fracture; Mortality; National hip fracture database; Neck of femur fracture; Surgery","Sarraf","Khaled M","Imperial College Healthcare NHS Trust, London, UK",NA
"299","34184206","10.1007/s11845-021-02696-y","The role of emergency department triage early warning score (TREWS) and modified early warning score (MEWS) to predict in-hospital mortality in COVID-19 patients.","It is necessary to identify critical patients requiring hospitalization early due to the rapid increase in the number of COVID-19 cases. This study aims to evaluate the effectiveness of scoring systems such as emergency department triage early warning score (TREWS) and modified early warning score (MEWS) in predicting mortality in COVID-19 patients. In this retrospective cohort study, PCR positive patients evaluated for COVID-19 and decided to be hospitalized were evaluated. During the first eva","2021","07","01","Ir J Med Sci","Irish journal of medical science","COVID-19; Early warning scores; Emergency; MEWS; Mortality; TREWS","Aygun","Huseyin","Emergency Department, University of Health Sciences Turkey, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey",NA
"300","34184206","10.1007/s11845-021-02696-y","The role of emergency department triage early warning score (TREWS) and modified early warning score (MEWS) to predict in-hospital mortality in COVID-19 patients.","It is necessary to identify critical patients requiring hospitalization early due to the rapid increase in the number of COVID-19 cases. This study aims to evaluate the effectiveness of scoring systems such as emergency department triage early warning score (TREWS) and modified early warning score (MEWS) in predicting mortality in COVID-19 patients. In this retrospective cohort study, PCR positive patients evaluated for COVID-19 and decided to be hospitalized were evaluated. During the first eva","2021","07","01","Ir J Med Sci","Irish journal of medical science","COVID-19; Early warning scores; Emergency; MEWS; Mortality; TREWS","Eraybar","Suna","Emergency Department, University of Health Sciences Turkey, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey. sunaeraybar@gmail","sunaeraybar@gmail.com"
"301","34184177","10.1007/s12028-021-01269-2","COVID-19 and the Pediatric Nervous System: Global Collaboration to Meet a Global Need.","The coronavirus disease 2019 (COVID-19) pandemic has affected mortality and morbidity across all ages, including children. It is now known that neurological manifestations of COVID-19, ranging from headaches to stroke, may involve the central and/or peripheral nervous system at any age. Neurologic involvement is also noted in the multisystem inflammatory syndrome in children, a pediatric condition that occurs weeks after infection with the causative virus of COVID-19, severe acute respiratory sy","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Child development; Neurological manifestations; Pediatrics","Schober","Michelle Elena","Division of Critical Care, Department of Pediatrics, University of Utah, Salt Lake City, UT, 84132, USA. michelle.schober@hsc.utah","michelle.schober@hsc.utah.edu"
"302","34184177","10.1007/s12028-021-01269-2","COVID-19 and the Pediatric Nervous System: Global Collaboration to Meet a Global Need.","The coronavirus disease 2019 (COVID-19) pandemic has affected mortality and morbidity across all ages, including children. It is now known that neurological manifestations of COVID-19, ranging from headaches to stroke, may involve the central and/or peripheral nervous system at any age. Neurologic involvement is also noted in the multisystem inflammatory syndrome in children, a pediatric condition that occurs weeks after infection with the causative virus of COVID-19, severe acute respiratory sy","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Child development; Neurological manifestations; Pediatrics","Robertson","Courtney Leigh","Departments of Anesthesiology and Critical Care Medicine and Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, MD, USA",NA
"303","34184177","10.1007/s12028-021-01269-2","COVID-19 and the Pediatric Nervous System: Global Collaboration to Meet a Global Need.","The coronavirus disease 2019 (COVID-19) pandemic has affected mortality and morbidity across all ages, including children. It is now known that neurological manifestations of COVID-19, ranging from headaches to stroke, may involve the central and/or peripheral nervous system at any age. Neurologic involvement is also noted in the multisystem inflammatory syndrome in children, a pediatric condition that occurs weeks after infection with the causative virus of COVID-19, severe acute respiratory sy","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Child development; Neurological manifestations; Pediatrics","Wainwright","Mark Stephen","Department of Pediatric Neurology, Seattle Children's Hospital, Seattle, WA, USA",NA
"304","34184177","10.1007/s12028-021-01269-2","COVID-19 and the Pediatric Nervous System: Global Collaboration to Meet a Global Need.","The coronavirus disease 2019 (COVID-19) pandemic has affected mortality and morbidity across all ages, including children. It is now known that neurological manifestations of COVID-19, ranging from headaches to stroke, may involve the central and/or peripheral nervous system at any age. Neurologic involvement is also noted in the multisystem inflammatory syndrome in children, a pediatric condition that occurs weeks after infection with the causative virus of COVID-19, severe acute respiratory sy","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Child development; Neurological manifestations; Pediatrics","Roa","Juan David","Division of Critical Care, Department of Pediatrics, Universidad Nacional de Colombia and Fundación Universitaria de Ciencias de la Salud, Bogotá, Colombia",NA
"305","34184177","10.1007/s12028-021-01269-2","COVID-19 and the Pediatric Nervous System: Global Collaboration to Meet a Global Need.","The coronavirus disease 2019 (COVID-19) pandemic has affected mortality and morbidity across all ages, including children. It is now known that neurological manifestations of COVID-19, ranging from headaches to stroke, may involve the central and/or peripheral nervous system at any age. Neurologic involvement is also noted in the multisystem inflammatory syndrome in children, a pediatric condition that occurs weeks after infection with the causative virus of COVID-19, severe acute respiratory sy","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Child development; Neurological manifestations; Pediatrics","Fink","Ericka Linn","Division of Pediatric Critical Care Medicine, Department of Pediatric Neurology and Critical Care, and Safar Center for Resuscitation Research, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, PA, USA",NA
"306","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Boehme","Amelia K","Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA",NA
"307","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Doyle","Kevin","Division of Critical Care Neurology, Department of Neurology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, 177 Fort Washington Avenue, MHB 8 Center, Room 300, New York, NY, 10032, USA",NA
"308","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Thakur","Kiran T","Division of Hospitalist Neurology, Department of Neurology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, NY, USA",NA
"309","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Roh","David","Division of Critical Care Neurology, Department of Neurology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, 177 Fort Washington Avenue, MHB 8 Center, Room 300, New York, NY, 10032, USA",NA
"310","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Park","Soojin","Division of Critical Care Neurology, Department of Neurology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, 177 Fort Washington Avenue, MHB 8 Center, Room 300, New York, NY, 10032, USA",NA
"311","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Agarwal","Sachin","Division of Critical Care Neurology, Department of Neurology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, 177 Fort Washington Avenue, MHB 8 Center, Room 300, New York, NY, 10032, USA",NA
"312","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Velazquez","Angela G","Division of Critical Care Neurology, Department of Neurology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, 177 Fort Washington Avenue, MHB 8 Center, Room 300, New York, NY, 10032, USA",NA
"313","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Egbebike","Jennifer A","Division of Critical Care Neurology, Department of Neurology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, 177 Fort Washington Avenue, MHB 8 Center, Room 300, New York, NY, 10032, USA",NA
"314","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Der Nigoghossian","Caroline","Pharmacy, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York, NY, USA",NA
"315","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Prust","Morgan L","Division of Critical Care Neurology, Department of Neurology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, 177 Fort Washington Avenue, MHB 8 Center, Room 300, New York, NY, 10032, USA",NA
"316","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Rosenberg","Jon","Division of Critical Care Neurology, Department of Neurology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, 177 Fort Washington Avenue, MHB 8 Center, Room 300, New York, NY, 10032, USA",NA
"317","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Brodie","Daniel","Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York-Presbyterian Hospital and Columbia University, New York, NY, USA",NA
"318","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Fishkoff","Katherine N","Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA",NA
"319","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Hochmann","Beth R","Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA",NA
"320","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Rabani","Leroy E","Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA",NA
"321","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Yip","Natalie H","Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York-Presbyterian Hospital and Columbia University, New York, NY, USA",NA
"322","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Panzer","Oliver","Division of Critical Care Medicine, Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY, USA",NA
"323","34184176","10.1007/s12028-021-01256-7","Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome.","Prevalence and etiology of unconsciousness are uncertain in hospitalized patients with coronavirus disease 2019 (COVID-19). We tested the hypothesis that increased inflammation in COVID-19 precedes coma, independent of medications, hypotension, and hypoxia. We retrospectively assessed 3203 hospitalized patients with COVID-19 from March 2 through July 30, 2020, in New York City with the Glasgow Coma Scale and systemic inflammatory response syndrome (SIRS) scores. We applied hazard ratio (HR) mode","2021","07","01","Neurocrit Care","Neurocritical care","COVID-19; Coma; Disorders of consciousness; Inflammation; Systemic inflammatory response syndrome","Claassen","Jan","Division of Critical Care Neurology, Department of Neurology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, 177 Fort Washington Avenue, MHB 8 Center, Room 300, New York, NY, 10032, USA. jc1439@cumc.columbia","jc1439@cumc.columbia.edu"
"324","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Smadja","David M","Innovative Therapies in Haemostasis, INSERM, Université de Paris, Paris, France. david.smadja@aphp","david.smadja@aphp.fr"
"325","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Mentzer","Steven J","Euro-American COVID-19 Working Group and Laboratory of Adaptive and Regenerative Biology, Brigham &amp",NA
"326","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Fontenay","Michaela","Institut Cochin, INSERM, Université de Paris, Paris, France",NA
"327","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Laffan","Mike A","Centre for Hematology, Imperial College London, London, UK",NA
"328","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Ackermann","Maximilian","F-CRIN INNOVTE Network, Paris, France",NA
"329","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Helms","Julie","Service de Médecine Intensive Réanimation, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg Cedex, France",NA
"330","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Jonigk","Danny","F-CRIN INNOVTE Network, Paris, France",NA
"331","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Chocron","Richard","PARCC, INSERM, Université de Paris, Paris, France",NA
"332","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Pier","Gerald B","Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA",NA
"333","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Gendron","Nicolas","Innovative Therapies in Haemostasis, INSERM, Université de Paris, Paris, France",NA
"334","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Pons","Stephanie","Department of Anesthesiology and Critical Care, Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France",NA
"335","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Diehl","Jean-Luc","Innovative Therapies in Haemostasis, INSERM, Université de Paris, Paris, France",NA
"336","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Margadant","Coert","Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands",NA
"337","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Guerin","Coralie","Innovative Therapies in Haemostasis, INSERM, Université de Paris, Paris, France",NA
"338","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Huijbers","Elisabeth J M","Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands",NA
"339","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Philippe","Aurélien","Innovative Therapies in Haemostasis, INSERM, Université de Paris, Paris, France",NA
"340","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Chapuis","Nicolas","Institut Cochin, INSERM, Université de Paris, Paris, France",NA
"341","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Nowak-Sliwinska","Patrycja","Molecular Pharmacology Group, School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland",NA
"342","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Karagiannidis","Christian","ARDS and ECMO Centre Cologne-Merheim, , University Witten-Herdecke, Cologne, Germany",NA
"343","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Sanchez","Olivier","F-CRIN INNOVTE Network, Paris, France",NA
"344","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Kümpers","Philipp","Department of Medicine D, Division of General Internal and Emergency Medicine, Nephrology, and Rheumatology, University Hospital Münster, Münster, Germany",NA
"345","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Skurnik","David","Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA",NA
"346","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Randi","Anna M","National Heart and Lung Institute, Imperial College London, London, UK",NA
"347","34184164","10.1007/s10456-021-09805-6","COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 ß [IL-1ß] or IL-6), s","2021","07","01","Angiogenesis","Angiogenesis",NA,"Griffioen","Arjan W","Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands",NA
"348","34184073","10.3892/mmr.2021.12250","Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID-19 (Review).","Genetic and nongenetic factors associated with an increased inflammatory response may mediate a link between severe coronavirus disease 2019 (COVID-19) and serious mental illness (SMI). However, systematic assessment of inflammatory response-related factors associated with SMI that could influence COVID-19 outcomes is lacking. In the present review, dietary patterns, smoking and the use of psychotropic medications are discussed as potential extrinsic risk factors and angiotensin-converting enzym","2021","07","02","Mol Med Rep","Molecular medicine reports","angiotensin-converting enzyme; coronavirus disease 2019; diet; inflammation; psychotropic drugs; serious mental illness; smoking; COVID-19; Comorbidity; Disease Susceptibility; Humans; Inflammation; Mental Disorders; Risk Factors; SARS-CoV-2","Nadalin","Sergej","Department of Medical Biology and Genetics, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia",NA
"349","34184073","10.3892/mmr.2021.12250","Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID-19 (Review).","Genetic and nongenetic factors associated with an increased inflammatory response may mediate a link between severe coronavirus disease 2019 (COVID-19) and serious mental illness (SMI). However, systematic assessment of inflammatory response-related factors associated with SMI that could influence COVID-19 outcomes is lacking. In the present review, dietary patterns, smoking and the use of psychotropic medications are discussed as potential extrinsic risk factors and angiotensin-converting enzym","2021","07","02","Mol Med Rep","Molecular medicine reports","angiotensin-converting enzyme; coronavirus disease 2019; diet; inflammation; psychotropic drugs; serious mental illness; smoking; COVID-19; Comorbidity; Disease Susceptibility; Humans; Inflammation; Mental Disorders; Risk Factors; SARS-CoV-2","Jakovac","Hrvoje","Department of Physiology and Immunology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia",NA
"350","34184073","10.3892/mmr.2021.12250","Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID-19 (Review).","Genetic and nongenetic factors associated with an increased inflammatory response may mediate a link between severe coronavirus disease 2019 (COVID-19) and serious mental illness (SMI). However, systematic assessment of inflammatory response-related factors associated with SMI that could influence COVID-19 outcomes is lacking. In the present review, dietary patterns, smoking and the use of psychotropic medications are discussed as potential extrinsic risk factors and angiotensin-converting enzym","2021","07","02","Mol Med Rep","Molecular medicine reports","angiotensin-converting enzyme; coronavirus disease 2019; diet; inflammation; psychotropic drugs; serious mental illness; smoking; COVID-19; Comorbidity; Disease Susceptibility; Humans; Inflammation; Mental Disorders; Risk Factors; SARS-CoV-2","Peitl","Vjekoslav","Department of Psychiatry, Sestre Milosrdnice University Hospital Center and Catholic University of Croatia, 10000 Zagreb, Croatia",NA
"351","34184073","10.3892/mmr.2021.12250","Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID-19 (Review).","Genetic and nongenetic factors associated with an increased inflammatory response may mediate a link between severe coronavirus disease 2019 (COVID-19) and serious mental illness (SMI). However, systematic assessment of inflammatory response-related factors associated with SMI that could influence COVID-19 outcomes is lacking. In the present review, dietary patterns, smoking and the use of psychotropic medications are discussed as potential extrinsic risk factors and angiotensin-converting enzym","2021","07","02","Mol Med Rep","Molecular medicine reports","angiotensin-converting enzyme; coronavirus disease 2019; diet; inflammation; psychotropic drugs; serious mental illness; smoking; COVID-19; Comorbidity; Disease Susceptibility; Humans; Inflammation; Mental Disorders; Risk Factors; SARS-CoV-2","Karlovic","Dalibor","Department of Psychiatry, Sestre Milosrdnice University Hospital Center and Catholic University of Croatia, 10000 Zagreb, Croatia",NA
"352","34184073","10.3892/mmr.2021.12250","Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID-19 (Review).","Genetic and nongenetic factors associated with an increased inflammatory response may mediate a link between severe coronavirus disease 2019 (COVID-19) and serious mental illness (SMI). However, systematic assessment of inflammatory response-related factors associated with SMI that could influence COVID-19 outcomes is lacking. In the present review, dietary patterns, smoking and the use of psychotropic medications are discussed as potential extrinsic risk factors and angiotensin-converting enzym","2021","07","02","Mol Med Rep","Molecular medicine reports","angiotensin-converting enzyme; coronavirus disease 2019; diet; inflammation; psychotropic drugs; serious mental illness; smoking; COVID-19; Comorbidity; Disease Susceptibility; Humans; Inflammation; Mental Disorders; Risk Factors; SARS-CoV-2","Buretic-Tomljanovic","Alena","Department of Medical Biology and Genetics, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia",NA
"353","34184063","10.1093/pubmed/fdab252","The Covid-19 pandemic and its concomitant benefits: the religio-spiritual wellness.",NA,"2021","06","29","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Macaraan","Willard Enrique R","Theology and Religious Education Department, De La Salle University, 2401 Taft Avenue, 1004 Manila, Philippines",NA
"354","34184052","10.1093/labmed/lmab038","A Persistent Positive Antibody Test in a Patient with No History of COVID-19 Infection.","Antibody testing for SARS-CoV-2 has been established as a tool with broad utility in the surveillance and control of the COVID-19 pandemic. However, because of limited knowledge about the duration of humoral immunity to COVID-19 and the existence of unique individual immune responses, the potential role of antibody testing in the diagnosis of current and past infections of COVID-19 remains ambiguous. Herein, we describe a unique case of an asymptomatic patient showing a persistent positive total","2021","06","29","Lab Med","Laboratory medicine","COVID-19; SARS-CoV-2; antibody; diagnostics; false positive; testing","McMurry","Jordan","Cedar Health Research, LLC, Dallas, Texas, USA",NA
"355","34184052","10.1093/labmed/lmab038","A Persistent Positive Antibody Test in a Patient with No History of COVID-19 Infection.","Antibody testing for SARS-CoV-2 has been established as a tool with broad utility in the surveillance and control of the COVID-19 pandemic. However, because of limited knowledge about the duration of humoral immunity to COVID-19 and the existence of unique individual immune responses, the potential role of antibody testing in the diagnosis of current and past infections of COVID-19 remains ambiguous. Herein, we describe a unique case of an asymptomatic patient showing a persistent positive total","2021","06","29","Lab Med","Laboratory medicine","COVID-19; SARS-CoV-2; antibody; diagnostics; false positive; testing","Fink","Ezekiel","Cedar Health Research, LLC, Dallas, Texas, USA",NA
"356","34184000","10.1016/j.jmh.2021.100051","Equity in access to COVID-19 testing for undocumented migrants and homeless persons during the initial phase of the pandemic.","The COVID-19 pandemic has excessively affected socially and economically deprived groups of population. There is a dearth of empirical evidence about the effect of policies regulating access to care for such groups. This study aims to document the impact of an equity-based strategy to facilitate access to COVID-19 testing during the initial phase of the pandemic. This cross-sectional study included all outpatients presenting at the Geneva University Hospital for COVID-19 testing in March and Apr","2021","06","30","J Migr Health","Journal of migration and health","COVID-19; Equity; Homeless; Testing; Undocumented migrants","Baggio","Stephanie","Division of prison health, Geneva University Hospital and University of Geneva, Switzerland",NA
"357","34184000","10.1016/j.jmh.2021.100051","Equity in access to COVID-19 testing for undocumented migrants and homeless persons during the initial phase of the pandemic.","The COVID-19 pandemic has excessively affected socially and economically deprived groups of population. There is a dearth of empirical evidence about the effect of policies regulating access to care for such groups. This study aims to document the impact of an equity-based strategy to facilitate access to COVID-19 testing during the initial phase of the pandemic. This cross-sectional study included all outpatients presenting at the Geneva University Hospital for COVID-19 testing in March and Apr","2021","06","30","J Migr Health","Journal of migration and health","COVID-19; Equity; Homeless; Testing; Undocumented migrants","Jacquerioz","Frederique","Division of primary care medicine, Geneva University Hospital and University of Geneva, Switzerland",NA
"358","34184000","10.1016/j.jmh.2021.100051","Equity in access to COVID-19 testing for undocumented migrants and homeless persons during the initial phase of the pandemic.","The COVID-19 pandemic has excessively affected socially and economically deprived groups of population. There is a dearth of empirical evidence about the effect of policies regulating access to care for such groups. This study aims to document the impact of an equity-based strategy to facilitate access to COVID-19 testing during the initial phase of the pandemic. This cross-sectional study included all outpatients presenting at the Geneva University Hospital for COVID-19 testing in March and Apr","2021","06","30","J Migr Health","Journal of migration and health","COVID-19; Equity; Homeless; Testing; Undocumented migrants","Salamun","Julien","Division of primary care medicine, Geneva University Hospital and University of Geneva, Switzerland",NA
"359","34184000","10.1016/j.jmh.2021.100051","Equity in access to COVID-19 testing for undocumented migrants and homeless persons during the initial phase of the pandemic.","The COVID-19 pandemic has excessively affected socially and economically deprived groups of population. There is a dearth of empirical evidence about the effect of policies regulating access to care for such groups. This study aims to document the impact of an equity-based strategy to facilitate access to COVID-19 testing during the initial phase of the pandemic. This cross-sectional study included all outpatients presenting at the Geneva University Hospital for COVID-19 testing in March and Apr","2021","06","30","J Migr Health","Journal of migration and health","COVID-19; Equity; Homeless; Testing; Undocumented migrants","Spechbach","Hervé","Division of primary care medicine, Geneva University Hospital and University of Geneva, Switzerland",NA
"360","34184000","10.1016/j.jmh.2021.100051","Equity in access to COVID-19 testing for undocumented migrants and homeless persons during the initial phase of the pandemic.","The COVID-19 pandemic has excessively affected socially and economically deprived groups of population. There is a dearth of empirical evidence about the effect of policies regulating access to care for such groups. This study aims to document the impact of an equity-based strategy to facilitate access to COVID-19 testing during the initial phase of the pandemic. This cross-sectional study included all outpatients presenting at the Geneva University Hospital for COVID-19 testing in March and Apr","2021","06","30","J Migr Health","Journal of migration and health","COVID-19; Equity; Homeless; Testing; Undocumented migrants","Jackson","Yves","Division of primary care medicine, Geneva University Hospital and University of Geneva, Switzerland",NA
"361","34183999","10.1016/j.jpap.2021.100050","Efficacy of 265-nm ultraviolet light in inactivating infectious SARS-CoV-2.","Although, Low-pressure (LP) mercury lamps that emit wavelengths of around 254 nm have been widely applied as ultraviolet (UV) light devices for decontamination of microorganisms, they have raised environmental concerns due to their mercury content. Therefore, UV-LED lamps have high potential for practical use as a replacement for LP mercury lamps. In this study, we evaluated the efficacy of 265-nm UV irradiation in comparison to 254-nm and 280-nm UV irradiation for inactivating infectious severe","2021","06","30","J Photochem Photobiol","Journal of photochemistry and photobiology","265-nm UV; Inactivation, DUV-LED; Sars-cov-2","Shimoda","Hiroshi","Laboratory of Veterinary Microbiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan",NA
"362","34183999","10.1016/j.jpap.2021.100050","Efficacy of 265-nm ultraviolet light in inactivating infectious SARS-CoV-2.","Although, Low-pressure (LP) mercury lamps that emit wavelengths of around 254 nm have been widely applied as ultraviolet (UV) light devices for decontamination of microorganisms, they have raised environmental concerns due to their mercury content. Therefore, UV-LED lamps have high potential for practical use as a replacement for LP mercury lamps. In this study, we evaluated the efficacy of 265-nm UV irradiation in comparison to 254-nm and 280-nm UV irradiation for inactivating infectious severe","2021","06","30","J Photochem Photobiol","Journal of photochemistry and photobiology","265-nm UV; Inactivation, DUV-LED; Sars-cov-2","Matsuda","Junji","Stanley Electric Co., Ltd., 2-9-13 Nakameguro, Meguro-ku, Tokyo 153-8636, Japan",NA
"363","34183999","10.1016/j.jpap.2021.100050","Efficacy of 265-nm ultraviolet light in inactivating infectious SARS-CoV-2.","Although, Low-pressure (LP) mercury lamps that emit wavelengths of around 254 nm have been widely applied as ultraviolet (UV) light devices for decontamination of microorganisms, they have raised environmental concerns due to their mercury content. Therefore, UV-LED lamps have high potential for practical use as a replacement for LP mercury lamps. In this study, we evaluated the efficacy of 265-nm UV irradiation in comparison to 254-nm and 280-nm UV irradiation for inactivating infectious severe","2021","06","30","J Photochem Photobiol","Journal of photochemistry and photobiology","265-nm UV; Inactivation, DUV-LED; Sars-cov-2","Iwasaki","Tatsuyuki","Stanley Electric Co., Ltd., 2-9-13 Nakameguro, Meguro-ku, Tokyo 153-8636, Japan",NA
"364","34183999","10.1016/j.jpap.2021.100050","Efficacy of 265-nm ultraviolet light in inactivating infectious SARS-CoV-2.","Although, Low-pressure (LP) mercury lamps that emit wavelengths of around 254 nm have been widely applied as ultraviolet (UV) light devices for decontamination of microorganisms, they have raised environmental concerns due to their mercury content. Therefore, UV-LED lamps have high potential for practical use as a replacement for LP mercury lamps. In this study, we evaluated the efficacy of 265-nm UV irradiation in comparison to 254-nm and 280-nm UV irradiation for inactivating infectious severe","2021","06","30","J Photochem Photobiol","Journal of photochemistry and photobiology","265-nm UV; Inactivation, DUV-LED; Sars-cov-2","Hayasaka","Daisuke","Laboratory of Veterinary Microbiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan",NA
"365","34183983","10.1093/ofid/ofab233","In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study.","Our objective was to characterize young adult patients hospitalized with coronavirus disease 2019 (COVID-19) and identify predictors of survival at 30 days. This retrospective cohort study took place at 12 acute care hospitals in the New York City area. Patients aged 18-39 hospitalized with confirmed COVID-19 between March 1 and April 27, 2020 were included in the study. Demographic, clinical, and outcome data were extracted from electronic health record reports. A total of 1013 patients were in","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","coronavirus disease 2019 (COVID-19); mortality; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); young adults","Richardson","Safiya","Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA",NA
"366","34183983","10.1093/ofid/ofab233","In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study.","Our objective was to characterize young adult patients hospitalized with coronavirus disease 2019 (COVID-19) and identify predictors of survival at 30 days. This retrospective cohort study took place at 12 acute care hospitals in the New York City area. Patients aged 18-39 hospitalized with confirmed COVID-19 between March 1 and April 27, 2020 were included in the study. Demographic, clinical, and outcome data were extracted from electronic health record reports. A total of 1013 patients were in","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","coronavirus disease 2019 (COVID-19); mortality; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); young adults","Gitlin","Jordan","Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York, USA",NA
"367","34183983","10.1093/ofid/ofab233","In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study.","Our objective was to characterize young adult patients hospitalized with coronavirus disease 2019 (COVID-19) and identify predictors of survival at 30 days. This retrospective cohort study took place at 12 acute care hospitals in the New York City area. Patients aged 18-39 hospitalized with confirmed COVID-19 between March 1 and April 27, 2020 were included in the study. Demographic, clinical, and outcome data were extracted from electronic health record reports. A total of 1013 patients were in","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","coronavirus disease 2019 (COVID-19); mortality; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); young adults","Kozel","Zachary","Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, New York, USA",NA
"368","34183983","10.1093/ofid/ofab233","In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study.","Our objective was to characterize young adult patients hospitalized with coronavirus disease 2019 (COVID-19) and identify predictors of survival at 30 days. This retrospective cohort study took place at 12 acute care hospitals in the New York City area. Patients aged 18-39 hospitalized with confirmed COVID-19 between March 1 and April 27, 2020 were included in the study. Demographic, clinical, and outcome data were extracted from electronic health record reports. A total of 1013 patients were in","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","coronavirus disease 2019 (COVID-19); mortality; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); young adults","Levy","Sera","Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA",NA
"369","34183983","10.1093/ofid/ofab233","In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study.","Our objective was to characterize young adult patients hospitalized with coronavirus disease 2019 (COVID-19) and identify predictors of survival at 30 days. This retrospective cohort study took place at 12 acute care hospitals in the New York City area. Patients aged 18-39 hospitalized with confirmed COVID-19 between March 1 and April 27, 2020 were included in the study. Demographic, clinical, and outcome data were extracted from electronic health record reports. A total of 1013 patients were in","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","coronavirus disease 2019 (COVID-19); mortality; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); young adults","Rahman","Husneara","Biostatistics Unit, Feinstein Institutes for Medical Research, Northwell Health, Great Neck, New York, USA",NA
"370","34183983","10.1093/ofid/ofab233","In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study.","Our objective was to characterize young adult patients hospitalized with coronavirus disease 2019 (COVID-19) and identify predictors of survival at 30 days. This retrospective cohort study took place at 12 acute care hospitals in the New York City area. Patients aged 18-39 hospitalized with confirmed COVID-19 between March 1 and April 27, 2020 were included in the study. Demographic, clinical, and outcome data were extracted from electronic health record reports. A total of 1013 patients were in","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","coronavirus disease 2019 (COVID-19); mortality; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); young adults","Hirsch","Jamie S","Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA",NA
"371","34183983","10.1093/ofid/ofab233","In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study.","Our objective was to characterize young adult patients hospitalized with coronavirus disease 2019 (COVID-19) and identify predictors of survival at 30 days. This retrospective cohort study took place at 12 acute care hospitals in the New York City area. Patients aged 18-39 hospitalized with confirmed COVID-19 between March 1 and April 27, 2020 were included in the study. Demographic, clinical, and outcome data were extracted from electronic health record reports. A total of 1013 patients were in","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","coronavirus disease 2019 (COVID-19); mortality; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); young adults","McGinn","Thomas","Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA",NA
"372","34183983","10.1093/ofid/ofab233","In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study.","Our objective was to characterize young adult patients hospitalized with coronavirus disease 2019 (COVID-19) and identify predictors of survival at 30 days. This retrospective cohort study took place at 12 acute care hospitals in the New York City area. Patients aged 18-39 hospitalized with confirmed COVID-19 between March 1 and April 27, 2020 were included in the study. Demographic, clinical, and outcome data were extracted from electronic health record reports. A total of 1013 patients were in","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","coronavirus disease 2019 (COVID-19); mortality; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); young adults","Diefenbach","Michael A","Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA",NA
"373","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Yoke","Leah H","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"374","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Lee","Juhye M","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"375","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Krantz","Elizabeth M","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"376","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Morris","Jessica","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"377","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Marquis","Sara","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"378","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Bhattacharyya","Pooja","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"379","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","So","Lisa","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"380","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Riedo","Francis X","EvergreenHealth, Kirkland, Washington, USA",NA
"381","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Simmons","Jason","Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA",NA
"382","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Khaki","Ali Raza","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"383","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Cheng","Guang-Shing","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"384","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Greninger","Alexander L","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"385","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Pergam","Steven A","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"386","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Waghmare","Alpana","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"387","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Ogimi","Chikara","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"388","34183982","10.1093/ofid/ofab193","Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.","High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding. We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values we","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; antimicrobial use; cancer; clinical outcomes; viral shedding","Liu","Catherine","Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA",NA
"389","34183981","10.1093/ofid/ofab185","Community Antibiotic Use at the Population Level During the SARS-CoV-2 Pandemic in British Columbia, Canada.","The objective of this study was to examine the aggregate rates of antibiotic use at the population level and compare these rates over time against historical averages to identify the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting control measures on community prescribing. We collected antibiotic prescriptions and physician office visits from January 1, 2016, to July 21, 2020. We calculated monthly prescription rates stratified by sex, age group, professi","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Canada; SARS-CoV-2; antibiotics; pandemic","Mamun","Abdullah A","British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada",NA
"390","34183981","10.1093/ofid/ofab185","Community Antibiotic Use at the Population Level During the SARS-CoV-2 Pandemic in British Columbia, Canada.","The objective of this study was to examine the aggregate rates of antibiotic use at the population level and compare these rates over time against historical averages to identify the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting control measures on community prescribing. We collected antibiotic prescriptions and physician office visits from January 1, 2016, to July 21, 2020. We calculated monthly prescription rates stratified by sex, age group, professi","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Canada; SARS-CoV-2; antibiotics; pandemic","Saatchi","Ariana","Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada",NA
"391","34183981","10.1093/ofid/ofab185","Community Antibiotic Use at the Population Level During the SARS-CoV-2 Pandemic in British Columbia, Canada.","The objective of this study was to examine the aggregate rates of antibiotic use at the population level and compare these rates over time against historical averages to identify the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting control measures on community prescribing. We collected antibiotic prescriptions and physician office visits from January 1, 2016, to July 21, 2020. We calculated monthly prescription rates stratified by sex, age group, professi","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Canada; SARS-CoV-2; antibiotics; pandemic","Xie","Max","British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada",NA
"392","34183981","10.1093/ofid/ofab185","Community Antibiotic Use at the Population Level During the SARS-CoV-2 Pandemic in British Columbia, Canada.","The objective of this study was to examine the aggregate rates of antibiotic use at the population level and compare these rates over time against historical averages to identify the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting control measures on community prescribing. We collected antibiotic prescriptions and physician office visits from January 1, 2016, to July 21, 2020. We calculated monthly prescription rates stratified by sex, age group, professi","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Canada; SARS-CoV-2; antibiotics; pandemic","Lishman","Hannah","School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada",NA
"393","34183981","10.1093/ofid/ofab185","Community Antibiotic Use at the Population Level During the SARS-CoV-2 Pandemic in British Columbia, Canada.","The objective of this study was to examine the aggregate rates of antibiotic use at the population level and compare these rates over time against historical averages to identify the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting control measures on community prescribing. We collected antibiotic prescriptions and physician office visits from January 1, 2016, to July 21, 2020. We calculated monthly prescription rates stratified by sex, age group, professi","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Canada; SARS-CoV-2; antibiotics; pandemic","Blondel-Hill","Edith","Interior Health Authority, Kelowna, British Columbia, Canada",NA
"394","34183981","10.1093/ofid/ofab185","Community Antibiotic Use at the Population Level During the SARS-CoV-2 Pandemic in British Columbia, Canada.","The objective of this study was to examine the aggregate rates of antibiotic use at the population level and compare these rates over time against historical averages to identify the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting control measures on community prescribing. We collected antibiotic prescriptions and physician office visits from January 1, 2016, to July 21, 2020. We calculated monthly prescription rates stratified by sex, age group, professi","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Canada; SARS-CoV-2; antibiotics; pandemic","Marra","Fawziah","Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada",NA
"395","34183981","10.1093/ofid/ofab185","Community Antibiotic Use at the Population Level During the SARS-CoV-2 Pandemic in British Columbia, Canada.","The objective of this study was to examine the aggregate rates of antibiotic use at the population level and compare these rates over time against historical averages to identify the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting control measures on community prescribing. We collected antibiotic prescriptions and physician office visits from January 1, 2016, to July 21, 2020. We calculated monthly prescription rates stratified by sex, age group, professi","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Canada; SARS-CoV-2; antibiotics; pandemic","Patrick","David M","British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada",NA
"396","34183980","10.1093/ofid/ofab155","Should Health Care Institutions Mandate SARS-CoV-2 Vaccination for Staff?","Health care workers have been prioritized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, but vaccine hesitancy among workers may limit uptake. Institutions may wish to consider SARS-CoV-2 vaccine mandates for health care workers, but such proposals raise important ethical questions. Arguments supporting mandates emphasize the proposed favorable balance of harms and benefits for both individuals and communities, as well as moral duties of health care workers and org","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases",NA,"Kates","Olivia S","Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA",NA
"397","34183980","10.1093/ofid/ofab155","Should Health Care Institutions Mandate SARS-CoV-2 Vaccination for Staff?","Health care workers have been prioritized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, but vaccine hesitancy among workers may limit uptake. Institutions may wish to consider SARS-CoV-2 vaccine mandates for health care workers, but such proposals raise important ethical questions. Arguments supporting mandates emphasize the proposed favorable balance of harms and benefits for both individuals and communities, as well as moral duties of health care workers and org","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases",NA,"Diekema","Douglas S","Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA",NA
"398","34183980","10.1093/ofid/ofab155","Should Health Care Institutions Mandate SARS-CoV-2 Vaccination for Staff?","Health care workers have been prioritized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, but vaccine hesitancy among workers may limit uptake. Institutions may wish to consider SARS-CoV-2 vaccine mandates for health care workers, but such proposals raise important ethical questions. Arguments supporting mandates emphasize the proposed favorable balance of harms and benefits for both individuals and communities, as well as moral duties of health care workers and org","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases",NA,"Blumberg","Emily A","Department of Medicine, Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"399","34183979","10.1093/ofid/ofab152","Strategies for Disseminating and Implementing COVID-19 Vaccines in Rural Areas.","The United States has well-documented rural-urban health disparities, and it is imperative that these are not exacerbated by an inefficient rollout of coronavirus disease 2019 (COVID-19) vaccines to rural areas. In addition to the preexisting barriers to delivering and receiving health care in rural areas, such as high patient:provider ratios and long geographic distances between patients and providers, rural residents are significantly more likely to say they have no intention of receiving a CO","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; coronavirus; rural; vaccination; vaccine","Prusaczyk","Beth","Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA",NA
"400","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Gharamti","Amal A","Department of Internal Medicine, American University of Beirut, Beirut, Lebanon",NA
"401","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Mei","Fei","Department of Vascular Surgery, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, China",NA
"402","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Jankousky","Katherine C","Department of Medicine, University of Colorado, Anschutz Medical Center Aurora, Aurora, Colorado, USA",NA
"403","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Huang","Jin","School of Medicine, University of Colorado, Anschutz Medical Center Aurora, Aurora, Colorado, USA",NA
"404","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Hyson","Peter","Department of Medicine, University of Colorado, Anschutz Medical Center Aurora, Aurora, Colorado, USA",NA
"405","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Chastain","Daniel B","Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, Georgia, USA",NA
"406","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Fan","Jiawei","Department of Vascular Surgery, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, China",NA
"407","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Osae","Sharmon","Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, Georgia, USA",NA
"408","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Zhang","Wayne W","Division of Vascular and Endovascular Surgery, Department of Surgery, University of Washington and Puget Sound VA Health Care System, Seattle, Washington, USA",NA
"409","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Montoya","José G","Dr Jack S. Remington Laboratory for Specialty Diagnostics, Palo Alto, California, USA",NA
"410","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Erlandson","Kristine M","Division of Infectious Diseases, University of Colorado, Anschutz Medical Center Aurora, Aurora, Colorado, USA",NA
"411","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Scherger","Sias J","Division of Infectious Diseases, University of Colorado, Anschutz Medical Center Aurora, Aurora, Colorado, USA",NA
"412","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Franco-Paredes","Carlos","Division of Infectious Diseases, University of Colorado, Anschutz Medical Center Aurora, Aurora, Colorado, USA",NA
"413","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Henao-Martínez","Andrés F","Division of Infectious Diseases, University of Colorado, Anschutz Medical Center Aurora, Aurora, Colorado, USA",NA
"414","34183978","10.1093/ofid/ofab124","Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study.","There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to bacterial pathogens. This multicenter case-control study compared patients with COVID-19 with those with bacterial pneumonia, admitted between March 1 and May 31, 2020. Patients with COVID-19 and bacterial pneumo","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; SARS-CoV-2; ferritin; pneumonia; procalcitonin","Shapiro","Leland","Division of Infectious Diseases, University of Colorado, Anschutz Medical Center Aurora, Aurora, Colorado, USA",NA
"415","34183977","10.1093/ofid/ofab115","Striking Decrease of Enteroviral Meningitis in Children During the COVID-19 Pandemic.","We report the unprecedented complete absence of pediatric enteroviral meningitis in 2020 in the area of Bern, Switzerland. Presumably an unintended effect of coronavirus disease 2019 public health measures, this finding highlights the potential of community-wide nonpharmaceutical interventions for controlling the circulation of a major pediatric pathogen, which is mainly transmitted by the fecal-oral route.","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Enterovirus; SARS-CoV-2; child; epidemiology; meningitis","Stoffel","Larissa","Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland",NA
"416","34183977","10.1093/ofid/ofab115","Striking Decrease of Enteroviral Meningitis in Children During the COVID-19 Pandemic.","We report the unprecedented complete absence of pediatric enteroviral meningitis in 2020 in the area of Bern, Switzerland. Presumably an unintended effect of coronavirus disease 2019 public health measures, this finding highlights the potential of community-wide nonpharmaceutical interventions for controlling the circulation of a major pediatric pathogen, which is mainly transmitted by the fecal-oral route.","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Enterovirus; SARS-CoV-2; child; epidemiology; meningitis","Agyeman","Philipp K A","Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland",NA
"417","34183977","10.1093/ofid/ofab115","Striking Decrease of Enteroviral Meningitis in Children During the COVID-19 Pandemic.","We report the unprecedented complete absence of pediatric enteroviral meningitis in 2020 in the area of Bern, Switzerland. Presumably an unintended effect of coronavirus disease 2019 public health measures, this finding highlights the potential of community-wide nonpharmaceutical interventions for controlling the circulation of a major pediatric pathogen, which is mainly transmitted by the fecal-oral route.","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Enterovirus; SARS-CoV-2; child; epidemiology; meningitis","Keitel","Kristina","Department of Pediatric Emergency Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland",NA
"418","34183977","10.1093/ofid/ofab115","Striking Decrease of Enteroviral Meningitis in Children During the COVID-19 Pandemic.","We report the unprecedented complete absence of pediatric enteroviral meningitis in 2020 in the area of Bern, Switzerland. Presumably an unintended effect of coronavirus disease 2019 public health measures, this finding highlights the potential of community-wide nonpharmaceutical interventions for controlling the circulation of a major pediatric pathogen, which is mainly transmitted by the fecal-oral route.","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Enterovirus; SARS-CoV-2; child; epidemiology; meningitis","Barbani","Maria Teresa","Institute for Infectious Diseases, University of Bern, Bern, Switzerland",NA
"419","34183977","10.1093/ofid/ofab115","Striking Decrease of Enteroviral Meningitis in Children During the COVID-19 Pandemic.","We report the unprecedented complete absence of pediatric enteroviral meningitis in 2020 in the area of Bern, Switzerland. Presumably an unintended effect of coronavirus disease 2019 public health measures, this finding highlights the potential of community-wide nonpharmaceutical interventions for controlling the circulation of a major pediatric pathogen, which is mainly transmitted by the fecal-oral route.","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Enterovirus; SARS-CoV-2; child; epidemiology; meningitis","Duppenthaler","Andrea","Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland",NA
"420","34183977","10.1093/ofid/ofab115","Striking Decrease of Enteroviral Meningitis in Children During the COVID-19 Pandemic.","We report the unprecedented complete absence of pediatric enteroviral meningitis in 2020 in the area of Bern, Switzerland. Presumably an unintended effect of coronavirus disease 2019 public health measures, this finding highlights the potential of community-wide nonpharmaceutical interventions for controlling the circulation of a major pediatric pathogen, which is mainly transmitted by the fecal-oral route.","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Enterovirus; SARS-CoV-2; child; epidemiology; meningitis","Kopp","Matthias V","Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland",NA
"421","34183977","10.1093/ofid/ofab115","Striking Decrease of Enteroviral Meningitis in Children During the COVID-19 Pandemic.","We report the unprecedented complete absence of pediatric enteroviral meningitis in 2020 in the area of Bern, Switzerland. Presumably an unintended effect of coronavirus disease 2019 public health measures, this finding highlights the potential of community-wide nonpharmaceutical interventions for controlling the circulation of a major pediatric pathogen, which is mainly transmitted by the fecal-oral route.","2021","07","09","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; Enterovirus; SARS-CoV-2; child; epidemiology; meningitis","Aebi","Christoph","Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland",NA
"422","34183976","10.1093/ofid/ofab107","Detection of Environmental Spread of SARS-CoV-2 and Associated Patient Characteristics.","Understanding transmission of severe acute respiratory syndrome coronavirus 2 informs infection prevention practices. Air sampling devices were placed in patient hospital rooms for consecutive collections with and without masks. With patient mask use, no virus was detected in the room. High viral load and fewer days from symptom onset were associated with viral particulate dispersion.","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; infection prevention and hospital epidemiology; viral pneumonia","Semelka","Charles T","Section on Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina, USA",NA
"423","34183976","10.1093/ofid/ofab107","Detection of Environmental Spread of SARS-CoV-2 and Associated Patient Characteristics.","Understanding transmission of severe acute respiratory syndrome coronavirus 2 informs infection prevention practices. Air sampling devices were placed in patient hospital rooms for consecutive collections with and without masks. With patient mask use, no virus was detected in the room. High viral load and fewer days from symptom onset were associated with viral particulate dispersion.","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; infection prevention and hospital epidemiology; viral pneumonia","Ornelles","David A","Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA",NA
"424","34183976","10.1093/ofid/ofab107","Detection of Environmental Spread of SARS-CoV-2 and Associated Patient Characteristics.","Understanding transmission of severe acute respiratory syndrome coronavirus 2 informs infection prevention practices. Air sampling devices were placed in patient hospital rooms for consecutive collections with and without masks. With patient mask use, no virus was detected in the room. High viral load and fewer days from symptom onset were associated with viral particulate dispersion.","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; infection prevention and hospital epidemiology; viral pneumonia","O'Connell","Nathaniel S","Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston Salem, North Carolina, USA",NA
"425","34183976","10.1093/ofid/ofab107","Detection of Environmental Spread of SARS-CoV-2 and Associated Patient Characteristics.","Understanding transmission of severe acute respiratory syndrome coronavirus 2 informs infection prevention practices. Air sampling devices were placed in patient hospital rooms for consecutive collections with and without masks. With patient mask use, no virus was detected in the room. High viral load and fewer days from symptom onset were associated with viral particulate dispersion.","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; infection prevention and hospital epidemiology; viral pneumonia","Parsons","Emma C","Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA",NA
"426","34183976","10.1093/ofid/ofab107","Detection of Environmental Spread of SARS-CoV-2 and Associated Patient Characteristics.","Understanding transmission of severe acute respiratory syndrome coronavirus 2 informs infection prevention practices. Air sampling devices were placed in patient hospital rooms for consecutive collections with and without masks. With patient mask use, no virus was detected in the room. High viral load and fewer days from symptom onset were associated with viral particulate dispersion.","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; infection prevention and hospital epidemiology; viral pneumonia","Blevins","Maria W","Section on Infectious Diseases, Department of Internal Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina, USA",NA
"427","34183976","10.1093/ofid/ofab107","Detection of Environmental Spread of SARS-CoV-2 and Associated Patient Characteristics.","Understanding transmission of severe acute respiratory syndrome coronavirus 2 informs infection prevention practices. Air sampling devices were placed in patient hospital rooms for consecutive collections with and without masks. With patient mask use, no virus was detected in the room. High viral load and fewer days from symptom onset were associated with viral particulate dispersion.","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; infection prevention and hospital epidemiology; viral pneumonia","Ivey","Lauren E","Internal Medicine Residency, Department of Internal Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina, USA",NA
"428","34183976","10.1093/ofid/ofab107","Detection of Environmental Spread of SARS-CoV-2 and Associated Patient Characteristics.","Understanding transmission of severe acute respiratory syndrome coronavirus 2 informs infection prevention practices. Air sampling devices were placed in patient hospital rooms for consecutive collections with and without masks. With patient mask use, no virus was detected in the room. High viral load and fewer days from symptom onset were associated with viral particulate dispersion.","2021","06","30","Open Forum Infect Dis","Open forum infectious diseases","COVID-19; infection prevention and hospital epidemiology; viral pneumonia","Bischoff","Werner E","Section on Infectious Diseases, Department of Internal Medicine, Wake Forest School of Medicine, Winston Salem, North Carolina, USA",NA
"429","34183961","10.18502/ijph.v50i5.6120","In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2.","The COVID-19 is a pandemic viral infection with a high morbidity rate, leading to many worldwide deaths since the end of 2019. The RBD (Receptor Binding Domain) of SARS-CoV-2 through its spike utilizes several host molecules to enter host cells. One of the most important ones is the angiotensin-converting enzyme 2 (ACE2), an enzyme normally engaged in renin angiotensin pathway and is responsible for hypertension regulation. As different articles have analyzed separate compounds which can bind AC","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Compound; Inhibitor; Receptor binding domain; SARS-CoV-2","Shakhsi-Niaei","Mostafa","Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran",NA
"430","34183961","10.18502/ijph.v50i5.6120","In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2.","The COVID-19 is a pandemic viral infection with a high morbidity rate, leading to many worldwide deaths since the end of 2019. The RBD (Receptor Binding Domain) of SARS-CoV-2 through its spike utilizes several host molecules to enter host cells. One of the most important ones is the angiotensin-converting enzyme 2 (ACE2), an enzyme normally engaged in renin angiotensin pathway and is responsible for hypertension regulation. As different articles have analyzed separate compounds which can bind AC","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Compound; Inhibitor; Receptor binding domain; SARS-CoV-2","Soureshjani","Ehsan Heidari","COVID-19 Research Group, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran",NA
"431","34183961","10.18502/ijph.v50i5.6120","In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2.","The COVID-19 is a pandemic viral infection with a high morbidity rate, leading to many worldwide deaths since the end of 2019. The RBD (Receptor Binding Domain) of SARS-CoV-2 through its spike utilizes several host molecules to enter host cells. One of the most important ones is the angiotensin-converting enzyme 2 (ACE2), an enzyme normally engaged in renin angiotensin pathway and is responsible for hypertension regulation. As different articles have analyzed separate compounds which can bind AC","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Compound; Inhibitor; Receptor binding domain; SARS-CoV-2","Babaheydari","Ali Kazemi","Department of Applied Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran",NA
"432","34183933","10.18502/ijph.v50i4.6009","The Probable Association between Blood Groups and Prognosis of COVID-19.","We aimed to verify the association between blood group systems and prognosis of SARS-Cov-2 disease. In this cross-sectional study, 329 patients infected with SARS-Cov-2 diagnosed based on their COVID-19 RT-PCR results and chest CT scans, were enrolled in the study. These patients were admitted to Kamkar Arab Nia Hospital, Qom, Iran from March to June 2020. Their blood groups and RH were determined, and demographic characteristics and clinical signs of patients were recorded. The patients' temper","2021","06","30","Iran J Public Health","Iranian journal of public health","Blood Group Antigens; Iran; SARS-Cov-2","Nasiri","Maryam","Department of Infectious Diseases, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran",NA
"433","34183933","10.18502/ijph.v50i4.6009","The Probable Association between Blood Groups and Prognosis of COVID-19.","We aimed to verify the association between blood group systems and prognosis of SARS-Cov-2 disease. In this cross-sectional study, 329 patients infected with SARS-Cov-2 diagnosed based on their COVID-19 RT-PCR results and chest CT scans, were enrolled in the study. These patients were admitted to Kamkar Arab Nia Hospital, Qom, Iran from March to June 2020. Their blood groups and RH were determined, and demographic characteristics and clinical signs of patients were recorded. The patients' temper","2021","06","30","Iran J Public Health","Iranian journal of public health","Blood Group Antigens; Iran; SARS-Cov-2","Khodadadi","Javad","Department of Infectious Diseases, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran",NA
"434","34183933","10.18502/ijph.v50i4.6009","The Probable Association between Blood Groups and Prognosis of COVID-19.","We aimed to verify the association between blood group systems and prognosis of SARS-Cov-2 disease. In this cross-sectional study, 329 patients infected with SARS-Cov-2 diagnosed based on their COVID-19 RT-PCR results and chest CT scans, were enrolled in the study. These patients were admitted to Kamkar Arab Nia Hospital, Qom, Iran from March to June 2020. Their blood groups and RH were determined, and demographic characteristics and clinical signs of patients were recorded. The patients' temper","2021","06","30","Iran J Public Health","Iranian journal of public health","Blood Group Antigens; Iran; SARS-Cov-2","Hajrezaei","Zahra","Student Research Committee, School of Medicine, Qom University of Medical Sciences, Qom, Iran",NA
"435","34183933","10.18502/ijph.v50i4.6009","The Probable Association between Blood Groups and Prognosis of COVID-19.","We aimed to verify the association between blood group systems and prognosis of SARS-Cov-2 disease. In this cross-sectional study, 329 patients infected with SARS-Cov-2 diagnosed based on their COVID-19 RT-PCR results and chest CT scans, were enrolled in the study. These patients were admitted to Kamkar Arab Nia Hospital, Qom, Iran from March to June 2020. Their blood groups and RH were determined, and demographic characteristics and clinical signs of patients were recorded. The patients' temper","2021","06","30","Iran J Public Health","Iranian journal of public health","Blood Group Antigens; Iran; SARS-Cov-2","Bizhani","Negar","Department of Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran",NA
"436","34183931","10.18502/ijph.v50i4.6007","Country-Wide Resilience Model for the Health System: A Case Study on Iran, under Coronavirus Outbreak.","The outbreak of the COVID-19 virus has had many destructive impacts on socio-economic and health systems. The health systems of countries could be supportive in crisis management, but they also are affected by the impact of the crisis, consequently, their operational level has declined. This study pursued resilience in an overall national health system under pandemic stress. Based on WHO building blocks, by interviewing informants of the Ministry of Health and Medical Education, in Tehran-Iran, ","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Dynamic capabilities; Health system; Resilience; Soft systems methodology","Pilevari","Nazanin","Department of Industrial Management, West Tehran Branch, Islamic Azad University, Tehran, Iran",NA
"437","34183931","10.18502/ijph.v50i4.6007","Country-Wide Resilience Model for the Health System: A Case Study on Iran, under Coronavirus Outbreak.","The outbreak of the COVID-19 virus has had many destructive impacts on socio-economic and health systems. The health systems of countries could be supportive in crisis management, but they also are affected by the impact of the crisis, consequently, their operational level has declined. This study pursued resilience in an overall national health system under pandemic stress. Based on WHO building blocks, by interviewing informants of the Ministry of Health and Medical Education, in Tehran-Iran, ","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Dynamic capabilities; Health system; Resilience; Soft systems methodology","Shiva","Mahyar Valeh","Department of Management and Economics, Sciences and Research Branch, Islamic Azad University, Tehran, Iran",NA
"438","34183929","10.18502/ijph.v50i4.6005","Effects of Logotherapy-Based Mindfulness Intervention on Internet Addiction among Adolescents during the COVID-19 Pandemic.","The global outbreak of the novel coronavirus pneumonia (COVID-19) has seriously affected people's work and lives. Disaster-related traumatic stress events increase the risk of substance abuse. Therefore, the COVID-19 outbreak, as a stress event, inevitably has a negative impact on Chinese adolescents with Internet addiction. In 2020, 1787 copies of the questionnaire were randomly distributed among adolescents aged 12-16 years in three communities in Shandong Province, China. Among the respondent","2021","06","30","Iran J Public Health","Iranian journal of public health","Adolescents; China; Internet addiction; Logotherapy; Mindfulness intervention","Liu","Xun","Department of Basic Medicine, Heze Medical College, Heze 274000, China",NA
"439","34183929","10.18502/ijph.v50i4.6005","Effects of Logotherapy-Based Mindfulness Intervention on Internet Addiction among Adolescents during the COVID-19 Pandemic.","The global outbreak of the novel coronavirus pneumonia (COVID-19) has seriously affected people's work and lives. Disaster-related traumatic stress events increase the risk of substance abuse. Therefore, the COVID-19 outbreak, as a stress event, inevitably has a negative impact on Chinese adolescents with Internet addiction. In 2020, 1787 copies of the questionnaire were randomly distributed among adolescents aged 12-16 years in three communities in Shandong Province, China. Among the respondent","2021","06","30","Iran J Public Health","Iranian journal of public health","Adolescents; China; Internet addiction; Logotherapy; Mindfulness intervention","Jiang","Jiguo","School Party Committee, Heze Medical College, Heze 274000, China",NA
"440","34183929","10.18502/ijph.v50i4.6005","Effects of Logotherapy-Based Mindfulness Intervention on Internet Addiction among Adolescents during the COVID-19 Pandemic.","The global outbreak of the novel coronavirus pneumonia (COVID-19) has seriously affected people's work and lives. Disaster-related traumatic stress events increase the risk of substance abuse. Therefore, the COVID-19 outbreak, as a stress event, inevitably has a negative impact on Chinese adolescents with Internet addiction. In 2020, 1787 copies of the questionnaire were randomly distributed among adolescents aged 12-16 years in three communities in Shandong Province, China. Among the respondent","2021","06","30","Iran J Public Health","Iranian journal of public health","Adolescents; China; Internet addiction; Logotherapy; Mindfulness intervention","Zhang","Yanli","School of Cultural Communication, Shandong Women's University, Jingzhou 250002, China",NA
"441","34183921","10.18502/ijph.v50i4.5996","The Effect of Chronic Diseases, Age and Gender on Morbidity and Mortality of COVID-19 Infection.","We aimed to reveal how chronic diseases, age and gender affected morbidity and mortality in patients with Coronavirus disease of 2019 (COVID-19). Medical records of all reverse transcription polymerase chain reaction (RT-PCR) positive COVID-19 patients followed up in hospital and home isolation between 13<sup>th</sup> of Mar 2020 and 12<sup>th</sup> of May 2020 were retrospectively reviewed. The patients were from Kayseri Province, Turkey. Patients' demographic and clinical characteristics and t","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Chronic disease; Morbidity; Mortality","Aslaner","Hümeyra","Kayseri City Hospital, Family Medicine, Kayseri, Turkey",NA
"442","34183921","10.18502/ijph.v50i4.5996","The Effect of Chronic Diseases, Age and Gender on Morbidity and Mortality of COVID-19 Infection.","We aimed to reveal how chronic diseases, age and gender affected morbidity and mortality in patients with Coronavirus disease of 2019 (COVID-19). Medical records of all reverse transcription polymerase chain reaction (RT-PCR) positive COVID-19 patients followed up in hospital and home isolation between 13<sup>th</sup> of Mar 2020 and 12<sup>th</sup> of May 2020 were retrospectively reviewed. The patients were from Kayseri Province, Turkey. Patients' demographic and clinical characteristics and t","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Chronic disease; Morbidity; Mortality","Aslaner","Haci Ahmet","Incesu County State Hospital, Internal Medicine, Kayseri, Turkey",NA
"443","34183921","10.18502/ijph.v50i4.5996","The Effect of Chronic Diseases, Age and Gender on Morbidity and Mortality of COVID-19 Infection.","We aimed to reveal how chronic diseases, age and gender affected morbidity and mortality in patients with Coronavirus disease of 2019 (COVID-19). Medical records of all reverse transcription polymerase chain reaction (RT-PCR) positive COVID-19 patients followed up in hospital and home isolation between 13<sup>th</sup> of Mar 2020 and 12<sup>th</sup> of May 2020 were retrospectively reviewed. The patients were from Kayseri Province, Turkey. Patients' demographic and clinical characteristics and t","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Chronic disease; Morbidity; Mortality","Gökçek","Mebrure Beyza","Health Directorate of Kayseri, Kayseri, Turkey",NA
"444","34183921","10.18502/ijph.v50i4.5996","The Effect of Chronic Diseases, Age and Gender on Morbidity and Mortality of COVID-19 Infection.","We aimed to reveal how chronic diseases, age and gender affected morbidity and mortality in patients with Coronavirus disease of 2019 (COVID-19). Medical records of all reverse transcription polymerase chain reaction (RT-PCR) positive COVID-19 patients followed up in hospital and home isolation between 13<sup>th</sup> of Mar 2020 and 12<sup>th</sup> of May 2020 were retrospectively reviewed. The patients were from Kayseri Province, Turkey. Patients' demographic and clinical characteristics and t","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Chronic disease; Morbidity; Mortality","Benli","Ali Ramazan","Health Directorate of Kayseri, Kayseri, Turkey",NA
"445","34183921","10.18502/ijph.v50i4.5996","The Effect of Chronic Diseases, Age and Gender on Morbidity and Mortality of COVID-19 Infection.","We aimed to reveal how chronic diseases, age and gender affected morbidity and mortality in patients with Coronavirus disease of 2019 (COVID-19). Medical records of all reverse transcription polymerase chain reaction (RT-PCR) positive COVID-19 patients followed up in hospital and home isolation between 13<sup>th</sup> of Mar 2020 and 12<sup>th</sup> of May 2020 were retrospectively reviewed. The patients were from Kayseri Province, Turkey. Patients' demographic and clinical characteristics and t","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Chronic disease; Morbidity; Mortality","Yildiz","Orhan","Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Erciyes University, Kayseri, Turkey",NA
"446","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Zavvar","Mahdi","Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran",NA
"447","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Kochak","Hamid Emadi","Department of Infectious Diseases, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran",NA
"448","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Abdolmohammadi","Kamal","Department of Medical Laboratory Sciences, Sari Branch, Islamic Azad University, Sari, Iran",NA
"449","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Rashidi","Nesa","Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran",NA
"450","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Mokhtari","Majid","Department of Medicine, Pulmonary &amp",NA
"451","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Noorbakhsh","Farshid","Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran",NA
"452","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Azadmanesh","Kayahan","Department of Virology, Pasteur Institute of Iran, Tehran, Iran",NA
"453","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Gooshki","Ehsan Shamsi","Medical Ethics and History of Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran",NA
"454","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Fatahi","Yousef","Department of Pharmaceutical Nanotechnology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran",NA
"455","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Azad","Talat Mokhtari","Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran",NA
"456","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Jahangirifard","Alireza","Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"457","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Mousavi","Mohammad Javad","Department of Hematology, School of Allied Medicine, Bushehr University of Medical Sciences, Bushehr, Iran",NA
"458","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Masoumi","Elham","Department of Medical Immunology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran",NA
"459","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Mirzaei","Hamid Reza","Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran",NA
"460","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Gouya","Mohammad Mahdi","Communicable Disease Control Centre, Ministry of Health and Medical Education, Tehran, Iran",NA
"461","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Rezaei","Farshid","Communicable Disease Control Centre, Ministry of Health and Medical Education, Tehran, Iran",NA
"462","34183916","10.18502/ijph.v50i4.5991","SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review.","In the last two decades, we have witnessed three major epidemics of the coronavirus human disease namely, severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome, and more recently an ongoing global pandemic of coronavirus disease 2019 (COVID-19). Iran, a country of nearly 84 million, in the Middle East, severely involved with the COVID-19 disease. A documented multidimensional approach to COVID-19 disease is therefore mandatory to provide a well-balanced platform for the c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus disease 2019; Coronaviruses; SARS-CoV-2","Nicknam","Mohammad Hossein","Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran",NA
"463","34183915","10.18502/ijph.v50i4.5990","A 50-Year Overview of the Coronavirus Family with Science Mapping Techniques: A Review.","The COVID-19 pandemic from the coronavirus family is the most important agenda of today's world, also called the ""New World"". In this outbreak period, declared a pandemic by WHO and affected the whole world and humanity on a global scale, all kinds of scientific information and evidence-based sharing on the subject gained great importance. Overall, 12,301 articles from the web of Science (WOS) Core Collection database were analyzed using SciMAT software, conducted to examine the development of c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus; Pandemic; Science mapping; Scimat","Tabur","Ayhan","Emergency Medical Specialist, SBÜ Diyarbakir Gazi Yasargil Egt.ve Aras.Hst., Diyarbakir, Turkey",NA
"464","34183915","10.18502/ijph.v50i4.5990","A 50-Year Overview of the Coronavirus Family with Science Mapping Techniques: A Review.","The COVID-19 pandemic from the coronavirus family is the most important agenda of today's world, also called the ""New World"". In this outbreak period, declared a pandemic by WHO and affected the whole world and humanity on a global scale, all kinds of scientific information and evidence-based sharing on the subject gained great importance. Overall, 12,301 articles from the web of Science (WOS) Core Collection database were analyzed using SciMAT software, conducted to examine the development of c","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Coronavirus; Pandemic; Science mapping; Scimat","Arslanoglu","Ali","Department of Health Management, Faculty of Health Sciences, University of Health Sciences, Istanbul, Turkey",NA
"465","34183914","10.18502/ijph.v50i4.5989","Latest Effective Measures to Combat COVID-19: A Review.","More and more people realize that implementation of preventive measures is the only option left to counteract the coronavirus disease 2019 (COVID-19) before specific antiviral drugs are developed. Hence, a number of behavioral, clinical and state interventions have been conducted by dozens of countries to stop or slow down the spread of the virus in the early stages of the epidemic. At present, with the evolution of COVID-19 pandemic getting worse, synthesizing and implementing all measures avai","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Cold chain; Effective measures; Routes of transmission; SARS-CoV-2","Chen","Fei","Department of Physiology, Jining Medical University, 133 Hehua Rd, Jining, 272067, China",NA
"466","34183914","10.18502/ijph.v50i4.5989","Latest Effective Measures to Combat COVID-19: A Review.","More and more people realize that implementation of preventive measures is the only option left to counteract the coronavirus disease 2019 (COVID-19) before specific antiviral drugs are developed. Hence, a number of behavioral, clinical and state interventions have been conducted by dozens of countries to stop or slow down the spread of the virus in the early stages of the epidemic. At present, with the evolution of COVID-19 pandemic getting worse, synthesizing and implementing all measures avai","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Cold chain; Effective measures; Routes of transmission; SARS-CoV-2","Liu","Yingjie","Department of Physiology, Jining Medical University, 133 Hehua Rd, Jining, 272067, China",NA
"467","34183914","10.18502/ijph.v50i4.5989","Latest Effective Measures to Combat COVID-19: A Review.","More and more people realize that implementation of preventive measures is the only option left to counteract the coronavirus disease 2019 (COVID-19) before specific antiviral drugs are developed. Hence, a number of behavioral, clinical and state interventions have been conducted by dozens of countries to stop or slow down the spread of the virus in the early stages of the epidemic. At present, with the evolution of COVID-19 pandemic getting worse, synthesizing and implementing all measures avai","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Cold chain; Effective measures; Routes of transmission; SARS-CoV-2","Ya","Bailiu","Department of Physiology, Jining Medical University, 133 Hehua Rd, Jining, 272067, China",NA
"468","34183914","10.18502/ijph.v50i4.5989","Latest Effective Measures to Combat COVID-19: A Review.","More and more people realize that implementation of preventive measures is the only option left to counteract the coronavirus disease 2019 (COVID-19) before specific antiviral drugs are developed. Hence, a number of behavioral, clinical and state interventions have been conducted by dozens of countries to stop or slow down the spread of the virus in the early stages of the epidemic. At present, with the evolution of COVID-19 pandemic getting worse, synthesizing and implementing all measures avai","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Cold chain; Effective measures; Routes of transmission; SARS-CoV-2","He","Jiarui","Department of Physiology, Jining Medical University, 133 Hehua Rd, Jining, 272067, China",NA
"469","34183914","10.18502/ijph.v50i4.5989","Latest Effective Measures to Combat COVID-19: A Review.","More and more people realize that implementation of preventive measures is the only option left to counteract the coronavirus disease 2019 (COVID-19) before specific antiviral drugs are developed. Hence, a number of behavioral, clinical and state interventions have been conducted by dozens of countries to stop or slow down the spread of the virus in the early stages of the epidemic. At present, with the evolution of COVID-19 pandemic getting worse, synthesizing and implementing all measures avai","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Cold chain; Effective measures; Routes of transmission; SARS-CoV-2","Leng","Taiyang","Department of Physiology, Jining Medical University, 133 Hehua Rd, Jining, 272067, China",NA
"470","34183914","10.18502/ijph.v50i4.5989","Latest Effective Measures to Combat COVID-19: A Review.","More and more people realize that implementation of preventive measures is the only option left to counteract the coronavirus disease 2019 (COVID-19) before specific antiviral drugs are developed. Hence, a number of behavioral, clinical and state interventions have been conducted by dozens of countries to stop or slow down the spread of the virus in the early stages of the epidemic. At present, with the evolution of COVID-19 pandemic getting worse, synthesizing and implementing all measures avai","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Cold chain; Effective measures; Routes of transmission; SARS-CoV-2","Sun","Yike","Department of Physiology, Jining Medical University, 133 Hehua Rd, Jining, 272067, China",NA
"471","34183914","10.18502/ijph.v50i4.5989","Latest Effective Measures to Combat COVID-19: A Review.","More and more people realize that implementation of preventive measures is the only option left to counteract the coronavirus disease 2019 (COVID-19) before specific antiviral drugs are developed. Hence, a number of behavioral, clinical and state interventions have been conducted by dozens of countries to stop or slow down the spread of the virus in the early stages of the epidemic. At present, with the evolution of COVID-19 pandemic getting worse, synthesizing and implementing all measures avai","2021","06","30","Iran J Public Health","Iranian journal of public health","COVID-19; Cold chain; Effective measures; Routes of transmission; SARS-CoV-2","Xin","Qing","Department of Physiology, Jining Medical University, 133 Hehua Rd, Jining, 272067, China",NA
"472","34183909","10.37616/2212-5043.1253","The Incidence of Acute Pulmonary Embolism with COVID-19 Pneumonia in Saudi Arabia: A Retrospective Single-Center Study.","Acute pulmonary embolism (APE) is a common and prognostically significant complication of COVID-19 infection. We investigated the clinical characteristics and chest CT findings of COVID-19 positive patients complicated with APE. A retrospective, record-based, case-series study was performed examining 483 patients admitted to King Saud Medical City during the pandemic, from April 2020 to June 2020. Of these, 92 patients who underwent chest CT scans were included in the final analysis. The inciden","2021","07","14","J Saudi Heart Assoc","Journal of the Saudi Heart Association","COVID_19; Coagulopathy; Pulmonary embolism; Saudi Arabia","Abohamr","Samah I","Heart Health Center, King Saud Medical City, Riyadh, Saudi Arabia",NA
"473","34183909","10.37616/2212-5043.1253","The Incidence of Acute Pulmonary Embolism with COVID-19 Pneumonia in Saudi Arabia: A Retrospective Single-Center Study.","Acute pulmonary embolism (APE) is a common and prognostically significant complication of COVID-19 infection. We investigated the clinical characteristics and chest CT findings of COVID-19 positive patients complicated with APE. A retrospective, record-based, case-series study was performed examining 483 patients admitted to King Saud Medical City during the pandemic, from April 2020 to June 2020. Of these, 92 patients who underwent chest CT scans were included in the final analysis. The inciden","2021","07","14","J Saudi Heart Assoc","Journal of the Saudi Heart Association","COVID_19; Coagulopathy; Pulmonary embolism; Saudi Arabia","Aldossari","Mubarak A","Heart Health Center, King Saud Medical City, Riyadh, Saudi Arabia",NA
"474","34183909","10.37616/2212-5043.1253","The Incidence of Acute Pulmonary Embolism with COVID-19 Pneumonia in Saudi Arabia: A Retrospective Single-Center Study.","Acute pulmonary embolism (APE) is a common and prognostically significant complication of COVID-19 infection. We investigated the clinical characteristics and chest CT findings of COVID-19 positive patients complicated with APE. A retrospective, record-based, case-series study was performed examining 483 patients admitted to King Saud Medical City during the pandemic, from April 2020 to June 2020. Of these, 92 patients who underwent chest CT scans were included in the final analysis. The inciden","2021","07","14","J Saudi Heart Assoc","Journal of the Saudi Heart Association","COVID_19; Coagulopathy; Pulmonary embolism; Saudi Arabia","Amer","Hala A","Department of Prevention and Control of Infection, King Saud Medical City, Riyadh, Saudi Arabia",NA
"475","34183909","10.37616/2212-5043.1253","The Incidence of Acute Pulmonary Embolism with COVID-19 Pneumonia in Saudi Arabia: A Retrospective Single-Center Study.","Acute pulmonary embolism (APE) is a common and prognostically significant complication of COVID-19 infection. We investigated the clinical characteristics and chest CT findings of COVID-19 positive patients complicated with APE. A retrospective, record-based, case-series study was performed examining 483 patients admitted to King Saud Medical City during the pandemic, from April 2020 to June 2020. Of these, 92 patients who underwent chest CT scans were included in the final analysis. The inciden","2021","07","14","J Saudi Heart Assoc","Journal of the Saudi Heart Association","COVID_19; Coagulopathy; Pulmonary embolism; Saudi Arabia","Saadeddin","Hiba M","Heart Health Center, King Saud Medical City, Riyadh, Saudi Arabia",NA
"476","34183909","10.37616/2212-5043.1253","The Incidence of Acute Pulmonary Embolism with COVID-19 Pneumonia in Saudi Arabia: A Retrospective Single-Center Study.","Acute pulmonary embolism (APE) is a common and prognostically significant complication of COVID-19 infection. We investigated the clinical characteristics and chest CT findings of COVID-19 positive patients complicated with APE. A retrospective, record-based, case-series study was performed examining 483 patients admitted to King Saud Medical City during the pandemic, from April 2020 to June 2020. Of these, 92 patients who underwent chest CT scans were included in the final analysis. The inciden","2021","07","14","J Saudi Heart Assoc","Journal of the Saudi Heart Association","COVID_19; Coagulopathy; Pulmonary embolism; Saudi Arabia","Abulhamid","Sara W","College of Medicine, Alfaisal University, Riyadh, Saudi Arabia",NA
"477","34183909","10.37616/2212-5043.1253","The Incidence of Acute Pulmonary Embolism with COVID-19 Pneumonia in Saudi Arabia: A Retrospective Single-Center Study.","Acute pulmonary embolism (APE) is a common and prognostically significant complication of COVID-19 infection. We investigated the clinical characteristics and chest CT findings of COVID-19 positive patients complicated with APE. A retrospective, record-based, case-series study was performed examining 483 patients admitted to King Saud Medical City during the pandemic, from April 2020 to June 2020. Of these, 92 patients who underwent chest CT scans were included in the final analysis. The inciden","2021","07","14","J Saudi Heart Assoc","Journal of the Saudi Heart Association","COVID_19; Coagulopathy; Pulmonary embolism; Saudi Arabia","Bhat","Fayaz A","Heart Health Center, King Saud Medical City, Riyadh, Saudi Arabia",NA
"478","34183909","10.37616/2212-5043.1253","The Incidence of Acute Pulmonary Embolism with COVID-19 Pneumonia in Saudi Arabia: A Retrospective Single-Center Study.","Acute pulmonary embolism (APE) is a common and prognostically significant complication of COVID-19 infection. We investigated the clinical characteristics and chest CT findings of COVID-19 positive patients complicated with APE. A retrospective, record-based, case-series study was performed examining 483 patients admitted to King Saud Medical City during the pandemic, from April 2020 to June 2020. Of these, 92 patients who underwent chest CT scans were included in the final analysis. The inciden","2021","07","14","J Saudi Heart Assoc","Journal of the Saudi Heart Association","COVID_19; Coagulopathy; Pulmonary embolism; Saudi Arabia","Elsheikh","Eman","Internal Medicine Department, College of Medicine, King Faisal University, Alahsa, Saudi Arabia",NA
"479","34183903","10.1016/j.rinp.2021.104478","Analysis of COVID-19 using a modified SLIR model with nonlinear incidence.","Infectious diseases kill millions of people each year, and they are the major public health problem in the world. This paper presents a modified Susceptible-Latent-Infected-Removed (SLIR) compartmental model of disease transmission with nonlinear incidence. We have obtained a threshold value of basic reproduction number <mml:math xmlns:mml=""http://www.w3.org/1998/Math/MathML""><mml:mrow><mml:mo>(</mml:mo> <mml:msub><mml:mi>R</mml:mi> <mml:mn>0</mml:mn></mml:msub> <mml:mo>)</mml:mo></mml:mr","2021","07","24","Results Phys","Results in physics","COVID-19; Epidemic model; Nonlinear incidence; Simulations; Stability analysis","Kuddus","Md Abdul","Department of Mathematics, University of Rajshahi, Rajshahi 6205, Bangladesh",NA
"480","34183903","10.1016/j.rinp.2021.104478","Analysis of COVID-19 using a modified SLIR model with nonlinear incidence.","Infectious diseases kill millions of people each year, and they are the major public health problem in the world. This paper presents a modified Susceptible-Latent-Infected-Removed (SLIR) compartmental model of disease transmission with nonlinear incidence. We have obtained a threshold value of basic reproduction number <mml:math xmlns:mml=""http://www.w3.org/1998/Math/MathML""><mml:mrow><mml:mo>(</mml:mo> <mml:msub><mml:mi>R</mml:mi> <mml:mn>0</mml:mn></mml:msub> <mml:mo>)</mml:mo></mml:mr","2021","07","24","Results Phys","Results in physics","COVID-19; Epidemic model; Nonlinear incidence; Simulations; Stability analysis","Rahman","Azizur","School of Computing and Mathematics, Charles Sturt University, Wagga Wagga, NSW 2678, Australia",NA
"481","34183902","10.1016/j.amsu.2021.102513","Emergent spine surgery during COVID-19 pandemic: 10 Months experience in Dr. Sardjito general hospital, Indonesia a case series.","During the COVID-19 pandemic, the spine surgeon had to deal with some new challenges in treating emergency spine cases. This paper aimed to report our experience with spine emergency surgery during the pandemic, with already limited resources for surgery. This was a retrospective, single-center study, involving all patients admitted to our hospital during a period of 1st March - 31<sup>st</sup> December 2020 and underwent emergent spinal surgery. The data were collected from the patients' medica","2021","06","30","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Covid-19 pandemic; Emergency spine surgery; Spine surgery; Spine trauma; Strategy during COVID-19 pandemic","Sakti","Yudha Mathan","Staff of Department of Orthopaedics and Traumatology, Dr. Sardjito General Hospital/Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Sleman Regency, Yogyakarta Special Region, Indonesia",NA
"482","34183902","10.1016/j.amsu.2021.102513","Emergent spine surgery during COVID-19 pandemic: 10 Months experience in Dr. Sardjito general hospital, Indonesia a case series.","During the COVID-19 pandemic, the spine surgeon had to deal with some new challenges in treating emergency spine cases. This paper aimed to report our experience with spine emergency surgery during the pandemic, with already limited resources for surgery. This was a retrospective, single-center study, involving all patients admitted to our hospital during a period of 1st March - 31<sup>st</sup> December 2020 and underwent emergent spinal surgery. The data were collected from the patients' medica","2021","06","30","Ann Med Surg (Lond)","Annals of medicine and surgery (2012)","Covid-19 pandemic; Emergency spine surgery; Spine surgery; Spine trauma; Strategy during COVID-19 pandemic","Khadafi","Rosyad Nur","Resident of Department of Orthopaedics and Traumatology, Dr. Sardjito General Hospital/Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Sleman Regency, Yogyakarta Special Region, Indonesia",NA
"483","34183901","10.1093/toxres/tfab015","COVID-19, hydroxychloroquine and the importance of disease progression.","The COVID-19 pandemic struck swiftly and forcefully. The medical response both commercial and clinical achieved what it could with the resources it had. In addition, society changed old habits and developed new behavior patterns. It is appropriate to identify what lessons were learned from COVID-19 for the future. The most important observation for managing SARS-CoV-2 infections was the identification, but not necessarily appreciation, of the manner in which the virus acts over time in the host ","2021","06","30","Toxicol Res (Camb)","Toxicology research","COVID-19; SARS-CoV-2; hydroxychloroquine (HCQ); pandemic","Budny","John A","PharmaCal, Ltd., 2205 Hilltop Dr. #190, Redding, CA 96002, USA",NA
"484","34183873","10.1016/j.chaos.2021.111188","Modeling the dynamic of COVID-19 with different types of transmissions.","In this paper, we propose a new epidemiological mathematical model for the spread of the COVID-19 disease with a special focus on the transmissibility of individuals with severe symptoms, mild symptoms, and asymptomatic symptoms. We compute the basic reproduction number and we study the local stability of the disease-free equilibrium in terms of the basic reproduction number. Numerical simulations were employed to illustrate our results. Furthermore, we study the present model in case we took in","2021","06","30","Chaos Solitons Fractals","Chaos, solitons, and fractals","34D05; 92D30; Basic reproduction number; Epidemic model; Stability; Vaccination","Amouch","Mohamed","Department of Mathematics, Faculty of Science, University Chouaib Doukkali, Eljadida, Morocco",NA
"485","34183873","10.1016/j.chaos.2021.111188","Modeling the dynamic of COVID-19 with different types of transmissions.","In this paper, we propose a new epidemiological mathematical model for the spread of the COVID-19 disease with a special focus on the transmissibility of individuals with severe symptoms, mild symptoms, and asymptomatic symptoms. We compute the basic reproduction number and we study the local stability of the disease-free equilibrium in terms of the basic reproduction number. Numerical simulations were employed to illustrate our results. Furthermore, we study the present model in case we took in","2021","06","30","Chaos Solitons Fractals","Chaos, solitons, and fractals","34D05; 92D30; Basic reproduction number; Epidemic model; Stability; Vaccination","Karim","Noureddine","Department of Mathematics, Faculty of Science, University Chouaib Doukkali, Eljadida, Morocco",NA
"486","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Yu","Shujuan","College of Chemistry, Fuzhou University, Fujian, 350108, China",NA
"487","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Sun","Gaohui","College of Chemistry, Fuzhou University, Fujian, 350108, China",NA
"488","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Sui","Yaqun","College of Chemistry, Fuzhou University, Fujian, 350108, China",NA
"489","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Li","Hanlin","College of Chemistry, Fuzhou University, Fujian, 350108, China",NA
"490","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Mai","Yuhan","College of Chemistry, Fuzhou University, Fujian, 350108, China",NA
"491","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Wang","Guodong","College of Chemistry, Fuzhou University, Fujian, 350108, China",NA
"492","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Zhang","Ning","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, 100101, China",NA
"493","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Bi","Yuhai","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, 100101, China",NA
"494","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Gao","George F","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, 100101, China",NA
"495","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Xu","Peng","College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian, 350108, China",NA
"496","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Jiang","Longguang","College of Chemistry, Fuzhou University, Fujian, 350108, China",NA
"497","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Yuan","Cai","College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian, 350108, China",NA
"498","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Yang","Yang","Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China",NA
"499","34183871","10.1016/j.dyepig.2021.109570","Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) posed a major challenge to the public health. Currently, no proven antiviral treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is available. Here we report compounds pentalysine ß-carbonylphthalocyanine zinc (ZnPc5K) and chlorin e6 (ce6) potently inhibited the viral infection and replication in vitro with EC50 values at nanomolar level. These compounds were first identified by screening a pa","2021","06","30","Dyes Pigm","Dyes and pigments : an international journal","COVID-19; Photodynamic; Photosensitizer; SARS-CoV-2 inactivation","Huang","Mingdong","College of Chemistry, Fuzhou University, Fujian, 350108, China",NA
"500","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Nguyen","Peter Q","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA",NA
"501","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Soenksen","Luis R","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA",NA
"502","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Donghia","Nina M","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA",NA
"503","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Angenent-Mari","Nicolaas M","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA",NA
"504","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"de Puig","Helena","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA",NA
"505","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Huang","Ally","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA",NA
"506","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Lee","Rose","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA",NA
"507","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Slomovic","Shimyn","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA",NA
"508","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Galbersanini","Tommaso","DREAMLUX, Samsara S.r.l., Milan, Italy",NA
"509","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Lansberry","Geoffrey","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA",NA
"510","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Sallum","Hani M","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA",NA
"511","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Zhao","Evan M","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA",NA
"512","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Niemi","James B","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA",NA
"513","34183860","10.1038/s41587-021-00950-3","Wearable materials with embedded synthetic biology sensors for biomolecule detection.","Integrating synthetic biology into wearables could expand opportunities for noninvasive monitoring of physiological status, disease states and exposure to pathogens or toxins. However, the operation of synthetic circuits generally requires the presence of living, engineered bacteria, which has limited their application in wearables. Here we report lightweight, flexible substrates and textiles functionalized with freeze-dried, cell-free synthetic circuits, including CRISPR-based tools, that detec","2021","06","29","Nat Biotechnol","Nature biotechnology",NA,"Collins","James J","Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA. jimjc@mit","jimjc@mit.edu"
"514","34183855","10.1038/s41590-021-00971-9","A STING in the tail for SARS-CoV-2.",NA,"2021","07","01","Nat Immunol","Nature immunology",NA,"Bernard","Nicholas J","Nature Immunology, . Nick.Bernard@nature","Nick.Bernard@nature.com"
"515","34183852","10.1038/d41591-021-00042-4","Building a pandemic-proof vaccine.",NA,"2021","06","29","Nat Med","Nature medicine","Infectious diseases; SARS-CoV-2; Vaccines","O'Leary","Karen",NA,NA
"516","34183846","10.1038/d41586-021-01569-9","The COVID pandemic's lingering impact on clinical trials.",NA,"2021","07","19","Nature","Nature","Health care; Medical research; SARS-CoV-2; COVID-19; Humans; Pandemics; SARS-CoV-2","Ledford","Heidi",NA,NA
"517","34183842","10.1038/d41586-021-01597-5","Audio long-read: How COVID exposed flaws in evidence-based medicine.",NA,"2021","06","29","Nature","Nature","Health care; Medical research; SARS-CoV-2; Virology","Pearson","Helen",NA,NA
"518","34183842","10.1038/d41586-021-01597-5","Audio long-read: How COVID exposed flaws in evidence-based medicine.",NA,"2021","06","29","Nature","Nature","Health care; Medical research; SARS-CoV-2; Virology","Thompson","Benjamin",NA,NA
"519","34183836","10.1038/s41591-021-01430-6","Emergence of measles during the COVID-19 pandemic threatens Pakistan's children and the wider region.",NA,"2021","07","19","Nat Med","Nature medicine",NA,"Rana","Muhammad Suleman","National Institute of Health, Islamabad, Pakistan. ranavirologist@gmail","ranavirologist@gmail.com"
"520","34183836","10.1038/s41591-021-01430-6","Emergence of measles during the COVID-19 pandemic threatens Pakistan's children and the wider region.",NA,"2021","07","19","Nat Med","Nature medicine",NA,"Alam","Muhammad Masroor","National Institute of Health, Islamabad, Pakistan",NA
"521","34183836","10.1038/s41591-021-01430-6","Emergence of measles during the COVID-19 pandemic threatens Pakistan's children and the wider region.",NA,"2021","07","19","Nat Med","Nature medicine",NA,"Ikram","Aamer","National Institute of Health, Islamabad, Pakistan",NA
"522","34183836","10.1038/s41591-021-01430-6","Emergence of measles during the COVID-19 pandemic threatens Pakistan's children and the wider region.",NA,"2021","07","19","Nat Med","Nature medicine",NA,"Salman","Muhammad","National Institute of Health, Islamabad, Pakistan",NA
"523","34183836","10.1038/s41591-021-01430-6","Emergence of measles during the COVID-19 pandemic threatens Pakistan's children and the wider region.",NA,"2021","07","19","Nat Med","Nature medicine",NA,"Mere","Mohammad Osama","World Health Organization, Islamabad, Pakistan",NA
"524","34183836","10.1038/s41591-021-01430-6","Emergence of measles during the COVID-19 pandemic threatens Pakistan's children and the wider region.",NA,"2021","07","19","Nat Med","Nature medicine",NA,"Usman","Muhammad","National Institute of Health, Islamabad, Pakistan",NA
"525","34183836","10.1038/s41591-021-01430-6","Emergence of measles during the COVID-19 pandemic threatens Pakistan's children and the wider region.",NA,"2021","07","19","Nat Med","Nature medicine",NA,"Umair","Massab","National Institute of Health, Islamabad, Pakistan",NA
"526","34183836","10.1038/s41591-021-01430-6","Emergence of measles during the COVID-19 pandemic threatens Pakistan's children and the wider region.",NA,"2021","07","19","Nat Med","Nature medicine",NA,"Zaidi","Syed Sohail Zahoor","National Institute of Health, Islamabad, Pakistan",NA
"527","34183836","10.1038/s41591-021-01430-6","Emergence of measles during the COVID-19 pandemic threatens Pakistan's children and the wider region.",NA,"2021","07","19","Nat Med","Nature medicine",NA,"Arshad","Yasir","National Institute of Health, Islamabad, Pakistan",NA
"528","34183834","10.1038/s41591-021-01424-4","Asian healthcare workers in the COVID-19 pandemic: a long road to recovery.",NA,"2021","07","23","Nat Med","Nature medicine","Asian Americans; COVID-19; Emigrants and Immigrants; Health Personnel; Humans; Racism; SARS-CoV-2; United States; Violence","Wu","Jo-Hsuan","Shiley Eye Institute and Viterbi Family Department of Ophthalmology, University of California, San Diego, CA, USA. Uuuuuu1swu@gmail","Uuuuuu1swu@gmail.com"
"529","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Bedson","Jamie","Independent Consultant, Seattle, WA, USA",NA
"530","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Skrip","Laura A","Institute for Disease Modeling, Global Health, Bill &amp",NA
"531","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Pedi","Danielle","Bill &amp",NA
"532","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Abramowitz","Sharon","Independent Consultant, Isle la Motte, VT, USA",NA
"533","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Carter","Simone","Social Science Analytics Cell, UNICEF, Kinshasa, Democratic Republic of the Congo",NA
"534","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Jalloh","Mohamed F","Karolinska Institutet, Stockholm, Sweden",NA
"535","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Funk","Sebastian","Centre for Mathematical Modelling of Infectious Disease Dynamics, London School of Hygiene &amp",NA
"536","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Gobat","Nina","University of Oxford, Oxford, UK",NA
"537","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Giles-Vernick","Tamara","Institut Pasteur, Paris, France",NA
"538","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Chowell","Gerardo","Population Health Sciences, School of Public Health, Georgia State University, Atlanta, GA, USA",NA
"539","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"de Almeida","João Rangel","Wellcome Trust, London, UK",NA
"540","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Elessawi","Rania","UNICEF C4D, New York, NY, USA",NA
"541","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Scarpino","Samuel V","Network Science Institute, Northeastern University, Boston, MA, USA",NA
"542","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Hammond","Ross A","Santa Fe Institute, Santa Fe, NM, USA",NA
"543","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Briand","Sylvie","World Health Organization, Geneva, Switzerland",NA
"544","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Epstein","Joshua M","Santa Fe Institute, Santa Fe, NM, USA",NA
"545","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Hébert-Dufresne","Laurent","Vermont Complex Systems Center, University of Vermont, Burlington, VT, USA",NA
"546","34183799","10.1038/s41562-021-01136-2","A review and agenda for integrated disease models including social and behavioural factors.","Social and behavioural factors are critical to the emergence, spread and containment of human disease, and are key determinants of the course, duration and outcomes of disease outbreaks. Recent epidemics of Ebola in West Africa and coronavirus disease 2019 (COVID-19) globally have reinforced the importance of developing infectious disease models that better integrate social and behavioural dynamics and theories. Meanwhile, the growth in capacity, coordination and prioritization of social science","2021","07","23","Nat Hum Behav","Nature human behaviour",NA,"Althouse","Benjamin M","Institute for Disease Modeling, Global Health, Bill &amp","balthouse@idmod.org"
"547","34183789","10.1038/s41436-021-01243-5","An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.","It is critical to identify putative causal targets for SARS coronavirus 2, which may guide drug repurposing options to reduce the public health burden of COVID-19. We applied complementary methods and multiphased design to pinpoint the most likely causal genes for COVID-19 severity. First, we applied cross-methylome omnibus (CMO) test and leveraged data from the COVID-19 Host Genetics Initiative (HGI) comparing 9,986 hospitalized COVID-19 patients and 1,877,672 population controls. Second, we ev","2021","07","01","Genet Med","Genetics in medicine : official journal of the American College of Medical Genetics",NA,"Wu","Lang","Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USA. lwu@cc.hawaii","lwu@cc.hawaii.edu"
"548","34183789","10.1038/s41436-021-01243-5","An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.","It is critical to identify putative causal targets for SARS coronavirus 2, which may guide drug repurposing options to reduce the public health burden of COVID-19. We applied complementary methods and multiphased design to pinpoint the most likely causal genes for COVID-19 severity. First, we applied cross-methylome omnibus (CMO) test and leveraged data from the COVID-19 Host Genetics Initiative (HGI) comparing 9,986 hospitalized COVID-19 patients and 1,877,672 population controls. Second, we ev","2021","07","01","Genet Med","Genetics in medicine : official journal of the American College of Medical Genetics",NA,"Zhu","Jingjing","Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USA",NA
"549","34183789","10.1038/s41436-021-01243-5","An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.","It is critical to identify putative causal targets for SARS coronavirus 2, which may guide drug repurposing options to reduce the public health burden of COVID-19. We applied complementary methods and multiphased design to pinpoint the most likely causal genes for COVID-19 severity. First, we applied cross-methylome omnibus (CMO) test and leveraged data from the COVID-19 Host Genetics Initiative (HGI) comparing 9,986 hospitalized COVID-19 patients and 1,877,672 population controls. Second, we ev","2021","07","01","Genet Med","Genetics in medicine : official journal of the American College of Medical Genetics",NA,"Liu","Duo","Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USA",NA
"550","34183789","10.1038/s41436-021-01243-5","An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.","It is critical to identify putative causal targets for SARS coronavirus 2, which may guide drug repurposing options to reduce the public health burden of COVID-19. We applied complementary methods and multiphased design to pinpoint the most likely causal genes for COVID-19 severity. First, we applied cross-methylome omnibus (CMO) test and leveraged data from the COVID-19 Host Genetics Initiative (HGI) comparing 9,986 hospitalized COVID-19 patients and 1,877,672 population controls. Second, we ev","2021","07","01","Genet Med","Genetics in medicine : official journal of the American College of Medical Genetics",NA,"Sun","Yanfa","Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, HI, USA",NA
"551","34183789","10.1038/s41436-021-01243-5","An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.","It is critical to identify putative causal targets for SARS coronavirus 2, which may guide drug repurposing options to reduce the public health burden of COVID-19. We applied complementary methods and multiphased design to pinpoint the most likely causal genes for COVID-19 severity. First, we applied cross-methylome omnibus (CMO) test and leveraged data from the COVID-19 Host Genetics Initiative (HGI) comparing 9,986 hospitalized COVID-19 patients and 1,877,672 population controls. Second, we ev","2021","07","01","Genet Med","Genetics in medicine : official journal of the American College of Medical Genetics",NA,"Wu","Chong","Department of Statistics, Florida State University, Tallahassee, FL, USA. cwu3@fsu","cwu3@fsu.edu"
"552","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Gritti","Giuseppe","Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy. g.gritti@asst-pg23",NA
"553","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Raimondi","Federico","Pneumology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"554","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Bottazzi","Barbara","Humanitas Clinical and Research Center - IRCCS, Milan, Italy",NA
"555","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Ripamonti","Diego","Infectious Diseases Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"556","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Riva","Ivano","Intensive Care Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"557","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Landi","Francesco","Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"558","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Alborghetti","Leonardo","Infectious Diseases Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"559","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Frigeni","Marco","Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"560","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Damiani","Marianna","Intensive Care Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"561","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Micò","Caterina","Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"562","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Fagiuoli","Stefano","Gastroenterology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"563","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Lorini","Ferdinando Luca","Intensive Care Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"564","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Gandini","Lucia","Intensive Care Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"565","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Novelli","Luca","Pneumology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"566","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Morgan","Jonathan P","EUSA Pharma, Hemel Hempstead, UK",NA
"567","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Owens","Benjamin M J","EUSA Pharma, Hemel Hempstead, UK",NA
"568","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Kanhai","Karan J K","EUSA Pharma, Hemel Hempstead, UK",NA
"569","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Reljanovic","Gordana Tonkovic","ErgoMed PLC, Guildford, UK",NA
"570","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Rizzi","Marco","Infectious Diseases Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"571","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Di Marco","Fabiano","Pneumology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"572","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Mantovani","Alberto","Humanitas Clinical and Research Center - IRCCS, Milan, Italy",NA
"573","34183767","10.1038/s41375-021-01329-8","Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.",NA,"2021","07","01","Leukemia","Leukemia",NA,"Rambaldi","Alessandro","Hematology Unit, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII, Bergamo, Italy",NA
"574","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Cammarota","Gianmaria","Dipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy. gmcamma@gmail","gmcamma@gmail.com"
"575","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Vaschetto","Rosanna","Department of Anesthesia and Intensive Care, AAzienda Ospedaliero Universitaria ""Maggiore della Carità"", Novara, Italy",NA
"576","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Azzolina","Danila","Translational Medicine Department, Università ""del Piemonte Orientale"", Novara, Italy",NA
"577","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","De Vita","Nello","Translational Medicine Department, Università ""del Piemonte Orientale"", Novara, Italy",NA
"578","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Olivieri","Carlo","Anesthesia and Intensive Care, Ospedale Sant'Andrea"", Vercelli, Italy",NA
"579","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Ronco","Chiara","Anesthesia and Intensive Care, Ospedale Sant'Andrea"", Vercelli, Italy",NA
"580","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Longhini","Federico","Department of Medical and Surgical Science, Università ""Magna Graecia"", Catanzaro, Italy",NA
"581","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Bruni","Andrea","Department of Medical and Surgical Science, Università ""Magna Graecia"", Catanzaro, Italy",NA
"582","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Colombo","Davide","Department of Anesthesia and Critical Care, Ospedale ""Ss. Trinità"", Borgomanero, Italy",NA
"583","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Pissaia","Claudio","Department of Anesthesia and Critical Care, Ospedale ""degli Infermi"", Biella, Italy",NA
"584","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Prato","Federico","Department of Anesthesia and Critical Care, Ospedale ""degli Infermi"", Biella, Italy",NA
"585","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Maestrone","Carlo","Department of Anesthesia and Critical Care, Presidio Ospedaliero Domodossola e Verbania ""ASL VCO"", Domodossola-Verbania, Italy",NA
"586","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Maestrone","Matteo","Department of Anesthesia and Critical Care, Presidio Ospedaliero Domodossola e Verbania ""ASL VCO"", Domodossola-Verbania, Italy",NA
"587","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Vetrugno","Luigi","Department of Medicine, Anesthesia and Intensive Care Clinic, Università di Udine, Udine, Italy",NA
"588","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Bove","Tiziana","Department of Medicine, Anesthesia and Intensive Care Clinic, Università di Udine, Udine, Italy",NA
"589","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Lemut","Francesco","Department of Anesthesia and Critical Care, Ospedale ""Monsignor Giovanni Galliano"", Acqui Terme, Italy",NA
"590","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Taretto","Elisa","Department of Anesthesia and Critical Care, Ospedale ""Monsignor Giovanni Galliano"", Acqui Terme, Italy",NA
"591","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Locatelli","Alessandro","Department of Anesthesia and Critical Care, Azienda Ospedaliera ""Santa Croce e Carle"", Cuneo, Italy",NA
"592","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Barzaghi","Nicoletta","Department of Anesthesia and Critical Care, Azienda Ospedaliera ""Santa Croce e Carle"", Cuneo, Italy",NA
"593","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Cerrano","Martina","Department of Anesthesia and Critical Care, Azienda Ospedaliera ""Santa Croce e Carle"", Cuneo, Italy",NA
"594","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Ravera","Enrico","Department of Emergency Medicine-Anesthesia and Critical Care-Michele, Pietro Ferrero Hospital, Verduno, Italy",NA
"595","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Zanza","Christian","Department of Emergency Medicine-Anesthesia and Critical Care-Michele, Pietro Ferrero Hospital, Verduno, Italy",NA
"596","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Selva","Andrea Della","Department of Emergency Medicine-Anesthesia and Critical Care-Michele, Pietro Ferrero Hospital, Verduno, Italy",NA
"597","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Blangetti","Ilaria","Department of Anesthesia and Intensive Care, Ospedale ""Regina Montis Regalis"", Mondovì, Italy",NA
"598","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Salvo","Francesco","Department of Anesthesia and Intensive Care, Ospedale ""Regina Montis Regalis"", Mondovì, Italy",NA
"599","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Racca","Fabrizio","Department of Anesthesia and Intensive Care, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy",NA
"600","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Longhitano","Yaroslava","Department of Anesthesia and Intensive Care, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy",NA
"601","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Boscolo","Annalisa","Anesthesia and Intensive Care Unit, Ospedale Universitario di Padova, Padova, Italy",NA
"602","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Sguazzotti","Ilaria","Department of Anesthesia and Intensive Care, AAzienda Ospedaliero Universitaria ""Maggiore della Carità"", Novara, Italy",NA
"603","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Bonato","Valeria","Department of Anesthesia and Intensive Care, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy",NA
"604","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Grossi","Francesca","Department of Anesthesia and Intensive Care, AAzienda Ospedaliero Universitaria ""Maggiore della Carità"", Novara, Italy",NA
"605","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Crimaldi","Federico","Translational Medicine Department, Università ""del Piemonte Orientale"", Novara, Italy",NA
"606","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Perucca","Raffaella","Department of Anesthesia and Intensive Care, AAzienda Ospedaliero Universitaria ""Maggiore della Carità"", Novara, Italy",NA
"607","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Boniolo","Ester","Translational Medicine Department, Università ""del Piemonte Orientale"", Novara, Italy",NA
"608","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Verdina","Federico","Translational Medicine Department, Università ""del Piemonte Orientale"", Novara, Italy",NA
"609","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Vignazia","Gian Luca","Department of Anesthesia and Intensive Care, AAzienda Ospedaliero Universitaria ""Maggiore della Carità"", Novara, Italy",NA
"610","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Santangelo","Erminio","Translational Medicine Department, Università ""del Piemonte Orientale"", Novara, Italy",NA
"611","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Tarquini","Riccardo","Translational Medicine Department, Università ""del Piemonte Orientale"", Novara, Italy",NA
"612","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Zanoni","Marta","Department of Anesthesia and Intensive Care, AAzienda Ospedaliero Universitaria ""Maggiore della Carità"", Novara, Italy",NA
"613","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Messina","Antonio","Humanitas, Clinical and Research Center - IRCCS, Rozzano, Milan, Italy",NA
"614","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Marin","Matteo","Department of Medicine, Anesthesia and Intensive Care Clinic, Università di Udine, Udine, Italy",NA
"615","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Bacigalupo","Paola","Department of Anesthesia and Critical Care, Ospedale ""Monsignor Giovanni Galliano"", Acqui Terme, Italy",NA
"616","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Sileci","Graziana","Department of Anesthesia and Critical Care, Ospedale ""Monsignor Giovanni Galliano"", Acqui Terme, Italy",NA
"617","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Sella","Nicolò","Department of Medicine-DIMED, Università di Padova, Padova, Italy",NA
"618","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","De Robertis","Edardo","Dipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy",NA
"619","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Corte","Francesco Della","Department of Anesthesia and Intensive Care, AAzienda Ospedaliero Universitaria ""Maggiore della Carità"", Novara, Italy",NA
"620","34183764","10.1038/s41598-021-92960-z","Early extubation with immediate non-invasive ventilation versus standard weaning in intubated patients for coronavirus disease 2019: a retrospective multicenter study.","In patients intubated for hypoxemic acute respiratory failure (ARF) related to novel coronavirus disease (COVID-19), we retrospectively compared two weaning strategies, early extubation with immediate non-invasive ventilation (NIV) versus standard weaning encompassing spontaneous breathing trial (SBT), with respect to IMV duration (primary endpoint), extubation failures and reintubations, rate of tracheostomy, intensive care unit (ICU) length of stay and mortality (additional endpoints). All COV","2021","07","08","Sci Rep","Scientific reports","Aged; COVID-19; Comorbidity; Female; Hospital Mortality; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Retrospective Studies; SARS-CoV-2; Time Factors; Tracheostomy; Ventilator Weaning","Navalesi","Paolo","Anesthesia and Intensive Care Unit, Ospedale Universitario di Padova, Padova, Italy",NA
"621","34183756","10.1038/s41401-021-00697-2","Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.","Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a variety of therapeutic agents, including antiviral drugs, anti-inflammatory drugs, and other Western medicines. However, it is unclear whether Jingyin granules modulate the pharmacokinetics of Western ","2021","07","01","Acta Pharmacol Sin","Acta pharmacologica Sinica","CYP3A substrate-drugs; cytochrome P450 enzymes (CYPs/P450s); herbal extract of Jingyin granules (HEJG); herbdrug interactions (HDIs)","Zhang","Feng","Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China",NA
"622","34183756","10.1038/s41401-021-00697-2","Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.","Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a variety of therapeutic agents, including antiviral drugs, anti-inflammatory drugs, and other Western medicines. However, it is unclear whether Jingyin granules modulate the pharmacokinetics of Western ","2021","07","01","Acta Pharmacol Sin","Acta pharmacologica Sinica","CYP3A substrate-drugs; cytochrome P450 enzymes (CYPs/P450s); herbal extract of Jingyin granules (HEJG); herbdrug interactions (HDIs)","Liu","Wei","Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China",NA
"623","34183756","10.1038/s41401-021-00697-2","Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.","Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a variety of therapeutic agents, including antiviral drugs, anti-inflammatory drugs, and other Western medicines. However, it is unclear whether Jingyin granules modulate the pharmacokinetics of Western ","2021","07","01","Acta Pharmacol Sin","Acta pharmacologica Sinica","CYP3A substrate-drugs; cytochrome P450 enzymes (CYPs/P450s); herbal extract of Jingyin granules (HEJG); herbdrug interactions (HDIs)","Huang","Jian","Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China",NA
"624","34183756","10.1038/s41401-021-00697-2","Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.","Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a variety of therapeutic agents, including antiviral drugs, anti-inflammatory drugs, and other Western medicines. However, it is unclear whether Jingyin granules modulate the pharmacokinetics of Western ","2021","07","01","Acta Pharmacol Sin","Acta pharmacologica Sinica","CYP3A substrate-drugs; cytochrome P450 enzymes (CYPs/P450s); herbal extract of Jingyin granules (HEJG); herbdrug interactions (HDIs)","Chen","Qi-Long","Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China",NA
"625","34183756","10.1038/s41401-021-00697-2","Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.","Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a variety of therapeutic agents, including antiviral drugs, anti-inflammatory drugs, and other Western medicines. However, it is unclear whether Jingyin granules modulate the pharmacokinetics of Western ","2021","07","01","Acta Pharmacol Sin","Acta pharmacologica Sinica","CYP3A substrate-drugs; cytochrome P450 enzymes (CYPs/P450s); herbal extract of Jingyin granules (HEJG); herbdrug interactions (HDIs)","Wang","Dan-Dan","SPH Xing Ling Sci. &amp",NA
"626","34183756","10.1038/s41401-021-00697-2","Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.","Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a variety of therapeutic agents, including antiviral drugs, anti-inflammatory drugs, and other Western medicines. However, it is unclear whether Jingyin granules modulate the pharmacokinetics of Western ","2021","07","01","Acta Pharmacol Sin","Acta pharmacologica Sinica","CYP3A substrate-drugs; cytochrome P450 enzymes (CYPs/P450s); herbal extract of Jingyin granules (HEJG); herbdrug interactions (HDIs)","Zou","Li-Wei","Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China",NA
"627","34183756","10.1038/s41401-021-00697-2","Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.","Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a variety of therapeutic agents, including antiviral drugs, anti-inflammatory drugs, and other Western medicines. However, it is unclear whether Jingyin granules modulate the pharmacokinetics of Western ","2021","07","01","Acta Pharmacol Sin","Acta pharmacologica Sinica","CYP3A substrate-drugs; cytochrome P450 enzymes (CYPs/P450s); herbal extract of Jingyin granules (HEJG); herbdrug interactions (HDIs)","Zhao","Yong-Fang","Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China",NA
"628","34183756","10.1038/s41401-021-00697-2","Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.","Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a variety of therapeutic agents, including antiviral drugs, anti-inflammatory drugs, and other Western medicines. However, it is unclear whether Jingyin granules modulate the pharmacokinetics of Western ","2021","07","01","Acta Pharmacol Sin","Acta pharmacologica Sinica","CYP3A substrate-drugs; cytochrome P450 enzymes (CYPs/P450s); herbal extract of Jingyin granules (HEJG); herbdrug interactions (HDIs)","Zhang","Wei-Dong","Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China",NA
"629","34183756","10.1038/s41401-021-00697-2","Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.","Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a variety of therapeutic agents, including antiviral drugs, anti-inflammatory drugs, and other Western medicines. However, it is unclear whether Jingyin granules modulate the pharmacokinetics of Western ","2021","07","01","Acta Pharmacol Sin","Acta pharmacologica Sinica","CYP3A substrate-drugs; cytochrome P450 enzymes (CYPs/P450s); herbal extract of Jingyin granules (HEJG); herbdrug interactions (HDIs)","Xu","Jian-Guang","Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China",NA
"630","34183756","10.1038/s41401-021-00697-2","Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.","Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a variety of therapeutic agents, including antiviral drugs, anti-inflammatory drugs, and other Western medicines. However, it is unclear whether Jingyin granules modulate the pharmacokinetics of Western ","2021","07","01","Acta Pharmacol Sin","Acta pharmacologica Sinica","CYP3A substrate-drugs; cytochrome P450 enzymes (CYPs/P450s); herbal extract of Jingyin granules (HEJG); herbdrug interactions (HDIs)","Chen","Hong-Zhuan","Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. hongzhuan_chen@hotmail","chen@hotmail.com"
"631","34183756","10.1038/s41401-021-00697-2","Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.","Jingyin granules, a marketed antiviral herbal medicine, have been recommended for treating H1N1 influenza A virus infection and Coronavirus disease 2019 (COVID-19) in China. To fight viral diseases in a more efficient way, Jingyin granules are frequently co-administered in clinical settings with a variety of therapeutic agents, including antiviral drugs, anti-inflammatory drugs, and other Western medicines. However, it is unclear whether Jingyin granules modulate the pharmacokinetics of Western ","2021","07","01","Acta Pharmacol Sin","Acta pharmacologica Sinica","CYP3A substrate-drugs; cytochrome P450 enzymes (CYPs/P450s); herbal extract of Jingyin granules (HEJG); herbdrug interactions (HDIs)","Ge","Guang-Bo","Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. geguangbo@dicp.ac","geguangbo@dicp.ac.cn"
"632","34183752","10.1038/s41598-021-92881-x","Structural characterisation of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9.","MMP-9 plays a number of important physiological functions but is also responsible for many pathological processes, including cancer invasion, metastasis, and angiogenesis. It is, therefore, crucial to understand its enzymatic activity, including activation and inhibition mechanisms. This enzyme may also be partially involved in the ""cytokine storm"" that is characteristic of COVID-19 disease (SARS-CoV-2), as well as in the molecular mechanisms responsible for lung fibrosis. Due to the variety of ","2021","07","08","Sci Rep","Scientific reports","Enzyme Precursors; Humans; Matrix Metalloproteinase 9; Molecular Dynamics Simulation; Protein Binding; Protein Domains; Protein Multimerization; Static Electricity; Tissue Inhibitor of Metalloproteinase-1","Charzewski","Lukasz","Department of Biophysics, Faculty of Physics, University of Warsaw, Pasteura 5, 02-093, Warsaw, Poland",NA
"633","34183752","10.1038/s41598-021-92881-x","Structural characterisation of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9.","MMP-9 plays a number of important physiological functions but is also responsible for many pathological processes, including cancer invasion, metastasis, and angiogenesis. It is, therefore, crucial to understand its enzymatic activity, including activation and inhibition mechanisms. This enzyme may also be partially involved in the ""cytokine storm"" that is characteristic of COVID-19 disease (SARS-CoV-2), as well as in the molecular mechanisms responsible for lung fibrosis. Due to the variety of ","2021","07","08","Sci Rep","Scientific reports","Enzyme Precursors; Humans; Matrix Metalloproteinase 9; Molecular Dynamics Simulation; Protein Binding; Protein Domains; Protein Multimerization; Static Electricity; Tissue Inhibitor of Metalloproteinase-1","Krzysko","Krystiana A","Department of Biophysics, Faculty of Physics, University of Warsaw, Pasteura 5, 02-093, Warsaw, Poland. krzysko@fuw.edu","krzysko@fuw.edu.pl"
"634","34183752","10.1038/s41598-021-92881-x","Structural characterisation of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9.","MMP-9 plays a number of important physiological functions but is also responsible for many pathological processes, including cancer invasion, metastasis, and angiogenesis. It is, therefore, crucial to understand its enzymatic activity, including activation and inhibition mechanisms. This enzyme may also be partially involved in the ""cytokine storm"" that is characteristic of COVID-19 disease (SARS-CoV-2), as well as in the molecular mechanisms responsible for lung fibrosis. Due to the variety of ","2021","07","08","Sci Rep","Scientific reports","Enzyme Precursors; Humans; Matrix Metalloproteinase 9; Molecular Dynamics Simulation; Protein Binding; Protein Domains; Protein Multimerization; Static Electricity; Tissue Inhibitor of Metalloproteinase-1","Lesyng","Bogdan","Department of Biophysics, Faculty of Physics, University of Warsaw, Pasteura 5, 02-093, Warsaw, Poland",NA
"635","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Tojo","Kentaro","Department of Anesthesiology and Critical Care Medicine, Yokohama City University School of Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. ktojo@yokohama-cu.ac",NA
"636","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Sugawara","Yoh","Department of Anesthesiology, Yokohama Municipal Citizen's Hospital, Yokohama, 221-0085, Japan",NA
"637","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Oi","Yasufumi","Department of Emergency Medicine, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan",NA
"638","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Ogawa","Fumihiro","Department of Emergency Medicine, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan",NA
"639","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Higurashi","Takuma","Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan",NA
"640","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Yoshimura","Yukihiro","Department of Infection Medicine, Yokohama Municipal Citizen's Hospital, Yokohama, 221-0085, Japan",NA
"641","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Miyata","Nobuyuki","Department of Infection Medicine, Yokohama Municipal Citizen's Hospital, Yokohama, 221-0085, Japan",NA
"642","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Hayami","Hajime","Department of Anesthesiology, Yokohama Municipal Citizen's Hospital, Yokohama, 221-0085, Japan",NA
"643","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Yamaguchi","Yoshikazu","Department of Anesthesiology, Yokohama Municipal Citizen's Hospital, Yokohama, 221-0085, Japan",NA
"644","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Ishikawa","Yoko","Department of Anesthesiology and Critical Care Medicine, Yokohama City University School of Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan",NA
"645","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Takeuchi","Ichiro","Department of Emergency Medicine, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan",NA
"646","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Tachikawa","Natsuo","Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan",NA
"647","34183735","10.1038/s41598-021-92921-6","The U-shaped association of serum iron level with disease severity in adult hospitalized patients with COVID-19.","Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that leads to severe respiratory failure (RF). It is known that host exposure to viral infection triggers an iron-lowering response to mitigate pathogenic load and tissue damage. However, the association between host iron-lowering response and COVID-19 severity is not clear. This two-center observational study of 136 adult hospitalized COVID-19 patients analyzed the association between disease severity and initial serum iron, ","2021","07","08","Sci Rep","Scientific reports","Adult; Aged; COVID-19; Female; Ferritins; Hospitalization; Humans; Iron; Logistic Models; Male; Middle Aged; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Transferrin","Goto","Takahisa","Department of Anesthesiology and Critical Care Medicine, Yokohama City University School of Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan",NA
"648","34183727","10.1038/s41598-021-92636-8","A control framework to optimize public health policies in the course of the COVID-19 pandemic.","The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able","2021","07","08","Sci Rep","Scientific reports","Algorithms; Brazil; COVID-19; Health Policy; Humans; Models, Theoretical; Pandemics; Public Policy; SARS-CoV-2","Pataro","Igor M L","Department of Informatics, University of Almería, Almería, Spain. ilp428@inlumine.ual","ilp428@inlumine.ual.es"
"649","34183727","10.1038/s41598-021-92636-8","A control framework to optimize public health policies in the course of the COVID-19 pandemic.","The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able","2021","07","08","Sci Rep","Scientific reports","Algorithms; Brazil; COVID-19; Health Policy; Humans; Models, Theoretical; Pandemics; Public Policy; SARS-CoV-2","Oliveira","Juliane F","Center for Data and Knowledge Integration for Health (CIDACS), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Bahia, Brazil. julianlanzin@gmail","julianlanzin@gmail.com"
"650","34183727","10.1038/s41598-021-92636-8","A control framework to optimize public health policies in the course of the COVID-19 pandemic.","The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able","2021","07","08","Sci Rep","Scientific reports","Algorithms; Brazil; COVID-19; Health Policy; Humans; Models, Theoretical; Pandemics; Public Policy; SARS-CoV-2","Morato","Marcelo M","Department of Automation and Systems, Federal University of Santa Catarina, Florianópolis, Brazil",NA
"651","34183727","10.1038/s41598-021-92636-8","A control framework to optimize public health policies in the course of the COVID-19 pandemic.","The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able","2021","07","08","Sci Rep","Scientific reports","Algorithms; Brazil; COVID-19; Health Policy; Humans; Models, Theoretical; Pandemics; Public Policy; SARS-CoV-2","Amad","Alan A S","College of Engineering, Swansea University, Swansea, Wales, UK",NA
"652","34183727","10.1038/s41598-021-92636-8","A control framework to optimize public health policies in the course of the COVID-19 pandemic.","The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able","2021","07","08","Sci Rep","Scientific reports","Algorithms; Brazil; COVID-19; Health Policy; Humans; Models, Theoretical; Pandemics; Public Policy; SARS-CoV-2","Ramos","Pablo I P","Center for Data and Knowledge Integration for Health (CIDACS), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Bahia, Brazil",NA
"653","34183727","10.1038/s41598-021-92636-8","A control framework to optimize public health policies in the course of the COVID-19 pandemic.","The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able","2021","07","08","Sci Rep","Scientific reports","Algorithms; Brazil; COVID-19; Health Policy; Humans; Models, Theoretical; Pandemics; Public Policy; SARS-CoV-2","Pereira","Felipe A C","Institute of Physics, University of São Paulo, São Paulo, Brazil",NA
"654","34183727","10.1038/s41598-021-92636-8","A control framework to optimize public health policies in the course of the COVID-19 pandemic.","The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able","2021","07","08","Sci Rep","Scientific reports","Algorithms; Brazil; COVID-19; Health Policy; Humans; Models, Theoretical; Pandemics; Public Policy; SARS-CoV-2","Silva","Mateus S","Institute of Physics, Federal University of Bahia, Salvador, Bahia, Brazil",NA
"655","34183727","10.1038/s41598-021-92636-8","A control framework to optimize public health policies in the course of the COVID-19 pandemic.","The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able","2021","07","08","Sci Rep","Scientific reports","Algorithms; Brazil; COVID-19; Health Policy; Humans; Models, Theoretical; Pandemics; Public Policy; SARS-CoV-2","Jorge","Daniel C P","Institute of Physics, Federal University of Bahia, Salvador, Bahia, Brazil",NA
"656","34183727","10.1038/s41598-021-92636-8","A control framework to optimize public health policies in the course of the COVID-19 pandemic.","The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able","2021","07","08","Sci Rep","Scientific reports","Algorithms; Brazil; COVID-19; Health Policy; Humans; Models, Theoretical; Pandemics; Public Policy; SARS-CoV-2","Andrade","Roberto F S","Center for Data and Knowledge Integration for Health (CIDACS), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Bahia, Brazil",NA
"657","34183727","10.1038/s41598-021-92636-8","A control framework to optimize public health policies in the course of the COVID-19 pandemic.","The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able","2021","07","08","Sci Rep","Scientific reports","Algorithms; Brazil; COVID-19; Health Policy; Humans; Models, Theoretical; Pandemics; Public Policy; SARS-CoV-2","Barreto","Mauricio L","Center for Data and Knowledge Integration for Health (CIDACS), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Bahia, Brazil",NA
"658","34183727","10.1038/s41598-021-92636-8","A control framework to optimize public health policies in the course of the COVID-19 pandemic.","The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able","2021","07","08","Sci Rep","Scientific reports","Algorithms; Brazil; COVID-19; Health Policy; Humans; Models, Theoretical; Pandemics; Public Policy; SARS-CoV-2","Costa","Marcus Americano da","Department of Chemical Engineering, Federal University of Bahia, Salvador, Bahia, Brazil",NA
"659","34183720","10.1038/s41598-021-92677-z","A rapid near-patient detection system for SARS-CoV-2 using saliva.","The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR ","2021","07","08","Sci Rep","Scientific reports","COVID-19; Fluorometry; Humans; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Saliva; Sensitivity and Specificity; Temperature","Toppings","Noah B","Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, AB, Canada",NA
"660","34183720","10.1038/s41598-021-92677-z","A rapid near-patient detection system for SARS-CoV-2 using saliva.","The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR ","2021","07","08","Sci Rep","Scientific reports","COVID-19; Fluorometry; Humans; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Saliva; Sensitivity and Specificity; Temperature","Mohon","Abu Naser","Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, AB, Canada",NA
"661","34183720","10.1038/s41598-021-92677-z","A rapid near-patient detection system for SARS-CoV-2 using saliva.","The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR ","2021","07","08","Sci Rep","Scientific reports","COVID-19; Fluorometry; Humans; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Saliva; Sensitivity and Specificity; Temperature","Lee","Yoonjung","Department of Mechanical and Manufacturing Engineering, University of Calgary, Calgary, AB, Canada",NA
"662","34183720","10.1038/s41598-021-92677-z","A rapid near-patient detection system for SARS-CoV-2 using saliva.","The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR ","2021","07","08","Sci Rep","Scientific reports","COVID-19; Fluorometry; Humans; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Saliva; Sensitivity and Specificity; Temperature","Kumar","Hitendra","Department of Mechanical and Manufacturing Engineering, University of Calgary, Calgary, AB, Canada",NA
"663","34183720","10.1038/s41598-021-92677-z","A rapid near-patient detection system for SARS-CoV-2 using saliva.","The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR ","2021","07","08","Sci Rep","Scientific reports","COVID-19; Fluorometry; Humans; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Saliva; Sensitivity and Specificity; Temperature","Lee","Daniel","Department of Mechanical and Manufacturing Engineering, University of Calgary, Calgary, AB, Canada",NA
"664","34183720","10.1038/s41598-021-92677-z","A rapid near-patient detection system for SARS-CoV-2 using saliva.","The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR ","2021","07","08","Sci Rep","Scientific reports","COVID-19; Fluorometry; Humans; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Saliva; Sensitivity and Specificity; Temperature","Kapoor","Ratik","Department of Mechanical and Manufacturing Engineering, University of Calgary, Calgary, AB, Canada",NA
"665","34183720","10.1038/s41598-021-92677-z","A rapid near-patient detection system for SARS-CoV-2 using saliva.","The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR ","2021","07","08","Sci Rep","Scientific reports","COVID-19; Fluorometry; Humans; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Saliva; Sensitivity and Specificity; Temperature","Singh","Gurmukh","Department of Mechanical and Manufacturing Engineering, University of Calgary, Calgary, AB, Canada",NA
"666","34183720","10.1038/s41598-021-92677-z","A rapid near-patient detection system for SARS-CoV-2 using saliva.","The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR ","2021","07","08","Sci Rep","Scientific reports","COVID-19; Fluorometry; Humans; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Saliva; Sensitivity and Specificity; Temperature","Oberding","Lisa","Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, AB, Canada",NA
"667","34183720","10.1038/s41598-021-92677-z","A rapid near-patient detection system for SARS-CoV-2 using saliva.","The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR ","2021","07","08","Sci Rep","Scientific reports","COVID-19; Fluorometry; Humans; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Saliva; Sensitivity and Specificity; Temperature","Abdullah","Omar","Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, AB, Canada",NA
"668","34183720","10.1038/s41598-021-92677-z","A rapid near-patient detection system for SARS-CoV-2 using saliva.","The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR ","2021","07","08","Sci Rep","Scientific reports","COVID-19; Fluorometry; Humans; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Saliva; Sensitivity and Specificity; Temperature","Kim","Keekyoung","Department of Mechanical and Manufacturing Engineering, University of Calgary, Calgary, AB, Canada",NA
"669","34183720","10.1038/s41598-021-92677-z","A rapid near-patient detection system for SARS-CoV-2 using saliva.","The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR ","2021","07","08","Sci Rep","Scientific reports","COVID-19; Fluorometry; Humans; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Saliva; Sensitivity and Specificity; Temperature","Berenger","Byron M","Clinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada",NA
"670","34183720","10.1038/s41598-021-92677-z","A rapid near-patient detection system for SARS-CoV-2 using saliva.","The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR ","2021","07","08","Sci Rep","Scientific reports","COVID-19; Fluorometry; Humans; Limit of Detection; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; RNA, Viral; Reference Standards; SARS-CoV-2; Saliva; Sensitivity and Specificity; Temperature","Pillai","Dylan R","Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, AB, Canada. drpillai@ucalgary","drpillai@ucalgary.ca"
"671","34183705","10.1038/s41598-021-92717-8","Follow-up of COVID-19 recovered patients with mild disease.","COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of t","2021","07","08","Sci Rep","Scientific reports","Adult; COVID-19; Comorbidity; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Sex Factors; Young Adult","Kashif","Alina","Medicine, CMH Lahore Medical College &amp",NA
"672","34183705","10.1038/s41598-021-92717-8","Follow-up of COVID-19 recovered patients with mild disease.","COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of t","2021","07","08","Sci Rep","Scientific reports","Adult; COVID-19; Comorbidity; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Sex Factors; Young Adult","Chaudhry","Manahil","Medicine, Hameed Latif Hospital, Lahore, Pakistan",NA
"673","34183705","10.1038/s41598-021-92717-8","Follow-up of COVID-19 recovered patients with mild disease.","COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of t","2021","07","08","Sci Rep","Scientific reports","Adult; COVID-19; Comorbidity; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Sex Factors; Young Adult","Fayyaz","Tehreem","Medicine, CMH Lahore Medical College &amp",NA
"674","34183705","10.1038/s41598-021-92717-8","Follow-up of COVID-19 recovered patients with mild disease.","COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of t","2021","07","08","Sci Rep","Scientific reports","Adult; COVID-19; Comorbidity; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Sex Factors; Young Adult","Abdullah","Mohammad","Medicine, CMH Lahore Medical College &amp","786@hotmail.com"
"675","34183705","10.1038/s41598-021-92717-8","Follow-up of COVID-19 recovered patients with mild disease.","COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of t","2021","07","08","Sci Rep","Scientific reports","Adult; COVID-19; Comorbidity; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Sex Factors; Young Adult","Malik","Ayesha","Medicine, Hameed Latif Hospital, Lahore, Pakistan",NA
"676","34183705","10.1038/s41598-021-92717-8","Follow-up of COVID-19 recovered patients with mild disease.","COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of t","2021","07","08","Sci Rep","Scientific reports","Adult; COVID-19; Comorbidity; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Sex Factors; Young Adult","Anwer","Javairia Manal Akmal","Medicine, CMH Lahore Medical College &amp",NA
"677","34183705","10.1038/s41598-021-92717-8","Follow-up of COVID-19 recovered patients with mild disease.","COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of t","2021","07","08","Sci Rep","Scientific reports","Adult; COVID-19; Comorbidity; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Sex Factors; Young Adult","Inam","Syed Hashim Ali","Medicine, CMH Lahore Medical College &amp",NA
"678","34183705","10.1038/s41598-021-92717-8","Follow-up of COVID-19 recovered patients with mild disease.","COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of t","2021","07","08","Sci Rep","Scientific reports","Adult; COVID-19; Comorbidity; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Sex Factors; Young Adult","Fatima","Tehreem","Medicine, Hameed Latif Hospital, Lahore, Pakistan",NA
"679","34183705","10.1038/s41598-021-92717-8","Follow-up of COVID-19 recovered patients with mild disease.","COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of t","2021","07","08","Sci Rep","Scientific reports","Adult; COVID-19; Comorbidity; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Sex Factors; Young Adult","Iqbal","Noreena","Medicine, Milton Keynes University Hospital, Milton Keynes, UK",NA
"680","34183705","10.1038/s41598-021-92717-8","Follow-up of COVID-19 recovered patients with mild disease.","COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of t","2021","07","08","Sci Rep","Scientific reports","Adult; COVID-19; Comorbidity; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Sex Factors; Young Adult","Shoaib","Khadija","Medicine, CMH Lahore Medical College &amp",NA
"681","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Jalkanen","Pinja","Institute of Biomedicine, University of Turku, Turku, Finland. pinja.r.jalkanen@utu","pinja.r.jalkanen@utu.fi"
"682","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Kolehmainen","Pekka","Institute of Biomedicine, University of Turku, Turku, Finland",NA
"683","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Häkkinen","Hanni K","Department of Infectious Diseases, Meilahti Vaccination Research Center, MeVac, Helsinki University Hospital and University of Helsinki, Helsinki, Finland",NA
"684","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Huttunen","Moona","Institute of Biomedicine, University of Turku, Turku, Finland",NA
"685","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Tähtinen","Paula A","Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland",NA
"686","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Lundberg","Rickard","Institute of Biomedicine, University of Turku, Turku, Finland",NA
"687","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Maljanen","Sari","Institute of Biomedicine, University of Turku, Turku, Finland",NA
"688","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Reinholm","Arttu","Institute of Biomedicine, University of Turku, Turku, Finland",NA
"689","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Tauriainen","Sisko","Institute of Biomedicine, University of Turku, Turku, Finland",NA
"690","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Pakkanen","Sari H","Department of Infectious Diseases, Meilahti Vaccination Research Center, MeVac, Helsinki University Hospital and University of Helsinki, Helsinki, Finland",NA
"691","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Levonen","Iris","Department of Infectious Diseases, Meilahti Vaccination Research Center, MeVac, Helsinki University Hospital and University of Helsinki, Helsinki, Finland",NA
"692","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Nousiainen","Arttu","Department of Infectious Diseases, Meilahti Vaccination Research Center, MeVac, Helsinki University Hospital and University of Helsinki, Helsinki, Finland",NA
"693","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Miller","Taru","Department of Infectious Diseases, Meilahti Vaccination Research Center, MeVac, Helsinki University Hospital and University of Helsinki, Helsinki, Finland",NA
"694","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Välimaa","Hanna","Department of Infectious Diseases, Meilahti Vaccination Research Center, MeVac, Helsinki University Hospital and University of Helsinki, Helsinki, Finland",NA
"695","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Ivaska","Lauri","Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland",NA
"696","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Pasternack","Arja","Department of Physiology, University of Helsinki, Helsinki, Finland",NA
"697","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Naves","Rauno","Department of Physiology, University of Helsinki, Helsinki, Finland",NA
"698","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Ritvos","Olli","Department of Physiology, University of Helsinki, Helsinki, Finland",NA
"699","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Österlund","Pamela","Finnish Institute for Health and Welfare, Helsinki, Finland",NA
"700","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Kuivanen","Suvi","Department of Virology, University of Helsinki, Helsinki, Finland",NA
"701","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Smura","Teemu","Department of Virology, University of Helsinki, Helsinki, Finland",NA
"702","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Hepojoki","Jussi","Department of Virology, University of Helsinki, Helsinki, Finland",NA
"703","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Vapalahti","Olli","Department of Virology, University of Helsinki, Helsinki, Finland",NA
"704","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Lempainen","Johanna","Institute of Biomedicine, University of Turku, Turku, Finland",NA
"705","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Kakkola","Laura","Institute of Biomedicine, University of Turku, Turku, Finland",NA
"706","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Kantele","Anu","Department of Infectious Diseases, Meilahti Vaccination Research Center, MeVac, Helsinki University Hospital and University of Helsinki, Helsinki, Finland",NA
"707","34183681","10.1038/s41467-021-24285-4","COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.","As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants has raised concerns of reduced vaccine efficacy and increased re-infection rates. Here we show, that after the second dose, the sera of BNT162b2-vaccinated health care workers (n = 180) effectively ne","2021","07","05","Nat Commun","Nature communications","Adult; Aged; Aged, 80 and over; Antibodies, Viral; Broadly Neutralizing Antibodies; COVID-19; COVID-19 Vaccines; Cross Protection; Female; Finland; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Mass Vaccination; Middle Aged; Neutralization Tests; Reinfection; SARS-CoV-2; Young Adult","Julkunen","Ilkka","Institute of Biomedicine, University of Turku, Turku, Finland. ilkka.julkunen@utu","ilkka.julkunen@utu.fi"
"708","34183657","10.1038/s41405-021-00079-0","Awareness of aerosol-related transmission of COVID-19 among the dentists of Nepal.","To access the awareness of dental practitioners of Nepal towards COVID-19 transmission through aerosols. The study involved 384 dentists from all over Nepal and was conducted for a period of 3 months. A self-reported online questionnaire was developed using Google forms and the link was shared. It emphasized the awareness related to the aerosol and ventilation system in their daily practices was prepared. The data were analyzed in Statistical Package for Social Sciences version 20.0 software. Th","2021","07","02","BDJ Open","BDJ open",NA,"Pandey","Nashib","Department of Periodontics, Kantipur Dental College Teaching Hospital, Kathmandu, Nepal. nashibpandey@gmail","nashibpandey@gmail.com"
"709","34183657","10.1038/s41405-021-00079-0","Awareness of aerosol-related transmission of COVID-19 among the dentists of Nepal.","To access the awareness of dental practitioners of Nepal towards COVID-19 transmission through aerosols. The study involved 384 dentists from all over Nepal and was conducted for a period of 3 months. A self-reported online questionnaire was developed using Google forms and the link was shared. It emphasized the awareness related to the aerosol and ventilation system in their daily practices was prepared. The data were analyzed in Statistical Package for Social Sciences version 20.0 software. Th","2021","07","02","BDJ Open","BDJ open",NA,"Basnet","Buddha Bahadur","Nepal Academy of Science &amp",NA
"710","34183657","10.1038/s41405-021-00079-0","Awareness of aerosol-related transmission of COVID-19 among the dentists of Nepal.","To access the awareness of dental practitioners of Nepal towards COVID-19 transmission through aerosols. The study involved 384 dentists from all over Nepal and was conducted for a period of 3 months. A self-reported online questionnaire was developed using Google forms and the link was shared. It emphasized the awareness related to the aerosol and ventilation system in their daily practices was prepared. The data were analyzed in Statistical Package for Social Sciences version 20.0 software. Th","2021","07","02","BDJ Open","BDJ open",NA,"Koju","Sushmit","Department of Oral Pathology, Kantipur Dental College Teaching Hospital, Kathmandu, Nepal",NA
"711","34183657","10.1038/s41405-021-00079-0","Awareness of aerosol-related transmission of COVID-19 among the dentists of Nepal.","To access the awareness of dental practitioners of Nepal towards COVID-19 transmission through aerosols. The study involved 384 dentists from all over Nepal and was conducted for a period of 3 months. A self-reported online questionnaire was developed using Google forms and the link was shared. It emphasized the awareness related to the aerosol and ventilation system in their daily practices was prepared. The data were analyzed in Statistical Package for Social Sciences version 20.0 software. Th","2021","07","02","BDJ Open","BDJ open",NA,"Khapung","Anju","Department of Community Dentistry, College of Dental Sciences, Nepal Medical College, Kathmandu, Nepal",NA
"712","34183657","10.1038/s41405-021-00079-0","Awareness of aerosol-related transmission of COVID-19 among the dentists of Nepal.","To access the awareness of dental practitioners of Nepal towards COVID-19 transmission through aerosols. The study involved 384 dentists from all over Nepal and was conducted for a period of 3 months. A self-reported online questionnaire was developed using Google forms and the link was shared. It emphasized the awareness related to the aerosol and ventilation system in their daily practices was prepared. The data were analyzed in Statistical Package for Social Sciences version 20.0 software. Th","2021","07","02","BDJ Open","BDJ open",NA,"Gupta","Alka","Department of Orthodontics, Kantipur Dental College Teaching Hospital, Kathmandu, Nepal",NA
"713","34183614","10.1097/MPG.0000000000003213","Acute liver injury among Pediatric Liver Transplantation recipients with COVID-19: An International Collaborative Study.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic. The occurrence of acute liver injury (ALI) has been reported in liver transplant (LT) recipients; however, the findings on children remain controversial. This is the first extensive, worldwide report on the impact of COVID-19 on pediatric LT recipients. Our online survey reported 110 pediatric LT recipients with SARS-CoV-2 infection. Of these, 37 were symptomatic and 20 out of them (54%) had complicated COVID-19, which included ALI and ","2021","07","01","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Sin","Priscila","Department of Pediatric Gastroenterology and Nutrition. Division of Pediatrics. School of Medicine. Pontificia Universidad Católica de Chile, Santiago, Chile",NA
"714","34183614","10.1097/MPG.0000000000003213","Acute liver injury among Pediatric Liver Transplantation recipients with COVID-19: An International Collaborative Study.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic. The occurrence of acute liver injury (ALI) has been reported in liver transplant (LT) recipients; however, the findings on children remain controversial. This is the first extensive, worldwide report on the impact of COVID-19 on pediatric LT recipients. Our online survey reported 110 pediatric LT recipients with SARS-CoV-2 infection. Of these, 37 were symptomatic and 20 out of them (54%) had complicated COVID-19, which included ALI and ","2021","07","01","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Díaz","Luis Antonio","Department of Gastroenterology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile",NA
"715","34183614","10.1097/MPG.0000000000003213","Acute liver injury among Pediatric Liver Transplantation recipients with COVID-19: An International Collaborative Study.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic. The occurrence of acute liver injury (ALI) has been reported in liver transplant (LT) recipients; however, the findings on children remain controversial. This is the first extensive, worldwide report on the impact of COVID-19 on pediatric LT recipients. Our online survey reported 110 pediatric LT recipients with SARS-CoV-2 infection. Of these, 37 were symptomatic and 20 out of them (54%) had complicated COVID-19, which included ALI and ","2021","07","01","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Martínez","Mercedes","Department of Pediatrics. Division of Pediatric Gastroenterology, Hepatology, and Nutrition. Abdominal Organ transplant. New York Presbyterian Hospital. Columbia University. New York",NA
"716","34183614","10.1097/MPG.0000000000003213","Acute liver injury among Pediatric Liver Transplantation recipients with COVID-19: An International Collaborative Study.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic. The occurrence of acute liver injury (ALI) has been reported in liver transplant (LT) recipients; however, the findings on children remain controversial. This is the first extensive, worldwide report on the impact of COVID-19 on pediatric LT recipients. Our online survey reported 110 pediatric LT recipients with SARS-CoV-2 infection. Of these, 37 were symptomatic and 20 out of them (54%) had complicated COVID-19, which included ALI and ","2021","07","01","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Vizcaya","Cecilia","Department of Pediatric Infectious diseases, Immunology and Rheumatology. Division of Pediatrics. School of Medicine. Pontificia Universidad Católica de Chile, Santiago, Chile",NA
"717","34183614","10.1097/MPG.0000000000003213","Acute liver injury among Pediatric Liver Transplantation recipients with COVID-19: An International Collaborative Study.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic. The occurrence of acute liver injury (ALI) has been reported in liver transplant (LT) recipients; however, the findings on children remain controversial. This is the first extensive, worldwide report on the impact of COVID-19 on pediatric LT recipients. Our online survey reported 110 pediatric LT recipients with SARS-CoV-2 infection. Of these, 37 were symptomatic and 20 out of them (54%) had complicated COVID-19, which included ALI and ","2021","07","01","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"D'Agostino","Daniel","Department of Pediatrics. Division of Pediatric Gastroenterology, Hepatology, Liver and Intestinal Transplantation . Hospital Italiano de Buenos Aires",NA
"718","34183614","10.1097/MPG.0000000000003213","Acute liver injury among Pediatric Liver Transplantation recipients with COVID-19: An International Collaborative Study.","Coronavirus disease 2019 (COVID-19) is an ongoing pandemic. The occurrence of acute liver injury (ALI) has been reported in liver transplant (LT) recipients; however, the findings on children remain controversial. This is the first extensive, worldwide report on the impact of COVID-19 on pediatric LT recipients. Our online survey reported 110 pediatric LT recipients with SARS-CoV-2 infection. Of these, 37 were symptomatic and 20 out of them (54%) had complicated COVID-19, which included ALI and ","2021","07","01","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Gana","Juan Cristóbal","Department of Pediatric Gastroenterology and Nutrition. Division of Pediatrics. School of Medicine. Pontificia Universidad Católica de Chile, Santiago, Chile",NA
"719","34183595","10.1097/ACM.0000000000004102","Harnessing the Potential Futures of CBME Here and Now.","The COVID-19 pandemic of 2020 exposed the reactive nature of the medical education community in response to a disruption that, at one time, may have seemed preposterous. In this article, the author reflected on the impact of an unpredictable plight on a system of medical education that (1) is continuous but doesn't function as a continuum and (2) requires adaptation but is steeped in a fixed mindset and structure that resists change. As a result, innovations which were previously considered impo","2021","07","12","Acad Med","Academic medicine : journal of the Association of American Medical Colleges","COVID-19; Competency-Based Education; Creativity; Education, Medical; Humans; Models, Educational; Organizational Innovation; Resilience, Psychological; Systems Analysis; United States","Carraccio","Carol","C. Carraccio is a former pediatrician, clinician educator, program director, and researcher with a focus on medical education",NA
"720","34183586","10.14309/ajg.0000000000001217","Famotidine and Hospitalized COVID-19 Patients: Are the Benefits True?",NA,"2021","07","01","Am J Gastroenterol","The American journal of gastroenterology","COVID-19; Famotidine; Histamine H2 Antagonists; Humans; Retrospective Studies; SARS-CoV-2","Amjad","Waseem","Department of Internal Medicine, Albany Medical Center, Albany, New York, USA",NA
"721","34183586","10.14309/ajg.0000000000001217","Famotidine and Hospitalized COVID-19 Patients: Are the Benefits True?",NA,"2021","07","01","Am J Gastroenterol","The American journal of gastroenterology","COVID-19; Famotidine; Histamine H2 Antagonists; Humans; Retrospective Studies; SARS-CoV-2","Malik","Adnan","Hepatology, Loyola University Medical Center, Maywood, Illinois, USA",NA
"722","34183569","10.1097/SLE.0000000000000971","SARS-CoV-2 During Abdominal Operations: Are Surgeons at Risk?","The safety of surgery in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients remains unclear. On the basis of data from other viral diseases, it has been assumed that coronavirus disease 2019 (COVID-19) has the potential risk of transmission during surgery. The presence of the virus within the peritoneal fluid and the peritoneal tissues is not known. This is a prospective cross-sectional study including adult patients with confirmed COVID-19 who underwent surgery at a ","2021","06","29","Surg Laparosc Endosc Percutan Tech","Surgical laparoscopy, endoscopy &amp; percutaneous techniques",NA,"Romero-Velez","Gustavo","Department of Surgery Albert Einstein College of Medicine, Montefiore Medical Center Jack D. Weiler Hospital of the Albert Einstein College of Medicine, Bronx, NY",NA
"723","34183569","10.1097/SLE.0000000000000971","SARS-CoV-2 During Abdominal Operations: Are Surgeons at Risk?","The safety of surgery in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients remains unclear. On the basis of data from other viral diseases, it has been assumed that coronavirus disease 2019 (COVID-19) has the potential risk of transmission during surgery. The presence of the virus within the peritoneal fluid and the peritoneal tissues is not known. This is a prospective cross-sectional study including adult patients with confirmed COVID-19 who underwent surgery at a ","2021","06","29","Surg Laparosc Endosc Percutan Tech","Surgical laparoscopy, endoscopy &amp; percutaneous techniques",NA,"Rodriguez Quintero","Jorge H","Department of Surgery Albert Einstein College of Medicine, Montefiore Medical Center Jack D. Weiler Hospital of the Albert Einstein College of Medicine, Bronx, NY",NA
"724","34183569","10.1097/SLE.0000000000000971","SARS-CoV-2 During Abdominal Operations: Are Surgeons at Risk?","The safety of surgery in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients remains unclear. On the basis of data from other viral diseases, it has been assumed that coronavirus disease 2019 (COVID-19) has the potential risk of transmission during surgery. The presence of the virus within the peritoneal fluid and the peritoneal tissues is not known. This is a prospective cross-sectional study including adult patients with confirmed COVID-19 who underwent surgery at a ","2021","06","29","Surg Laparosc Endosc Percutan Tech","Surgical laparoscopy, endoscopy &amp; percutaneous techniques",NA,"Pereira","Xavier","Department of Surgery Albert Einstein College of Medicine, Montefiore Medical Center Jack D. Weiler Hospital of the Albert Einstein College of Medicine, Bronx, NY",NA
"725","34183569","10.1097/SLE.0000000000000971","SARS-CoV-2 During Abdominal Operations: Are Surgeons at Risk?","The safety of surgery in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients remains unclear. On the basis of data from other viral diseases, it has been assumed that coronavirus disease 2019 (COVID-19) has the potential risk of transmission during surgery. The presence of the virus within the peritoneal fluid and the peritoneal tissues is not known. This is a prospective cross-sectional study including adult patients with confirmed COVID-19 who underwent surgery at a ","2021","06","29","Surg Laparosc Endosc Percutan Tech","Surgical laparoscopy, endoscopy &amp; percutaneous techniques",NA,"Nussbaum","Jeffrey E","Department of Surgery Albert Einstein College of Medicine, Montefiore Medical Center Jack D. Weiler Hospital of the Albert Einstein College of Medicine, Bronx, NY",NA
"726","34183569","10.1097/SLE.0000000000000971","SARS-CoV-2 During Abdominal Operations: Are Surgeons at Risk?","The safety of surgery in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients remains unclear. On the basis of data from other viral diseases, it has been assumed that coronavirus disease 2019 (COVID-19) has the potential risk of transmission during surgery. The presence of the virus within the peritoneal fluid and the peritoneal tissues is not known. This is a prospective cross-sectional study including adult patients with confirmed COVID-19 who underwent surgery at a ","2021","06","29","Surg Laparosc Endosc Percutan Tech","Surgical laparoscopy, endoscopy &amp; percutaneous techniques",NA,"McAuliffe","John C","Department of Surgery Albert Einstein College of Medicine, Montefiore Medical Center Jack D. Weiler Hospital of the Albert Einstein College of Medicine, Bronx, NY",NA
"727","34183551","10.1097/GCO.0000000000000713","Looking at cancer health disparities in gynecologic oncology in 2020.","To summarize the most recent evidence on gynecologic cancer disparities and to describe studies investigating the social determinants of health and receipt of evidence-based care and potential interventions to address inequities in care. Significant disparities in disease-specific survival by race/ethnicity, socioeconomic status, and payer status have persisted in women with gynecologic cancers. Compared with white women, black women have an increased likelihood of disease-specific mortality for","2021","07","19","Curr Opin Obstet Gynecol","Current opinion in obstetrics &amp; gynecology","African Americans; Female; Genital Neoplasms, Female; Healthcare Disparities; Humans; Medicaid; Minority Groups; Quality of Health Care; United States","Clair","Kiran","Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine, California, USA",NA
"728","34183551","10.1097/GCO.0000000000000713","Looking at cancer health disparities in gynecologic oncology in 2020.","To summarize the most recent evidence on gynecologic cancer disparities and to describe studies investigating the social determinants of health and receipt of evidence-based care and potential interventions to address inequities in care. Significant disparities in disease-specific survival by race/ethnicity, socioeconomic status, and payer status have persisted in women with gynecologic cancers. Compared with white women, black women have an increased likelihood of disease-specific mortality for","2021","07","19","Curr Opin Obstet Gynecol","Current opinion in obstetrics &amp; gynecology","African Americans; Female; Genital Neoplasms, Female; Healthcare Disparities; Humans; Medicaid; Minority Groups; Quality of Health Care; United States","Bristow","Robert E","Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine, California, USA",NA
"729","34183549","10.1097/GCO.0000000000000718","Perioperative management for gynecologic minimally invasive surgery during the COVID-19 pandemic.","This article will review current guidelines regarding surgical protocols for elective and nonelective surgeries during the severe acute respiratory syndrome coronavirus 2 pandemic. Perioperative management for surgical patients should be modified to promote the safety and wellbeing of patients and caregivers amidst the COVID-19 pandemic. COVID-19 testing should be performed preoperatively with subsequent preprocedure quarantine. Nonemergent or nonlife-threatening surgery should be postponed for ","2021","07","19","Curr Opin Obstet Gynecol","Current opinion in obstetrics &amp; gynecology","COVID-19; Disease Transmission, Infectious; Female; Gynecologic Surgical Procedures; Humans; Laparoscopy; Minimally Invasive Surgical Procedures; Perioperative Care; Personal Protective Equipment; Practice Guidelines as Topic; SARS-CoV-2","García-Ruiz","Nuria S","Department of Gynecology, Cleveland Clinic Florida, Weston, Florida, USA",NA
"730","34183549","10.1097/GCO.0000000000000718","Perioperative management for gynecologic minimally invasive surgery during the COVID-19 pandemic.","This article will review current guidelines regarding surgical protocols for elective and nonelective surgeries during the severe acute respiratory syndrome coronavirus 2 pandemic. Perioperative management for surgical patients should be modified to promote the safety and wellbeing of patients and caregivers amidst the COVID-19 pandemic. COVID-19 testing should be performed preoperatively with subsequent preprocedure quarantine. Nonemergent or nonlife-threatening surgery should be postponed for ","2021","07","19","Curr Opin Obstet Gynecol","Current opinion in obstetrics &amp; gynecology","COVID-19; Disease Transmission, Infectious; Female; Gynecologic Surgical Procedures; Humans; Laparoscopy; Minimally Invasive Surgical Procedures; Perioperative Care; Personal Protective Equipment; Practice Guidelines as Topic; SARS-CoV-2","Ramirez-Caban","Laura","Department of Gynecology, Cleveland Clinic Florida, Weston, Florida, USA",NA
"731","34183549","10.1097/GCO.0000000000000718","Perioperative management for gynecologic minimally invasive surgery during the COVID-19 pandemic.","This article will review current guidelines regarding surgical protocols for elective and nonelective surgeries during the severe acute respiratory syndrome coronavirus 2 pandemic. Perioperative management for surgical patients should be modified to promote the safety and wellbeing of patients and caregivers amidst the COVID-19 pandemic. COVID-19 testing should be performed preoperatively with subsequent preprocedure quarantine. Nonemergent or nonlife-threatening surgery should be postponed for ","2021","07","19","Curr Opin Obstet Gynecol","Current opinion in obstetrics &amp; gynecology","COVID-19; Disease Transmission, Infectious; Female; Gynecologic Surgical Procedures; Humans; Laparoscopy; Minimally Invasive Surgical Procedures; Perioperative Care; Personal Protective Equipment; Practice Guidelines as Topic; SARS-CoV-2","Malekzadeh","Maral","Department of Gynecology, Cleveland Clinic Florida, Weston, Florida, USA",NA
"732","34183549","10.1097/GCO.0000000000000718","Perioperative management for gynecologic minimally invasive surgery during the COVID-19 pandemic.","This article will review current guidelines regarding surgical protocols for elective and nonelective surgeries during the severe acute respiratory syndrome coronavirus 2 pandemic. Perioperative management for surgical patients should be modified to promote the safety and wellbeing of patients and caregivers amidst the COVID-19 pandemic. COVID-19 testing should be performed preoperatively with subsequent preprocedure quarantine. Nonemergent or nonlife-threatening surgery should be postponed for ","2021","07","19","Curr Opin Obstet Gynecol","Current opinion in obstetrics &amp; gynecology","COVID-19; Disease Transmission, Infectious; Female; Gynecologic Surgical Procedures; Humans; Laparoscopy; Minimally Invasive Surgical Procedures; Perioperative Care; Personal Protective Equipment; Practice Guidelines as Topic; SARS-CoV-2","Padilla","Pamela Frazzini","Department of Gynecology, Cleveland Clinic Florida, Weston, Florida, USA",NA
"733","34183531","10.1097/EDE.0000000000001385","Identifiability and Estimation Under the Test-negative Design With Population Controls With the Goal of Identifying Risk and Preventive Factors for SARS-CoV-2 Infection.","Owing to the rapidly evolving coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, quick public health investigations of the relationships between behaviors and infection risk are essential. Recently the test-negative design (TND) was proposed to recruit and survey participants who are symptomatic and being tested for SARS-CoV-2 infection with the goal of evaluating associations between the survey responses (including beha","2021","06","29","Epidemiology","Epidemiology (Cambridge, Mass.)",NA,"Schnitzer","Mireille E","From the Faculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, Québec, Canada Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada Department of Appied Statistics, Social Science, and Humanities, Steinhardt School of Culture Education and Human Development, New York University, New York, NY Center for Practice and Research at the Intersection of Information, Society, and Methodology (PRIISM), Steinhardt School of Culture Education and Human Development, New York University, New York, NY Université de Montréal Hospital Research Centre (CRCHUM), Montréal, Québec, Canada",NA
"734","34183531","10.1097/EDE.0000000000001385","Identifiability and Estimation Under the Test-negative Design With Population Controls With the Goal of Identifying Risk and Preventive Factors for SARS-CoV-2 Infection.","Owing to the rapidly evolving coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, quick public health investigations of the relationships between behaviors and infection risk are essential. Recently the test-negative design (TND) was proposed to recruit and survey participants who are symptomatic and being tested for SARS-CoV-2 infection with the goal of evaluating associations between the survey responses (including beha","2021","06","29","Epidemiology","Epidemiology (Cambridge, Mass.)",NA,"Harel","Daphna","From the Faculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, Québec, Canada Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada Department of Appied Statistics, Social Science, and Humanities, Steinhardt School of Culture Education and Human Development, New York University, New York, NY Center for Practice and Research at the Intersection of Information, Society, and Methodology (PRIISM), Steinhardt School of Culture Education and Human Development, New York University, New York, NY Université de Montréal Hospital Research Centre (CRCHUM), Montréal, Québec, Canada",NA
"735","34183531","10.1097/EDE.0000000000001385","Identifiability and Estimation Under the Test-negative Design With Population Controls With the Goal of Identifying Risk and Preventive Factors for SARS-CoV-2 Infection.","Owing to the rapidly evolving coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, quick public health investigations of the relationships between behaviors and infection risk are essential. Recently the test-negative design (TND) was proposed to recruit and survey participants who are symptomatic and being tested for SARS-CoV-2 infection with the goal of evaluating associations between the survey responses (including beha","2021","06","29","Epidemiology","Epidemiology (Cambridge, Mass.)",NA,"Ho","Vikki","From the Faculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, Québec, Canada Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada Department of Appied Statistics, Social Science, and Humanities, Steinhardt School of Culture Education and Human Development, New York University, New York, NY Center for Practice and Research at the Intersection of Information, Society, and Methodology (PRIISM), Steinhardt School of Culture Education and Human Development, New York University, New York, NY Université de Montréal Hospital Research Centre (CRCHUM), Montréal, Québec, Canada",NA
"736","34183531","10.1097/EDE.0000000000001385","Identifiability and Estimation Under the Test-negative Design With Population Controls With the Goal of Identifying Risk and Preventive Factors for SARS-CoV-2 Infection.","Owing to the rapidly evolving coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, quick public health investigations of the relationships between behaviors and infection risk are essential. Recently the test-negative design (TND) was proposed to recruit and survey participants who are symptomatic and being tested for SARS-CoV-2 infection with the goal of evaluating associations between the survey responses (including beha","2021","06","29","Epidemiology","Epidemiology (Cambridge, Mass.)",NA,"Koushik","Anita","From the Faculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, Québec, Canada Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada Department of Appied Statistics, Social Science, and Humanities, Steinhardt School of Culture Education and Human Development, New York University, New York, NY Center for Practice and Research at the Intersection of Information, Society, and Methodology (PRIISM), Steinhardt School of Culture Education and Human Development, New York University, New York, NY Université de Montréal Hospital Research Centre (CRCHUM), Montréal, Québec, Canada",NA
"737","34183531","10.1097/EDE.0000000000001385","Identifiability and Estimation Under the Test-negative Design With Population Controls With the Goal of Identifying Risk and Preventive Factors for SARS-CoV-2 Infection.","Owing to the rapidly evolving coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, quick public health investigations of the relationships between behaviors and infection risk are essential. Recently the test-negative design (TND) was proposed to recruit and survey participants who are symptomatic and being tested for SARS-CoV-2 infection with the goal of evaluating associations between the survey responses (including beha","2021","06","29","Epidemiology","Epidemiology (Cambridge, Mass.)",NA,"Merckx","Joanna","From the Faculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, Québec, Canada Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada Department of Appied Statistics, Social Science, and Humanities, Steinhardt School of Culture Education and Human Development, New York University, New York, NY Center for Practice and Research at the Intersection of Information, Society, and Methodology (PRIISM), Steinhardt School of Culture Education and Human Development, New York University, New York, NY Université de Montréal Hospital Research Centre (CRCHUM), Montréal, Québec, Canada",NA
"738","34183516","10.1097/SLA.0000000000004988","Outcomes of the First Virtual General Surgery Certifying Exam of the American Board of Surgery.","The American Board of Surgery (ABS) General Surgery Certifying Exam (CE) is normally an in-person oral examination. Due to the COVID-19 outbreak, the ABS was required to reschedule these. After two small pilots, the CE's October administration represented the first large scale remote virtual exam. The purpose of this report is to compare the outcomes of this virtual and the previous in-person CEs. CE candidates were asked to provide feedback on their experience via a survey. The passing rate was","2021","06","29","Ann Surg","Annals of surgery",NA,"Chen","Herbert","From the Research Committee of the American Board of Surgery",NA
"739","34183516","10.1097/SLA.0000000000004988","Outcomes of the First Virtual General Surgery Certifying Exam of the American Board of Surgery.","The American Board of Surgery (ABS) General Surgery Certifying Exam (CE) is normally an in-person oral examination. Due to the COVID-19 outbreak, the ABS was required to reschedule these. After two small pilots, the CE's October administration represented the first large scale remote virtual exam. The purpose of this report is to compare the outcomes of this virtual and the previous in-person CEs. CE candidates were asked to provide feedback on their experience via a survey. The passing rate was","2021","06","29","Ann Surg","Annals of surgery",NA,"Tseng","Jennifer F","From the Research Committee of the American Board of Surgery",NA
"740","34183516","10.1097/SLA.0000000000004988","Outcomes of the First Virtual General Surgery Certifying Exam of the American Board of Surgery.","The American Board of Surgery (ABS) General Surgery Certifying Exam (CE) is normally an in-person oral examination. Due to the COVID-19 outbreak, the ABS was required to reschedule these. After two small pilots, the CE's October administration represented the first large scale remote virtual exam. The purpose of this report is to compare the outcomes of this virtual and the previous in-person CEs. CE candidates were asked to provide feedback on their experience via a survey. The passing rate was","2021","06","29","Ann Surg","Annals of surgery",NA,"Chaer","Rabih","From the Research Committee of the American Board of Surgery",NA
"741","34183516","10.1097/SLA.0000000000004988","Outcomes of the First Virtual General Surgery Certifying Exam of the American Board of Surgery.","The American Board of Surgery (ABS) General Surgery Certifying Exam (CE) is normally an in-person oral examination. Due to the COVID-19 outbreak, the ABS was required to reschedule these. After two small pilots, the CE's October administration represented the first large scale remote virtual exam. The purpose of this report is to compare the outcomes of this virtual and the previous in-person CEs. CE candidates were asked to provide feedback on their experience via a survey. The passing rate was","2021","06","29","Ann Surg","Annals of surgery",NA,"Spain","David A","From the Research Committee of the American Board of Surgery",NA
"742","34183516","10.1097/SLA.0000000000004988","Outcomes of the First Virtual General Surgery Certifying Exam of the American Board of Surgery.","The American Board of Surgery (ABS) General Surgery Certifying Exam (CE) is normally an in-person oral examination. Due to the COVID-19 outbreak, the ABS was required to reschedule these. After two small pilots, the CE's October administration represented the first large scale remote virtual exam. The purpose of this report is to compare the outcomes of this virtual and the previous in-person CEs. CE candidates were asked to provide feedback on their experience via a survey. The passing rate was","2021","06","29","Ann Surg","Annals of surgery",NA,"Stewart","John H","From the Research Committee of the American Board of Surgery",NA
"743","34183516","10.1097/SLA.0000000000004988","Outcomes of the First Virtual General Surgery Certifying Exam of the American Board of Surgery.","The American Board of Surgery (ABS) General Surgery Certifying Exam (CE) is normally an in-person oral examination. Due to the COVID-19 outbreak, the ABS was required to reschedule these. After two small pilots, the CE's October administration represented the first large scale remote virtual exam. The purpose of this report is to compare the outcomes of this virtual and the previous in-person CEs. CE candidates were asked to provide feedback on their experience via a survey. The passing rate was","2021","06","29","Ann Surg","Annals of surgery",NA,"Dent","Daniel","From the Research Committee of the American Board of Surgery",NA
"744","34183516","10.1097/SLA.0000000000004988","Outcomes of the First Virtual General Surgery Certifying Exam of the American Board of Surgery.","The American Board of Surgery (ABS) General Surgery Certifying Exam (CE) is normally an in-person oral examination. Due to the COVID-19 outbreak, the ABS was required to reschedule these. After two small pilots, the CE's October administration represented the first large scale remote virtual exam. The purpose of this report is to compare the outcomes of this virtual and the previous in-person CEs. CE candidates were asked to provide feedback on their experience via a survey. The passing rate was","2021","06","29","Ann Surg","Annals of surgery",NA,"Ibáñez","Beatriz","From the Research Committee of the American Board of Surgery",NA
"745","34183516","10.1097/SLA.0000000000004988","Outcomes of the First Virtual General Surgery Certifying Exam of the American Board of Surgery.","The American Board of Surgery (ABS) General Surgery Certifying Exam (CE) is normally an in-person oral examination. Due to the COVID-19 outbreak, the ABS was required to reschedule these. After two small pilots, the CE's October administration represented the first large scale remote virtual exam. The purpose of this report is to compare the outcomes of this virtual and the previous in-person CEs. CE candidates were asked to provide feedback on their experience via a survey. The passing rate was","2021","06","29","Ann Surg","Annals of surgery",NA,"Barry","Carol L","From the Research Committee of the American Board of Surgery",NA
"746","34183516","10.1097/SLA.0000000000004988","Outcomes of the First Virtual General Surgery Certifying Exam of the American Board of Surgery.","The American Board of Surgery (ABS) General Surgery Certifying Exam (CE) is normally an in-person oral examination. Due to the COVID-19 outbreak, the ABS was required to reschedule these. After two small pilots, the CE's October administration represented the first large scale remote virtual exam. The purpose of this report is to compare the outcomes of this virtual and the previous in-person CEs. CE candidates were asked to provide feedback on their experience via a survey. The passing rate was","2021","06","29","Ann Surg","Annals of surgery",NA,"Jones","Andrew T","From the Research Committee of the American Board of Surgery",NA
"747","34183516","10.1097/SLA.0000000000004988","Outcomes of the First Virtual General Surgery Certifying Exam of the American Board of Surgery.","The American Board of Surgery (ABS) General Surgery Certifying Exam (CE) is normally an in-person oral examination. Due to the COVID-19 outbreak, the ABS was required to reschedule these. After two small pilots, the CE's October administration represented the first large scale remote virtual exam. The purpose of this report is to compare the outcomes of this virtual and the previous in-person CEs. CE candidates were asked to provide feedback on their experience via a survey. The passing rate was","2021","06","29","Ann Surg","Annals of surgery",NA,"Buyske","Jo","From the Research Committee of the American Board of Surgery",NA
"748","34183513","10.1097/SLA.0000000000004994","Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.","During the initial wave of the COVID-19 pandemic, organ transplantation was classified a CMS Tier 3b procedure which should not be postponed. The differential impact of the pandemic on access to liver transplantation was assessed. Disparities in organ access and transplant outcomes among vulnerable populations have served as obstacles in liver transplantation. Using UNOS STARfile data, adult waitlisted candidates were identified from March 1, 2020 - November 30, 2020 (n=21,702 pandemic) and Marc","2021","06","29","Ann Surg","Annals of surgery",NA,"MacConmara","Malcolm","Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX Department of Transplantation, University of Toronto, Toronto, ON, Canada Division of Transplantation, Department of Surgery, Emory University, Atlanta, GA Division of Nephrology, Department of Medicine, University of Arizona, Tuscon, AZ",NA
"749","34183513","10.1097/SLA.0000000000004994","Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.","During the initial wave of the COVID-19 pandemic, organ transplantation was classified a CMS Tier 3b procedure which should not be postponed. The differential impact of the pandemic on access to liver transplantation was assessed. Disparities in organ access and transplant outcomes among vulnerable populations have served as obstacles in liver transplantation. Using UNOS STARfile data, adult waitlisted candidates were identified from March 1, 2020 - November 30, 2020 (n=21,702 pandemic) and Marc","2021","06","29","Ann Surg","Annals of surgery",NA,"Wang","Benjamin","Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX Department of Transplantation, University of Toronto, Toronto, ON, Canada Division of Transplantation, Department of Surgery, Emory University, Atlanta, GA Division of Nephrology, Department of Medicine, University of Arizona, Tuscon, AZ",NA
"750","34183513","10.1097/SLA.0000000000004994","Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.","During the initial wave of the COVID-19 pandemic, organ transplantation was classified a CMS Tier 3b procedure which should not be postponed. The differential impact of the pandemic on access to liver transplantation was assessed. Disparities in organ access and transplant outcomes among vulnerable populations have served as obstacles in liver transplantation. Using UNOS STARfile data, adult waitlisted candidates were identified from March 1, 2020 - November 30, 2020 (n=21,702 pandemic) and Marc","2021","06","29","Ann Surg","Annals of surgery",NA,"Patel","Madhukar S","Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX Department of Transplantation, University of Toronto, Toronto, ON, Canada Division of Transplantation, Department of Surgery, Emory University, Atlanta, GA Division of Nephrology, Department of Medicine, University of Arizona, Tuscon, AZ",NA
"751","34183513","10.1097/SLA.0000000000004994","Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.","During the initial wave of the COVID-19 pandemic, organ transplantation was classified a CMS Tier 3b procedure which should not be postponed. The differential impact of the pandemic on access to liver transplantation was assessed. Disparities in organ access and transplant outcomes among vulnerable populations have served as obstacles in liver transplantation. Using UNOS STARfile data, adult waitlisted candidates were identified from March 1, 2020 - November 30, 2020 (n=21,702 pandemic) and Marc","2021","06","29","Ann Surg","Annals of surgery",NA,"Hwang","Christine S","Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX Department of Transplantation, University of Toronto, Toronto, ON, Canada Division of Transplantation, Department of Surgery, Emory University, Atlanta, GA Division of Nephrology, Department of Medicine, University of Arizona, Tuscon, AZ",NA
"752","34183513","10.1097/SLA.0000000000004994","Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.","During the initial wave of the COVID-19 pandemic, organ transplantation was classified a CMS Tier 3b procedure which should not be postponed. The differential impact of the pandemic on access to liver transplantation was assessed. Disparities in organ access and transplant outcomes among vulnerable populations have served as obstacles in liver transplantation. Using UNOS STARfile data, adult waitlisted candidates were identified from March 1, 2020 - November 30, 2020 (n=21,702 pandemic) and Marc","2021","06","29","Ann Surg","Annals of surgery",NA,"DeGregorio","Lucia","Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX Department of Transplantation, University of Toronto, Toronto, ON, Canada Division of Transplantation, Department of Surgery, Emory University, Atlanta, GA Division of Nephrology, Department of Medicine, University of Arizona, Tuscon, AZ",NA
"753","34183513","10.1097/SLA.0000000000004994","Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.","During the initial wave of the COVID-19 pandemic, organ transplantation was classified a CMS Tier 3b procedure which should not be postponed. The differential impact of the pandemic on access to liver transplantation was assessed. Disparities in organ access and transplant outcomes among vulnerable populations have served as obstacles in liver transplantation. Using UNOS STARfile data, adult waitlisted candidates were identified from March 1, 2020 - November 30, 2020 (n=21,702 pandemic) and Marc","2021","06","29","Ann Surg","Annals of surgery",NA,"Shah","Jigesh","Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX Department of Transplantation, University of Toronto, Toronto, ON, Canada Division of Transplantation, Department of Surgery, Emory University, Atlanta, GA Division of Nephrology, Department of Medicine, University of Arizona, Tuscon, AZ",NA
"754","34183513","10.1097/SLA.0000000000004994","Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.","During the initial wave of the COVID-19 pandemic, organ transplantation was classified a CMS Tier 3b procedure which should not be postponed. The differential impact of the pandemic on access to liver transplantation was assessed. Disparities in organ access and transplant outcomes among vulnerable populations have served as obstacles in liver transplantation. Using UNOS STARfile data, adult waitlisted candidates were identified from March 1, 2020 - November 30, 2020 (n=21,702 pandemic) and Marc","2021","06","29","Ann Surg","Annals of surgery",NA,"Hanish","Steven I","Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX Department of Transplantation, University of Toronto, Toronto, ON, Canada Division of Transplantation, Department of Surgery, Emory University, Atlanta, GA Division of Nephrology, Department of Medicine, University of Arizona, Tuscon, AZ",NA
"755","34183513","10.1097/SLA.0000000000004994","Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.","During the initial wave of the COVID-19 pandemic, organ transplantation was classified a CMS Tier 3b procedure which should not be postponed. The differential impact of the pandemic on access to liver transplantation was assessed. Disparities in organ access and transplant outcomes among vulnerable populations have served as obstacles in liver transplantation. Using UNOS STARfile data, adult waitlisted candidates were identified from March 1, 2020 - November 30, 2020 (n=21,702 pandemic) and Marc","2021","06","29","Ann Surg","Annals of surgery",NA,"Desai","Dev","Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX Department of Transplantation, University of Toronto, Toronto, ON, Canada Division of Transplantation, Department of Surgery, Emory University, Atlanta, GA Division of Nephrology, Department of Medicine, University of Arizona, Tuscon, AZ",NA
"756","34183513","10.1097/SLA.0000000000004994","Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.","During the initial wave of the COVID-19 pandemic, organ transplantation was classified a CMS Tier 3b procedure which should not be postponed. The differential impact of the pandemic on access to liver transplantation was assessed. Disparities in organ access and transplant outcomes among vulnerable populations have served as obstacles in liver transplantation. Using UNOS STARfile data, adult waitlisted candidates were identified from March 1, 2020 - November 30, 2020 (n=21,702 pandemic) and Marc","2021","06","29","Ann Surg","Annals of surgery",NA,"Lynch","Raymond","Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX Department of Transplantation, University of Toronto, Toronto, ON, Canada Division of Transplantation, Department of Surgery, Emory University, Atlanta, GA Division of Nephrology, Department of Medicine, University of Arizona, Tuscon, AZ",NA
"757","34183513","10.1097/SLA.0000000000004994","Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.","During the initial wave of the COVID-19 pandemic, organ transplantation was classified a CMS Tier 3b procedure which should not be postponed. The differential impact of the pandemic on access to liver transplantation was assessed. Disparities in organ access and transplant outcomes among vulnerable populations have served as obstacles in liver transplantation. Using UNOS STARfile data, adult waitlisted candidates were identified from March 1, 2020 - November 30, 2020 (n=21,702 pandemic) and Marc","2021","06","29","Ann Surg","Annals of surgery",NA,"Tanriover","Bekir","Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX Department of Transplantation, University of Toronto, Toronto, ON, Canada Division of Transplantation, Department of Surgery, Emory University, Atlanta, GA Division of Nephrology, Department of Medicine, University of Arizona, Tuscon, AZ",NA
"758","34183513","10.1097/SLA.0000000000004994","Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.","During the initial wave of the COVID-19 pandemic, organ transplantation was classified a CMS Tier 3b procedure which should not be postponed. The differential impact of the pandemic on access to liver transplantation was assessed. Disparities in organ access and transplant outcomes among vulnerable populations have served as obstacles in liver transplantation. Using UNOS STARfile data, adult waitlisted candidates were identified from March 1, 2020 - November 30, 2020 (n=21,702 pandemic) and Marc","2021","06","29","Ann Surg","Annals of surgery",NA,"Zeh","Herbert","Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX Department of Transplantation, University of Toronto, Toronto, ON, Canada Division of Transplantation, Department of Surgery, Emory University, Atlanta, GA Division of Nephrology, Department of Medicine, University of Arizona, Tuscon, AZ",NA
"759","34183513","10.1097/SLA.0000000000004994","Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.","During the initial wave of the COVID-19 pandemic, organ transplantation was classified a CMS Tier 3b procedure which should not be postponed. The differential impact of the pandemic on access to liver transplantation was assessed. Disparities in organ access and transplant outcomes among vulnerable populations have served as obstacles in liver transplantation. Using UNOS STARfile data, adult waitlisted candidates were identified from March 1, 2020 - November 30, 2020 (n=21,702 pandemic) and Marc","2021","06","29","Ann Surg","Annals of surgery",NA,"Vagefi","Parsia A","Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX Department of Transplantation, University of Toronto, Toronto, ON, Canada Division of Transplantation, Department of Surgery, Emory University, Atlanta, GA Division of Nephrology, Department of Medicine, University of Arizona, Tuscon, AZ",NA
"760","34183501","10.1097/RLU.0000000000003844","18F-Fluciclovine-Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination.","A 74-year-old man presenting with biochemical recurrent prostate cancer 9 months after robotic-assisted radical prostatectomy and pelvic lymphadenectomy underwent 18F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. Serum prostate-specific antigen was 0.7 ng/mL at the time of imaging. Images demonstrated foci of abnormal increased 18F-fluciclovine uptake corresponding to prominent round lymph nodes in the left axilla, some of which with fatty hila. Due to recent mRNA","2021","06","29","Clin Nucl Med","Clinical nuclear medicine",NA,"Wong","Franklin C","From the University of Texas MD Anderson Cancer Center, Houston, TX",NA
"761","34183501","10.1097/RLU.0000000000003844","18F-Fluciclovine-Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination.","A 74-year-old man presenting with biochemical recurrent prostate cancer 9 months after robotic-assisted radical prostatectomy and pelvic lymphadenectomy underwent 18F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. Serum prostate-specific antigen was 0.7 ng/mL at the time of imaging. Images demonstrated foci of abnormal increased 18F-fluciclovine uptake corresponding to prominent round lymph nodes in the left axilla, some of which with fatty hila. Due to recent mRNA","2021","06","29","Clin Nucl Med","Clinical nuclear medicine",NA,"Martiniova","Lucia","From the University of Texas MD Anderson Cancer Center, Houston, TX",NA
"762","34183501","10.1097/RLU.0000000000003844","18F-Fluciclovine-Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination.","A 74-year-old man presenting with biochemical recurrent prostate cancer 9 months after robotic-assisted radical prostatectomy and pelvic lymphadenectomy underwent 18F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. Serum prostate-specific antigen was 0.7 ng/mL at the time of imaging. Images demonstrated foci of abnormal increased 18F-fluciclovine uptake corresponding to prominent round lymph nodes in the left axilla, some of which with fatty hila. Due to recent mRNA","2021","06","29","Clin Nucl Med","Clinical nuclear medicine",NA,"Masrani","Avantika","From the University of Texas MD Anderson Cancer Center, Houston, TX",NA
"763","34183501","10.1097/RLU.0000000000003844","18F-Fluciclovine-Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination.","A 74-year-old man presenting with biochemical recurrent prostate cancer 9 months after robotic-assisted radical prostatectomy and pelvic lymphadenectomy underwent 18F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. Serum prostate-specific antigen was 0.7 ng/mL at the time of imaging. Images demonstrated foci of abnormal increased 18F-fluciclovine uptake corresponding to prominent round lymph nodes in the left axilla, some of which with fatty hila. Due to recent mRNA","2021","06","29","Clin Nucl Med","Clinical nuclear medicine",NA,"Ravizzini","Gregory C","From the University of Texas MD Anderson Cancer Center, Houston, TX",NA
"764","34183494","10.1097/CAD.0000000000001097","Levatinib treatment for thyroid cancer in COVID era: safety in a patient with lung metastases and SARS-CoV-2 infection.","During the coronavirus disease 2019 (COVID-19) pandemic, clinicians are required to manage patient care for pre-existing conditions. Currently, there are no clear indications regarding the management of lenvatinib-treated patients for radioiodine-refractory thyroid cancer and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A 74-year-old male patient was treated with lenvatinib since March 2019, with disease recurrence in the thyroid bed and bilateral multiple lung metasta","2021","06","29","Anticancer Drugs","Anti-cancer drugs",NA,"Locantore","Pietro","Unit of Endocrinology, Fondazione Policlinico Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome",NA
"765","34183494","10.1097/CAD.0000000000001097","Levatinib treatment for thyroid cancer in COVID era: safety in a patient with lung metastases and SARS-CoV-2 infection.","During the coronavirus disease 2019 (COVID-19) pandemic, clinicians are required to manage patient care for pre-existing conditions. Currently, there are no clear indications regarding the management of lenvatinib-treated patients for radioiodine-refractory thyroid cancer and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A 74-year-old male patient was treated with lenvatinib since March 2019, with disease recurrence in the thyroid bed and bilateral multiple lung metasta","2021","06","29","Anticancer Drugs","Anti-cancer drugs",NA,"Del Gatto","Valeria","Unit of Endocrinology, Fondazione Policlinico Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome",NA
"766","34183494","10.1097/CAD.0000000000001097","Levatinib treatment for thyroid cancer in COVID era: safety in a patient with lung metastases and SARS-CoV-2 infection.","During the coronavirus disease 2019 (COVID-19) pandemic, clinicians are required to manage patient care for pre-existing conditions. Currently, there are no clear indications regarding the management of lenvatinib-treated patients for radioiodine-refractory thyroid cancer and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A 74-year-old male patient was treated with lenvatinib since March 2019, with disease recurrence in the thyroid bed and bilateral multiple lung metasta","2021","06","29","Anticancer Drugs","Anti-cancer drugs",NA,"Corsello","Andrea","Unit of Endocrinology, Fondazione Policlinico Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome",NA
"767","34183494","10.1097/CAD.0000000000001097","Levatinib treatment for thyroid cancer in COVID era: safety in a patient with lung metastases and SARS-CoV-2 infection.","During the coronavirus disease 2019 (COVID-19) pandemic, clinicians are required to manage patient care for pre-existing conditions. Currently, there are no clear indications regarding the management of lenvatinib-treated patients for radioiodine-refractory thyroid cancer and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A 74-year-old male patient was treated with lenvatinib since March 2019, with disease recurrence in the thyroid bed and bilateral multiple lung metasta","2021","06","29","Anticancer Drugs","Anti-cancer drugs",NA,"Pontecorvi","Alfredo","Unit of Endocrinology, Fondazione Policlinico Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome",NA
"768","34183487","10.1097/ACM.0000000000004009","From Natural Disasters to the COVID-19 Crisis: Maintaining Courage and Connection in a Puerto Rican Residency Program.",NA,"2021","07","12","Acad Med","Academic medicine : journal of the Association of American Medical Colleges","Attitude of Health Personnel; COVID-19; Courage; Education, Distance; Fear; Humans; Internship and Residency; Natural Disasters; Pediatricians; Pediatrics; Physician-Patient Relations; Puerto Rico","Kuziez","Mohamed","Second-year resident, Department of Pediatrics, Saint Lukes Episcopal Medical Center, Ponce, Puerto Rico","mkuziez18@stu.psm.edu"
"769","34183487","10.1097/ACM.0000000000004009","From Natural Disasters to the COVID-19 Crisis: Maintaining Courage and Connection in a Puerto Rican Residency Program.",NA,"2021","07","12","Acad Med","Academic medicine : journal of the Association of American Medical Colleges","Attitude of Health Personnel; COVID-19; Courage; Education, Distance; Fear; Humans; Internship and Residency; Natural Disasters; Pediatricians; Pediatrics; Physician-Patient Relations; Puerto Rico","Abbasi","Denise","Second-year resident, Department of Pediatrics, Saint Lukes Episcopal Medical Center, Ponce, Puerto Rico",NA
"770","34183487","10.1097/ACM.0000000000004009","From Natural Disasters to the COVID-19 Crisis: Maintaining Courage and Connection in a Puerto Rican Residency Program.",NA,"2021","07","12","Acad Med","Academic medicine : journal of the Association of American Medical Colleges","Attitude of Health Personnel; COVID-19; Courage; Education, Distance; Fear; Humans; Internship and Residency; Natural Disasters; Pediatricians; Pediatrics; Physician-Patient Relations; Puerto Rico","Gómez","Evelyn","Second-year resident, Department of Pediatrics, Saint Lukes Episcopal Medical Center, Ponce, Puerto Rico",NA
"771","34183486","10.1097/ACM.0000000000004007","Unity in Times of Isolation: Centralizing Volunteerism During the COVID-19 Pandemic.",NA,"2021","07","12","Acad Med","Academic medicine : journal of the Association of American Medical Colleges","COVID-19; Education, Medical, Undergraduate; Humans; Nebraska; Physical Distancing; Social Isolation; Students, Medical; Volunteers","Tandon","Hannah K","Third-year medical student, University of Nebraska Medical Center College of Medicine, Omaha, Nebraska, and UNMC CoRe community mask-sewing program coordinator","hannah.tandon@unmc.edu"
"772","34183486","10.1097/ACM.0000000000004007","Unity in Times of Isolation: Centralizing Volunteerism During the COVID-19 Pandemic.",NA,"2021","07","12","Acad Med","Academic medicine : journal of the Association of American Medical Colleges","COVID-19; Education, Medical, Undergraduate; Humans; Nebraska; Physical Distancing; Social Isolation; Students, Medical; Volunteers","Reidelberger","Keely O","Third-year medical student, University of Nebraska Medical Center College of Medicine, Omaha, Nebraska, and UNMC CoRe PPE donations coordinator",NA
"773","34183486","10.1097/ACM.0000000000004007","Unity in Times of Isolation: Centralizing Volunteerism During the COVID-19 Pandemic.",NA,"2021","07","12","Acad Med","Academic medicine : journal of the Association of American Medical Colleges","COVID-19; Education, Medical, Undergraduate; Humans; Nebraska; Physical Distancing; Social Isolation; Students, Medical; Volunteers","Kratochvil","Taylor J","Third-year medical student, University of Nebraska Medical Center College of Medicine, Omaha, Nebraska, and UNMC CoRe program director",NA
"774","34183470","","Autism Spectrum Disorder in the COVID 19 Era: New Challenges - New Solutions.","This survey explored the support available and the effect of lockdown on children with autism spectrum disorder and their families in India and the United Kingdom. Our findings showed significant problems for children and families due to lockdown. App-based information delivered to parents with support showed encouraging feedback.","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Bharat","Rahul","Department of Pediatrics, Royal Cornwall Hospitals Truro, Truro, United Kingdom. r.bharat@gmail","r.bharat@gmail.com"
"775","34183470","","Autism Spectrum Disorder in the COVID 19 Era: New Challenges - New Solutions.","This survey explored the support available and the effect of lockdown on children with autism spectrum disorder and their families in India and the United Kingdom. Our findings showed significant problems for children and families due to lockdown. App-based information delivered to parents with support showed encouraging feedback.","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Uzaina","-","Geniuslane Child Development Centre, Lucknow, India",NA
"776","34183470","","Autism Spectrum Disorder in the COVID 19 Era: New Challenges - New Solutions.","This survey explored the support available and the effect of lockdown on children with autism spectrum disorder and their families in India and the United Kingdom. Our findings showed significant problems for children and families due to lockdown. App-based information delivered to parents with support showed encouraging feedback.","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Niranjan","Sanjay","Neo Child Clinic, Lucknow, India",NA
"777","34183470","","Autism Spectrum Disorder in the COVID 19 Era: New Challenges - New Solutions.","This survey explored the support available and the effect of lockdown on children with autism spectrum disorder and their families in India and the United Kingdom. Our findings showed significant problems for children and families due to lockdown. App-based information delivered to parents with support showed encouraging feedback.","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Yadav","Tribhuvanesh","Global Child Clinic, Lucknow India",NA
"778","34183470","","Autism Spectrum Disorder in the COVID 19 Era: New Challenges - New Solutions.","This survey explored the support available and the effect of lockdown on children with autism spectrum disorder and their families in India and the United Kingdom. Our findings showed significant problems for children and families due to lockdown. App-based information delivered to parents with support showed encouraging feedback.","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Newman","Sue","Children's Services, Cornwall Partnership",NA
"779","34183470","","Autism Spectrum Disorder in the COVID 19 Era: New Challenges - New Solutions.","This survey explored the support available and the effect of lockdown on children with autism spectrum disorder and their families in India and the United Kingdom. Our findings showed significant problems for children and families due to lockdown. App-based information delivered to parents with support showed encouraging feedback.","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Marriott","Jonathan","NHS Foundation Trust, Truro, United Kingdom",NA
"780","34183470","","Autism Spectrum Disorder in the COVID 19 Era: New Challenges - New Solutions.","This survey explored the support available and the effect of lockdown on children with autism spectrum disorder and their families in India and the United Kingdom. Our findings showed significant problems for children and families due to lockdown. App-based information delivered to parents with support showed encouraging feedback.","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Smith","Gemma","ASD Assessment Team, Children's Care Management Centre, Cornwall Partnership NHS Foundation Trust, Truro, United Kingdom",NA
"781","34183470","","Autism Spectrum Disorder in the COVID 19 Era: New Challenges - New Solutions.","This survey explored the support available and the effect of lockdown on children with autism spectrum disorder and their families in India and the United Kingdom. Our findings showed significant problems for children and families due to lockdown. App-based information delivered to parents with support showed encouraging feedback.","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Sawlani","Garima","Geniuslane Child Development Centre, Lucknow, India",NA
"782","34183466","","Clinical Spectrum of Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection.","To compare the clinical profile, treatment, and outcomes of PCR-positive and PCR-negative antibody-positive critically ill children with multisystem inflammatory syndrome (MIS-C). This retrospective observational study was done at a tertiary care coronavirus disease 19 (COVID-19) pediatric intensive care unit in India. The baseline characteristics, clinical profile, treatment, and outcomes in seventeen critically ill children diagnosed with MIS-C were analyzed from 1 July to 31 October, 2020. Si","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Chandran","Jolly","Pediatric Intensive care unit, Department of Pediatrics, Christian Medical College, Vellore, Tamil Nadu",NA
"783","34183466","","Clinical Spectrum of Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection.","To compare the clinical profile, treatment, and outcomes of PCR-positive and PCR-negative antibody-positive critically ill children with multisystem inflammatory syndrome (MIS-C). This retrospective observational study was done at a tertiary care coronavirus disease 19 (COVID-19) pediatric intensive care unit in India. The baseline characteristics, clinical profile, treatment, and outcomes in seventeen critically ill children diagnosed with MIS-C were analyzed from 1 July to 31 October, 2020. Si","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"James","Ebor Jacob","Pediatric Intensive care unit, Department of Pediatrics, Christian Medical College, Vellore, Tamil Nadu. Correspondence to: Dr Ebor Jacob James, Professor, Pediatric Intensive Care Unit, Department of Pediatrics, Christian Medical College and Hospital, Vellore, Tamil Nadu. eborjacob@cmcvellore.ac","eborjacob@cmcvellore.ac.in"
"784","34183466","","Clinical Spectrum of Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection.","To compare the clinical profile, treatment, and outcomes of PCR-positive and PCR-negative antibody-positive critically ill children with multisystem inflammatory syndrome (MIS-C). This retrospective observational study was done at a tertiary care coronavirus disease 19 (COVID-19) pediatric intensive care unit in India. The baseline characteristics, clinical profile, treatment, and outcomes in seventeen critically ill children diagnosed with MIS-C were analyzed from 1 July to 31 October, 2020. Si","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Verghese","Valsan P","Pediatric Infectious Diseases, Department of Pediatrics, Christian Medical College, Vellore, Tamil Nadu",NA
"785","34183466","","Clinical Spectrum of Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection.","To compare the clinical profile, treatment, and outcomes of PCR-positive and PCR-negative antibody-positive critically ill children with multisystem inflammatory syndrome (MIS-C). This retrospective observational study was done at a tertiary care coronavirus disease 19 (COVID-19) pediatric intensive care unit in India. The baseline characteristics, clinical profile, treatment, and outcomes in seventeen critically ill children diagnosed with MIS-C were analyzed from 1 July to 31 October, 2020. Si","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Sathish Kumar","T","Pediatric Rheumatology, Department of Pediatrics, Christian Medical College, Vellore, Tamil Nadu",NA
"786","34183466","","Clinical Spectrum of Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection.","To compare the clinical profile, treatment, and outcomes of PCR-positive and PCR-negative antibody-positive critically ill children with multisystem inflammatory syndrome (MIS-C). This retrospective observational study was done at a tertiary care coronavirus disease 19 (COVID-19) pediatric intensive care unit in India. The baseline characteristics, clinical profile, treatment, and outcomes in seventeen critically ill children diagnosed with MIS-C were analyzed from 1 July to 31 October, 2020. Si","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Kala Ranjini Sundaravalli","E","Pediatric Intensive care unit, Department of Pediatrics, Christian Medical College, Vellore, Tamil Nadu",NA
"787","34183466","","Clinical Spectrum of Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection.","To compare the clinical profile, treatment, and outcomes of PCR-positive and PCR-negative antibody-positive critically ill children with multisystem inflammatory syndrome (MIS-C). This retrospective observational study was done at a tertiary care coronavirus disease 19 (COVID-19) pediatric intensive care unit in India. The baseline characteristics, clinical profile, treatment, and outcomes in seventeen critically ill children diagnosed with MIS-C were analyzed from 1 July to 31 October, 2020. Si","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Vyasam","Siva","Pediatric Intensive care unit, Department of Pediatrics, Christian Medical College, Vellore, Tamil Nadu",NA
"788","34183462","","Effect of Earmuffs on Physiological Parameters of Preterm Neonates Nursed in Incubators: A Before-and-After Study.","To determine the effect of earmuffs on stability of physiological parameters i.e. heart rate, respiratory rate, and oximeter saturation (SpO2)] in preterm neonates. Non-randomized, cross-over study. 60 stable preterm neonates observed without and with earmuffs for 2 hours each (control and intervention periods, respectively). The above parameters were recorded every 60 seconds. Spikes of parameters and fluctuation [by coefficient of variation (CoV)] were compared between periods. Spikes of all p","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Kaur","Amanpreet","National Institute of Nursing Education (NINE), Chandigarh",NA
"789","34183462","","Effect of Earmuffs on Physiological Parameters of Preterm Neonates Nursed in Incubators: A Before-and-After Study.","To determine the effect of earmuffs on stability of physiological parameters i.e. heart rate, respiratory rate, and oximeter saturation (SpO2)] in preterm neonates. Non-randomized, cross-over study. 60 stable preterm neonates observed without and with earmuffs for 2 hours each (control and intervention periods, respectively). The above parameters were recorded every 60 seconds. Spikes of parameters and fluctuation [by coefficient of variation (CoV)] were compared between periods. Spikes of all p","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Kaur","Sukhwinder","National Institute of Nursing Education (NINE), Chandigarh",NA
"790","34183462","","Effect of Earmuffs on Physiological Parameters of Preterm Neonates Nursed in Incubators: A Before-and-After Study.","To determine the effect of earmuffs on stability of physiological parameters i.e. heart rate, respiratory rate, and oximeter saturation (SpO2)] in preterm neonates. Non-randomized, cross-over study. 60 stable preterm neonates observed without and with earmuffs for 2 hours each (control and intervention periods, respectively). The above parameters were recorded every 60 seconds. Spikes of parameters and fluctuation [by coefficient of variation (CoV)] were compared between periods. Spikes of all p","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Munjal","Sanjay","Department of Otolaryngology, PGIMER, Chandigarh",NA
"791","34183462","","Effect of Earmuffs on Physiological Parameters of Preterm Neonates Nursed in Incubators: A Before-and-After Study.","To determine the effect of earmuffs on stability of physiological parameters i.e. heart rate, respiratory rate, and oximeter saturation (SpO2)] in preterm neonates. Non-randomized, cross-over study. 60 stable preterm neonates observed without and with earmuffs for 2 hours each (control and intervention periods, respectively). The above parameters were recorded every 60 seconds. Spikes of parameters and fluctuation [by coefficient of variation (CoV)] were compared between periods. Spikes of all p","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Ghai","Sandhya","National Institute of Nursing Education (NINE), Chandigarh",NA
"792","34183462","","Effect of Earmuffs on Physiological Parameters of Preterm Neonates Nursed in Incubators: A Before-and-After Study.","To determine the effect of earmuffs on stability of physiological parameters i.e. heart rate, respiratory rate, and oximeter saturation (SpO2)] in preterm neonates. Non-randomized, cross-over study. 60 stable preterm neonates observed without and with earmuffs for 2 hours each (control and intervention periods, respectively). The above parameters were recorded every 60 seconds. Spikes of parameters and fluctuation [by coefficient of variation (CoV)] were compared between periods. Spikes of all p","2021","06","29","Indian Pediatr","Indian pediatrics",NA,"Dutta","Sourabh","Department of Pediatrics, PGIMER, Chandigarh. Correspondence to: Prof Sourabh Dutta, Neonatology Unit, Department of Pediatrics, Post graduate Institute of Medical Education and Research, Chandigarh 160012. sourabhdutta1@gmail","sourabhdutta1@gmail.com"
"793","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Lamb","Danielle","Department of Applied Health Research, University College London, London, UK d.lamb@ucl.ac","d.lamb@ucl.ac.uk"
"794","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Gnanapragasam","Sam","Maudsley NHS Foundation Trust, London, UK",NA
"795","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Greenberg","Neil","Academic Department of Military Mental Health, King's College London, London, UK",NA
"796","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Bhundia","Rupa","Department of Psychological Medicine, King's College London, London, UK",NA
"797","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Carr","Ewan","Department of Biostatistics and Health Informatics, King's College London, London, UK",NA
"798","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Hotopf","Matthew","Maudsley NHS Foundation Trust, London, UK",NA
"799","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Razavi","Reza","Life Sciences and Medicine, King's College London, London, UK",NA
"800","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Raine","Rosalind","Department of Applied Health Research, University College London, London, UK",NA
"801","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Cross","Sean","Department of Psychological Medicine, King's College London, London, UK",NA
"802","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Dewar","Amy","Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"803","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Docherty","Mary","Department of Psychological Medicine, King's College London, London, UK",NA
"804","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Dorrington","Sarah","Institute of Psychiatry, Psychology &amp",NA
"805","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Hatch","Stephani","Institute of Psychiatry, Psychology &amp",NA
"806","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Wilson-Jones","Charlotte","Institute of Psychiatry, Psychology &amp",NA
"807","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Leightley","Daniel","Academic Department of Military Mental Health, King's College London, London, UK",NA
"808","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Madan","Ira","Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"809","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Marlow","Sally","Institute of Psychiatry, Psychology &amp",NA
"810","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","McMullen","Isabel","Department of Psychological Medicine, King's College London, London, UK",NA
"811","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Rafferty","Anne-Marie","Adult Nursing, King's College London, London, UK",NA
"812","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Parsons","Martin","Mental Health Liaison Team, King's College London, London, UK",NA
"813","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Polling","Catherine","Institute of Psychiatry, Psychology &amp",NA
"814","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Serfioti","Danai","Academic Department of Military Mental Health, King's College London, London, UK",NA
"815","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Gaunt","Helen","University Hospitals of Leicester NHS Trust, Leicester, UK",NA
"816","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Aitken","Peter","Devon Partnership NHS Trust, Exeter, UK",NA
"817","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Morris-Bone","Joanna","Avon &amp",NA
"818","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Simela","Chloe","Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"819","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","French","Veronica","Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK",NA
"820","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Harris","Rachel","Cornwall Partnership Foundation NHS Trust, Cornwall, UK",NA
"821","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Stevelink","Sharon A M","Academic Department of Military Mental Health, King's College London, London, UK",NA
"822","34183447","10.1136/oemed-2020-107276","Psychosocial impact of the COVID-19 pandemic on 4378 UK healthcare workers and ancillary staff: initial baseline data from a cohort study collected during the first wave of the pandemic.","This study reports preliminary findings on the prevalence of, and factors associated with, mental health and well-being outcomes of healthcare workers during the early months (April-June) of the COVID-19 pandemic in the UK. Preliminary cross-sectional data were analysed from a cohort study (n=4378). Clinical and non-clinical staff of three London-based NHS Trusts, including acute and mental health Trusts, took part in an online baseline survey. The primary outcome measure used is the presence of","2021","07","05","Occup Environ Med","Occupational and environmental medicine","health personnel; mental health; post-traumatic; psychiatry; psychology; stress disorders","Wessely","Simon","Department of Psychological Medicine, King's College London, London, UK",NA
"824","34183423","10.1073/pnas.2109720118","Correction for Edwards et al., Exhaled aerosol increases with COVID-19 infection, age, and obesity.",NA,"2021","07","17","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America",NA,NA,NA,NA,NA
"825","34183411","10.1073/pnas.2023212118","Epidemics and the future of coffee production.","In this perspective, we draw on recent scientific research on the coffee leaf rust (CLR) epidemic that severely impacted several countries across Latin America and the Caribbean over the last decade, to explore how the socioeconomic impacts from COVID-19 could lead to the reemergence of another rust epidemic. We describe how past CLR outbreaks have been linked to reduced crop care and investment in coffee farms, as evidenced in the years following the 2008 global financial crisis. We discuss rel","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; Hemileia vastatrix; coffee; plant diseases; social environmental systems; Basidiomycota; COVID-19; Coffee; Environment; Epidemics; Farms; Industry; Plant Diseases; SARS-CoV-2; Socioeconomic Factors","Rhiney","Kevon","Department of Geography, Rutgers University-New Brunswick, Piscataway, NJ 08854","kevon.rhiney@rutgers.edu"
"826","34183411","10.1073/pnas.2023212118","Epidemics and the future of coffee production.","In this perspective, we draw on recent scientific research on the coffee leaf rust (CLR) epidemic that severely impacted several countries across Latin America and the Caribbean over the last decade, to explore how the socioeconomic impacts from COVID-19 could lead to the reemergence of another rust epidemic. We describe how past CLR outbreaks have been linked to reduced crop care and investment in coffee farms, as evidenced in the years following the 2008 global financial crisis. We discuss rel","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; Hemileia vastatrix; coffee; plant diseases; social environmental systems; Basidiomycota; COVID-19; Coffee; Environment; Epidemics; Farms; Industry; Plant Diseases; SARS-CoV-2; Socioeconomic Factors","Guido","Zack","Institute of the Environment, University of Arizona, Tucson, AZ 85721",NA
"827","34183411","10.1073/pnas.2023212118","Epidemics and the future of coffee production.","In this perspective, we draw on recent scientific research on the coffee leaf rust (CLR) epidemic that severely impacted several countries across Latin America and the Caribbean over the last decade, to explore how the socioeconomic impacts from COVID-19 could lead to the reemergence of another rust epidemic. We describe how past CLR outbreaks have been linked to reduced crop care and investment in coffee farms, as evidenced in the years following the 2008 global financial crisis. We discuss rel","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; Hemileia vastatrix; coffee; plant diseases; social environmental systems; Basidiomycota; COVID-19; Coffee; Environment; Epidemics; Farms; Industry; Plant Diseases; SARS-CoV-2; Socioeconomic Factors","Knudson","Chris","Department of Geography and Environmental Science, University of Hawaii at Hilo, Hilo, HI 96720",NA
"828","34183411","10.1073/pnas.2023212118","Epidemics and the future of coffee production.","In this perspective, we draw on recent scientific research on the coffee leaf rust (CLR) epidemic that severely impacted several countries across Latin America and the Caribbean over the last decade, to explore how the socioeconomic impacts from COVID-19 could lead to the reemergence of another rust epidemic. We describe how past CLR outbreaks have been linked to reduced crop care and investment in coffee farms, as evidenced in the years following the 2008 global financial crisis. We discuss rel","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; Hemileia vastatrix; coffee; plant diseases; social environmental systems; Basidiomycota; COVID-19; Coffee; Environment; Epidemics; Farms; Industry; Plant Diseases; SARS-CoV-2; Socioeconomic Factors","Avelino","Jacques","Centre de Coopération Internationale en Recherche Agronomique pour le Développement (CIRAD), UMR Plant Health Institute of Montpellier (PHIM), Turrialba 30501, Costa Rica",NA
"829","34183411","10.1073/pnas.2023212118","Epidemics and the future of coffee production.","In this perspective, we draw on recent scientific research on the coffee leaf rust (CLR) epidemic that severely impacted several countries across Latin America and the Caribbean over the last decade, to explore how the socioeconomic impacts from COVID-19 could lead to the reemergence of another rust epidemic. We describe how past CLR outbreaks have been linked to reduced crop care and investment in coffee farms, as evidenced in the years following the 2008 global financial crisis. We discuss rel","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; Hemileia vastatrix; coffee; plant diseases; social environmental systems; Basidiomycota; COVID-19; Coffee; Environment; Epidemics; Farms; Industry; Plant Diseases; SARS-CoV-2; Socioeconomic Factors","Bacon","Christopher M","Department of Environmental Studies and Sciences, Santa Clara University, Santa Clara, CA 95053",NA
"830","34183411","10.1073/pnas.2023212118","Epidemics and the future of coffee production.","In this perspective, we draw on recent scientific research on the coffee leaf rust (CLR) epidemic that severely impacted several countries across Latin America and the Caribbean over the last decade, to explore how the socioeconomic impacts from COVID-19 could lead to the reemergence of another rust epidemic. We describe how past CLR outbreaks have been linked to reduced crop care and investment in coffee farms, as evidenced in the years following the 2008 global financial crisis. We discuss rel","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; Hemileia vastatrix; coffee; plant diseases; social environmental systems; Basidiomycota; COVID-19; Coffee; Environment; Epidemics; Farms; Industry; Plant Diseases; SARS-CoV-2; Socioeconomic Factors","Leclerc","Grégoire","Centro Agronómico Tropical de Investigación y Enseñanza (CATIE), Turrialba 30501, Costa Rica",NA
"831","34183411","10.1073/pnas.2023212118","Epidemics and the future of coffee production.","In this perspective, we draw on recent scientific research on the coffee leaf rust (CLR) epidemic that severely impacted several countries across Latin America and the Caribbean over the last decade, to explore how the socioeconomic impacts from COVID-19 could lead to the reemergence of another rust epidemic. We describe how past CLR outbreaks have been linked to reduced crop care and investment in coffee farms, as evidenced in the years following the 2008 global financial crisis. We discuss rel","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; Hemileia vastatrix; coffee; plant diseases; social environmental systems; Basidiomycota; COVID-19; Coffee; Environment; Epidemics; Farms; Industry; Plant Diseases; SARS-CoV-2; Socioeconomic Factors","Aime","M Catherine","Department of Botany and Plant Pathology, Purdue University, West Lafayette, IN 47907",NA
"832","34183411","10.1073/pnas.2023212118","Epidemics and the future of coffee production.","In this perspective, we draw on recent scientific research on the coffee leaf rust (CLR) epidemic that severely impacted several countries across Latin America and the Caribbean over the last decade, to explore how the socioeconomic impacts from COVID-19 could lead to the reemergence of another rust epidemic. We describe how past CLR outbreaks have been linked to reduced crop care and investment in coffee farms, as evidenced in the years following the 2008 global financial crisis. We discuss rel","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; Hemileia vastatrix; coffee; plant diseases; social environmental systems; Basidiomycota; COVID-19; Coffee; Environment; Epidemics; Farms; Industry; Plant Diseases; SARS-CoV-2; Socioeconomic Factors","Bebber","Daniel P","Department of Biosciences, University of Exeter, EX4 4PY Exeter, United Kingdom",NA
"833","34183391","10.1073/pnas.2101497118","IgA potentiates NETosis in response to viral infection.","IgA is the second most abundant antibody present in circulation and is enriched at mucosal surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens including viruses. In addition to neutralizing viruses directly, IgA can also stimulate Fc-dependent effector functions via engagement of Fc alpha receptors (Fc-aRI) expressed on the surface of certain immune effector cells. Neutrophils are the most abundant leukocyte, express Fc-aRI, and are often the first to res","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","NETosis; SARS-CoV-2; influenza; neutrophils; viruses; Antigen-Antibody Complex; Antigens, CD; Extracellular Traps; Humans; Immunoglobulin A; Influenzavirus A; NADPH Oxidases; Neutrophils; Receptors, Fc; SARS-CoV-2; Signal Transduction; Virion; Virus Diseases","Stacey","Hannah D","Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, ON, Canada, L8S 4K1",NA
"834","34183391","10.1073/pnas.2101497118","IgA potentiates NETosis in response to viral infection.","IgA is the second most abundant antibody present in circulation and is enriched at mucosal surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens including viruses. In addition to neutralizing viruses directly, IgA can also stimulate Fc-dependent effector functions via engagement of Fc alpha receptors (Fc-aRI) expressed on the surface of certain immune effector cells. Neutrophils are the most abundant leukocyte, express Fc-aRI, and are often the first to res","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","NETosis; SARS-CoV-2; influenza; neutrophils; viruses; Antigen-Antibody Complex; Antigens, CD; Extracellular Traps; Humans; Immunoglobulin A; Influenzavirus A; NADPH Oxidases; Neutrophils; Receptors, Fc; SARS-CoV-2; Signal Transduction; Virion; Virus Diseases","Golubeva","Diana","Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, ON, Canada, L8S 4K1",NA
"835","34183391","10.1073/pnas.2101497118","IgA potentiates NETosis in response to viral infection.","IgA is the second most abundant antibody present in circulation and is enriched at mucosal surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens including viruses. In addition to neutralizing viruses directly, IgA can also stimulate Fc-dependent effector functions via engagement of Fc alpha receptors (Fc-aRI) expressed on the surface of certain immune effector cells. Neutrophils are the most abundant leukocyte, express Fc-aRI, and are often the first to res","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","NETosis; SARS-CoV-2; influenza; neutrophils; viruses; Antigen-Antibody Complex; Antigens, CD; Extracellular Traps; Humans; Immunoglobulin A; Influenzavirus A; NADPH Oxidases; Neutrophils; Receptors, Fc; SARS-CoV-2; Signal Transduction; Virion; Virus Diseases","Posca","Alyssa","Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, ON, Canada, L8S 4K1",NA
"836","34183391","10.1073/pnas.2101497118","IgA potentiates NETosis in response to viral infection.","IgA is the second most abundant antibody present in circulation and is enriched at mucosal surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens including viruses. In addition to neutralizing viruses directly, IgA can also stimulate Fc-dependent effector functions via engagement of Fc alpha receptors (Fc-aRI) expressed on the surface of certain immune effector cells. Neutrophils are the most abundant leukocyte, express Fc-aRI, and are often the first to res","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","NETosis; SARS-CoV-2; influenza; neutrophils; viruses; Antigen-Antibody Complex; Antigens, CD; Extracellular Traps; Humans; Immunoglobulin A; Influenzavirus A; NADPH Oxidases; Neutrophils; Receptors, Fc; SARS-CoV-2; Signal Transduction; Virion; Virus Diseases","Ang","Jann C","Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, ON, Canada, L8S 4K1",NA
"837","34183391","10.1073/pnas.2101497118","IgA potentiates NETosis in response to viral infection.","IgA is the second most abundant antibody present in circulation and is enriched at mucosal surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens including viruses. In addition to neutralizing viruses directly, IgA can also stimulate Fc-dependent effector functions via engagement of Fc alpha receptors (Fc-aRI) expressed on the surface of certain immune effector cells. Neutrophils are the most abundant leukocyte, express Fc-aRI, and are often the first to res","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","NETosis; SARS-CoV-2; influenza; neutrophils; viruses; Antigen-Antibody Complex; Antigens, CD; Extracellular Traps; Humans; Immunoglobulin A; Influenzavirus A; NADPH Oxidases; Neutrophils; Receptors, Fc; SARS-CoV-2; Signal Transduction; Virion; Virus Diseases","Novakowski","Kyle E","Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, ON, Canada, L8S 4K1",NA
"838","34183391","10.1073/pnas.2101497118","IgA potentiates NETosis in response to viral infection.","IgA is the second most abundant antibody present in circulation and is enriched at mucosal surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens including viruses. In addition to neutralizing viruses directly, IgA can also stimulate Fc-dependent effector functions via engagement of Fc alpha receptors (Fc-aRI) expressed on the surface of certain immune effector cells. Neutrophils are the most abundant leukocyte, express Fc-aRI, and are often the first to res","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","NETosis; SARS-CoV-2; influenza; neutrophils; viruses; Antigen-Antibody Complex; Antigens, CD; Extracellular Traps; Humans; Immunoglobulin A; Influenzavirus A; NADPH Oxidases; Neutrophils; Receptors, Fc; SARS-CoV-2; Signal Transduction; Virion; Virus Diseases","Zahoor","Muhammad Atif","McMaster Immunology Research Centre, McMaster University, Hamilton, ON, Canada, L8S 4K1",NA
"839","34183391","10.1073/pnas.2101497118","IgA potentiates NETosis in response to viral infection.","IgA is the second most abundant antibody present in circulation and is enriched at mucosal surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens including viruses. In addition to neutralizing viruses directly, IgA can also stimulate Fc-dependent effector functions via engagement of Fc alpha receptors (Fc-aRI) expressed on the surface of certain immune effector cells. Neutrophils are the most abundant leukocyte, express Fc-aRI, and are often the first to res","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","NETosis; SARS-CoV-2; influenza; neutrophils; viruses; Antigen-Antibody Complex; Antigens, CD; Extracellular Traps; Humans; Immunoglobulin A; Influenzavirus A; NADPH Oxidases; Neutrophils; Receptors, Fc; SARS-CoV-2; Signal Transduction; Virion; Virus Diseases","Kaushic","Charu","McMaster Immunology Research Centre, McMaster University, Hamilton, ON, Canada, L8S 4K1",NA
"840","34183391","10.1073/pnas.2101497118","IgA potentiates NETosis in response to viral infection.","IgA is the second most abundant antibody present in circulation and is enriched at mucosal surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens including viruses. In addition to neutralizing viruses directly, IgA can also stimulate Fc-dependent effector functions via engagement of Fc alpha receptors (Fc-aRI) expressed on the surface of certain immune effector cells. Neutrophils are the most abundant leukocyte, express Fc-aRI, and are often the first to res","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","NETosis; SARS-CoV-2; influenza; neutrophils; viruses; Antigen-Antibody Complex; Antigens, CD; Extracellular Traps; Humans; Immunoglobulin A; Influenzavirus A; NADPH Oxidases; Neutrophils; Receptors, Fc; SARS-CoV-2; Signal Transduction; Virion; Virus Diseases","Cairns","Ewa","Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, N6A 3K7",NA
"841","34183391","10.1073/pnas.2101497118","IgA potentiates NETosis in response to viral infection.","IgA is the second most abundant antibody present in circulation and is enriched at mucosal surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens including viruses. In addition to neutralizing viruses directly, IgA can also stimulate Fc-dependent effector functions via engagement of Fc alpha receptors (Fc-aRI) expressed on the surface of certain immune effector cells. Neutrophils are the most abundant leukocyte, express Fc-aRI, and are often the first to res","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","NETosis; SARS-CoV-2; influenza; neutrophils; viruses; Antigen-Antibody Complex; Antigens, CD; Extracellular Traps; Humans; Immunoglobulin A; Influenzavirus A; NADPH Oxidases; Neutrophils; Receptors, Fc; SARS-CoV-2; Signal Transduction; Virion; Virus Diseases","Bowdish","Dawn M E","Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, ON, Canada, L8S 4K1",NA
"842","34183391","10.1073/pnas.2101497118","IgA potentiates NETosis in response to viral infection.","IgA is the second most abundant antibody present in circulation and is enriched at mucosal surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens including viruses. In addition to neutralizing viruses directly, IgA can also stimulate Fc-dependent effector functions via engagement of Fc alpha receptors (Fc-aRI) expressed on the surface of certain immune effector cells. Neutrophils are the most abundant leukocyte, express Fc-aRI, and are often the first to res","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","NETosis; SARS-CoV-2; influenza; neutrophils; viruses; Antigen-Antibody Complex; Antigens, CD; Extracellular Traps; Humans; Immunoglobulin A; Influenzavirus A; NADPH Oxidases; Neutrophils; Receptors, Fc; SARS-CoV-2; Signal Transduction; Virion; Virus Diseases","Mullarkey","Caitlin E","Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, ON, Canada, L8S 4K1",NA
"843","34183391","10.1073/pnas.2101497118","IgA potentiates NETosis in response to viral infection.","IgA is the second most abundant antibody present in circulation and is enriched at mucosal surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens including viruses. In addition to neutralizing viruses directly, IgA can also stimulate Fc-dependent effector functions via engagement of Fc alpha receptors (Fc-aRI) expressed on the surface of certain immune effector cells. Neutrophils are the most abundant leukocyte, express Fc-aRI, and are often the first to res","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","NETosis; SARS-CoV-2; influenza; neutrophils; viruses; Antigen-Antibody Complex; Antigens, CD; Extracellular Traps; Humans; Immunoglobulin A; Influenzavirus A; NADPH Oxidases; Neutrophils; Receptors, Fc; SARS-CoV-2; Signal Transduction; Virion; Virus Diseases","Miller","Matthew S","Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, ON, Canada, L8S 4K1","mmiller@mcmaster.ca"
"844","34183379","10.1136/archdischild-2021-322139","Celebrating our wins.",NA,"2021","06","29","Arch Dis Child Educ Pract Ed","Archives of disease in childhood. Education and practice edition","Covid-19; psychology","Crosby","Laura","Paediatrics, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK l.crosby@nhs","l.crosby@nhs.net"
"845","34183379","10.1136/archdischild-2021-322139","Celebrating our wins.",NA,"2021","06","29","Arch Dis Child Educ Pract Ed","Archives of disease in childhood. Education and practice edition","Covid-19; psychology","Finlay","Fiona","Community Child Health, Virgin Care Ltd, Bath, UK",NA
"846","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Huang","Deli","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA","delih@zju.edu.cn"
"847","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Tran","Jenny Tuyet","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA",NA
"848","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Peng","Linghang","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA",NA
"849","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Yang","Linlin","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA",NA
"850","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Suhandynata","Raymond T","Department of Pathology, University of California San Diego Health, San Diego, CA",NA
"851","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Hoffman","Melissa A","Department of Pathology, University of California San Diego Health, San Diego, CA",NA
"852","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Zhao","Fangzhu","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA",NA
"853","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Song","Ge","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA",NA
"854","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"He","Wan-Ting","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA",NA
"855","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Limbo","Oliver","International Aids Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA",NA
"856","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Callaghan","Sean","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA",NA
"857","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Landais","Elise","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA",NA
"858","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Andrabi","Raiees","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA",NA
"859","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Sok","Devin","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA",NA
"860","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Jardine","Joseph G","International Aids Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA",NA
"861","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Burton","Dennis R","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA",NA
"862","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Voss","James E","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA",NA
"863","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Fitzgerald","Robert L","Department of Pathology, University of California San Diego Health, San Diego, CA",NA
"864","34183368","10.4049/jimmunol.2100155","A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike pseudotyped virus (PSV) assays are widely used to measure neutralization titers of sera and of isolated neutralizing Abs (nAbs). PSV neutralization assays are safer than live virus neutralization assays and do not require access to biosafety level 3 laboratories. However, many PSV assays are nevertheless somewhat challenging and require at least 2 d to carry out. In this study, we report a rapid (&lt;30 min), sensitive, cell-free","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Nemazee","David","Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA","delih@zju.edu.cn"
"865","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Avendaño-Ortiz","José","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"866","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Lozano-Rodríguez","Roberto","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"867","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Martín-Quirós","Alejandro","Emergency Department and Emergent Pathology Research Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"868","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Maroun-Eid","Charbel","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"869","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Terrón-Arcos","Verónica","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"870","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Montalbán-Hernández","Karla","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"871","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Valentín","Jaime","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"872","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Muñoz Del Val","Elena","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"873","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"García-Garrido","Miguel A","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"874","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Del Balzo-Castillo","Álvaro","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"875","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Casalvilla-Dueñas","José Carlos","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"876","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Peinado","María","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"877","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Gómez","Laura","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"878","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Herrero-Benito","Carmen","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"879","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Rubio","Carolina","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"880","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Cubillos-Zapata","Carolina","Center for Biomedical Research Network, Madrid, Spain",NA
"881","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Pascual-Iglesias","Alejandro","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"882","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Del Fresno","Carlos","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"883","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Aguirre","Luis A","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain",NA
"884","34183364","10.4049/jimmunol.2001449","SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.","According to a large number of reported cohorts, sepsis has been observed in nearly all deceased patients with COVID-19. We and others have described sepsis, among other pathologies, to be an endotoxin tolerance (ET)-related disease. In this study, we demonstrate that the culture of human blood cells from healthy volunteers in the presence of SARS-CoV-2 proteins induced ET hallmarks, including impairment of proinflammatory cytokine production, low MHC class II (HLA-DR) expression, poor T cell pr","2021","06","29","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"López-Collazo","Eduardo","Innate Immunity Group, Hospital La Paz Institute for Health Research, La Paz University Hospital, Madrid, Spain","elopezc@salud.madrid.org"
"885","34183357","10.1136/bmj.n1654","Covid-19: GPs urge government to clear up confusion over symptoms.",NA,"2021","06","30","BMJ","BMJ (Clinical research ed.)",NA,"Mahase","Elisabeth","The BMJ",NA
"886","34183352","10.1136/bmj.n1655","Covid-19: Pandemic will cast ""a long shadow"" on mental health, warns England's CMO.",NA,"2021","06","30","BMJ","BMJ (Clinical research ed.)",NA,"Nabavi","Nikki","The BMJ",NA
"887","34183349","10.1136/bmjopen-2021-049190","What are the measures taken to prevent COVID-19 infection among healthcare workers? A retrospective study in a cluster of primary care clinics in Singapore.","To examine factors contributing to the low COVID-19 infectivity rate among healthcare workers in SingHealth Polyclinics (SHP), Singapore, from February to July 2020. Retrospective description, analysis and discussion of the factors and their contribution. Single-institution study. We describe and discuss the healthcare policies, infrastructure, people and processes contributing to the low COVID-19 infectivity rate in SHP.There were 1212 full-time and 198 contract staff. Of these, 171 SHP employe","2021","07","01","BMJ Open","BMJ open","COVID-19; infection control; occupational &amp; industrial medicine; primary care; risk management; COVID-19; COVID-19 Vaccines; Health Personnel; Humans; Primary Health Care; Retrospective Studies; SARS-CoV-2; Singapore","Moey","Peter Kirm Seng","SingHealth Polyclinics, Singapore peter.moey.k.s@singhealth.com","peter.moey.k.s@singhealth.com.sg"
"888","34183349","10.1136/bmjopen-2021-049190","What are the measures taken to prevent COVID-19 infection among healthcare workers? A retrospective study in a cluster of primary care clinics in Singapore.","To examine factors contributing to the low COVID-19 infectivity rate among healthcare workers in SingHealth Polyclinics (SHP), Singapore, from February to July 2020. Retrospective description, analysis and discussion of the factors and their contribution. Single-institution study. We describe and discuss the healthcare policies, infrastructure, people and processes contributing to the low COVID-19 infectivity rate in SHP.There were 1212 full-time and 198 contract staff. Of these, 171 SHP employe","2021","07","01","BMJ Open","BMJ open","COVID-19; infection control; occupational &amp; industrial medicine; primary care; risk management; COVID-19; COVID-19 Vaccines; Health Personnel; Humans; Primary Health Care; Retrospective Studies; SARS-CoV-2; Singapore","Ang","Andrew Teck Wee","SingHealth Polyclinics, Singapore",NA
"889","34183349","10.1136/bmjopen-2021-049190","What are the measures taken to prevent COVID-19 infection among healthcare workers? A retrospective study in a cluster of primary care clinics in Singapore.","To examine factors contributing to the low COVID-19 infectivity rate among healthcare workers in SingHealth Polyclinics (SHP), Singapore, from February to July 2020. Retrospective description, analysis and discussion of the factors and their contribution. Single-institution study. We describe and discuss the healthcare policies, infrastructure, people and processes contributing to the low COVID-19 infectivity rate in SHP.There were 1212 full-time and 198 contract staff. Of these, 171 SHP employe","2021","07","01","BMJ Open","BMJ open","COVID-19; infection control; occupational &amp; industrial medicine; primary care; risk management; COVID-19; COVID-19 Vaccines; Health Personnel; Humans; Primary Health Care; Retrospective Studies; SARS-CoV-2; Singapore","Ee","Adrian Guan Liang","SingHealth Polyclinics, Singapore",NA
"890","34183349","10.1136/bmjopen-2021-049190","What are the measures taken to prevent COVID-19 infection among healthcare workers? A retrospective study in a cluster of primary care clinics in Singapore.","To examine factors contributing to the low COVID-19 infectivity rate among healthcare workers in SingHealth Polyclinics (SHP), Singapore, from February to July 2020. Retrospective description, analysis and discussion of the factors and their contribution. Single-institution study. We describe and discuss the healthcare policies, infrastructure, people and processes contributing to the low COVID-19 infectivity rate in SHP.There were 1212 full-time and 198 contract staff. Of these, 171 SHP employe","2021","07","01","BMJ Open","BMJ open","COVID-19; infection control; occupational &amp; industrial medicine; primary care; risk management; COVID-19; COVID-19 Vaccines; Health Personnel; Humans; Primary Health Care; Retrospective Studies; SARS-CoV-2; Singapore","Ng","David Chee Chin","SingHealth Polyclinics, Singapore",NA
"891","34183349","10.1136/bmjopen-2021-049190","What are the measures taken to prevent COVID-19 infection among healthcare workers? A retrospective study in a cluster of primary care clinics in Singapore.","To examine factors contributing to the low COVID-19 infectivity rate among healthcare workers in SingHealth Polyclinics (SHP), Singapore, from February to July 2020. Retrospective description, analysis and discussion of the factors and their contribution. Single-institution study. We describe and discuss the healthcare policies, infrastructure, people and processes contributing to the low COVID-19 infectivity rate in SHP.There were 1212 full-time and 198 contract staff. Of these, 171 SHP employe","2021","07","01","BMJ Open","BMJ open","COVID-19; infection control; occupational &amp; industrial medicine; primary care; risk management; COVID-19; COVID-19 Vaccines; Health Personnel; Humans; Primary Health Care; Retrospective Studies; SARS-CoV-2; Singapore","Ng","Mark Chung Wai","SingHealth Polyclinics, Singapore",NA
"892","34183349","10.1136/bmjopen-2021-049190","What are the measures taken to prevent COVID-19 infection among healthcare workers? A retrospective study in a cluster of primary care clinics in Singapore.","To examine factors contributing to the low COVID-19 infectivity rate among healthcare workers in SingHealth Polyclinics (SHP), Singapore, from February to July 2020. Retrospective description, analysis and discussion of the factors and their contribution. Single-institution study. We describe and discuss the healthcare policies, infrastructure, people and processes contributing to the low COVID-19 infectivity rate in SHP.There were 1212 full-time and 198 contract staff. Of these, 171 SHP employe","2021","07","01","BMJ Open","BMJ open","COVID-19; infection control; occupational &amp; industrial medicine; primary care; risk management; COVID-19; COVID-19 Vaccines; Health Personnel; Humans; Primary Health Care; Retrospective Studies; SARS-CoV-2; Singapore","Teo","Stephanie Swee Hong","SingHealth Polyclinics, Singapore",NA
"893","34183349","10.1136/bmjopen-2021-049190","What are the measures taken to prevent COVID-19 infection among healthcare workers? A retrospective study in a cluster of primary care clinics in Singapore.","To examine factors contributing to the low COVID-19 infectivity rate among healthcare workers in SingHealth Polyclinics (SHP), Singapore, from February to July 2020. Retrospective description, analysis and discussion of the factors and their contribution. Single-institution study. We describe and discuss the healthcare policies, infrastructure, people and processes contributing to the low COVID-19 infectivity rate in SHP.There were 1212 full-time and 198 contract staff. Of these, 171 SHP employe","2021","07","01","BMJ Open","BMJ open","COVID-19; infection control; occupational &amp; industrial medicine; primary care; risk management; COVID-19; COVID-19 Vaccines; Health Personnel; Humans; Primary Health Care; Retrospective Studies; SARS-CoV-2; Singapore","Tay","Ee Guan","SingHealth Polyclinics, Singapore",NA
"894","34183349","10.1136/bmjopen-2021-049190","What are the measures taken to prevent COVID-19 infection among healthcare workers? A retrospective study in a cluster of primary care clinics in Singapore.","To examine factors contributing to the low COVID-19 infectivity rate among healthcare workers in SingHealth Polyclinics (SHP), Singapore, from February to July 2020. Retrospective description, analysis and discussion of the factors and their contribution. Single-institution study. We describe and discuss the healthcare policies, infrastructure, people and processes contributing to the low COVID-19 infectivity rate in SHP.There were 1212 full-time and 198 contract staff. Of these, 171 SHP employe","2021","07","01","BMJ Open","BMJ open","COVID-19; infection control; occupational &amp; industrial medicine; primary care; risk management; COVID-19; COVID-19 Vaccines; Health Personnel; Humans; Primary Health Care; Retrospective Studies; SARS-CoV-2; Singapore","Tan","Ngiap Chuan","SingHealth Polyclinics, Singapore",NA
"895","34183342","10.1136/bmjopen-2020-046392","United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.","COVID-19 has spread rapidly worldwide, causing significant morbidity and mortality. People from ethnic minorities, particularly those working in healthcare settings, have been disproportionately affected. Current evidence of the association between ethnicity and COVID-19 outcomes in people working in healthcare settings is insufficient to inform plans to address health inequalities. This study combines anonymised human resource databases with professional registration and National Health Service","2021","07","01","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; epidemiology; public health; COVID-19; COVID-19 Testing; Ethnic Groups; Health Personnel; Humans; Meta-Analysis as Topic; Retrospective Studies; Routinely Collected Health Data; SARS-CoV-2; State Medicine; United Kingdom","Teece","Lucy","Biostatistics Research Group, Department of Health Sciences, University of Leicester, Leicester, UK",NA
"896","34183342","10.1136/bmjopen-2020-046392","United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.","COVID-19 has spread rapidly worldwide, causing significant morbidity and mortality. People from ethnic minorities, particularly those working in healthcare settings, have been disproportionately affected. Current evidence of the association between ethnicity and COVID-19 outcomes in people working in healthcare settings is insufficient to inform plans to address health inequalities. This study combines anonymised human resource databases with professional registration and National Health Service","2021","07","01","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; epidemiology; public health; COVID-19; COVID-19 Testing; Ethnic Groups; Health Personnel; Humans; Meta-Analysis as Topic; Retrospective Studies; Routinely Collected Health Data; SARS-CoV-2; State Medicine; United Kingdom","Gray","Laura J","Biostatistics Research Group, Department of Health Sciences, University of Leicester, Leicester, UK",NA
"897","34183342","10.1136/bmjopen-2020-046392","United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.","COVID-19 has spread rapidly worldwide, causing significant morbidity and mortality. People from ethnic minorities, particularly those working in healthcare settings, have been disproportionately affected. Current evidence of the association between ethnicity and COVID-19 outcomes in people working in healthcare settings is insufficient to inform plans to address health inequalities. This study combines anonymised human resource databases with professional registration and National Health Service","2021","07","01","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; epidemiology; public health; COVID-19; COVID-19 Testing; Ethnic Groups; Health Personnel; Humans; Meta-Analysis as Topic; Retrospective Studies; Routinely Collected Health Data; SARS-CoV-2; State Medicine; United Kingdom","Melbourne","Carl","Genetic Epidemiology Research Group, Department of Health Sciences, University of Leicester, Leicester, UK",NA
"898","34183342","10.1136/bmjopen-2020-046392","United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.","COVID-19 has spread rapidly worldwide, causing significant morbidity and mortality. People from ethnic minorities, particularly those working in healthcare settings, have been disproportionately affected. Current evidence of the association between ethnicity and COVID-19 outcomes in people working in healthcare settings is insufficient to inform plans to address health inequalities. This study combines anonymised human resource databases with professional registration and National Health Service","2021","07","01","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; epidemiology; public health; COVID-19; COVID-19 Testing; Ethnic Groups; Health Personnel; Humans; Meta-Analysis as Topic; Retrospective Studies; Routinely Collected Health Data; SARS-CoV-2; State Medicine; United Kingdom","Orton","Chris","Population Data Science, Swansea University Medical School, Swansea, UK",NA
"899","34183342","10.1136/bmjopen-2020-046392","United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.","COVID-19 has spread rapidly worldwide, causing significant morbidity and mortality. People from ethnic minorities, particularly those working in healthcare settings, have been disproportionately affected. Current evidence of the association between ethnicity and COVID-19 outcomes in people working in healthcare settings is insufficient to inform plans to address health inequalities. This study combines anonymised human resource databases with professional registration and National Health Service","2021","07","01","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; epidemiology; public health; COVID-19; COVID-19 Testing; Ethnic Groups; Health Personnel; Humans; Meta-Analysis as Topic; Retrospective Studies; Routinely Collected Health Data; SARS-CoV-2; State Medicine; United Kingdom","Ford","David V","Population Data Science, Swansea University Medical School, Swansea, UK",NA
"900","34183342","10.1136/bmjopen-2020-046392","United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.","COVID-19 has spread rapidly worldwide, causing significant morbidity and mortality. People from ethnic minorities, particularly those working in healthcare settings, have been disproportionately affected. Current evidence of the association between ethnicity and COVID-19 outcomes in people working in healthcare settings is insufficient to inform plans to address health inequalities. This study combines anonymised human resource databases with professional registration and National Health Service","2021","07","01","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; epidemiology; public health; COVID-19; COVID-19 Testing; Ethnic Groups; Health Personnel; Humans; Meta-Analysis as Topic; Retrospective Studies; Routinely Collected Health Data; SARS-CoV-2; State Medicine; United Kingdom","Martin","Christopher A","Department of Respiratory Sciences, University of Leicester, Leicester, UK",NA
"901","34183342","10.1136/bmjopen-2020-046392","United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.","COVID-19 has spread rapidly worldwide, causing significant morbidity and mortality. People from ethnic minorities, particularly those working in healthcare settings, have been disproportionately affected. Current evidence of the association between ethnicity and COVID-19 outcomes in people working in healthcare settings is insufficient to inform plans to address health inequalities. This study combines anonymised human resource databases with professional registration and National Health Service","2021","07","01","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; epidemiology; public health; COVID-19; COVID-19 Testing; Ethnic Groups; Health Personnel; Humans; Meta-Analysis as Topic; Retrospective Studies; Routinely Collected Health Data; SARS-CoV-2; State Medicine; United Kingdom","McAllister","David","Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK",NA
"902","34183342","10.1136/bmjopen-2020-046392","United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.","COVID-19 has spread rapidly worldwide, causing significant morbidity and mortality. People from ethnic minorities, particularly those working in healthcare settings, have been disproportionately affected. Current evidence of the association between ethnicity and COVID-19 outcomes in people working in healthcare settings is insufficient to inform plans to address health inequalities. This study combines anonymised human resource databases with professional registration and National Health Service","2021","07","01","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; epidemiology; public health; COVID-19; COVID-19 Testing; Ethnic Groups; Health Personnel; Humans; Meta-Analysis as Topic; Retrospective Studies; Routinely Collected Health Data; SARS-CoV-2; State Medicine; United Kingdom","Khunti","Kamlesh","Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK",NA
"903","34183342","10.1136/bmjopen-2020-046392","United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.","COVID-19 has spread rapidly worldwide, causing significant morbidity and mortality. People from ethnic minorities, particularly those working in healthcare settings, have been disproportionately affected. Current evidence of the association between ethnicity and COVID-19 outcomes in people working in healthcare settings is insufficient to inform plans to address health inequalities. This study combines anonymised human resource databases with professional registration and National Health Service","2021","07","01","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; epidemiology; public health; COVID-19; COVID-19 Testing; Ethnic Groups; Health Personnel; Humans; Meta-Analysis as Topic; Retrospective Studies; Routinely Collected Health Data; SARS-CoV-2; State Medicine; United Kingdom","Tobin","Martin","Genetic Epidemiology Research Group, Department of Health Sciences, University of Leicester, Leicester, UK",NA
"904","34183342","10.1136/bmjopen-2020-046392","United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.","COVID-19 has spread rapidly worldwide, causing significant morbidity and mortality. People from ethnic minorities, particularly those working in healthcare settings, have been disproportionately affected. Current evidence of the association between ethnicity and COVID-19 outcomes in people working in healthcare settings is insufficient to inform plans to address health inequalities. This study combines anonymised human resource databases with professional registration and National Health Service","2021","07","01","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; epidemiology; public health; COVID-19; COVID-19 Testing; Ethnic Groups; Health Personnel; Humans; Meta-Analysis as Topic; Retrospective Studies; Routinely Collected Health Data; SARS-CoV-2; State Medicine; United Kingdom","John","Catherine","Genetic Epidemiology Research Group, Department of Health Sciences, University of Leicester, Leicester, UK",NA
"905","34183342","10.1136/bmjopen-2020-046392","United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.","COVID-19 has spread rapidly worldwide, causing significant morbidity and mortality. People from ethnic minorities, particularly those working in healthcare settings, have been disproportionately affected. Current evidence of the association between ethnicity and COVID-19 outcomes in people working in healthcare settings is insufficient to inform plans to address health inequalities. This study combines anonymised human resource databases with professional registration and National Health Service","2021","07","01","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; epidemiology; public health; COVID-19; COVID-19 Testing; Ethnic Groups; Health Personnel; Humans; Meta-Analysis as Topic; Retrospective Studies; Routinely Collected Health Data; SARS-CoV-2; State Medicine; United Kingdom","Abrams","Keith R","Centre for Health Economics, University of York, York, North Yorkshire, UK",NA
"906","34183342","10.1136/bmjopen-2020-046392","United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol.","COVID-19 has spread rapidly worldwide, causing significant morbidity and mortality. People from ethnic minorities, particularly those working in healthcare settings, have been disproportionately affected. Current evidence of the association between ethnicity and COVID-19 outcomes in people working in healthcare settings is insufficient to inform plans to address health inequalities. This study combines anonymised human resource databases with professional registration and National Health Service","2021","07","01","BMJ Open","BMJ open","COVID-19; adult intensive &amp; critical care; epidemiology; public health; COVID-19; COVID-19 Testing; Ethnic Groups; Health Personnel; Humans; Meta-Analysis as Topic; Retrospective Studies; Routinely Collected Health Data; SARS-CoV-2; State Medicine; United Kingdom","Pareek","Manish","Department of Respiratory Sciences, University of Leicester, Leicester, UK manish.pareek@leicester.ac","manish.pareek@leicester.ac.uk"
"907","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","Casey-Bryars","Miriam","Centre for Veterinary Epidemiology and Risk Analysis, University College Dublin, Dublin, Ireland miriam.casey@ucd","miriam.casey@ucd.ie"
"908","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","Griffin","John","Centre for Veterinary Epidemiology and Risk Analysis, University College Dublin, Dublin, Ireland",NA
"909","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","McAloon","Conor","School of Veterinary Medicine, UCD School of Agriculture Food Science and Veterinary Medicine, Dublin, Ireland",NA
"910","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","Byrne","Andrew","One Health Scientific Support Unit, Government of Ireland Department of Agriculture Food and the Marine, Dublin, Ireland",NA
"911","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","Madden","Jamie","Centre for Veterinary Epidemiology and Risk Analysis, University College Dublin, Dublin, Ireland",NA
"912","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","Mc Evoy","David","School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland",NA
"913","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","Collins","Áine","Centre for Veterinary Epidemiology and Risk Analysis, University College Dublin, Dublin, Ireland",NA
"914","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","Hunt","Kevin","Centre for Food Safety, University College Dublin, Dublin, Ireland",NA
"915","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","Barber","Ann","Centre for Veterinary Epidemiology and Risk Analysis, University College Dublin, Dublin, Ireland",NA
"916","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","Butler","Francis","Centre for Food Safety, University College Dublin, Dublin, Ireland",NA
"917","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","Lane","Elizabeth Ann","Centre for Veterinary Epidemiology and Risk Analysis, University College Dublin, Belfield, Ireland",NA
"918","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","O'Brien","Kirsty","Health Information and Quality Authority, Cork, Ireland",NA
"919","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","Wall","Patrick","Public Health, University College Dublin, Dublin, Ireland",NA
"920","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","Walsh","Kieran","Health Information and Quality Authority, Cork, Ireland",NA
"921","34183334","10.1136/bmjopen-2020-041240","Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data.","To estimate the proportion of presymptomatic transmission of SARS-CoV-2 infection that can occur, and the timing of transmission relative to symptom onset. Secondary analysis of international published data. Meta-analysis of COVID-19 incubation period and a rapid review of serial interval and generation time, which are published separately. Data from China, the Islamic Republic of Iran, Italy, Republic of Korea, Singapore and Vietnam from December 2019 to May 2020. Simulations were generated of ","2021","07","01","BMJ Open","BMJ open","epidemiology; infection control; infectious diseases; public health; virology; COVID-19; China; Contact Tracing; Humans; Iran; Italy; Republic of Korea; SARS-CoV-2; Singapore; Vietnam","More","Simon John","Centre for Veterinary Epidemiology and Risk Analysis, University College Dublin, Dublin, Ireland",NA
"922","34183332","10.1136/bmj.n1271","How can countries create outbreak response policies that are sensitive to maternal health?",NA,"2021","07","06","BMJ","BMJ (Clinical research ed.)","COVID-19; Disease Outbreaks; Female; Health Policy; Health Services Needs and Demand; Humans; Maternal Health; Pregnancy; Reproductive Health; SARS-CoV-2; Sexual Health","Takemoto","Maira L S","Universidade Estadual Paulista Júlio de Mesquita Filho, Botucatu, SP, Brazil",NA
"923","34183332","10.1136/bmj.n1271","How can countries create outbreak response policies that are sensitive to maternal health?",NA,"2021","07","06","BMJ","BMJ (Clinical research ed.)","COVID-19; Disease Outbreaks; Female; Health Policy; Health Services Needs and Demand; Humans; Maternal Health; Pregnancy; Reproductive Health; SARS-CoV-2; Sexual Health","McKay","Gillian","London School of Hygiene and Tropical Medicine, Faculty of Public Health and Policy, London, UK",NA
"924","34183332","10.1136/bmj.n1271","How can countries create outbreak response policies that are sensitive to maternal health?",NA,"2021","07","06","BMJ","BMJ (Clinical research ed.)","COVID-19; Disease Outbreaks; Female; Health Policy; Health Services Needs and Demand; Humans; Maternal Health; Pregnancy; Reproductive Health; SARS-CoV-2; Sexual Health","Amorim","Melania","Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil",NA
"925","34183332","10.1136/bmj.n1271","How can countries create outbreak response policies that are sensitive to maternal health?",NA,"2021","07","06","BMJ","BMJ (Clinical research ed.)","COVID-19; Disease Outbreaks; Female; Health Policy; Health Services Needs and Demand; Humans; Maternal Health; Pregnancy; Reproductive Health; SARS-CoV-2; Sexual Health","Gbomosa","Cady N","University of Ottawa Faculty of Health Sciences, Ottawa, Ontario, Canada",NA
"926","34183332","10.1136/bmj.n1271","How can countries create outbreak response policies that are sensitive to maternal health?",NA,"2021","07","06","BMJ","BMJ (Clinical research ed.)","COVID-19; Disease Outbreaks; Female; Health Policy; Health Services Needs and Demand; Humans; Maternal Health; Pregnancy; Reproductive Health; SARS-CoV-2; Sexual Health","Tengbeh","Angus F","Institute for Global Health and Development, Queen Margaret University, School of Health Sciences, Edinburgh, UK",NA
"927","34183332","10.1136/bmj.n1271","How can countries create outbreak response policies that are sensitive to maternal health?",NA,"2021","07","06","BMJ","BMJ (Clinical research ed.)","COVID-19; Disease Outbreaks; Female; Health Policy; Health Services Needs and Demand; Humans; Maternal Health; Pregnancy; Reproductive Health; SARS-CoV-2; Sexual Health","Wenham","Clare","London School of Economics and Political Science, London, UK C.Wenham@lse.ac","C.Wenham@lse.ac.uk"
"928","34183331","10.1136/bmj.n1621","Gender equality by 2045: reimagining a healthier future for women and girls.",NA,"2021","07","06","BMJ","BMJ (Clinical research ed.)","COVID-19; Female; Forecasting; Gender Equity; Humans; SARS-CoV-2; Women's Health","Amin","Avni","Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland amina@who","amina@who.int"
"929","34183331","10.1136/bmj.n1621","Gender equality by 2045: reimagining a healthier future for women and girls.",NA,"2021","07","06","BMJ","BMJ (Clinical research ed.)","COVID-19; Female; Forecasting; Gender Equity; Humans; SARS-CoV-2; Women's Health","Remme","Michelle","International Institute for Global Health at the United Nations University, Kuala Lumpur, Malaysia",NA
"930","34183331","10.1136/bmj.n1621","Gender equality by 2045: reimagining a healthier future for women and girls.",NA,"2021","07","06","BMJ","BMJ (Clinical research ed.)","COVID-19; Female; Forecasting; Gender Equity; Humans; SARS-CoV-2; Women's Health","Allotey","Pascale","International Institute for Global Health at the United Nations University, Kuala Lumpur, Malaysia",NA
"931","34183331","10.1136/bmj.n1621","Gender equality by 2045: reimagining a healthier future for women and girls.",NA,"2021","07","06","BMJ","BMJ (Clinical research ed.)","COVID-19; Female; Forecasting; Gender Equity; Humans; SARS-CoV-2; Women's Health","Askew","Ian","Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland",NA
"932","34183330","10.1136/bmjgh-2021-006108","Building resilient health systems in Africa beyond the COVID-19 pandemic response.",NA,"2021","07","02","BMJ Glob Health","BMJ global health","COVID-19; health policies and all other topics; public Health; Africa; COVID-19; Humans; Pandemics; Public Health; SARS-CoV-2","Gebremeskel","Akalewold T","School of International Development and Global Studies, University of Ottawa, Ottawa, Ontario, Canada",NA
"933","34183330","10.1136/bmjgh-2021-006108","Building resilient health systems in Africa beyond the COVID-19 pandemic response.",NA,"2021","07","02","BMJ Glob Health","BMJ global health","COVID-19; health policies and all other topics; public Health; Africa; COVID-19; Humans; Pandemics; Public Health; SARS-CoV-2","Otu","Akaninyene","Department of Infection and Travel Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK",NA
"934","34183330","10.1136/bmjgh-2021-006108","Building resilient health systems in Africa beyond the COVID-19 pandemic response.",NA,"2021","07","02","BMJ Glob Health","BMJ global health","COVID-19; health policies and all other topics; public Health; Africa; COVID-19; Humans; Pandemics; Public Health; SARS-CoV-2","Abimbola","Seye","School of Public Health, University of Sydney, Sydney, New South Wales, Australia",NA
"935","34183330","10.1136/bmjgh-2021-006108","Building resilient health systems in Africa beyond the COVID-19 pandemic response.",NA,"2021","07","02","BMJ Glob Health","BMJ global health","COVID-19; health policies and all other topics; public Health; Africa; COVID-19; Humans; Pandemics; Public Health; SARS-CoV-2","Yaya","Sanni","School of International Development and Global Studies, University of Ottawa, Ottawa, Ontario, Canada sanni.yaya@uottawa","sanni.yaya@uottawa.ca"
"936","34183328","10.1136/bmj.n1638","The government must support communities across the UK to tackle covid-19 long term.",NA,"2021","06","30","BMJ","BMJ (Clinical research ed.)",NA,"Rae","Maggie","Faculty of Public Health, UK",NA
"937","34183316","10.1136/bcr-2021-243338","Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab.","Severe cases of the new COVID-19 are being reported in immunosuppressed patients. The risk seems to depend on the type of immunosuppressive agents used and it is particularly important in patients under the long-lasting effect of rituximab. Information regarding the best therapeutic approach to these patients is scarce and further studies are needed. We present a case of a young woman with rheumatoid arthritis treated with rituximab (last administration 4 months before her admission). She presen","2021","06","30","BMJ Case Rep","BMJ case reports","COVID-19; biological agents; rheumatoid arthritis; COVID-19; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Rituximab; SARS-CoV-2","Vasconcelos","Joana","Infectious Diseases, Centro Hospitalar de Lisboa Ocidental EPE Hospital de Egas Moniz, Lisboa, Portugal joanapfvasconcelos@hotmail","joanapfvasconcelos@hotmail.com"
"938","34183316","10.1136/bcr-2021-243338","Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab.","Severe cases of the new COVID-19 are being reported in immunosuppressed patients. The risk seems to depend on the type of immunosuppressive agents used and it is particularly important in patients under the long-lasting effect of rituximab. Information regarding the best therapeutic approach to these patients is scarce and further studies are needed. We present a case of a young woman with rheumatoid arthritis treated with rituximab (last administration 4 months before her admission). She presen","2021","06","30","BMJ Case Rep","BMJ case reports","COVID-19; biological agents; rheumatoid arthritis; COVID-19; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Rituximab; SARS-CoV-2","Portugal","Rita","Internal Medicine, Centro Hospitalar do Médio Tejo EPE, Torres Novas, Portugal",NA
"939","34183316","10.1136/bcr-2021-243338","Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab.","Severe cases of the new COVID-19 are being reported in immunosuppressed patients. The risk seems to depend on the type of immunosuppressive agents used and it is particularly important in patients under the long-lasting effect of rituximab. Information regarding the best therapeutic approach to these patients is scarce and further studies are needed. We present a case of a young woman with rheumatoid arthritis treated with rituximab (last administration 4 months before her admission). She presen","2021","06","30","BMJ Case Rep","BMJ case reports","COVID-19; biological agents; rheumatoid arthritis; COVID-19; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Rituximab; SARS-CoV-2","Torres","Rita","Rheumatology, Centro Hospitalar de Lisboa Ocidental EPE, Lisboa, Portugal",NA
"940","34183316","10.1136/bcr-2021-243338","Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab.","Severe cases of the new COVID-19 are being reported in immunosuppressed patients. The risk seems to depend on the type of immunosuppressive agents used and it is particularly important in patients under the long-lasting effect of rituximab. Information regarding the best therapeutic approach to these patients is scarce and further studies are needed. We present a case of a young woman with rheumatoid arthritis treated with rituximab (last administration 4 months before her admission). She presen","2021","06","30","BMJ Case Rep","BMJ case reports","COVID-19; biological agents; rheumatoid arthritis; COVID-19; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Rituximab; SARS-CoV-2","Falcão","Sandra","Rheumatology, Centro Hospitalar de Lisboa Ocidental EPE, Lisboa, Portugal",NA
"941","34183307","10.1016/j.bj.2021.04.008","Reply to ""Comparison of the Roche cobas 6800 SARS-CoV-2 test and the Taiwan CDC protocol for the molecular diagnosis of COVID-19"".",NA,"2021","07","01","Biomed J","Biomedical journal",NA,"You","Huey-Ling","Department of Laboratory Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan",NA
"942","34183307","10.1016/j.bj.2021.04.008","Reply to ""Comparison of the Roche cobas 6800 SARS-CoV-2 test and the Taiwan CDC protocol for the molecular diagnosis of COVID-19"".",NA,"2021","07","01","Biomed J","Biomedical journal",NA,"Lee","Chen-Hsiang","Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. Electronic address: lee900@cgmh.org","lee900@cgmh.org.tw"
"943","34183299","10.1016/j.diii.2021.06.003","COVID-19 after 18 months: Where do we stand?",NA,"2021","07","01","Diagn Interv Imaging","Diagnostic and interventional imaging","Artificial intelligence; COVID-19; Computed tomography; Imaging","Chassagnon","Guillaume","Université de Paris, Faculté de Médecine, 75006 Paris, France","guillaume.chassagnon@aphp.fr"
"944","34183299","10.1016/j.diii.2021.06.003","COVID-19 after 18 months: Where do we stand?",NA,"2021","07","01","Diagn Interv Imaging","Diagnostic and interventional imaging","Artificial intelligence; COVID-19; Computed tomography; Imaging","Regard","Lucile","Université de Paris, Faculté de Médecine, 75006 Paris, France",NA
"945","34183299","10.1016/j.diii.2021.06.003","COVID-19 after 18 months: Where do we stand?",NA,"2021","07","01","Diagn Interv Imaging","Diagnostic and interventional imaging","Artificial intelligence; COVID-19; Computed tomography; Imaging","Soyer","Philippe","Université de Paris, Faculté de Médecine, 75006 Paris, France",NA
"946","34183299","10.1016/j.diii.2021.06.003","COVID-19 after 18 months: Where do we stand?",NA,"2021","07","01","Diagn Interv Imaging","Diagnostic and interventional imaging","Artificial intelligence; COVID-19; Computed tomography; Imaging","Revel","Marie-Pierre","Université de Paris, Faculté de Médecine, 75006 Paris, France",NA
"947","34183289","10.1016/j.dhjo.2021.101153","Food sufficiency and the utilization of free food resources for working-age Americans with disabilities during the COVID-19 pandemic.","Working-age people with disabilities are an economically disadvantaged population more likely than those without disabilities to live in food insecure households. Compare rates of food sufficiency and utilization of free food sources between working-age persons with and without disabilities in the US during the COVID-19 pandemic. In September 2020, an online survey was conducted with n = 13,277 working-age individuals with and without disabilities to gather information about food sufficiency pri","2021","06","29","Disabil Health J","Disability and health journal","COVID; COVID-19; Disability; Food insecurity; Food pantry; Food sufficiency; Pandemic; Working-age persons with disabilities","Brucker","Debra L","University of New Hampshire, Institute on Disability, 10 West Edge Drive, Suite 101, Durham, NH 03824, USA. Electronic address: debra.brucker@unh","debra.brucker@unh.edu"
"948","34183289","10.1016/j.dhjo.2021.101153","Food sufficiency and the utilization of free food resources for working-age Americans with disabilities during the COVID-19 pandemic.","Working-age people with disabilities are an economically disadvantaged population more likely than those without disabilities to live in food insecure households. Compare rates of food sufficiency and utilization of free food sources between working-age persons with and without disabilities in the US during the COVID-19 pandemic. In September 2020, an online survey was conducted with n = 13,277 working-age individuals with and without disabilities to gather information about food sufficiency pri","2021","06","29","Disabil Health J","Disability and health journal","COVID; COVID-19; Disability; Food insecurity; Food pantry; Food sufficiency; Pandemic; Working-age persons with disabilities","Stott","Grace","University of New Hampshire, Institute on Disability, 10 West Edge Drive, Suite 101, Durham, NH 03824, USA",NA
"949","34183289","10.1016/j.dhjo.2021.101153","Food sufficiency and the utilization of free food resources for working-age Americans with disabilities during the COVID-19 pandemic.","Working-age people with disabilities are an economically disadvantaged population more likely than those without disabilities to live in food insecure households. Compare rates of food sufficiency and utilization of free food sources between working-age persons with and without disabilities in the US during the COVID-19 pandemic. In September 2020, an online survey was conducted with n = 13,277 working-age individuals with and without disabilities to gather information about food sufficiency pri","2021","06","29","Disabil Health J","Disability and health journal","COVID; COVID-19; Disability; Food insecurity; Food pantry; Food sufficiency; Pandemic; Working-age persons with disabilities","Phillips","Kimberly G","University of New Hampshire, Institute on Disability, 10 West Edge Drive, Suite 101, Durham, NH 03824, USA",NA
"950","34183281","10.1016/j.anpedi.2021.04.009","[QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs].","Many antiviral agents, such as hydroxychloroquine, have been used to treat COVID-19, without being broadly accepted. QTc prolongation is a worrisome adverse effect, scarcely studied in pediatrics. Pediatric patients affected from COVID-19 who received antivirals were matched (1:2) with controls not infected nor exposed. Electrocardiograms were prospectively analyzed at baseline, during the first 72 h in treatment and after 72 h. Eleven (22.9%) out of 48 patients admitted due to COVID-19 (March-J","2021","06","29","An Pediatr (Barc)","Anales de pediatria (Barcelona, Spain : 2003)","Azithromycin; Azitromicina; COVID-19; Child; Electrocardiograma; Electrocardiography; Hidroxicloroquina; Hydroxychloroquine; Long QT syndrome; Lopinavir; Pediatría; QT largo; Remdesivir; Ritonavir; SARS-CoV-2","Esmel-Vilomara","Roger","Servicio de Cardiología Pediátrica, Hospital Universitario Vall d'Hebron, Barcelona, España",NA
"951","34183281","10.1016/j.anpedi.2021.04.009","[QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs].","Many antiviral agents, such as hydroxychloroquine, have been used to treat COVID-19, without being broadly accepted. QTc prolongation is a worrisome adverse effect, scarcely studied in pediatrics. Pediatric patients affected from COVID-19 who received antivirals were matched (1:2) with controls not infected nor exposed. Electrocardiograms were prospectively analyzed at baseline, during the first 72 h in treatment and after 72 h. Eleven (22.9%) out of 48 patients admitted due to COVID-19 (March-J","2021","06","29","An Pediatr (Barc)","Anales de pediatria (Barcelona, Spain : 2003)","Azithromycin; Azitromicina; COVID-19; Child; Electrocardiograma; Electrocardiography; Hidroxicloroquina; Hydroxychloroquine; Long QT syndrome; Lopinavir; Pediatría; QT largo; Remdesivir; Ritonavir; SARS-CoV-2","Dolader","Paola","Servicio de Cardiología Pediátrica, Hospital Universitario Vall d'Hebron, Barcelona, España",NA
"952","34183281","10.1016/j.anpedi.2021.04.009","[QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs].","Many antiviral agents, such as hydroxychloroquine, have been used to treat COVID-19, without being broadly accepted. QTc prolongation is a worrisome adverse effect, scarcely studied in pediatrics. Pediatric patients affected from COVID-19 who received antivirals were matched (1:2) with controls not infected nor exposed. Electrocardiograms were prospectively analyzed at baseline, during the first 72 h in treatment and after 72 h. Eleven (22.9%) out of 48 patients admitted due to COVID-19 (March-J","2021","06","29","An Pediatr (Barc)","Anales de pediatria (Barcelona, Spain : 2003)","Azithromycin; Azitromicina; COVID-19; Child; Electrocardiograma; Electrocardiography; Hidroxicloroquina; Hydroxychloroquine; Long QT syndrome; Lopinavir; Pediatría; QT largo; Remdesivir; Ritonavir; SARS-CoV-2","Sabaté-Rotes","Anna","Servicio de Cardiología Pediátrica, Hospital Universitario Vall d'Hebron, Barcelona, España",NA
"953","34183281","10.1016/j.anpedi.2021.04.009","[QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs].","Many antiviral agents, such as hydroxychloroquine, have been used to treat COVID-19, without being broadly accepted. QTc prolongation is a worrisome adverse effect, scarcely studied in pediatrics. Pediatric patients affected from COVID-19 who received antivirals were matched (1:2) with controls not infected nor exposed. Electrocardiograms were prospectively analyzed at baseline, during the first 72 h in treatment and after 72 h. Eleven (22.9%) out of 48 patients admitted due to COVID-19 (March-J","2021","06","29","An Pediatr (Barc)","Anales de pediatria (Barcelona, Spain : 2003)","Azithromycin; Azitromicina; COVID-19; Child; Electrocardiograma; Electrocardiography; Hidroxicloroquina; Hydroxychloroquine; Long QT syndrome; Lopinavir; Pediatría; QT largo; Remdesivir; Ritonavir; SARS-CoV-2","Soriano-Arandes","Antoni","Unidad de Patología Infecciosa e Inmunodeficiencias Pediátricas, Hospital Universitario Vall d'Hebron, Barcelona, España",NA
"954","34183281","10.1016/j.anpedi.2021.04.009","[QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs].","Many antiviral agents, such as hydroxychloroquine, have been used to treat COVID-19, without being broadly accepted. QTc prolongation is a worrisome adverse effect, scarcely studied in pediatrics. Pediatric patients affected from COVID-19 who received antivirals were matched (1:2) with controls not infected nor exposed. Electrocardiograms were prospectively analyzed at baseline, during the first 72 h in treatment and after 72 h. Eleven (22.9%) out of 48 patients admitted due to COVID-19 (March-J","2021","06","29","An Pediatr (Barc)","Anales de pediatria (Barcelona, Spain : 2003)","Azithromycin; Azitromicina; COVID-19; Child; Electrocardiograma; Electrocardiography; Hidroxicloroquina; Hydroxychloroquine; Long QT syndrome; Lopinavir; Pediatría; QT largo; Remdesivir; Ritonavir; SARS-CoV-2","Gran","Ferran","Servicio de Cardiología Pediátrica, Hospital Universitario Vall d'Hebron, Barcelona, España",NA
"955","34183281","10.1016/j.anpedi.2021.04.009","[QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs].","Many antiviral agents, such as hydroxychloroquine, have been used to treat COVID-19, without being broadly accepted. QTc prolongation is a worrisome adverse effect, scarcely studied in pediatrics. Pediatric patients affected from COVID-19 who received antivirals were matched (1:2) with controls not infected nor exposed. Electrocardiograms were prospectively analyzed at baseline, during the first 72 h in treatment and after 72 h. Eleven (22.9%) out of 48 patients admitted due to COVID-19 (March-J","2021","06","29","An Pediatr (Barc)","Anales de pediatria (Barcelona, Spain : 2003)","Azithromycin; Azitromicina; COVID-19; Child; Electrocardiograma; Electrocardiography; Hidroxicloroquina; Hydroxychloroquine; Long QT syndrome; Lopinavir; Pediatría; QT largo; Remdesivir; Ritonavir; SARS-CoV-2","Rosés-Noguer","Ferran","Servicio de Cardiología Pediátrica, Hospital Universitario Vall d'Hebron, Barcelona, España","froses@vhebron.net"
"956","34183280","10.1016/j.anpedi.2021.05.015","[Acute appendicitis in children with multisystemic inflammatory syndrome associated to SARS-CoV-2 (MIS-C). A complication to consider].",NA,"2021","06","29","An Pediatr (Barc)","Anales de pediatria (Barcelona, Spain : 2003)",NA,"Olmos García","José María","Servicio de Pediatría, Hospital Mare de Déu dels Lliris, Alcoi, Alicante, España. Electronic address: josemari_olmos@yahoo","olmos@yahoo.es"
"957","34183280","10.1016/j.anpedi.2021.05.015","[Acute appendicitis in children with multisystemic inflammatory syndrome associated to SARS-CoV-2 (MIS-C). A complication to consider].",NA,"2021","06","29","An Pediatr (Barc)","Anales de pediatria (Barcelona, Spain : 2003)",NA,"Pareja Marín","Fátima","Servicio de Pediatría, Hospital Mare de Déu dels Lliris, Alcoi, Alicante, España",NA
"958","34183280","10.1016/j.anpedi.2021.05.015","[Acute appendicitis in children with multisystemic inflammatory syndrome associated to SARS-CoV-2 (MIS-C). A complication to consider].",NA,"2021","06","29","An Pediatr (Barc)","Anales de pediatria (Barcelona, Spain : 2003)",NA,"Martínez Bayo","Ángela","Servicio de Pediatría, Hospital Mare de Déu dels Lliris, Alcoi, Alicante, España",NA
"959","34183280","10.1016/j.anpedi.2021.05.015","[Acute appendicitis in children with multisystemic inflammatory syndrome associated to SARS-CoV-2 (MIS-C). A complication to consider].",NA,"2021","06","29","An Pediatr (Barc)","Anales de pediatria (Barcelona, Spain : 2003)",NA,"Silvestre Beneyto","Raúl","Servicio de Pediatría, Hospital Mare de Déu dels Lliris, Alcoi, Alicante, España",NA
"960","34183280","10.1016/j.anpedi.2021.05.015","[Acute appendicitis in children with multisystemic inflammatory syndrome associated to SARS-CoV-2 (MIS-C). A complication to consider].",NA,"2021","06","29","An Pediatr (Barc)","Anales de pediatria (Barcelona, Spain : 2003)",NA,"Escrivá Tomás","Pascual","Servicio de Pediatría, Hospital Mare de Déu dels Lliris, Alcoi, Alicante, España",NA
"961","34183274","10.1016/j.intimp.2021.107878","Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting.","We appreciate the efforts of the authors in their study on the clinical outcome of hydroxychloroquine (HCQ) therapy in mild coronavirus disease 2019 (COVID-19) (Mokhtari et al., 2021). We would like to make some comments based on our understanding of the study.","2021","07","01","Int Immunopharmacol","International immunopharmacology","HCQ; Hospitalization; Hydroxychloroquine; Mild COVID-19; Mortality","Janapala","Rajesh Naidu","International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington, DC, United States. Electronic address: rjanapala@gwu","rjanapala@gwu.edu"
"962","34183274","10.1016/j.intimp.2021.107878","Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting.","We appreciate the efforts of the authors in their study on the clinical outcome of hydroxychloroquine (HCQ) therapy in mild coronavirus disease 2019 (COVID-19) (Mokhtari et al., 2021). We would like to make some comments based on our understanding of the study.","2021","07","01","Int Immunopharmacol","International immunopharmacology","HCQ; Hospitalization; Hydroxychloroquine; Mild COVID-19; Mortality","Patel","Jigar","International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington, DC, United States. Electronic address: jigar.r.patel@outlook","jigar.r.patel@outlook.com"
"963","34183274","10.1016/j.intimp.2021.107878","Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting.","We appreciate the efforts of the authors in their study on the clinical outcome of hydroxychloroquine (HCQ) therapy in mild coronavirus disease 2019 (COVID-19) (Mokhtari et al., 2021). We would like to make some comments based on our understanding of the study.","2021","07","01","Int Immunopharmacol","International immunopharmacology","HCQ; Hospitalization; Hydroxychloroquine; Mild COVID-19; Mortality","Belfaqeeh","Omar","International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington, DC, United States. Electronic address: obelfaqeeh@seha","obelfaqeeh@seha.ae"
"964","34183274","10.1016/j.intimp.2021.107878","Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting.","We appreciate the efforts of the authors in their study on the clinical outcome of hydroxychloroquine (HCQ) therapy in mild coronavirus disease 2019 (COVID-19) (Mokhtari et al., 2021). We would like to make some comments based on our understanding of the study.","2021","07","01","Int Immunopharmacol","International immunopharmacology","HCQ; Hospitalization; Hydroxychloroquine; Mild COVID-19; Mortality","Pourmand","Ali","International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington, DC, United States. Electronic address: Pourmand@Gwu","Pourmand@Gwu.edu"
"965","34183271","10.1016/j.jpurol.2021.06.012","Can lockdown and homeschooling change the outcome of urotherapy for lower urinary tract dysfunction in children?","Lower urinary tract dysfunction (LUTD) are still important for both children and pediatric urologists. Urotherapy is recommended in LUTD treatment management. In our country, all citizens under the age of 20 were banned from going out of their homes due to Covid-19 and the homeschooling system has been adopted The aim of this study is to investigate the effect of lockdown and homeschooling on the effectiveness of urotherapy used for LUTD treatment. 83 patients were included in the study group. B","2021","06","29","J Pediatr Urol","Journal of pediatric urology","Home schooling; Lockdown; Lower urinary tract dysfunction; Urotherapy","Akinci","Aykut","Department of Pediatric Urology, Ankara University School of Medicine, Cebeci Children's Hospital, Ankara, Turkey. Electronic address: aykut-akinci@hotmail","akinci@hotmail.com"
"966","34183271","10.1016/j.jpurol.2021.06.012","Can lockdown and homeschooling change the outcome of urotherapy for lower urinary tract dysfunction in children?","Lower urinary tract dysfunction (LUTD) are still important for both children and pediatric urologists. Urotherapy is recommended in LUTD treatment management. In our country, all citizens under the age of 20 were banned from going out of their homes due to Covid-19 and the homeschooling system has been adopted The aim of this study is to investigate the effect of lockdown and homeschooling on the effectiveness of urotherapy used for LUTD treatment. 83 patients were included in the study group. B","2021","06","29","J Pediatr Urol","Journal of pediatric urology","Home schooling; Lockdown; Lower urinary tract dysfunction; Urotherapy","Baklaci","Can Utku","Department of Urology, Ankara University School of Medicine, Ankara, Turkey",NA
"967","34183271","10.1016/j.jpurol.2021.06.012","Can lockdown and homeschooling change the outcome of urotherapy for lower urinary tract dysfunction in children?","Lower urinary tract dysfunction (LUTD) are still important for both children and pediatric urologists. Urotherapy is recommended in LUTD treatment management. In our country, all citizens under the age of 20 were banned from going out of their homes due to Covid-19 and the homeschooling system has been adopted The aim of this study is to investigate the effect of lockdown and homeschooling on the effectiveness of urotherapy used for LUTD treatment. 83 patients were included in the study group. B","2021","06","29","J Pediatr Urol","Journal of pediatric urology","Home schooling; Lockdown; Lower urinary tract dysfunction; Urotherapy","Oguz","Efe Semetey","Department of Urology, Ankara University School of Medicine, Ankara, Turkey",NA
"968","34183271","10.1016/j.jpurol.2021.06.012","Can lockdown and homeschooling change the outcome of urotherapy for lower urinary tract dysfunction in children?","Lower urinary tract dysfunction (LUTD) are still important for both children and pediatric urologists. Urotherapy is recommended in LUTD treatment management. In our country, all citizens under the age of 20 were banned from going out of their homes due to Covid-19 and the homeschooling system has been adopted The aim of this study is to investigate the effect of lockdown and homeschooling on the effectiveness of urotherapy used for LUTD treatment. 83 patients were included in the study group. B","2021","06","29","J Pediatr Urol","Journal of pediatric urology","Home schooling; Lockdown; Lower urinary tract dysfunction; Urotherapy","Kubilay","Eralp","Department of Urology, Ankara University School of Medicine, Ankara, Turkey",NA
"969","34183271","10.1016/j.jpurol.2021.06.012","Can lockdown and homeschooling change the outcome of urotherapy for lower urinary tract dysfunction in children?","Lower urinary tract dysfunction (LUTD) are still important for both children and pediatric urologists. Urotherapy is recommended in LUTD treatment management. In our country, all citizens under the age of 20 were banned from going out of their homes due to Covid-19 and the homeschooling system has been adopted The aim of this study is to investigate the effect of lockdown and homeschooling on the effectiveness of urotherapy used for LUTD treatment. 83 patients were included in the study group. B","2021","06","29","J Pediatr Urol","Journal of pediatric urology","Home schooling; Lockdown; Lower urinary tract dysfunction; Urotherapy","Sanci","Adem","Department of Urology, Ankara University School of Medicine, Ankara, Turkey",NA
"970","34183271","10.1016/j.jpurol.2021.06.012","Can lockdown and homeschooling change the outcome of urotherapy for lower urinary tract dysfunction in children?","Lower urinary tract dysfunction (LUTD) are still important for both children and pediatric urologists. Urotherapy is recommended in LUTD treatment management. In our country, all citizens under the age of 20 were banned from going out of their homes due to Covid-19 and the homeschooling system has been adopted The aim of this study is to investigate the effect of lockdown and homeschooling on the effectiveness of urotherapy used for LUTD treatment. 83 patients were included in the study group. B","2021","06","29","J Pediatr Urol","Journal of pediatric urology","Home schooling; Lockdown; Lower urinary tract dysfunction; Urotherapy","Aydog","Ezel","Department of Urology, Ankara University School of Medicine, Ankara, Turkey",NA
"971","34183271","10.1016/j.jpurol.2021.06.012","Can lockdown and homeschooling change the outcome of urotherapy for lower urinary tract dysfunction in children?","Lower urinary tract dysfunction (LUTD) are still important for both children and pediatric urologists. Urotherapy is recommended in LUTD treatment management. In our country, all citizens under the age of 20 were banned from going out of their homes due to Covid-19 and the homeschooling system has been adopted The aim of this study is to investigate the effect of lockdown and homeschooling on the effectiveness of urotherapy used for LUTD treatment. 83 patients were included in the study group. B","2021","06","29","J Pediatr Urol","Journal of pediatric urology","Home schooling; Lockdown; Lower urinary tract dysfunction; Urotherapy","Hajiyev","Perviz","Department of Pediatric Urology, Guven Klinik Hospital, Baku, Azerbaijan",NA
"972","34183271","10.1016/j.jpurol.2021.06.012","Can lockdown and homeschooling change the outcome of urotherapy for lower urinary tract dysfunction in children?","Lower urinary tract dysfunction (LUTD) are still important for both children and pediatric urologists. Urotherapy is recommended in LUTD treatment management. In our country, all citizens under the age of 20 were banned from going out of their homes due to Covid-19 and the homeschooling system has been adopted The aim of this study is to investigate the effect of lockdown and homeschooling on the effectiveness of urotherapy used for LUTD treatment. 83 patients were included in the study group. B","2021","06","29","J Pediatr Urol","Journal of pediatric urology","Home schooling; Lockdown; Lower urinary tract dysfunction; Urotherapy","Soygür","Tarkan","Department of Pediatric Urology, Ankara University School of Medicine, Cebeci Children's Hospital, Ankara, Turkey",NA
"973","34183271","10.1016/j.jpurol.2021.06.012","Can lockdown and homeschooling change the outcome of urotherapy for lower urinary tract dysfunction in children?","Lower urinary tract dysfunction (LUTD) are still important for both children and pediatric urologists. Urotherapy is recommended in LUTD treatment management. In our country, all citizens under the age of 20 were banned from going out of their homes due to Covid-19 and the homeschooling system has been adopted The aim of this study is to investigate the effect of lockdown and homeschooling on the effectiveness of urotherapy used for LUTD treatment. 83 patients were included in the study group. B","2021","06","29","J Pediatr Urol","Journal of pediatric urology","Home schooling; Lockdown; Lower urinary tract dysfunction; Urotherapy","Burgu","Berk","Department of Pediatric Urology, Ankara University School of Medicine, Cebeci Children's Hospital, Ankara, Turkey",NA
"974","34183264","10.1016/j.surge.2021.05.003","Cycling injuries requiring orthopaedic intervention during the first COVID-19 lockdown period: A multi-centre SCottish Orthopaedic Research collaborativE (SCORE) study.","The COVID-19 lockdown resulted in decreased vehicle use and an increased uptake in cycling. This study investigated the trends in cycling-related injuries requiring orthopaedic intervention during the COVID-19 lockdown period compared with similar time periods in 2018 and 2019. Data were collected prospectively for patients in 2020 and collected retrospectively for 2019 and 2018, from hospitals within four NHS Scotland Health Boards encompassing three major trauma centres. All patients who susta","2021","06","29","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","COVID-19; Coronavirus; Cycling injuries; Injury; Lockdown; Orthopaedics; Sports injury; Trauma","Faulkner","Alastair","Department of Trauma and Orthopaedics, Ninewells Hospital, James Arrott Dr, Dundee, DD2 1SG, UK. Electronic address: alastair.faulkner@nhs","alastair.faulkner@nhs.scot"
"975","34183264","10.1016/j.surge.2021.05.003","Cycling injuries requiring orthopaedic intervention during the first COVID-19 lockdown period: A multi-centre SCottish Orthopaedic Research collaborativE (SCORE) study.","The COVID-19 lockdown resulted in decreased vehicle use and an increased uptake in cycling. This study investigated the trends in cycling-related injuries requiring orthopaedic intervention during the COVID-19 lockdown period compared with similar time periods in 2018 and 2019. Data were collected prospectively for patients in 2020 and collected retrospectively for 2019 and 2018, from hospitals within four NHS Scotland Health Boards encompassing three major trauma centres. All patients who susta","2021","06","29","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","COVID-19; Coronavirus; Cycling injuries; Injury; Lockdown; Orthopaedics; Sports injury; Trauma","MacDonald","David R W","Department of Trauma and Orthopaedics, Aberdeen Royal Infirmary, Foresterhill Rd, Aberdeen, AB25 2ZN, UK",NA
"976","34183264","10.1016/j.surge.2021.05.003","Cycling injuries requiring orthopaedic intervention during the first COVID-19 lockdown period: A multi-centre SCottish Orthopaedic Research collaborativE (SCORE) study.","The COVID-19 lockdown resulted in decreased vehicle use and an increased uptake in cycling. This study investigated the trends in cycling-related injuries requiring orthopaedic intervention during the COVID-19 lockdown period compared with similar time periods in 2018 and 2019. Data were collected prospectively for patients in 2020 and collected retrospectively for 2019 and 2018, from hospitals within four NHS Scotland Health Boards encompassing three major trauma centres. All patients who susta","2021","06","29","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","COVID-19; Coronavirus; Cycling injuries; Injury; Lockdown; Orthopaedics; Sports injury; Trauma","Neilly","David W","Department of Trauma and Orthopaedics, Aberdeen Royal Infirmary, Foresterhill Rd, Aberdeen, AB25 2ZN, UK",NA
"977","34183264","10.1016/j.surge.2021.05.003","Cycling injuries requiring orthopaedic intervention during the first COVID-19 lockdown period: A multi-centre SCottish Orthopaedic Research collaborativE (SCORE) study.","The COVID-19 lockdown resulted in decreased vehicle use and an increased uptake in cycling. This study investigated the trends in cycling-related injuries requiring orthopaedic intervention during the COVID-19 lockdown period compared with similar time periods in 2018 and 2019. Data were collected prospectively for patients in 2020 and collected retrospectively for 2019 and 2018, from hospitals within four NHS Scotland Health Boards encompassing three major trauma centres. All patients who susta","2021","06","29","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","COVID-19; Coronavirus; Cycling injuries; Injury; Lockdown; Orthopaedics; Sports injury; Trauma","Davies","Peter S E","Department of Trauma and Orthopaedics, Ninewells Hospital, James Arrott Dr, Dundee, DD2 1SG, UK",NA
"978","34183264","10.1016/j.surge.2021.05.003","Cycling injuries requiring orthopaedic intervention during the first COVID-19 lockdown period: A multi-centre SCottish Orthopaedic Research collaborativE (SCORE) study.","The COVID-19 lockdown resulted in decreased vehicle use and an increased uptake in cycling. This study investigated the trends in cycling-related injuries requiring orthopaedic intervention during the COVID-19 lockdown period compared with similar time periods in 2018 and 2019. Data were collected prospectively for patients in 2020 and collected retrospectively for 2019 and 2018, from hospitals within four NHS Scotland Health Boards encompassing three major trauma centres. All patients who susta","2021","06","29","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","COVID-19; Coronavirus; Cycling injuries; Injury; Lockdown; Orthopaedics; Sports injury; Trauma","Ha","Taegyeong T","Department of Trauma and Orthopaedics Glasgow Royal Infirmary, 84 Castle St, Glasgow, G4 0SF, UK",NA
"979","34183264","10.1016/j.surge.2021.05.003","Cycling injuries requiring orthopaedic intervention during the first COVID-19 lockdown period: A multi-centre SCottish Orthopaedic Research collaborativE (SCORE) study.","The COVID-19 lockdown resulted in decreased vehicle use and an increased uptake in cycling. This study investigated the trends in cycling-related injuries requiring orthopaedic intervention during the COVID-19 lockdown period compared with similar time periods in 2018 and 2019. Data were collected prospectively for patients in 2020 and collected retrospectively for 2019 and 2018, from hospitals within four NHS Scotland Health Boards encompassing three major trauma centres. All patients who susta","2021","06","29","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","COVID-19; Coronavirus; Cycling injuries; Injury; Lockdown; Orthopaedics; Sports injury; Trauma","Stevenson","Iain M","Department of Trauma and Orthopaedics, Aberdeen Royal Infirmary, Foresterhill Rd, Aberdeen, AB25 2ZN, UK",NA
"980","34183264","10.1016/j.surge.2021.05.003","Cycling injuries requiring orthopaedic intervention during the first COVID-19 lockdown period: A multi-centre SCottish Orthopaedic Research collaborativE (SCORE) study.","The COVID-19 lockdown resulted in decreased vehicle use and an increased uptake in cycling. This study investigated the trends in cycling-related injuries requiring orthopaedic intervention during the COVID-19 lockdown period compared with similar time periods in 2018 and 2019. Data were collected prospectively for patients in 2020 and collected retrospectively for 2019 and 2018, from hospitals within four NHS Scotland Health Boards encompassing three major trauma centres. All patients who susta","2021","06","29","Surgeon","The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland","COVID-19; Coronavirus; Cycling injuries; Injury; Lockdown; Orthopaedics; Sports injury; Trauma","Jariwala","Arpit C","Department of Trauma and Orthopaedics, Ninewells Hospital, James Arrott Dr, Dundee, DD2 1SG, UK",NA
"981","34183244","10.1016/j.jcyt.2021.05.005","Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.",NA,"2021","07","01","Cytotherapy","Cytotherapy",NA,"Soni","Mithil","Columbia Center for Translational Immunology (CCTI), Division of Hematology/ Oncology, Columbia University Medical Center, New York, New York, USA",NA
"982","34183244","10.1016/j.jcyt.2021.05.005","Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.",NA,"2021","07","01","Cytotherapy","Cytotherapy",NA,"Migliori","Edoardo","Columbia Center for Translational Immunology (CCTI), Division of Hematology/ Oncology, Columbia University Medical Center, New York, New York, USA",NA
"983","34183244","10.1016/j.jcyt.2021.05.005","Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.",NA,"2021","07","01","Cytotherapy","Cytotherapy",NA,"Assal","Amer","Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, USA",NA
"984","34183244","10.1016/j.jcyt.2021.05.005","Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.",NA,"2021","07","01","Cytotherapy","Cytotherapy",NA,"Chan","Hei T","Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, USA",NA
"985","34183244","10.1016/j.jcyt.2021.05.005","Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.",NA,"2021","07","01","Cytotherapy","Cytotherapy",NA,"Ciubotariu","Rodica","Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, USA",NA
"986","34183244","10.1016/j.jcyt.2021.05.005","Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.",NA,"2021","07","01","Cytotherapy","Cytotherapy",NA,"Pan","Jian B","Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, USA",NA
"987","34183244","10.1016/j.jcyt.2021.05.005","Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.",NA,"2021","07","01","Cytotherapy","Cytotherapy",NA,"Cicero","Kara","Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, USA",NA
"988","34183244","10.1016/j.jcyt.2021.05.005","Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.",NA,"2021","07","01","Cytotherapy","Cytotherapy",NA,"Pereira","Marcus","Department of Medicine, Division of Infectious Disease, Columbia University College of Physicians and Surgeons, New York, NY, USA",NA
"989","34183244","10.1016/j.jcyt.2021.05.005","Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.",NA,"2021","07","01","Cytotherapy","Cytotherapy",NA,"Mapara","Markus Y","Columbia Center for Translational Immunology (CCTI), Division of Hematology/ Oncology, Columbia University Medical Center, New York, New York, USA",NA
"990","34183244","10.1016/j.jcyt.2021.05.005","Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.",NA,"2021","07","01","Cytotherapy","Cytotherapy",NA,"Muranski","Pawel","Columbia Center for Translational Immunology (CCTI), Division of Hematology/ Oncology, Columbia University Medical Center, New York, New York, USA","pjm2170@cumc.columbia.edu"
"991","34183243","10.1016/j.cytogfr.2021.06.002","The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), exhibits a wide spectrum of clinical presentations, ranging from asymptomatic cases to severe pneumonia or even death. In severe COVID-19 cases, an increased level of proinflammatory cytokines has been observed in the bloodstream, forming the so-called ""cytokine storm"". Generally, nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 (NLRP3) inflammasome activa","2021","07","01","Cytokine Growth Factor Rev","Cytokine &amp; growth factor reviews","COVID-19; Inhibitor; NLRP3 inflammasomeome; Pathogenesis; SARS-CoV-2","Zhao","Ni","Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China",NA
"992","34183243","10.1016/j.cytogfr.2021.06.002","The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), exhibits a wide spectrum of clinical presentations, ranging from asymptomatic cases to severe pneumonia or even death. In severe COVID-19 cases, an increased level of proinflammatory cytokines has been observed in the bloodstream, forming the so-called ""cytokine storm"". Generally, nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 (NLRP3) inflammasome activa","2021","07","01","Cytokine Growth Factor Rev","Cytokine &amp; growth factor reviews","COVID-19; Inhibitor; NLRP3 inflammasomeome; Pathogenesis; SARS-CoV-2","Di","Bin","Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China","dibin@cpu.edu.cn"
"993","34183243","10.1016/j.cytogfr.2021.06.002","The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), exhibits a wide spectrum of clinical presentations, ranging from asymptomatic cases to severe pneumonia or even death. In severe COVID-19 cases, an increased level of proinflammatory cytokines has been observed in the bloodstream, forming the so-called ""cytokine storm"". Generally, nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 (NLRP3) inflammasome activa","2021","07","01","Cytokine Growth Factor Rev","Cytokine &amp; growth factor reviews","COVID-19; Inhibitor; NLRP3 inflammasomeome; Pathogenesis; SARS-CoV-2","Xu","Li-Li","Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China","1620174420@cpu.edu.cn"
"994","34183237","10.1016/j.drugpo.2021.103348","""I'm pretty sure it's either food poisoning or Covid-19"": Lived experience versus medical knowledge in diagnosing substance use problems.","People who use drugs, or who have in the past, often report that doctors and/or treatment providers devalue, or are unwilling to believe their claims in regards to substance use issues, in particular the presence and severity of withdrawal. In the case of benzodiazepine withdrawal this can not only lead to significant discomfort, frustration, and trauma for patients, but can lead to serious medical problems. This commentary uses the authors' recent first-person experience with a disbelieving doc","2021","07","01","Int J Drug Policy","The International journal on drug policy","Addiction medicine; Benzodiazepines; Harm reduction; Methadone maintenance treatment (MMT); Stigma; Withdrawal","Frank","David",NA,NA
"995","34183225","10.1016/j.ejca.2021.05.006","The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.","Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affected by solid tumours. Patients with cancer afferent to Medical Oncology 1 Unit of Regina Elena National Cancer Institute in Rome were considered eligible for vaccination if they were receiving systemic immunosuppress","2021","07","01","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","BNT162b2; COVID-19; Cancer patients; Public health; Refusal; SARS-CoV-2; Vaccine","Di Noia","Vincenzo","Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: vincenzo.dinoia@ifo.gov","vincenzo.dinoia@ifo.gov.it"
"996","34183225","10.1016/j.ejca.2021.05.006","The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.","Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affected by solid tumours. Patients with cancer afferent to Medical Oncology 1 Unit of Regina Elena National Cancer Institute in Rome were considered eligible for vaccination if they were receiving systemic immunosuppress","2021","07","01","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","BNT162b2; COVID-19; Cancer patients; Public health; Refusal; SARS-CoV-2; Vaccine","Renna","Davide","Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: renna.davide@ifo.gov","renna.davide@ifo.gov.it"
"997","34183225","10.1016/j.ejca.2021.05.006","The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.","Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affected by solid tumours. Patients with cancer afferent to Medical Oncology 1 Unit of Regina Elena National Cancer Institute in Rome were considered eligible for vaccination if they were receiving systemic immunosuppress","2021","07","01","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","BNT162b2; COVID-19; Cancer patients; Public health; Refusal; SARS-CoV-2; Vaccine","Barberi","Vittoria","Dipartimento di Medicina Clinica e Molecolare, Università La Sapienza di Roma, Rome, Italy. Electronic address: vittoria.barberi@ifo.gov","vittoria.barberi@ifo.gov.it"
"998","34183225","10.1016/j.ejca.2021.05.006","The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.","Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affected by solid tumours. Patients with cancer afferent to Medical Oncology 1 Unit of Regina Elena National Cancer Institute in Rome were considered eligible for vaccination if they were receiving systemic immunosuppress","2021","07","01","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","BNT162b2; COVID-19; Cancer patients; Public health; Refusal; SARS-CoV-2; Vaccine","Di Civita","Mattia","Dipartimento di Medicina Clinica e Molecolare, Università La Sapienza di Roma, Rome, Italy. Electronic address: mattia.dicivita@ifo.gov","mattia.dicivita@ifo.gov.it"
"999","34183225","10.1016/j.ejca.2021.05.006","The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.","Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affected by solid tumours. Patients with cancer afferent to Medical Oncology 1 Unit of Regina Elena National Cancer Institute in Rome were considered eligible for vaccination if they were receiving systemic immunosuppress","2021","07","01","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","BNT162b2; COVID-19; Cancer patients; Public health; Refusal; SARS-CoV-2; Vaccine","Riva","Federica","Dipartimento di Medicina Clinica e Molecolare, Università La Sapienza di Roma, Rome, Italy. Electronic address: federica.riva@ifo.gov","federica.riva@ifo.gov.it"
"1000","34183225","10.1016/j.ejca.2021.05.006","The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.","Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affected by solid tumours. Patients with cancer afferent to Medical Oncology 1 Unit of Regina Elena National Cancer Institute in Rome were considered eligible for vaccination if they were receiving systemic immunosuppress","2021","07","01","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","BNT162b2; COVID-19; Cancer patients; Public health; Refusal; SARS-CoV-2; Vaccine","Costantini","Giulia","Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: giulia.costantini@ifo.gov","giulia.costantini@ifo.gov.it"
"1001","34183225","10.1016/j.ejca.2021.05.006","The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.","Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affected by solid tumours. Patients with cancer afferent to Medical Oncology 1 Unit of Regina Elena National Cancer Institute in Rome were considered eligible for vaccination if they were receiving systemic immunosuppress","2021","07","01","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","BNT162b2; COVID-19; Cancer patients; Public health; Refusal; SARS-CoV-2; Vaccine","Aquila","Emanuela Dell'","Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: emanuela.dellaquila@ifo.gov","emanuela.dellaquila@ifo.gov.it"
"1002","34183225","10.1016/j.ejca.2021.05.006","The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.","Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affected by solid tumours. Patients with cancer afferent to Medical Oncology 1 Unit of Regina Elena National Cancer Institute in Rome were considered eligible for vaccination if they were receiving systemic immunosuppress","2021","07","01","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","BNT162b2; COVID-19; Cancer patients; Public health; Refusal; SARS-CoV-2; Vaccine","Russillo","Michelangelo","Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: michelangelo.russillo@ifo.gov","michelangelo.russillo@ifo.gov.it"
"1003","34183225","10.1016/j.ejca.2021.05.006","The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.","Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affected by solid tumours. Patients with cancer afferent to Medical Oncology 1 Unit of Regina Elena National Cancer Institute in Rome were considered eligible for vaccination if they were receiving systemic immunosuppress","2021","07","01","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","BNT162b2; COVID-19; Cancer patients; Public health; Refusal; SARS-CoV-2; Vaccine","Bracco","Domenico","Medical Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: domenico.bracco@ifo.gov","domenico.bracco@ifo.gov.it"
"1004","34183225","10.1016/j.ejca.2021.05.006","The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.","Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affected by solid tumours. Patients with cancer afferent to Medical Oncology 1 Unit of Regina Elena National Cancer Institute in Rome were considered eligible for vaccination if they were receiving systemic immunosuppress","2021","07","01","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","BNT162b2; COVID-19; Cancer patients; Public health; Refusal; SARS-CoV-2; Vaccine","La Malfa","Antonia Marina","Hospital Pharmacy, Regina Elena National Cancer Institute, Rome, Italy. Electronic address: antonia.lamalfa@ifo.gov","antonia.lamalfa@ifo.gov.it"
"1005","34183225","10.1016/j.ejca.2021.05.006","The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.","Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affected by solid tumours. Patients with cancer afferent to Medical Oncology 1 Unit of Regina Elena National Cancer Institute in Rome were considered eligible for vaccination if they were receiving systemic immunosuppress","2021","07","01","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","BNT162b2; COVID-19; Cancer patients; Public health; Refusal; SARS-CoV-2; Vaccine","Giannarelli","Diana","Biostatistical Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. Electronic address: diana.giannarelli@ifo.gov","diana.giannarelli@ifo.gov.it"
"1006","34183225","10.1016/j.ejca.2021.05.006","The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.","Patients with cancer have an increased risk of complications from coronavirus disease 2019 (COVID-19) infection, including death, and thus, they were considered as high-priority subjects for COVID-19 vaccination. We report on the compliance with the COVID-19 vaccine of patients affected by solid tumours. Patients with cancer afferent to Medical Oncology 1 Unit of Regina Elena National Cancer Institute in Rome were considered eligible for vaccination if they were receiving systemic immunosuppress","2021","07","01","Eur J Cancer","European journal of cancer (Oxford, England : 1990)","BNT162b2; COVID-19; Cancer patients; Public health; Refusal; SARS-CoV-2; Vaccine","Cognetti","Francesco","Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy","francesco.cognetti@ifo.gov.it"
"1007","34183221","10.1016/j.jfma.2021.06.008","Initiating narrative medicine into dental education: Opportunity, change, and challenge.","Recently, the patient-centered and comprehensive dental treatment are emphasized as the same important competency as traditional clinical skill training in dental education. It is a silver lining to reorganize current dental education and redefine the role of dentistry to dentist, patient, and society. Narrative medicine has emerged as a variant from medical humanities and takes inspiration from philosophy, literature, poetry, art, ethics, and social sciences. Narrative medicine adds humanistic ","2021","06","29","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi","Dental education; Narrative dentistry; Narrative medicine","Huang","Yung-Kai","Department of Oral Hygiene, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan",NA
"1008","34183221","10.1016/j.jfma.2021.06.008","Initiating narrative medicine into dental education: Opportunity, change, and challenge.","Recently, the patient-centered and comprehensive dental treatment are emphasized as the same important competency as traditional clinical skill training in dental education. It is a silver lining to reorganize current dental education and redefine the role of dentistry to dentist, patient, and society. Narrative medicine has emerged as a variant from medical humanities and takes inspiration from philosophy, literature, poetry, art, ethics, and social sciences. Narrative medicine adds humanistic ","2021","06","29","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi","Dental education; Narrative dentistry; Narrative medicine","Chen","Yi-Tzu","School of Dentistry, Chung Shan Medical University, Taichung, Taiwan",NA
"1009","34183221","10.1016/j.jfma.2021.06.008","Initiating narrative medicine into dental education: Opportunity, change, and challenge.","Recently, the patient-centered and comprehensive dental treatment are emphasized as the same important competency as traditional clinical skill training in dental education. It is a silver lining to reorganize current dental education and redefine the role of dentistry to dentist, patient, and society. Narrative medicine has emerged as a variant from medical humanities and takes inspiration from philosophy, literature, poetry, art, ethics, and social sciences. Narrative medicine adds humanistic ","2021","06","29","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi","Dental education; Narrative dentistry; Narrative medicine","Chang","Yu-Chao","School of Dentistry, Chung Shan Medical University, Taichung, Taiwan","cyc@csmu.edu.tw"
"1010","34183213","10.1016/j.jsat.2021.108544","The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives.","The COVID-19 pandemic has had a profound impact on the U.S. health care system, including addiction treatment. The objective of this study is to describe the impact of COVID on the delivery of treatment for substance use disorders (SUDs) from the perspectives of service providers. Between May and September 2020, 61 service providers from 16 SUD treatment sites in California participated in virtual focus groups that lasted about an hour. We recorded the discussions and transcribed them verbatim. ","2021","06","29","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Qualitative research; Service provider; Substance use disorder","Lin","Chunqing","Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, USA","lincq@ucla.edu"
"1011","34183213","10.1016/j.jsat.2021.108544","The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives.","The COVID-19 pandemic has had a profound impact on the U.S. health care system, including addiction treatment. The objective of this study is to describe the impact of COVID on the delivery of treatment for substance use disorders (SUDs) from the perspectives of service providers. Between May and September 2020, 61 service providers from 16 SUD treatment sites in California participated in virtual focus groups that lasted about an hour. We recorded the discussions and transcribed them verbatim. ","2021","06","29","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Qualitative research; Service provider; Substance use disorder","Clingan","Sarah E","Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, USA",NA
"1012","34183213","10.1016/j.jsat.2021.108544","The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives.","The COVID-19 pandemic has had a profound impact on the U.S. health care system, including addiction treatment. The objective of this study is to describe the impact of COVID on the delivery of treatment for substance use disorders (SUDs) from the perspectives of service providers. Between May and September 2020, 61 service providers from 16 SUD treatment sites in California participated in virtual focus groups that lasted about an hour. We recorded the discussions and transcribed them verbatim. ","2021","06","29","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Qualitative research; Service provider; Substance use disorder","Cousins","Sarah J","Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, USA",NA
"1013","34183213","10.1016/j.jsat.2021.108544","The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives.","The COVID-19 pandemic has had a profound impact on the U.S. health care system, including addiction treatment. The objective of this study is to describe the impact of COVID on the delivery of treatment for substance use disorders (SUDs) from the perspectives of service providers. Between May and September 2020, 61 service providers from 16 SUD treatment sites in California participated in virtual focus groups that lasted about an hour. We recorded the discussions and transcribed them verbatim. ","2021","06","29","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Qualitative research; Service provider; Substance use disorder","Valdez","Jonathan","Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, USA",NA
"1014","34183213","10.1016/j.jsat.2021.108544","The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives.","The COVID-19 pandemic has had a profound impact on the U.S. health care system, including addiction treatment. The objective of this study is to describe the impact of COVID on the delivery of treatment for substance use disorders (SUDs) from the perspectives of service providers. Between May and September 2020, 61 service providers from 16 SUD treatment sites in California participated in virtual focus groups that lasted about an hour. We recorded the discussions and transcribed them verbatim. ","2021","06","29","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Qualitative research; Service provider; Substance use disorder","Mooney","Larissa J","Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, USA",NA
"1015","34183213","10.1016/j.jsat.2021.108544","The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives.","The COVID-19 pandemic has had a profound impact on the U.S. health care system, including addiction treatment. The objective of this study is to describe the impact of COVID on the delivery of treatment for substance use disorders (SUDs) from the perspectives of service providers. Between May and September 2020, 61 service providers from 16 SUD treatment sites in California participated in virtual focus groups that lasted about an hour. We recorded the discussions and transcribed them verbatim. ","2021","06","29","J Subst Abuse Treat","Journal of substance abuse treatment","COVID-19; Qualitative research; Service provider; Substance use disorder","Hser","Yih-Ing","Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, USA",NA
"1016","34183192","10.1016/j.jen.2021.04.010","Emergency Response: A Cross-sectional Study of Core Competencies for Nurses Regarding Major Infectious Disease Outbreaks.","The core competencies of nursing personnel have been identified as a main factor affecting nursing effectiveness. This study examined core emergency response competencies of Chinese nursing personnel related to the outbreak of major infectious diseases. A survey was conducted among 960 nurses working in a tertiary hospital in Shanghai, China. Data were collected on core emergency response competencies of nursing personnel caring for patients with major infectious diseases, measuring overall comp","2021","06","29","J Emerg Nurs","Journal of emergency nursing","Capacity building; Emergencies; Infectious diseases; Nurse; Outbreak; Pandemics; SARS-CoV-2; Surveys and questionnaires","Song","Shu",NA,NA
"1017","34183192","10.1016/j.jen.2021.04.010","Emergency Response: A Cross-sectional Study of Core Competencies for Nurses Regarding Major Infectious Disease Outbreaks.","The core competencies of nursing personnel have been identified as a main factor affecting nursing effectiveness. This study examined core emergency response competencies of Chinese nursing personnel related to the outbreak of major infectious diseases. A survey was conducted among 960 nurses working in a tertiary hospital in Shanghai, China. Data were collected on core emergency response competencies of nursing personnel caring for patients with major infectious diseases, measuring overall comp","2021","06","29","J Emerg Nurs","Journal of emergency nursing","Capacity building; Emergencies; Infectious diseases; Nurse; Outbreak; Pandemics; SARS-CoV-2; Surveys and questionnaires","Li","Xueyan",NA,NA
"1018","34183192","10.1016/j.jen.2021.04.010","Emergency Response: A Cross-sectional Study of Core Competencies for Nurses Regarding Major Infectious Disease Outbreaks.","The core competencies of nursing personnel have been identified as a main factor affecting nursing effectiveness. This study examined core emergency response competencies of Chinese nursing personnel related to the outbreak of major infectious diseases. A survey was conducted among 960 nurses working in a tertiary hospital in Shanghai, China. Data were collected on core emergency response competencies of nursing personnel caring for patients with major infectious diseases, measuring overall comp","2021","06","29","J Emerg Nurs","Journal of emergency nursing","Capacity building; Emergencies; Infectious diseases; Nurse; Outbreak; Pandemics; SARS-CoV-2; Surveys and questionnaires","Bell","Sue Anne",NA,NA
"1019","34183192","10.1016/j.jen.2021.04.010","Emergency Response: A Cross-sectional Study of Core Competencies for Nurses Regarding Major Infectious Disease Outbreaks.","The core competencies of nursing personnel have been identified as a main factor affecting nursing effectiveness. This study examined core emergency response competencies of Chinese nursing personnel related to the outbreak of major infectious diseases. A survey was conducted among 960 nurses working in a tertiary hospital in Shanghai, China. Data were collected on core emergency response competencies of nursing personnel caring for patients with major infectious diseases, measuring overall comp","2021","06","29","J Emerg Nurs","Journal of emergency nursing","Capacity building; Emergencies; Infectious diseases; Nurse; Outbreak; Pandemics; SARS-CoV-2; Surveys and questionnaires","Yang","Xingjing",NA,NA
"1020","34183192","10.1016/j.jen.2021.04.010","Emergency Response: A Cross-sectional Study of Core Competencies for Nurses Regarding Major Infectious Disease Outbreaks.","The core competencies of nursing personnel have been identified as a main factor affecting nursing effectiveness. This study examined core emergency response competencies of Chinese nursing personnel related to the outbreak of major infectious diseases. A survey was conducted among 960 nurses working in a tertiary hospital in Shanghai, China. Data were collected on core emergency response competencies of nursing personnel caring for patients with major infectious diseases, measuring overall comp","2021","06","29","J Emerg Nurs","Journal of emergency nursing","Capacity building; Emergencies; Infectious diseases; Nurse; Outbreak; Pandemics; SARS-CoV-2; Surveys and questionnaires","Zhang","Weiying",NA,NA
"1021","34183191","10.1016/j.outlook.2021.05.004","Undergraduate nursing students' perceptions on nursing education during the 2020 COVID-19 pandemic: A national sample.","In 2020, nursing educational programs were abruptly interrupted and largely moved online due to the COVID-19 pandemic. To explore nursing students' perspectives about the effects of the pandemic on their education and intention to join the nursing workforce. Undergraduate nursing students from 5 universities across 5 United States regions were invited to participate in an online survey to elicit both quantitative and qualitative data. The final sample included quantitative data on 772 students a","2021","06","29","Nurs Outlook","Nursing outlook","COVID-19; education; nursing; nursing students; pandemic; workforce","Michel","Alexandra","University of Hawaii at Manoa, School of Nursing &amp",NA
"1022","34183191","10.1016/j.outlook.2021.05.004","Undergraduate nursing students' perceptions on nursing education during the 2020 COVID-19 pandemic: A national sample.","In 2020, nursing educational programs were abruptly interrupted and largely moved online due to the COVID-19 pandemic. To explore nursing students' perspectives about the effects of the pandemic on their education and intention to join the nursing workforce. Undergraduate nursing students from 5 universities across 5 United States regions were invited to participate in an online survey to elicit both quantitative and qualitative data. The final sample included quantitative data on 772 students a","2021","06","29","Nurs Outlook","Nursing outlook","COVID-19; education; nursing; nursing students; pandemic; workforce","Ryan","Nicole","University of Hawaii at Manoa, School of Nursing &amp",NA
"1023","34183191","10.1016/j.outlook.2021.05.004","Undergraduate nursing students' perceptions on nursing education during the 2020 COVID-19 pandemic: A national sample.","In 2020, nursing educational programs were abruptly interrupted and largely moved online due to the COVID-19 pandemic. To explore nursing students' perspectives about the effects of the pandemic on their education and intention to join the nursing workforce. Undergraduate nursing students from 5 universities across 5 United States regions were invited to participate in an online survey to elicit both quantitative and qualitative data. The final sample included quantitative data on 772 students a","2021","06","29","Nurs Outlook","Nursing outlook","COVID-19; education; nursing; nursing students; pandemic; workforce","Mattheus","Deborah","University of Hawaii at Manoa, School of Nursing &amp",NA
"1024","34183191","10.1016/j.outlook.2021.05.004","Undergraduate nursing students' perceptions on nursing education during the 2020 COVID-19 pandemic: A national sample.","In 2020, nursing educational programs were abruptly interrupted and largely moved online due to the COVID-19 pandemic. To explore nursing students' perspectives about the effects of the pandemic on their education and intention to join the nursing workforce. Undergraduate nursing students from 5 universities across 5 United States regions were invited to participate in an online survey to elicit both quantitative and qualitative data. The final sample included quantitative data on 772 students a","2021","06","29","Nurs Outlook","Nursing outlook","COVID-19; education; nursing; nursing students; pandemic; workforce","Knopf","Amelia","Indiana University, School of Nursing, Department of Community and Health Services, Indianapolis, IN",NA
"1025","34183191","10.1016/j.outlook.2021.05.004","Undergraduate nursing students' perceptions on nursing education during the 2020 COVID-19 pandemic: A national sample.","In 2020, nursing educational programs were abruptly interrupted and largely moved online due to the COVID-19 pandemic. To explore nursing students' perspectives about the effects of the pandemic on their education and intention to join the nursing workforce. Undergraduate nursing students from 5 universities across 5 United States regions were invited to participate in an online survey to elicit both quantitative and qualitative data. The final sample included quantitative data on 772 students a","2021","06","29","Nurs Outlook","Nursing outlook","COVID-19; education; nursing; nursing students; pandemic; workforce","Abuelezam","Nadia N","Boston College, Connell School of Nursing, Chestnut Hill, MA",NA
"1026","34183191","10.1016/j.outlook.2021.05.004","Undergraduate nursing students' perceptions on nursing education during the 2020 COVID-19 pandemic: A national sample.","In 2020, nursing educational programs were abruptly interrupted and largely moved online due to the COVID-19 pandemic. To explore nursing students' perspectives about the effects of the pandemic on their education and intention to join the nursing workforce. Undergraduate nursing students from 5 universities across 5 United States regions were invited to participate in an online survey to elicit both quantitative and qualitative data. The final sample included quantitative data on 772 students a","2021","06","29","Nurs Outlook","Nursing outlook","COVID-19; education; nursing; nursing students; pandemic; workforce","Stamp","Kelly","University of North Carolina at Greensboro, School of Nursing, Greensboro, NC",NA
"1027","34183191","10.1016/j.outlook.2021.05.004","Undergraduate nursing students' perceptions on nursing education during the 2020 COVID-19 pandemic: A national sample.","In 2020, nursing educational programs were abruptly interrupted and largely moved online due to the COVID-19 pandemic. To explore nursing students' perspectives about the effects of the pandemic on their education and intention to join the nursing workforce. Undergraduate nursing students from 5 universities across 5 United States regions were invited to participate in an online survey to elicit both quantitative and qualitative data. The final sample included quantitative data on 772 students a","2021","06","29","Nurs Outlook","Nursing outlook","COVID-19; education; nursing; nursing students; pandemic; workforce","Branson","Sandra","Cizik School of Nursing at The University of Texas Health Sciences Center at Houston (UTHealth), Houston, TX",NA
"1028","34183191","10.1016/j.outlook.2021.05.004","Undergraduate nursing students' perceptions on nursing education during the 2020 COVID-19 pandemic: A national sample.","In 2020, nursing educational programs were abruptly interrupted and largely moved online due to the COVID-19 pandemic. To explore nursing students' perspectives about the effects of the pandemic on their education and intention to join the nursing workforce. Undergraduate nursing students from 5 universities across 5 United States regions were invited to participate in an online survey to elicit both quantitative and qualitative data. The final sample included quantitative data on 772 students a","2021","06","29","Nurs Outlook","Nursing outlook","COVID-19; education; nursing; nursing students; pandemic; workforce","Hekel","Barbara","Cizik School of Nursing at The University of Texas Health Sciences Center at Houston (UTHealth), Houston, TX",NA
"1029","34183191","10.1016/j.outlook.2021.05.004","Undergraduate nursing students' perceptions on nursing education during the 2020 COVID-19 pandemic: A national sample.","In 2020, nursing educational programs were abruptly interrupted and largely moved online due to the COVID-19 pandemic. To explore nursing students' perspectives about the effects of the pandemic on their education and intention to join the nursing workforce. Undergraduate nursing students from 5 universities across 5 United States regions were invited to participate in an online survey to elicit both quantitative and qualitative data. The final sample included quantitative data on 772 students a","2021","06","29","Nurs Outlook","Nursing outlook","COVID-19; education; nursing; nursing students; pandemic; workforce","Fontenot","Holly B","University of Hawaii at Manoa, School of Nursing &amp","hbfont@hawaii.edu"
"1030","34183188","10.1016/j.outlook.2021.05.006","A blueprint for nursing innovation centers.","The interest in and demand for healthcare innovation has heightened amid the COVID-19 pandemic. Organizations are challenged to balance the goals of daily operations with innovation to stay relevant and compete in the marketplace. Innovation is critical for not only the success and sustainability of organizations, but the well-being of the faculty, staff, and clients they serve. In this article, we present an overview of several Nursing Innovation Centers in the United States as well as examples","2021","06","29","Nurs Outlook","Nursing outlook","Center; Culture; Innovation; Leadership development; Nursing leadership","Barr","Taura L","Center for Healthcare Innovation and Leadership, The Ohio State University College of Nursing, Columbus, OH. Electronic address: barr.428@osu","barr.428@osu.edu"
"1031","34183188","10.1016/j.outlook.2021.05.006","A blueprint for nursing innovation centers.","The interest in and demand for healthcare innovation has heightened amid the COVID-19 pandemic. Organizations are challenged to balance the goals of daily operations with innovation to stay relevant and compete in the marketplace. Innovation is critical for not only the success and sustainability of organizations, but the well-being of the faculty, staff, and clients they serve. In this article, we present an overview of several Nursing Innovation Centers in the United States as well as examples","2021","06","29","Nurs Outlook","Nursing outlook","Center; Culture; Innovation; Leadership development; Nursing leadership","Malloch","Kathy","College of Nursing, The Ohio State University, Columbus, OH",NA
"1032","34183188","10.1016/j.outlook.2021.05.006","A blueprint for nursing innovation centers.","The interest in and demand for healthcare innovation has heightened amid the COVID-19 pandemic. Organizations are challenged to balance the goals of daily operations with innovation to stay relevant and compete in the marketplace. Innovation is critical for not only the success and sustainability of organizations, but the well-being of the faculty, staff, and clients they serve. In this article, we present an overview of several Nursing Innovation Centers in the United States as well as examples","2021","06","29","Nurs Outlook","Nursing outlook","Center; Culture; Innovation; Leadership development; Nursing leadership","Ackerman","Michael H","Center for Healthcare Innovation and Leadership, College of Nursing, The Ohio State University, Columbus, OH",NA
"1033","34183188","10.1016/j.outlook.2021.05.006","A blueprint for nursing innovation centers.","The interest in and demand for healthcare innovation has heightened amid the COVID-19 pandemic. Organizations are challenged to balance the goals of daily operations with innovation to stay relevant and compete in the marketplace. Innovation is critical for not only the success and sustainability of organizations, but the well-being of the faculty, staff, and clients they serve. In this article, we present an overview of several Nursing Innovation Centers in the United States as well as examples","2021","06","29","Nurs Outlook","Nursing outlook","Center; Culture; Innovation; Leadership development; Nursing leadership","Raderstorf","Tim","Center for Healthcare Innovation and Leadership, College of Nursing, The Ohio State University, Columbus, OH",NA
"1034","34183188","10.1016/j.outlook.2021.05.006","A blueprint for nursing innovation centers.","The interest in and demand for healthcare innovation has heightened amid the COVID-19 pandemic. Organizations are challenged to balance the goals of daily operations with innovation to stay relevant and compete in the marketplace. Innovation is critical for not only the success and sustainability of organizations, but the well-being of the faculty, staff, and clients they serve. In this article, we present an overview of several Nursing Innovation Centers in the United States as well as examples","2021","06","29","Nurs Outlook","Nursing outlook","Center; Culture; Innovation; Leadership development; Nursing leadership","Melnyk","Bernadette Mazurek","College of Nursing, Pediatrics &amp",NA
"1035","34183089","10.1017/S1047951121002754","Pre-operative Assessment of Pediatric Congenital Heart Disease Patients in the COVID-19 Era: Lessons Learned.","Equal to COVID-19 patients, non-COVID-19 patients are affected by the medical and social drawbacks of the COVID-19 pandemic. A significant reduction in elective life-changing surgeries has been witnessed in almost all affected countries. This study discusses an applicable and effective pre-operative assessment protocol that can be applied during the COVID-19 era. Our study is a descriptive retrospective observational study that involves pediatric patients with CHD requiring open heart surgeries ","2021","06","29","Cardiol Young","Cardiology in the young","CHD; COVID-19; pediatric patients; pre-operative assessment; surgery","Younis","Nour K","Faculty of Medicine, American University of Beirut Medical Center, Beirut, P.O. Box 11-0236, Lebanon","nky02@mail.aub.edu"
"1036","34183089","10.1017/S1047951121002754","Pre-operative Assessment of Pediatric Congenital Heart Disease Patients in the COVID-19 Era: Lessons Learned.","Equal to COVID-19 patients, non-COVID-19 patients are affected by the medical and social drawbacks of the COVID-19 pandemic. A significant reduction in elective life-changing surgeries has been witnessed in almost all affected countries. This study discusses an applicable and effective pre-operative assessment protocol that can be applied during the COVID-19 era. Our study is a descriptive retrospective observational study that involves pediatric patients with CHD requiring open heart surgeries ","2021","06","29","Cardiol Young","Cardiology in the young","CHD; COVID-19; pediatric patients; pre-operative assessment; surgery","Zareef","Rana O","Faculty of Medicine, American University of Beirut Medical Center, Beirut, P.O. Box 11-0236, Lebanon","nky02@mail.aub.edu"
"1037","34183089","10.1017/S1047951121002754","Pre-operative Assessment of Pediatric Congenital Heart Disease Patients in the COVID-19 Era: Lessons Learned.","Equal to COVID-19 patients, non-COVID-19 patients are affected by the medical and social drawbacks of the COVID-19 pandemic. A significant reduction in elective life-changing surgeries has been witnessed in almost all affected countries. This study discusses an applicable and effective pre-operative assessment protocol that can be applied during the COVID-19 era. Our study is a descriptive retrospective observational study that involves pediatric patients with CHD requiring open heart surgeries ","2021","06","29","Cardiol Young","Cardiology in the young","CHD; COVID-19; pediatric patients; pre-operative assessment; surgery","Diab","Marwa A","Faculty of Medicine, American University of Beirut Medical Center, Beirut, P.O. Box 11-0236, Lebanon","nky02@mail.aub.edu"
"1038","34183089","10.1017/S1047951121002754","Pre-operative Assessment of Pediatric Congenital Heart Disease Patients in the COVID-19 Era: Lessons Learned.","Equal to COVID-19 patients, non-COVID-19 patients are affected by the medical and social drawbacks of the COVID-19 pandemic. A significant reduction in elective life-changing surgeries has been witnessed in almost all affected countries. This study discusses an applicable and effective pre-operative assessment protocol that can be applied during the COVID-19 era. Our study is a descriptive retrospective observational study that involves pediatric patients with CHD requiring open heart surgeries ","2021","06","29","Cardiol Young","Cardiology in the young","CHD; COVID-19; pediatric patients; pre-operative assessment; surgery","El Sedawi","Omar","Pediatric Department, Division of Pediatric Cardiology, American University of Beirut Medical Center, Beirut, P.O. Box 11-0236, Lebanon","oe24@aub.edu.lb"
"1039","34183089","10.1017/S1047951121002754","Pre-operative Assessment of Pediatric Congenital Heart Disease Patients in the COVID-19 Era: Lessons Learned.","Equal to COVID-19 patients, non-COVID-19 patients are affected by the medical and social drawbacks of the COVID-19 pandemic. A significant reduction in elective life-changing surgeries has been witnessed in almost all affected countries. This study discusses an applicable and effective pre-operative assessment protocol that can be applied during the COVID-19 era. Our study is a descriptive retrospective observational study that involves pediatric patients with CHD requiring open heart surgeries ","2021","06","29","Cardiol Young","Cardiology in the young","CHD; COVID-19; pediatric patients; pre-operative assessment; surgery","El-Rassi","Issam M","Surgery Department, American University of Beirut Medical Center, Beirut, P.O. Box 11-0236, Lebanon","ie13@aub.edu.lb"
"1040","34183089","10.1017/S1047951121002754","Pre-operative Assessment of Pediatric Congenital Heart Disease Patients in the COVID-19 Era: Lessons Learned.","Equal to COVID-19 patients, non-COVID-19 patients are affected by the medical and social drawbacks of the COVID-19 pandemic. A significant reduction in elective life-changing surgeries has been witnessed in almost all affected countries. This study discusses an applicable and effective pre-operative assessment protocol that can be applied during the COVID-19 era. Our study is a descriptive retrospective observational study that involves pediatric patients with CHD requiring open heart surgeries ","2021","06","29","Cardiol Young","Cardiology in the young","CHD; COVID-19; pediatric patients; pre-operative assessment; surgery","Bitar","Fadi","Faculty of Medicine, American University of Beirut Medical Center, Beirut, P.O. Box 11-0236, Lebanon","nky02@mail.aub.edu"
"1041","34183089","10.1017/S1047951121002754","Pre-operative Assessment of Pediatric Congenital Heart Disease Patients in the COVID-19 Era: Lessons Learned.","Equal to COVID-19 patients, non-COVID-19 patients are affected by the medical and social drawbacks of the COVID-19 pandemic. A significant reduction in elective life-changing surgeries has been witnessed in almost all affected countries. This study discusses an applicable and effective pre-operative assessment protocol that can be applied during the COVID-19 era. Our study is a descriptive retrospective observational study that involves pediatric patients with CHD requiring open heart surgeries ","2021","06","29","Cardiol Young","Cardiology in the young","CHD; COVID-19; pediatric patients; pre-operative assessment; surgery","Arabi","Mariam","Faculty of Medicine, American University of Beirut Medical Center, Beirut, P.O. Box 11-0236, Lebanon","nky02@mail.aub.edu"
"1042","34183081","10.1017/S0950268821001394","What is the status of nucleic acid contamination in 2019-nCOV vaccination sites? Can it be avoided?",NA,"2021","06","29","Epidemiol Infect","Epidemiology and infection",NA,"Li","Zhanjie","Department of Infection Control, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China",NA
"1043","34183081","10.1017/S0950268821001394","What is the status of nucleic acid contamination in 2019-nCOV vaccination sites? Can it be avoided?",NA,"2021","06","29","Epidemiol Infect","Epidemiology and infection",NA,"Zhang","Baiyan","Department of Public Health and Hospital infection, The Affiliated Kizilsu Kirghiz Autonomous Prefecture People's Hospital of Nanjing Medical University, Artux, 845350, Xinjiang, China",NA
"1044","34183081","10.1017/S0950268821001394","What is the status of nucleic acid contamination in 2019-nCOV vaccination sites? Can it be avoided?",NA,"2021","06","29","Epidemiol Infect","Epidemiology and infection",NA,"Wu","Xinhua","Department of Inspection, The Affiliated Kizilsu Kirghiz Autonomous Prefecture People's Hospital of Nanjing Medical University, Artux, 845350, Xinjiang, China",NA
"1045","34183081","10.1017/S0950268821001394","What is the status of nucleic acid contamination in 2019-nCOV vaccination sites? Can it be avoided?",NA,"2021","06","29","Epidemiol Infect","Epidemiology and infection",NA,"Yang","Min","Department of Public Health and Hospital infection, The Affiliated Kizilsu Kirghiz Autonomous Prefecture People's Hospital of Nanjing Medical University, Artux, 845350, Xinjiang, China",NA
"1046","34183081","10.1017/S0950268821001394","What is the status of nucleic acid contamination in 2019-nCOV vaccination sites? Can it be avoided?",NA,"2021","06","29","Epidemiol Infect","Epidemiology and infection",NA,"Zhang","Qi","Department of Public Health and Hospital infection, The Affiliated Kizilsu Kirghiz Autonomous Prefecture People's Hospital of Nanjing Medical University, Artux, 845350, Xinjiang, China",NA
"1047","34183081","10.1017/S0950268821001394","What is the status of nucleic acid contamination in 2019-nCOV vaccination sites? Can it be avoided?",NA,"2021","06","29","Epidemiol Infect","Epidemiology and infection",NA,"Xiang","Guohua","Department of Public Health and Hospital infection, The Affiliated Kizilsu Kirghiz Autonomous Prefecture People's Hospital of Nanjing Medical University, Artux, 845350, Xinjiang, China",NA
"1048","34183081","10.1017/S0950268821001394","What is the status of nucleic acid contamination in 2019-nCOV vaccination sites? Can it be avoided?",NA,"2021","06","29","Epidemiol Infect","Epidemiology and infection",NA,"Chen","Yongxin","Department of Public Health and Hospital infection, The Affiliated Kizilsu Kirghiz Autonomous Prefecture People's Hospital of Nanjing Medical University, Artux, 845350, Xinjiang, China",NA
"1049","34183081","10.1017/S0950268821001394","What is the status of nucleic acid contamination in 2019-nCOV vaccination sites? Can it be avoided?",NA,"2021","06","29","Epidemiol Infect","Epidemiology and infection",NA,"Zeng","Lin","Department of Public Health and Hospital infection, The Affiliated Kizilsu Kirghiz Autonomous Prefecture People's Hospital of Nanjing Medical University, Artux, 845350, Xinjiang, China",NA
"1050","34183081","10.1017/S0950268821001394","What is the status of nucleic acid contamination in 2019-nCOV vaccination sites? Can it be avoided?",NA,"2021","06","29","Epidemiol Infect","Epidemiology and infection",NA,"Tayier","Dilirena","Department of Public Health and Hospital infection, The Affiliated Kizilsu Kirghiz Autonomous Prefecture People's Hospital of Nanjing Medical University, Artux, 845350, Xinjiang, China",NA
"1051","34183081","10.1017/S0950268821001394","What is the status of nucleic acid contamination in 2019-nCOV vaccination sites? Can it be avoided?",NA,"2021","06","29","Epidemiol Infect","Epidemiology and infection",NA,"Zhang","Weihong","Office of the Dean, Jiangsu Shengze Hospital affiliated to Nanjing Medical University, Suzhou, 215228, Jiangsu, China",NA
"1052","34183081","10.1017/S0950268821001394","What is the status of nucleic acid contamination in 2019-nCOV vaccination sites? Can it be avoided?",NA,"2021","06","29","Epidemiol Infect","Epidemiology and infection",NA,"Song","Ninghong","Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China",NA
"1053","34183033","10.1186/s12985-021-01598-w","Impact of joint management of a COVID-19 mother and her newborn on the virus transmission: a case report.","Since last year, COVID-19, the disease caused by the novel Sars-Cov-2 virus, has been globally spread to all the world. COVID-19 infection among pregnant women has been described. However, transplacental transmission of Sars-Cov-2 virus from infected mother to the newborn is not yet established. The appropriate management of infants born to mothers with confirmed or suspected COVID-19 and the start of early breastfeeding are being debated. We report a case of the joint management of a healthy ne","2021","07","12","Virol J","Virology journal","Breastfeeding; Neonates; Rooming-in; SARS-CoV2 transmission; Adult; Breast Feeding; COVID-19; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Mothers; Nasopharynx; SARS-CoV-2","De Nardo","Maria Chiara","Pediatric and Neonatal Unit, Sapienza University of Rome, Polo Pontino, Santa Maria Goretti Hospital, Via A. Canova, 04100, Latina, Italy. mariachiara.denardo@uniromal","mariachiara.denardo@uniromal.it"
"1054","34183033","10.1186/s12985-021-01598-w","Impact of joint management of a COVID-19 mother and her newborn on the virus transmission: a case report.","Since last year, COVID-19, the disease caused by the novel Sars-Cov-2 virus, has been globally spread to all the world. COVID-19 infection among pregnant women has been described. However, transplacental transmission of Sars-Cov-2 virus from infected mother to the newborn is not yet established. The appropriate management of infants born to mothers with confirmed or suspected COVID-19 and the start of early breastfeeding are being debated. We report a case of the joint management of a healthy ne","2021","07","12","Virol J","Virology journal","Breastfeeding; Neonates; Rooming-in; SARS-CoV2 transmission; Adult; Breast Feeding; COVID-19; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Mothers; Nasopharynx; SARS-CoV-2","Bellomo","Anna Rita","Pediatric and Neonatal Unit, Sapienza University of Rome, Polo Pontino, Santa Maria Goretti Hospital, Via A. Canova, 04100, Latina, Italy",NA
"1055","34183033","10.1186/s12985-021-01598-w","Impact of joint management of a COVID-19 mother and her newborn on the virus transmission: a case report.","Since last year, COVID-19, the disease caused by the novel Sars-Cov-2 virus, has been globally spread to all the world. COVID-19 infection among pregnant women has been described. However, transplacental transmission of Sars-Cov-2 virus from infected mother to the newborn is not yet established. The appropriate management of infants born to mothers with confirmed or suspected COVID-19 and the start of early breastfeeding are being debated. We report a case of the joint management of a healthy ne","2021","07","12","Virol J","Virology journal","Breastfeeding; Neonates; Rooming-in; SARS-CoV2 transmission; Adult; Breast Feeding; COVID-19; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Mothers; Nasopharynx; SARS-CoV-2","Perfetti","Francesca","Pediatric and Neonatal Unit, Sapienza University of Rome, Polo Pontino, Santa Maria Goretti Hospital, Via A. Canova, 04100, Latina, Italy",NA
"1056","34183033","10.1186/s12985-021-01598-w","Impact of joint management of a COVID-19 mother and her newborn on the virus transmission: a case report.","Since last year, COVID-19, the disease caused by the novel Sars-Cov-2 virus, has been globally spread to all the world. COVID-19 infection among pregnant women has been described. However, transplacental transmission of Sars-Cov-2 virus from infected mother to the newborn is not yet established. The appropriate management of infants born to mothers with confirmed or suspected COVID-19 and the start of early breastfeeding are being debated. We report a case of the joint management of a healthy ne","2021","07","12","Virol J","Virology journal","Breastfeeding; Neonates; Rooming-in; SARS-CoV2 transmission; Adult; Breast Feeding; COVID-19; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Mothers; Nasopharynx; SARS-CoV-2","Battaglia","Francesco Antonino","Gynecological and Obstetrical Unit, Santa Maria Goretti Hospital, Latina, Italy",NA
"1057","34183033","10.1186/s12985-021-01598-w","Impact of joint management of a COVID-19 mother and her newborn on the virus transmission: a case report.","Since last year, COVID-19, the disease caused by the novel Sars-Cov-2 virus, has been globally spread to all the world. COVID-19 infection among pregnant women has been described. However, transplacental transmission of Sars-Cov-2 virus from infected mother to the newborn is not yet established. The appropriate management of infants born to mothers with confirmed or suspected COVID-19 and the start of early breastfeeding are being debated. We report a case of the joint management of a healthy ne","2021","07","12","Virol J","Virology journal","Breastfeeding; Neonates; Rooming-in; SARS-CoV2 transmission; Adult; Breast Feeding; COVID-19; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Mothers; Nasopharynx; SARS-CoV-2","Lichtner","Miriam","Infectious Diseases Unit, Sapienza University of Rome, Polo Pontino, Santa Maria Goretti Hospital, Latina, Italy",NA
"1058","34183033","10.1186/s12985-021-01598-w","Impact of joint management of a COVID-19 mother and her newborn on the virus transmission: a case report.","Since last year, COVID-19, the disease caused by the novel Sars-Cov-2 virus, has been globally spread to all the world. COVID-19 infection among pregnant women has been described. However, transplacental transmission of Sars-Cov-2 virus from infected mother to the newborn is not yet established. The appropriate management of infants born to mothers with confirmed or suspected COVID-19 and the start of early breastfeeding are being debated. We report a case of the joint management of a healthy ne","2021","07","12","Virol J","Virology journal","Breastfeeding; Neonates; Rooming-in; SARS-CoV2 transmission; Adult; Breast Feeding; COVID-19; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Mothers; Nasopharynx; SARS-CoV-2","Lubrano","Riccardo","Pediatric and Neonatal Unit, Sapienza University of Rome, Polo Pontino, Santa Maria Goretti Hospital, Via A. Canova, 04100, Latina, Italy",NA
"1059","34183030","10.1186/s12992-021-00710-7","Mental health solutions for domestic violence victims amid COVID-19: a review of the literature.","Due to COVID-19, domestic violence victims face a range of mental health challenges, possibly resulting in substantial human and economic consequences. However, there is a lack of mental health interventions tailored to domestic violence victims and in the context of COVID-19. In this study, we aim to identify interventions that can improve domestic violence victims' mental health amid the COVID-19 pandemic to address the research gap. Drawing insights from established COVID-19 review frameworks","2021","07","01","Global Health","Globalization and health","COVID-19; Coronavirus; Domestic violence and abuse; Interventions; Intimate partner violence; Mental health; Pandemic; SARS-CoV-2; Violence against women; COVID-19; Crime Victims; Domestic Violence; Humans; Mental Disorders; Randomized Controlled Trials as Topic","Su","Zhaohui","Center on Smart and Connected Health Technologies, Mays Cancer Center, School of Nursing, UT Health San Antonio, San Antonio, TX, 78229, USA. szh@utexas","szh@utexas.edu"
"1060","34183030","10.1186/s12992-021-00710-7","Mental health solutions for domestic violence victims amid COVID-19: a review of the literature.","Due to COVID-19, domestic violence victims face a range of mental health challenges, possibly resulting in substantial human and economic consequences. However, there is a lack of mental health interventions tailored to domestic violence victims and in the context of COVID-19. In this study, we aim to identify interventions that can improve domestic violence victims' mental health amid the COVID-19 pandemic to address the research gap. Drawing insights from established COVID-19 review frameworks","2021","07","01","Global Health","Globalization and health","COVID-19; Coronavirus; Domestic violence and abuse; Interventions; Intimate partner violence; Mental health; Pandemic; SARS-CoV-2; Violence against women; COVID-19; Crime Victims; Domestic Violence; Humans; Mental Disorders; Randomized Controlled Trials as Topic","McDonnell","Dean","Department of Humanities, Institute of Technology Carlow, Carlow, R93 V960, Ireland",NA
"1061","34183030","10.1186/s12992-021-00710-7","Mental health solutions for domestic violence victims amid COVID-19: a review of the literature.","Due to COVID-19, domestic violence victims face a range of mental health challenges, possibly resulting in substantial human and economic consequences. However, there is a lack of mental health interventions tailored to domestic violence victims and in the context of COVID-19. In this study, we aim to identify interventions that can improve domestic violence victims' mental health amid the COVID-19 pandemic to address the research gap. Drawing insights from established COVID-19 review frameworks","2021","07","01","Global Health","Globalization and health","COVID-19; Coronavirus; Domestic violence and abuse; Interventions; Intimate partner violence; Mental health; Pandemic; SARS-CoV-2; Violence against women; COVID-19; Crime Victims; Domestic Violence; Humans; Mental Disorders; Randomized Controlled Trials as Topic","Roth","Stephanie","Simmy and Harry Ginsburg Library, Temple University, Philadelphia, PA, 19140, USA",NA
"1062","34183030","10.1186/s12992-021-00710-7","Mental health solutions for domestic violence victims amid COVID-19: a review of the literature.","Due to COVID-19, domestic violence victims face a range of mental health challenges, possibly resulting in substantial human and economic consequences. However, there is a lack of mental health interventions tailored to domestic violence victims and in the context of COVID-19. In this study, we aim to identify interventions that can improve domestic violence victims' mental health amid the COVID-19 pandemic to address the research gap. Drawing insights from established COVID-19 review frameworks","2021","07","01","Global Health","Globalization and health","COVID-19; Coronavirus; Domestic violence and abuse; Interventions; Intimate partner violence; Mental health; Pandemic; SARS-CoV-2; Violence against women; COVID-19; Crime Victims; Domestic Violence; Humans; Mental Disorders; Randomized Controlled Trials as Topic","Li","Quanlei","School of Nursing, Johns Hopkins University, Baltimore, MD, 21205, USA",NA
"1063","34183030","10.1186/s12992-021-00710-7","Mental health solutions for domestic violence victims amid COVID-19: a review of the literature.","Due to COVID-19, domestic violence victims face a range of mental health challenges, possibly resulting in substantial human and economic consequences. However, there is a lack of mental health interventions tailored to domestic violence victims and in the context of COVID-19. In this study, we aim to identify interventions that can improve domestic violence victims' mental health amid the COVID-19 pandemic to address the research gap. Drawing insights from established COVID-19 review frameworks","2021","07","01","Global Health","Globalization and health","COVID-19; Coronavirus; Domestic violence and abuse; Interventions; Intimate partner violence; Mental health; Pandemic; SARS-CoV-2; Violence against women; COVID-19; Crime Victims; Domestic Violence; Humans; Mental Disorders; Randomized Controlled Trials as Topic","egalo","Sabina","Department of Microbiology, Faculty of Medicine, University of Sarajevo, 71000, Sarajevo, Bosnia and Herzegovina",NA
"1064","34183030","10.1186/s12992-021-00710-7","Mental health solutions for domestic violence victims amid COVID-19: a review of the literature.","Due to COVID-19, domestic violence victims face a range of mental health challenges, possibly resulting in substantial human and economic consequences. However, there is a lack of mental health interventions tailored to domestic violence victims and in the context of COVID-19. In this study, we aim to identify interventions that can improve domestic violence victims' mental health amid the COVID-19 pandemic to address the research gap. Drawing insights from established COVID-19 review frameworks","2021","07","01","Global Health","Globalization and health","COVID-19; Coronavirus; Domestic violence and abuse; Interventions; Intimate partner violence; Mental health; Pandemic; SARS-CoV-2; Violence against women; COVID-19; Crime Victims; Domestic Violence; Humans; Mental Disorders; Randomized Controlled Trials as Topic","Shi","Feng","Department of Research and Development, Shanghai United Imaging Intelligence, 200232, Shanghai, China",NA
"1065","34183030","10.1186/s12992-021-00710-7","Mental health solutions for domestic violence victims amid COVID-19: a review of the literature.","Due to COVID-19, domestic violence victims face a range of mental health challenges, possibly resulting in substantial human and economic consequences. However, there is a lack of mental health interventions tailored to domestic violence victims and in the context of COVID-19. In this study, we aim to identify interventions that can improve domestic violence victims' mental health amid the COVID-19 pandemic to address the research gap. Drawing insights from established COVID-19 review frameworks","2021","07","01","Global Health","Globalization and health","COVID-19; Coronavirus; Domestic violence and abuse; Interventions; Intimate partner violence; Mental health; Pandemic; SARS-CoV-2; Violence against women; COVID-19; Crime Victims; Domestic Violence; Humans; Mental Disorders; Randomized Controlled Trials as Topic","Wagers","Shelly","Department of Criminology, University of South Florida St. Petersburg, St. Petersburg, FL, 33701, USA",NA
"1066","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Dobaño","Carlota","ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK building), E-08036, Barcelona, Catalonia, Spain. carlota.dobano@isglobal","carlota.dobano@isglobal.org"
"1067","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Ramírez-Morros","Anna","Unitat de Suport a la Recerca de la Catalunya Central, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, Sant Fruitós de Bages, Spain. amramirez.cc.ics@gencat","amramirez.cc.ics@gencat.cat"
"1068","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Alonso","Selena","ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK building), E-08036, Barcelona, Catalonia, Spain",NA
"1069","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Vidal-Alaball","Josep","Unitat de Suport a la Recerca de la Catalunya Central, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, Sant Fruitós de Bages, Spain",NA
"1070","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Ruiz-Olalla","Gemma","ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK building), E-08036, Barcelona, Catalonia, Spain",NA
"1071","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Vidal","Marta","ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK building), E-08036, Barcelona, Catalonia, Spain",NA
"1072","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Rubio","Rocío","ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK building), E-08036, Barcelona, Catalonia, Spain",NA
"1073","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Cascant","Emma","ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK building), E-08036, Barcelona, Catalonia, Spain",NA
"1074","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Parras","Daniel","Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain",NA
"1075","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Rodrigo Melero","Natalia","Biomolecular Screening and Protein Technologies Unit, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain",NA
"1076","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Serra","Pau","Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain",NA
"1077","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Carolis","Carlo","Biomolecular Screening and Protein Technologies Unit, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain",NA
"1078","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Santamaria","Pere","Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPs), Barcelona, Spain",NA
"1079","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Forcada","Anna","Gerència Territorial de la Catalunya Central, Institut Català de la Salut, Sant Fruitós de Bages, Spain",NA
"1080","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Mendioroz","Jacobo","Health Promotion in Rural Areas Research Group, Gerència Territorial de la Catalunya Central, Institut Català de la Salut, Sant Fruitós de Bages, Spain",NA
"1081","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Aguilar","Ruth","ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK building), E-08036, Barcelona, Catalonia, Spain",NA
"1082","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Moncunill","Gemma","ISGlobal, Hospital Clínic, Universitat de Barcelona, Carrer Roselló 153 (CEK building), E-08036, Barcelona, Catalonia, Spain",NA
"1083","34183003","10.1186/s12916-021-02032-2","Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19.","We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not y","2021","07","06","BMC Med","BMC medicine","Antibodies; Baseline determinants; COVID-19; Cohort; Duration; Health care workers; Kinetics; Reinfection; SARS-CoV-2; Spike antigen; Adult; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cohort Studies; Cross-Sectional Studies; Female; Health Personnel; Humans; Middle Aged; Prospective Studies; Reinfection; SARS-CoV-2; Seroepidemiologic Studies; Spain","Ruiz-Comellas","Anna","Unitat de Suport a la Recerca de la Catalunya Central, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, Sant Fruitós de Bages, Spain",NA
"1084","34183002","10.1186/s12913-021-06606-x","'Bare-bones' to 'silver linings': lessons on integrating a palliative approach to care in long-term care in Western Canada.","'Whole-person' palliative approaches to care (PAC) are important for enhancing the quality of life of residents with life-limiting conditions in long-term care (LTC). This research is part of a larger, four province study, the 'SALTY (Seniors Adding Life to Years)' project to address quality of care in later life. A Quality Improvement (QI) project to integrate a PAC (PAC-QI) in LTC was implemented in Western Canada in four diverse facilities that varied in terms of ownership, leadership models,","2021","06","30","BMC Health Serv Res","BMC health services research","Care team; Life limiting conditions; trajectory; Long-term care; Palliative care; Quality of life; COVID-19; Canada; Humans; Long-Term Care; Palliative Care; Pandemics; Quality of Life; SARS-CoV-2","Cloutier","Denise","Department of Geography, University of Victoria, 3800 Finnerty Road, Victoria, BC, V8P 5C2, Canada. dcloutier@uvic","dcloutier@uvic.ca"
"1085","34183002","10.1186/s12913-021-06606-x","'Bare-bones' to 'silver linings': lessons on integrating a palliative approach to care in long-term care in Western Canada.","'Whole-person' palliative approaches to care (PAC) are important for enhancing the quality of life of residents with life-limiting conditions in long-term care (LTC). This research is part of a larger, four province study, the 'SALTY (Seniors Adding Life to Years)' project to address quality of care in later life. A Quality Improvement (QI) project to integrate a PAC (PAC-QI) in LTC was implemented in Western Canada in four diverse facilities that varied in terms of ownership, leadership models,","2021","06","30","BMC Health Serv Res","BMC health services research","Care team; Life limiting conditions; trajectory; Long-term care; Palliative care; Quality of life; COVID-19; Canada; Humans; Long-Term Care; Palliative Care; Pandemics; Quality of Life; SARS-CoV-2","Stajduhar","Kelli I","Institute on Aging and Lifelong Health, University of Victoria, 3800 Finnerty Road, Victoria, BC, V8P 5C2, Canada",NA
"1086","34183002","10.1186/s12913-021-06606-x","'Bare-bones' to 'silver linings': lessons on integrating a palliative approach to care in long-term care in Western Canada.","'Whole-person' palliative approaches to care (PAC) are important for enhancing the quality of life of residents with life-limiting conditions in long-term care (LTC). This research is part of a larger, four province study, the 'SALTY (Seniors Adding Life to Years)' project to address quality of care in later life. A Quality Improvement (QI) project to integrate a PAC (PAC-QI) in LTC was implemented in Western Canada in four diverse facilities that varied in terms of ownership, leadership models,","2021","06","30","BMC Health Serv Res","BMC health services research","Care team; Life limiting conditions; trajectory; Long-term care; Palliative care; Quality of life; COVID-19; Canada; Humans; Long-Term Care; Palliative Care; Pandemics; Quality of Life; SARS-CoV-2","Roberts","Della","Palliative &amp",NA
"1087","34183002","10.1186/s12913-021-06606-x","'Bare-bones' to 'silver linings': lessons on integrating a palliative approach to care in long-term care in Western Canada.","'Whole-person' palliative approaches to care (PAC) are important for enhancing the quality of life of residents with life-limiting conditions in long-term care (LTC). This research is part of a larger, four province study, the 'SALTY (Seniors Adding Life to Years)' project to address quality of care in later life. A Quality Improvement (QI) project to integrate a PAC (PAC-QI) in LTC was implemented in Western Canada in four diverse facilities that varied in terms of ownership, leadership models,","2021","06","30","BMC Health Serv Res","BMC health services research","Care team; Life limiting conditions; trajectory; Long-term care; Palliative care; Quality of life; COVID-19; Canada; Humans; Long-Term Care; Palliative Care; Pandemics; Quality of Life; SARS-CoV-2","Dujela","Carren","Institute on Aging and Lifelong Health, University of Victoria, 3800 Finnerty Road, Victoria, BC, V8P 5C2, Canada",NA
"1088","34183002","10.1186/s12913-021-06606-x","'Bare-bones' to 'silver linings': lessons on integrating a palliative approach to care in long-term care in Western Canada.","'Whole-person' palliative approaches to care (PAC) are important for enhancing the quality of life of residents with life-limiting conditions in long-term care (LTC). This research is part of a larger, four province study, the 'SALTY (Seniors Adding Life to Years)' project to address quality of care in later life. A Quality Improvement (QI) project to integrate a PAC (PAC-QI) in LTC was implemented in Western Canada in four diverse facilities that varied in terms of ownership, leadership models,","2021","06","30","BMC Health Serv Res","BMC health services research","Care team; Life limiting conditions; trajectory; Long-term care; Palliative care; Quality of life; COVID-19; Canada; Humans; Long-Term Care; Palliative Care; Pandemics; Quality of Life; SARS-CoV-2","Roland","Kaitlyn","Institute on Aging and Lifelong Health, University of Victoria, 3800 Finnerty Road, Victoria, BC, V8P 5C2, Canada",NA
"1089","34182972","10.1186/s12889-021-11236-3","State variation in effects of state social distancing policies on COVID-19 cases.","The novel coronavirus disease 2019 (COVID-19) sickened over 20 million residents in the United States (US) by January 2021. Our objective was to describe state variation in the effect of initial social distancing policies and non-essential business (NEB) closure on infection rates early in 2020. We used an interrupted time series study design to estimate the total effect of all state social distancing orders, including NEB closure, shelter-in-place, and stay-at-home orders, on cumulative COVID-1","2021","07","01","BMC Public Health","BMC public health","COVID-19; Health policy; Outcomes research; Public health; Social distancing; COVID-19; Humans; New Jersey; New York; Pennsylvania; Physical Distancing; Policy; SARS-CoV-2; United States","Kaufman","Brystana G","Margolis Center for Health Policy, Duke University, 230 Science Drive, Durham, NC, 27705, USA. Brystana.kaufman@duke","Brystana.kaufman@duke.edu"
"1090","34182972","10.1186/s12889-021-11236-3","State variation in effects of state social distancing policies on COVID-19 cases.","The novel coronavirus disease 2019 (COVID-19) sickened over 20 million residents in the United States (US) by January 2021. Our objective was to describe state variation in the effect of initial social distancing policies and non-essential business (NEB) closure on infection rates early in 2020. We used an interrupted time series study design to estimate the total effect of all state social distancing orders, including NEB closure, shelter-in-place, and stay-at-home orders, on cumulative COVID-1","2021","07","01","BMC Public Health","BMC public health","COVID-19; Health policy; Outcomes research; Public health; Social distancing; COVID-19; Humans; New Jersey; New York; Pennsylvania; Physical Distancing; Policy; SARS-CoV-2; United States","Whitaker","Rebecca","Margolis Center for Health Policy, Duke University, 230 Science Drive, Durham, NC, 27705, USA",NA
"1091","34182972","10.1186/s12889-021-11236-3","State variation in effects of state social distancing policies on COVID-19 cases.","The novel coronavirus disease 2019 (COVID-19) sickened over 20 million residents in the United States (US) by January 2021. Our objective was to describe state variation in the effect of initial social distancing policies and non-essential business (NEB) closure on infection rates early in 2020. We used an interrupted time series study design to estimate the total effect of all state social distancing orders, including NEB closure, shelter-in-place, and stay-at-home orders, on cumulative COVID-1","2021","07","01","BMC Public Health","BMC public health","COVID-19; Health policy; Outcomes research; Public health; Social distancing; COVID-19; Humans; New Jersey; New York; Pennsylvania; Physical Distancing; Policy; SARS-CoV-2; United States","Mahendraratnam","Nirosha","Margolis Center for Health Policy, Duke University, 230 Science Drive, Durham, NC, 27705, USA",NA
"1092","34182972","10.1186/s12889-021-11236-3","State variation in effects of state social distancing policies on COVID-19 cases.","The novel coronavirus disease 2019 (COVID-19) sickened over 20 million residents in the United States (US) by January 2021. Our objective was to describe state variation in the effect of initial social distancing policies and non-essential business (NEB) closure on infection rates early in 2020. We used an interrupted time series study design to estimate the total effect of all state social distancing orders, including NEB closure, shelter-in-place, and stay-at-home orders, on cumulative COVID-1","2021","07","01","BMC Public Health","BMC public health","COVID-19; Health policy; Outcomes research; Public health; Social distancing; COVID-19; Humans; New Jersey; New York; Pennsylvania; Physical Distancing; Policy; SARS-CoV-2; United States","Hurewitz","Sophie","Margolis Center for Health Policy, Duke University, 230 Science Drive, Durham, NC, 27705, USA",NA
"1093","34182972","10.1186/s12889-021-11236-3","State variation in effects of state social distancing policies on COVID-19 cases.","The novel coronavirus disease 2019 (COVID-19) sickened over 20 million residents in the United States (US) by January 2021. Our objective was to describe state variation in the effect of initial social distancing policies and non-essential business (NEB) closure on infection rates early in 2020. We used an interrupted time series study design to estimate the total effect of all state social distancing orders, including NEB closure, shelter-in-place, and stay-at-home orders, on cumulative COVID-1","2021","07","01","BMC Public Health","BMC public health","COVID-19; Health policy; Outcomes research; Public health; Social distancing; COVID-19; Humans; New Jersey; New York; Pennsylvania; Physical Distancing; Policy; SARS-CoV-2; United States","Yi","Jeremy","Margolis Center for Health Policy, Duke University, 230 Science Drive, Durham, NC, 27705, USA",NA
"1094","34182972","10.1186/s12889-021-11236-3","State variation in effects of state social distancing policies on COVID-19 cases.","The novel coronavirus disease 2019 (COVID-19) sickened over 20 million residents in the United States (US) by January 2021. Our objective was to describe state variation in the effect of initial social distancing policies and non-essential business (NEB) closure on infection rates early in 2020. We used an interrupted time series study design to estimate the total effect of all state social distancing orders, including NEB closure, shelter-in-place, and stay-at-home orders, on cumulative COVID-1","2021","07","01","BMC Public Health","BMC public health","COVID-19; Health policy; Outcomes research; Public health; Social distancing; COVID-19; Humans; New Jersey; New York; Pennsylvania; Physical Distancing; Policy; SARS-CoV-2; United States","Smith","Valerie A","Population Health Sciences, Duke University School of Medicine, Durham, NC, USA",NA
"1095","34182972","10.1186/s12889-021-11236-3","State variation in effects of state social distancing policies on COVID-19 cases.","The novel coronavirus disease 2019 (COVID-19) sickened over 20 million residents in the United States (US) by January 2021. Our objective was to describe state variation in the effect of initial social distancing policies and non-essential business (NEB) closure on infection rates early in 2020. We used an interrupted time series study design to estimate the total effect of all state social distancing orders, including NEB closure, shelter-in-place, and stay-at-home orders, on cumulative COVID-1","2021","07","01","BMC Public Health","BMC public health","COVID-19; Health policy; Outcomes research; Public health; Social distancing; COVID-19; Humans; New Jersey; New York; Pennsylvania; Physical Distancing; Policy; SARS-CoV-2; United States","McClellan","Mark","Margolis Center for Health Policy, Duke University, 230 Science Drive, Durham, NC, 27705, USA",NA
"1096","34182966","10.1186/s12891-021-04303-8","Survival analysis and influence of the surgical aggression of a cohort of orthopedic and trauma patients in a non-controlled spread COVID-19 scenario.","Determining the infection rate and mortality probability in healthy patients who have undergone orthopedic and trauma surgeries (OTS) during a period of uncontrolled COVID-19 transmission may help to inform preparations for future waves. This study performed a survival analysis in a cohort of non-infected OTS patients and determined the effect of COVID-19 on mortality. This observational study included 184 patients who underwent OTS in the month before surgical activities ceased and before the i","2021","06","30","BMC Musculoskelet Disord","BMC musculoskeletal disorders","COVID-19; Coronavirus; Elective orthopedic surgery; Trauma surgery; Aggression; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Survival Analysis","Corella","Fernando","Orthopedic and Trauma Department, Hospital Universitario Infanta Leonor, C/ Gran Vía del Este N° 80, 28031, Madrid, Spain. Fernando.corella@gmail","Fernando.corella@gmail.com"
"1097","34182966","10.1186/s12891-021-04303-8","Survival analysis and influence of the surgical aggression of a cohort of orthopedic and trauma patients in a non-controlled spread COVID-19 scenario.","Determining the infection rate and mortality probability in healthy patients who have undergone orthopedic and trauma surgeries (OTS) during a period of uncontrolled COVID-19 transmission may help to inform preparations for future waves. This study performed a survival analysis in a cohort of non-infected OTS patients and determined the effect of COVID-19 on mortality. This observational study included 184 patients who underwent OTS in the month before surgical activities ceased and before the i","2021","06","30","BMC Musculoskelet Disord","BMC musculoskeletal disorders","COVID-19; Coronavirus; Elective orthopedic surgery; Trauma surgery; Aggression; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Survival Analysis","Rosales","Roberto S","Unit for Hand &amp",NA
"1098","34182966","10.1186/s12891-021-04303-8","Survival analysis and influence of the surgical aggression of a cohort of orthopedic and trauma patients in a non-controlled spread COVID-19 scenario.","Determining the infection rate and mortality probability in healthy patients who have undergone orthopedic and trauma surgeries (OTS) during a period of uncontrolled COVID-19 transmission may help to inform preparations for future waves. This study performed a survival analysis in a cohort of non-infected OTS patients and determined the effect of COVID-19 on mortality. This observational study included 184 patients who underwent OTS in the month before surgical activities ceased and before the i","2021","06","30","BMC Musculoskelet Disord","BMC musculoskeletal disorders","COVID-19; Coronavirus; Elective orthopedic surgery; Trauma surgery; Aggression; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Survival Analysis","Guzman Domenech","David","Orthopedic and Trauma Department, Hospital Universitario Infanta Leonor, C/ Gran Vía del Este N° 80, 28031, Madrid, Spain",NA
"1099","34182966","10.1186/s12891-021-04303-8","Survival analysis and influence of the surgical aggression of a cohort of orthopedic and trauma patients in a non-controlled spread COVID-19 scenario.","Determining the infection rate and mortality probability in healthy patients who have undergone orthopedic and trauma surgeries (OTS) during a period of uncontrolled COVID-19 transmission may help to inform preparations for future waves. This study performed a survival analysis in a cohort of non-infected OTS patients and determined the effect of COVID-19 on mortality. This observational study included 184 patients who underwent OTS in the month before surgical activities ceased and before the i","2021","06","30","BMC Musculoskelet Disord","BMC musculoskeletal disorders","COVID-19; Coronavirus; Elective orthopedic surgery; Trauma surgery; Aggression; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Survival Analysis","Cañones Martín","Miguel","Orthopedic and Trauma Department, Hospital Universitario Infanta Leonor, C/ Gran Vía del Este N° 80, 28031, Madrid, Spain",NA
"1100","34182966","10.1186/s12891-021-04303-8","Survival analysis and influence of the surgical aggression of a cohort of orthopedic and trauma patients in a non-controlled spread COVID-19 scenario.","Determining the infection rate and mortality probability in healthy patients who have undergone orthopedic and trauma surgeries (OTS) during a period of uncontrolled COVID-19 transmission may help to inform preparations for future waves. This study performed a survival analysis in a cohort of non-infected OTS patients and determined the effect of COVID-19 on mortality. This observational study included 184 patients who underwent OTS in the month before surgical activities ceased and before the i","2021","06","30","BMC Musculoskelet Disord","BMC musculoskeletal disorders","COVID-19; Coronavirus; Elective orthopedic surgery; Trauma surgery; Aggression; COVID-19; COVID-19 Testing; Humans; SARS-CoV-2; Survival Analysis","Larrainzar-Garijo","Ricardo","Orthopedic and Trauma Department, Hospital Universitario Infanta Leonor, C/ Gran Vía del Este N° 80, 28031, Madrid, Spain",NA
"1101","34182962","10.1186/s12910-021-00649-9","Adherence with reporting of ethical standards in COVID-19 human studies: a rapid review.","Patients with COVID-19 may feel under pressure to participate in research during the pandemic. Safeguards to protect research participants include ethical guidelines [e.g. Declaration of Helsinki and good clinical practice (GCP)], legislation to protect participants' privacy, research ethics committees (RECs) and informed consent. The International Committee of Medical Journal Editors (ICMJE) advises researchers to document compliance with these safeguards. Adherence to publication guidelines ha","2021","07","02","BMC Med Ethics","BMC medical ethics","COVID-19; Clinical research; Clinical trials; Declaration of Helsinki; Good Clinical Practice; Informed Consent; Pandemic; Patient and Public Involvement; Research Ethics Committee; Research ethics","O'Sullivan","Lydia","School of Medicine, University College Dublin, Dublin 4, D04 V1W8, Ireland. lydia.osullivan@ucd","lydia.osullivan@ucd.ie"
"1102","34182962","10.1186/s12910-021-00649-9","Adherence with reporting of ethical standards in COVID-19 human studies: a rapid review.","Patients with COVID-19 may feel under pressure to participate in research during the pandemic. Safeguards to protect research participants include ethical guidelines [e.g. Declaration of Helsinki and good clinical practice (GCP)], legislation to protect participants' privacy, research ethics committees (RECs) and informed consent. The International Committee of Medical Journal Editors (ICMJE) advises researchers to document compliance with these safeguards. Adherence to publication guidelines ha","2021","07","02","BMC Med Ethics","BMC medical ethics","COVID-19; Clinical research; Clinical trials; Declaration of Helsinki; Good Clinical Practice; Informed Consent; Pandemic; Patient and Public Involvement; Research Ethics Committee; Research ethics","Killeen","Ronan P","Ethics and Medical Research Committee, Saint Vincent's University Hospital, Dublin 4, D04 T6F4, Ireland",NA
"1103","34182962","10.1186/s12910-021-00649-9","Adherence with reporting of ethical standards in COVID-19 human studies: a rapid review.","Patients with COVID-19 may feel under pressure to participate in research during the pandemic. Safeguards to protect research participants include ethical guidelines [e.g. Declaration of Helsinki and good clinical practice (GCP)], legislation to protect participants' privacy, research ethics committees (RECs) and informed consent. The International Committee of Medical Journal Editors (ICMJE) advises researchers to document compliance with these safeguards. Adherence to publication guidelines ha","2021","07","02","BMC Med Ethics","BMC medical ethics","COVID-19; Clinical research; Clinical trials; Declaration of Helsinki; Good Clinical Practice; Informed Consent; Pandemic; Patient and Public Involvement; Research Ethics Committee; Research ethics","Doran","Peter","School of Medicine, University College Dublin, Dublin 4, D04 V1W8, Ireland",NA
"1104","34182962","10.1186/s12910-021-00649-9","Adherence with reporting of ethical standards in COVID-19 human studies: a rapid review.","Patients with COVID-19 may feel under pressure to participate in research during the pandemic. Safeguards to protect research participants include ethical guidelines [e.g. Declaration of Helsinki and good clinical practice (GCP)], legislation to protect participants' privacy, research ethics committees (RECs) and informed consent. The International Committee of Medical Journal Editors (ICMJE) advises researchers to document compliance with these safeguards. Adherence to publication guidelines ha","2021","07","02","BMC Med Ethics","BMC medical ethics","COVID-19; Clinical research; Clinical trials; Declaration of Helsinki; Good Clinical Practice; Informed Consent; Pandemic; Patient and Public Involvement; Research Ethics Committee; Research ethics","Crowley","Rachel K","School of Medicine, University College Dublin, Dublin 4, D04 V1W8, Ireland",NA
"1105","34182960","10.1186/s12889-021-11290-x","SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers.","Smoking negatively impacts COVID-19 severity and adverse outcomes. Evidence on whether smoking is associated with SARS-Co-V2 infection and having a positive test is scarce, particularly from low-and middle-income countries, where most of the world's billion smokers live. The inconsistency in relevant findings calls for study designs and analyses to account for possible confounders including background characteristics and pre-existing co-morbidities, to disentangle the specific effect of smoking.","2021","07","01","BMC Public Health","BMC public health","COVID-19; Cohort; Egypt; Healthcare workers; Nicotine; SARS-co-V2; Smoking; Tobacco; COVID-19; Cohort Studies; Egypt; Health Personnel; Humans; Nicotine; Prospective Studies; SARS-CoV-2; Smoking; Tobacco","Mostafa","Aya","Department of Community, Environmental, and Occupational Medicine, Faculty of Medicine, Ain Shams University, 38 Ramses st., Abbassia square, PO-box 11566, Cairo, Egypt. aya.kamaleldin@med.asu.edu","aya.kamaleldin@med.asu.edu.eg"
"1106","34182960","10.1186/s12889-021-11290-x","SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers.","Smoking negatively impacts COVID-19 severity and adverse outcomes. Evidence on whether smoking is associated with SARS-Co-V2 infection and having a positive test is scarce, particularly from low-and middle-income countries, where most of the world's billion smokers live. The inconsistency in relevant findings calls for study designs and analyses to account for possible confounders including background characteristics and pre-existing co-morbidities, to disentangle the specific effect of smoking.","2021","07","01","BMC Public Health","BMC public health","COVID-19; Cohort; Egypt; Healthcare workers; Nicotine; SARS-co-V2; Smoking; Tobacco; COVID-19; Cohort Studies; Egypt; Health Personnel; Humans; Nicotine; Prospective Studies; SARS-CoV-2; Smoking; Tobacco","El-Sayed","Manal H","Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"1107","34182960","10.1186/s12889-021-11290-x","SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers.","Smoking negatively impacts COVID-19 severity and adverse outcomes. Evidence on whether smoking is associated with SARS-Co-V2 infection and having a positive test is scarce, particularly from low-and middle-income countries, where most of the world's billion smokers live. The inconsistency in relevant findings calls for study designs and analyses to account for possible confounders including background characteristics and pre-existing co-morbidities, to disentangle the specific effect of smoking.","2021","07","01","BMC Public Health","BMC public health","COVID-19; Cohort; Egypt; Healthcare workers; Nicotine; SARS-co-V2; Smoking; Tobacco; COVID-19; Cohort Studies; Egypt; Health Personnel; Humans; Nicotine; Prospective Studies; SARS-CoV-2; Smoking; Tobacco","El-Meteini","Mahmoud","Department of Hepatobiliary Surgery &amp",NA
"1108","34182960","10.1186/s12889-021-11290-x","SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers.","Smoking negatively impacts COVID-19 severity and adverse outcomes. Evidence on whether smoking is associated with SARS-Co-V2 infection and having a positive test is scarce, particularly from low-and middle-income countries, where most of the world's billion smokers live. The inconsistency in relevant findings calls for study designs and analyses to account for possible confounders including background characteristics and pre-existing co-morbidities, to disentangle the specific effect of smoking.","2021","07","01","BMC Public Health","BMC public health","COVID-19; Cohort; Egypt; Healthcare workers; Nicotine; SARS-co-V2; Smoking; Tobacco; COVID-19; Cohort Studies; Egypt; Health Personnel; Humans; Nicotine; Prospective Studies; SARS-CoV-2; Smoking; Tobacco","Saleh","Ayman","Department of Cardiology, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"1109","34182960","10.1186/s12889-021-11290-x","SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers.","Smoking negatively impacts COVID-19 severity and adverse outcomes. Evidence on whether smoking is associated with SARS-Co-V2 infection and having a positive test is scarce, particularly from low-and middle-income countries, where most of the world's billion smokers live. The inconsistency in relevant findings calls for study designs and analyses to account for possible confounders including background characteristics and pre-existing co-morbidities, to disentangle the specific effect of smoking.","2021","07","01","BMC Public Health","BMC public health","COVID-19; Cohort; Egypt; Healthcare workers; Nicotine; SARS-co-V2; Smoking; Tobacco; COVID-19; Cohort Studies; Egypt; Health Personnel; Humans; Nicotine; Prospective Studies; SARS-CoV-2; Smoking; Tobacco","Omar","Ashraf","Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"1110","34182960","10.1186/s12889-021-11290-x","SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers.","Smoking negatively impacts COVID-19 severity and adverse outcomes. Evidence on whether smoking is associated with SARS-Co-V2 infection and having a positive test is scarce, particularly from low-and middle-income countries, where most of the world's billion smokers live. The inconsistency in relevant findings calls for study designs and analyses to account for possible confounders including background characteristics and pre-existing co-morbidities, to disentangle the specific effect of smoking.","2021","07","01","BMC Public Health","BMC public health","COVID-19; Cohort; Egypt; Healthcare workers; Nicotine; SARS-co-V2; Smoking; Tobacco; COVID-19; Cohort Studies; Egypt; Health Personnel; Humans; Nicotine; Prospective Studies; SARS-CoV-2; Smoking; Tobacco","Mansour","Ossama","Department of Otolaryngology, Head and Neck Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"1111","34182960","10.1186/s12889-021-11290-x","SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers.","Smoking negatively impacts COVID-19 severity and adverse outcomes. Evidence on whether smoking is associated with SARS-Co-V2 infection and having a positive test is scarce, particularly from low-and middle-income countries, where most of the world's billion smokers live. The inconsistency in relevant findings calls for study designs and analyses to account for possible confounders including background characteristics and pre-existing co-morbidities, to disentangle the specific effect of smoking.","2021","07","01","BMC Public Health","BMC public health","COVID-19; Cohort; Egypt; Healthcare workers; Nicotine; SARS-co-V2; Smoking; Tobacco; COVID-19; Cohort Studies; Egypt; Health Personnel; Humans; Nicotine; Prospective Studies; SARS-CoV-2; Smoking; Tobacco","Girgis","Samia","Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"1112","34182960","10.1186/s12889-021-11290-x","SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers.","Smoking negatively impacts COVID-19 severity and adverse outcomes. Evidence on whether smoking is associated with SARS-Co-V2 infection and having a positive test is scarce, particularly from low-and middle-income countries, where most of the world's billion smokers live. The inconsistency in relevant findings calls for study designs and analyses to account for possible confounders including background characteristics and pre-existing co-morbidities, to disentangle the specific effect of smoking.","2021","07","01","BMC Public Health","BMC public health","COVID-19; Cohort; Egypt; Healthcare workers; Nicotine; SARS-co-V2; Smoking; Tobacco; COVID-19; Cohort Studies; Egypt; Health Personnel; Humans; Nicotine; Prospective Studies; SARS-CoV-2; Smoking; Tobacco","Hafez","Hala","Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"1113","34182960","10.1186/s12889-021-11290-x","SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers.","Smoking negatively impacts COVID-19 severity and adverse outcomes. Evidence on whether smoking is associated with SARS-Co-V2 infection and having a positive test is scarce, particularly from low-and middle-income countries, where most of the world's billion smokers live. The inconsistency in relevant findings calls for study designs and analyses to account for possible confounders including background characteristics and pre-existing co-morbidities, to disentangle the specific effect of smoking.","2021","07","01","BMC Public Health","BMC public health","COVID-19; Cohort; Egypt; Healthcare workers; Nicotine; SARS-co-V2; Smoking; Tobacco; COVID-19; Cohort Studies; Egypt; Health Personnel; Humans; Nicotine; Prospective Studies; SARS-CoV-2; Smoking; Tobacco","Kandil","Sahar","Department of Community, Environmental, and Occupational Medicine, Faculty of Medicine, Ain Shams University, 38 Ramses st., Abbassia square, PO-box 11566, Cairo, Egypt",NA
"1114","34182946","10.1186/s12871-021-01396-5","Lung ultrasound predicts clinical course but not outcome in COVID-19 ICU patients: a retrospective single-center analysis.","Point-of-care lung ultrasound (LU) is an established tool in the first assessment of patients with coronavirus disease (COVID-19). Purpose of this study was to evaluate the value of lung ultrasound in COVID-19 intensive care unit (ICU) patients in predicting clinical course and outcome. We analyzed lung ultrasound score (LUS) of all COVID-19 patients admitted from March 2020 to December 2020 to the Internal Intensive Care Unit, Ludwig-Maximilians-University (LMU) of Munich. LU was performed acco","2021","07","07","BMC Anesthesiol","BMC anesthesiology","COVID-19; Clinical course; Deterioration; Lung ultrasound; Lung ultrasound score; Outcome; Aged; COVID-19; Critical Care; Female; Germany; Humans; Lung; Male; Middle Aged; Point-of-Care Testing; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Ultrasonography","Stecher","Stephanie-Susanne","Medical Department II, LMU Hospital Munich, Marchioninistr. 15, 81377, Munich, Germany. StephanieSusanne.Stecher@med.uni-muenchen","StephanieSusanne.Stecher@med.uni"
"1115","34182946","10.1186/s12871-021-01396-5","Lung ultrasound predicts clinical course but not outcome in COVID-19 ICU patients: a retrospective single-center analysis.","Point-of-care lung ultrasound (LU) is an established tool in the first assessment of patients with coronavirus disease (COVID-19). Purpose of this study was to evaluate the value of lung ultrasound in COVID-19 intensive care unit (ICU) patients in predicting clinical course and outcome. We analyzed lung ultrasound score (LUS) of all COVID-19 patients admitted from March 2020 to December 2020 to the Internal Intensive Care Unit, Ludwig-Maximilians-University (LMU) of Munich. LU was performed acco","2021","07","07","BMC Anesthesiol","BMC anesthesiology","COVID-19; Clinical course; Deterioration; Lung ultrasound; Lung ultrasound score; Outcome; Aged; COVID-19; Critical Care; Female; Germany; Humans; Lung; Male; Middle Aged; Point-of-Care Testing; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Ultrasonography","Anton","Sofia","Medical Department II, LMU Hospital Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1116","34182946","10.1186/s12871-021-01396-5","Lung ultrasound predicts clinical course but not outcome in COVID-19 ICU patients: a retrospective single-center analysis.","Point-of-care lung ultrasound (LU) is an established tool in the first assessment of patients with coronavirus disease (COVID-19). Purpose of this study was to evaluate the value of lung ultrasound in COVID-19 intensive care unit (ICU) patients in predicting clinical course and outcome. We analyzed lung ultrasound score (LUS) of all COVID-19 patients admitted from March 2020 to December 2020 to the Internal Intensive Care Unit, Ludwig-Maximilians-University (LMU) of Munich. LU was performed acco","2021","07","07","BMC Anesthesiol","BMC anesthesiology","COVID-19; Clinical course; Deterioration; Lung ultrasound; Lung ultrasound score; Outcome; Aged; COVID-19; Critical Care; Female; Germany; Humans; Lung; Male; Middle Aged; Point-of-Care Testing; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Ultrasonography","Fraccaroli","Alessia","Medical Department III, LMU Hospital Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1117","34182946","10.1186/s12871-021-01396-5","Lung ultrasound predicts clinical course but not outcome in COVID-19 ICU patients: a retrospective single-center analysis.","Point-of-care lung ultrasound (LU) is an established tool in the first assessment of patients with coronavirus disease (COVID-19). Purpose of this study was to evaluate the value of lung ultrasound in COVID-19 intensive care unit (ICU) patients in predicting clinical course and outcome. We analyzed lung ultrasound score (LUS) of all COVID-19 patients admitted from March 2020 to December 2020 to the Internal Intensive Care Unit, Ludwig-Maximilians-University (LMU) of Munich. LU was performed acco","2021","07","07","BMC Anesthesiol","BMC anesthesiology","COVID-19; Clinical course; Deterioration; Lung ultrasound; Lung ultrasound score; Outcome; Aged; COVID-19; Critical Care; Female; Germany; Humans; Lung; Male; Middle Aged; Point-of-Care Testing; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Ultrasonography","Götschke","Jeremias","Medical Department V, LMU Hospital Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1118","34182946","10.1186/s12871-021-01396-5","Lung ultrasound predicts clinical course but not outcome in COVID-19 ICU patients: a retrospective single-center analysis.","Point-of-care lung ultrasound (LU) is an established tool in the first assessment of patients with coronavirus disease (COVID-19). Purpose of this study was to evaluate the value of lung ultrasound in COVID-19 intensive care unit (ICU) patients in predicting clinical course and outcome. We analyzed lung ultrasound score (LUS) of all COVID-19 patients admitted from March 2020 to December 2020 to the Internal Intensive Care Unit, Ludwig-Maximilians-University (LMU) of Munich. LU was performed acco","2021","07","07","BMC Anesthesiol","BMC anesthesiology","COVID-19; Clinical course; Deterioration; Lung ultrasound; Lung ultrasound score; Outcome; Aged; COVID-19; Critical Care; Female; Germany; Humans; Lung; Male; Middle Aged; Point-of-Care Testing; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Ultrasonography","Stemmler","Hans Joachim","Medical Department III, LMU Hospital Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1119","34182946","10.1186/s12871-021-01396-5","Lung ultrasound predicts clinical course but not outcome in COVID-19 ICU patients: a retrospective single-center analysis.","Point-of-care lung ultrasound (LU) is an established tool in the first assessment of patients with coronavirus disease (COVID-19). Purpose of this study was to evaluate the value of lung ultrasound in COVID-19 intensive care unit (ICU) patients in predicting clinical course and outcome. We analyzed lung ultrasound score (LUS) of all COVID-19 patients admitted from March 2020 to December 2020 to the Internal Intensive Care Unit, Ludwig-Maximilians-University (LMU) of Munich. LU was performed acco","2021","07","07","BMC Anesthesiol","BMC anesthesiology","COVID-19; Clinical course; Deterioration; Lung ultrasound; Lung ultrasound score; Outcome; Aged; COVID-19; Critical Care; Female; Germany; Humans; Lung; Male; Middle Aged; Point-of-Care Testing; Predictive Value of Tests; Prognosis; Retrospective Studies; SARS-CoV-2; Ultrasonography","Barnikel","Michaela","Medical Department V, LMU Hospital Munich, Marchioninistr. 15, 81377, Munich, Germany",NA
"1120","34182927","10.1186/s12873-021-00464-w","Emergency department reorganisation to cope with COVID-19 outbreak in Milan university hospital: a time-sensitive challenge.","In March 2020 we faced a huge spread of the epidemic of SARS-CoV2 in northern Italy; the Emergency Departments (ED) and the Emergency Medical Services (EMS) were overwhelmed by patients requiring care. The hospitals were forced to reorganize their services, and the ED was the focal point of this challenge. As Emergency Department in a metropolitan area of the region most affected, we saw an increasing number of patients with COVID-19, and we made some structural and staff implementations accordi","2021","07","13","BMC Emerg Med","BMC emergency medicine","COVID-19; Emergency department; Management; COVID-19; Disease Outbreaks; Emergency Service, Hospital; Hospitals, University; Humans; Italy; Urban Health Services","Jachetti","A","UOC Pronto Soccorso e Medicina d'Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. alessandro.jachetti@policlinico.mi","alessandro.jachetti@policlinico.mi.it"
"1121","34182927","10.1186/s12873-021-00464-w","Emergency department reorganisation to cope with COVID-19 outbreak in Milan university hospital: a time-sensitive challenge.","In March 2020 we faced a huge spread of the epidemic of SARS-CoV2 in northern Italy; the Emergency Departments (ED) and the Emergency Medical Services (EMS) were overwhelmed by patients requiring care. The hospitals were forced to reorganize their services, and the ED was the focal point of this challenge. As Emergency Department in a metropolitan area of the region most affected, we saw an increasing number of patients with COVID-19, and we made some structural and staff implementations accordi","2021","07","13","BMC Emerg Med","BMC emergency medicine","COVID-19; Emergency department; Management; COVID-19; Disease Outbreaks; Emergency Service, Hospital; Hospitals, University; Humans; Italy; Urban Health Services","Colombo","G","UOC Pronto Soccorso e Medicina d'Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"1122","34182927","10.1186/s12873-021-00464-w","Emergency department reorganisation to cope with COVID-19 outbreak in Milan university hospital: a time-sensitive challenge.","In March 2020 we faced a huge spread of the epidemic of SARS-CoV2 in northern Italy; the Emergency Departments (ED) and the Emergency Medical Services (EMS) were overwhelmed by patients requiring care. The hospitals were forced to reorganize their services, and the ED was the focal point of this challenge. As Emergency Department in a metropolitan area of the region most affected, we saw an increasing number of patients with COVID-19, and we made some structural and staff implementations accordi","2021","07","13","BMC Emerg Med","BMC emergency medicine","COVID-19; Emergency department; Management; COVID-19; Disease Outbreaks; Emergency Service, Hospital; Hospitals, University; Humans; Italy; Urban Health Services","Brignolo-Ottolini","B","UOC Pronto Soccorso e Medicina d'Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"1123","34182927","10.1186/s12873-021-00464-w","Emergency department reorganisation to cope with COVID-19 outbreak in Milan university hospital: a time-sensitive challenge.","In March 2020 we faced a huge spread of the epidemic of SARS-CoV2 in northern Italy; the Emergency Departments (ED) and the Emergency Medical Services (EMS) were overwhelmed by patients requiring care. The hospitals were forced to reorganize their services, and the ED was the focal point of this challenge. As Emergency Department in a metropolitan area of the region most affected, we saw an increasing number of patients with COVID-19, and we made some structural and staff implementations accordi","2021","07","13","BMC Emerg Med","BMC emergency medicine","COVID-19; Emergency department; Management; COVID-19; Disease Outbreaks; Emergency Service, Hospital; Hospitals, University; Humans; Italy; Urban Health Services","Franchi","J","UOC Pronto Soccorso e Medicina d'Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"1124","34182927","10.1186/s12873-021-00464-w","Emergency department reorganisation to cope with COVID-19 outbreak in Milan university hospital: a time-sensitive challenge.","In March 2020 we faced a huge spread of the epidemic of SARS-CoV2 in northern Italy; the Emergency Departments (ED) and the Emergency Medical Services (EMS) were overwhelmed by patients requiring care. The hospitals were forced to reorganize their services, and the ED was the focal point of this challenge. As Emergency Department in a metropolitan area of the region most affected, we saw an increasing number of patients with COVID-19, and we made some structural and staff implementations accordi","2021","07","13","BMC Emerg Med","BMC emergency medicine","COVID-19; Emergency department; Management; COVID-19; Disease Outbreaks; Emergency Service, Hospital; Hospitals, University; Humans; Italy; Urban Health Services","Solbiati","M","UOC Pronto Soccorso e Medicina d'Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"1125","34182927","10.1186/s12873-021-00464-w","Emergency department reorganisation to cope with COVID-19 outbreak in Milan university hospital: a time-sensitive challenge.","In March 2020 we faced a huge spread of the epidemic of SARS-CoV2 in northern Italy; the Emergency Departments (ED) and the Emergency Medical Services (EMS) were overwhelmed by patients requiring care. The hospitals were forced to reorganize their services, and the ED was the focal point of this challenge. As Emergency Department in a metropolitan area of the region most affected, we saw an increasing number of patients with COVID-19, and we made some structural and staff implementations accordi","2021","07","13","BMC Emerg Med","BMC emergency medicine","COVID-19; Emergency department; Management; COVID-19; Disease Outbreaks; Emergency Service, Hospital; Hospitals, University; Humans; Italy; Urban Health Services","Pecorino Meli","M","UOC Pronto Soccorso e Medicina d'Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"1126","34182927","10.1186/s12873-021-00464-w","Emergency department reorganisation to cope with COVID-19 outbreak in Milan university hospital: a time-sensitive challenge.","In March 2020 we faced a huge spread of the epidemic of SARS-CoV2 in northern Italy; the Emergency Departments (ED) and the Emergency Medical Services (EMS) were overwhelmed by patients requiring care. The hospitals were forced to reorganize their services, and the ED was the focal point of this challenge. As Emergency Department in a metropolitan area of the region most affected, we saw an increasing number of patients with COVID-19, and we made some structural and staff implementations accordi","2021","07","13","BMC Emerg Med","BMC emergency medicine","COVID-19; Emergency department; Management; COVID-19; Disease Outbreaks; Emergency Service, Hospital; Hospitals, University; Humans; Italy; Urban Health Services","Bosco","P","UOC Pronto Soccorso e Medicina d'Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"1127","34182927","10.1186/s12873-021-00464-w","Emergency department reorganisation to cope with COVID-19 outbreak in Milan university hospital: a time-sensitive challenge.","In March 2020 we faced a huge spread of the epidemic of SARS-CoV2 in northern Italy; the Emergency Departments (ED) and the Emergency Medical Services (EMS) were overwhelmed by patients requiring care. The hospitals were forced to reorganize their services, and the ED was the focal point of this challenge. As Emergency Department in a metropolitan area of the region most affected, we saw an increasing number of patients with COVID-19, and we made some structural and staff implementations accordi","2021","07","13","BMC Emerg Med","BMC emergency medicine","COVID-19; Emergency department; Management; COVID-19; Disease Outbreaks; Emergency Service, Hospital; Hospitals, University; Humans; Italy; Urban Health Services","Costantino","G","UOC Pronto Soccorso e Medicina d'Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"1128","34182912","10.2174/1573405617666210628161017","Chemotherapy-Induced Pulmonary Toxicity Mimicking COVID-19 Pneumonia.","COVID-19 generally affects the lungs by causing pneumonic infiltration. Typical computed tomography (CT) findings are bilateral, multifocal, peripheral, and patchy ground-glass opacities. These CT findings can also be seen in drug toxicities. Rapid and accurate differential diagnosis of COVID-19 pneumonia from chemotherapy-induced pulmonary toxicity (CPT) is essential because the treatment strategies are different. In this case report, we define the clinical and lung CT findings of two cases of ","2021","06","29","Curr Med Imaging","Current medical imaging","COVID-19; chemotherapy; computed tomography; diagnosis; lung; toxicity","Karasu","Sebnem","Katip Celebi University Ataturk Training and Research Hospital, Department of Radiology, Turkey",NA
"1129","34182912","10.2174/1573405617666210628161017","Chemotherapy-Induced Pulmonary Toxicity Mimicking COVID-19 Pneumonia.","COVID-19 generally affects the lungs by causing pneumonic infiltration. Typical computed tomography (CT) findings are bilateral, multifocal, peripheral, and patchy ground-glass opacities. These CT findings can also be seen in drug toxicities. Rapid and accurate differential diagnosis of COVID-19 pneumonia from chemotherapy-induced pulmonary toxicity (CPT) is essential because the treatment strategies are different. In this case report, we define the clinical and lung CT findings of two cases of ","2021","06","29","Curr Med Imaging","Current medical imaging","COVID-19; chemotherapy; computed tomography; diagnosis; lung; toxicity","Sinci","Kazim Ayberk","Katip Celebi University Ataturk Education and Research Hospital, Department of Radiology, Basin sitesi, Karabaglar, Izmir, Turkey",NA
"1130","34182912","10.2174/1573405617666210628161017","Chemotherapy-Induced Pulmonary Toxicity Mimicking COVID-19 Pneumonia.","COVID-19 generally affects the lungs by causing pneumonic infiltration. Typical computed tomography (CT) findings are bilateral, multifocal, peripheral, and patchy ground-glass opacities. These CT findings can also be seen in drug toxicities. Rapid and accurate differential diagnosis of COVID-19 pneumonia from chemotherapy-induced pulmonary toxicity (CPT) is essential because the treatment strategies are different. In this case report, we define the clinical and lung CT findings of two cases of ","2021","06","29","Curr Med Imaging","Current medical imaging","COVID-19; chemotherapy; computed tomography; diagnosis; lung; toxicity","Yildiz","Yasar","Katip Celebi University Ataturk Training and Research Hospital, Department of Medical Oncology, Turkey",NA
"1131","34182912","10.2174/1573405617666210628161017","Chemotherapy-Induced Pulmonary Toxicity Mimicking COVID-19 Pneumonia.","COVID-19 generally affects the lungs by causing pneumonic infiltration. Typical computed tomography (CT) findings are bilateral, multifocal, peripheral, and patchy ground-glass opacities. These CT findings can also be seen in drug toxicities. Rapid and accurate differential diagnosis of COVID-19 pneumonia from chemotherapy-induced pulmonary toxicity (CPT) is essential because the treatment strategies are different. In this case report, we define the clinical and lung CT findings of two cases of ","2021","06","29","Curr Med Imaging","Current medical imaging","COVID-19; chemotherapy; computed tomography; diagnosis; lung; toxicity","Gumus","Cesur","Katip Celebi University Ataturk Training and Research Hospital, Department of Radiology, Turkey",NA
"1132","34182912","10.2174/1573405617666210628161017","Chemotherapy-Induced Pulmonary Toxicity Mimicking COVID-19 Pneumonia.","COVID-19 generally affects the lungs by causing pneumonic infiltration. Typical computed tomography (CT) findings are bilateral, multifocal, peripheral, and patchy ground-glass opacities. These CT findings can also be seen in drug toxicities. Rapid and accurate differential diagnosis of COVID-19 pneumonia from chemotherapy-induced pulmonary toxicity (CPT) is essential because the treatment strategies are different. In this case report, we define the clinical and lung CT findings of two cases of ","2021","06","29","Curr Med Imaging","Current medical imaging","COVID-19; chemotherapy; computed tomography; diagnosis; lung; toxicity","Tosun","Ozgur","Katip Celebi University Ataturk Training and Research Hospital, Department of Radiology, Turkey",NA
"1133","34182897","10.1080/19371918.2021.1932664","Knowledge, Attitudes and Practices (KAP) regarding the Novel Coronavirus Disease (COVID-19) Post-lockdown in Trinidad and Tobago.","The Novel Coronavirus Disease (COVID-19) was declared a pandemic by the World Health Organization (WHO) in March 2020. Trinidad and Tobago reported its first infection on March 12<sup>th</sup> 2020. This study assessed knowledge, attitudes and practices toward COVID-19 among Trinidadians during the post-lockdown period. A validated questionnaire was used to conduct a cross-sectional survey from May 25<sup>th</sup> to June 6<sup>th</sup> 2020.Most respondents (512, 96.6%) knew that COVID-19 is hi","2021","07","19","Soc Work Public Health","Social work in public health","Attitudes; COVID-19; KAP; Knowledge; Novel Coronavirus; Practices; Trinidad And Tobago; COVID-19; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Humans; Quarantine; Surveys and Questionnaires; Trinidad and Tobago","Selby","Lori","Department of Foundations and Prior Learning, The University of Trinidad and Tobago, Point Lisas, Trinidad and Tobago",NA
"1134","34182897","10.1080/19371918.2021.1932664","Knowledge, Attitudes and Practices (KAP) regarding the Novel Coronavirus Disease (COVID-19) Post-lockdown in Trinidad and Tobago.","The Novel Coronavirus Disease (COVID-19) was declared a pandemic by the World Health Organization (WHO) in March 2020. Trinidad and Tobago reported its first infection on March 12<sup>th</sup> 2020. This study assessed knowledge, attitudes and practices toward COVID-19 among Trinidadians during the post-lockdown period. A validated questionnaire was used to conduct a cross-sectional survey from May 25<sup>th</sup> to June 6<sup>th</sup> 2020.Most respondents (512, 96.6%) knew that COVID-19 is hi","2021","07","19","Soc Work Public Health","Social work in public health","Attitudes; COVID-19; KAP; Knowledge; Novel Coronavirus; Practices; Trinidad And Tobago; COVID-19; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Humans; Quarantine; Surveys and Questionnaires; Trinidad and Tobago","Tripathi","Vrijesh","Department of Mathematics and Statistics, Faculty of Science and Technology, The University of the West Indies, St. Augustine, Trinidad and Tobago",NA
"1135","34182897","10.1080/19371918.2021.1932664","Knowledge, Attitudes and Practices (KAP) regarding the Novel Coronavirus Disease (COVID-19) Post-lockdown in Trinidad and Tobago.","The Novel Coronavirus Disease (COVID-19) was declared a pandemic by the World Health Organization (WHO) in March 2020. Trinidad and Tobago reported its first infection on March 12<sup>th</sup> 2020. This study assessed knowledge, attitudes and practices toward COVID-19 among Trinidadians during the post-lockdown period. A validated questionnaire was used to conduct a cross-sectional survey from May 25<sup>th</sup> to June 6<sup>th</sup> 2020.Most respondents (512, 96.6%) knew that COVID-19 is hi","2021","07","19","Soc Work Public Health","Social work in public health","Attitudes; COVID-19; KAP; Knowledge; Novel Coronavirus; Practices; Trinidad And Tobago; COVID-19; Cross-Sectional Studies; Health Knowledge, Attitudes, Practice; Humans; Quarantine; Surveys and Questionnaires; Trinidad and Tobago","Hariharan","Seetharaman","Department of Clinical Surgical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago",NA
"1136","34182892","10.1080/17513758.2021.1946177","Effects of social-distancing on infectious disease dynamics: an evolutionary game theory and economic perspective.","We propose two models inspired by the COVID-19 pandemic: a coupled disease-human behaviour (or disease-game theoretic), and a coupled disease-human behaviour-economic model, both of which account for the impact of social-distancing on disease control and economic growth. The models exhibit rich dynamical behaviour including multistable equilibria, a backward bifurcation, and sustained bounded periodic oscillations. Analyses of the first model suggests that the disease can be eliminated if everyb","2021","07","07","J Biol Dyn","Journal of biological dynamics","34K20; 49K20; 92B05; COVID-19; SARS-CoV-2; economic modelling; epidemic modelling; game theory; COVID-19; Communicable Diseases, Emerging; Game Theory; Humans; Pandemics; Physical Distancing","Martcheva","Maia","Department of Mathematics, University of Florida, Gainesville, FL, USA",NA
"1137","34182892","10.1080/17513758.2021.1946177","Effects of social-distancing on infectious disease dynamics: an evolutionary game theory and economic perspective.","We propose two models inspired by the COVID-19 pandemic: a coupled disease-human behaviour (or disease-game theoretic), and a coupled disease-human behaviour-economic model, both of which account for the impact of social-distancing on disease control and economic growth. The models exhibit rich dynamical behaviour including multistable equilibria, a backward bifurcation, and sustained bounded periodic oscillations. Analyses of the first model suggests that the disease can be eliminated if everyb","2021","07","07","J Biol Dyn","Journal of biological dynamics","34K20; 49K20; 92B05; COVID-19; SARS-CoV-2; economic modelling; epidemic modelling; game theory; COVID-19; Communicable Diseases, Emerging; Game Theory; Humans; Pandemics; Physical Distancing","Tuncer","Necibe","Department of Mathematics, Florida Atlantic University, Boca Raton, FL, USA",NA
"1138","34182892","10.1080/17513758.2021.1946177","Effects of social-distancing on infectious disease dynamics: an evolutionary game theory and economic perspective.","We propose two models inspired by the COVID-19 pandemic: a coupled disease-human behaviour (or disease-game theoretic), and a coupled disease-human behaviour-economic model, both of which account for the impact of social-distancing on disease control and economic growth. The models exhibit rich dynamical behaviour including multistable equilibria, a backward bifurcation, and sustained bounded periodic oscillations. Analyses of the first model suggests that the disease can be eliminated if everyb","2021","07","07","J Biol Dyn","Journal of biological dynamics","34K20; 49K20; 92B05; COVID-19; SARS-CoV-2; economic modelling; epidemic modelling; game theory; COVID-19; Communicable Diseases, Emerging; Game Theory; Humans; Pandemics; Physical Distancing","Ngonghala","Calistus N","Department of Mathematics, University of Florida, Gainesville, FL, USA",NA
"1139","34182891","10.1080/14739879.2021.1920475","Virtual teaching of undergraduate primary care small groups during Covid-19.","The impact of the COVID-19 pandemic required Higher Educational Institutions to redesign and implement new ways of delivering core-learning outcomes for medical students. Much of this change resulted in a transition to virtual teaching across medical schools. Medical education in primary care is often delivered as part of GP-facilitated small group teaching and with this came unique challenges for the transition to online education.Transition to virtual small group teaching utilised blended lear","2021","06","29","Educ Prim Care","Education for primary care : an official publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors","MESH terms; blended curriculum; flipped classroom; medical education; primary care education; small group teaching; virtual teaching","Patel","Bakula","Division of Primary Care, Medical SchoolUniversity of Nottingham, Nottingham, UK",NA
"1140","34182891","10.1080/14739879.2021.1920475","Virtual teaching of undergraduate primary care small groups during Covid-19.","The impact of the COVID-19 pandemic required Higher Educational Institutions to redesign and implement new ways of delivering core-learning outcomes for medical students. Much of this change resulted in a transition to virtual teaching across medical schools. Medical education in primary care is often delivered as part of GP-facilitated small group teaching and with this came unique challenges for the transition to online education.Transition to virtual small group teaching utilised blended lear","2021","06","29","Educ Prim Care","Education for primary care : an official publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors","MESH terms; blended curriculum; flipped classroom; medical education; primary care education; small group teaching; virtual teaching","Taggar","Jaspal S","Division of Primary Care, Medical SchoolUniversity of Nottingham, Nottingham, UK",NA
"1141","34182889","10.1080/07391102.2021.1944909","<i>In silico</i> screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2.","Due to the unavailability specific drugs or vaccines (FDA approved) that can cure COVID-19, the development of potent antiviral drug candidates/therapeutic molecules against COVID-19 is urgently required. This study was aimed at in silico screening and study of polyphenolic phytochemical compounds in a rational way by virtual screening, molecular docking and molecular dynamics studies against SARS-CoV-2 main protease (Mpro) and papain-like protease (PLpro) enzymes. The objective of the st","2021","06","29","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","MD simulation; SARS-CoV-2; flavonoids; molecular docking; phytomedicine; polyphenolics; protease inhibitors","Rudrapal","Mithun","Rasiklal M. Dhariwal Institute of Pharmaceutical Education and Research, Pune, Maharashtra, India",NA
"1142","34182889","10.1080/07391102.2021.1944909","<i>In silico</i> screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2.","Due to the unavailability specific drugs or vaccines (FDA approved) that can cure COVID-19, the development of potent antiviral drug candidates/therapeutic molecules against COVID-19 is urgently required. This study was aimed at in silico screening and study of polyphenolic phytochemical compounds in a rational way by virtual screening, molecular docking and molecular dynamics studies against SARS-CoV-2 main protease (Mpro) and papain-like protease (PLpro) enzymes. The objective of the st","2021","06","29","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","MD simulation; SARS-CoV-2; flavonoids; molecular docking; phytomedicine; polyphenolics; protease inhibitors","Issahaku","Abdul Rashid","Molecular Bio-Computation and Drug Design Laboratory, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa",NA
"1143","34182889","10.1080/07391102.2021.1944909","<i>In silico</i> screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2.","Due to the unavailability specific drugs or vaccines (FDA approved) that can cure COVID-19, the development of potent antiviral drug candidates/therapeutic molecules against COVID-19 is urgently required. This study was aimed at in silico screening and study of polyphenolic phytochemical compounds in a rational way by virtual screening, molecular docking and molecular dynamics studies against SARS-CoV-2 main protease (Mpro) and papain-like protease (PLpro) enzymes. The objective of the st","2021","06","29","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","MD simulation; SARS-CoV-2; flavonoids; molecular docking; phytomedicine; polyphenolics; protease inhibitors","Agoni","Clement","Molecular Bio-Computation and Drug Design Laboratory, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa",NA
"1144","34182889","10.1080/07391102.2021.1944909","<i>In silico</i> screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2.","Due to the unavailability specific drugs or vaccines (FDA approved) that can cure COVID-19, the development of potent antiviral drug candidates/therapeutic molecules against COVID-19 is urgently required. This study was aimed at in silico screening and study of polyphenolic phytochemical compounds in a rational way by virtual screening, molecular docking and molecular dynamics studies against SARS-CoV-2 main protease (Mpro) and papain-like protease (PLpro) enzymes. The objective of the st","2021","06","29","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","MD simulation; SARS-CoV-2; flavonoids; molecular docking; phytomedicine; polyphenolics; protease inhibitors","Bendale","Atul R","Sandip Institute of Pharmaceutical Sciences, Nashik, Maharashtra, India",NA
"1145","34182889","10.1080/07391102.2021.1944909","<i>In silico</i> screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2.","Due to the unavailability specific drugs or vaccines (FDA approved) that can cure COVID-19, the development of potent antiviral drug candidates/therapeutic molecules against COVID-19 is urgently required. This study was aimed at in silico screening and study of polyphenolic phytochemical compounds in a rational way by virtual screening, molecular docking and molecular dynamics studies against SARS-CoV-2 main protease (Mpro) and papain-like protease (PLpro) enzymes. The objective of the st","2021","06","29","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","MD simulation; SARS-CoV-2; flavonoids; molecular docking; phytomedicine; polyphenolics; protease inhibitors","Nagar","Akhil","R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra, India",NA
"1146","34182889","10.1080/07391102.2021.1944909","<i>In silico</i> screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2.","Due to the unavailability specific drugs or vaccines (FDA approved) that can cure COVID-19, the development of potent antiviral drug candidates/therapeutic molecules against COVID-19 is urgently required. This study was aimed at in silico screening and study of polyphenolic phytochemical compounds in a rational way by virtual screening, molecular docking and molecular dynamics studies against SARS-CoV-2 main protease (Mpro) and papain-like protease (PLpro) enzymes. The objective of the st","2021","06","29","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","MD simulation; SARS-CoV-2; flavonoids; molecular docking; phytomedicine; polyphenolics; protease inhibitors","Soliman","Mahmoud E S","Molecular Bio-Computation and Drug Design Laboratory, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa",NA
"1147","34182889","10.1080/07391102.2021.1944909","<i>In silico</i> screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2.","Due to the unavailability specific drugs or vaccines (FDA approved) that can cure COVID-19, the development of potent antiviral drug candidates/therapeutic molecules against COVID-19 is urgently required. This study was aimed at in silico screening and study of polyphenolic phytochemical compounds in a rational way by virtual screening, molecular docking and molecular dynamics studies against SARS-CoV-2 main protease (Mpro) and papain-like protease (PLpro) enzymes. The objective of the st","2021","06","29","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","MD simulation; SARS-CoV-2; flavonoids; molecular docking; phytomedicine; polyphenolics; protease inhibitors","Lokwani","Deepak","R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra, India",NA
"1148","34182881","10.1080/23744235.2021.1945675","N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study.","N-acetyl-cysteine (NAC) has been previously shown to exert beneficial effects in diverse respiratory diseases, through antioxidant and anti-inflammatory actions. Our aim was to evaluate NAC potential impact in hospitalised patients with COVID-19 pneumonia, in terms of progression to severe respiratory failure (SRF) and mortality. This retrospective, two-centre cohort study included consecutive patients hospitalised with moderate or severe COVID-19 pneumonia. Patients who received standard of car","2021","06","29","Infect Dis (Lond)","Infectious diseases (London, England)","ARDS; COVID-19; N-acetyl-cysteine; antioxidant; mortality; pneumonia","Assimakopoulos","Stelios F","Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1149","34182881","10.1080/23744235.2021.1945675","N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study.","N-acetyl-cysteine (NAC) has been previously shown to exert beneficial effects in diverse respiratory diseases, through antioxidant and anti-inflammatory actions. Our aim was to evaluate NAC potential impact in hospitalised patients with COVID-19 pneumonia, in terms of progression to severe respiratory failure (SRF) and mortality. This retrospective, two-centre cohort study included consecutive patients hospitalised with moderate or severe COVID-19 pneumonia. Patients who received standard of car","2021","06","29","Infect Dis (Lond)","Infectious diseases (London, England)","ARDS; COVID-19; N-acetyl-cysteine; antioxidant; mortality; pneumonia","Aretha","Diamanto","Department of Anesthesiology and Intensive Care Medicine, University of Patras Medical School, Patras, Greece",NA
"1150","34182881","10.1080/23744235.2021.1945675","N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study.","N-acetyl-cysteine (NAC) has been previously shown to exert beneficial effects in diverse respiratory diseases, through antioxidant and anti-inflammatory actions. Our aim was to evaluate NAC potential impact in hospitalised patients with COVID-19 pneumonia, in terms of progression to severe respiratory failure (SRF) and mortality. This retrospective, two-centre cohort study included consecutive patients hospitalised with moderate or severe COVID-19 pneumonia. Patients who received standard of car","2021","06","29","Infect Dis (Lond)","Infectious diseases (London, England)","ARDS; COVID-19; N-acetyl-cysteine; antioxidant; mortality; pneumonia","Komninos","Dimitris","Department of Internal Medicine, ""St Andrews"" State General Hospital, Patras, Greece",NA
"1151","34182881","10.1080/23744235.2021.1945675","N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study.","N-acetyl-cysteine (NAC) has been previously shown to exert beneficial effects in diverse respiratory diseases, through antioxidant and anti-inflammatory actions. Our aim was to evaluate NAC potential impact in hospitalised patients with COVID-19 pneumonia, in terms of progression to severe respiratory failure (SRF) and mortality. This retrospective, two-centre cohort study included consecutive patients hospitalised with moderate or severe COVID-19 pneumonia. Patients who received standard of car","2021","06","29","Infect Dis (Lond)","Infectious diseases (London, England)","ARDS; COVID-19; N-acetyl-cysteine; antioxidant; mortality; pneumonia","Dimitropoulou","Dimitra","Department of Internal Medicine, ""St Andrews"" State General Hospital, Patras, Greece",NA
"1152","34182881","10.1080/23744235.2021.1945675","N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study.","N-acetyl-cysteine (NAC) has been previously shown to exert beneficial effects in diverse respiratory diseases, through antioxidant and anti-inflammatory actions. Our aim was to evaluate NAC potential impact in hospitalised patients with COVID-19 pneumonia, in terms of progression to severe respiratory failure (SRF) and mortality. This retrospective, two-centre cohort study included consecutive patients hospitalised with moderate or severe COVID-19 pneumonia. Patients who received standard of car","2021","06","29","Infect Dis (Lond)","Infectious diseases (London, England)","ARDS; COVID-19; N-acetyl-cysteine; antioxidant; mortality; pneumonia","Lagadinou","Maria","Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1153","34182881","10.1080/23744235.2021.1945675","N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study.","N-acetyl-cysteine (NAC) has been previously shown to exert beneficial effects in diverse respiratory diseases, through antioxidant and anti-inflammatory actions. Our aim was to evaluate NAC potential impact in hospitalised patients with COVID-19 pneumonia, in terms of progression to severe respiratory failure (SRF) and mortality. This retrospective, two-centre cohort study included consecutive patients hospitalised with moderate or severe COVID-19 pneumonia. Patients who received standard of car","2021","06","29","Infect Dis (Lond)","Infectious diseases (London, England)","ARDS; COVID-19; N-acetyl-cysteine; antioxidant; mortality; pneumonia","Leonidou","Lydia","Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1154","34182881","10.1080/23744235.2021.1945675","N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study.","N-acetyl-cysteine (NAC) has been previously shown to exert beneficial effects in diverse respiratory diseases, through antioxidant and anti-inflammatory actions. Our aim was to evaluate NAC potential impact in hospitalised patients with COVID-19 pneumonia, in terms of progression to severe respiratory failure (SRF) and mortality. This retrospective, two-centre cohort study included consecutive patients hospitalised with moderate or severe COVID-19 pneumonia. Patients who received standard of car","2021","06","29","Infect Dis (Lond)","Infectious diseases (London, England)","ARDS; COVID-19; N-acetyl-cysteine; antioxidant; mortality; pneumonia","Oikonomou","Ioanna","Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1155","34182881","10.1080/23744235.2021.1945675","N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study.","N-acetyl-cysteine (NAC) has been previously shown to exert beneficial effects in diverse respiratory diseases, through antioxidant and anti-inflammatory actions. Our aim was to evaluate NAC potential impact in hospitalised patients with COVID-19 pneumonia, in terms of progression to severe respiratory failure (SRF) and mortality. This retrospective, two-centre cohort study included consecutive patients hospitalised with moderate or severe COVID-19 pneumonia. Patients who received standard of car","2021","06","29","Infect Dis (Lond)","Infectious diseases (London, England)","ARDS; COVID-19; N-acetyl-cysteine; antioxidant; mortality; pneumonia","Mouzaki","Athanasia","Division of Hematology, Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1156","34182881","10.1080/23744235.2021.1945675","N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study.","N-acetyl-cysteine (NAC) has been previously shown to exert beneficial effects in diverse respiratory diseases, through antioxidant and anti-inflammatory actions. Our aim was to evaluate NAC potential impact in hospitalised patients with COVID-19 pneumonia, in terms of progression to severe respiratory failure (SRF) and mortality. This retrospective, two-centre cohort study included consecutive patients hospitalised with moderate or severe COVID-19 pneumonia. Patients who received standard of car","2021","06","29","Infect Dis (Lond)","Infectious diseases (London, England)","ARDS; COVID-19; N-acetyl-cysteine; antioxidant; mortality; pneumonia","Marangos","Markos","Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1157","34182880","10.1080/07391102.2021.1942210","Study of potentiality of dexamethasone and its derivatives against Covid-19.","In December 2019, COVID-19 epidemic was reported in Wuhan, China, and subsequently the infection has spread all over the world and became pandemic. The death toll associated with the pandemic is increasing day by day in a high rate. Herein, an effort has been made to identify the potentiality of commercially available drugs and also their probable derivatives for creation of better opportunity to make more powerful drugs against coronavirus. This study involves the in-silico interactions ","2021","06","29","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","COVID 19; binding energy; descriptor parameters; dexamethasone; molecular dynamic simulation","Mitra","Debanjan","Department of Microbiology, Raiganj University, Raiganj, West Bengal, India",NA
"1158","34182880","10.1080/07391102.2021.1942210","Study of potentiality of dexamethasone and its derivatives against Covid-19.","In December 2019, COVID-19 epidemic was reported in Wuhan, China, and subsequently the infection has spread all over the world and became pandemic. The death toll associated with the pandemic is increasing day by day in a high rate. Herein, an effort has been made to identify the potentiality of commercially available drugs and also their probable derivatives for creation of better opportunity to make more powerful drugs against coronavirus. This study involves the in-silico interactions ","2021","06","29","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","COVID 19; binding energy; descriptor parameters; dexamethasone; molecular dynamic simulation","Paul","Manish","Department of Biotechnology, Maharaja Sriram Chandra Bhanja Deo University, Baripada, Odisha, India",NA
"1159","34182880","10.1080/07391102.2021.1942210","Study of potentiality of dexamethasone and its derivatives against Covid-19.","In December 2019, COVID-19 epidemic was reported in Wuhan, China, and subsequently the infection has spread all over the world and became pandemic. The death toll associated with the pandemic is increasing day by day in a high rate. Herein, an effort has been made to identify the potentiality of commercially available drugs and also their probable derivatives for creation of better opportunity to make more powerful drugs against coronavirus. This study involves the in-silico interactions ","2021","06","29","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","COVID 19; binding energy; descriptor parameters; dexamethasone; molecular dynamic simulation","Thatoi","Hrudayanath","Department of Biotechnology, Maharaja Sriram Chandra Bhanja Deo University, Baripada, Odisha, India",NA
"1160","34182880","10.1080/07391102.2021.1942210","Study of potentiality of dexamethasone and its derivatives against Covid-19.","In December 2019, COVID-19 epidemic was reported in Wuhan, China, and subsequently the infection has spread all over the world and became pandemic. The death toll associated with the pandemic is increasing day by day in a high rate. Herein, an effort has been made to identify the potentiality of commercially available drugs and also their probable derivatives for creation of better opportunity to make more powerful drugs against coronavirus. This study involves the in-silico interactions ","2021","06","29","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","COVID 19; binding energy; descriptor parameters; dexamethasone; molecular dynamic simulation","Mohapatra","Pradeep K Das","Department of Microbiology, Raiganj University, Raiganj, West Bengal, India",NA
"1161","34182877","10.1080/09546634.2021.1945655","Future perspectives on care for patients with psoriasis. What did we learn during the COVID-19.",NA,"2021","06","30","J Dermatolog Treat","The Journal of dermatological treatment",NA,"van de Kerkhof","Peter C M","Department of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands",NA
"1162","34182871","10.1080/14767058.2021.1946506","Differences in obstetric healthcare utilization and delivery complications before and after the COVID-19 pandemic - a retrospective study.","To investigate the effect of the COVID-19 pandemic on healthcare utilization related to labor and delivery and to assess the effect of the COVID-19 pandemic on intra-partum and delivery complications. This retrospective study was performed at a university-affiliated, tertiary medical center. It included women admitted to the delivery room from 1 March 2020 to 23 July 2020 during the first wave of the COVID-19 pandemic. They were compared against women who were admitted to the delivery room durin","2021","06","29","J Matern Fetal Neonatal Med","The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians","Birth; COVID-19; SARS-CoV-2; complications; obstetric management; pandemic","Haikin Herzberger","Einat","Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel",NA
"1163","34182871","10.1080/14767058.2021.1946506","Differences in obstetric healthcare utilization and delivery complications before and after the COVID-19 pandemic - a retrospective study.","To investigate the effect of the COVID-19 pandemic on healthcare utilization related to labor and delivery and to assess the effect of the COVID-19 pandemic on intra-partum and delivery complications. This retrospective study was performed at a university-affiliated, tertiary medical center. It included women admitted to the delivery room from 1 March 2020 to 23 July 2020 during the first wave of the COVID-19 pandemic. They were compared against women who were admitted to the delivery room durin","2021","06","29","J Matern Fetal Neonatal Med","The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians","Birth; COVID-19; SARS-CoV-2; complications; obstetric management; pandemic","Efros","Orly","Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1164","34182871","10.1080/14767058.2021.1946506","Differences in obstetric healthcare utilization and delivery complications before and after the COVID-19 pandemic - a retrospective study.","To investigate the effect of the COVID-19 pandemic on healthcare utilization related to labor and delivery and to assess the effect of the COVID-19 pandemic on intra-partum and delivery complications. This retrospective study was performed at a university-affiliated, tertiary medical center. It included women admitted to the delivery room from 1 March 2020 to 23 July 2020 during the first wave of the COVID-19 pandemic. They were compared against women who were admitted to the delivery room durin","2021","06","29","J Matern Fetal Neonatal Med","The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians","Birth; COVID-19; SARS-CoV-2; complications; obstetric management; pandemic","Herzberger","Shai","Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1165","34182871","10.1080/14767058.2021.1946506","Differences in obstetric healthcare utilization and delivery complications before and after the COVID-19 pandemic - a retrospective study.","To investigate the effect of the COVID-19 pandemic on healthcare utilization related to labor and delivery and to assess the effect of the COVID-19 pandemic on intra-partum and delivery complications. This retrospective study was performed at a university-affiliated, tertiary medical center. It included women admitted to the delivery room from 1 March 2020 to 23 July 2020 during the first wave of the COVID-19 pandemic. They were compared against women who were admitted to the delivery room durin","2021","06","29","J Matern Fetal Neonatal Med","The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians","Birth; COVID-19; SARS-CoV-2; complications; obstetric management; pandemic","Biron-Shental","Tal","Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel",NA
"1166","34182871","10.1080/14767058.2021.1946506","Differences in obstetric healthcare utilization and delivery complications before and after the COVID-19 pandemic - a retrospective study.","To investigate the effect of the COVID-19 pandemic on healthcare utilization related to labor and delivery and to assess the effect of the COVID-19 pandemic on intra-partum and delivery complications. This retrospective study was performed at a university-affiliated, tertiary medical center. It included women admitted to the delivery room from 1 March 2020 to 23 July 2020 during the first wave of the COVID-19 pandemic. They were compared against women who were admitted to the delivery room durin","2021","06","29","J Matern Fetal Neonatal Med","The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians","Birth; COVID-19; SARS-CoV-2; complications; obstetric management; pandemic","Shechter-Maor","Gil","Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel",NA
"1167","34182825","10.1089/tmj.2021.0124","Spanish-Speaking Therapists Increasingly Switch to Telepsychology During COVID-19: Networked Virtual Reality May Be Next.","Background: Social distancing restrictions imposed due to the Novel Coronavirus 2019 (COVID-19) pandemic resulted in a rapid shift in the delivery of psychological interventions from in-person to telehealth. Much of the research on this transition has been conducted with English-speaking mental health providers, leaving a gap in understanding related to how this shift has impacted Spanish-speaking treatment providers. Methods: Fifty non-U.S. Spanish-speaking","2021","06","29","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; Spanish-speaking therapists; telehealth; telepsychology; underserved; virtual reality","Sampaio","Mariana","Department of Psychology, University of Coimbra, Coimbra, Portugal",NA
"1168","34182825","10.1089/tmj.2021.0124","Spanish-Speaking Therapists Increasingly Switch to Telepsychology During COVID-19: Networked Virtual Reality May Be Next.","Background: Social distancing restrictions imposed due to the Novel Coronavirus 2019 (COVID-19) pandemic resulted in a rapid shift in the delivery of psychological interventions from in-person to telehealth. Much of the research on this transition has been conducted with English-speaking mental health providers, leaving a gap in understanding related to how this shift has impacted Spanish-speaking treatment providers. Methods: Fifty non-U.S. Spanish-speaking","2021","06","29","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; Spanish-speaking therapists; telehealth; telepsychology; underserved; virtual reality","Navarro Haro","Maria Vicenta","Instituto Aragonés de Investigaciones Sanitarias, Universidad de Zaragoza, Zaragoza, Spain",NA
"1169","34182825","10.1089/tmj.2021.0124","Spanish-Speaking Therapists Increasingly Switch to Telepsychology During COVID-19: Networked Virtual Reality May Be Next.","Background: Social distancing restrictions imposed due to the Novel Coronavirus 2019 (COVID-19) pandemic resulted in a rapid shift in the delivery of psychological interventions from in-person to telehealth. Much of the research on this transition has been conducted with English-speaking mental health providers, leaving a gap in understanding related to how this shift has impacted Spanish-speaking treatment providers. Methods: Fifty non-U.S. Spanish-speaking","2021","06","29","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; Spanish-speaking therapists; telehealth; telepsychology; underserved; virtual reality","Wilks","Chelsey","Department of Psychological Sciences, University of Missouri-St. Louis, St. Louis, Missouri, USA",NA
"1170","34182825","10.1089/tmj.2021.0124","Spanish-Speaking Therapists Increasingly Switch to Telepsychology During COVID-19: Networked Virtual Reality May Be Next.","Background: Social distancing restrictions imposed due to the Novel Coronavirus 2019 (COVID-19) pandemic resulted in a rapid shift in the delivery of psychological interventions from in-person to telehealth. Much of the research on this transition has been conducted with English-speaking mental health providers, leaving a gap in understanding related to how this shift has impacted Spanish-speaking treatment providers. Methods: Fifty non-U.S. Spanish-speaking","2021","06","29","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; Spanish-speaking therapists; telehealth; telepsychology; underserved; virtual reality","De Sousa","Bruno","Faculty of Psychology and Educational Sciences, CINEICC University of Coimbra, Coimbra, Portugal",NA
"1171","34182825","10.1089/tmj.2021.0124","Spanish-Speaking Therapists Increasingly Switch to Telepsychology During COVID-19: Networked Virtual Reality May Be Next.","Background: Social distancing restrictions imposed due to the Novel Coronavirus 2019 (COVID-19) pandemic resulted in a rapid shift in the delivery of psychological interventions from in-person to telehealth. Much of the research on this transition has been conducted with English-speaking mental health providers, leaving a gap in understanding related to how this shift has impacted Spanish-speaking treatment providers. Methods: Fifty non-U.S. Spanish-speaking","2021","06","29","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; Spanish-speaking therapists; telehealth; telepsychology; underserved; virtual reality","Garcia-Palacios","Azucena","CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Carlos III, Madrid, Spain",NA
"1172","34182825","10.1089/tmj.2021.0124","Spanish-Speaking Therapists Increasingly Switch to Telepsychology During COVID-19: Networked Virtual Reality May Be Next.","Background: Social distancing restrictions imposed due to the Novel Coronavirus 2019 (COVID-19) pandemic resulted in a rapid shift in the delivery of psychological interventions from in-person to telehealth. Much of the research on this transition has been conducted with English-speaking mental health providers, leaving a gap in understanding related to how this shift has impacted Spanish-speaking treatment providers. Methods: Fifty non-U.S. Spanish-speaking","2021","06","29","Telemed J E Health","Telemedicine journal and e-health : the official journal of the American Telemedicine Association","COVID-19; Spanish-speaking therapists; telehealth; telepsychology; underserved; virtual reality","Hoffman","Hunter G","Department of Mechanical Engineering, University of Washington, Seattle, Washington, USA",NA
"1173","34182794","10.1089/cmb.2020.0627","Mapping the Nonstructural Transmembrane Proteins of Severe Acute Respiratory Syndrome Coronavirus 2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the disease coronavirus-19 disease (COVID-19) has wreaked havoc on the health and economy of humanity. In addition, the disease is observed in domestic and wild animals. The disease has impacted directly and indirectly every corner of the planet. Currently, there are no effective therapies for the treatment of COVID-19. Vaccination to protect against COVID-19 started in December 2020. SARS-CoV-2 is an enveloped virus wi","2021","06","30","J Comput Biol","Journal of computational biology : a journal of computational molecular cell biology","COVID-19; Orf1ab; Orf3a; SARS-CoV-2; coronavirus; double-membrane vesicle; endoplasmic reticulum; nonstructural proteins; nsp3; nsp4; nsp6; nsps","Thomas","Sunil","Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA",NA
"1174","34182791","10.1161/CIRCEP.121.009811","Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.",NA,"2021","07","24","Circ Arrhythm Electrophysiol","Circulation. Arrhythmia and electrophysiology","COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir","Attena","Emilio","Division of Cardiology (E.A., S.S.), Cotugno Hospital- A.O.R.N. Dei Colli, Naples",NA
"1175","34182791","10.1161/CIRCEP.121.009811","Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.",NA,"2021","07","24","Circ Arrhythm Electrophysiol","Circulation. Arrhythmia and electrophysiology","COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir","Albani","Stefano","Division of Cardiology (E.A., S.S.), Cotugno Hospital- A.O.R.N. Dei Colli, Naples",NA
"1176","34182791","10.1161/CIRCEP.121.009811","Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.",NA,"2021","07","24","Circ Arrhythm Electrophysiol","Circulation. Arrhythmia and electrophysiology","COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir","Maraolo","Alberto Enrico","First Division of Infectious Diseases (A.E.M., R.P.), Cotugno Hospital- A.O.R.N. Dei Colli, Naples",NA
"1177","34182791","10.1161/CIRCEP.121.009811","Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.",NA,"2021","07","24","Circ Arrhythm Electrophysiol","Circulation. Arrhythmia and electrophysiology","COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir","Mollica","Mariano","Sub-intensive Care Unit and Respiratory Pathophysiology Department (M.M., G.F.), Cotugno Hospital- A.O.R.N. Dei Colli, Naples",NA
"1178","34182791","10.1161/CIRCEP.121.009811","Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.",NA,"2021","07","24","Circ Arrhythm Electrophysiol","Circulation. Arrhythmia and electrophysiology","COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir","De Rosa","Annunziata","Respiratory Infectious Diseases Unit (A.D.R., R.P.), Cotugno Hospital- A.O.R.N. Dei Colli, Naples",NA
"1179","34182791","10.1161/CIRCEP.121.009811","Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.",NA,"2021","07","24","Circ Arrhythm Electrophysiol","Circulation. Arrhythmia and electrophysiology","COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir","Pisapia","Raffaella","First Division of Infectious Diseases (A.E.M., R.P.), Cotugno Hospital- A.O.R.N. Dei Colli, Naples",NA
"1180","34182791","10.1161/CIRCEP.121.009811","Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.",NA,"2021","07","24","Circ Arrhythm Electrophysiol","Circulation. Arrhythmia and electrophysiology","COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir","Fiorentino","Giuseppe","Sub-intensive Care Unit and Respiratory Pathophysiology Department (M.M., G.F.), Cotugno Hospital- A.O.R.N. Dei Colli, Naples",NA
"1181","34182791","10.1161/CIRCEP.121.009811","Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.",NA,"2021","07","24","Circ Arrhythm Electrophysiol","Circulation. Arrhythmia and electrophysiology","COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir","Parrella","Roberto","Respiratory Infectious Diseases Unit (A.D.R., R.P.), Cotugno Hospital- A.O.R.N. Dei Colli, Naples",NA
"1182","34182791","10.1161/CIRCEP.121.009811","Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.",NA,"2021","07","24","Circ Arrhythm Electrophysiol","Circulation. Arrhythmia and electrophysiology","COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir","Severino","Sergio","Respiratory Infectious Diseases Unit (A.D.R., R.P.), Cotugno Hospital- A.O.R.N. Dei Colli, Naples",NA
"1183","34182791","10.1161/CIRCEP.121.009811","Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.",NA,"2021","07","24","Circ Arrhythm Electrophysiol","Circulation. Arrhythmia and electrophysiology","COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir","Russo","Vincenzo","Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli-Monaldi Hospital - A.O.R.N. Dei Colli, Naples, Italy (V",NA
"1184","34182784","10.1128/mBio.00788-21","Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that is continuously evolving. Although its RNA-dependent RNA polymerase exhibits some exonuclease proofreading activity, viral sequence diversity can be produced by replication errors and host factors. A diversity of genetic variants can be observed in the intrahost viral population structure of infected individuals. Most mutations will follow a neutral molecular evolution and will not make significant contributions to ","2021","07","22","mBio","mBio","COVID-19; SARS-CoV-2; genetic variants; high-throughput sequencing; spike protein; syncytia; COVID-19; Cell Line; Evolution, Molecular; Genetic Variation; Genome, Viral; Giant Cells; HEK293 Cells; High-Throughput Nucleotide Sequencing; Humans; Mutation Rate; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Rocheleau","Lynda","Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada",NA
"1185","34182784","10.1128/mBio.00788-21","Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that is continuously evolving. Although its RNA-dependent RNA polymerase exhibits some exonuclease proofreading activity, viral sequence diversity can be produced by replication errors and host factors. A diversity of genetic variants can be observed in the intrahost viral population structure of infected individuals. Most mutations will follow a neutral molecular evolution and will not make significant contributions to ","2021","07","22","mBio","mBio","COVID-19; SARS-CoV-2; genetic variants; high-throughput sequencing; spike protein; syncytia; COVID-19; Cell Line; Evolution, Molecular; Genetic Variation; Genome, Viral; Giant Cells; HEK293 Cells; High-Throughput Nucleotide Sequencing; Humans; Mutation Rate; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Laroche","Geneviève","Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada",NA
"1186","34182784","10.1128/mBio.00788-21","Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that is continuously evolving. Although its RNA-dependent RNA polymerase exhibits some exonuclease proofreading activity, viral sequence diversity can be produced by replication errors and host factors. A diversity of genetic variants can be observed in the intrahost viral population structure of infected individuals. Most mutations will follow a neutral molecular evolution and will not make significant contributions to ","2021","07","22","mBio","mBio","COVID-19; SARS-CoV-2; genetic variants; high-throughput sequencing; spike protein; syncytia; COVID-19; Cell Line; Evolution, Molecular; Genetic Variation; Genome, Viral; Giant Cells; HEK293 Cells; High-Throughput Nucleotide Sequencing; Humans; Mutation Rate; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Fu","Kathy","Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada",NA
"1187","34182784","10.1128/mBio.00788-21","Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that is continuously evolving. Although its RNA-dependent RNA polymerase exhibits some exonuclease proofreading activity, viral sequence diversity can be produced by replication errors and host factors. A diversity of genetic variants can be observed in the intrahost viral population structure of infected individuals. Most mutations will follow a neutral molecular evolution and will not make significant contributions to ","2021","07","22","mBio","mBio","COVID-19; SARS-CoV-2; genetic variants; high-throughput sequencing; spike protein; syncytia; COVID-19; Cell Line; Evolution, Molecular; Genetic Variation; Genome, Viral; Giant Cells; HEK293 Cells; High-Throughput Nucleotide Sequencing; Humans; Mutation Rate; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Stewart","Corina M","Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada",NA
"1188","34182784","10.1128/mBio.00788-21","Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that is continuously evolving. Although its RNA-dependent RNA polymerase exhibits some exonuclease proofreading activity, viral sequence diversity can be produced by replication errors and host factors. A diversity of genetic variants can be observed in the intrahost viral population structure of infected individuals. Most mutations will follow a neutral molecular evolution and will not make significant contributions to ","2021","07","22","mBio","mBio","COVID-19; SARS-CoV-2; genetic variants; high-throughput sequencing; spike protein; syncytia; COVID-19; Cell Line; Evolution, Molecular; Genetic Variation; Genome, Viral; Giant Cells; HEK293 Cells; High-Throughput Nucleotide Sequencing; Humans; Mutation Rate; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Mohamud","Abdulhamid O","Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada",NA
"1189","34182784","10.1128/mBio.00788-21","Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that is continuously evolving. Although its RNA-dependent RNA polymerase exhibits some exonuclease proofreading activity, viral sequence diversity can be produced by replication errors and host factors. A diversity of genetic variants can be observed in the intrahost viral population structure of infected individuals. Most mutations will follow a neutral molecular evolution and will not make significant contributions to ","2021","07","22","mBio","mBio","COVID-19; SARS-CoV-2; genetic variants; high-throughput sequencing; spike protein; syncytia; COVID-19; Cell Line; Evolution, Molecular; Genetic Variation; Genome, Viral; Giant Cells; HEK293 Cells; High-Throughput Nucleotide Sequencing; Humans; Mutation Rate; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Côté","Marceline","Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada",NA
"1190","34182784","10.1128/mBio.00788-21","Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that is continuously evolving. Although its RNA-dependent RNA polymerase exhibits some exonuclease proofreading activity, viral sequence diversity can be produced by replication errors and host factors. A diversity of genetic variants can be observed in the intrahost viral population structure of infected individuals. Most mutations will follow a neutral molecular evolution and will not make significant contributions to ","2021","07","22","mBio","mBio","COVID-19; SARS-CoV-2; genetic variants; high-throughput sequencing; spike protein; syncytia; COVID-19; Cell Line; Evolution, Molecular; Genetic Variation; Genome, Viral; Giant Cells; HEK293 Cells; High-Throughput Nucleotide Sequencing; Humans; Mutation Rate; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Giguère","Patrick M","Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada",NA
"1191","34182784","10.1128/mBio.00788-21","Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that is continuously evolving. Although its RNA-dependent RNA polymerase exhibits some exonuclease proofreading activity, viral sequence diversity can be produced by replication errors and host factors. A diversity of genetic variants can be observed in the intrahost viral population structure of infected individuals. Most mutations will follow a neutral molecular evolution and will not make significant contributions to ","2021","07","22","mBio","mBio","COVID-19; SARS-CoV-2; genetic variants; high-throughput sequencing; spike protein; syncytia; COVID-19; Cell Line; Evolution, Molecular; Genetic Variation; Genome, Viral; Giant Cells; HEK293 Cells; High-Throughput Nucleotide Sequencing; Humans; Mutation Rate; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Langlois","Marc-André","Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada",NA
"1192","34182784","10.1128/mBio.00788-21","Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that is continuously evolving. Although its RNA-dependent RNA polymerase exhibits some exonuclease proofreading activity, viral sequence diversity can be produced by replication errors and host factors. A diversity of genetic variants can be observed in the intrahost viral population structure of infected individuals. Most mutations will follow a neutral molecular evolution and will not make significant contributions to ","2021","07","22","mBio","mBio","COVID-19; SARS-CoV-2; genetic variants; high-throughput sequencing; spike protein; syncytia; COVID-19; Cell Line; Evolution, Molecular; Genetic Variation; Genome, Viral; Giant Cells; HEK293 Cells; High-Throughput Nucleotide Sequencing; Humans; Mutation Rate; SARS-CoV-2; Spike Glycoprotein, Coronavirus","Pelchat","Martin","Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada",NA
"1193","34182776","10.1128/mBio.01502-21","Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa.","Previously, we documented that Stenotrophomonas maltophilia encodes a type IV secretion system (T4SS) that allows the organism to kill, in contact-dependent fashion, heterologous bacteria, including wild-type Pseudomonas aeruginosa. Bioinformatic screens based largely on the presence of both a C-terminal consensus sequence and an adjacent gene encoding a cognate immunity protein identified 13 potential antibacterial effectors, most of which were highly conserved among sequenced strains of S. mal","2021","07","22","mBio","mBio","Pseudomonas aeruginosa; Stenotrophomonas; Stenotrophomonas maltophilia; bacterial competition; bactericidal activity; cystic fibrosis; lipase; peptidoglycan hydrolases; type IV secretion; Antibiosis; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Type IV Secretion Systems","Nas","Megan Y","Department of Microbiology and Immunology, Northwestern University Medical School, Chicago, Illinois, USA",NA
"1194","34182776","10.1128/mBio.01502-21","Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa.","Previously, we documented that Stenotrophomonas maltophilia encodes a type IV secretion system (T4SS) that allows the organism to kill, in contact-dependent fashion, heterologous bacteria, including wild-type Pseudomonas aeruginosa. Bioinformatic screens based largely on the presence of both a C-terminal consensus sequence and an adjacent gene encoding a cognate immunity protein identified 13 potential antibacterial effectors, most of which were highly conserved among sequenced strains of S. mal","2021","07","22","mBio","mBio","Pseudomonas aeruginosa; Stenotrophomonas; Stenotrophomonas maltophilia; bacterial competition; bactericidal activity; cystic fibrosis; lipase; peptidoglycan hydrolases; type IV secretion; Antibiosis; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Type IV Secretion Systems","Gabell","Jeffrey","Department of Microbiology and Immunology, Northwestern University Medical School, Chicago, Illinois, USA",NA
"1195","34182776","10.1128/mBio.01502-21","Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa.","Previously, we documented that Stenotrophomonas maltophilia encodes a type IV secretion system (T4SS) that allows the organism to kill, in contact-dependent fashion, heterologous bacteria, including wild-type Pseudomonas aeruginosa. Bioinformatic screens based largely on the presence of both a C-terminal consensus sequence and an adjacent gene encoding a cognate immunity protein identified 13 potential antibacterial effectors, most of which were highly conserved among sequenced strains of S. mal","2021","07","22","mBio","mBio","Pseudomonas aeruginosa; Stenotrophomonas; Stenotrophomonas maltophilia; bacterial competition; bactericidal activity; cystic fibrosis; lipase; peptidoglycan hydrolases; type IV secretion; Antibiosis; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Type IV Secretion Systems","Cianciotto","Nicholas P","Department of Microbiology and Immunology, Northwestern University Medical School, Chicago, Illinois, USA",NA
"1196","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Sasson","Jennifer M","Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA",NA
"1197","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Campo","Joseph J","Antigen Discovery, Incorporated, Irvine, California, USA",NA
"1198","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Carpenter","Rebecca M","Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA",NA
"1199","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Young","Mary K","Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA",NA
"1200","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Randall","Arlo Z","Antigen Discovery, Incorporated, Irvine, California, USA",NA
"1201","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Trappl-Kimmons","Krista","Antigen Discovery, Incorporated, Irvine, California, USA",NA
"1202","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Oberai","Amit","Antigen Discovery, Incorporated, Irvine, California, USA",NA
"1203","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Hung","Christopher","Antigen Discovery, Incorporated, Irvine, California, USA",NA
"1204","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Edgar","Joshua","Antigen Discovery, Incorporated, Irvine, California, USA",NA
"1205","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Teng","Andy A","Antigen Discovery, Incorporated, Irvine, California, USA",NA
"1206","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Pablo","Jozelyn V","Antigen Discovery, Incorporated, Irvine, California, USA",NA
"1207","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Liang","Xiaowu","Antigen Discovery, Incorporated, Irvine, California, USA",NA
"1208","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Yee","Angela","Antigen Discovery, Incorporated, Irvine, California, USA",NA
"1209","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Petri","William A","Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA",NA
"1210","34182775","10.1128/mBio.01229-21","Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.","We sought to discover links between antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient clinical variables, cytokine profiles, and antibodies to endemic coronaviruses. Serum samples from 30 patients of younger (26 to 39 years) and older (69 to 83 years) age groups and with varying clinical severities ranging from outpatient to mechanically ventilated were collected and used to probe a novel multi-coronavirus protein microarray. This microarray contained","2021","07","22","mBio","mBio","SARS-CoV-2; clinical severity; endemic coronaviruses; epitopes; humoral immunity; viral variants; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; Coronavirus Envelope Proteins; Coronavirus NL63, Human; Coronavirus Nucleocapsid Proteins; Coronavirus OC43, Human; Cytokines; Female; Humans; Immunoglobulin G; Male; Middle East Respiratory Syndrome Coronavirus; Phosphoproteins; Protein Array Analysis; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus","Camerini","David","Antigen Discovery, Incorporated, Irvine, California, USA",NA
"1211","34182740","10.4045/tidsskr.21.0070","Resistance requires revolution.","If the COVID-19 pandemic is an uphill slope, antimicrobial resistance is a steep mountainside. Focusing on individual behavioural change in order to limit resistance is not sufficient. To stand a chance of success, we need structural interventions such as less ambitious expectations for production efficiency, stricter regulation of antibiotic use and poverty reduction.","2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","Anti-Bacterial Agents; COVID-19; Humans","Spjeldnæs","Amanda Hylland",NA,NA
"1212","34182727","10.4045/tidsskr.21.0425","Norway must say yes to fair access to COVID-19 vaccines.",NA,"2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","COVID-19; COVID-19 Vaccines; Humans; Norway; SARS-CoV-2","Foss-Solbrekk","Katarina",NA,NA
"1213","34182721","10.4045/tidsskr.21.0429","COVID-19 and epilepsy.","Can COVID-19 cause epilepsy, or increase the tendency to seizures in those with epilepsy? Is it safe for persons with epilepsy to be vaccinated against COVID-19?","2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","COVID-19; Epilepsy; Humans; SARS-CoV-2; Seizures","Heuser","Kjell",NA,NA
"1214","34182721","10.4045/tidsskr.21.0429","COVID-19 and epilepsy.","Can COVID-19 cause epilepsy, or increase the tendency to seizures in those with epilepsy? Is it safe for persons with epilepsy to be vaccinated against COVID-19?","2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","COVID-19; Epilepsy; Humans; SARS-CoV-2; Seizures","Berger","Toni Christoph",NA,NA
"1215","34182721","10.4045/tidsskr.21.0429","COVID-19 and epilepsy.","Can COVID-19 cause epilepsy, or increase the tendency to seizures in those with epilepsy? Is it safe for persons with epilepsy to be vaccinated against COVID-19?","2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","COVID-19; Epilepsy; Humans; SARS-CoV-2; Seizures","Henning","Oliver",NA,NA
"1216","34182721","10.4045/tidsskr.21.0429","COVID-19 and epilepsy.","Can COVID-19 cause epilepsy, or increase the tendency to seizures in those with epilepsy? Is it safe for persons with epilepsy to be vaccinated against COVID-19?","2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","COVID-19; Epilepsy; Humans; SARS-CoV-2; Seizures","Svalheim","Sigrid",NA,NA
"1217","34182721","10.4045/tidsskr.21.0429","COVID-19 and epilepsy.","Can COVID-19 cause epilepsy, or increase the tendency to seizures in those with epilepsy? Is it safe for persons with epilepsy to be vaccinated against COVID-19?","2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","COVID-19; Epilepsy; Humans; SARS-CoV-2; Seizures","Sibeko","Jørn Mandla",NA,NA
"1218","34182721","10.4045/tidsskr.21.0429","COVID-19 and epilepsy.","Can COVID-19 cause epilepsy, or increase the tendency to seizures in those with epilepsy? Is it safe for persons with epilepsy to be vaccinated against COVID-19?","2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","COVID-19; Epilepsy; Humans; SARS-CoV-2; Seizures","Nakken","Karl O",NA,NA
"1219","34182721","10.4045/tidsskr.21.0429","COVID-19 and epilepsy.","Can COVID-19 cause epilepsy, or increase the tendency to seizures in those with epilepsy? Is it safe for persons with epilepsy to be vaccinated against COVID-19?","2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","COVID-19; Epilepsy; Humans; SARS-CoV-2; Seizures","Taubøll","Erik",NA,NA
"1220","34182720","10.4045/tidsskr.21.0169","Subacute thyroiditis after COVID-19.","Since the beginning of the pandemic we have learned much about acute organ complications due to COVID-19, but we are still only beginning to understand the post-infection complications. A man in his forties was diagnosed with subacute thyroiditis after a mild COVID-19 infection. This is an important differential diagnosis to consider if after a period of improvement, an infected patient develops fever, pain around the region of the thyroid (throat/neck) and/or symptoms of hyperthyroidism. Subacu","2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","COVID-19; Fever; Humans; Male; Pandemics; SARS-CoV-2; Thyroiditis, Subacute","Tjønnfjord","Eirik",NA,NA
"1221","34182720","10.4045/tidsskr.21.0169","Subacute thyroiditis after COVID-19.","Since the beginning of the pandemic we have learned much about acute organ complications due to COVID-19, but we are still only beginning to understand the post-infection complications. A man in his forties was diagnosed with subacute thyroiditis after a mild COVID-19 infection. This is an important differential diagnosis to consider if after a period of improvement, an infected patient develops fever, pain around the region of the thyroid (throat/neck) and/or symptoms of hyperthyroidism. Subacu","2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","COVID-19; Fever; Humans; Male; Pandemics; SARS-CoV-2; Thyroiditis, Subacute","Moe","Ragnar Bekkhus",NA,NA
"1222","34182720","10.4045/tidsskr.21.0169","Subacute thyroiditis after COVID-19.","Since the beginning of the pandemic we have learned much about acute organ complications due to COVID-19, but we are still only beginning to understand the post-infection complications. A man in his forties was diagnosed with subacute thyroiditis after a mild COVID-19 infection. This is an important differential diagnosis to consider if after a period of improvement, an infected patient develops fever, pain around the region of the thyroid (throat/neck) and/or symptoms of hyperthyroidism. Subacu","2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","COVID-19; Fever; Humans; Male; Pandemics; SARS-CoV-2; Thyroiditis, Subacute","Ghanima","Waleed",NA,NA
"1223","34182720","10.4045/tidsskr.21.0169","Subacute thyroiditis after COVID-19.","Since the beginning of the pandemic we have learned much about acute organ complications due to COVID-19, but we are still only beginning to understand the post-infection complications. A man in his forties was diagnosed with subacute thyroiditis after a mild COVID-19 infection. This is an important differential diagnosis to consider if after a period of improvement, an infected patient develops fever, pain around the region of the thyroid (throat/neck) and/or symptoms of hyperthyroidism. Subacu","2021","07","02","Tidsskr Nor Laegeforen","Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","COVID-19; Fever; Humans; Male; Pandemics; SARS-CoV-2; Thyroiditis, Subacute","Aballi","Saad",NA,NA
"1224","34182609","10.1111/jonm.13395","Healthcare worker resilience during the COVID-19 pandemic: An integrative review.","The purpose of this review was to examine resilience among healthcare workers during the coronavirus-disease-2019 (COVID-19) pandemic. The COVID-19 pandemic has caused an unprecedented strain on healthcare workers internationally. Rising infection rates, inadequate personal protective equipment, and the lack of availability of hospital beds has resulted in further deterioration of the already-fragile mental health of healthcare workers. Resilient workers have lower rates of burnout and improved ","2021","07","09","J Nurs Manag","Journal of nursing management","COVID-19; burnout; health personnel; psychological; resilience, psychological; review (publication type)","Baskin","Rachel G","M. Louise Fitzpatrick College of Nursing, Villanova University, Villanova, Pennsylvania, USA",NA
"1225","34182609","10.1111/jonm.13395","Healthcare worker resilience during the COVID-19 pandemic: An integrative review.","The purpose of this review was to examine resilience among healthcare workers during the coronavirus-disease-2019 (COVID-19) pandemic. The COVID-19 pandemic has caused an unprecedented strain on healthcare workers internationally. Rising infection rates, inadequate personal protective equipment, and the lack of availability of hospital beds has resulted in further deterioration of the already-fragile mental health of healthcare workers. Resilient workers have lower rates of burnout and improved ","2021","07","09","J Nurs Manag","Journal of nursing management","COVID-19; burnout; health personnel; psychological; resilience, psychological; review (publication type)","Bartlett","Robin","Capstone College of Nursing, University of Alabama, Tuscaloosa, Alabama, USA",NA
"1226","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Lobato Gómez","Maria","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1227","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Huang","Xin","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1228","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Alvarez","Derry","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1229","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","He","Wenshu","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1230","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Baysal","Can","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1231","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Zhu","Changfu","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1232","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Armario-Najera","Victoria","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1233","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Blanco Perera","Amaya","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1234","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Cerda Bennasser","Pedro","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1235","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Saba-Mayoral","Andera","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1236","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Sobrino-Mengual","Guillermo","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1237","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Vargheese","Ashwin","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1238","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Abranches","Rita","Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal",NA
"1239","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Abreu","Isabel Alexandra","Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal",NA
"1240","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Balamurugan","Shanmugaraj","Plant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore, India",NA
"1241","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Bock","Ralph","Max Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany",NA
"1242","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Buyel","Johannes F","Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany",NA
"1243","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","da Cunha","Nicolau B","Centro de Análise Proteômicas e Bioquímicas de Brasília, Universidade Católica de Brasília, Brasília, Brazil",NA
"1244","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Daniell","Henry","School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA",NA
"1245","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Faller","Roland","Department of Chemical Engineering, University of California, Davis, Davis, CA, USA",NA
"1246","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Folgado","André","Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal",NA
"1247","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Gowtham","Iyappan","Plant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore, India",NA
"1248","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Häkkinen","Suvi T","Industrial Biotechnology and Food Solutions, VTT Technical Research Centre of Finland Ltd, Espoo, Finland",NA
"1249","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Kumar","Shashi","International Centre for Genetic Engineering and Biotechnology, New Delhi, India",NA
"1250","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Ramalingam","Sathish Kumar","Plant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore, India",NA
"1251","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Lacorte","Cristiano","Brazilian Agriculture Research Corporation, Embrapa Genetic Resources and Biotechnology and National Institute of Science and Technology Synthetic in Biology, Parque Estação Biológica, Brasilia, Brazil",NA
"1252","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Lomonossoff","George P","Department of Biological Chemistry, John Innes Centre, Norwich, UK",NA
"1253","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Luís","Ines M","Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal",NA
"1254","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Ma","Julian K-C","Institute for Infection and Immunity, St. George's University of London, London, UK",NA
"1255","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","McDonald","Karen A","Department of Chemical Engineering, University of California, Davis, Davis, CA, USA",NA
"1256","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Murad","Andre","Brazilian Agriculture Research Corporation, Embrapa Genetic Resources and Biotechnology and National Institute of Science and Technology Synthetic in Biology, Parque Estação Biológica, Brasilia, Brazil",NA
"1257","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Nandi","Somen","Department of Chemical Engineering, University of California, Davis, Davis, CA, USA",NA
"1258","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","O'Keef","Barry","Molecular Targets Program, Center for Cancer Research, National Cancer Institute, and Natural Products Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Frederick, MD, USA",NA
"1259","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Oksman-Caldentey","Kirsi-Marja","Industrial Biotechnology and Food Solutions, VTT Technical Research Centre of Finland Ltd, Espoo, Finland",NA
"1260","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Parthiban","Subramanian","Plant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore, India",NA
"1261","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Paul","Mathew J","Institute for Infection and Immunity, St. George's University of London, London, UK",NA
"1262","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Ponndorf","Daniel","Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal",NA
"1263","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Rech","Elibio","Brazilian Agriculture Research Corporation, Embrapa Genetic Resources and Biotechnology and National Institute of Science and Technology Synthetic in Biology, Parque Estação Biológica, Brasilia, Brazil",NA
"1264","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Rodrigues","Julio C M","Brazilian Agriculture Research Corporation, Embrapa Genetic Resources and Biotechnology and National Institute of Science and Technology Synthetic in Biology, Parque Estação Biológica, Brasilia, Brazil",NA
"1265","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Ruf","Stephanie","Max Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany",NA
"1266","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Schillberg","Stefan","Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany",NA
"1267","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Schwestka","Jennifer","Institute of Plant Biotechnology and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Austria",NA
"1268","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Shah","Priya S","Department of Chemical Engineering, University of California, Davis, Davis, CA, USA",NA
"1269","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Singh","Rahul","School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA",NA
"1270","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Stoger","Eva","Institute of Plant Biotechnology and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Austria",NA
"1271","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Twyman","Richard M","TRM Ltd, Scarborough, UK",NA
"1272","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Varghese","Inchakalody P","Plant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore, India",NA
"1273","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Vianna","Giovanni R","Brazilian Agriculture Research Corporation, Embrapa Genetic Resources and Biotechnology and National Institute of Science and Technology Synthetic in Biology, Parque Estação Biológica, Brasilia, Brazil",NA
"1274","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Webster","Gina","Institute for Infection and Immunity, St. George's University of London, London, UK",NA
"1275","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Wilbers","Ruud H P","Laboratory of Nematology, Plant Sciences Group, Wageningen University and Research, Wageningen, The Netherlands",NA
"1276","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Capell","Teresa","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1277","34182608","10.1111/pbi.13657","Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases.","Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccin","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","COVID-19; HIV/AIDS; Molecular farming; SARS-CoV-2; plant-made pharmaceuticals","Christou","Paul","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1278","34182593","10.1111/1475-6773.13688","Comparing the impact on COVID-19 mortality of self-imposed behavior change and of government regulations across 13 countries.","Countries have adopted different approaches, at different times, to reduce the transmission of coronavirus disease 2019 (COVID-19). Cross-country comparison could indicate the relative efficacy of these approaches. We assess various nonpharmaceutical interventions (NPIs), comparing the effects of voluntary behavior change and of changes enforced via official regulations, by examining their impacts on subsequent death rates. Secondary data on COVID-19 deaths from 13 European countries, over March","2021","06","28","Health Serv Res","Health services research","SARS-CoV-2; Western Europe; lockdown; nonpharmaceutical interventions; salience; voluntary behavior change","Jamison","Julian C","Economics Department, University of Exeter, Exeter, UK",NA
"1279","34182593","10.1111/1475-6773.13688","Comparing the impact on COVID-19 mortality of self-imposed behavior change and of government regulations across 13 countries.","Countries have adopted different approaches, at different times, to reduce the transmission of coronavirus disease 2019 (COVID-19). Cross-country comparison could indicate the relative efficacy of these approaches. We assess various nonpharmaceutical interventions (NPIs), comparing the effects of voluntary behavior change and of changes enforced via official regulations, by examining their impacts on subsequent death rates. Secondary data on COVID-19 deaths from 13 European countries, over March","2021","06","28","Health Serv Res","Health services research","SARS-CoV-2; Western Europe; lockdown; nonpharmaceutical interventions; salience; voluntary behavior change","Bundy","Donald","Department of Disease Control, London School of Hygiene &amp",NA
"1280","34182593","10.1111/1475-6773.13688","Comparing the impact on COVID-19 mortality of self-imposed behavior change and of government regulations across 13 countries.","Countries have adopted different approaches, at different times, to reduce the transmission of coronavirus disease 2019 (COVID-19). Cross-country comparison could indicate the relative efficacy of these approaches. We assess various nonpharmaceutical interventions (NPIs), comparing the effects of voluntary behavior change and of changes enforced via official regulations, by examining their impacts on subsequent death rates. Secondary data on COVID-19 deaths from 13 European countries, over March","2021","06","28","Health Serv Res","Health services research","SARS-CoV-2; Western Europe; lockdown; nonpharmaceutical interventions; salience; voluntary behavior change","Jamison","Dean T","Institute for Global Health Sciences, University of California at San Francisco, San Francisco, California, USA",NA
"1281","34182593","10.1111/1475-6773.13688","Comparing the impact on COVID-19 mortality of self-imposed behavior change and of government regulations across 13 countries.","Countries have adopted different approaches, at different times, to reduce the transmission of coronavirus disease 2019 (COVID-19). Cross-country comparison could indicate the relative efficacy of these approaches. We assess various nonpharmaceutical interventions (NPIs), comparing the effects of voluntary behavior change and of changes enforced via official regulations, by examining their impacts on subsequent death rates. Secondary data on COVID-19 deaths from 13 European countries, over March","2021","06","28","Health Serv Res","Health services research","SARS-CoV-2; Western Europe; lockdown; nonpharmaceutical interventions; salience; voluntary behavior change","Spitz","Jacob","The World Bank, Washington, District of Columbia, USA",NA
"1282","34182593","10.1111/1475-6773.13688","Comparing the impact on COVID-19 mortality of self-imposed behavior change and of government regulations across 13 countries.","Countries have adopted different approaches, at different times, to reduce the transmission of coronavirus disease 2019 (COVID-19). Cross-country comparison could indicate the relative efficacy of these approaches. We assess various nonpharmaceutical interventions (NPIs), comparing the effects of voluntary behavior change and of changes enforced via official regulations, by examining their impacts on subsequent death rates. Secondary data on COVID-19 deaths from 13 European countries, over March","2021","06","28","Health Serv Res","Health services research","SARS-CoV-2; Western Europe; lockdown; nonpharmaceutical interventions; salience; voluntary behavior change","Verguet","Stéphane","Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA",NA
"1283","34182586","10.1055/s-0041-1730444","Our Aspirin Rose.",NA,"2021","07","14","Thorac Cardiovasc Surg","The Thoracic and cardiovascular surgeon","Anti-Inflammatory Agents, Non-Steroidal; Aspirin; COVID-19; Gardening; Humans; Platelet Aggregation Inhibitors; Rosa","Heinemann","Markus K","Department of Cardiac, Thoracic and Vascular Surgery, Universitaetsmedizin Mainz, Mainz, Germany",NA
"1284","34182583","10.1055/s-0041-1729145","Clinical Features and Maternal-fetal Results of Pregnant Women in COVID-19 Times."," Coronavirus disease 2019 (COVID-19) is a disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which usually leads to non-specific respiratory symptoms. Although pregnant women are considered at risk for respiratory infections by other viruses, such as SARS and Middle East respiratory syndrome (MERS), little is known about their vulnerability to SARS-CoV-2. Therefore, this study aims to identify and present the main studies on the topic,","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Female; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious","Godoi","Ana Paula Nogueira","Universidade Federal de São João del-Rei, Divinópolis, MG, Brazil",NA
"1285","34182583","10.1055/s-0041-1729145","Clinical Features and Maternal-fetal Results of Pregnant Women in COVID-19 Times."," Coronavirus disease 2019 (COVID-19) is a disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which usually leads to non-specific respiratory symptoms. Although pregnant women are considered at risk for respiratory infections by other viruses, such as SARS and Middle East respiratory syndrome (MERS), little is known about their vulnerability to SARS-CoV-2. Therefore, this study aims to identify and present the main studies on the topic,","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Female; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious","Bernardes","Gilcelia Correia Santos","Universidade Federal de São João del-Rei, Divinópolis, MG, Brazil",NA
"1286","34182583","10.1055/s-0041-1729145","Clinical Features and Maternal-fetal Results of Pregnant Women in COVID-19 Times."," Coronavirus disease 2019 (COVID-19) is a disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which usually leads to non-specific respiratory symptoms. Although pregnant women are considered at risk for respiratory infections by other viruses, such as SARS and Middle East respiratory syndrome (MERS), little is known about their vulnerability to SARS-CoV-2. Therefore, this study aims to identify and present the main studies on the topic,","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Female; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious","Nogueira","Leilismara Sousa","Universidade Federal de São João del-Rei, Divinópolis, MG, Brazil",NA
"1287","34182583","10.1055/s-0041-1729145","Clinical Features and Maternal-fetal Results of Pregnant Women in COVID-19 Times."," Coronavirus disease 2019 (COVID-19) is a disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which usually leads to non-specific respiratory symptoms. Although pregnant women are considered at risk for respiratory infections by other viruses, such as SARS and Middle East respiratory syndrome (MERS), little is known about their vulnerability to SARS-CoV-2. Therefore, this study aims to identify and present the main studies on the topic,","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Female; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious","Alpoim","Patrícia Nessralla","Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil",NA
"1288","34182583","10.1055/s-0041-1729145","Clinical Features and Maternal-fetal Results of Pregnant Women in COVID-19 Times."," Coronavirus disease 2019 (COVID-19) is a disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which usually leads to non-specific respiratory symptoms. Although pregnant women are considered at risk for respiratory infections by other viruses, such as SARS and Middle East respiratory syndrome (MERS), little is known about their vulnerability to SARS-CoV-2. Therefore, this study aims to identify and present the main studies on the topic,","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Female; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious","Pinheiro","Melina de Barros","Universidade Federal de São João del-Rei, Divinópolis, MG, Brazil",NA
"1289","34182582","10.1055/s-0041-1729146","Placental Sampling for Understanding Viral Infections - A Simplified Protocol for the COVID-19 Pandemic."," The coronavirus disease 2019 (COVID-19) is a pandemic viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The impact of the disease among the obstetric population remains unclear, and the study of the placenta can provide valuable information. Adequate sampling of the placental tissue can help characterize the pathways of viral infections.  A protocol of placental sampling is proposed, aiming at guaranteeing representativity of the placenta and describing the ","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Female; Humans; Placenta; Pregnancy; Specimen Handling; Virology; Virus Diseases","Nobrega","Guilherme de Moraes","Universidade Estadual de Campinas, Campinas, SP, Brazil",NA
"1290","34182582","10.1055/s-0041-1729146","Placental Sampling for Understanding Viral Infections - A Simplified Protocol for the COVID-19 Pandemic."," The coronavirus disease 2019 (COVID-19) is a pandemic viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The impact of the disease among the obstetric population remains unclear, and the study of the placenta can provide valuable information. Adequate sampling of the placental tissue can help characterize the pathways of viral infections.  A protocol of placental sampling is proposed, aiming at guaranteeing representativity of the placenta and describing the ","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Female; Humans; Placenta; Pregnancy; Specimen Handling; Virology; Virus Diseases","Guida","José Paulo Siqueira","Universidade Estadual de Campinas, Campinas, SP, Brazil",NA
"1291","34182582","10.1055/s-0041-1729146","Placental Sampling for Understanding Viral Infections - A Simplified Protocol for the COVID-19 Pandemic."," The coronavirus disease 2019 (COVID-19) is a pandemic viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The impact of the disease among the obstetric population remains unclear, and the study of the placenta can provide valuable information. Adequate sampling of the placental tissue can help characterize the pathways of viral infections.  A protocol of placental sampling is proposed, aiming at guaranteeing representativity of the placenta and describing the ","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Female; Humans; Placenta; Pregnancy; Specimen Handling; Virology; Virus Diseases","Japecanga","Rodolfo Rosa","Universidade Estadual de Campinas, Campinas, SP, Brazil",NA
"1292","34182582","10.1055/s-0041-1729146","Placental Sampling for Understanding Viral Infections - A Simplified Protocol for the COVID-19 Pandemic."," The coronavirus disease 2019 (COVID-19) is a pandemic viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The impact of the disease among the obstetric population remains unclear, and the study of the placenta can provide valuable information. Adequate sampling of the placental tissue can help characterize the pathways of viral infections.  A protocol of placental sampling is proposed, aiming at guaranteeing representativity of the placenta and describing the ","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Female; Humans; Placenta; Pregnancy; Specimen Handling; Virology; Virus Diseases","Antolini-Tavares","Arthur","Universidade Estadual de Campinas, Campinas, SP, Brazil",NA
"1293","34182582","10.1055/s-0041-1729146","Placental Sampling for Understanding Viral Infections - A Simplified Protocol for the COVID-19 Pandemic."," The coronavirus disease 2019 (COVID-19) is a pandemic viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The impact of the disease among the obstetric population remains unclear, and the study of the placenta can provide valuable information. Adequate sampling of the placental tissue can help characterize the pathways of viral infections.  A protocol of placental sampling is proposed, aiming at guaranteeing representativity of the placenta and describing the ","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Female; Humans; Placenta; Pregnancy; Specimen Handling; Virology; Virus Diseases","Mysorekar","Indira","Washington University School of Medicine, St. Louis, MO, United States of America",NA
"1294","34182582","10.1055/s-0041-1729146","Placental Sampling for Understanding Viral Infections - A Simplified Protocol for the COVID-19 Pandemic."," The coronavirus disease 2019 (COVID-19) is a pandemic viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The impact of the disease among the obstetric population remains unclear, and the study of the placenta can provide valuable information. Adequate sampling of the placental tissue can help characterize the pathways of viral infections.  A protocol of placental sampling is proposed, aiming at guaranteeing representativity of the placenta and describing the ","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Female; Humans; Placenta; Pregnancy; Specimen Handling; Virology; Virus Diseases","Costa","Maria Laura","Universidade Estadual de Campinas, Campinas, SP, Brazil",NA
"1295","34182581","10.1055/s-0041-1729144","Surgical Site Infection after Cesarean Delivery in Times of COVID-19."," To analyze effects of the COVID-19 pandemic on the consumption of personal protective equipment and products (PPEP), as well as the frequency of surgical site infection (SSI) among non-COVID-19 patients submitted to cesarean sections.  A retrospective study was conducted in a maternity unity of a public teaching hospital which was not part of the reference service for COVID-19 treatment. It compared PPEP consumption and the occurrence of SSI after cesarean sections in monthly periods before and","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Cesarean Section; Female; Hand Sanitizers; Health Personnel; Humans; Personal Protective Equipment; Pregnancy; Retrospective Studies; Surgical Wound Infection","Antonello","Vicente Sperb","Department of Prevention and Infection Control, Hospital Fêmina, Porto Alegre, RS, Brazil",NA
"1296","34182581","10.1055/s-0041-1729144","Surgical Site Infection after Cesarean Delivery in Times of COVID-19."," To analyze effects of the COVID-19 pandemic on the consumption of personal protective equipment and products (PPEP), as well as the frequency of surgical site infection (SSI) among non-COVID-19 patients submitted to cesarean sections.  A retrospective study was conducted in a maternity unity of a public teaching hospital which was not part of the reference service for COVID-19 treatment. It compared PPEP consumption and the occurrence of SSI after cesarean sections in monthly periods before and","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Cesarean Section; Female; Hand Sanitizers; Health Personnel; Humans; Personal Protective Equipment; Pregnancy; Retrospective Studies; Surgical Wound Infection","Dallé","Jessica","Department of Prevention and Infection Control, Hospital Fêmina, Porto Alegre, RS, Brazil",NA
"1297","34182581","10.1055/s-0041-1729144","Surgical Site Infection after Cesarean Delivery in Times of COVID-19."," To analyze effects of the COVID-19 pandemic on the consumption of personal protective equipment and products (PPEP), as well as the frequency of surgical site infection (SSI) among non-COVID-19 patients submitted to cesarean sections.  A retrospective study was conducted in a maternity unity of a public teaching hospital which was not part of the reference service for COVID-19 treatment. It compared PPEP consumption and the occurrence of SSI after cesarean sections in monthly periods before and","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Cesarean Section; Female; Hand Sanitizers; Health Personnel; Humans; Personal Protective Equipment; Pregnancy; Retrospective Studies; Surgical Wound Infection","Antonello","Ivan Carlos Ferreira","Medical School, Pontificia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil",NA
"1298","34182581","10.1055/s-0041-1729144","Surgical Site Infection after Cesarean Delivery in Times of COVID-19."," To analyze effects of the COVID-19 pandemic on the consumption of personal protective equipment and products (PPEP), as well as the frequency of surgical site infection (SSI) among non-COVID-19 patients submitted to cesarean sections.  A retrospective study was conducted in a maternity unity of a public teaching hospital which was not part of the reference service for COVID-19 treatment. It compared PPEP consumption and the occurrence of SSI after cesarean sections in monthly periods before and","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Cesarean Section; Female; Hand Sanitizers; Health Personnel; Humans; Personal Protective Equipment; Pregnancy; Retrospective Studies; Surgical Wound Infection","Benzano","Daniela","Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil",NA
"1299","34182581","10.1055/s-0041-1729144","Surgical Site Infection after Cesarean Delivery in Times of COVID-19."," To analyze effects of the COVID-19 pandemic on the consumption of personal protective equipment and products (PPEP), as well as the frequency of surgical site infection (SSI) among non-COVID-19 patients submitted to cesarean sections.  A retrospective study was conducted in a maternity unity of a public teaching hospital which was not part of the reference service for COVID-19 treatment. It compared PPEP consumption and the occurrence of SSI after cesarean sections in monthly periods before and","2021","07","08","Rev Bras Ginecol Obstet","Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia","COVID-19; Cesarean Section; Female; Hand Sanitizers; Health Personnel; Humans; Personal Protective Equipment; Pregnancy; Retrospective Studies; Surgical Wound Infection","Ramos","Mauro Cunha","Sanitary Dermatology Outpatient Unity, State Health Secretariat, Porto Alegre, RS Brazil",NA
"1300","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Kunjumon","Bgee","Department of Pediatrics, New York University Grossman School of Medicine, New York City, New York",NA
"1301","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Wachtel","Elena V","Department of Pediatrics, New York University Grossman School of Medicine, New York City, New York",NA
"1302","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Lumba","Rishi","Department of Pediatrics, New York University Grossman School of Medicine, New York City, New York",NA
"1303","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Quan","Michelle","Department of Pediatrics, New York University Grossman School of Medicine, New York City, New York",NA
"1304","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Remon","Juan","Department of Pediatrics, New York University Grossman School of Medicine, New York City, New York",NA
"1305","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Louie","Moi","Department of Pediatrics, New York University Grossman School of Medicine, New York City, New York",NA
"1306","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Verma","Sourabh","Department of Pediatrics, New York University Grossman School of Medicine, New York City, New York",NA
"1307","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Moffat","Michael A","Department of Pediatrics, New York University Grossman School of Medicine, New York City, New York",NA
"1308","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Kouba","Insaf","Department of Obstetrics and Gynecology, New York University Grossman School of Medicine, New York City, New York",NA
"1309","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Bennett","Terri-Ann","Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, New York University Grossman School of Medicine, New York City, New York",NA
"1310","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Mejia","Claudia Manzano De","Department of Pediatrics, New York University Long Island School of Medicine, New York City, New York",NA
"1311","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Mally","Pradeep V","Department of Pediatrics, New York University Grossman School of Medicine, New York City, New York",NA
"1312","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Lin","Xinhua","Department of Pediatrics, New York University Long Island School of Medicine, New York City, New York",NA
"1313","34182576","10.1055/s-0041-1731451","Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study."," There are limited published data on the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus from mothers to newborns through breastfeeding or from breast milk. The World Health Organization released guidelines encouraging mothers with suspected or confirmed COVID-19 to breastfeed as the benefits of breastfeeding outweighs the possible risk of transmission. The objective of this study was to determine if SARS-CoV-2 was present in the breast milk of lactating mo","2021","06","28","Am J Perinatol","American journal of perinatology",NA,"Hanna","Nazeeh","Department of Pediatrics, New York University Long Island School of Medicine, New York City, New York",NA
"1314","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Turner","Jackson S","Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA",NA
"1315","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"O'Halloran","Jane A","Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA",NA
"1316","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Kalaidina","Elizaveta","Division of Allergy and Immunology, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA",NA
"1317","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Kim","Wooseob","Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA",NA
"1318","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Schmitz","Aaron J","Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA",NA
"1319","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Zhou","Julian Q","Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA",NA
"1320","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Lei","Tingting","Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA",NA
"1321","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Thapa","Mahima","Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA",NA
"1322","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Chen","Rita E","Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA",NA
"1323","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Case","James Brett","Department of Medicine, Washington University School of Medicine, St Louis, MO, USA",NA
"1324","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Amanat","Fatima","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1325","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Rauseo","Adriana M","Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA",NA
"1326","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Haile","Alem","Clinical Trials Unit, Washington University School of Medicine, St Louis, MO, USA",NA
"1327","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Xie","Xuping","University of Texas Medical Branch, Galveston, TX, USA",NA
"1328","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Klebert","Michael K","Clinical Trials Unit, Washington University School of Medicine, St Louis, MO, USA",NA
"1329","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Suessen","Teresa","Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA",NA
"1330","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Middleton","William D","Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA",NA
"1331","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Shi","Pei-Yong","University of Texas Medical Branch, Galveston, TX, USA",NA
"1332","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Krammer","Florian","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1333","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Teefey","Sharlene A","Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA",NA
"1334","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Diamond","Michael S","Department of Medicine, Washington University School of Medicine, St Louis, MO, USA",NA
"1335","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Presti","Rachel M","Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA. prestir@wustl","prestir@wustl.edu"
"1336","34182569","10.1038/s41586-021-03738-2","SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.","SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19<sup>1-5</sup>. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph nodes in 14 individuals who had received 2 doses of BNT162b2, an mRNA-based vaccine that encodes the full-length SARS-CoV-2 spike (S) gene<sup>1</sup>. Circulating IgG- and IgA-sec","2021","07","15","Nature","Nature",NA,"Ellebedy","Ali H","Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. ellebedy@wustl","ellebedy@wustl.edu"
"1337","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Gareri","Pietro","CDCD Catanzaro Lido - ASP Catanzaro, Catanzaro, Italy",NA
"1338","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Fumagalli","Stefano","Department of Experimental and Clinical Medicine, University of Florence and SOD Geriatrics-UTIG, AOU Careggi, Florence, Italy",NA
"1339","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Malara","Alba","Scientific Committee of National Association of Third Age Residences (ANASTE) Calabria, Lamezia Terme, Italy",NA
"1340","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Mossello","Enrico","Department of Experimental and Clinical Medicine, University of Florence and SOD Geriatrics-UTIG, AOU Careggi, Florence, Italy",NA
"1341","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Trevisan","Caterina","Geriatrics Division, Department of Medicine (DIMED), University of Padua, Padua, Italy",NA
"1342","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Volpato","Stefano","Department of Medical Science, University of Ferrara, Ferrara, Italy",NA
"1343","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Coin","Alessandra","Department of Experimental and Clinical Medicine, University of Florence and SOD Geriatrics-UTIG, AOU Careggi, Florence, Italy",NA
"1344","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Calsolaro","Valeria","Geriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy",NA
"1345","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Bellelli","Giuseppe","School of Medicine and Surgery, University of Milano-Bicocca and Acute Geriatic Unit, San Gerardo Hospital, Monza, Italy",NA
"1346","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Del Signore","Susanna","Blue Companion Ltd, London, United Kingdom",NA
"1347","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Zia","Gianluca","Blue Companion Ltd, London, United Kingdom",NA
"1348","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Ranhoff","Anette Hylen","Department of Clinical Science, University of Bergen, Norway and Diakonhjemmet Hospital, Oslo, Norway",NA
"1349","34182557","10.1159/000516969","Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study.","The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients' care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. Prospectively recorded patients in an electro","2021","06","28","Gerontology","Gerontology","COVID-19; GeroCovid study; Home care patients; Older patients; Outpatients","Incalzi","Raffaele Antonelli","Unit of Geriatrics, Department of Medicine, Campus Bio-Medico University and Teaching Hospital, Rome, Italy",NA
"1350","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Deng","Liehua","Department of Critical Care Medicine of Affiliated Hospital of Guangdong Medical University, Guangdong, China",NA
"1351","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Lei","Shaoqing","Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China",NA
"1352","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Wang","Xiaoyan","Guangdong Medical University Affiliated Lianjiang People's Hospital, Guangdong, China",NA
"1353","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Jiang","Fang","Department of Anesthesiology, The University of Hong Kong, Hong Kong, China",NA
"1354","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Lubarsky","David A","Department of Anesthesiology and Pain Medicine, University of California Davis Health, Sacramento, CA 95817, USA",NA
"1355","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Zhang","Liangqing","The Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China",NA
"1356","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Liu","Danyong","The Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China",NA
"1357","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Han","Conghua","Department of Critical Care Medicine of Xiantao First People's Hospital of Xiantao City, Hubei, China",NA
"1358","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Zhou","Dunrong","Department of Critical Care Medicine of People's Hospital of Yangjiang City, Guangdong, China",NA
"1359","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Wang","Zheng","Department of Critical Care Medicine of People's Hospital of Maoming City, Guangdong, China",NA
"1360","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Sun","Xiaocong","Department of Critical Care Medicine of Affiliated Hospital of Guangdong Medical University, Guangdong, China",NA
"1361","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Zhang","Yuanli","Department of Critical Care Medicine of Affiliated Hospital of Guangdong Medical University, Guangdong, China",NA
"1362","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Cheung","Chi Wai","Department of Anesthesiology, The University of Hong Kong, Hong Kong, China",NA
"1363","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Wang","Sheng","Department of Anesthesiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China",NA
"1364","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Xia","Zhongyuan","Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China",NA
"1365","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Applegate","Richard L","The Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China",NA
"1366","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Tang","Jing","The Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China",NA
"1367","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Mai","Zhenhua","Department of Critical Care Medicine of Affiliated Hospital of Guangdong Medical University, Guangdong, China",NA
"1368","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Liu","Hong","Department of Anesthesiology and Pain Medicine, University of California Davis Health, Sacramento, CA 95817, USA",NA
"1369","34182540","10.18632/aging.203224","Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.","Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide and causes high mortality of elderly patients. High-flow nasal cannula therapy (HFNC) is an oxygen delivery method for severely ill patients. We retrospectively analyzed the course of illness and outcomes in 110 elderly COVID-19 patients (=65 years) treated with HFNC from 6 hospitals. 38 patients received HFNC (200 mmHg &lt; PaO2/FiO2 = 300 mmHg, early HFNC group), and 72 patients received HFNC (100 mmHg &lt; ","2021","07","23","Aging (Albany NY)","Aging","COVID-19; acute respiratory distress syndrome; elderly patients; high-flow nasal cannula therapy; Aged; COVID-19; Cannula; China; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Logistic Models; Male; Multivariate Analysis; Oxygen Inhalation Therapy; Respiratory Distress Syndrome; Retrospective Studies","Xia","Zhengyuan","Department of Anesthesiology, The University of Hong Kong, Hong Kong, China",NA
"1370","34182534","10.21873/invivo.12528","Intestinal Barrier Biomarker ZO1 and Endotoxin Are Increased in Blood of Patients With COVID-19-associated Pneumonia.","The present study was undertaken to investigate (i) whether hospitalized patients with COVID-19 pneumonia present intestinal barrier dysfunction with consequent translocation of endotoxin into the systemic circulation and (ii) whether intestinal barrier biomarkers have any prognostic role in terms of progression to severe respiratory failure. In this prospective study, 22 patients with COVID-19-associated pneumonia and 19 patients with non-COVID-19-related community-acquired pneumonia (CAP group","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; ZO1; bacterial translocation; endotoxin; gut barrier; pneumonia; Biomarkers; COVID-19; Endotoxins; Humans; Pneumonia; Prospective Studies; SARS-CoV-2; Tight Junctions","Assimakopoulos","Stelios F","Department of Internal Medicine, University of Patras Medical School, Patras, Greece","sassim@upatras.gr"
"1371","34182534","10.21873/invivo.12528","Intestinal Barrier Biomarker ZO1 and Endotoxin Are Increased in Blood of Patients With COVID-19-associated Pneumonia.","The present study was undertaken to investigate (i) whether hospitalized patients with COVID-19 pneumonia present intestinal barrier dysfunction with consequent translocation of endotoxin into the systemic circulation and (ii) whether intestinal barrier biomarkers have any prognostic role in terms of progression to severe respiratory failure. In this prospective study, 22 patients with COVID-19-associated pneumonia and 19 patients with non-COVID-19-related community-acquired pneumonia (CAP group","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; ZO1; bacterial translocation; endotoxin; gut barrier; pneumonia; Biomarkers; COVID-19; Endotoxins; Humans; Pneumonia; Prospective Studies; SARS-CoV-2; Tight Junctions","Mastronikolis","Stylianos","School of Medicine, University of Crete, Heraklion, Greece",NA
"1372","34182534","10.21873/invivo.12528","Intestinal Barrier Biomarker ZO1 and Endotoxin Are Increased in Blood of Patients With COVID-19-associated Pneumonia.","The present study was undertaken to investigate (i) whether hospitalized patients with COVID-19 pneumonia present intestinal barrier dysfunction with consequent translocation of endotoxin into the systemic circulation and (ii) whether intestinal barrier biomarkers have any prognostic role in terms of progression to severe respiratory failure. In this prospective study, 22 patients with COVID-19-associated pneumonia and 19 patients with non-COVID-19-related community-acquired pneumonia (CAP group","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; ZO1; bacterial translocation; endotoxin; gut barrier; pneumonia; Biomarkers; COVID-19; Endotoxins; Humans; Pneumonia; Prospective Studies; SARS-CoV-2; Tight Junctions","DE Lastic","Anne-Lise","Division of Hematology, Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1373","34182534","10.21873/invivo.12528","Intestinal Barrier Biomarker ZO1 and Endotoxin Are Increased in Blood of Patients With COVID-19-associated Pneumonia.","The present study was undertaken to investigate (i) whether hospitalized patients with COVID-19 pneumonia present intestinal barrier dysfunction with consequent translocation of endotoxin into the systemic circulation and (ii) whether intestinal barrier biomarkers have any prognostic role in terms of progression to severe respiratory failure. In this prospective study, 22 patients with COVID-19-associated pneumonia and 19 patients with non-COVID-19-related community-acquired pneumonia (CAP group","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; ZO1; bacterial translocation; endotoxin; gut barrier; pneumonia; Biomarkers; COVID-19; Endotoxins; Humans; Pneumonia; Prospective Studies; SARS-CoV-2; Tight Junctions","Aretha","Diamanto","Department of Anesthesiology and Intensive Care Medicine, University of Patras Medical School, Patras, Greece",NA
"1374","34182534","10.21873/invivo.12528","Intestinal Barrier Biomarker ZO1 and Endotoxin Are Increased in Blood of Patients With COVID-19-associated Pneumonia.","The present study was undertaken to investigate (i) whether hospitalized patients with COVID-19 pneumonia present intestinal barrier dysfunction with consequent translocation of endotoxin into the systemic circulation and (ii) whether intestinal barrier biomarkers have any prognostic role in terms of progression to severe respiratory failure. In this prospective study, 22 patients with COVID-19-associated pneumonia and 19 patients with non-COVID-19-related community-acquired pneumonia (CAP group","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; ZO1; bacterial translocation; endotoxin; gut barrier; pneumonia; Biomarkers; COVID-19; Endotoxins; Humans; Pneumonia; Prospective Studies; SARS-CoV-2; Tight Junctions","Papageorgiou","Dimitris","Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1375","34182534","10.21873/invivo.12528","Intestinal Barrier Biomarker ZO1 and Endotoxin Are Increased in Blood of Patients With COVID-19-associated Pneumonia.","The present study was undertaken to investigate (i) whether hospitalized patients with COVID-19 pneumonia present intestinal barrier dysfunction with consequent translocation of endotoxin into the systemic circulation and (ii) whether intestinal barrier biomarkers have any prognostic role in terms of progression to severe respiratory failure. In this prospective study, 22 patients with COVID-19-associated pneumonia and 19 patients with non-COVID-19-related community-acquired pneumonia (CAP group","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; ZO1; bacterial translocation; endotoxin; gut barrier; pneumonia; Biomarkers; COVID-19; Endotoxins; Humans; Pneumonia; Prospective Studies; SARS-CoV-2; Tight Junctions","Chalkidi","Theodora","Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1376","34182534","10.21873/invivo.12528","Intestinal Barrier Biomarker ZO1 and Endotoxin Are Increased in Blood of Patients With COVID-19-associated Pneumonia.","The present study was undertaken to investigate (i) whether hospitalized patients with COVID-19 pneumonia present intestinal barrier dysfunction with consequent translocation of endotoxin into the systemic circulation and (ii) whether intestinal barrier biomarkers have any prognostic role in terms of progression to severe respiratory failure. In this prospective study, 22 patients with COVID-19-associated pneumonia and 19 patients with non-COVID-19-related community-acquired pneumonia (CAP group","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; ZO1; bacterial translocation; endotoxin; gut barrier; pneumonia; Biomarkers; COVID-19; Endotoxins; Humans; Pneumonia; Prospective Studies; SARS-CoV-2; Tight Junctions","Oikonomou","Ioanna","Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1377","34182534","10.21873/invivo.12528","Intestinal Barrier Biomarker ZO1 and Endotoxin Are Increased in Blood of Patients With COVID-19-associated Pneumonia.","The present study was undertaken to investigate (i) whether hospitalized patients with COVID-19 pneumonia present intestinal barrier dysfunction with consequent translocation of endotoxin into the systemic circulation and (ii) whether intestinal barrier biomarkers have any prognostic role in terms of progression to severe respiratory failure. In this prospective study, 22 patients with COVID-19-associated pneumonia and 19 patients with non-COVID-19-related community-acquired pneumonia (CAP group","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; ZO1; bacterial translocation; endotoxin; gut barrier; pneumonia; Biomarkers; COVID-19; Endotoxins; Humans; Pneumonia; Prospective Studies; SARS-CoV-2; Tight Junctions","Triantos","Christos","Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1378","34182534","10.21873/invivo.12528","Intestinal Barrier Biomarker ZO1 and Endotoxin Are Increased in Blood of Patients With COVID-19-associated Pneumonia.","The present study was undertaken to investigate (i) whether hospitalized patients with COVID-19 pneumonia present intestinal barrier dysfunction with consequent translocation of endotoxin into the systemic circulation and (ii) whether intestinal barrier biomarkers have any prognostic role in terms of progression to severe respiratory failure. In this prospective study, 22 patients with COVID-19-associated pneumonia and 19 patients with non-COVID-19-related community-acquired pneumonia (CAP group","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; ZO1; bacterial translocation; endotoxin; gut barrier; pneumonia; Biomarkers; COVID-19; Endotoxins; Humans; Pneumonia; Prospective Studies; SARS-CoV-2; Tight Junctions","Mouzaki","Athanasia","Division of Hematology, Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1379","34182534","10.21873/invivo.12528","Intestinal Barrier Biomarker ZO1 and Endotoxin Are Increased in Blood of Patients With COVID-19-associated Pneumonia.","The present study was undertaken to investigate (i) whether hospitalized patients with COVID-19 pneumonia present intestinal barrier dysfunction with consequent translocation of endotoxin into the systemic circulation and (ii) whether intestinal barrier biomarkers have any prognostic role in terms of progression to severe respiratory failure. In this prospective study, 22 patients with COVID-19-associated pneumonia and 19 patients with non-COVID-19-related community-acquired pneumonia (CAP group","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; ZO1; bacterial translocation; endotoxin; gut barrier; pneumonia; Biomarkers; COVID-19; Endotoxins; Humans; Pneumonia; Prospective Studies; SARS-CoV-2; Tight Junctions","Marangos","Markos","Department of Internal Medicine, University of Patras Medical School, Patras, Greece",NA
"1380","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","Vanni","Gianluca","Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy",NA
"1381","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","Santori","Francesca","Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy",NA
"1382","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","Pellicciaro","Marco","Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy","marcopell62@gmail.com"
"1383","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","Materazzo","Marco","Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy",NA
"1384","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","Caspi","Jonathan","Tor Vergata School of Medicine and Surgery, Policlinico Tor Vergata University, Rome, Italy",NA
"1385","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","Granai","Alessandra Vittoria","Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy",NA
"1386","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","DE Majo","Adriano","Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy",NA
"1387","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","Servadei","Francesca","Anatomic Pathology, Department of Experimental Medicine,Policlinico Tor Vergata University, Rome, Italy",NA
"1388","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","Giacobbi","Erica","Anatomic Pathology, Department of Experimental Medicine,Policlinico Tor Vergata University, Rome, Italy",NA
"1389","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","Perretta","Tommaso","Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy, Policlinico Tor Vergata University, Rome, Italy",NA
"1390","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","Meucci","Rosaria","Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy, Policlinico Tor Vergata University, Rome, Italy",NA
"1391","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","Pistolese","Chiara Adriana","Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy, Policlinico Tor Vergata University, Rome, Italy",NA
"1392","34182514","10.21873/invivo.12508","Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety.","Corona virus infection dramatically spread worldwide during 2020 and extraordinary restrictions have been implemented in order to reduce viral transmission. These measures compelled a complete restructuring of the health system, including temporary cancer screening suspension and a significant slow-down in cancer diagnoses and treatments. We report five cases of extremely advanced breast cancer referred to our Department amid the COVID-19 pandemic. These patients exhibited a poor prognosis or wo","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19; COVID-19 pandemic; advanced breast cancer; breast cancer clinical presentation; lockdown.; Anxiety; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; Quality of Life; SARS-CoV-2","Buonomo","Oreste Claudio","Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy",NA
"1393","34182513","10.21873/invivo.12507","Accurate Monitoring of Parkinson's Disease Symptoms With a Wearable Device During COVID-19 Pandemic.","Accurate assessment of symptoms in Parkinson's disease (PD) is essential for optimal treatment decisions. During the past few years, different monitoring modalities have started to be used in the everyday clinical practice, mainly for the evaluation of motor symptoms. However, monitoring technologies for PD have not yet gained wide acceptance among physicians, patients, and caregivers. The COVID-19 pandemic disrupted the patients' access to healthcare, bringing to the forefront the need for wear","2021","06","30","In Vivo","In vivo (Athens, Greece)","Parkinsons disease; fluctuations; objective measurements.; remote monitoring; wearables; COVID-19; Humans; Pandemics; Parkinson Disease; SARS-CoV-2; Wearable Electronic Devices","Tsamis","Konstantinos I","Department of Neurology, University Hospital of Ioannina, Ioannina, Greece","ktsamis@uoi.gr"
"1394","34182513","10.21873/invivo.12507","Accurate Monitoring of Parkinson's Disease Symptoms With a Wearable Device During COVID-19 Pandemic.","Accurate assessment of symptoms in Parkinson's disease (PD) is essential for optimal treatment decisions. During the past few years, different monitoring modalities have started to be used in the everyday clinical practice, mainly for the evaluation of motor symptoms. However, monitoring technologies for PD have not yet gained wide acceptance among physicians, patients, and caregivers. The COVID-19 pandemic disrupted the patients' access to healthcare, bringing to the forefront the need for wear","2021","06","30","In Vivo","In vivo (Athens, Greece)","Parkinsons disease; fluctuations; objective measurements.; remote monitoring; wearables; COVID-19; Humans; Pandemics; Parkinson Disease; SARS-CoV-2; Wearable Electronic Devices","Rigas","George","Unit of Medical Technology and Intelligent Information System, Department of Materials Science and Engineering, University of Ioannina, Ioannina, Greece",NA
"1395","34182513","10.21873/invivo.12507","Accurate Monitoring of Parkinson's Disease Symptoms With a Wearable Device During COVID-19 Pandemic.","Accurate assessment of symptoms in Parkinson's disease (PD) is essential for optimal treatment decisions. During the past few years, different monitoring modalities have started to be used in the everyday clinical practice, mainly for the evaluation of motor symptoms. However, monitoring technologies for PD have not yet gained wide acceptance among physicians, patients, and caregivers. The COVID-19 pandemic disrupted the patients' access to healthcare, bringing to the forefront the need for wear","2021","06","30","In Vivo","In vivo (Athens, Greece)","Parkinsons disease; fluctuations; objective measurements.; remote monitoring; wearables; COVID-19; Humans; Pandemics; Parkinson Disease; SARS-CoV-2; Wearable Electronic Devices","Nikolaos","Kostikis","PD Neurotechnology Ltd, Ioannina, Greece",NA
"1396","34182513","10.21873/invivo.12507","Accurate Monitoring of Parkinson's Disease Symptoms With a Wearable Device During COVID-19 Pandemic.","Accurate assessment of symptoms in Parkinson's disease (PD) is essential for optimal treatment decisions. During the past few years, different monitoring modalities have started to be used in the everyday clinical practice, mainly for the evaluation of motor symptoms. However, monitoring technologies for PD have not yet gained wide acceptance among physicians, patients, and caregivers. The COVID-19 pandemic disrupted the patients' access to healthcare, bringing to the forefront the need for wear","2021","06","30","In Vivo","In vivo (Athens, Greece)","Parkinsons disease; fluctuations; objective measurements.; remote monitoring; wearables; COVID-19; Humans; Pandemics; Parkinson Disease; SARS-CoV-2; Wearable Electronic Devices","Fotiadis","Dimitrios I","Unit of Medical Technology and Intelligent Information System, Department of Materials Science and Engineering, University of Ioannina, Ioannina, Greece",NA
"1397","34182513","10.21873/invivo.12507","Accurate Monitoring of Parkinson's Disease Symptoms With a Wearable Device During COVID-19 Pandemic.","Accurate assessment of symptoms in Parkinson's disease (PD) is essential for optimal treatment decisions. During the past few years, different monitoring modalities have started to be used in the everyday clinical practice, mainly for the evaluation of motor symptoms. However, monitoring technologies for PD have not yet gained wide acceptance among physicians, patients, and caregivers. The COVID-19 pandemic disrupted the patients' access to healthcare, bringing to the forefront the need for wear","2021","06","30","In Vivo","In vivo (Athens, Greece)","Parkinsons disease; fluctuations; objective measurements.; remote monitoring; wearables; COVID-19; Humans; Pandemics; Parkinson Disease; SARS-CoV-2; Wearable Electronic Devices","Konitsiotis","Spyridon","Department of Neurology, University Hospital of Ioannina, Ioannina, Greece",NA
"1398","34182504","10.21873/invivo.12498","Sleep Disorders Before and During the COVID-19 Pandemic in Patients Assigned to Adjuvant Radiotherapy for Breast Cancer.","The anticipation of radiotherapy can cause distress and sleep disorders, which may be aggravated by the COVID-19 pandemic. This study investigated sleep disorders in a large cohort of patients with breast cancer before and during the pandemic. Twenty-three characteristics were retrospectively analyzed for associations with pre-radiotherapy sleep disorders in 338 patients. Moreover, 163 patients presenting before and 175 patients presenting during the COVID-19 pandemic were compared for sleep dis","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19 pandemic; breast cancer; pre-radiotherapy sleep disorders; prevalence; risk factors; Breast Neoplasms; COVID-19; Female; Humans; Middle Aged; Pandemics; Radiotherapy, Adjuvant; Retrospective Studies; SARS-CoV-2; Sleep Wake Disorders","Rades","Dirk","Department of Radiation Oncology, University of Lübeck, Lübeck, Germany","dirk.rades@uksh.de"
"1399","34182504","10.21873/invivo.12498","Sleep Disorders Before and During the COVID-19 Pandemic in Patients Assigned to Adjuvant Radiotherapy for Breast Cancer.","The anticipation of radiotherapy can cause distress and sleep disorders, which may be aggravated by the COVID-19 pandemic. This study investigated sleep disorders in a large cohort of patients with breast cancer before and during the pandemic. Twenty-three characteristics were retrospectively analyzed for associations with pre-radiotherapy sleep disorders in 338 patients. Moreover, 163 patients presenting before and 175 patients presenting during the COVID-19 pandemic were compared for sleep dis","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19 pandemic; breast cancer; pre-radiotherapy sleep disorders; prevalence; risk factors; Breast Neoplasms; COVID-19; Female; Humans; Middle Aged; Pandemics; Radiotherapy, Adjuvant; Retrospective Studies; SARS-CoV-2; Sleep Wake Disorders","Narvaez","Carlos A","Department of Radiation Oncology, University of Lübeck, Lübeck, Germany",NA
"1400","34182504","10.21873/invivo.12498","Sleep Disorders Before and During the COVID-19 Pandemic in Patients Assigned to Adjuvant Radiotherapy for Breast Cancer.","The anticipation of radiotherapy can cause distress and sleep disorders, which may be aggravated by the COVID-19 pandemic. This study investigated sleep disorders in a large cohort of patients with breast cancer before and during the pandemic. Twenty-three characteristics were retrospectively analyzed for associations with pre-radiotherapy sleep disorders in 338 patients. Moreover, 163 patients presenting before and 175 patients presenting during the COVID-19 pandemic were compared for sleep dis","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19 pandemic; breast cancer; pre-radiotherapy sleep disorders; prevalence; risk factors; Breast Neoplasms; COVID-19; Female; Humans; Middle Aged; Pandemics; Radiotherapy, Adjuvant; Retrospective Studies; SARS-CoV-2; Sleep Wake Disorders","Schild","Steven E","Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U",NA
"1401","34182504","10.21873/invivo.12498","Sleep Disorders Before and During the COVID-19 Pandemic in Patients Assigned to Adjuvant Radiotherapy for Breast Cancer.","The anticipation of radiotherapy can cause distress and sleep disorders, which may be aggravated by the COVID-19 pandemic. This study investigated sleep disorders in a large cohort of patients with breast cancer before and during the pandemic. Twenty-three characteristics were retrospectively analyzed for associations with pre-radiotherapy sleep disorders in 338 patients. Moreover, 163 patients presenting before and 175 patients presenting during the COVID-19 pandemic were compared for sleep dis","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19 pandemic; breast cancer; pre-radiotherapy sleep disorders; prevalence; risk factors; Breast Neoplasms; COVID-19; Female; Humans; Middle Aged; Pandemics; Radiotherapy, Adjuvant; Retrospective Studies; SARS-CoV-2; Sleep Wake Disorders","Tvilsted","Soeren","Research Projects and Clinical Optimization, Zealand University Hospital, Koege, Denmark",NA
"1402","34182504","10.21873/invivo.12498","Sleep Disorders Before and During the COVID-19 Pandemic in Patients Assigned to Adjuvant Radiotherapy for Breast Cancer.","The anticipation of radiotherapy can cause distress and sleep disorders, which may be aggravated by the COVID-19 pandemic. This study investigated sleep disorders in a large cohort of patients with breast cancer before and during the pandemic. Twenty-three characteristics were retrospectively analyzed for associations with pre-radiotherapy sleep disorders in 338 patients. Moreover, 163 patients presenting before and 175 patients presenting during the COVID-19 pandemic were compared for sleep dis","2021","06","30","In Vivo","In vivo (Athens, Greece)","COVID-19 pandemic; breast cancer; pre-radiotherapy sleep disorders; prevalence; risk factors; Breast Neoplasms; COVID-19; Female; Humans; Middle Aged; Pandemics; Radiotherapy, Adjuvant; Retrospective Studies; SARS-CoV-2; Sleep Wake Disorders","Kjaer","Troels W","Neurological Department, Zealand University Hospital, Roskilde, Denmark",NA
"1403","34182461","10.2196/29671","Mental health service user and worker experience of psychosocial support via telehealth through the COVID-19 pandemic: A qualitative study.","No changes required. No changes required. Clarifying details added under study setting. Additional paragraph added to discussion. No changes required. No changes required.","2021","06","28","JMIR Ment Health","JMIR mental health",NA,"Venville","Annie","Social Work, College of Health and Biomedicine, Victoria University, Ballarat RoadFootscray, Melbourne, AU",NA
"1404","34182461","10.2196/29671","Mental health service user and worker experience of psychosocial support via telehealth through the COVID-19 pandemic: A qualitative study.","No changes required. No changes required. Clarifying details added under study setting. Additional paragraph added to discussion. No changes required. No changes required.","2021","06","28","JMIR Ment Health","JMIR mental health",NA,"O'Connor","Sarah","Neami National, Melbourne, AU",NA
"1405","34182461","10.2196/29671","Mental health service user and worker experience of psychosocial support via telehealth through the COVID-19 pandemic: A qualitative study.","No changes required. No changes required. Clarifying details added under study setting. Additional paragraph added to discussion. No changes required. No changes required.","2021","06","28","JMIR Ment Health","JMIR mental health",NA,"Roeschlein","Hannah","Neami National, Melbourne, AU",NA
"1406","34182461","10.2196/29671","Mental health service user and worker experience of psychosocial support via telehealth through the COVID-19 pandemic: A qualitative study.","No changes required. No changes required. Clarifying details added under study setting. Additional paragraph added to discussion. No changes required. No changes required.","2021","06","28","JMIR Ment Health","JMIR mental health",NA,"Ennals","Priscilla","Neami National, Melbourne, AU",NA
"1407","34182461","10.2196/29671","Mental health service user and worker experience of psychosocial support via telehealth through the COVID-19 pandemic: A qualitative study.","No changes required. No changes required. Clarifying details added under study setting. Additional paragraph added to discussion. No changes required. No changes required.","2021","06","28","JMIR Ment Health","JMIR mental health",NA,"McLoughlan","Grace","Neami National, Melbourne, AU",NA
"1408","34182461","10.2196/29671","Mental health service user and worker experience of psychosocial support via telehealth through the COVID-19 pandemic: A qualitative study.","No changes required. No changes required. Clarifying details added under study setting. Additional paragraph added to discussion. No changes required. No changes required.","2021","06","28","JMIR Ment Health","JMIR mental health",NA,"Thomas","Neil","Centre for Mental Health, Swinburne University of Technology, Melbourne, AU",NA
"1409","34182460","10.2196/30612","Predictors of COVID-19 Preventive Perceptions and Behaviors: Two Cross-Sectional Studies of Millennials.","COVID-19 preventive perceptions and behaviors, especially among U.S. Millennials, are an important means by which the pandemic can be slowed and negative health outcomes can be averted. This manuscript aims to advance knowledge on COVID-19 preventive perceptions and behaviors and their main predictors, including digital health information seeking behavior (HISB), political party identification, and COVID-19 testing status. Two cross-sectional online surveys of U.S. Millennials were conducted fro","2021","06","28","J Med Internet Res","Journal of medical Internet research",NA,"Beaudoin","Christopher E","Boston University, 640 Commonwealth Ave., Boston, US",NA
"1410","34182460","10.2196/30612","Predictors of COVID-19 Preventive Perceptions and Behaviors: Two Cross-Sectional Studies of Millennials.","COVID-19 preventive perceptions and behaviors, especially among U.S. Millennials, are an important means by which the pandemic can be slowed and negative health outcomes can be averted. This manuscript aims to advance knowledge on COVID-19 preventive perceptions and behaviors and their main predictors, including digital health information seeking behavior (HISB), political party identification, and COVID-19 testing status. Two cross-sectional online surveys of U.S. Millennials were conducted fro","2021","06","28","J Med Internet Res","Journal of medical Internet research",NA,"Hong","Traci","Boston University, 640 Commonwealth Ave., Boston, US",NA
"1411","34182446","10.1016/j.scitotenv.2021.148626","Urban attributes and the spread of COVID-19: The effects of density, compliance and socio-political factors in Israel.","Current debates identifying urban population density as a major catalyst for the spread of COVID-19, and the praise for de-densification and urban sprawl that they entail, may have dire environmental consequences. Juxtaposing competing theories about the urban antecedents of COVID-19, our key argument is that urban political attributes overshadow the effects of cities' spatial characteristics. This is true even when considering levels of compliance with movement restrictions and controlling for ","2021","07","17","Sci Total Environ","The Science of the total environment","COVID-19; Cities; Minorities; Population density; Urban planning; Urban sustainability","Barak","Nir","Deparment of Politics and Government, Ben Gurion University of the Negev, Israel. Electronic address: nirbarak@bgu.ac","nirbarak@bgu.ac.il"
"1412","34182446","10.1016/j.scitotenv.2021.148626","Urban attributes and the spread of COVID-19: The effects of density, compliance and socio-political factors in Israel.","Current debates identifying urban population density as a major catalyst for the spread of COVID-19, and the praise for de-densification and urban sprawl that they entail, may have dire environmental consequences. Juxtaposing competing theories about the urban antecedents of COVID-19, our key argument is that urban political attributes overshadow the effects of cities' spatial characteristics. This is true even when considering levels of compliance with movement restrictions and controlling for ","2021","07","17","Sci Total Environ","The Science of the total environment","COVID-19; Cities; Minorities; Population density; Urban planning; Urban sustainability","Sommer","Udi","Department of Political Science, Tel Aviv University, Israel. Electronic address: udi.sommer@gmail","udi.sommer@gmail.com"
"1413","34182446","10.1016/j.scitotenv.2021.148626","Urban attributes and the spread of COVID-19: The effects of density, compliance and socio-political factors in Israel.","Current debates identifying urban population density as a major catalyst for the spread of COVID-19, and the praise for de-densification and urban sprawl that they entail, may have dire environmental consequences. Juxtaposing competing theories about the urban antecedents of COVID-19, our key argument is that urban political attributes overshadow the effects of cities' spatial characteristics. This is true even when considering levels of compliance with movement restrictions and controlling for ","2021","07","17","Sci Total Environ","The Science of the total environment","COVID-19; Cities; Minorities; Population density; Urban planning; Urban sustainability","Mualam","Nir","Faculty of Architecture and Town Planning, Technion, Israel Institute of Technology, Israel. Electronic address: nirm@technion.ac","nirm@technion.ac.il"
"1414","34182354","10.1016/j.sleep.2021.06.002","Impact of COVID-19 pandemic on sleep in children and adolescents: a systematic review and meta-analysis.","This systematic review and meta-analysis were conducted to study the prevalence and pattern of sleep disturbances in children and adolescents during the COVID-19 pandemic. MEDLINE, EMBASE, and Web of Science were searched for original studies describing sleep abnormalities in children and adolescents with or without pre-existing neurobehavioral disorders during the COVID-19 pandemic. The pooled estimates for various sleep abnormalities were calculated using a random-effect model. Of 371 articles","2021","07","07","Sleep Med","Sleep medicine","Adolescents; COVID-19; Children; Pandemic; Sleep","Sharma","Mohit","Department of Psychiatry, Institute of Human Behaviour and Allied Sciences, Delhi, India",NA
"1415","34182354","10.1016/j.sleep.2021.06.002","Impact of COVID-19 pandemic on sleep in children and adolescents: a systematic review and meta-analysis.","This systematic review and meta-analysis were conducted to study the prevalence and pattern of sleep disturbances in children and adolescents during the COVID-19 pandemic. MEDLINE, EMBASE, and Web of Science were searched for original studies describing sleep abnormalities in children and adolescents with or without pre-existing neurobehavioral disorders during the COVID-19 pandemic. The pooled estimates for various sleep abnormalities were calculated using a random-effect model. Of 371 articles","2021","07","07","Sleep Med","Sleep medicine","Adolescents; COVID-19; Children; Pandemic; Sleep","Aggarwal","Shivali","Department of Psychiatry, All Indian Institute of Medical Sciences, New Delhi, India. Electronic address: shivaliaggarwal88@gmail","shivaliaggarwal88@gmail.com"
"1416","34182354","10.1016/j.sleep.2021.06.002","Impact of COVID-19 pandemic on sleep in children and adolescents: a systematic review and meta-analysis.","This systematic review and meta-analysis were conducted to study the prevalence and pattern of sleep disturbances in children and adolescents during the COVID-19 pandemic. MEDLINE, EMBASE, and Web of Science were searched for original studies describing sleep abnormalities in children and adolescents with or without pre-existing neurobehavioral disorders during the COVID-19 pandemic. The pooled estimates for various sleep abnormalities were calculated using a random-effect model. Of 371 articles","2021","07","07","Sleep Med","Sleep medicine","Adolescents; COVID-19; Children; Pandemic; Sleep","Madaan","Priyanka","Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India",NA
"1417","34182354","10.1016/j.sleep.2021.06.002","Impact of COVID-19 pandemic on sleep in children and adolescents: a systematic review and meta-analysis.","This systematic review and meta-analysis were conducted to study the prevalence and pattern of sleep disturbances in children and adolescents during the COVID-19 pandemic. MEDLINE, EMBASE, and Web of Science were searched for original studies describing sleep abnormalities in children and adolescents with or without pre-existing neurobehavioral disorders during the COVID-19 pandemic. The pooled estimates for various sleep abnormalities were calculated using a random-effect model. Of 371 articles","2021","07","07","Sleep Med","Sleep medicine","Adolescents; COVID-19; Children; Pandemic; Sleep","Saini","Lokesh","Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India",NA
"1418","34182354","10.1016/j.sleep.2021.06.002","Impact of COVID-19 pandemic on sleep in children and adolescents: a systematic review and meta-analysis.","This systematic review and meta-analysis were conducted to study the prevalence and pattern of sleep disturbances in children and adolescents during the COVID-19 pandemic. MEDLINE, EMBASE, and Web of Science were searched for original studies describing sleep abnormalities in children and adolescents with or without pre-existing neurobehavioral disorders during the COVID-19 pandemic. The pooled estimates for various sleep abnormalities were calculated using a random-effect model. Of 371 articles","2021","07","07","Sleep Med","Sleep medicine","Adolescents; COVID-19; Children; Pandemic; Sleep","Bhutani","Mohit","Department of Cardiology, Amcare Hospital, Zirakpur, Punjab, India",NA
"1419","34182331","10.1016/j.compbiomed.2021.104572","COVID-19 cough classification using machine learning and global smartphone recordings.","We present a machine learning based COVID-19 cough classifier which can discriminate COVID-19 positive coughs from both COVID-19 negative and healthy coughs recorded on a smartphone. This type of screening is non-contact, easy to apply, and can reduce the workload in testing centres as well as limit transmission by recommending early self-isolation to those who have a cough suggestive of COVID-19. The datasets used in this study include subjects from all six continents and contain both forced an","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19; Convolutional neural network (CNN); Cough classification; K-nearest neighbour (KNN); Logistic regression (LR); Long short-term memory (LSTM); Machine learning; Multilayer perceptron (MLP); Resnet50; Support vector machine (SVM)","Pahar","Madhurananda","Department of Electrical and Electronic Engineering, Stellenbosch University, South Africa. Electronic address: mpahar@sun.ac","mpahar@sun.ac.za"
"1420","34182331","10.1016/j.compbiomed.2021.104572","COVID-19 cough classification using machine learning and global smartphone recordings.","We present a machine learning based COVID-19 cough classifier which can discriminate COVID-19 positive coughs from both COVID-19 negative and healthy coughs recorded on a smartphone. This type of screening is non-contact, easy to apply, and can reduce the workload in testing centres as well as limit transmission by recommending early self-isolation to those who have a cough suggestive of COVID-19. The datasets used in this study include subjects from all six continents and contain both forced an","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19; Convolutional neural network (CNN); Cough classification; K-nearest neighbour (KNN); Logistic regression (LR); Long short-term memory (LSTM); Machine learning; Multilayer perceptron (MLP); Resnet50; Support vector machine (SVM)","Klopper","Marisa","SAMRC Centre for Tuberculosis Research, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa. Electronic address: marisat@sun.ac","marisat@sun.ac.za"
"1421","34182331","10.1016/j.compbiomed.2021.104572","COVID-19 cough classification using machine learning and global smartphone recordings.","We present a machine learning based COVID-19 cough classifier which can discriminate COVID-19 positive coughs from both COVID-19 negative and healthy coughs recorded on a smartphone. This type of screening is non-contact, easy to apply, and can reduce the workload in testing centres as well as limit transmission by recommending early self-isolation to those who have a cough suggestive of COVID-19. The datasets used in this study include subjects from all six continents and contain both forced an","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19; Convolutional neural network (CNN); Cough classification; K-nearest neighbour (KNN); Logistic regression (LR); Long short-term memory (LSTM); Machine learning; Multilayer perceptron (MLP); Resnet50; Support vector machine (SVM)","Warren","Robin","SAMRC Centre for Tuberculosis Research, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa. Electronic address: rw1@sun.ac","rw1@sun.ac.za"
"1422","34182331","10.1016/j.compbiomed.2021.104572","COVID-19 cough classification using machine learning and global smartphone recordings.","We present a machine learning based COVID-19 cough classifier which can discriminate COVID-19 positive coughs from both COVID-19 negative and healthy coughs recorded on a smartphone. This type of screening is non-contact, easy to apply, and can reduce the workload in testing centres as well as limit transmission by recommending early self-isolation to those who have a cough suggestive of COVID-19. The datasets used in this study include subjects from all six continents and contain both forced an","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19; Convolutional neural network (CNN); Cough classification; K-nearest neighbour (KNN); Logistic regression (LR); Long short-term memory (LSTM); Machine learning; Multilayer perceptron (MLP); Resnet50; Support vector machine (SVM)","Niesler","Thomas","Department of Electrical and Electronic Engineering, Stellenbosch University, South Africa. Electronic address: trn@sun.ac","trn@sun.ac.za"
"1423","34182330","10.1016/j.compbiomed.2021.104588","COVID-19 deep classification network based on convolution and deconvolution local enhancement.","Computer Tomography (CT) detection can effectively overcome the problems of traditional detection of Corona Virus Disease 2019 (COVID-19), such as lagging detection results and wrong diagnosis results, which lead to the increase of disease infection rate and prevalence rate. The novel coronavirus pneumonia is a significant difference between the positive and negative patients with asymptomatic infections. To effectively improve the accuracy of doctors' manual judgment of positive and negative CO","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19 classification network; Convolution; Deconvolution; Enhanced CT features; ROI extraction","Fang","Lingling","Department of Computing and Information Technology, Liaoning Normal University, Dalian City, Liaoning Province, China. Electronic address: fanglingling@lnnu.edu","fanglingling@lnnu.edu.cn"
"1424","34182330","10.1016/j.compbiomed.2021.104588","COVID-19 deep classification network based on convolution and deconvolution local enhancement.","Computer Tomography (CT) detection can effectively overcome the problems of traditional detection of Corona Virus Disease 2019 (COVID-19), such as lagging detection results and wrong diagnosis results, which lead to the increase of disease infection rate and prevalence rate. The novel coronavirus pneumonia is a significant difference between the positive and negative patients with asymptomatic infections. To effectively improve the accuracy of doctors' manual judgment of positive and negative CO","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19 classification network; Convolution; Deconvolution; Enhanced CT features; ROI extraction","Wang","Xin","Department of Computing and Information Technology, Liaoning Normal University, Dalian City, Liaoning Province, China",NA
"1425","34182300","10.1016/j.jcv.2021.104903","Rapid screening method for the detection of SARS-CoV-2 variants of concern.","Comprehensive and up-to-date monitoring of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) is crucial as these are characterized by their increased transmissibility, immune evasion and virulence. To describe the wide-scale implementation of a reverse transcriptase polymerase chain reaction (RT-PCR) multiple variants assay with melting curve analysis as a routine procedure. We prospectively performed multiple variants RT-PCR on consecutive SARS-CoV-2 RT-PCR ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","COVID-19; Melting curve; PCR; SARS-CoV-2; Variants; screening","Ong","David S Y","Department of Medical Microbiology and Infection Control, Franciscus Gasthuis &amp","davidsyong@gmail.com"
"1426","34182300","10.1016/j.jcv.2021.104903","Rapid screening method for the detection of SARS-CoV-2 variants of concern.","Comprehensive and up-to-date monitoring of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) is crucial as these are characterized by their increased transmissibility, immune evasion and virulence. To describe the wide-scale implementation of a reverse transcriptase polymerase chain reaction (RT-PCR) multiple variants assay with melting curve analysis as a routine procedure. We prospectively performed multiple variants RT-PCR on consecutive SARS-CoV-2 RT-PCR ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","COVID-19; Melting curve; PCR; SARS-CoV-2; Variants; screening","Koeleman","Johannes G M","Department of Medical Microbiology and Infection Control, Franciscus Gasthuis &amp",NA
"1427","34182300","10.1016/j.jcv.2021.104903","Rapid screening method for the detection of SARS-CoV-2 variants of concern.","Comprehensive and up-to-date monitoring of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) is crucial as these are characterized by their increased transmissibility, immune evasion and virulence. To describe the wide-scale implementation of a reverse transcriptase polymerase chain reaction (RT-PCR) multiple variants assay with melting curve analysis as a routine procedure. We prospectively performed multiple variants RT-PCR on consecutive SARS-CoV-2 RT-PCR ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","COVID-19; Melting curve; PCR; SARS-CoV-2; Variants; screening","Vaessen","Norbert","Department of Medical Microbiology and Infection Control, Franciscus Gasthuis &amp",NA
"1428","34182300","10.1016/j.jcv.2021.104903","Rapid screening method for the detection of SARS-CoV-2 variants of concern.","Comprehensive and up-to-date monitoring of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) is crucial as these are characterized by their increased transmissibility, immune evasion and virulence. To describe the wide-scale implementation of a reverse transcriptase polymerase chain reaction (RT-PCR) multiple variants assay with melting curve analysis as a routine procedure. We prospectively performed multiple variants RT-PCR on consecutive SARS-CoV-2 RT-PCR ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","COVID-19; Melting curve; PCR; SARS-CoV-2; Variants; screening","Breijer","Simone","Department of Medical Microbiology and Infection Control, Franciscus Gasthuis &amp",NA
"1429","34182300","10.1016/j.jcv.2021.104903","Rapid screening method for the detection of SARS-CoV-2 variants of concern.","Comprehensive and up-to-date monitoring of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) is crucial as these are characterized by their increased transmissibility, immune evasion and virulence. To describe the wide-scale implementation of a reverse transcriptase polymerase chain reaction (RT-PCR) multiple variants assay with melting curve analysis as a routine procedure. We prospectively performed multiple variants RT-PCR on consecutive SARS-CoV-2 RT-PCR ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","COVID-19; Melting curve; PCR; SARS-CoV-2; Variants; screening","Paltansing","Sunita","Department of Medical Microbiology and Infection Control, Franciscus Gasthuis &amp",NA
"1430","34182300","10.1016/j.jcv.2021.104903","Rapid screening method for the detection of SARS-CoV-2 variants of concern.","Comprehensive and up-to-date monitoring of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) is crucial as these are characterized by their increased transmissibility, immune evasion and virulence. To describe the wide-scale implementation of a reverse transcriptase polymerase chain reaction (RT-PCR) multiple variants assay with melting curve analysis as a routine procedure. We prospectively performed multiple variants RT-PCR on consecutive SARS-CoV-2 RT-PCR ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","COVID-19; Melting curve; PCR; SARS-CoV-2; Variants; screening","de Man","Peter","Department of Medical Microbiology and Infection Control, Franciscus Gasthuis &amp",NA
"1431","34182299","10.1016/j.jcv.2021.104894","Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7.","New SARS-CoV-2 variants with increased transmissibility, like B.1.1.7, first detected in England or B.1.351, first detected in South Africa, have caused considerable concern worldwide. In order to contain the spread of these lineages, it is of utmost importance to have rapid, sensitive and high-throughput detection methods at hand. A set of RT-qPCR assays was modified for a diagnostic SARS-CoV-2 multiplex assay including detection of the del-HV69/70 and N501Y mutations on the cobas6800 platform.","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Del-HV69/70; High-throughput; N501Y; RT-qPCR; SARS-CoV-2; Variants","Nörz","Dominik","Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany",NA
"1432","34182299","10.1016/j.jcv.2021.104894","Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7.","New SARS-CoV-2 variants with increased transmissibility, like B.1.1.7, first detected in England or B.1.351, first detected in South Africa, have caused considerable concern worldwide. In order to contain the spread of these lineages, it is of utmost importance to have rapid, sensitive and high-throughput detection methods at hand. A set of RT-qPCR assays was modified for a diagnostic SARS-CoV-2 multiplex assay including detection of the del-HV69/70 and N501Y mutations on the cobas6800 platform.","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Del-HV69/70; High-throughput; N501Y; RT-qPCR; SARS-CoV-2; Variants","Grunwald","Moritz","Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany",NA
"1433","34182299","10.1016/j.jcv.2021.104894","Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7.","New SARS-CoV-2 variants with increased transmissibility, like B.1.1.7, first detected in England or B.1.351, first detected in South Africa, have caused considerable concern worldwide. In order to contain the spread of these lineages, it is of utmost importance to have rapid, sensitive and high-throughput detection methods at hand. A set of RT-qPCR assays was modified for a diagnostic SARS-CoV-2 multiplex assay including detection of the del-HV69/70 and N501Y mutations on the cobas6800 platform.","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Del-HV69/70; High-throughput; N501Y; RT-qPCR; SARS-CoV-2; Variants","Olearo","Flaminia","Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany",NA
"1434","34182299","10.1016/j.jcv.2021.104894","Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7.","New SARS-CoV-2 variants with increased transmissibility, like B.1.1.7, first detected in England or B.1.351, first detected in South Africa, have caused considerable concern worldwide. In order to contain the spread of these lineages, it is of utmost importance to have rapid, sensitive and high-throughput detection methods at hand. A set of RT-qPCR assays was modified for a diagnostic SARS-CoV-2 multiplex assay including detection of the del-HV69/70 and N501Y mutations on the cobas6800 platform.","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Del-HV69/70; High-throughput; N501Y; RT-qPCR; SARS-CoV-2; Variants","Fischer","Nicole","Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany",NA
"1435","34182299","10.1016/j.jcv.2021.104894","Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7.","New SARS-CoV-2 variants with increased transmissibility, like B.1.1.7, first detected in England or B.1.351, first detected in South Africa, have caused considerable concern worldwide. In order to contain the spread of these lineages, it is of utmost importance to have rapid, sensitive and high-throughput detection methods at hand. A set of RT-qPCR assays was modified for a diagnostic SARS-CoV-2 multiplex assay including detection of the del-HV69/70 and N501Y mutations on the cobas6800 platform.","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Del-HV69/70; High-throughput; N501Y; RT-qPCR; SARS-CoV-2; Variants","Aepfelbacher","Martin","Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany",NA
"1436","34182299","10.1016/j.jcv.2021.104894","Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7.","New SARS-CoV-2 variants with increased transmissibility, like B.1.1.7, first detected in England or B.1.351, first detected in South Africa, have caused considerable concern worldwide. In order to contain the spread of these lineages, it is of utmost importance to have rapid, sensitive and high-throughput detection methods at hand. A set of RT-qPCR assays was modified for a diagnostic SARS-CoV-2 multiplex assay including detection of the del-HV69/70 and N501Y mutations on the cobas6800 platform.","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Del-HV69/70; High-throughput; N501Y; RT-qPCR; SARS-CoV-2; Variants","Pfefferle","Susanne","Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany",NA
"1437","34182299","10.1016/j.jcv.2021.104894","Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7.","New SARS-CoV-2 variants with increased transmissibility, like B.1.1.7, first detected in England or B.1.351, first detected in South Africa, have caused considerable concern worldwide. In order to contain the spread of these lineages, it is of utmost importance to have rapid, sensitive and high-throughput detection methods at hand. A set of RT-qPCR assays was modified for a diagnostic SARS-CoV-2 multiplex assay including detection of the del-HV69/70 and N501Y mutations on the cobas6800 platform.","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Del-HV69/70; High-throughput; N501Y; RT-qPCR; SARS-CoV-2; Variants","Lütgehetmann","Marc","Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. Electronic address: mluetgeh@uke","mluetgeh@uke.de"
"1438","34182270","10.1016/j.psychres.2021.114069","Help-seeking intentions in the U.S. population during the COVID-19 pandemic: Examining the role of COVID-19 financial hardship, suicide risk, and stigma.","The primary goal of this study was to increase understanding of help-seeking intentions in the U.S. population during the COVID-19 pandemic and to examine influencing factors such as COVID-19 financial hardship, suicide risk, and stigma in order to contribute to effective theory-based help-seeking and suicide prevention campaigns. In a representative sample of U.S. adults (N = 5,010), this research tested whether COVID-19 financial hardship was associated with higher levels of depression and sui","2021","07","23","Psychiatry Res","Psychiatry research","Depression; Health promotion; Reasoned Action Theory; Suicide prevention","Lueck","Jennifer A","Department of Communication, Texas A&amp","jlueck@tamu.edu"
"1439","34182261","10.1016/j.jclinane.2021.110406","Effect of prone versus supine position in COVID-19 patients: A systematic review and meta-analysis.","To review the effects of prone position and supine position on oxygenation parameters in patients with Coronavirus Disease 2019 (COVID-19). Systematic review and meta-analysis of non-randomized trials. Databases of EMBASE, MEDLINE and CENTRAL were systematically searched from its inception until March 2021. COVID-19 patients being positioned in the prone position either whilst awake or mechanically ventilated. Primary outcomes were oxygenation parameters (PaO2/FiO2 ratio, PaCO2, SpO2). Secondary","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus Disease 2019; Meta-analysis; Oxygenation; Prone; Supine","Chua","Ee Xin","Department of Anaesthesiology, Faculty of Medicine, University of Malaya, Jalan Universiti, Kuala Lumpur, Malaysia",NA
"1440","34182261","10.1016/j.jclinane.2021.110406","Effect of prone versus supine position in COVID-19 patients: A systematic review and meta-analysis.","To review the effects of prone position and supine position on oxygenation parameters in patients with Coronavirus Disease 2019 (COVID-19). Systematic review and meta-analysis of non-randomized trials. Databases of EMBASE, MEDLINE and CENTRAL were systematically searched from its inception until March 2021. COVID-19 patients being positioned in the prone position either whilst awake or mechanically ventilated. Primary outcomes were oxygenation parameters (PaO2/FiO2 ratio, PaCO2, SpO2). Secondary","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus Disease 2019; Meta-analysis; Oxygenation; Prone; Supine","Zahir","Syed Mohd Ikhmal Syed Mohd","Department of Anaesthesiology, Faculty of Medicine, University of Malaya, Jalan Universiti, Kuala Lumpur, Malaysia",NA
"1441","34182261","10.1016/j.jclinane.2021.110406","Effect of prone versus supine position in COVID-19 patients: A systematic review and meta-analysis.","To review the effects of prone position and supine position on oxygenation parameters in patients with Coronavirus Disease 2019 (COVID-19). Systematic review and meta-analysis of non-randomized trials. Databases of EMBASE, MEDLINE and CENTRAL were systematically searched from its inception until March 2021. COVID-19 patients being positioned in the prone position either whilst awake or mechanically ventilated. Primary outcomes were oxygenation parameters (PaO2/FiO2 ratio, PaCO2, SpO2). Secondary","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus Disease 2019; Meta-analysis; Oxygenation; Prone; Supine","Ng","Ka Ting","Department of Anaesthesiology, Faculty of Medicine, University of Malaya, Jalan Universiti, Kuala Lumpur, Malaysia. Electronic address: katingng1@gmail","katingng1@gmail.com"
"1442","34182261","10.1016/j.jclinane.2021.110406","Effect of prone versus supine position in COVID-19 patients: A systematic review and meta-analysis.","To review the effects of prone position and supine position on oxygenation parameters in patients with Coronavirus Disease 2019 (COVID-19). Systematic review and meta-analysis of non-randomized trials. Databases of EMBASE, MEDLINE and CENTRAL were systematically searched from its inception until March 2021. COVID-19 patients being positioned in the prone position either whilst awake or mechanically ventilated. Primary outcomes were oxygenation parameters (PaO2/FiO2 ratio, PaCO2, SpO2). Secondary","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus Disease 2019; Meta-analysis; Oxygenation; Prone; Supine","Teoh","Wan Yi","Faculty of Medicine, University of Liverpool, Liverpool L69 3BX, United Kingdom",NA
"1443","34182261","10.1016/j.jclinane.2021.110406","Effect of prone versus supine position in COVID-19 patients: A systematic review and meta-analysis.","To review the effects of prone position and supine position on oxygenation parameters in patients with Coronavirus Disease 2019 (COVID-19). Systematic review and meta-analysis of non-randomized trials. Databases of EMBASE, MEDLINE and CENTRAL were systematically searched from its inception until March 2021. COVID-19 patients being positioned in the prone position either whilst awake or mechanically ventilated. Primary outcomes were oxygenation parameters (PaO2/FiO2 ratio, PaCO2, SpO2). Secondary","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus Disease 2019; Meta-analysis; Oxygenation; Prone; Supine","Hasan","Mohd Shahnaz","Department of Anaesthesiology, Faculty of Medicine, University of Malaya, Jalan Universiti, Kuala Lumpur, Malaysia",NA
"1444","34182261","10.1016/j.jclinane.2021.110406","Effect of prone versus supine position in COVID-19 patients: A systematic review and meta-analysis.","To review the effects of prone position and supine position on oxygenation parameters in patients with Coronavirus Disease 2019 (COVID-19). Systematic review and meta-analysis of non-randomized trials. Databases of EMBASE, MEDLINE and CENTRAL were systematically searched from its inception until March 2021. COVID-19 patients being positioned in the prone position either whilst awake or mechanically ventilated. Primary outcomes were oxygenation parameters (PaO2/FiO2 ratio, PaCO2, SpO2). Secondary","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus Disease 2019; Meta-analysis; Oxygenation; Prone; Supine","Ruslan","Shairil Rahayu Binti","Department of Anaesthesiology, Faculty of Medicine, University of Malaya, Jalan Universiti, Kuala Lumpur, Malaysia",NA
"1445","34182261","10.1016/j.jclinane.2021.110406","Effect of prone versus supine position in COVID-19 patients: A systematic review and meta-analysis.","To review the effects of prone position and supine position on oxygenation parameters in patients with Coronavirus Disease 2019 (COVID-19). Systematic review and meta-analysis of non-randomized trials. Databases of EMBASE, MEDLINE and CENTRAL were systematically searched from its inception until March 2021. COVID-19 patients being positioned in the prone position either whilst awake or mechanically ventilated. Primary outcomes were oxygenation parameters (PaO2/FiO2 ratio, PaCO2, SpO2). Secondary","2021","07","19","J Clin Anesth","Journal of clinical anesthesia","Coronavirus Disease 2019; Meta-analysis; Oxygenation; Prone; Supine","Abosamak","Mohammed F","Department of Anaesthesia and Intensive care medicine, Faculty of medicine, Tanta University, Egypt",NA
"1446","34182256","10.1016/j.puhe.2021.05.010","A forensic analysis of SARS-CoV-2 cases and COVID-19 mortality misreporting in the Brazilian population.","The study aimed to investigate the misreporting number of positively tested individuals for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) succumbed or not to coronavirus disease 2019 (COVID-19) pandemic in Brazil at the city, state, and national scales using statistical forensic analysis. This is a register-based study over public health data collected, organized, and maintained by the Ministry of Health covering the Brazilian population. We evaluated the Brazilian notifications o","2021","07","21","Public Health","Public health","Benford's law; Brazil SARS-CoV-2 pandemic; COVID-19; SARS-CoV-2 misreporting","Galvêas","D","FUCAPE Business School, Vitória-ES, Brazil",NA
"1447","34182256","10.1016/j.puhe.2021.05.010","A forensic analysis of SARS-CoV-2 cases and COVID-19 mortality misreporting in the Brazilian population.","The study aimed to investigate the misreporting number of positively tested individuals for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) succumbed or not to coronavirus disease 2019 (COVID-19) pandemic in Brazil at the city, state, and national scales using statistical forensic analysis. This is a register-based study over public health data collected, organized, and maintained by the Ministry of Health covering the Brazilian population. We evaluated the Brazilian notifications o","2021","07","21","Public Health","Public health","Benford's law; Brazil SARS-CoV-2 pandemic; COVID-19; SARS-CoV-2 misreporting","Barros","F","School of Economics, Business Administration and Accounting of Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil. Electronic address: fabarrosjr@usp","fabarrosjr@usp.br"
"1448","34182256","10.1016/j.puhe.2021.05.010","A forensic analysis of SARS-CoV-2 cases and COVID-19 mortality misreporting in the Brazilian population.","The study aimed to investigate the misreporting number of positively tested individuals for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) succumbed or not to coronavirus disease 2019 (COVID-19) pandemic in Brazil at the city, state, and national scales using statistical forensic analysis. This is a register-based study over public health data collected, organized, and maintained by the Ministry of Health covering the Brazilian population. We evaluated the Brazilian notifications o","2021","07","21","Public Health","Public health","Benford's law; Brazil SARS-CoV-2 pandemic; COVID-19; SARS-CoV-2 misreporting","Fuzo","C A","Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil. Electronic address: cafuzo@usp","cafuzo@usp.br"
"1449","34182207","10.1016/j.jneuroim.2021.577606","A case of longitudinally extensive transverse myelitis following vaccination against Covid-19.","Longitudinally extensive transverse myelitis (LETM) is a rare subtype of transverse myelitis (TM) that potentially results in relevant disability. Apart from association to neuromyelitis optica and other chronic demyelinating diseases of the central nervous system, many other aetiologies are known. Particularly systemic infections and vaccination are considered potential triggers for immune mediated inflammation of the spinal cord. In the course of the current Covid-19 pandemic several cases of ","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","Covid-19; Covid-19 vaccination; Longitudinally extensive transverse myelitis; SARS-CoV-2; Transverse myelitis; Vaccine related disorder","Pagenkopf","Claudia","Klinikum Ernst von Bergmann, Department of Neurology, Charlottenstrasse 72, 14467 Potsdam, Germany. Electronic address: claudia.pagenkopf@klinikumevb","claudia.pagenkopf@klinikumevb.de"
"1450","34182207","10.1016/j.jneuroim.2021.577606","A case of longitudinally extensive transverse myelitis following vaccination against Covid-19.","Longitudinally extensive transverse myelitis (LETM) is a rare subtype of transverse myelitis (TM) that potentially results in relevant disability. Apart from association to neuromyelitis optica and other chronic demyelinating diseases of the central nervous system, many other aetiologies are known. Particularly systemic infections and vaccination are considered potential triggers for immune mediated inflammation of the spinal cord. In the course of the current Covid-19 pandemic several cases of ","2021","07","23","J Neuroimmunol","Journal of neuroimmunology","Covid-19; Covid-19 vaccination; Longitudinally extensive transverse myelitis; SARS-CoV-2; Transverse myelitis; Vaccine related disorder","Südmeyer","Martin","Klinikum Ernst von Bergmann, Department of Neurology, Charlottenstrasse 72, 14467 Potsdam, Germany","martin.suedmeyer@klinikumevb.de"
"1451","34182190","10.1016/j.meegid.2021.104980","Replication and vaccine protection of multiple infectious bronchitis virus strains in pheasants (Phasianus colchicus).","This study demonstrates that infectious bronchitis virus (IBV) strain M41, which is pathogenic for chickens, is nonpathogenic for pheasants. However, M41 replicated in the respiratory tracts of most inoculated pheasants and the virus was shed from their respiratory tracts in the early stages of infection (4 and 8 dpc). Similarly, the attenuated IBV H120 vaccine strain also replicated and the virus was shed from their respiratory tracts of most inoculated pheasants, whereas the pheasant coronavir","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","Infectious bronchitis virus; Pheasant coronavirus; Protection; Replication; Vaccination","Han","Zongxi","Division of Avian Infectious Diseases, The State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, People's Republic of China",NA
"1452","34182190","10.1016/j.meegid.2021.104980","Replication and vaccine protection of multiple infectious bronchitis virus strains in pheasants (Phasianus colchicus).","This study demonstrates that infectious bronchitis virus (IBV) strain M41, which is pathogenic for chickens, is nonpathogenic for pheasants. However, M41 replicated in the respiratory tracts of most inoculated pheasants and the virus was shed from their respiratory tracts in the early stages of infection (4 and 8 dpc). Similarly, the attenuated IBV H120 vaccine strain also replicated and the virus was shed from their respiratory tracts of most inoculated pheasants, whereas the pheasant coronavir","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","Infectious bronchitis virus; Pheasant coronavirus; Protection; Replication; Vaccination","Xu","Xiaochen","Division of Avian Infectious Diseases, The State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, People's Republic of China",NA
"1453","34182190","10.1016/j.meegid.2021.104980","Replication and vaccine protection of multiple infectious bronchitis virus strains in pheasants (Phasianus colchicus).","This study demonstrates that infectious bronchitis virus (IBV) strain M41, which is pathogenic for chickens, is nonpathogenic for pheasants. However, M41 replicated in the respiratory tracts of most inoculated pheasants and the virus was shed from their respiratory tracts in the early stages of infection (4 and 8 dpc). Similarly, the attenuated IBV H120 vaccine strain also replicated and the virus was shed from their respiratory tracts of most inoculated pheasants, whereas the pheasant coronavir","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","Infectious bronchitis virus; Pheasant coronavirus; Protection; Replication; Vaccination","Li","Huixin","Division of Avian Infectious Diseases, The State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, People's Republic of China",NA
"1454","34182190","10.1016/j.meegid.2021.104980","Replication and vaccine protection of multiple infectious bronchitis virus strains in pheasants (Phasianus colchicus).","This study demonstrates that infectious bronchitis virus (IBV) strain M41, which is pathogenic for chickens, is nonpathogenic for pheasants. However, M41 replicated in the respiratory tracts of most inoculated pheasants and the virus was shed from their respiratory tracts in the early stages of infection (4 and 8 dpc). Similarly, the attenuated IBV H120 vaccine strain also replicated and the virus was shed from their respiratory tracts of most inoculated pheasants, whereas the pheasant coronavir","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","Infectious bronchitis virus; Pheasant coronavirus; Protection; Replication; Vaccination","Zhang","Lili","Division of Avian Infectious Diseases, The State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, People's Republic of China",NA
"1455","34182190","10.1016/j.meegid.2021.104980","Replication and vaccine protection of multiple infectious bronchitis virus strains in pheasants (Phasianus colchicus).","This study demonstrates that infectious bronchitis virus (IBV) strain M41, which is pathogenic for chickens, is nonpathogenic for pheasants. However, M41 replicated in the respiratory tracts of most inoculated pheasants and the virus was shed from their respiratory tracts in the early stages of infection (4 and 8 dpc). Similarly, the attenuated IBV H120 vaccine strain also replicated and the virus was shed from their respiratory tracts of most inoculated pheasants, whereas the pheasant coronavir","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","Infectious bronchitis virus; Pheasant coronavirus; Protection; Replication; Vaccination","Hou","Yutong","Division of Avian Infectious Diseases, The State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, People's Republic of China",NA
"1456","34182190","10.1016/j.meegid.2021.104980","Replication and vaccine protection of multiple infectious bronchitis virus strains in pheasants (Phasianus colchicus).","This study demonstrates that infectious bronchitis virus (IBV) strain M41, which is pathogenic for chickens, is nonpathogenic for pheasants. However, M41 replicated in the respiratory tracts of most inoculated pheasants and the virus was shed from their respiratory tracts in the early stages of infection (4 and 8 dpc). Similarly, the attenuated IBV H120 vaccine strain also replicated and the virus was shed from their respiratory tracts of most inoculated pheasants, whereas the pheasant coronavir","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","Infectious bronchitis virus; Pheasant coronavirus; Protection; Replication; Vaccination","Liu","Shengwang","Division of Avian Infectious Diseases, The State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, People's Republic of China. Electronic address: liushengwang@caas","liushengwang@caas.cn"
"1457","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Daste","Camille","Université de Paris, Faculté de Santé, UFR Médecine de Paris Centre, 75006 Paris, France","camille.daste@aphp.fr"
"1458","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Ficarra","Simona","AP-HP, Centre-Université de Paris, Hôpital Cochin, Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis, 75014 Paris, France",NA
"1459","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Dumitrache","Alina","AP-HP, Centre-Université de Paris, Hôpital Corentin Celton, Service de Rééducation et de Réadaptation, 92130 Issy-les-Moulineaux, France",NA
"1460","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Cariou","Alain","AP-HP, Centre-Université de Paris, Hôpital Cochin, Service de Médecine intensive et Réanimation, 75014 Paris, France",NA
"1461","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Lefèbvre","Aurélie","AP-HP, Centre-Université de Paris, Hôpital Cochin, Service de Pneumologie, 75014 Paris, France",NA
"1462","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Pène","Frédéric","AP-HP, Centre-Université de Paris, Hôpital Corentin Celton, Service de Rééducation et de Réadaptation, 92130 Issy-les-Moulineaux, France",NA
"1463","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Roche","Nicolas","AP-HP, Centre-Université de Paris, Hôpital Cochin, Service de Pneumologie, 75014 Paris, France",NA
"1464","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Roren","Alexandra","AP-HP, Centre-Université de Paris, Hôpital Cochin, Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis, 75014 Paris, France",NA
"1465","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Thery","Camille","AP-HP, Centre-Université de Paris, Hôpital Cochin, Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis, 75014 Paris, France",NA
"1466","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Vidal","Jean","AP-HP, Centre-Université de Paris, Hôpital Corentin Celton, Service de Rééducation et de Réadaptation, 92130 Issy-les-Moulineaux, France",NA
"1467","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Nguyen","Christelle","Université de Paris, Faculté de Santé, UFR Médecine de Paris Centre, 75006 Paris, France",NA
"1468","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Rannou","François","Université de Paris, Faculté de Santé, UFR Médecine de Paris Centre, 75006 Paris, France",NA
"1469","34182168","10.1016/j.rehab.2021.101549","Post-intensive care syndrome in patients surviving COVID-19.",NA,"2021","07","01","Ann Phys Rehabil Med","Annals of physical and rehabilitation medicine",NA,"Lefèvre-Colau","Marie-Martine","Université de Paris, Faculté de Santé, UFR Médecine de Paris Centre, 75006 Paris, France",NA
"1470","34182166","10.1016/j.accpm.2021.100919","Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).",NA,"2021","07","01","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Anticoagulation; Bleeding risk; COVID-19; Thromboprophylaxis; Thrombotic risk; Venous thromboembolism","Godon","Alexandre","Department of Anaesthesiology and Critical Care, Université Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France. Electronic address: agodon1@chu-grenoble",NA
"1471","34182166","10.1016/j.accpm.2021.100919","Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).",NA,"2021","07","01","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Anticoagulation; Bleeding risk; COVID-19; Thromboprophylaxis; Thrombotic risk; Venous thromboembolism","Tacquard","Charles Ambroise","Department of Anaesthesia and Intensive Care, Hôpitaux Universitaires de Strasbourg, Strasbourg, France",NA
"1472","34182166","10.1016/j.accpm.2021.100919","Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).",NA,"2021","07","01","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Anticoagulation; Bleeding risk; COVID-19; Thromboprophylaxis; Thrombotic risk; Venous thromboembolism","Mansour","Alexandre","Department of Anaesthesiology Critical Care Medicine and Perioperative Medicine, CHU de Rennes, France",NA
"1473","34182166","10.1016/j.accpm.2021.100919","Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).",NA,"2021","07","01","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Anticoagulation; Bleeding risk; COVID-19; Thromboprophylaxis; Thrombotic risk; Venous thromboembolism","Garrigue","Delphine","Department of Anaesthesia and Critical Care, CHU de Lille, France",NA
"1474","34182166","10.1016/j.accpm.2021.100919","Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).",NA,"2021","07","01","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Anticoagulation; Bleeding risk; COVID-19; Thromboprophylaxis; Thrombotic risk; Venous thromboembolism","Nguyen","Philippe","Department of Haematology Laboratory, CHU de Reims, France",NA
"1475","34182166","10.1016/j.accpm.2021.100919","Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).",NA,"2021","07","01","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Anticoagulation; Bleeding risk; COVID-19; Thromboprophylaxis; Thrombotic risk; Venous thromboembolism","Lasne","Dominique","Department of Haematology Laboratory, Hôpital Necker, AP-HP, Paris, France",NA
"1476","34182166","10.1016/j.accpm.2021.100919","Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).",NA,"2021","07","01","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Anticoagulation; Bleeding risk; COVID-19; Thromboprophylaxis; Thrombotic risk; Venous thromboembolism","Testa","Sophie","AO Istituti Ospitalieri, Cremona, Italy",NA
"1477","34182166","10.1016/j.accpm.2021.100919","Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).",NA,"2021","07","01","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Anticoagulation; Bleeding risk; COVID-19; Thromboprophylaxis; Thrombotic risk; Venous thromboembolism","Levy","Jerrold H","Department of Anaesthesiology, Critical Care, and Surgery, Duke University Hospital, Durham, NC, USA",NA
"1478","34182166","10.1016/j.accpm.2021.100919","Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).",NA,"2021","07","01","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Anticoagulation; Bleeding risk; COVID-19; Thromboprophylaxis; Thrombotic risk; Venous thromboembolism","Albaladejo","Pierre","Department of Anaesthesiology and Critical Care, Université Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France",NA
"1479","34182166","10.1016/j.accpm.2021.100919","Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).",NA,"2021","07","01","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Anticoagulation; Bleeding risk; COVID-19; Thromboprophylaxis; Thrombotic risk; Venous thromboembolism","Gruel","Yves","Department of Haematology-Haemostasis, Hôpital Universitaire de Tours, France",NA
"1480","34182166","10.1016/j.accpm.2021.100919","Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).",NA,"2021","07","01","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Anticoagulation; Bleeding risk; COVID-19; Thromboprophylaxis; Thrombotic risk; Venous thromboembolism","Susen","Sophie","Department of Haematology and Transfusion, Université de Lille, Lille, France",NA
"1481","34182166","10.1016/j.accpm.2021.100919","Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).",NA,"2021","07","01","Anaesth Crit Care Pain Med","Anaesthesia, critical care &amp; pain medicine","Anticoagulation; Bleeding risk; COVID-19; Thromboprophylaxis; Thrombotic risk; Venous thromboembolism","Godier","Anne","Department of Anaesthesia and Intensive Care, AP-HP, Hôpital Européen Georges Pompidou, and INSERM UMRS-1140, Université de Paris, France",NA
"1482","34182162","10.1016/j.jaip.2021.06.019","Common Variable Immunodeficiency Disorders, T cell responses to SARS-CoV-2 vaccines and the risk of Chronic COVID-19.","COVID-19 has had a calamitous effect on the global community. In spite of intense study, the immunological response to the infection is only partially understood. In addition to older age and ethnicity, patients with co-morbidities including obesity, diabetes, hypertension, coronary artery disease, malignancy, renal and pulmonary disease, may experience severe outcomes. Some patients with primary and secondary immunodeficiencies also appear to be at increased risk from COVID-19. In addition to t","2021","07","01","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Antibody tests; COVID-19; CVID; CVID-like disorders; SARS-CoV-2; T cell assays; Vaccination","Ameratunga","Rohan","Department of Clinical immunology, Auckland Hospital, Park Rd, Grafton 1010, Auckland New Zealand","rohana@adhb.govt.nz"
"1483","34182162","10.1016/j.jaip.2021.06.019","Common Variable Immunodeficiency Disorders, T cell responses to SARS-CoV-2 vaccines and the risk of Chronic COVID-19.","COVID-19 has had a calamitous effect on the global community. In spite of intense study, the immunological response to the infection is only partially understood. In addition to older age and ethnicity, patients with co-morbidities including obesity, diabetes, hypertension, coronary artery disease, malignancy, renal and pulmonary disease, may experience severe outcomes. Some patients with primary and secondary immunodeficiencies also appear to be at increased risk from COVID-19. In addition to t","2021","07","01","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Antibody tests; COVID-19; CVID; CVID-like disorders; SARS-CoV-2; T cell assays; Vaccination","Longhurst","Hilary","Department of Clinical immunology, Auckland Hospital, Park Rd, Grafton 1010, Auckland New Zealand",NA
"1484","34182162","10.1016/j.jaip.2021.06.019","Common Variable Immunodeficiency Disorders, T cell responses to SARS-CoV-2 vaccines and the risk of Chronic COVID-19.","COVID-19 has had a calamitous effect on the global community. In spite of intense study, the immunological response to the infection is only partially understood. In addition to older age and ethnicity, patients with co-morbidities including obesity, diabetes, hypertension, coronary artery disease, malignancy, renal and pulmonary disease, may experience severe outcomes. Some patients with primary and secondary immunodeficiencies also appear to be at increased risk from COVID-19. In addition to t","2021","07","01","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Antibody tests; COVID-19; CVID; CVID-like disorders; SARS-CoV-2; T cell assays; Vaccination","Steele","Richard","Department of Virology and Immunology, Auckland Hospital, Park Rd, Grafton 1010, Auckland, New Zealand",NA
"1485","34182162","10.1016/j.jaip.2021.06.019","Common Variable Immunodeficiency Disorders, T cell responses to SARS-CoV-2 vaccines and the risk of Chronic COVID-19.","COVID-19 has had a calamitous effect on the global community. In spite of intense study, the immunological response to the infection is only partially understood. In addition to older age and ethnicity, patients with co-morbidities including obesity, diabetes, hypertension, coronary artery disease, malignancy, renal and pulmonary disease, may experience severe outcomes. Some patients with primary and secondary immunodeficiencies also appear to be at increased risk from COVID-19. In addition to t","2021","07","01","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Antibody tests; COVID-19; CVID; CVID-like disorders; SARS-CoV-2; T cell assays; Vaccination","Lehnert","Klaus","Centre for Brain Research, School of Biological Sciences, University of Auckland, Symonds St, Auckland, New Zealand",NA
"1486","34182162","10.1016/j.jaip.2021.06.019","Common Variable Immunodeficiency Disorders, T cell responses to SARS-CoV-2 vaccines and the risk of Chronic COVID-19.","COVID-19 has had a calamitous effect on the global community. In spite of intense study, the immunological response to the infection is only partially understood. In addition to older age and ethnicity, patients with co-morbidities including obesity, diabetes, hypertension, coronary artery disease, malignancy, renal and pulmonary disease, may experience severe outcomes. Some patients with primary and secondary immunodeficiencies also appear to be at increased risk from COVID-19. In addition to t","2021","07","01","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Antibody tests; COVID-19; CVID; CVID-like disorders; SARS-CoV-2; T cell assays; Vaccination","Leung","Euphemia","Auckland Cancer Society Research Centre, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand",NA
"1487","34182162","10.1016/j.jaip.2021.06.019","Common Variable Immunodeficiency Disorders, T cell responses to SARS-CoV-2 vaccines and the risk of Chronic COVID-19.","COVID-19 has had a calamitous effect on the global community. In spite of intense study, the immunological response to the infection is only partially understood. In addition to older age and ethnicity, patients with co-morbidities including obesity, diabetes, hypertension, coronary artery disease, malignancy, renal and pulmonary disease, may experience severe outcomes. Some patients with primary and secondary immunodeficiencies also appear to be at increased risk from COVID-19. In addition to t","2021","07","01","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Antibody tests; COVID-19; CVID; CVID-like disorders; SARS-CoV-2; T cell assays; Vaccination","Brooks","Anna E S","Maurice Wilkins Centre, School of Biological Sciences, University of Auckland, Symonds St, Auckland, New Zealand",NA
"1488","34182162","10.1016/j.jaip.2021.06.019","Common Variable Immunodeficiency Disorders, T cell responses to SARS-CoV-2 vaccines and the risk of Chronic COVID-19.","COVID-19 has had a calamitous effect on the global community. In spite of intense study, the immunological response to the infection is only partially understood. In addition to older age and ethnicity, patients with co-morbidities including obesity, diabetes, hypertension, coronary artery disease, malignancy, renal and pulmonary disease, may experience severe outcomes. Some patients with primary and secondary immunodeficiencies also appear to be at increased risk from COVID-19. In addition to t","2021","07","01","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","Antibody tests; COVID-19; CVID; CVID-like disorders; SARS-CoV-2; T cell assays; Vaccination","Woon","See-Tarn","Department of Virology and Immunology, Auckland Hospital, Park Rd, Grafton 1010, Auckland, New Zealand",NA
"1489","34182120","10.1016/j.vascn.2021.107089","Safety pharmacology during the COVID pandemic.","This editorial summarizes the content of the current themed issue of J Pharmacol Toxicol Methods derived from the 2020 Annual Safety Pharmacology Society (SPS) meeting that was held virtually September 14-17, 2020 due to the ongoing COVID-19 global pandemic. A selection of articles arising from the virtual meeting is summarized. Like previous years they continue to reflect current areas of innovation in SP including new methodologies to predict human safety, best practices for IKr current measur","2021","07","05","J Pharmacol Toxicol Methods","Journal of pharmacological and toxicological methods",NA,"Pugsley","Michael K","Cytokinetics, South San Francisco, CA 94080, United States of America. Electronic address: mpugsley@cytokinetics","mpugsley@cytokinetics.com"
"1490","34182120","10.1016/j.vascn.2021.107089","Safety pharmacology during the COVID pandemic.","This editorial summarizes the content of the current themed issue of J Pharmacol Toxicol Methods derived from the 2020 Annual Safety Pharmacology Society (SPS) meeting that was held virtually September 14-17, 2020 due to the ongoing COVID-19 global pandemic. A selection of articles arising from the virtual meeting is summarized. Like previous years they continue to reflect current areas of innovation in SP including new methodologies to predict human safety, best practices for IKr current measur","2021","07","05","J Pharmacol Toxicol Methods","Journal of pharmacological and toxicological methods",NA,"Koshman","Yevgeniya","Abbvie, North Chicago, IL 60064, United States of America",NA
"1491","34182120","10.1016/j.vascn.2021.107089","Safety pharmacology during the COVID pandemic.","This editorial summarizes the content of the current themed issue of J Pharmacol Toxicol Methods derived from the 2020 Annual Safety Pharmacology Society (SPS) meeting that was held virtually September 14-17, 2020 due to the ongoing COVID-19 global pandemic. A selection of articles arising from the virtual meeting is summarized. Like previous years they continue to reflect current areas of innovation in SP including new methodologies to predict human safety, best practices for IKr current measur","2021","07","05","J Pharmacol Toxicol Methods","Journal of pharmacological and toxicological methods",NA,"de Korte","Tessa","Ncardia, Leiden 2333, BD, the Netherlands",NA
"1492","34182120","10.1016/j.vascn.2021.107089","Safety pharmacology during the COVID pandemic.","This editorial summarizes the content of the current themed issue of J Pharmacol Toxicol Methods derived from the 2020 Annual Safety Pharmacology Society (SPS) meeting that was held virtually September 14-17, 2020 due to the ongoing COVID-19 global pandemic. A selection of articles arising from the virtual meeting is summarized. Like previous years they continue to reflect current areas of innovation in SP including new methodologies to predict human safety, best practices for IKr current measur","2021","07","05","J Pharmacol Toxicol Methods","Journal of pharmacological and toxicological methods",NA,"Authier","Simon","Charles River Laboratories, Laval, QC H7V 4B3, Canada",NA
"1493","34182120","10.1016/j.vascn.2021.107089","Safety pharmacology during the COVID pandemic.","This editorial summarizes the content of the current themed issue of J Pharmacol Toxicol Methods derived from the 2020 Annual Safety Pharmacology Society (SPS) meeting that was held virtually September 14-17, 2020 due to the ongoing COVID-19 global pandemic. A selection of articles arising from the virtual meeting is summarized. Like previous years they continue to reflect current areas of innovation in SP including new methodologies to predict human safety, best practices for IKr current measur","2021","07","05","J Pharmacol Toxicol Methods","Journal of pharmacological and toxicological methods",NA,"Curtis","Michael J","Cardiovascular Division, King's College London, Rayne Institute, St Thomas' Hospital, London SE17EH, UK",NA
"1494","34182111","10.1016/j.avsg.2021.05.012","Treatment-Resistant Acute Upper Limb Ischemia in a Patient With Systemic Lupus Erythematous and Concomitant SARS-CoV-2 Infection: A Case Report.","To describe the case of a young female patient, affected by Systemic Lupus Erythematous, hospitalized for severe SARS-CoV-2 infection pneumonia and presenting a treatment-resistant acute upper limb ischemia. Two days after hospital admission, the patient suffered sudden right upper limb pain associated with mild functional impairment. At physical examination, radial and ulnar pulses were absent, and no flow signal was detected at duplex ultrasound scan. Therefore, an acute limb ischemia diagnose","2021","07","19","Ann Vasc Surg","Annals of vascular surgery","COVID 19; SARS-CoV-2; acute limb ischemia; arterial thrombosis","Nespola","Martina","Department of Clinical and Molecular Medicine, ``Sapienza'' University of Rome, Italy",NA
"1495","34182111","10.1016/j.avsg.2021.05.012","Treatment-Resistant Acute Upper Limb Ischemia in a Patient With Systemic Lupus Erythematous and Concomitant SARS-CoV-2 Infection: A Case Report.","To describe the case of a young female patient, affected by Systemic Lupus Erythematous, hospitalized for severe SARS-CoV-2 infection pneumonia and presenting a treatment-resistant acute upper limb ischemia. Two days after hospital admission, the patient suffered sudden right upper limb pain associated with mild functional impairment. At physical examination, radial and ulnar pulses were absent, and no flow signal was detected at duplex ultrasound scan. Therefore, an acute limb ischemia diagnose","2021","07","19","Ann Vasc Surg","Annals of vascular surgery","COVID 19; SARS-CoV-2; acute limb ischemia; arterial thrombosis","Sirignano","Pasqualino","Department of Surgery ""Paride Stefanini"", ""Sapienza"" University of Rome, Italy,","pasqualino.sirignano@uniroma1.it"
"1496","34182111","10.1016/j.avsg.2021.05.012","Treatment-Resistant Acute Upper Limb Ischemia in a Patient With Systemic Lupus Erythematous and Concomitant SARS-CoV-2 Infection: A Case Report.","To describe the case of a young female patient, affected by Systemic Lupus Erythematous, hospitalized for severe SARS-CoV-2 infection pneumonia and presenting a treatment-resistant acute upper limb ischemia. Two days after hospital admission, the patient suffered sudden right upper limb pain associated with mild functional impairment. At physical examination, radial and ulnar pulses were absent, and no flow signal was detected at duplex ultrasound scan. Therefore, an acute limb ischemia diagnose","2021","07","19","Ann Vasc Surg","Annals of vascular surgery","COVID 19; SARS-CoV-2; acute limb ischemia; arterial thrombosis","Fermani","Nicoletta","Department of Clinical and Molecular Medicine, ``Sapienza'' University of Rome, Italy",NA
"1497","34182111","10.1016/j.avsg.2021.05.012","Treatment-Resistant Acute Upper Limb Ischemia in a Patient With Systemic Lupus Erythematous and Concomitant SARS-CoV-2 Infection: A Case Report.","To describe the case of a young female patient, affected by Systemic Lupus Erythematous, hospitalized for severe SARS-CoV-2 infection pneumonia and presenting a treatment-resistant acute upper limb ischemia. Two days after hospital admission, the patient suffered sudden right upper limb pain associated with mild functional impairment. At physical examination, radial and ulnar pulses were absent, and no flow signal was detected at duplex ultrasound scan. Therefore, an acute limb ischemia diagnose","2021","07","19","Ann Vasc Surg","Annals of vascular surgery","COVID 19; SARS-CoV-2; acute limb ischemia; arterial thrombosis","Battocchio","Cesare","Department of Clinical and Molecular Medicine, ``Sapienza'' University of Rome, Italy",NA
"1498","34182111","10.1016/j.avsg.2021.05.012","Treatment-Resistant Acute Upper Limb Ischemia in a Patient With Systemic Lupus Erythematous and Concomitant SARS-CoV-2 Infection: A Case Report.","To describe the case of a young female patient, affected by Systemic Lupus Erythematous, hospitalized for severe SARS-CoV-2 infection pneumonia and presenting a treatment-resistant acute upper limb ischemia. Two days after hospital admission, the patient suffered sudden right upper limb pain associated with mild functional impairment. At physical examination, radial and ulnar pulses were absent, and no flow signal was detected at duplex ultrasound scan. Therefore, an acute limb ischemia diagnose","2021","07","19","Ann Vasc Surg","Annals of vascular surgery","COVID 19; SARS-CoV-2; acute limb ischemia; arterial thrombosis","Tosti","Filomena","Department of Clinical and Molecular Medicine, ``Sapienza'' University of Rome, Italy",NA
"1499","34182111","10.1016/j.avsg.2021.05.012","Treatment-Resistant Acute Upper Limb Ischemia in a Patient With Systemic Lupus Erythematous and Concomitant SARS-CoV-2 Infection: A Case Report.","To describe the case of a young female patient, affected by Systemic Lupus Erythematous, hospitalized for severe SARS-CoV-2 infection pneumonia and presenting a treatment-resistant acute upper limb ischemia. Two days after hospital admission, the patient suffered sudden right upper limb pain associated with mild functional impairment. At physical examination, radial and ulnar pulses were absent, and no flow signal was detected at duplex ultrasound scan. Therefore, an acute limb ischemia diagnose","2021","07","19","Ann Vasc Surg","Annals of vascular surgery","COVID 19; SARS-CoV-2; acute limb ischemia; arterial thrombosis","Pranteda","Chiara","Department of Clinical and Molecular Medicine, ``Sapienza'' University of Rome, Italy",NA
"1500","34182111","10.1016/j.avsg.2021.05.012","Treatment-Resistant Acute Upper Limb Ischemia in a Patient With Systemic Lupus Erythematous and Concomitant SARS-CoV-2 Infection: A Case Report.","To describe the case of a young female patient, affected by Systemic Lupus Erythematous, hospitalized for severe SARS-CoV-2 infection pneumonia and presenting a treatment-resistant acute upper limb ischemia. Two days after hospital admission, the patient suffered sudden right upper limb pain associated with mild functional impairment. At physical examination, radial and ulnar pulses were absent, and no flow signal was detected at duplex ultrasound scan. Therefore, an acute limb ischemia diagnose","2021","07","19","Ann Vasc Surg","Annals of vascular surgery","COVID 19; SARS-CoV-2; acute limb ischemia; arterial thrombosis","Taurino","Maurizio","Department of Clinical and Molecular Medicine, ``Sapienza'' University of Rome, Italy",NA
"1501","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Salomon","Tom","School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel",NA
"1502","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Cohen","Adi","School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel",NA
"1503","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Barazany","Daniel","The Strauss Center for Computational Neuroimaging, Tel Aviv University, Tel Aviv, Israel",NA
"1504","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Ben-Zvi","Gal","School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel",NA
"1505","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Botvinik-Nezer","Rotem","School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel",NA
"1506","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Gera","Rani","School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel",NA
"1507","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Oren","Shiran","School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel",NA
"1508","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Roll","Dana","School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel",NA
"1509","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Rozic","Gal","School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel",NA
"1510","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Saliy","Anastasia","School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel",NA
"1511","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Tik","Niv","Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel",NA
"1512","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Tsarfati","Galia","Division of Diagnostic Imaging, Sheba Medical Center, Tel-Hashomer, affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel",NA
"1513","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Tavor","Ido","Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel",NA
"1514","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Schonberg","Tom","School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel",NA
"1515","34182098","10.1016/j.neuroimage.2021.118311","Brain volumetric changes in the general population following the COVID-19 outbreak and lockdown.","The coronavirus disease 2019 (COVID-19) outbreak introduced unprecedented health-risks, as well as pressure on the economy, society, and psychological well-being due to the response to the outbreak. In a preregistered study, we hypothesized that the intense experience of the outbreak potentially induced stress-related brain modifications in the healthy population, not infected with the virus. We examined volumetric changes in 50 participants who underwent MRI scans before and after the COVID-19 ","2021","07","04","Neuroimage","NeuroImage",NA,"Assaf","Yaniv","School of Neurobiology, Biochemistry and Biophysics, Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel","assafyan@tauex.tau.ac.il"
"1516","34182069","10.1016/j.ajic.2021.06.012","Review of Aerosolized Hydrogen Peroxide, Vaporized Hydrogen Peroxide, and Hydrogen Peroxide Gas Plasma in the Decontamination of Filtering Facepiece Respirators.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to over 170 million cases worldwide with over 33.2 million cases and 594,000 deaths in the US alone as of May 31st, 2021.The pandemic has also created severe shortages of PPE, particularly of filtering facepiece respirators (FFRs). The Centers for Disease Control and Prevention (CDC) has issued recommendations to help conserve FFRs, as well as crisis standards, including four crit","2021","07","01","Am J Infect Control","American journal of infection control",NA,"Berger","Daniel","Penn State College of Medicine, 700 HMC Cres Rd, Hershey, Pennsylvania, 17033",NA
"1517","34182069","10.1016/j.ajic.2021.06.012","Review of Aerosolized Hydrogen Peroxide, Vaporized Hydrogen Peroxide, and Hydrogen Peroxide Gas Plasma in the Decontamination of Filtering Facepiece Respirators.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to over 170 million cases worldwide with over 33.2 million cases and 594,000 deaths in the US alone as of May 31st, 2021.The pandemic has also created severe shortages of PPE, particularly of filtering facepiece respirators (FFRs). The Centers for Disease Control and Prevention (CDC) has issued recommendations to help conserve FFRs, as well as crisis standards, including four crit","2021","07","01","Am J Infect Control","American journal of infection control",NA,"Gundermann","Gabrielle","Penn State College of Medicine, 700 HMC Cres Rd, Hershey, Pennsylvania, 17033",NA
"1518","34182069","10.1016/j.ajic.2021.06.012","Review of Aerosolized Hydrogen Peroxide, Vaporized Hydrogen Peroxide, and Hydrogen Peroxide Gas Plasma in the Decontamination of Filtering Facepiece Respirators.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to over 170 million cases worldwide with over 33.2 million cases and 594,000 deaths in the US alone as of May 31st, 2021.The pandemic has also created severe shortages of PPE, particularly of filtering facepiece respirators (FFRs). The Centers for Disease Control and Prevention (CDC) has issued recommendations to help conserve FFRs, as well as crisis standards, including four crit","2021","07","01","Am J Infect Control","American journal of infection control",NA,"Sinha","Anjana","Penn State College of Medicine, 700 HMC Cres Rd, Hershey, Pennsylvania, 17033",NA
"1519","34182069","10.1016/j.ajic.2021.06.012","Review of Aerosolized Hydrogen Peroxide, Vaporized Hydrogen Peroxide, and Hydrogen Peroxide Gas Plasma in the Decontamination of Filtering Facepiece Respirators.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to over 170 million cases worldwide with over 33.2 million cases and 594,000 deaths in the US alone as of May 31st, 2021.The pandemic has also created severe shortages of PPE, particularly of filtering facepiece respirators (FFRs). The Centers for Disease Control and Prevention (CDC) has issued recommendations to help conserve FFRs, as well as crisis standards, including four crit","2021","07","01","Am J Infect Control","American journal of infection control",NA,"Moroi","Morgan","Penn State College of Medicine, 700 HMC Cres Rd, Hershey, Pennsylvania, 17033",NA
"1520","34182069","10.1016/j.ajic.2021.06.012","Review of Aerosolized Hydrogen Peroxide, Vaporized Hydrogen Peroxide, and Hydrogen Peroxide Gas Plasma in the Decontamination of Filtering Facepiece Respirators.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to over 170 million cases worldwide with over 33.2 million cases and 594,000 deaths in the US alone as of May 31st, 2021.The pandemic has also created severe shortages of PPE, particularly of filtering facepiece respirators (FFRs). The Centers for Disease Control and Prevention (CDC) has issued recommendations to help conserve FFRs, as well as crisis standards, including four crit","2021","07","01","Am J Infect Control","American journal of infection control",NA,"Goyal","Neerav","Penn State College of Medicine, 700 HMC Cres Rd, Hershey, Pennsylvania, 17033",NA
"1521","34182069","10.1016/j.ajic.2021.06.012","Review of Aerosolized Hydrogen Peroxide, Vaporized Hydrogen Peroxide, and Hydrogen Peroxide Gas Plasma in the Decontamination of Filtering Facepiece Respirators.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to over 170 million cases worldwide with over 33.2 million cases and 594,000 deaths in the US alone as of May 31st, 2021.The pandemic has also created severe shortages of PPE, particularly of filtering facepiece respirators (FFRs). The Centers for Disease Control and Prevention (CDC) has issued recommendations to help conserve FFRs, as well as crisis standards, including four crit","2021","07","01","Am J Infect Control","American journal of infection control",NA,"Tsai","Anthony","Penn State College of Medicine, 700 HMC Cres Rd, Hershey, Pennsylvania, 17033. Electronic address: atsai1@pennstatehealth.psu","atsai1@pennstatehealth.psu.edu"
"1522","34182068","10.1016/j.ajic.2021.06.014","Hand hygiene compliance of healthcare workers before and during the COVID-19 pandemic: A long-term follow-up study.","Information about the long-term effects of hand hygiene (HH) interventions is needed. We aimed to investigate the change in HH compliance (HHC) of healthcare workers (HCWs) once a data-driven feedback intervention was stopped, and to assess if the COVID-19 pandemic influenced the HH behavior. We conducted an observational, extension trial in a surgical department between January 2019-December 2020. Doctors (n = 19) and nurses (n = 53) were included and their HHC was measured using an electronic ","2021","07","21","Am J Infect Control","American journal of infection control","Automated hand-hygiene monitoring; Electronic monitoring systems; Infection prevention and control; Nosocomial; Real-time measurement","Stangerup","Marie","The Infection Control Unit, Bispebjerg and Frederiksberg Hospitals, Denmark",NA
"1523","34182068","10.1016/j.ajic.2021.06.014","Hand hygiene compliance of healthcare workers before and during the COVID-19 pandemic: A long-term follow-up study.","Information about the long-term effects of hand hygiene (HH) interventions is needed. We aimed to investigate the change in HH compliance (HHC) of healthcare workers (HCWs) once a data-driven feedback intervention was stopped, and to assess if the COVID-19 pandemic influenced the HH behavior. We conducted an observational, extension trial in a surgical department between January 2019-December 2020. Doctors (n = 19) and nurses (n = 53) were included and their HHC was measured using an electronic ","2021","07","21","Am J Infect Control","American journal of infection control","Automated hand-hygiene monitoring; Electronic monitoring systems; Infection prevention and control; Nosocomial; Real-time measurement","Hansen","Marco B","Konduto ApS, Denmark. Electronic address: marcobhansen@gmail","marcobhansen@gmail.com"
"1524","34182068","10.1016/j.ajic.2021.06.014","Hand hygiene compliance of healthcare workers before and during the COVID-19 pandemic: A long-term follow-up study.","Information about the long-term effects of hand hygiene (HH) interventions is needed. We aimed to investigate the change in HH compliance (HHC) of healthcare workers (HCWs) once a data-driven feedback intervention was stopped, and to assess if the COVID-19 pandemic influenced the HH behavior. We conducted an observational, extension trial in a surgical department between January 2019-December 2020. Doctors (n = 19) and nurses (n = 53) were included and their HHC was measured using an electronic ","2021","07","21","Am J Infect Control","American journal of infection control","Automated hand-hygiene monitoring; Electronic monitoring systems; Infection prevention and control; Nosocomial; Real-time measurement","Hansen","Rosa","Department of Orthopedic, Bispebjerg University Hospital, Denmark",NA
"1525","34182068","10.1016/j.ajic.2021.06.014","Hand hygiene compliance of healthcare workers before and during the COVID-19 pandemic: A long-term follow-up study.","Information about the long-term effects of hand hygiene (HH) interventions is needed. We aimed to investigate the change in HH compliance (HHC) of healthcare workers (HCWs) once a data-driven feedback intervention was stopped, and to assess if the COVID-19 pandemic influenced the HH behavior. We conducted an observational, extension trial in a surgical department between January 2019-December 2020. Doctors (n = 19) and nurses (n = 53) were included and their HHC was measured using an electronic ","2021","07","21","Am J Infect Control","American journal of infection control","Automated hand-hygiene monitoring; Electronic monitoring systems; Infection prevention and control; Nosocomial; Real-time measurement","Sode","Louise P","Department of Orthopedic, Bispebjerg University Hospital, Denmark",NA
"1526","34182068","10.1016/j.ajic.2021.06.014","Hand hygiene compliance of healthcare workers before and during the COVID-19 pandemic: A long-term follow-up study.","Information about the long-term effects of hand hygiene (HH) interventions is needed. We aimed to investigate the change in HH compliance (HHC) of healthcare workers (HCWs) once a data-driven feedback intervention was stopped, and to assess if the COVID-19 pandemic influenced the HH behavior. We conducted an observational, extension trial in a surgical department between January 2019-December 2020. Doctors (n = 19) and nurses (n = 53) were included and their HHC was measured using an electronic ","2021","07","21","Am J Infect Control","American journal of infection control","Automated hand-hygiene monitoring; Electronic monitoring systems; Infection prevention and control; Nosocomial; Real-time measurement","Hesselbo","Bjørn","The Infection Control Unit, Bispebjerg and Frederiksberg Hospitals, Denmark",NA
"1527","34182068","10.1016/j.ajic.2021.06.014","Hand hygiene compliance of healthcare workers before and during the COVID-19 pandemic: A long-term follow-up study.","Information about the long-term effects of hand hygiene (HH) interventions is needed. We aimed to investigate the change in HH compliance (HHC) of healthcare workers (HCWs) once a data-driven feedback intervention was stopped, and to assess if the COVID-19 pandemic influenced the HH behavior. We conducted an observational, extension trial in a surgical department between January 2019-December 2020. Doctors (n = 19) and nurses (n = 53) were included and their HHC was measured using an electronic ","2021","07","21","Am J Infect Control","American journal of infection control","Automated hand-hygiene monitoring; Electronic monitoring systems; Infection prevention and control; Nosocomial; Real-time measurement","Kostadinov","Krassimir","Department of Orthopedic, Bispebjerg University Hospital, Denmark",NA
"1528","34182068","10.1016/j.ajic.2021.06.014","Hand hygiene compliance of healthcare workers before and during the COVID-19 pandemic: A long-term follow-up study.","Information about the long-term effects of hand hygiene (HH) interventions is needed. We aimed to investigate the change in HH compliance (HHC) of healthcare workers (HCWs) once a data-driven feedback intervention was stopped, and to assess if the COVID-19 pandemic influenced the HH behavior. We conducted an observational, extension trial in a surgical department between January 2019-December 2020. Doctors (n = 19) and nurses (n = 53) were included and their HHC was measured using an electronic ","2021","07","21","Am J Infect Control","American journal of infection control","Automated hand-hygiene monitoring; Electronic monitoring systems; Infection prevention and control; Nosocomial; Real-time measurement","Olesen","Bente S","Department of Clinical Microbiology, Herlev and Gentofte Hospital, University of Copenhagen, Denmark",NA
"1529","34182068","10.1016/j.ajic.2021.06.014","Hand hygiene compliance of healthcare workers before and during the COVID-19 pandemic: A long-term follow-up study.","Information about the long-term effects of hand hygiene (HH) interventions is needed. We aimed to investigate the change in HH compliance (HHC) of healthcare workers (HCWs) once a data-driven feedback intervention was stopped, and to assess if the COVID-19 pandemic influenced the HH behavior. We conducted an observational, extension trial in a surgical department between January 2019-December 2020. Doctors (n = 19) and nurses (n = 53) were included and their HHC was measured using an electronic ","2021","07","21","Am J Infect Control","American journal of infection control","Automated hand-hygiene monitoring; Electronic monitoring systems; Infection prevention and control; Nosocomial; Real-time measurement","Calum","Henrik","Department of Orthopedic, Bispebjerg University Hospital, Denmark",NA
"1530","34182049","10.1053/j.ajkd.2021.06.004","De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?",NA,"2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation",NA,"Bomback","Andrew S","Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, NY 10032. Electronic address: asb68@cumc.columbia","asb68@cumc.columbia.edu"
"1531","34182049","10.1053/j.ajkd.2021.06.004","De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?",NA,"2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation",NA,"Kudose","Satoru","Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032",NA
"1532","34182049","10.1053/j.ajkd.2021.06.004","De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?",NA,"2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation",NA,"D'Agati","Vivette D","Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032",NA
"1533","34182038","10.1016/j.jviromet.2021.114221","An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research.","SARS-CoV-2 is the culprit causing Coronavirus Disease 2019 (COVID-19). For the study of SARS-CoV-2 infection in a BSL-2 laboratory, a SARS-CoV-2 pseudovirus particle (SARS2pp) production and infection system was constructed by using a lentiviral vector bearing dual-reporter genes eGFP and firefly luciferase (Luc2) for easy observation and analysis. Comparison of SARS2pp different production conditions revealed that the pseudovirus titer could be greatly improved by: 1) removing the last 19 amino","2021","07","23","J Virol Methods","Journal of virological methods","Pseudovirus; SARS-CoV-2; Susceptible cell lines; Viral entry inhibitors; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antiviral Agents; Cell Line; Genes, Reporter; Green Fluorescent Proteins; Humans; Lentivirus; Luciferases, Firefly; Neutralization Tests; Recombinant Proteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virion; Virus Internalization","Yang","Peng","College of Life Sciences, Henan Normal University, Xinxiang 453007, China",NA
"1534","34182038","10.1016/j.jviromet.2021.114221","An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research.","SARS-CoV-2 is the culprit causing Coronavirus Disease 2019 (COVID-19). For the study of SARS-CoV-2 infection in a BSL-2 laboratory, a SARS-CoV-2 pseudovirus particle (SARS2pp) production and infection system was constructed by using a lentiviral vector bearing dual-reporter genes eGFP and firefly luciferase (Luc2) for easy observation and analysis. Comparison of SARS2pp different production conditions revealed that the pseudovirus titer could be greatly improved by: 1) removing the last 19 amino","2021","07","23","J Virol Methods","Journal of virological methods","Pseudovirus; SARS-CoV-2; Susceptible cell lines; Viral entry inhibitors; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antiviral Agents; Cell Line; Genes, Reporter; Green Fluorescent Proteins; Humans; Lentivirus; Luciferases, Firefly; Neutralization Tests; Recombinant Proteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virion; Virus Internalization","Yang","Yang","Beijing Institute of Radiation Medicine, Beijing 100850, China",NA
"1535","34182038","10.1016/j.jviromet.2021.114221","An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research.","SARS-CoV-2 is the culprit causing Coronavirus Disease 2019 (COVID-19). For the study of SARS-CoV-2 infection in a BSL-2 laboratory, a SARS-CoV-2 pseudovirus particle (SARS2pp) production and infection system was constructed by using a lentiviral vector bearing dual-reporter genes eGFP and firefly luciferase (Luc2) for easy observation and analysis. Comparison of SARS2pp different production conditions revealed that the pseudovirus titer could be greatly improved by: 1) removing the last 19 amino","2021","07","23","J Virol Methods","Journal of virological methods","Pseudovirus; SARS-CoV-2; Susceptible cell lines; Viral entry inhibitors; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antiviral Agents; Cell Line; Genes, Reporter; Green Fluorescent Proteins; Humans; Lentivirus; Luciferases, Firefly; Neutralization Tests; Recombinant Proteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virion; Virus Internalization","Wu","Yuming","Beijing Institute of Radiation Medicine, Beijing 100850, China",NA
"1536","34182038","10.1016/j.jviromet.2021.114221","An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research.","SARS-CoV-2 is the culprit causing Coronavirus Disease 2019 (COVID-19). For the study of SARS-CoV-2 infection in a BSL-2 laboratory, a SARS-CoV-2 pseudovirus particle (SARS2pp) production and infection system was constructed by using a lentiviral vector bearing dual-reporter genes eGFP and firefly luciferase (Luc2) for easy observation and analysis. Comparison of SARS2pp different production conditions revealed that the pseudovirus titer could be greatly improved by: 1) removing the last 19 amino","2021","07","23","J Virol Methods","Journal of virological methods","Pseudovirus; SARS-CoV-2; Susceptible cell lines; Viral entry inhibitors; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antiviral Agents; Cell Line; Genes, Reporter; Green Fluorescent Proteins; Humans; Lentivirus; Luciferases, Firefly; Neutralization Tests; Recombinant Proteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virion; Virus Internalization","Huang","Cong","Beijing Institute of Radiation Medicine, Beijing 100850, China",NA
"1537","34182038","10.1016/j.jviromet.2021.114221","An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research.","SARS-CoV-2 is the culprit causing Coronavirus Disease 2019 (COVID-19). For the study of SARS-CoV-2 infection in a BSL-2 laboratory, a SARS-CoV-2 pseudovirus particle (SARS2pp) production and infection system was constructed by using a lentiviral vector bearing dual-reporter genes eGFP and firefly luciferase (Luc2) for easy observation and analysis. Comparison of SARS2pp different production conditions revealed that the pseudovirus titer could be greatly improved by: 1) removing the last 19 amino","2021","07","23","J Virol Methods","Journal of virological methods","Pseudovirus; SARS-CoV-2; Susceptible cell lines; Viral entry inhibitors; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antiviral Agents; Cell Line; Genes, Reporter; Green Fluorescent Proteins; Humans; Lentivirus; Luciferases, Firefly; Neutralization Tests; Recombinant Proteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virion; Virus Internalization","Ding","Yanlei","Beijing Institute of Radiation Medicine, Beijing 100850, China",NA
"1538","34182038","10.1016/j.jviromet.2021.114221","An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research.","SARS-CoV-2 is the culprit causing Coronavirus Disease 2019 (COVID-19). For the study of SARS-CoV-2 infection in a BSL-2 laboratory, a SARS-CoV-2 pseudovirus particle (SARS2pp) production and infection system was constructed by using a lentiviral vector bearing dual-reporter genes eGFP and firefly luciferase (Luc2) for easy observation and analysis. Comparison of SARS2pp different production conditions revealed that the pseudovirus titer could be greatly improved by: 1) removing the last 19 amino","2021","07","23","J Virol Methods","Journal of virological methods","Pseudovirus; SARS-CoV-2; Susceptible cell lines; Viral entry inhibitors; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antiviral Agents; Cell Line; Genes, Reporter; Green Fluorescent Proteins; Humans; Lentivirus; Luciferases, Firefly; Neutralization Tests; Recombinant Proteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virion; Virus Internalization","Wang","Xuejun","Beijing Institute of Radiation Medicine, Beijing 100850, China. Electronic address: xjwang@bmi.ac","xjwang@bmi.ac.cn"
"1539","34182038","10.1016/j.jviromet.2021.114221","An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research.","SARS-CoV-2 is the culprit causing Coronavirus Disease 2019 (COVID-19). For the study of SARS-CoV-2 infection in a BSL-2 laboratory, a SARS-CoV-2 pseudovirus particle (SARS2pp) production and infection system was constructed by using a lentiviral vector bearing dual-reporter genes eGFP and firefly luciferase (Luc2) for easy observation and analysis. Comparison of SARS2pp different production conditions revealed that the pseudovirus titer could be greatly improved by: 1) removing the last 19 amino","2021","07","23","J Virol Methods","Journal of virological methods","Pseudovirus; SARS-CoV-2; Susceptible cell lines; Viral entry inhibitors; Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antiviral Agents; Cell Line; Genes, Reporter; Green Fluorescent Proteins; Humans; Lentivirus; Luciferases, Firefly; Neutralization Tests; Recombinant Proteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virion; Virus Internalization","Wang","Shengqi","College of Life Sciences, Henan Normal University, Xinxiang 453007, China","sqwang@bmi.ac.cn"
"1540","34182036","10.1016/j.tmaid.2021.102133","Probability and estimated risk of SARS-CoV-2 transmission in the air travel system.","As an emerging virus, SARS-CoV-2 and the risk of transmission during air travel is of high interest. This paper is a retrospective estimate of the probability of an infectious passenger in the air travel system transmitting the SARS-CoV-2 virus to a fellow passenger. Literature was reviewed from May-September 2020 to identify COVID-19 cases related to air travel. The studies were limited to publicly available literature for passengers; studies of flight crews were not reviewed. A novel quantitat","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","COVID-19; Emerging communicable diseases; Epidemiology; Risk","Pang","Jenna K","The Boeing Company, USA. Electronic address: jenna.k.pang@boeing","jenna.k.pang@boeing.com"
"1541","34182036","10.1016/j.tmaid.2021.102133","Probability and estimated risk of SARS-CoV-2 transmission in the air travel system.","As an emerging virus, SARS-CoV-2 and the risk of transmission during air travel is of high interest. This paper is a retrospective estimate of the probability of an infectious passenger in the air travel system transmitting the SARS-CoV-2 virus to a fellow passenger. Literature was reviewed from May-September 2020 to identify COVID-19 cases related to air travel. The studies were limited to publicly available literature for passengers; studies of flight crews were not reviewed. A novel quantitat","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","COVID-19; Emerging communicable diseases; Epidemiology; Risk","Jones","Stephen P","The Boeing Company, USA",NA
"1542","34182036","10.1016/j.tmaid.2021.102133","Probability and estimated risk of SARS-CoV-2 transmission in the air travel system.","As an emerging virus, SARS-CoV-2 and the risk of transmission during air travel is of high interest. This paper is a retrospective estimate of the probability of an infectious passenger in the air travel system transmitting the SARS-CoV-2 virus to a fellow passenger. Literature was reviewed from May-September 2020 to identify COVID-19 cases related to air travel. The studies were limited to publicly available literature for passengers; studies of flight crews were not reviewed. A novel quantitat","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","COVID-19; Emerging communicable diseases; Epidemiology; Risk","Waite","Lindsay L","The Boeing Company, USA",NA
"1543","34182036","10.1016/j.tmaid.2021.102133","Probability and estimated risk of SARS-CoV-2 transmission in the air travel system.","As an emerging virus, SARS-CoV-2 and the risk of transmission during air travel is of high interest. This paper is a retrospective estimate of the probability of an infectious passenger in the air travel system transmitting the SARS-CoV-2 virus to a fellow passenger. Literature was reviewed from May-September 2020 to identify COVID-19 cases related to air travel. The studies were limited to publicly available literature for passengers; studies of flight crews were not reviewed. A novel quantitat","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","COVID-19; Emerging communicable diseases; Epidemiology; Risk","Olson","Nels A","The Boeing Company, USA",NA
"1544","34182036","10.1016/j.tmaid.2021.102133","Probability and estimated risk of SARS-CoV-2 transmission in the air travel system.","As an emerging virus, SARS-CoV-2 and the risk of transmission during air travel is of high interest. This paper is a retrospective estimate of the probability of an infectious passenger in the air travel system transmitting the SARS-CoV-2 virus to a fellow passenger. Literature was reviewed from May-September 2020 to identify COVID-19 cases related to air travel. The studies were limited to publicly available literature for passengers; studies of flight crews were not reviewed. A novel quantitat","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","COVID-19; Emerging communicable diseases; Epidemiology; Risk","Armstrong","Jason W","Boeing Defence Australia",NA
"1545","34182036","10.1016/j.tmaid.2021.102133","Probability and estimated risk of SARS-CoV-2 transmission in the air travel system.","As an emerging virus, SARS-CoV-2 and the risk of transmission during air travel is of high interest. This paper is a retrospective estimate of the probability of an infectious passenger in the air travel system transmitting the SARS-CoV-2 virus to a fellow passenger. Literature was reviewed from May-September 2020 to identify COVID-19 cases related to air travel. The studies were limited to publicly available literature for passengers; studies of flight crews were not reviewed. A novel quantitat","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","COVID-19; Emerging communicable diseases; Epidemiology; Risk","Atmur","Robert J","The Boeing Company, USA",NA
"1546","34182036","10.1016/j.tmaid.2021.102133","Probability and estimated risk of SARS-CoV-2 transmission in the air travel system.","As an emerging virus, SARS-CoV-2 and the risk of transmission during air travel is of high interest. This paper is a retrospective estimate of the probability of an infectious passenger in the air travel system transmitting the SARS-CoV-2 virus to a fellow passenger. Literature was reviewed from May-September 2020 to identify COVID-19 cases related to air travel. The studies were limited to publicly available literature for passengers; studies of flight crews were not reviewed. A novel quantitat","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","COVID-19; Emerging communicable diseases; Epidemiology; Risk","Cummins","Joshua J","The Boeing Company, USA",NA
"1547","34182016","10.1016/j.addr.2021.113848","Drug delivery systems as Immunomodulators for therapy of infectious disease: relevance to COVID-19.","The emergence of SARS-CoV-2, and the ensuing global pandemic, has resulted in an unprecedented response to identify therapies that can limit uncontrolled inflammation observed in patients with moderate to severe COVID-19. The immune pathology behind COVID-19 is complex and involves the activation and interaction of multiple systems including, but not limited to, complement, inflammasomes, endothelial as well as innate and adaptive immune cells to bring about a convoluted profile of inflammation,","2021","07","01","Adv Drug Deliv Rev","Advanced drug delivery reviews","COVID-19; SARS-CoV-2; complement; endothelium; inflammasome; nanomedicine","Brain","Danielle","Immunocompatibility Group, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK",NA
"1548","34182016","10.1016/j.addr.2021.113848","Drug delivery systems as Immunomodulators for therapy of infectious disease: relevance to COVID-19.","The emergence of SARS-CoV-2, and the ensuing global pandemic, has resulted in an unprecedented response to identify therapies that can limit uncontrolled inflammation observed in patients with moderate to severe COVID-19. The immune pathology behind COVID-19 is complex and involves the activation and interaction of multiple systems including, but not limited to, complement, inflammasomes, endothelial as well as innate and adaptive immune cells to bring about a convoluted profile of inflammation,","2021","07","01","Adv Drug Deliv Rev","Advanced drug delivery reviews","COVID-19; SARS-CoV-2; complement; endothelium; inflammasome; nanomedicine","Plant-Hately","Alex","Immunocompatibility Group, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK",NA
"1549","34182016","10.1016/j.addr.2021.113848","Drug delivery systems as Immunomodulators for therapy of infectious disease: relevance to COVID-19.","The emergence of SARS-CoV-2, and the ensuing global pandemic, has resulted in an unprecedented response to identify therapies that can limit uncontrolled inflammation observed in patients with moderate to severe COVID-19. The immune pathology behind COVID-19 is complex and involves the activation and interaction of multiple systems including, but not limited to, complement, inflammasomes, endothelial as well as innate and adaptive immune cells to bring about a convoluted profile of inflammation,","2021","07","01","Adv Drug Deliv Rev","Advanced drug delivery reviews","COVID-19; SARS-CoV-2; complement; endothelium; inflammasome; nanomedicine","Heaton","Bethany","Immunocompatibility Group, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK",NA
"1550","34182016","10.1016/j.addr.2021.113848","Drug delivery systems as Immunomodulators for therapy of infectious disease: relevance to COVID-19.","The emergence of SARS-CoV-2, and the ensuing global pandemic, has resulted in an unprecedented response to identify therapies that can limit uncontrolled inflammation observed in patients with moderate to severe COVID-19. The immune pathology behind COVID-19 is complex and involves the activation and interaction of multiple systems including, but not limited to, complement, inflammasomes, endothelial as well as innate and adaptive immune cells to bring about a convoluted profile of inflammation,","2021","07","01","Adv Drug Deliv Rev","Advanced drug delivery reviews","COVID-19; SARS-CoV-2; complement; endothelium; inflammasome; nanomedicine","Arshad","Usman","Centre of Excellence for Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK",NA
"1551","34182016","10.1016/j.addr.2021.113848","Drug delivery systems as Immunomodulators for therapy of infectious disease: relevance to COVID-19.","The emergence of SARS-CoV-2, and the ensuing global pandemic, has resulted in an unprecedented response to identify therapies that can limit uncontrolled inflammation observed in patients with moderate to severe COVID-19. The immune pathology behind COVID-19 is complex and involves the activation and interaction of multiple systems including, but not limited to, complement, inflammasomes, endothelial as well as innate and adaptive immune cells to bring about a convoluted profile of inflammation,","2021","07","01","Adv Drug Deliv Rev","Advanced drug delivery reviews","COVID-19; SARS-CoV-2; complement; endothelium; inflammasome; nanomedicine","David","Christopher","Immunocompatibility Group, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK",NA
"1552","34182016","10.1016/j.addr.2021.113848","Drug delivery systems as Immunomodulators for therapy of infectious disease: relevance to COVID-19.","The emergence of SARS-CoV-2, and the ensuing global pandemic, has resulted in an unprecedented response to identify therapies that can limit uncontrolled inflammation observed in patients with moderate to severe COVID-19. The immune pathology behind COVID-19 is complex and involves the activation and interaction of multiple systems including, but not limited to, complement, inflammasomes, endothelial as well as innate and adaptive immune cells to bring about a convoluted profile of inflammation,","2021","07","01","Adv Drug Deliv Rev","Advanced drug delivery reviews","COVID-19; SARS-CoV-2; complement; endothelium; inflammasome; nanomedicine","Hedrich","Christian","Department of Women's &amp",NA
"1553","34182016","10.1016/j.addr.2021.113848","Drug delivery systems as Immunomodulators for therapy of infectious disease: relevance to COVID-19.","The emergence of SARS-CoV-2, and the ensuing global pandemic, has resulted in an unprecedented response to identify therapies that can limit uncontrolled inflammation observed in patients with moderate to severe COVID-19. The immune pathology behind COVID-19 is complex and involves the activation and interaction of multiple systems including, but not limited to, complement, inflammasomes, endothelial as well as innate and adaptive immune cells to bring about a convoluted profile of inflammation,","2021","07","01","Adv Drug Deliv Rev","Advanced drug delivery reviews","COVID-19; SARS-CoV-2; complement; endothelium; inflammasome; nanomedicine","Owen","Andrew","Centre of Excellence for Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK",NA
"1554","34182016","10.1016/j.addr.2021.113848","Drug delivery systems as Immunomodulators for therapy of infectious disease: relevance to COVID-19.","The emergence of SARS-CoV-2, and the ensuing global pandemic, has resulted in an unprecedented response to identify therapies that can limit uncontrolled inflammation observed in patients with moderate to severe COVID-19. The immune pathology behind COVID-19 is complex and involves the activation and interaction of multiple systems including, but not limited to, complement, inflammasomes, endothelial as well as innate and adaptive immune cells to bring about a convoluted profile of inflammation,","2021","07","01","Adv Drug Deliv Rev","Advanced drug delivery reviews","COVID-19; SARS-CoV-2; complement; endothelium; inflammasome; nanomedicine","Liptrott","Neill J","Immunocompatibility Group, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK","Neill.liptrott@liverpool.ac.uk"
"1555","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","DeBiasi","Roberta L","Division of Pediatric Infectious Diseases, Children's National Hospital, Washington, DC",NA
"1556","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Harahsheh","Ashraf S","Division of Cardiology, Children's National Hospital, Washington, DC",NA
"1557","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Srinivasalu","Hemalatha","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1558","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Krishnan","Anita","Division of Cardiology, Children's National Hospital, Washington, DC",NA
"1559","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Sharron","Matthew P","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1560","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Parikh","Kavita","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1561","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Smith","Karen","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1562","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Bell","Michael","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1563","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Michael","Drew","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1564","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Delaney","Meghan","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1565","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Campos","Joseph","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1566","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Vilain","Eric","Department of Genomics and Precision Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC",NA
"1567","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","LoTiempo","Jonathan","Department of Genomics and Precision Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC",NA
"1568","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Kline","Jaclyn N","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1569","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Ronis","Tova","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1570","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Majumdar","Suvankar","Division of Critical Care Medicine, Children's National Hospital, Washington, DC",NA
"1571","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Sadler","Eleanor","Division of Pharmacy, The Mount Sinai Hospital, New York, New York",NA
"1572","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Conway","Susan R","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1573","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Berul","Charles I","Division of Cardiology, Children's National Hospital, Washington, DC",NA
"1574","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Sule","Sangeeta","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1575","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Lahoz","Rebeca","Division of Pediatric Infectious Diseases, Children's National Hospital, Washington, DC",NA
"1576","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Ansusinha","Emily","Division of Pediatric Infectious Diseases, Children's National Hospital, Washington, DC",NA
"1577","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Pershad","Jay","Division of Emergency Medicine, Children's National Hospital, Washington, DC",NA
"1578","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Bundy","Vanessa","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1579","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Wells","Elizabeth","Department of Pediatrics, Immunology and Tropical Medicine, Washington, DC",NA
"1580","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Bost","James E","Division of Biostatistics, Children's National Hospital, Washington, DC",NA
"1581","34181987","10.1016/j.jpeds.2021.06.002","Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.","To assess demographic, clinical, and biomarker features distinguishing patients with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub-phenotypes; identify cytokine biosignatures; and characterize viral genome sequences. We performed a prospective observational cohort study of 124 children hospitalized and treated under the institutional MIS-C Task Force protocol from March to September 2020 at Children's National, a quaternary freestanding children's hospital in Washingto","2021","07","19","J Pediatr","The Journal of pediatrics","COVID; SARS-CoV-2","Wessel","David","Division of Cardiology, Children's National Hospital, Washington, DC",NA
"1582","34181926","10.1016/j.envres.2021.111601","New research on reduction and/or elimination of hazardous substances in the design, manufacture and application of chemical products.","The Virtual Special Issue (VSI) ""New research on reduction and/or elimination of hazardous substances in the design, manufacture and application of chemical products"" was initially associated to the ""International Conference on Green Chemistry and Sustainable Engineering, GreenChem-20"" that was postponed due to the COVID-19 pandemic. Anyway, the international conference will take place in the near future. However, the VSI was maintained in this journal, received a high number of submissions, and","2021","07","20","Environ Res","Environmental research","Green chemistry; Hazardous materials; Pollutants removal; Sustainable engineering","Núñez-Delgado","Avelino","Dept. Soil Sci. and Agric. Chem., Univ. Santiago de Compostela, Engineering Polytech. School, Campus Univ. S/n, 27002, Lugo, Spain. Electronic address: avelino.nunez@usc","avelino.nunez@usc.es"
"1583","34181926","10.1016/j.envres.2021.111601","New research on reduction and/or elimination of hazardous substances in the design, manufacture and application of chemical products.","The Virtual Special Issue (VSI) ""New research on reduction and/or elimination of hazardous substances in the design, manufacture and application of chemical products"" was initially associated to the ""International Conference on Green Chemistry and Sustainable Engineering, GreenChem-20"" that was postponed due to the COVID-19 pandemic. Anyway, the international conference will take place in the near future. However, the VSI was maintained in this journal, received a high number of submissions, and","2021","07","20","Environ Res","Environmental research","Green chemistry; Hazardous materials; Pollutants removal; Sustainable engineering","Dominguez","Joaquín R","Department of Chemical Engineering and Physical Chemistry, University of Extremadura, Spain",NA
"1584","34181926","10.1016/j.envres.2021.111601","New research on reduction and/or elimination of hazardous substances in the design, manufacture and application of chemical products.","The Virtual Special Issue (VSI) ""New research on reduction and/or elimination of hazardous substances in the design, manufacture and application of chemical products"" was initially associated to the ""International Conference on Green Chemistry and Sustainable Engineering, GreenChem-20"" that was postponed due to the COVID-19 pandemic. Anyway, the international conference will take place in the near future. However, the VSI was maintained in this journal, received a high number of submissions, and","2021","07","20","Environ Res","Environmental research","Green chemistry; Hazardous materials; Pollutants removal; Sustainable engineering","Zhou","Yaoyu","College of Resources and Environment, Hunan Agricultural University, Changsha, 410128, Hunan Province, China",NA
"1585","34181926","10.1016/j.envres.2021.111601","New research on reduction and/or elimination of hazardous substances in the design, manufacture and application of chemical products.","The Virtual Special Issue (VSI) ""New research on reduction and/or elimination of hazardous substances in the design, manufacture and application of chemical products"" was initially associated to the ""International Conference on Green Chemistry and Sustainable Engineering, GreenChem-20"" that was postponed due to the COVID-19 pandemic. Anyway, the international conference will take place in the near future. However, the VSI was maintained in this journal, received a high number of submissions, and","2021","07","20","Environ Res","Environmental research","Green chemistry; Hazardous materials; Pollutants removal; Sustainable engineering","Race","Marco","Department of Civil and Mechanical Engineering, University of Cassino and Southern Lazio, Via di Biasio 43, 03043, Cassino, Italy",NA
"1586","34181926","10.1016/j.envres.2021.111601","New research on reduction and/or elimination of hazardous substances in the design, manufacture and application of chemical products.","The Virtual Special Issue (VSI) ""New research on reduction and/or elimination of hazardous substances in the design, manufacture and application of chemical products"" was initially associated to the ""International Conference on Green Chemistry and Sustainable Engineering, GreenChem-20"" that was postponed due to the COVID-19 pandemic. Anyway, the international conference will take place in the near future. However, the VSI was maintained in this journal, received a high number of submissions, and","2021","07","20","Environ Res","Environmental research","Green chemistry; Hazardous materials; Pollutants removal; Sustainable engineering","Domingo","José L","Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Universitat Rovira I Virgili, Reus, Spain",NA
"1587","34181924","10.1016/j.envres.2021.111606","SARS-CoV-2 and other pathogenic microorganisms in the environment.","The title of the Virtual Special Issue (VSI) ""SARS-CoV-2 and other pathogenic microorganisms in the environment"", clearly indicates a main focus not only on the virus causing the current pandemic, but also on other pathogenic microorganisms and their spatial and temporal dynamics in environmental compartments. Overall, the VSI has received more than 100 submissions relating to most of the possible fields connected to the pandemic, many of them of high scientific value. A rigorous peer-reviewing ","2021","07","20","Environ Res","Environmental research","COVID-19; Environmental issues; Epidemics; Infectious diseases microorganisms; Pandemics; SARS-CoV-2; Virus","Núñez-Delgado","Avelino","Dept. Soil Sci. and Agric. Chem., Univ. Santiago de Compostela, Engineering Polytech. School, Campus Univ. S/n, 27002, Lugo, Spain. Electronic address: avelino.nunez@usc","avelino.nunez@usc.es"
"1588","34181924","10.1016/j.envres.2021.111606","SARS-CoV-2 and other pathogenic microorganisms in the environment.","The title of the Virtual Special Issue (VSI) ""SARS-CoV-2 and other pathogenic microorganisms in the environment"", clearly indicates a main focus not only on the virus causing the current pandemic, but also on other pathogenic microorganisms and their spatial and temporal dynamics in environmental compartments. Overall, the VSI has received more than 100 submissions relating to most of the possible fields connected to the pandemic, many of them of high scientific value. A rigorous peer-reviewing ","2021","07","20","Environ Res","Environmental research","COVID-19; Environmental issues; Epidemics; Infectious diseases microorganisms; Pandemics; SARS-CoV-2; Virus","Bontempi","Elza","INSTM and University of Brescia, Via Branze 38, 25123, Brescia, Italy",NA
"1589","34181924","10.1016/j.envres.2021.111606","SARS-CoV-2 and other pathogenic microorganisms in the environment.","The title of the Virtual Special Issue (VSI) ""SARS-CoV-2 and other pathogenic microorganisms in the environment"", clearly indicates a main focus not only on the virus causing the current pandemic, but also on other pathogenic microorganisms and their spatial and temporal dynamics in environmental compartments. Overall, the VSI has received more than 100 submissions relating to most of the possible fields connected to the pandemic, many of them of high scientific value. A rigorous peer-reviewing ","2021","07","20","Environ Res","Environmental research","COVID-19; Environmental issues; Epidemics; Infectious diseases microorganisms; Pandemics; SARS-CoV-2; Virus","Coccia","Mario","National Research Council of Italy, Research Institute on Sustainable Economic Growth, Roma, Italy",NA
"1590","34181924","10.1016/j.envres.2021.111606","SARS-CoV-2 and other pathogenic microorganisms in the environment.","The title of the Virtual Special Issue (VSI) ""SARS-CoV-2 and other pathogenic microorganisms in the environment"", clearly indicates a main focus not only on the virus causing the current pandemic, but also on other pathogenic microorganisms and their spatial and temporal dynamics in environmental compartments. Overall, the VSI has received more than 100 submissions relating to most of the possible fields connected to the pandemic, many of them of high scientific value. A rigorous peer-reviewing ","2021","07","20","Environ Res","Environmental research","COVID-19; Environmental issues; Epidemics; Infectious diseases microorganisms; Pandemics; SARS-CoV-2; Virus","Kumar","Manish","Indian Institute of Technology Gandhinagar, Palaj, Gujarat, 382 355, India",NA
"1591","34181924","10.1016/j.envres.2021.111606","SARS-CoV-2 and other pathogenic microorganisms in the environment.","The title of the Virtual Special Issue (VSI) ""SARS-CoV-2 and other pathogenic microorganisms in the environment"", clearly indicates a main focus not only on the virus causing the current pandemic, but also on other pathogenic microorganisms and their spatial and temporal dynamics in environmental compartments. Overall, the VSI has received more than 100 submissions relating to most of the possible fields connected to the pandemic, many of them of high scientific value. A rigorous peer-reviewing ","2021","07","20","Environ Res","Environmental research","COVID-19; Environmental issues; Epidemics; Infectious diseases microorganisms; Pandemics; SARS-CoV-2; Virus","Farkas","Kata","School of Natural Sciences, Bangor University, Deiniol Rd, Bangor, Gwynedd, UK",NA
"1592","34181924","10.1016/j.envres.2021.111606","SARS-CoV-2 and other pathogenic microorganisms in the environment.","The title of the Virtual Special Issue (VSI) ""SARS-CoV-2 and other pathogenic microorganisms in the environment"", clearly indicates a main focus not only on the virus causing the current pandemic, but also on other pathogenic microorganisms and their spatial and temporal dynamics in environmental compartments. Overall, the VSI has received more than 100 submissions relating to most of the possible fields connected to the pandemic, many of them of high scientific value. A rigorous peer-reviewing ","2021","07","20","Environ Res","Environmental research","COVID-19; Environmental issues; Epidemics; Infectious diseases microorganisms; Pandemics; SARS-CoV-2; Virus","Domingo","José L","Laboratory of Toxicology and Environmental Health, School of Medicine, Universitat Rovira I Virgili, Reus, Spain",NA
"1593","34181910","10.1016/j.ahj.2021.06.011","Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.","The COVID-19 pandemic has disrupted routine cardiovascular care, with unclear impact on procedural deferrals and associated outcomes across diverse patient populations. Cardiovascular procedures performed at 30 hospitals across six Western states in two large, non-profit healthcare systems (Providence St. Joseph Health and Stanford Healthcare) from December 2018-June 2020 were analyzed for changes over time. Risk-adjusted in-hospital mortality was compared across pandemic phases with multivariat","2021","07","01","Am Heart J","American heart journal","CABG; PCI; SAVR; TAVR; disparities","Yong","Celina M","Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA","cyong@stanford.edu"
"1594","34181910","10.1016/j.ahj.2021.06.011","Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.","The COVID-19 pandemic has disrupted routine cardiovascular care, with unclear impact on procedural deferrals and associated outcomes across diverse patient populations. Cardiovascular procedures performed at 30 hospitals across six Western states in two large, non-profit healthcare systems (Providence St. Joseph Health and Stanford Healthcare) from December 2018-June 2020 were analyzed for changes over time. Risk-adjusted in-hospital mortality was compared across pandemic phases with multivariat","2021","07","01","Am Heart J","American heart journal","CABG; PCI; SAVR; TAVR; disparities","Spinelli","Kateri J","Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR",NA
"1595","34181910","10.1016/j.ahj.2021.06.011","Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.","The COVID-19 pandemic has disrupted routine cardiovascular care, with unclear impact on procedural deferrals and associated outcomes across diverse patient populations. Cardiovascular procedures performed at 30 hospitals across six Western states in two large, non-profit healthcare systems (Providence St. Joseph Health and Stanford Healthcare) from December 2018-June 2020 were analyzed for changes over time. Risk-adjusted in-hospital mortality was compared across pandemic phases with multivariat","2021","07","01","Am Heart J","American heart journal","CABG; PCI; SAVR; TAVR; disparities","Chiu","Shih Ting","Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR",NA
"1596","34181910","10.1016/j.ahj.2021.06.011","Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.","The COVID-19 pandemic has disrupted routine cardiovascular care, with unclear impact on procedural deferrals and associated outcomes across diverse patient populations. Cardiovascular procedures performed at 30 hospitals across six Western states in two large, non-profit healthcare systems (Providence St. Joseph Health and Stanford Healthcare) from December 2018-June 2020 were analyzed for changes over time. Risk-adjusted in-hospital mortality was compared across pandemic phases with multivariat","2021","07","01","Am Heart J","American heart journal","CABG; PCI; SAVR; TAVR; disparities","Jones","Brandon","Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR",NA
"1597","34181910","10.1016/j.ahj.2021.06.011","Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.","The COVID-19 pandemic has disrupted routine cardiovascular care, with unclear impact on procedural deferrals and associated outcomes across diverse patient populations. Cardiovascular procedures performed at 30 hospitals across six Western states in two large, non-profit healthcare systems (Providence St. Joseph Health and Stanford Healthcare) from December 2018-June 2020 were analyzed for changes over time. Risk-adjusted in-hospital mortality was compared across pandemic phases with multivariat","2021","07","01","Am Heart J","American heart journal","CABG; PCI; SAVR; TAVR; disparities","Penny","Brian","Clinical Analytics, Providence St Joseph Health, Renton, Washington",NA
"1598","34181910","10.1016/j.ahj.2021.06.011","Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.","The COVID-19 pandemic has disrupted routine cardiovascular care, with unclear impact on procedural deferrals and associated outcomes across diverse patient populations. Cardiovascular procedures performed at 30 hospitals across six Western states in two large, non-profit healthcare systems (Providence St. Joseph Health and Stanford Healthcare) from December 2018-June 2020 were analyzed for changes over time. Risk-adjusted in-hospital mortality was compared across pandemic phases with multivariat","2021","07","01","Am Heart J","American heart journal","CABG; PCI; SAVR; TAVR; disparities","Gummidipundi","Santosh","Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA",NA
"1599","34181910","10.1016/j.ahj.2021.06.011","Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.","The COVID-19 pandemic has disrupted routine cardiovascular care, with unclear impact on procedural deferrals and associated outcomes across diverse patient populations. Cardiovascular procedures performed at 30 hospitals across six Western states in two large, non-profit healthcare systems (Providence St. Joseph Health and Stanford Healthcare) from December 2018-June 2020 were analyzed for changes over time. Risk-adjusted in-hospital mortality was compared across pandemic phases with multivariat","2021","07","01","Am Heart J","American heart journal","CABG; PCI; SAVR; TAVR; disparities","Beach","Shire","Department of Internal Medicine, University of Los Angeles, Los Angeles, CA",NA
"1600","34181910","10.1016/j.ahj.2021.06.011","Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.","The COVID-19 pandemic has disrupted routine cardiovascular care, with unclear impact on procedural deferrals and associated outcomes across diverse patient populations. Cardiovascular procedures performed at 30 hospitals across six Western states in two large, non-profit healthcare systems (Providence St. Joseph Health and Stanford Healthcare) from December 2018-June 2020 were analyzed for changes over time. Risk-adjusted in-hospital mortality was compared across pandemic phases with multivariat","2021","07","01","Am Heart J","American heart journal","CABG; PCI; SAVR; TAVR; disparities","Perino","Alex","Department of Medicine, Stanford University School of Medicine, and Stanford Cardiovascular Institute, Stanford, CA",NA
"1601","34181910","10.1016/j.ahj.2021.06.011","Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.","The COVID-19 pandemic has disrupted routine cardiovascular care, with unclear impact on procedural deferrals and associated outcomes across diverse patient populations. Cardiovascular procedures performed at 30 hospitals across six Western states in two large, non-profit healthcare systems (Providence St. Joseph Health and Stanford Healthcare) from December 2018-June 2020 were analyzed for changes over time. Risk-adjusted in-hospital mortality was compared across pandemic phases with multivariat","2021","07","01","Am Heart J","American heart journal","CABG; PCI; SAVR; TAVR; disparities","Turakhia","Mintu","Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA",NA
"1602","34181910","10.1016/j.ahj.2021.06.011","Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.","The COVID-19 pandemic has disrupted routine cardiovascular care, with unclear impact on procedural deferrals and associated outcomes across diverse patient populations. Cardiovascular procedures performed at 30 hospitals across six Western states in two large, non-profit healthcare systems (Providence St. Joseph Health and Stanford Healthcare) from December 2018-June 2020 were analyzed for changes over time. Risk-adjusted in-hospital mortality was compared across pandemic phases with multivariat","2021","07","01","Am Heart J","American heart journal","CABG; PCI; SAVR; TAVR; disparities","Heidenreich","Paul","Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA",NA
"1603","34181910","10.1016/j.ahj.2021.06.011","Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.","The COVID-19 pandemic has disrupted routine cardiovascular care, with unclear impact on procedural deferrals and associated outcomes across diverse patient populations. Cardiovascular procedures performed at 30 hospitals across six Western states in two large, non-profit healthcare systems (Providence St. Joseph Health and Stanford Healthcare) from December 2018-June 2020 were analyzed for changes over time. Risk-adjusted in-hospital mortality was compared across pandemic phases with multivariat","2021","07","01","Am Heart J","American heart journal","CABG; PCI; SAVR; TAVR; disparities","Gluckman","Ty J","Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR",NA
"1604","34181889","10.1016/j.jped.2021.05.007","Fast, cheap and feasible: Implementation of pediatric telemedicine in a public hospital during the Covid-19 pandemic.","In Brazil, telemedicine was allowed as an exception during the coronavirus disease (COVID-19) pandemic. Despite its recognized value and availability, telemedicine is not universally used, suggesting that some barriers prevent its adoption and acceptance within the community. This study aims to describe the implementation of a low-cost telemedicine service in a pediatric hospital in Brazil. Retrospective descriptive study reporting the first three months (April to June 2020) of the experience of","2021","07","10","J Pediatr (Rio J)","Jornal de pediatria","COVID-19; Children; Emergency department; Pediatric; Pediatric emergency; Telemedicine","Severini","Rafael da Silva Giannasi","Faculdade de Medicina, Hospital das Clínicas, Instituto da Criança, Departamento de Emergência, Universidade de São Paulo, São Paulo, SP, Brazil","rafaelgiannasi@gmail.com"
"1605","34181889","10.1016/j.jped.2021.05.007","Fast, cheap and feasible: Implementation of pediatric telemedicine in a public hospital during the Covid-19 pandemic.","In Brazil, telemedicine was allowed as an exception during the coronavirus disease (COVID-19) pandemic. Despite its recognized value and availability, telemedicine is not universally used, suggesting that some barriers prevent its adoption and acceptance within the community. This study aims to describe the implementation of a low-cost telemedicine service in a pediatric hospital in Brazil. Retrospective descriptive study reporting the first three months (April to June 2020) of the experience of","2021","07","10","J Pediatr (Rio J)","Jornal de pediatria","COVID-19; Children; Emergency department; Pediatric; Pediatric emergency; Telemedicine","Oliveira","Pedro Carpini de","Faculdade de Medicina, Hospital das Clínicas, Instituto da Criança, Departamento de Emergência, Universidade de São Paulo, São Paulo, SP, Brazil",NA
"1606","34181889","10.1016/j.jped.2021.05.007","Fast, cheap and feasible: Implementation of pediatric telemedicine in a public hospital during the Covid-19 pandemic.","In Brazil, telemedicine was allowed as an exception during the coronavirus disease (COVID-19) pandemic. Despite its recognized value and availability, telemedicine is not universally used, suggesting that some barriers prevent its adoption and acceptance within the community. This study aims to describe the implementation of a low-cost telemedicine service in a pediatric hospital in Brazil. Retrospective descriptive study reporting the first three months (April to June 2020) of the experience of","2021","07","10","J Pediatr (Rio J)","Jornal de pediatria","COVID-19; Children; Emergency department; Pediatric; Pediatric emergency; Telemedicine","Couto","Thomaz Bittencourt","Faculdade de Medicina, Hospital das Clínicas, Instituto da Criança, Departamento de Emergência, Universidade de São Paulo, São Paulo, SP, Brazil",NA
"1607","34181889","10.1016/j.jped.2021.05.007","Fast, cheap and feasible: Implementation of pediatric telemedicine in a public hospital during the Covid-19 pandemic.","In Brazil, telemedicine was allowed as an exception during the coronavirus disease (COVID-19) pandemic. Despite its recognized value and availability, telemedicine is not universally used, suggesting that some barriers prevent its adoption and acceptance within the community. This study aims to describe the implementation of a low-cost telemedicine service in a pediatric hospital in Brazil. Retrospective descriptive study reporting the first three months (April to June 2020) of the experience of","2021","07","10","J Pediatr (Rio J)","Jornal de pediatria","COVID-19; Children; Emergency department; Pediatric; Pediatric emergency; Telemedicine","Simon Junior","Hany","Faculdade de Medicina, Hospital das Clínicas, Instituto da Criança, Departamento de Emergência, Universidade de São Paulo, São Paulo, SP, Brazil",NA
"1608","34181889","10.1016/j.jped.2021.05.007","Fast, cheap and feasible: Implementation of pediatric telemedicine in a public hospital during the Covid-19 pandemic.","In Brazil, telemedicine was allowed as an exception during the coronavirus disease (COVID-19) pandemic. Despite its recognized value and availability, telemedicine is not universally used, suggesting that some barriers prevent its adoption and acceptance within the community. This study aims to describe the implementation of a low-cost telemedicine service in a pediatric hospital in Brazil. Retrospective descriptive study reporting the first three months (April to June 2020) of the experience of","2021","07","10","J Pediatr (Rio J)","Jornal de pediatria","COVID-19; Children; Emergency department; Pediatric; Pediatric emergency; Telemedicine","Andrade","Anarella Penha Meirelles de","Faculdade de Medicina, Hospital das Clínicas, Instituto da Criança, Departamento de Emergência, Universidade de São Paulo, São Paulo, SP, Brazil",NA
"1609","34181889","10.1016/j.jped.2021.05.007","Fast, cheap and feasible: Implementation of pediatric telemedicine in a public hospital during the Covid-19 pandemic.","In Brazil, telemedicine was allowed as an exception during the coronavirus disease (COVID-19) pandemic. Despite its recognized value and availability, telemedicine is not universally used, suggesting that some barriers prevent its adoption and acceptance within the community. This study aims to describe the implementation of a low-cost telemedicine service in a pediatric hospital in Brazil. Retrospective descriptive study reporting the first three months (April to June 2020) of the experience of","2021","07","10","J Pediatr (Rio J)","Jornal de pediatria","COVID-19; Children; Emergency department; Pediatric; Pediatric emergency; Telemedicine","Nanbu","Danilo Yamamoto","Faculdade de Medicina, Hospital das Clínicas, Instituto da Criança, Departamento de Emergência, Universidade de São Paulo, São Paulo, SP, Brazil",NA
"1610","34181889","10.1016/j.jped.2021.05.007","Fast, cheap and feasible: Implementation of pediatric telemedicine in a public hospital during the Covid-19 pandemic.","In Brazil, telemedicine was allowed as an exception during the coronavirus disease (COVID-19) pandemic. Despite its recognized value and availability, telemedicine is not universally used, suggesting that some barriers prevent its adoption and acceptance within the community. This study aims to describe the implementation of a low-cost telemedicine service in a pediatric hospital in Brazil. Retrospective descriptive study reporting the first three months (April to June 2020) of the experience of","2021","07","10","J Pediatr (Rio J)","Jornal de pediatria","COVID-19; Children; Emergency department; Pediatric; Pediatric emergency; Telemedicine","Farhat","Sylvia C L","Faculdade de Medicina, Hospital das Clínicas, Instituto da Criança, Departamento de Emergência, Universidade de São Paulo, São Paulo, SP, Brazil",NA
"1611","34181889","10.1016/j.jped.2021.05.007","Fast, cheap and feasible: Implementation of pediatric telemedicine in a public hospital during the Covid-19 pandemic.","In Brazil, telemedicine was allowed as an exception during the coronavirus disease (COVID-19) pandemic. Despite its recognized value and availability, telemedicine is not universally used, suggesting that some barriers prevent its adoption and acceptance within the community. This study aims to describe the implementation of a low-cost telemedicine service in a pediatric hospital in Brazil. Retrospective descriptive study reporting the first three months (April to June 2020) of the experience of","2021","07","10","J Pediatr (Rio J)","Jornal de pediatria","COVID-19; Children; Emergency department; Pediatric; Pediatric emergency; Telemedicine","Schvartsman","Cláudio","Faculdade de Medicina, Hospital das Clínicas, Instituto da Criança, Departamento de Emergência, Universidade de São Paulo, São Paulo, SP, Brazil",NA
"1612","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Alharbi","Khalid Saad","Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Al-Jouf, Saudi Arabia",NA
"1613","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Fuloria","Neeraj Kumar","Faculty of Pharmacy, AIMST University, Kedah, 08100, Malaysia",NA
"1614","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Fuloria","Shivkanya","Faculty of Pharmacy, AIMST University, Kedah, 08100, Malaysia",NA
"1615","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Rahman","Sk Batin","Bengal School of Technology, Churchura, Hooghly, West Bengal, India",NA
"1616","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Al-Malki","Waleed Hassan","Department of Pharmacology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia",NA
"1617","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Javed Shaikh","Mohammad Arshad","School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, 302017, Mahal Road, Jaipur, India",NA
"1618","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Thangavelu","Lakshmi","Department of Pharmacology, Saveetha Dental College, Saveetha University, Chennai, India",NA
"1619","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Singh","Sachin K","School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India",NA
"1620","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Rama Raju Allam","Venkata Sita","Department of Medical Biochemistry and Microbiology, Biomedical Centre (BMC), Uppsala University, Uppsala, Sweden",NA
"1621","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Jha","Niraj Kumar","Department of Biotechnology, School of Engineering &amp",NA
"1622","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Chellappan","Dinesh Kumar","Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia",NA
"1623","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Dua","Kamal","Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia. Electronic address: kamalpharmacist@gmail","kamalpharmacist@gmail.com"
"1624","34181887","10.1016/j.cbi.2021.109568","Nuclear factor-kappa B and its role in inflammatory lung disease.","Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-<U+03BA>B signaling, which is a member of the Rel protein family","2021","07","17","Chem Biol Interact","Chemico-biological interactions","Asthma; COPD; COVID-19; Cytokines; Inflammation; Nuclear factor-kappa B","Gupta","Gaurav","School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, 302017, Mahal Road, Jaipur, India. Electronic address: gauravpharma25@gmail","gauravpharma25@gmail.com"
"1625","34181882","10.1016/S0140-6736(21)01244-7","What constitutes success in the roll-out of COVID-19 vaccines?",NA,"2021","07","19","Lancet","Lancet (London, England)","COVID-19; COVID-19 Vaccines; Humans; Mass Vaccination; Pandemics; Program Evaluation; SARS-CoV-2","Smith","Maxwell J","Faculty of Health Sciences, Western University, London, ON N6A 5B9, Canada. Electronic address: maxwell.smith@uwo","maxwell.smith@uwo.ca"
"1626","34181881","10.1016/S0140-6736(21)01442-2","Heterologous vaccine regimens against COVID-19.",NA,"2021","07","15","Lancet","Lancet (London, England)","COVID-19; Humans; SARS-CoV-2; Viral Vaccines","Duarte-Salles","Talita","Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, 08007, Barcelona, Spain. Electronic address: tduarte@idiapjgol","tduarte@idiapjgol.org"
"1627","34181881","10.1016/S0140-6736(21)01442-2","Heterologous vaccine regimens against COVID-19.",NA,"2021","07","15","Lancet","Lancet (London, England)","COVID-19; Humans; SARS-CoV-2; Viral Vaccines","Prieto-Alhambra","Daniel","Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK",NA
"1628","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Borobia","Alberto M","Servicio de Farmacología Clínica, Departamento de Farmacología y Terapéutica, Facultad de Medicina, Hospital Universitario La Paz, IdiPAZ, Universidad Autónoma de Madrid, Madrid, Spain",NA
"1629","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Carcas","Antonio J","Servicio de Farmacología Clínica, Departamento de Farmacología y Terapéutica, Facultad de Medicina, Hospital Universitario La Paz, IdiPAZ, Universidad Autónoma de Madrid, Madrid, Spain",NA
"1630","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Pérez-Olmeda","Mayte","Laboratorio de Serología, Instituto de Salud Carlos III, Madrid, Spain",NA
"1631","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Castaño","Luis","Hospital Universitario de Cruces, Biocruces Bizkaia HRI, UPV/EHU, OSAKIDETZA, CIBERDEM, CIBERER, Endo-ERN, Barakaldo-Bilbao, Spain",NA
"1632","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Bertran","María Jesús","Servicio de Medicina Preventiva y Epidemiología, Hospital Clínic de Barcelona, Barcelona, Spain",NA
"1633","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","García-Pérez","Javier","Unidad de Inmunopatología del SIDA, Instituto de Salud Carlos III, Madrid, Spain",NA
"1634","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Campins","Magdalena","Servicio de Medicina Preventiva y Epidemiología, Servicio de Farmacología Clínica, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain",NA
"1635","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Portolés","Antonio","Servicio de Farmacología Clínica, Hospital Clínico San Carlos, IdISSC, Departamento de Farmacología y Toxicología, Universidad Complutense de Madrid, Madrid, Spain",NA
"1636","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","González-Pérez","María","Laboratorio de Referencia en Inmunología, Instituto de Salud Carlos III, Madrid, Spain",NA
"1637","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","García Morales","María Teresa","Instituto de Investigación Sanitaria Hospital 12 de Octubre, CIBER de Epidemiología y Salud Pública, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain",NA
"1638","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Arana-Arri","Eunate","Hospital Universitario de Cruces, Biocruces Bizkaia HRI, UPV/EHU, OSAKIDETZA, CIBERDEM, CIBERER, Endo-ERN, Barakaldo-Bilbao, Spain",NA
"1639","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Aldea","Marta","Servicio de Medicina Preventiva y Epidemiología, Hospital Clínic de Barcelona, Barcelona, Spain",NA
"1640","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Díez-Fuertes","Francisco","Unidad de Inmunopatología del SIDA, Instituto de Salud Carlos III, Madrid, Spain",NA
"1641","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Fuentes","Inmaculada","Unidad de Soporte a la Investigación Clínica, Vall d'Hebron Institut de Recerca, Servicio de Farmacología Clínica, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain",NA
"1642","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Ascaso","Ana","Servicio de Farmacología Clínica, Hospital Clínico San Carlos, IdISSC, Departamento de Farmacología y Toxicología, Universidad Complutense de Madrid, Madrid, Spain",NA
"1643","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Lora","David","Instituto de Investigación Sanitaria Hospital 12 de Octubre, CIBER de Epidemiología y Salud Pública, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain",NA
"1644","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Imaz-Ayo","Natale","Hospital Universitario de Cruces, Biocruces Bizkaia HRI, UPV/EHU, OSAKIDETZA, CIBERDEM, CIBERER, Endo-ERN, Barakaldo-Bilbao, Spain",NA
"1645","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Barón-Mira","Lourdes E","Servicio de Medicina Preventiva y Epidemiología, Hospital Clínic de Barcelona, Barcelona, Spain",NA
"1646","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Agustí","Antonia","Departmento de Farmacología, Terapéutica y Toxicología, Servicio de Farmacología Clínica, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain",NA
"1647","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Pérez-Ingidua","Carla","Servicio de Farmacología Clínica, Hospital Clínico San Carlos, IdISSC, Departamento de Farmacología y Toxicología, Universidad Complutense de Madrid, Madrid, Spain",NA
"1648","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Gómez de la Cámara","Agustín","Instituto de Investigación Sanitaria Hospital 12 de Octubre, CIBER de Epidemiología y Salud Pública, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain",NA
"1649","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Arribas","José Ramón","Servicio de Medicina Interna, Hospital Universitario La Paz, IdiPAZ, Universidad Autónoma de Madrid, Madrid, Spain",NA
"1650","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Ochando","Jordi","Laboratorio de Referencia en Inmunología, Instituto de Salud Carlos III, Madrid, Spain",NA
"1651","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Alcamí","José","Unidad de Inmunopatología del SIDA, Instituto de Salud Carlos III, Madrid, Spain",NA
"1652","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Belda-Iniesta","Cristóbal","Centro Nacional de Microbiología, and Evaluation and Promotion of Research, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: cbelda@isciii","cbelda@isciii.es"
"1653","34181880","10.1016/S0140-6736(21)01420-3","Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.","To date, no immunological data on COVID-19 heterologous vaccination schedules in humans have been reported. We assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK). We did a phase 2, open-label, randomised, controlled trial on adults aged 18-60 years, vaccinated with a single dose of ChAdOx1-S 8-12 weeks before screening, and no history of SARS-CoV-2 ","2021","07","19","Lancet","Lancet (London, England)","Adolescent; Adult; COVID-19; COVID-19 Vaccines; Female; Humans; Immunization, Secondary; Immunogenicity, Vaccine; Male; Middle Aged; Spain; Spike Glycoprotein, Coronavirus; Young Adult","Frías","Jesús","Servicio de Farmacología Clínica, Departamento de Farmacología y Terapéutica, Facultad de Medicina, Hospital Universitario La Paz, IdiPAZ, Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: jesus.frias@uam","jesus.frias@uam.es"
"1654","34181868","10.1139/apnm-2021-0204","Exploring the impact of COVID-19 on the willingness of older adults to participate in physiology research: views from past and potential volunteers.","We explored the views of older (=65 years) past and potential volunteers in regard to participating in physiology research during the COVID-19 pandemic. Using an online questionnaire and focus groups, we found that past volunteers (n=55) were more likely to take part in both acute (p&lt;0.05) and chronic (p&lt;0.05) physiology studies, compared to potential future volunteers (n=57). Both cohorts demonstrated a positive attitude towards volunteering during the COVID-19 pandemic, although concern ","2021","06","28","Appl Physiol Nutr Metab","Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme",NA,"Deane","Colleen S","University of Exeter School of Sport and Health Sciences, 71398, Exeter, United Kingdom of Great Britain and Northern Ireland","C.S.Deane@exeter.ac.uk"
"1655","34181868","10.1139/apnm-2021-0204","Exploring the impact of COVID-19 on the willingness of older adults to participate in physiology research: views from past and potential volunteers.","We explored the views of older (=65 years) past and potential volunteers in regard to participating in physiology research during the COVID-19 pandemic. Using an online questionnaire and focus groups, we found that past volunteers (n=55) were more likely to take part in both acute (p&lt;0.05) and chronic (p&lt;0.05) physiology studies, compared to potential future volunteers (n=57). Both cohorts demonstrated a positive attitude towards volunteering during the COVID-19 pandemic, although concern ","2021","06","28","Appl Physiol Nutr Metab","Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme",NA,"Gates","Amanda","University of Nottingham Division of Medical Sciences and Graduate Entry Medicine, 218361, MRC-ARUK Centre for Musculoskeletal Ageing Research, Derby, Derby, United Kingdom of Great Britain and Northern Ireland","amanda.gates@nottingham.ac.uk"
"1656","34181868","10.1139/apnm-2021-0204","Exploring the impact of COVID-19 on the willingness of older adults to participate in physiology research: views from past and potential volunteers.","We explored the views of older (=65 years) past and potential volunteers in regard to participating in physiology research during the COVID-19 pandemic. Using an online questionnaire and focus groups, we found that past volunteers (n=55) were more likely to take part in both acute (p&lt;0.05) and chronic (p&lt;0.05) physiology studies, compared to potential future volunteers (n=57). Both cohorts demonstrated a positive attitude towards volunteering during the COVID-19 pandemic, although concern ","2021","06","28","Appl Physiol Nutr Metab","Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme",NA,"Traviss-Turner","Gemma D","Leeds Institute of Health Sciences University of Leeds, Leeds, United Kingdom of Great Britain and Northern Ireland","G.Traviss@leeds.ac.uk"
"1657","34181868","10.1139/apnm-2021-0204","Exploring the impact of COVID-19 on the willingness of older adults to participate in physiology research: views from past and potential volunteers.","We explored the views of older (=65 years) past and potential volunteers in regard to participating in physiology research during the COVID-19 pandemic. Using an online questionnaire and focus groups, we found that past volunteers (n=55) were more likely to take part in both acute (p&lt;0.05) and chronic (p&lt;0.05) physiology studies, compared to potential future volunteers (n=57). Both cohorts demonstrated a positive attitude towards volunteering during the COVID-19 pandemic, although concern ","2021","06","28","Appl Physiol Nutr Metab","Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme",NA,"Wilkinson","Daniel James","University of Nottingham, Clinical, Metabolic and Molecular Physiology, Derby, United Kingdom of Great Britain and Northern Ireland","daniel.wilkinson@nottingham.ac.uk"
"1658","34181868","10.1139/apnm-2021-0204","Exploring the impact of COVID-19 on the willingness of older adults to participate in physiology research: views from past and potential volunteers.","We explored the views of older (=65 years) past and potential volunteers in regard to participating in physiology research during the COVID-19 pandemic. Using an online questionnaire and focus groups, we found that past volunteers (n=55) were more likely to take part in both acute (p&lt;0.05) and chronic (p&lt;0.05) physiology studies, compared to potential future volunteers (n=57). Both cohorts demonstrated a positive attitude towards volunteering during the COVID-19 pandemic, although concern ","2021","06","28","Appl Physiol Nutr Metab","Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme",NA,"Smith","Kenneth","University of Nottingham, Division of Medical Sciences, Derby, United Kingdom of Great Britain and Northern Ireland","ken.smith@nottingham.ac.uk"
"1659","34181868","10.1139/apnm-2021-0204","Exploring the impact of COVID-19 on the willingness of older adults to participate in physiology research: views from past and potential volunteers.","We explored the views of older (=65 years) past and potential volunteers in regard to participating in physiology research during the COVID-19 pandemic. Using an online questionnaire and focus groups, we found that past volunteers (n=55) were more likely to take part in both acute (p&lt;0.05) and chronic (p&lt;0.05) physiology studies, compared to potential future volunteers (n=57). Both cohorts demonstrated a positive attitude towards volunteering during the COVID-19 pandemic, although concern ","2021","06","28","Appl Physiol Nutr Metab","Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme",NA,"Atherton","Philip J","University of Nottingham, Derby, United Kingdom of Great Britain and Northern Ireland","Philip.Atherton@nottingham.ac.uk"
"1660","34181868","10.1139/apnm-2021-0204","Exploring the impact of COVID-19 on the willingness of older adults to participate in physiology research: views from past and potential volunteers.","We explored the views of older (=65 years) past and potential volunteers in regard to participating in physiology research during the COVID-19 pandemic. Using an online questionnaire and focus groups, we found that past volunteers (n=55) were more likely to take part in both acute (p&lt;0.05) and chronic (p&lt;0.05) physiology studies, compared to potential future volunteers (n=57). Both cohorts demonstrated a positive attitude towards volunteering during the COVID-19 pandemic, although concern ","2021","06","28","Appl Physiol Nutr Metab","Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme",NA,"Phillips","Bethan E","University of Nottingham, School of Medicine, Derby, Derbyshire, United Kingdom of Great Britain and Northern Ireland","beth.phillips@nottingham.ac.uk"
"1661","34181863","10.1080/10852352.2021.1924593","Prioritizing health: Churches response to the COVID-19 pandemic.","Churches serve as a source of connection and support for spiritual wellbeing. More recently, church communities recognize the importance of extending support beyond spirituality and taking a holistic approach that includes mental and physical health. How each church goes about providing support varies among denominations and the needs of their communities. This exploratory study examines how churches of various denominations in the Tri-City region (Pomona, La Verne, and Claremont) of Los Angeles","2021","06","28","J Prev Interv Community","Journal of prevention &amp; intervention in the community","COVID-19; Church; religion; risk perception","Williams","Monique J","Physician Assistant Program, University of La Verne, La Verne, California, USA",NA
"1662","34181863","10.1080/10852352.2021.1924593","Prioritizing health: Churches response to the COVID-19 pandemic.","Churches serve as a source of connection and support for spiritual wellbeing. More recently, church communities recognize the importance of extending support beyond spirituality and taking a holistic approach that includes mental and physical health. How each church goes about providing support varies among denominations and the needs of their communities. This exploratory study examines how churches of various denominations in the Tri-City region (Pomona, La Verne, and Claremont) of Los Angeles","2021","06","28","J Prev Interv Community","Journal of prevention &amp; intervention in the community","COVID-19; Church; religion; risk perception","Wagoner","Zandra","University Chaplain, University of La Verne, La Verne, California, USA",NA
"1663","34181863","10.1080/10852352.2021.1924593","Prioritizing health: Churches response to the COVID-19 pandemic.","Churches serve as a source of connection and support for spiritual wellbeing. More recently, church communities recognize the importance of extending support beyond spirituality and taking a holistic approach that includes mental and physical health. How each church goes about providing support varies among denominations and the needs of their communities. This exploratory study examines how churches of various denominations in the Tri-City region (Pomona, La Verne, and Claremont) of Los Angeles","2021","06","28","J Prev Interv Community","Journal of prevention &amp; intervention in the community","COVID-19; Church; religion; risk perception","Rodman-Alvarez","Sarah","Randall Lewis Center for Well-Being &amp",NA
"1664","34181863","10.1080/10852352.2021.1924593","Prioritizing health: Churches response to the COVID-19 pandemic.","Churches serve as a source of connection and support for spiritual wellbeing. More recently, church communities recognize the importance of extending support beyond spirituality and taking a holistic approach that includes mental and physical health. How each church goes about providing support varies among denominations and the needs of their communities. This exploratory study examines how churches of various denominations in the Tri-City region (Pomona, La Verne, and Claremont) of Los Angeles","2021","06","28","J Prev Interv Community","Journal of prevention &amp; intervention in the community","COVID-19; Church; religion; risk perception","Pasillas","Valerie","Sociology and Anthropology Department, University of La Verne, La Verne, California, USA",NA
"1665","34181863","10.1080/10852352.2021.1924593","Prioritizing health: Churches response to the COVID-19 pandemic.","Churches serve as a source of connection and support for spiritual wellbeing. More recently, church communities recognize the importance of extending support beyond spirituality and taking a holistic approach that includes mental and physical health. How each church goes about providing support varies among denominations and the needs of their communities. This exploratory study examines how churches of various denominations in the Tri-City region (Pomona, La Verne, and Claremont) of Los Angeles","2021","06","28","J Prev Interv Community","Journal of prevention &amp; intervention in the community","COVID-19; Church; religion; risk perception","Sanchez","America","Religion/Philosophy Department, University of La Verne, La Verne, California, USA",NA
"1666","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Ryzhov","Ivan M","Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow 117997, Russian Federation",NA
"1667","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Tuzikov","Alexander B","Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow 117997, Russian Federation",NA
"1668","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Nizovtsev","Alexey V","Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow 117997, Russian Federation",NA
"1669","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Baidakova","Ludmila K","Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Pushchino, Moscow Region 142290, Russian Federation",NA
"1670","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Galanina","Oxana E","Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow 117997, Russian Federation",NA
"1671","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Shilova","Nadezhda V","Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow 117997, Russian Federation",NA
"1672","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Ziganshina","Marina M","National Medical Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russian Federation, Moscow 117997, Russian Federation",NA
"1673","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Dolgushina","Nataliya V","National Medical Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russian Federation, Moscow 117997, Russian Federation",NA
"1674","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Bayramova","Guldana R","National Medical Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russian Federation, Moscow 117997, Russian Federation",NA
"1675","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Sukhikh","Gennady T","National Medical Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russian Federation, Moscow 117997, Russian Federation",NA
"1676","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Williams","Eleanor C","Centre for Kode Technology Innovation, School of Engineering, Computer and Mathematical Sciences, Faculty of Design and Creative Technologies, Auckland University of Technology, Auckland 1010, New Zealand",NA
"1677","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Nagappan","Radhika","Centre for Kode Technology Innovation, School of Engineering, Computer and Mathematical Sciences, Faculty of Design and Creative Technologies, Auckland University of Technology, Auckland 1010, New Zealand",NA
"1678","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Henry","Stephen M","Centre for Kode Technology Innovation, School of Engineering, Computer and Mathematical Sciences, Faculty of Design and Creative Technologies, Auckland University of Technology, Auckland 1010, New Zealand",NA
"1679","34181851","10.1021/acs.bioconjchem.1c00186","SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics.","In the near future, the increase in the number of required tests for COVID-19 antibodies is expected to be many hundreds of millions. Obviously, this will be done using a variety of analytical methods and using different antigens, including peptides. In this work, we compare three method variations for detecting specific immunoglobulins directed against peptides of approximately 15-aa of the SARS-CoV-2 spike protein. These linear peptide epitopes were selected using antigenicity algorithms, and ","2021","06","28","Bioconjug Chem","Bioconjugate chemistry",NA,"Bovin","Nicolai V","Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow 117997, Russian Federation",NA
"1680","34181830","10.31053/1853.0605.v78.n2.32077","Perception of memory in university students of Venezuela during COVID-19","University students need memory to manage the learning processes based on metacognition and in this way they can respond to future demands as professionals. was structured with a quantitative approach, comparative type, non-experimental cross-sectional design, the sample consisted of 237 responses from students. the age was 26.45 ± 8.96 years, 66% female and 34% male, students older than 27 years had a higher average in the use of memory strategies (p = 0.003); a longer semester was obtained, th","2021","06","30","Rev Fac Cien Med Univ Nac Cordoba","Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)","memory; COVID-19; higher education; information and communication technologies; Venezuela; COVID-19; Humans; Perception; SARS-CoV-2; Students; Universities","Chipia Lobo","Joan","Universidad de Los Andes (ULA). joanfernando130885@gmail","joanfernando130885@gmail.com"
"1681","34181830","10.31053/1853.0605.v78.n2.32077","Perception of memory in university students of Venezuela during COVID-19","University students need memory to manage the learning processes based on metacognition and in this way they can respond to future demands as professionals. was structured with a quantitative approach, comparative type, non-experimental cross-sectional design, the sample consisted of 237 responses from students. the age was 26.45 ± 8.96 years, 66% female and 34% male, students older than 27 years had a higher average in the use of memory strategies (p = 0.003); a longer semester was obtained, th","2021","06","30","Rev Fac Cien Med Univ Nac Cordoba","Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)","memory; COVID-19; higher education; information and communication technologies; Venezuela; COVID-19; Humans; Perception; SARS-CoV-2; Students; Universities","Paredes","Yorman","Universidad de Los Andes (ULA). paredesy@gmail","paredesy@gmail.com"
"1682","34181830","10.31053/1853.0605.v78.n2.32077","Perception of memory in university students of Venezuela during COVID-19","University students need memory to manage the learning processes based on metacognition and in this way they can respond to future demands as professionals. was structured with a quantitative approach, comparative type, non-experimental cross-sectional design, the sample consisted of 237 responses from students. the age was 26.45 ± 8.96 years, 66% female and 34% male, students older than 27 years had a higher average in the use of memory strategies (p = 0.003); a longer semester was obtained, th","2021","06","30","Rev Fac Cien Med Univ Nac Cordoba","Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)","memory; COVID-19; higher education; information and communication technologies; Venezuela; COVID-19; Humans; Perception; SARS-CoV-2; Students; Universities","Lobo","Sandra","Universidad de Los Andes (ULA). wolfsami.2016@gmail","wolfsami.2016@gmail.com"
"1683","34181830","10.31053/1853.0605.v78.n2.32077","Perception of memory in university students of Venezuela during COVID-19","University students need memory to manage the learning processes based on metacognition and in this way they can respond to future demands as professionals. was structured with a quantitative approach, comparative type, non-experimental cross-sectional design, the sample consisted of 237 responses from students. the age was 26.45 ± 8.96 years, 66% female and 34% male, students older than 27 years had a higher average in the use of memory strategies (p = 0.003); a longer semester was obtained, th","2021","06","30","Rev Fac Cien Med Univ Nac Cordoba","Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)","memory; COVID-19; higher education; information and communication technologies; Venezuela; COVID-19; Humans; Perception; SARS-CoV-2; Students; Universities","Sánchez","Mariana","Instituto Autónomo Hospital Universitario de Los Andes (IAHULA). negra7690@hotmail","negra7690@hotmail.com"
"1684","34181830","10.31053/1853.0605.v78.n2.32077","Perception of memory in university students of Venezuela during COVID-19","University students need memory to manage the learning processes based on metacognition and in this way they can respond to future demands as professionals. was structured with a quantitative approach, comparative type, non-experimental cross-sectional design, the sample consisted of 237 responses from students. the age was 26.45 ± 8.96 years, 66% female and 34% male, students older than 27 years had a higher average in the use of memory strategies (p = 0.003); a longer semester was obtained, th","2021","06","30","Rev Fac Cien Med Univ Nac Cordoba","Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)","memory; COVID-19; higher education; information and communication technologies; Venezuela; COVID-19; Humans; Perception; SARS-CoV-2; Students; Universities","González","Alexy","Universidad de Los Andes (ULA). alexygonzalezcastillo@gmail","alexygonzalezcastillo@gmail.com"
"1685","34181827","10.31053/1853.0605.v78.n2.32550","Child disability in a changing world: a human rights approach","The COVID-19 pandemic is pronounced as a turning point in our professional health practice, from which new opportunities will arise with which we must promote the rights of children and people with disabilities. La pandemia del COVID-19 se pronuncia como un punto de inflexión en nuestra práctica profesional en salud, a partir de la cual nuevas oportunidades surgirán con las que debemos promover los derechos de niños, niñas y personas con discapacidad.","2021","06","30","Rev Fac Cien Med Univ Nac Cordoba","Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)","disabiality; human rights; pandemic; COVID-19; child; Child; Human Rights; Humans","Schiariti","Verónica","Universidad de Victoria, BC, Canadá. ruiz@gmail","ruiz@gmail.com"
"1686","34181827","10.31053/1853.0605.v78.n2.32550","Child disability in a changing world: a human rights approach","The COVID-19 pandemic is pronounced as a turning point in our professional health practice, from which new opportunities will arise with which we must promote the rights of children and people with disabilities. La pandemia del COVID-19 se pronuncia como un punto de inflexión en nuestra práctica profesional en salud, a partir de la cual nuevas oportunidades surgirán con las que debemos promover los derechos de niños, niñas y personas con discapacidad.","2021","06","30","Rev Fac Cien Med Univ Nac Cordoba","Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)","disabiality; human rights; pandemic; COVID-19; child; Child; Human Rights; Humans","Ruiz Brunner","Maria de Las Mercedes","Universidad Nacional de Córdoba. Facultad de Ciencias Médicas. Escuela de Nutrición. Córdoba, Argentina.. mercedesruizb@gmail","mercedesruizb@gmail.com"
"1687","34181827","10.31053/1853.0605.v78.n2.32550","Child disability in a changing world: a human rights approach","The COVID-19 pandemic is pronounced as a turning point in our professional health practice, from which new opportunities will arise with which we must promote the rights of children and people with disabilities. La pandemia del COVID-19 se pronuncia como un punto de inflexión en nuestra práctica profesional en salud, a partir de la cual nuevas oportunidades surgirán con las que debemos promover los derechos de niños, niñas y personas con discapacidad.","2021","06","30","Rev Fac Cien Med Univ Nac Cordoba","Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)","disabiality; human rights; pandemic; COVID-19; child; Child; Human Rights; Humans","Escobar Zuluaga","L Johana","Universidad Nacional de Córdoba. Facultad de Ciencias Médicas. Córdoba, Argentina.. rrr@gmail","rrr@gmail.com"
"1688","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","He","Wenshu","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1689","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Baysal","Can","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1690","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Lobato Gómez","Maria","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1691","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Huang","Xin","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1692","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Alvarez","Derry","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1693","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Zhu","Changfu","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1694","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Armario-Najera","Victoria","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1695","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Blanco Perera","Aamaya","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1696","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Cerda Bennaser","Pedro","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1697","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Saba-Mayoral","Andrea","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1698","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Sobrino-Mengual","Guillermo","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1699","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Vargheese","Ashwin","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1700","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Abranches","Rita","Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal",NA
"1701","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Alexandra Abreu","Isabel","Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal",NA
"1702","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Balamurugan","Shanmugaraj","Plant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Tamil Nadu, India",NA
"1703","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Bock","Ralph","Max Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany",NA
"1704","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Buyel","Johannes F","Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany",NA
"1705","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","da Cunha","Nicolau B","Centro de Análise Proteômicas e Bioquímicas de Brasília, Universidade Católica de Brasília, Brasília, Brazil",NA
"1706","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Daniell","Henry","School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA",NA
"1707","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Faller","Roland","Department of Chemical Engineering, University of California, Davis, Davis, CA, USA",NA
"1708","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Folgado","André","Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal",NA
"1709","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Gowtham","Iyappan","Plant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Tamil Nadu, India",NA
"1710","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Häkkinen","Suvi T","Industrial Biotechnology and Food Solutions, VTT Technical Research Centre of Finland Ltd, Espoo, Finland",NA
"1711","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Kumar","Shashi","International Centre for Genetic Engineering and Biotechnology, New Delhi, India",NA
"1712","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Sathish Kumar","Ramalingam","Plant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Tamil Nadu, India",NA
"1713","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Lacorte","Cristiano","Brazilian Agriculture Research Corporation, Embrapa Genetic Resources and Biotechnology and National Institute of Science and Technology Synthetic in Biology, Parque Estação Biológica, Brasilia, Brazil",NA
"1714","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Lomonossoff","George P","Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich, UK",NA
"1715","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Luís","Ines M","Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal",NA
"1716","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","K-C Ma","Julian","Institute for Infection and Immunity, St. George's University of London, London, UK",NA
"1717","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","McDonald","Karen A","Department of Chemical Engineering, University of California, Davis, Davis, CA, USA",NA
"1718","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Murad","Andre","Brazilian Agriculture Research Corporation, Embrapa Genetic Resources and Biotechnology and National Institute of Science and Technology Synthetic in Biology, Parque Estação Biológica, Brasilia, Brazil",NA
"1719","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Nandi","Somen","Department of Chemical Engineering, University of California, Davis, Davis, CA, USA",NA
"1720","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","O'Keef","Barry","Division of Cancer Treatment and Diagnosis, Molecular Targets Program, Center for Cancer Research, National Cancer Institute, and Natural Products Branch, Developmental Therapeutics Program, National Cancer Institute, NIH, Frederick, MD, USA",NA
"1721","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Parthiban","Subramanian","Plant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Tamil Nadu, India",NA
"1722","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Paul","Mathew J","Institute for Infection and Immunity, St. George's University of London, London, UK",NA
"1723","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Ponndorf","Daniel","Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich, UK",NA
"1724","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Rech","Elibio","Brazilian Agriculture Research Corporation, Embrapa Genetic Resources and Biotechnology and National Institute of Science and Technology Synthetic in Biology, Parque Estação Biológica, Brasilia, Brazil",NA
"1725","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Rodrigues","Julio C M","Brazilian Agriculture Research Corporation, Embrapa Genetic Resources and Biotechnology and National Institute of Science and Technology Synthetic in Biology, Parque Estação Biológica, Brasilia, Brazil",NA
"1726","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Ruf","Stephanie","Max Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany",NA
"1727","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Schillberg","Stefan","Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany",NA
"1728","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Schwestka","Jennifer","Institute of Plant Biotechnology and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Austria",NA
"1729","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Shah","Priya S","Department of Chemical Engineering, University of California, Davis, Davis, CA, USA",NA
"1730","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Singh","Rahul","School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA",NA
"1731","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Stoger","Eva","Institute of Plant Biotechnology and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Austria",NA
"1732","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Twyman","Richard M","TRM Ltd, Scarborough, UK",NA
"1733","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Varghese","Inchakalody P","Plant Genetic Engineering Laboratory, Department of Biotechnology, Bharathiar University, Tamil Nadu, India",NA
"1734","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Vianna","Giovanni R","Brazilian Agriculture Research Corporation, Embrapa Genetic Resources and Biotechnology and National Institute of Science and Technology Synthetic in Biology, Parque Estação Biológica, Brasilia, Brazil",NA
"1735","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Webster","Gina","Institute for Infection and Immunity, St. George's University of London, London, UK",NA
"1736","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Wilbers","Ruud H P","Laboratory of Nematology, Plant Sciences Group, Wageningen University and Research, Wageningen, The Netherlands",NA
"1737","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Christou","Paul","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1738","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Oksman-Caldentey","Kirsi-Marja","Industrial Biotechnology and Food Solutions, VTT Technical Research Centre of Finland Ltd, Espoo, Finland",NA
"1739","34181810","10.1111/pbi.13658","Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.","The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and","2021","07","21","Plant Biotechnol J","Plant biotechnology journal","endemic disease; molecular farming; oral delivery; plant-made pharmaceuticals; re-emerging disease","Capell","Teresa","Department of Crop and Forest Sciences, University of Lleida-Agrotecnio CERCA Center, Lleida, Spain",NA
"1740","34181804","10.1111/odi.13951","Self-reported taste and smell impairment among patients diagnosed with COVID-19 in Brazil.",NA,"2021","07","08","Oral Dis","Oral diseases","SARS-CoV-2; ageusia; anosmia; oral changes","Silva","Felipe T D","São Leopoldo Mandic Institute and Research Center, Campinas, Brazil",NA
"1741","34181804","10.1111/odi.13951","Self-reported taste and smell impairment among patients diagnosed with COVID-19 in Brazil.",NA,"2021","07","08","Oral Dis","Oral diseases","SARS-CoV-2; ageusia; anosmia; oral changes","Sperandio","Marcelo","São Leopoldo Mandic Institute and Research Center, Campinas, Brazil",NA
"1742","34181804","10.1111/odi.13951","Self-reported taste and smell impairment among patients diagnosed with COVID-19 in Brazil.",NA,"2021","07","08","Oral Dis","Oral diseases","SARS-CoV-2; ageusia; anosmia; oral changes","Suzuki","Selly S","São Leopoldo Mandic Institute and Research Center, Campinas, Brazil",NA
"1743","34181804","10.1111/odi.13951","Self-reported taste and smell impairment among patients diagnosed with COVID-19 in Brazil.",NA,"2021","07","08","Oral Dis","Oral diseases","SARS-CoV-2; ageusia; anosmia; oral changes","Silva","Heglayne P V","LACEN/RN, Natal, Brazil",NA
"1744","34181804","10.1111/odi.13951","Self-reported taste and smell impairment among patients diagnosed with COVID-19 in Brazil.",NA,"2021","07","08","Oral Dis","Oral diseases","SARS-CoV-2; ageusia; anosmia; oral changes","de Oliveira","Derley G","LACEN/RN, Natal, Brazil",NA
"1745","34181804","10.1111/odi.13951","Self-reported taste and smell impairment among patients diagnosed with COVID-19 in Brazil.",NA,"2021","07","08","Oral Dis","Oral diseases","SARS-CoV-2; ageusia; anosmia; oral changes","Stefenon","Letícia","São Leopoldo Mandic Institute and Research Center, Campinas, Brazil",NA
"1746","34181804","10.1111/odi.13951","Self-reported taste and smell impairment among patients diagnosed with COVID-19 in Brazil.",NA,"2021","07","08","Oral Dis","Oral diseases","SARS-CoV-2; ageusia; anosmia; oral changes","Garcez","Aguinaldo S","São Leopoldo Mandic Institute and Research Center, Campinas, Brazil",NA
"1747","34181766","10.1111/ina.12899","Affordable measures to monitor and alarm nosocomial SARS-CoV-2 infection due to poor ventilation.","Since the coronavirus disease 2019 (COVID-19) outbreak, the nosocomial infection rate worldwide has been reported high. It is urgent to figure out an affordable way to monitor and alarm nosocomial infection. Carbon dioxide (CO2 ) concentration can reflect the ventilation performance and crowdedness, so CO2 sensors were placed in Beijing Tsinghua Changgung Hospital's fever clinic and emergency department where the nosocomial infection risk was high. Patients' medical records","2021","06","28","Indoor Air","Indoor air","COVID-19; Carbon dioxide; nosocomial infection; ventilation","Lu","Yiran","Department of Building Science, Tsinghua University, Beijing, China",NA
"1748","34181766","10.1111/ina.12899","Affordable measures to monitor and alarm nosocomial SARS-CoV-2 infection due to poor ventilation.","Since the coronavirus disease 2019 (COVID-19) outbreak, the nosocomial infection rate worldwide has been reported high. It is urgent to figure out an affordable way to monitor and alarm nosocomial infection. Carbon dioxide (CO2 ) concentration can reflect the ventilation performance and crowdedness, so CO2 sensors were placed in Beijing Tsinghua Changgung Hospital's fever clinic and emergency department where the nosocomial infection risk was high. Patients' medical records","2021","06","28","Indoor Air","Indoor air","COVID-19; Carbon dioxide; nosocomial infection; ventilation","Li","Yifan","Department of Building Science, Tsinghua University, Beijing, China",NA
"1749","34181766","10.1111/ina.12899","Affordable measures to monitor and alarm nosocomial SARS-CoV-2 infection due to poor ventilation.","Since the coronavirus disease 2019 (COVID-19) outbreak, the nosocomial infection rate worldwide has been reported high. It is urgent to figure out an affordable way to monitor and alarm nosocomial infection. Carbon dioxide (CO2 ) concentration can reflect the ventilation performance and crowdedness, so CO2 sensors were placed in Beijing Tsinghua Changgung Hospital's fever clinic and emergency department where the nosocomial infection risk was high. Patients' medical records","2021","06","28","Indoor Air","Indoor air","COVID-19; Carbon dioxide; nosocomial infection; ventilation","Zhou","Hao","Department of Building Science, Tsinghua University, Beijing, China",NA
"1750","34181766","10.1111/ina.12899","Affordable measures to monitor and alarm nosocomial SARS-CoV-2 infection due to poor ventilation.","Since the coronavirus disease 2019 (COVID-19) outbreak, the nosocomial infection rate worldwide has been reported high. It is urgent to figure out an affordable way to monitor and alarm nosocomial infection. Carbon dioxide (CO2 ) concentration can reflect the ventilation performance and crowdedness, so CO2 sensors were placed in Beijing Tsinghua Changgung Hospital's fever clinic and emergency department where the nosocomial infection risk was high. Patients' medical records","2021","06","28","Indoor Air","Indoor air","COVID-19; Carbon dioxide; nosocomial infection; ventilation","Lin","Jinlan","Department of Disease &amp",NA
"1751","34181766","10.1111/ina.12899","Affordable measures to monitor and alarm nosocomial SARS-CoV-2 infection due to poor ventilation.","Since the coronavirus disease 2019 (COVID-19) outbreak, the nosocomial infection rate worldwide has been reported high. It is urgent to figure out an affordable way to monitor and alarm nosocomial infection. Carbon dioxide (CO2 ) concentration can reflect the ventilation performance and crowdedness, so CO2 sensors were placed in Beijing Tsinghua Changgung Hospital's fever clinic and emergency department where the nosocomial infection risk was high. Patients' medical records","2021","06","28","Indoor Air","Indoor air","COVID-19; Carbon dioxide; nosocomial infection; ventilation","Zheng","Zhuozhao","School of Clinical Medicine, Tsinghua University, Beijing, China",NA
"1752","34181766","10.1111/ina.12899","Affordable measures to monitor and alarm nosocomial SARS-CoV-2 infection due to poor ventilation.","Since the coronavirus disease 2019 (COVID-19) outbreak, the nosocomial infection rate worldwide has been reported high. It is urgent to figure out an affordable way to monitor and alarm nosocomial infection. Carbon dioxide (CO2 ) concentration can reflect the ventilation performance and crowdedness, so CO2 sensors were placed in Beijing Tsinghua Changgung Hospital's fever clinic and emergency department where the nosocomial infection risk was high. Patients' medical records","2021","06","28","Indoor Air","Indoor air","COVID-19; Carbon dioxide; nosocomial infection; ventilation","Xu","Huji","School of Clinical Medicine, Tsinghua University, Beijing, China",NA
"1753","34181766","10.1111/ina.12899","Affordable measures to monitor and alarm nosocomial SARS-CoV-2 infection due to poor ventilation.","Since the coronavirus disease 2019 (COVID-19) outbreak, the nosocomial infection rate worldwide has been reported high. It is urgent to figure out an affordable way to monitor and alarm nosocomial infection. Carbon dioxide (CO2 ) concentration can reflect the ventilation performance and crowdedness, so CO2 sensors were placed in Beijing Tsinghua Changgung Hospital's fever clinic and emergency department where the nosocomial infection risk was high. Patients' medical records","2021","06","28","Indoor Air","Indoor air","COVID-19; Carbon dioxide; nosocomial infection; ventilation","Lin","Borong","Department of Building Science, Tsinghua University, Beijing, China",NA
"1754","34181766","10.1111/ina.12899","Affordable measures to monitor and alarm nosocomial SARS-CoV-2 infection due to poor ventilation.","Since the coronavirus disease 2019 (COVID-19) outbreak, the nosocomial infection rate worldwide has been reported high. It is urgent to figure out an affordable way to monitor and alarm nosocomial infection. Carbon dioxide (CO2 ) concentration can reflect the ventilation performance and crowdedness, so CO2 sensors were placed in Beijing Tsinghua Changgung Hospital's fever clinic and emergency department where the nosocomial infection risk was high. Patients' medical records","2021","06","28","Indoor Air","Indoor air","COVID-19; Carbon dioxide; nosocomial infection; ventilation","Lin","Minggui","School of Clinical Medicine, Tsinghua University, Beijing, China",NA
"1755","34181766","10.1111/ina.12899","Affordable measures to monitor and alarm nosocomial SARS-CoV-2 infection due to poor ventilation.","Since the coronavirus disease 2019 (COVID-19) outbreak, the nosocomial infection rate worldwide has been reported high. It is urgent to figure out an affordable way to monitor and alarm nosocomial infection. Carbon dioxide (CO2 ) concentration can reflect the ventilation performance and crowdedness, so CO2 sensors were placed in Beijing Tsinghua Changgung Hospital's fever clinic and emergency department where the nosocomial infection risk was high. Patients' medical records","2021","06","28","Indoor Air","Indoor air","COVID-19; Carbon dioxide; nosocomial infection; ventilation","Liu","Li","Department of Building Science, Tsinghua University, Beijing, China",NA
"1756","34181752","10.1111/aor.14030","Mobile ECMO retrieval of patients during the COVID-19 pandemic.","ECMO support is particularly resource-intensive and should be provided in highly specialized centers. Occasionally, ECMO needs to be initiated in non-ECMO centers by mobile ECMO retrieval teams. Subsequently, patients must be transferred on ECMO to the ECMO center. We report single-center data from out-of-center initiations of ECMO during the COVID-19 pandemic. From March 2020 through February 2021, nine patients were connected to ECMO before transfer to our center. Median travel distance (IQR) ","2021","07","21","Artif Organs","Artificial organs","COVID-19; ECMO; mobile ECMO retrieval","Widmeier","Eugen","Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany",NA
"1757","34181752","10.1111/aor.14030","Mobile ECMO retrieval of patients during the COVID-19 pandemic.","ECMO support is particularly resource-intensive and should be provided in highly specialized centers. Occasionally, ECMO needs to be initiated in non-ECMO centers by mobile ECMO retrieval teams. Subsequently, patients must be transferred on ECMO to the ECMO center. We report single-center data from out-of-center initiations of ECMO during the COVID-19 pandemic. From March 2020 through February 2021, nine patients were connected to ECMO before transfer to our center. Median travel distance (IQR) ","2021","07","21","Artif Organs","Artificial organs","COVID-19; ECMO; mobile ECMO retrieval","Duerschmied","Daniel","Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany",NA
"1758","34181752","10.1111/aor.14030","Mobile ECMO retrieval of patients during the COVID-19 pandemic.","ECMO support is particularly resource-intensive and should be provided in highly specialized centers. Occasionally, ECMO needs to be initiated in non-ECMO centers by mobile ECMO retrieval teams. Subsequently, patients must be transferred on ECMO to the ECMO center. We report single-center data from out-of-center initiations of ECMO during the COVID-19 pandemic. From March 2020 through February 2021, nine patients were connected to ECMO before transfer to our center. Median travel distance (IQR) ","2021","07","21","Artif Organs","Artificial organs","COVID-19; ECMO; mobile ECMO retrieval","Benk","Christoph","Department of Cardiovascular Surgery, Heart Center, University of Freiburg, Freiburg, Germany",NA
"1759","34181752","10.1111/aor.14030","Mobile ECMO retrieval of patients during the COVID-19 pandemic.","ECMO support is particularly resource-intensive and should be provided in highly specialized centers. Occasionally, ECMO needs to be initiated in non-ECMO centers by mobile ECMO retrieval teams. Subsequently, patients must be transferred on ECMO to the ECMO center. We report single-center data from out-of-center initiations of ECMO during the COVID-19 pandemic. From March 2020 through February 2021, nine patients were connected to ECMO before transfer to our center. Median travel distance (IQR) ","2021","07","21","Artif Organs","Artificial organs","COVID-19; ECMO; mobile ECMO retrieval","Staudacher","Dawid","Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany",NA
"1760","34181752","10.1111/aor.14030","Mobile ECMO retrieval of patients during the COVID-19 pandemic.","ECMO support is particularly resource-intensive and should be provided in highly specialized centers. Occasionally, ECMO needs to be initiated in non-ECMO centers by mobile ECMO retrieval teams. Subsequently, patients must be transferred on ECMO to the ECMO center. We report single-center data from out-of-center initiations of ECMO during the COVID-19 pandemic. From March 2020 through February 2021, nine patients were connected to ECMO before transfer to our center. Median travel distance (IQR) ","2021","07","21","Artif Organs","Artificial organs","COVID-19; ECMO; mobile ECMO retrieval","Wengenmayer","Tobias","Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany",NA
"1761","34181752","10.1111/aor.14030","Mobile ECMO retrieval of patients during the COVID-19 pandemic.","ECMO support is particularly resource-intensive and should be provided in highly specialized centers. Occasionally, ECMO needs to be initiated in non-ECMO centers by mobile ECMO retrieval teams. Subsequently, patients must be transferred on ECMO to the ECMO center. We report single-center data from out-of-center initiations of ECMO during the COVID-19 pandemic. From March 2020 through February 2021, nine patients were connected to ECMO before transfer to our center. Median travel distance (IQR) ","2021","07","21","Artif Organs","Artificial organs","COVID-19; ECMO; mobile ECMO retrieval","Supady","Alexander","Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany",NA
"1762","34181716","10.1093/cid/ciab591","Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.","We systematically assessed benefits and harms of the use of ivermectin (IVM) in COVID-19 patients. Published and preprint randomized controlled trials (RCTs) assessing IVM effects on COVID-19 adult patients were searched until March 22, 2021 in five engines. Primary outcomes were all-cause mortality, length of stay (LOS), and adverse events (AE). Secondary outcomes included viral clearance and severe AEs. Risk of bias (RoB) was evaluated using Cochrane RoB 2·0 tool. Inverse variance random effec","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; Ivermectin; SARS-CoV-2; meta-analysis; mortality","Roman","Yuani M","Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut School of Pharmacy, 69 N Eagleville Rd U-3092, Storrs, CT 06269, USA",NA
"1763","34181716","10.1093/cid/ciab591","Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.","We systematically assessed benefits and harms of the use of ivermectin (IVM) in COVID-19 patients. Published and preprint randomized controlled trials (RCTs) assessing IVM effects on COVID-19 adult patients were searched until March 22, 2021 in five engines. Primary outcomes were all-cause mortality, length of stay (LOS), and adverse events (AE). Secondary outcomes included viral clearance and severe AEs. Risk of bias (RoB) was evaluated using Cochrane RoB 2·0 tool. Inverse variance random effec","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; Ivermectin; SARS-CoV-2; meta-analysis; mortality","Burela","Paula Alejandra","Universidad Científica del Sur, Carretera Panamericana Sur 19, Villa EL Salvador, Lima 15067, Peru",NA
"1764","34181716","10.1093/cid/ciab591","Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.","We systematically assessed benefits and harms of the use of ivermectin (IVM) in COVID-19 patients. Published and preprint randomized controlled trials (RCTs) assessing IVM effects on COVID-19 adult patients were searched until March 22, 2021 in five engines. Primary outcomes were all-cause mortality, length of stay (LOS), and adverse events (AE). Secondary outcomes included viral clearance and severe AEs. Risk of bias (RoB) was evaluated using Cochrane RoB 2·0 tool. Inverse variance random effec","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; Ivermectin; SARS-CoV-2; meta-analysis; mortality","Pasupuleti","Vinay","Cello Health, 790 Township Line Rd #200, Yardley, PA 19067, USA",NA
"1765","34181716","10.1093/cid/ciab591","Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.","We systematically assessed benefits and harms of the use of ivermectin (IVM) in COVID-19 patients. Published and preprint randomized controlled trials (RCTs) assessing IVM effects on COVID-19 adult patients were searched until March 22, 2021 in five engines. Primary outcomes were all-cause mortality, length of stay (LOS), and adverse events (AE). Secondary outcomes included viral clearance and severe AEs. Risk of bias (RoB) was evaluated using Cochrane RoB 2·0 tool. Inverse variance random effec","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; Ivermectin; SARS-CoV-2; meta-analysis; mortality","Piscoya","Alejandro","Unidad de revisiones sistemáticas y meta-análisis, guías de práctica clínica y evaluaciones de tecnologías sanitarias (URSIGET), Vicerrectorado de Investigación, Universidad San Ignacio de Loyola (USIL), Av. La Fontana 550, La Molina, Lima 15024, Peru",NA
"1766","34181716","10.1093/cid/ciab591","Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.","We systematically assessed benefits and harms of the use of ivermectin (IVM) in COVID-19 patients. Published and preprint randomized controlled trials (RCTs) assessing IVM effects on COVID-19 adult patients were searched until March 22, 2021 in five engines. Primary outcomes were all-cause mortality, length of stay (LOS), and adverse events (AE). Secondary outcomes included viral clearance and severe AEs. Risk of bias (RoB) was evaluated using Cochrane RoB 2·0 tool. Inverse variance random effec","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; Ivermectin; SARS-CoV-2; meta-analysis; mortality","Vidal","Jose E","Division of Infectious Diseases, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, R. Eneas de Carvalho Aguiar 255, São Paulo 05403-000, Brazil",NA
"1767","34181716","10.1093/cid/ciab591","Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.","We systematically assessed benefits and harms of the use of ivermectin (IVM) in COVID-19 patients. Published and preprint randomized controlled trials (RCTs) assessing IVM effects on COVID-19 adult patients were searched until March 22, 2021 in five engines. Primary outcomes were all-cause mortality, length of stay (LOS), and adverse events (AE). Secondary outcomes included viral clearance and severe AEs. Risk of bias (RoB) was evaluated using Cochrane RoB 2·0 tool. Inverse variance random effec","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","COVID-19; Ivermectin; SARS-CoV-2; meta-analysis; mortality","Hernandez","Adrian V","Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut School of Pharmacy, 69 N Eagleville Rd U-3092, Storrs, CT 06269, USA",NA
"1768","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Nandakumar","Vijayalakshmi","ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA (Nandakumar, Profaizer, Lozier, Elgort, Rychert, Slev, Delgado)",NA
"1769","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Profaizer","Tracie","ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA (Nandakumar, Profaizer, Lozier, Elgort, Rychert, Slev, Delgado)",NA
"1770","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Lozier","Bucky K","ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA (Nandakumar, Profaizer, Lozier, Elgort, Rychert, Slev, Delgado)",NA
"1771","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Elgort","Marc G","ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA (Nandakumar, Profaizer, Lozier, Elgort, Rychert, Slev, Delgado)",NA
"1772","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Larragoite","Erin T","Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA (Nandakumar, Larragoite, Williams, Planelles, Rychert, Slev, Delgado)",NA
"1773","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Williams","Elizabeth S C P","Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA (Nandakumar, Larragoite, Williams, Planelles, Rychert, Slev, Delgado)",NA
"1774","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Solis-Leal","Antonio","Department of Microbiology &amp",NA
"1775","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Lopez","J Brandon","Department of Microbiology &amp",NA
"1776","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Berges","Bradford K","Department of Microbiology &amp",NA
"1777","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Planelles","Vicente","Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA (Nandakumar, Larragoite, Williams, Planelles, Rychert, Slev, Delgado)",NA
"1778","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Rychert","Jenna","ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA (Nandakumar, Profaizer, Lozier, Elgort, Rychert, Slev, Delgado)",NA
"1779","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Slev","Patricia R","ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA (Nandakumar, Profaizer, Lozier, Elgort, Rychert, Slev, Delgado)",NA
"1780","34181714","10.5858/arpa.2021-0213-SA","Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays.","Emerging evidence shows correlation between the presence of neutralization antibodies (nAbs) and protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently available commercial serology assays lack the ability to specifically identify nAbs. An ELISAbased nAb assay (GenScript cPass neutralization antibody assay) has recently received emergency use authorization from the Food and Drug Administration (FDA). To evaluate the performance characteristics of this","2021","06","28","Arch Pathol Lab Med","Archives of pathology &amp; laboratory medicine",NA,"Delgado","Julio C","ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA (Nandakumar, Profaizer, Lozier, Elgort, Rychert, Slev, Delgado)",NA
"1781","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Walker","Andreas","Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1782","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Houwaart","Torsten","Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1783","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Finzer","Patrick","Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1784","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Ehlkes","Lutz","Düsseldorf Health Department (Gesundheitsamt Düsseldorf), Düsseldorf, Germany",NA
"1785","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Tyshaieva","Alona","Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1786","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Damagnez","Maximilian","Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1787","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Strelow","Daniel","Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1788","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Duplessis","Ashley","Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1789","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Nicolai","Jessica","Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1790","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Wienemann","Tobias","Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1791","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Tamayo","Teresa","Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1792","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Kohns Vasconcelos","Malte","Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1793","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Hülse","Lisanna","Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1794","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Hoffmann","Katrin","Zotz | Klimas, Düsseldorf, Germany",NA
"1795","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Lübke","Nadine","Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1796","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Hauka","Sandra","Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1797","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Andree","Marcel","Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1798","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Däumer","Martin P","SeqIT GmbH, Pfaffplatz 10, 67655 Kaiserslautern",NA
"1799","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Thielen","Alexander","SeqIT GmbH, Pfaffplatz 10, 67655 Kaiserslautern",NA
"1800","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Kolbe-Busch","Susanne","Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1801","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Göbels","Klaus","Düsseldorf Health Department (Gesundheitsamt Düsseldorf), Düsseldorf, Germany",NA
"1802","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Zotz","Rainer","Zotz | Klimas, Düsseldorf, Germany",NA
"1803","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Pfeffer","Klaus","Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1804","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Timm","Jörg","Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1805","34181711","10.1093/cid/ciab588","Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.","Tracing of SARS-CoV-2 transmission chains is still a major challenge for public health authorities, when incidental contacts are not recalled or are not perceived as potential risk contacts. Viral sequencing can address key questions about SARS-CoV-2 evolution and may support reconstruction of viral transmission networks by integration of molecular epidemiology into classical contact tracing. In collaboration with local public health authorities, we set up an integrated system of genomic surveil","2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","Genomic epidemiology; Nanopore sequencing; community transmission; infection chain; rapid sequencing","Dilthey","Alexander T","Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany",NA
"1806","34181705","10.1093/cid/ciab593","Extensive SARS-CoV-2 transmission associated with low mortality in Kinshasa, Democratic Republic of Congo. For how long?",NA,"2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Colebunders","Robert","Global Health Institute, University of Antwerp, Antwerp, Belgium",NA
"1807","34181705","10.1093/cid/ciab593","Extensive SARS-CoV-2 transmission associated with low mortality in Kinshasa, Democratic Republic of Congo. For how long?",NA,"2021","06","28","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Kenyon","Chris","Institute of Tropical Medicine, Department of Clinical Science, Antwerp , Belgium",NA
"1808","34181704","10.2217/fvl-2020-0393","The COVID-19 pandemic: an increased risk of rheumatoid arthritis.","COVID-19 is a respiratory infection similar to viral pneumonia and is caused by SARS-CoV-2. Chloroquine and hydroxychloroquine make up the major part of the treatment regimen for the management of COVID-19 infections, which are also commonly used in treatment of patients with malaria as well as autoimmune diseases like rheumatoid arthritis (RA). In this review, we analyzed the scientific evidences pertaining to any possible association of SARS-CoV-2 infection with RA. We thus believe that people","2021","06","30","Future Virol","Future virology","SARS-CoV-2; Th1/17 response; angiotensin II; angiotensin-converting enzyme 2; rheumatoid arthritis","Tripathy","Archana","Disease Biology Laboratory, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) deemed to be University, Bhubaneswar, Odisha, 751024, India",NA
"1809","34181704","10.2217/fvl-2020-0393","The COVID-19 pandemic: an increased risk of rheumatoid arthritis.","COVID-19 is a respiratory infection similar to viral pneumonia and is caused by SARS-CoV-2. Chloroquine and hydroxychloroquine make up the major part of the treatment regimen for the management of COVID-19 infections, which are also commonly used in treatment of patients with malaria as well as autoimmune diseases like rheumatoid arthritis (RA). In this review, we analyzed the scientific evidences pertaining to any possible association of SARS-CoV-2 infection with RA. We thus believe that people","2021","06","30","Future Virol","Future virology","SARS-CoV-2; Th1/17 response; angiotensin II; angiotensin-converting enzyme 2; rheumatoid arthritis","Swain","Nitish","Disease Biology Laboratory, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) deemed to be University, Bhubaneswar, Odisha, 751024, India",NA
"1810","34181704","10.2217/fvl-2020-0393","The COVID-19 pandemic: an increased risk of rheumatoid arthritis.","COVID-19 is a respiratory infection similar to viral pneumonia and is caused by SARS-CoV-2. Chloroquine and hydroxychloroquine make up the major part of the treatment regimen for the management of COVID-19 infections, which are also commonly used in treatment of patients with malaria as well as autoimmune diseases like rheumatoid arthritis (RA). In this review, we analyzed the scientific evidences pertaining to any possible association of SARS-CoV-2 infection with RA. We thus believe that people","2021","06","30","Future Virol","Future virology","SARS-CoV-2; Th1/17 response; angiotensin II; angiotensin-converting enzyme 2; rheumatoid arthritis","Gupta","Bhawna","Disease Biology Laboratory, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) deemed to be University, Bhubaneswar, Odisha, 751024, India",NA
"1811","34181703","10.2217/fvl-2020-0324","Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates.","Background: Limited details are available regarding the vertical transmission potential of COVID-19 infection in pregnant women. The authors' current study aimed to report the vertical transmission potential of COVID-19 infection in a woman pregnant with twins. Case description: The authors report the case of a 27-year-old woman infected with SARS-CoV-2. The patient was pregnant with dichorionic diamniotic fraternal twins and admitted to Renmin Hospital of Wuhan University, Wuhan, ","2021","06","30","Future Virol","Future virology","COVID-19 infection; pregnancy outcomes; twins; vertical transmission","Peng","Liangyu","Department of Gynecology &amp",NA
"1812","34181703","10.2217/fvl-2020-0324","Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates.","Background: Limited details are available regarding the vertical transmission potential of COVID-19 infection in pregnant women. The authors' current study aimed to report the vertical transmission potential of COVID-19 infection in a woman pregnant with twins. Case description: The authors report the case of a 27-year-old woman infected with SARS-CoV-2. The patient was pregnant with dichorionic diamniotic fraternal twins and admitted to Renmin Hospital of Wuhan University, Wuhan, ","2021","06","30","Future Virol","Future virology","COVID-19 infection; pregnancy outcomes; twins; vertical transmission","Khan","Suliman","The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China",NA
"1813","34181703","10.2217/fvl-2020-0324","Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates.","Background: Limited details are available regarding the vertical transmission potential of COVID-19 infection in pregnant women. The authors' current study aimed to report the vertical transmission potential of COVID-19 infection in a woman pregnant with twins. Case description: The authors report the case of a 27-year-old woman infected with SARS-CoV-2. The patient was pregnant with dichorionic diamniotic fraternal twins and admitted to Renmin Hospital of Wuhan University, Wuhan, ","2021","06","30","Future Virol","Future virology","COVID-19 infection; pregnancy outcomes; twins; vertical transmission","Ali","Ashaq","State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430070, China",NA
"1814","34181703","10.2217/fvl-2020-0324","Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates.","Background: Limited details are available regarding the vertical transmission potential of COVID-19 infection in pregnant women. The authors' current study aimed to report the vertical transmission potential of COVID-19 infection in a woman pregnant with twins. Case description: The authors report the case of a 27-year-old woman infected with SARS-CoV-2. The patient was pregnant with dichorionic diamniotic fraternal twins and admitted to Renmin Hospital of Wuhan University, Wuhan, ","2021","06","30","Future Virol","Future virology","COVID-19 infection; pregnancy outcomes; twins; vertical transmission","Ahmed","Saeed","Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, 46000, Pakistan",NA
"1815","34181703","10.2217/fvl-2020-0324","Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates.","Background: Limited details are available regarding the vertical transmission potential of COVID-19 infection in pregnant women. The authors' current study aimed to report the vertical transmission potential of COVID-19 infection in a woman pregnant with twins. Case description: The authors report the case of a 27-year-old woman infected with SARS-CoV-2. The patient was pregnant with dichorionic diamniotic fraternal twins and admitted to Renmin Hospital of Wuhan University, Wuhan, ","2021","06","30","Future Virol","Future virology","COVID-19 infection; pregnancy outcomes; twins; vertical transmission","Ali","Liaqat","Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, 46000, Pakistan",NA
"1816","34181703","10.2217/fvl-2020-0324","Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates.","Background: Limited details are available regarding the vertical transmission potential of COVID-19 infection in pregnant women. The authors' current study aimed to report the vertical transmission potential of COVID-19 infection in a woman pregnant with twins. Case description: The authors report the case of a 27-year-old woman infected with SARS-CoV-2. The patient was pregnant with dichorionic diamniotic fraternal twins and admitted to Renmin Hospital of Wuhan University, Wuhan, ","2021","06","30","Future Virol","Future virology","COVID-19 infection; pregnancy outcomes; twins; vertical transmission","Han","Guang","Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science &amp",NA
"1817","34181703","10.2217/fvl-2020-0324","Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates.","Background: Limited details are available regarding the vertical transmission potential of COVID-19 infection in pregnant women. The authors' current study aimed to report the vertical transmission potential of COVID-19 infection in a woman pregnant with twins. Case description: The authors report the case of a 27-year-old woman infected with SARS-CoV-2. The patient was pregnant with dichorionic diamniotic fraternal twins and admitted to Renmin Hospital of Wuhan University, Wuhan, ","2021","06","30","Future Virol","Future virology","COVID-19 infection; pregnancy outcomes; twins; vertical transmission","Jing","Yang","Reproductive Medicine Center, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan, 430060, China",NA
"1818","34181691","10.1371/journal.ppat.1009687","The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.","COVID-19 outbreak is the biggest threat to human health in recent history. Currently, there are over 1.5 million related deaths and 75 million people infected around the world (as of 22/12/2020). The identification of virulence factors which determine disease susceptibility and severity in different cell types remains an essential challenge. The serine protease TMPRSS2 has been shown to be important for S protein priming and viral entry, however, little is known about its regulation. SPINT2 is a","2021","07","19","PLoS Pathog","PLoS pathogens","A549 Cells; COVID-19; Caco-2 Cells; Humans; Membrane Glycoproteins; SARS-CoV-2; Serine Endopeptidases; Severity of Illness Index; Virus Internalization","Ramirez Alvarez","Carlos","Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany",NA
"1819","34181691","10.1371/journal.ppat.1009687","The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.","COVID-19 outbreak is the biggest threat to human health in recent history. Currently, there are over 1.5 million related deaths and 75 million people infected around the world (as of 22/12/2020). The identification of virulence factors which determine disease susceptibility and severity in different cell types remains an essential challenge. The serine protease TMPRSS2 has been shown to be important for S protein priming and viral entry, however, little is known about its regulation. SPINT2 is a","2021","07","19","PLoS Pathog","PLoS pathogens","A549 Cells; COVID-19; Caco-2 Cells; Humans; Membrane Glycoproteins; SARS-CoV-2; Serine Endopeptidases; Severity of Illness Index; Virus Internalization","Kee","Carmon","Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany",NA
"1820","34181691","10.1371/journal.ppat.1009687","The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.","COVID-19 outbreak is the biggest threat to human health in recent history. Currently, there are over 1.5 million related deaths and 75 million people infected around the world (as of 22/12/2020). The identification of virulence factors which determine disease susceptibility and severity in different cell types remains an essential challenge. The serine protease TMPRSS2 has been shown to be important for S protein priming and viral entry, however, little is known about its regulation. SPINT2 is a","2021","07","19","PLoS Pathog","PLoS pathogens","A549 Cells; COVID-19; Caco-2 Cells; Humans; Membrane Glycoproteins; SARS-CoV-2; Serine Endopeptidases; Severity of Illness Index; Virus Internalization","Sharma","Ashwini Kumar","Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany",NA
"1821","34181691","10.1371/journal.ppat.1009687","The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.","COVID-19 outbreak is the biggest threat to human health in recent history. Currently, there are over 1.5 million related deaths and 75 million people infected around the world (as of 22/12/2020). The identification of virulence factors which determine disease susceptibility and severity in different cell types remains an essential challenge. The serine protease TMPRSS2 has been shown to be important for S protein priming and viral entry, however, little is known about its regulation. SPINT2 is a","2021","07","19","PLoS Pathog","PLoS pathogens","A549 Cells; COVID-19; Caco-2 Cells; Humans; Membrane Glycoproteins; SARS-CoV-2; Serine Endopeptidases; Severity of Illness Index; Virus Internalization","Thomas","Leonie","Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany",NA
"1822","34181691","10.1371/journal.ppat.1009687","The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.","COVID-19 outbreak is the biggest threat to human health in recent history. Currently, there are over 1.5 million related deaths and 75 million people infected around the world (as of 22/12/2020). The identification of virulence factors which determine disease susceptibility and severity in different cell types remains an essential challenge. The serine protease TMPRSS2 has been shown to be important for S protein priming and viral entry, however, little is known about its regulation. SPINT2 is a","2021","07","19","PLoS Pathog","PLoS pathogens","A549 Cells; COVID-19; Caco-2 Cells; Humans; Membrane Glycoproteins; SARS-CoV-2; Serine Endopeptidases; Severity of Illness Index; Virus Internalization","Schmidt","Florian I","Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany",NA
"1823","34181691","10.1371/journal.ppat.1009687","The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.","COVID-19 outbreak is the biggest threat to human health in recent history. Currently, there are over 1.5 million related deaths and 75 million people infected around the world (as of 22/12/2020). The identification of virulence factors which determine disease susceptibility and severity in different cell types remains an essential challenge. The serine protease TMPRSS2 has been shown to be important for S protein priming and viral entry, however, little is known about its regulation. SPINT2 is a","2021","07","19","PLoS Pathog","PLoS pathogens","A549 Cells; COVID-19; Caco-2 Cells; Humans; Membrane Glycoproteins; SARS-CoV-2; Serine Endopeptidases; Severity of Illness Index; Virus Internalization","Stanifer","Megan L","Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany",NA
"1824","34181691","10.1371/journal.ppat.1009687","The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.","COVID-19 outbreak is the biggest threat to human health in recent history. Currently, there are over 1.5 million related deaths and 75 million people infected around the world (as of 22/12/2020). The identification of virulence factors which determine disease susceptibility and severity in different cell types remains an essential challenge. The serine protease TMPRSS2 has been shown to be important for S protein priming and viral entry, however, little is known about its regulation. SPINT2 is a","2021","07","19","PLoS Pathog","PLoS pathogens","A549 Cells; COVID-19; Caco-2 Cells; Humans; Membrane Glycoproteins; SARS-CoV-2; Serine Endopeptidases; Severity of Illness Index; Virus Internalization","Boulant","Steeve","Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany",NA
"1825","34181691","10.1371/journal.ppat.1009687","The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.","COVID-19 outbreak is the biggest threat to human health in recent history. Currently, there are over 1.5 million related deaths and 75 million people infected around the world (as of 22/12/2020). The identification of virulence factors which determine disease susceptibility and severity in different cell types remains an essential challenge. The serine protease TMPRSS2 has been shown to be important for S protein priming and viral entry, however, little is known about its regulation. SPINT2 is a","2021","07","19","PLoS Pathog","PLoS pathogens","A549 Cells; COVID-19; Caco-2 Cells; Humans; Membrane Glycoproteins; SARS-CoV-2; Serine Endopeptidases; Severity of Illness Index; Virus Internalization","Herrmann","Carl","Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany",NA
"1826","34181686","10.1371/journal.pone.0253381","Infection rate models for COVID-19: Model risk and public health news sentiment exposure adjustments.","During the COVID-19 pandemic, governments globally had to impose severe contact restriction measures and social mobility limitations in order to limit the exposure of the population to COVID-19. These public health policy decisions were informed by statistical models for infection rates in national populations. In this work, we are interested in modelling the temporal evolution of national-level infection counts for the United Kingdom (UK-Wales, England, Scotland), Germany (GM), Italy (IT), Spai","2021","07","08","PLoS One","PloS one","COVID-19; Humans; Mass Media; Models, Statistical; Pandemics; Public Health; Regression Analysis; Risk; Stochastic Processes","Chalkiadakis","Ioannis","Department of Computer Science, School of Mathematical and Computer Sciences, Heriot-Watt University, Edinburgh, Scotland, United Kingdom",NA
"1827","34181686","10.1371/journal.pone.0253381","Infection rate models for COVID-19: Model risk and public health news sentiment exposure adjustments.","During the COVID-19 pandemic, governments globally had to impose severe contact restriction measures and social mobility limitations in order to limit the exposure of the population to COVID-19. These public health policy decisions were informed by statistical models for infection rates in national populations. In this work, we are interested in modelling the temporal evolution of national-level infection counts for the United Kingdom (UK-Wales, England, Scotland), Germany (GM), Italy (IT), Spai","2021","07","08","PLoS One","PloS one","COVID-19; Humans; Mass Media; Models, Statistical; Pandemics; Public Health; Regression Analysis; Risk; Stochastic Processes","Yan","Hongxuan","Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China",NA
"1828","34181686","10.1371/journal.pone.0253381","Infection rate models for COVID-19: Model risk and public health news sentiment exposure adjustments.","During the COVID-19 pandemic, governments globally had to impose severe contact restriction measures and social mobility limitations in order to limit the exposure of the population to COVID-19. These public health policy decisions were informed by statistical models for infection rates in national populations. In this work, we are interested in modelling the temporal evolution of national-level infection counts for the United Kingdom (UK-Wales, England, Scotland), Germany (GM), Italy (IT), Spai","2021","07","08","PLoS One","PloS one","COVID-19; Humans; Mass Media; Models, Statistical; Pandemics; Public Health; Regression Analysis; Risk; Stochastic Processes","Peters","Gareth W","Department of Actuarial Mathematics and Statistics, School of Mathematical and Computer Sciences, Heriot-Watt University, Edinburgh, Scotland, United Kingdom",NA
"1829","34181686","10.1371/journal.pone.0253381","Infection rate models for COVID-19: Model risk and public health news sentiment exposure adjustments.","During the COVID-19 pandemic, governments globally had to impose severe contact restriction measures and social mobility limitations in order to limit the exposure of the population to COVID-19. These public health policy decisions were informed by statistical models for infection rates in national populations. In this work, we are interested in modelling the temporal evolution of national-level infection counts for the United Kingdom (UK-Wales, England, Scotland), Germany (GM), Italy (IT), Spai","2021","07","08","PLoS One","PloS one","COVID-19; Humans; Mass Media; Models, Statistical; Pandemics; Public Health; Regression Analysis; Risk; Stochastic Processes","Shevchenko","Pavel V","Department of Actuarial Studies and Business Analytics, Macquarie University, Sydney, Australia",NA
"1830","34181685","10.1371/journal.pone.0253348","Pandemic catch-22: The role of mobility restrictions and institutional inequalities in halting the spread of COVID-19.","Countries across the world responded to the COVID-19 pandemic with what might well be the set of biggest state-led mobility and activity restrictions in the history of humankind. But how effective were these measures across countries? Compared to multiple recent studies that document an association between such restrictions and the control of the contagion, we use an instrumental variable approach to estimate the causal effect of these restrictions on mobility, and the growth rate of confirmed c","2021","07","08","PLoS One","PloS one","COVID-19; Humans; Pandemics; Quarantine; Socioeconomic Factors","Fakir","Adnan M S","Economics Department, University of Western Australia Business School, Perth, Australia",NA
"1831","34181685","10.1371/journal.pone.0253348","Pandemic catch-22: The role of mobility restrictions and institutional inequalities in halting the spread of COVID-19.","Countries across the world responded to the COVID-19 pandemic with what might well be the set of biggest state-led mobility and activity restrictions in the history of humankind. But how effective were these measures across countries? Compared to multiple recent studies that document an association between such restrictions and the control of the contagion, we use an instrumental variable approach to estimate the causal effect of these restrictions on mobility, and the growth rate of confirmed c","2021","07","08","PLoS One","PloS one","COVID-19; Humans; Pandemics; Quarantine; Socioeconomic Factors","Bharati","Tushar","Economics Department, University of Western Australia Business School, Perth, Australia",NA
"1832","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Iddi","Samuel","Department of Statistics and Actuarial Science, University of Ghana, Legon-Accra, Ghana",NA
"1833","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Obiri-Yeboah","Dorcas","Department of Microbiology &amp",NA
"1834","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Aboh","Irene Korkoi","Department of Adult Health, School of Nursing and Midwifery, University of Cape Coast, Cape Coast, Ghana",NA
"1835","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Quansah","Reginald","Biological, Environmental &amp",NA
"1836","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Owusu","Samuel Asiedu","Directorate of Research, Innovation and Consultancy, University of Cape Coast, Cape Coast, Ghana",NA
"1837","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Enyan","Nancy Innocentia Ebu","Department of Adult Health, School of Nursing and Midwifery, University of Cape Coast, Cape Coast, Ghana",NA
"1838","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Kodom","Ruby Victoria","Department of Public Administration and Health Services, University of Ghana, Legon-Accra, Ghana",NA
"1839","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Nsabimana","Epaphrodite","Mental Health &amp",NA
"1840","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Jansen","Stefan","Mental Health &amp",NA
"1841","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Ekumah","Benard","Department of Environmental Science, University of Cape Coast, Cape Coast, Ghana",NA
"1842","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Boamah","Sheila A","School of Nursing, Faculty of Health Sciences, McMaster University, Hamilton, Canada",NA
"1843","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Boateng","Godfred Odei","Global &amp",NA
"1844","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Doku","David Teye","Directorate of Research, Innovation and Consultancy, University of Cape Coast, Cape Coast, Ghana",NA
"1845","34181679","10.1371/journal.pone.0253800","Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.","The COVID-19 pandemic and control measures adopted by countries globally can lead to stress and anxiety. Investigating the coping strategies to this unprecedented crisis is essential to guide mental health intervention and public health policy. This study examined how people are coping with the COVID-19 crisis in Ghana and identify factors influencing it. This study was part of a multinational online cross-sectional survey on Personal and Family Coping with COVID-19 in the Global South. The stud","2021","07","08","PLoS One","PloS one","Adaptation, Psychological; Adolescent; Adult; Aged; COVID-19; Female; Ghana; Humans; Male; Middle Aged; Pandemics; Quarantine; Young Adult","Armah","Frederick Ato","Directorate of Research, Innovation and Consultancy, University of Cape Coast, Cape Coast, Ghana",NA
"1846","34181675","10.1371/journal.pone.0252599","Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients.","Inflammation has an important role in the progression of various viral pneumonia, including COVID-19. Circulating biomarkers that can evaluate inflammation and immune status are potentially useful in diagnosing and prognosis of COVID-19 patients. Even more so when they are a part of the routine evaluation, chest CT could have even higher diagnostic accuracy than RT-PCT alone in a suggestive clinical context. This study aims to evaluate the correlation between inflammatory markers such as neutrop","2021","07","08","PLoS One","PloS one","Adult; Blood Platelets; COVID-19; Eosinophils; Female; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Signal-To-Noise Ratio; Tomography, X-Ray Computed","Man","Milena Adina","Department of Medical Sciences, Pulmonology, ""Iuliu Hatieganu"" University of Medicine and Pharmacy, Cluj Napoca, Cluj, Romania",NA
"1847","34181675","10.1371/journal.pone.0252599","Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients.","Inflammation has an important role in the progression of various viral pneumonia, including COVID-19. Circulating biomarkers that can evaluate inflammation and immune status are potentially useful in diagnosing and prognosis of COVID-19 patients. Even more so when they are a part of the routine evaluation, chest CT could have even higher diagnostic accuracy than RT-PCT alone in a suggestive clinical context. This study aims to evaluate the correlation between inflammatory markers such as neutrop","2021","07","08","PLoS One","PloS one","Adult; Blood Platelets; COVID-19; Eosinophils; Female; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Signal-To-Noise Ratio; Tomography, X-Ray Computed","Rajnoveanu","Ruxandra-Mioara","Department of Medical Sciences, Pulmonology, ""Iuliu Hatieganu"" University of Medicine and Pharmacy, Cluj Napoca, Cluj, Romania",NA
"1848","34181675","10.1371/journal.pone.0252599","Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients.","Inflammation has an important role in the progression of various viral pneumonia, including COVID-19. Circulating biomarkers that can evaluate inflammation and immune status are potentially useful in diagnosing and prognosis of COVID-19 patients. Even more so when they are a part of the routine evaluation, chest CT could have even higher diagnostic accuracy than RT-PCT alone in a suggestive clinical context. This study aims to evaluate the correlation between inflammatory markers such as neutrop","2021","07","08","PLoS One","PloS one","Adult; Blood Platelets; COVID-19; Eosinophils; Female; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Signal-To-Noise Ratio; Tomography, X-Ray Computed","Motoc","Nicoleta Stefania","Department of Medical Sciences, Pulmonology, ""Iuliu Hatieganu"" University of Medicine and Pharmacy, Cluj Napoca, Cluj, Romania",NA
"1849","34181675","10.1371/journal.pone.0252599","Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients.","Inflammation has an important role in the progression of various viral pneumonia, including COVID-19. Circulating biomarkers that can evaluate inflammation and immune status are potentially useful in diagnosing and prognosis of COVID-19 patients. Even more so when they are a part of the routine evaluation, chest CT could have even higher diagnostic accuracy than RT-PCT alone in a suggestive clinical context. This study aims to evaluate the correlation between inflammatory markers such as neutrop","2021","07","08","PLoS One","PloS one","Adult; Blood Platelets; COVID-19; Eosinophils; Female; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Signal-To-Noise Ratio; Tomography, X-Ray Computed","Bondor","Cosmina Ioana","Department of Medical Biostatistics, ""Iuliu Hatieganu"" University of Medicine and Pharmacy, Cluj Napoca, Romania",NA
"1850","34181675","10.1371/journal.pone.0252599","Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients.","Inflammation has an important role in the progression of various viral pneumonia, including COVID-19. Circulating biomarkers that can evaluate inflammation and immune status are potentially useful in diagnosing and prognosis of COVID-19 patients. Even more so when they are a part of the routine evaluation, chest CT could have even higher diagnostic accuracy than RT-PCT alone in a suggestive clinical context. This study aims to evaluate the correlation between inflammatory markers such as neutrop","2021","07","08","PLoS One","PloS one","Adult; Blood Platelets; COVID-19; Eosinophils; Female; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Signal-To-Noise Ratio; Tomography, X-Ray Computed","Chis","Ana Florica","Department of Medical Sciences, Pulmonology, ""Iuliu Hatieganu"" University of Medicine and Pharmacy, Cluj Napoca, Cluj, Romania",NA
"1851","34181675","10.1371/journal.pone.0252599","Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients.","Inflammation has an important role in the progression of various viral pneumonia, including COVID-19. Circulating biomarkers that can evaluate inflammation and immune status are potentially useful in diagnosing and prognosis of COVID-19 patients. Even more so when they are a part of the routine evaluation, chest CT could have even higher diagnostic accuracy than RT-PCT alone in a suggestive clinical context. This study aims to evaluate the correlation between inflammatory markers such as neutrop","2021","07","08","PLoS One","PloS one","Adult; Blood Platelets; COVID-19; Eosinophils; Female; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Signal-To-Noise Ratio; Tomography, X-Ray Computed","Lesan","Andrei","Department of Medical Sciences, Pulmonology, ""Iuliu Hatieganu"" University of Medicine and Pharmacy, Cluj Napoca, Cluj, Romania",NA
"1852","34181675","10.1371/journal.pone.0252599","Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients.","Inflammation has an important role in the progression of various viral pneumonia, including COVID-19. Circulating biomarkers that can evaluate inflammation and immune status are potentially useful in diagnosing and prognosis of COVID-19 patients. Even more so when they are a part of the routine evaluation, chest CT could have even higher diagnostic accuracy than RT-PCT alone in a suggestive clinical context. This study aims to evaluate the correlation between inflammatory markers such as neutrop","2021","07","08","PLoS One","PloS one","Adult; Blood Platelets; COVID-19; Eosinophils; Female; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Signal-To-Noise Ratio; Tomography, X-Ray Computed","Puiu","Ruxandra","Department of Medical Sciences, Pulmonology, ""Iuliu Hatieganu"" University of Medicine and Pharmacy, Cluj Napoca, Cluj, Romania",NA
"1853","34181675","10.1371/journal.pone.0252599","Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients.","Inflammation has an important role in the progression of various viral pneumonia, including COVID-19. Circulating biomarkers that can evaluate inflammation and immune status are potentially useful in diagnosing and prognosis of COVID-19 patients. Even more so when they are a part of the routine evaluation, chest CT could have even higher diagnostic accuracy than RT-PCT alone in a suggestive clinical context. This study aims to evaluate the correlation between inflammatory markers such as neutrop","2021","07","08","PLoS One","PloS one","Adult; Blood Platelets; COVID-19; Eosinophils; Female; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Signal-To-Noise Ratio; Tomography, X-Ray Computed","Lucaciu","Sergiu-Remus","Department of Medical Sciences, Pulmonology, ""Iuliu Hatieganu"" University of Medicine and Pharmacy, Cluj Napoca, Cluj, Romania",NA
"1854","34181675","10.1371/journal.pone.0252599","Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients.","Inflammation has an important role in the progression of various viral pneumonia, including COVID-19. Circulating biomarkers that can evaluate inflammation and immune status are potentially useful in diagnosing and prognosis of COVID-19 patients. Even more so when they are a part of the routine evaluation, chest CT could have even higher diagnostic accuracy than RT-PCT alone in a suggestive clinical context. This study aims to evaluate the correlation between inflammatory markers such as neutrop","2021","07","08","PLoS One","PloS one","Adult; Blood Platelets; COVID-19; Eosinophils; Female; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Signal-To-Noise Ratio; Tomography, X-Ray Computed","Dantes","Elena","Faculty of Medicine, ""Ovidius"" University, Constanta, Romania",NA
"1855","34181675","10.1371/journal.pone.0252599","Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients.","Inflammation has an important role in the progression of various viral pneumonia, including COVID-19. Circulating biomarkers that can evaluate inflammation and immune status are potentially useful in diagnosing and prognosis of COVID-19 patients. Even more so when they are a part of the routine evaluation, chest CT could have even higher diagnostic accuracy than RT-PCT alone in a suggestive clinical context. This study aims to evaluate the correlation between inflammatory markers such as neutrop","2021","07","08","PLoS One","PloS one","Adult; Blood Platelets; COVID-19; Eosinophils; Female; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Signal-To-Noise Ratio; Tomography, X-Ray Computed","Gergely-Domokos","Bianca","Department of Medical Sciences, Pulmonology, ""Iuliu Hatieganu"" University of Medicine and Pharmacy, Cluj Napoca, Cluj, Romania",NA
"1856","34181675","10.1371/journal.pone.0252599","Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients.","Inflammation has an important role in the progression of various viral pneumonia, including COVID-19. Circulating biomarkers that can evaluate inflammation and immune status are potentially useful in diagnosing and prognosis of COVID-19 patients. Even more so when they are a part of the routine evaluation, chest CT could have even higher diagnostic accuracy than RT-PCT alone in a suggestive clinical context. This study aims to evaluate the correlation between inflammatory markers such as neutrop","2021","07","08","PLoS One","PloS one","Adult; Blood Platelets; COVID-19; Eosinophils; Female; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Signal-To-Noise Ratio; Tomography, X-Ray Computed","Fira-Mladinescu","Ovidiu","Center for Research and Innovation in Personalized Medicine of Respiratory Diseases, Department of Infectious Diseases, Pulmonology, ""Victor Babes"" University of Medicine and Pharmacy, Timisoara, Romania",NA
"1857","34181666","10.1371/journal.pone.0251731","Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.","Immunotherapy using checkpoint blockade (ICB) with antibodies such as anti-PD-1 has revolutionised the treatment of many cancers. Despite its use to treat COVID-19 patients and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, the effect of hydroxychloroquine (HCQ) on cancer immunotherapy has not been examined. In this study, remarkably, we find that HCQ alone, or in combination with azithromycin (AZ), at doses used to treat patients, decreased the therapeutic be","2021","07","08","PLoS One","PloS one","Animals; Azithromycin; Cell Line, Tumor; Drug Antagonism; Hydroxychloroquine; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Mice; Programmed Cell Death 1 Receptor; T-Lymphocytes","Krueger","Janna","Division of Immuno-Oncology, Research Center Maisonneuve-Rosemont Hospital (CR-HMR) Montreal, Quebec, Canada",NA
"1858","34181666","10.1371/journal.pone.0251731","Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.","Immunotherapy using checkpoint blockade (ICB) with antibodies such as anti-PD-1 has revolutionised the treatment of many cancers. Despite its use to treat COVID-19 patients and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, the effect of hydroxychloroquine (HCQ) on cancer immunotherapy has not been examined. In this study, remarkably, we find that HCQ alone, or in combination with azithromycin (AZ), at doses used to treat patients, decreased the therapeutic be","2021","07","08","PLoS One","PloS one","Animals; Azithromycin; Cell Line, Tumor; Drug Antagonism; Hydroxychloroquine; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Mice; Programmed Cell Death 1 Receptor; T-Lymphocytes","Santinon","Francois","Division of Immuno-Oncology, Research Center Maisonneuve-Rosemont Hospital (CR-HMR) Montreal, Quebec, Canada",NA
"1859","34181666","10.1371/journal.pone.0251731","Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.","Immunotherapy using checkpoint blockade (ICB) with antibodies such as anti-PD-1 has revolutionised the treatment of many cancers. Despite its use to treat COVID-19 patients and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, the effect of hydroxychloroquine (HCQ) on cancer immunotherapy has not been examined. In this study, remarkably, we find that HCQ alone, or in combination with azithromycin (AZ), at doses used to treat patients, decreased the therapeutic be","2021","07","08","PLoS One","PloS one","Animals; Azithromycin; Cell Line, Tumor; Drug Antagonism; Hydroxychloroquine; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Mice; Programmed Cell Death 1 Receptor; T-Lymphocytes","Kazanova","Alexandra","Division of Immuno-Oncology, Research Center Maisonneuve-Rosemont Hospital (CR-HMR) Montreal, Quebec, Canada",NA
"1860","34181666","10.1371/journal.pone.0251731","Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.","Immunotherapy using checkpoint blockade (ICB) with antibodies such as anti-PD-1 has revolutionised the treatment of many cancers. Despite its use to treat COVID-19 patients and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, the effect of hydroxychloroquine (HCQ) on cancer immunotherapy has not been examined. In this study, remarkably, we find that HCQ alone, or in combination with azithromycin (AZ), at doses used to treat patients, decreased the therapeutic be","2021","07","08","PLoS One","PloS one","Animals; Azithromycin; Cell Line, Tumor; Drug Antagonism; Hydroxychloroquine; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Mice; Programmed Cell Death 1 Receptor; T-Lymphocytes","Issa","Mark E","Division of Immuno-Oncology, Research Center Maisonneuve-Rosemont Hospital (CR-HMR) Montreal, Quebec, Canada",NA
"1861","34181666","10.1371/journal.pone.0251731","Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.","Immunotherapy using checkpoint blockade (ICB) with antibodies such as anti-PD-1 has revolutionised the treatment of many cancers. Despite its use to treat COVID-19 patients and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, the effect of hydroxychloroquine (HCQ) on cancer immunotherapy has not been examined. In this study, remarkably, we find that HCQ alone, or in combination with azithromycin (AZ), at doses used to treat patients, decreased the therapeutic be","2021","07","08","PLoS One","PloS one","Animals; Azithromycin; Cell Line, Tumor; Drug Antagonism; Hydroxychloroquine; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Mice; Programmed Cell Death 1 Receptor; T-Lymphocytes","Larrivee","Bruno","Department of Ophthalmology, Universite de Montreal, Montreal, Quebec, Canada",NA
"1862","34181666","10.1371/journal.pone.0251731","Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.","Immunotherapy using checkpoint blockade (ICB) with antibodies such as anti-PD-1 has revolutionised the treatment of many cancers. Despite its use to treat COVID-19 patients and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, the effect of hydroxychloroquine (HCQ) on cancer immunotherapy has not been examined. In this study, remarkably, we find that HCQ alone, or in combination with azithromycin (AZ), at doses used to treat patients, decreased the therapeutic be","2021","07","08","PLoS One","PloS one","Animals; Azithromycin; Cell Line, Tumor; Drug Antagonism; Hydroxychloroquine; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Mice; Programmed Cell Death 1 Receptor; T-Lymphocytes","Kremer","Richard","Division of Experimental Medicine, Department of Medicine, McGill University Health Center, Montreal, Canada",NA
"1863","34181666","10.1371/journal.pone.0251731","Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.","Immunotherapy using checkpoint blockade (ICB) with antibodies such as anti-PD-1 has revolutionised the treatment of many cancers. Despite its use to treat COVID-19 patients and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, the effect of hydroxychloroquine (HCQ) on cancer immunotherapy has not been examined. In this study, remarkably, we find that HCQ alone, or in combination with azithromycin (AZ), at doses used to treat patients, decreased the therapeutic be","2021","07","08","PLoS One","PloS one","Animals; Azithromycin; Cell Line, Tumor; Drug Antagonism; Hydroxychloroquine; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Mice; Programmed Cell Death 1 Receptor; T-Lymphocytes","Milhalcioiu","Catalin","Division of Medical Oncology, Department of Medicine, McGill University Health Center, Montreal, Canada",NA
"1864","34181666","10.1371/journal.pone.0251731","Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.","Immunotherapy using checkpoint blockade (ICB) with antibodies such as anti-PD-1 has revolutionised the treatment of many cancers. Despite its use to treat COVID-19 patients and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, the effect of hydroxychloroquine (HCQ) on cancer immunotherapy has not been examined. In this study, remarkably, we find that HCQ alone, or in combination with azithromycin (AZ), at doses used to treat patients, decreased the therapeutic be","2021","07","08","PLoS One","PloS one","Animals; Azithromycin; Cell Line, Tumor; Drug Antagonism; Hydroxychloroquine; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Mice; Programmed Cell Death 1 Receptor; T-Lymphocytes","Rudd","Christopher E","Division of Immuno-Oncology, Research Center Maisonneuve-Rosemont Hospital (CR-HMR) Montreal, Quebec, Canada",NA
"1865","34181650","10.1371/journal.pone.0251580","College from home during COVID-19: A mixed-methods study of heterogeneous experiences.","This mixed-method study examined the experiences of college students during the COVID-19 pandemic through surveys, experience sampling data collected over two academic quarters (Spring 2019 n1 = 253; Spring 2020 n2 = 147), and semi-structured interviews with 27 undergraduate students. There were no marked changes in mean levels of depressive symptoms, anxiety, stress, or loneliness between 2019 and 2020, or over the course of the Spring 2020 term. Students in both the 2019 and 2020 cohort who in","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Anxiety; COVID-19; Cohort Studies; Depression; Education, Distance; Female; Housing; Humans; Loneliness; Male; Psychological Distress; Students; Surveys and Questionnaires; Universities; Young Adult","Morris","Margaret E","Information School, University of Washington, Seattle, Washington, United States of America",NA
"1866","34181650","10.1371/journal.pone.0251580","College from home during COVID-19: A mixed-methods study of heterogeneous experiences.","This mixed-method study examined the experiences of college students during the COVID-19 pandemic through surveys, experience sampling data collected over two academic quarters (Spring 2019 n1 = 253; Spring 2020 n2 = 147), and semi-structured interviews with 27 undergraduate students. There were no marked changes in mean levels of depressive symptoms, anxiety, stress, or loneliness between 2019 and 2020, or over the course of the Spring 2020 term. Students in both the 2019 and 2020 cohort who in","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Anxiety; COVID-19; Cohort Studies; Depression; Education, Distance; Female; Housing; Humans; Loneliness; Male; Psychological Distress; Students; Surveys and Questionnaires; Universities; Young Adult","Kuehn","Kevin S","Department of Psychology, University of Washington, Seattle, Washington, United States of America",NA
"1867","34181650","10.1371/journal.pone.0251580","College from home during COVID-19: A mixed-methods study of heterogeneous experiences.","This mixed-method study examined the experiences of college students during the COVID-19 pandemic through surveys, experience sampling data collected over two academic quarters (Spring 2019 n1 = 253; Spring 2020 n2 = 147), and semi-structured interviews with 27 undergraduate students. There were no marked changes in mean levels of depressive symptoms, anxiety, stress, or loneliness between 2019 and 2020, or over the course of the Spring 2020 term. Students in both the 2019 and 2020 cohort who in","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Anxiety; COVID-19; Cohort Studies; Depression; Education, Distance; Female; Housing; Humans; Loneliness; Male; Psychological Distress; Students; Surveys and Questionnaires; Universities; Young Adult","Brown","Jennifer","School of Public Health, University of Washington, Seattle, Washington, United States of America",NA
"1868","34181650","10.1371/journal.pone.0251580","College from home during COVID-19: A mixed-methods study of heterogeneous experiences.","This mixed-method study examined the experiences of college students during the COVID-19 pandemic through surveys, experience sampling data collected over two academic quarters (Spring 2019 n1 = 253; Spring 2020 n2 = 147), and semi-structured interviews with 27 undergraduate students. There were no marked changes in mean levels of depressive symptoms, anxiety, stress, or loneliness between 2019 and 2020, or over the course of the Spring 2020 term. Students in both the 2019 and 2020 cohort who in","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Anxiety; COVID-19; Cohort Studies; Depression; Education, Distance; Female; Housing; Humans; Loneliness; Male; Psychological Distress; Students; Surveys and Questionnaires; Universities; Young Adult","Nurius","Paula S","School of Social Work, University of Washington, Seattle, Washington, United States of America",NA
"1869","34181650","10.1371/journal.pone.0251580","College from home during COVID-19: A mixed-methods study of heterogeneous experiences.","This mixed-method study examined the experiences of college students during the COVID-19 pandemic through surveys, experience sampling data collected over two academic quarters (Spring 2019 n1 = 253; Spring 2020 n2 = 147), and semi-structured interviews with 27 undergraduate students. There were no marked changes in mean levels of depressive symptoms, anxiety, stress, or loneliness between 2019 and 2020, or over the course of the Spring 2020 term. Students in both the 2019 and 2020 cohort who in","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Anxiety; COVID-19; Cohort Studies; Depression; Education, Distance; Female; Housing; Humans; Loneliness; Male; Psychological Distress; Students; Surveys and Questionnaires; Universities; Young Adult","Zhang","Han","Computer Science &amp",NA
"1870","34181650","10.1371/journal.pone.0251580","College from home during COVID-19: A mixed-methods study of heterogeneous experiences.","This mixed-method study examined the experiences of college students during the COVID-19 pandemic through surveys, experience sampling data collected over two academic quarters (Spring 2019 n1 = 253; Spring 2020 n2 = 147), and semi-structured interviews with 27 undergraduate students. There were no marked changes in mean levels of depressive symptoms, anxiety, stress, or loneliness between 2019 and 2020, or over the course of the Spring 2020 term. Students in both the 2019 and 2020 cohort who in","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Anxiety; COVID-19; Cohort Studies; Depression; Education, Distance; Female; Housing; Humans; Loneliness; Male; Psychological Distress; Students; Surveys and Questionnaires; Universities; Young Adult","Sefidgar","Yasaman S","Computer Science &amp",NA
"1871","34181650","10.1371/journal.pone.0251580","College from home during COVID-19: A mixed-methods study of heterogeneous experiences.","This mixed-method study examined the experiences of college students during the COVID-19 pandemic through surveys, experience sampling data collected over two academic quarters (Spring 2019 n1 = 253; Spring 2020 n2 = 147), and semi-structured interviews with 27 undergraduate students. There were no marked changes in mean levels of depressive symptoms, anxiety, stress, or loneliness between 2019 and 2020, or over the course of the Spring 2020 term. Students in both the 2019 and 2020 cohort who in","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Anxiety; COVID-19; Cohort Studies; Depression; Education, Distance; Female; Housing; Humans; Loneliness; Male; Psychological Distress; Students; Surveys and Questionnaires; Universities; Young Adult","Xu","Xuhai","Information School, University of Washington, Seattle, Washington, United States of America",NA
"1872","34181650","10.1371/journal.pone.0251580","College from home during COVID-19: A mixed-methods study of heterogeneous experiences.","This mixed-method study examined the experiences of college students during the COVID-19 pandemic through surveys, experience sampling data collected over two academic quarters (Spring 2019 n1 = 253; Spring 2020 n2 = 147), and semi-structured interviews with 27 undergraduate students. There were no marked changes in mean levels of depressive symptoms, anxiety, stress, or loneliness between 2019 and 2020, or over the course of the Spring 2020 term. Students in both the 2019 and 2020 cohort who in","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Anxiety; COVID-19; Cohort Studies; Depression; Education, Distance; Female; Housing; Humans; Loneliness; Male; Psychological Distress; Students; Surveys and Questionnaires; Universities; Young Adult","Riskin","Eve A","Department of Electrical &amp",NA
"1873","34181650","10.1371/journal.pone.0251580","College from home during COVID-19: A mixed-methods study of heterogeneous experiences.","This mixed-method study examined the experiences of college students during the COVID-19 pandemic through surveys, experience sampling data collected over two academic quarters (Spring 2019 n1 = 253; Spring 2020 n2 = 147), and semi-structured interviews with 27 undergraduate students. There were no marked changes in mean levels of depressive symptoms, anxiety, stress, or loneliness between 2019 and 2020, or over the course of the Spring 2020 term. Students in both the 2019 and 2020 cohort who in","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Anxiety; COVID-19; Cohort Studies; Depression; Education, Distance; Female; Housing; Humans; Loneliness; Male; Psychological Distress; Students; Surveys and Questionnaires; Universities; Young Adult","Dey","Anind K","Information School, University of Washington, Seattle, Washington, United States of America",NA
"1874","34181650","10.1371/journal.pone.0251580","College from home during COVID-19: A mixed-methods study of heterogeneous experiences.","This mixed-method study examined the experiences of college students during the COVID-19 pandemic through surveys, experience sampling data collected over two academic quarters (Spring 2019 n1 = 253; Spring 2020 n2 = 147), and semi-structured interviews with 27 undergraduate students. There were no marked changes in mean levels of depressive symptoms, anxiety, stress, or loneliness between 2019 and 2020, or over the course of the Spring 2020 term. Students in both the 2019 and 2020 cohort who in","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Anxiety; COVID-19; Cohort Studies; Depression; Education, Distance; Female; Housing; Humans; Loneliness; Male; Psychological Distress; Students; Surveys and Questionnaires; Universities; Young Adult","Consolvo","Sunny","Google, Mountain View, California, United States of America",NA
"1875","34181650","10.1371/journal.pone.0251580","College from home during COVID-19: A mixed-methods study of heterogeneous experiences.","This mixed-method study examined the experiences of college students during the COVID-19 pandemic through surveys, experience sampling data collected over two academic quarters (Spring 2019 n1 = 253; Spring 2020 n2 = 147), and semi-structured interviews with 27 undergraduate students. There were no marked changes in mean levels of depressive symptoms, anxiety, stress, or loneliness between 2019 and 2020, or over the course of the Spring 2020 term. Students in both the 2019 and 2020 cohort who in","2021","07","08","PLoS One","PloS one","Adolescent; Adult; Anxiety; COVID-19; Cohort Studies; Depression; Education, Distance; Female; Housing; Humans; Loneliness; Male; Psychological Distress; Students; Surveys and Questionnaires; Universities; Young Adult","Mankoff","Jennifer C","Computer Science &amp",NA
"1876","34181636","10.12659/MSM.929851","Factors Influencing Nurses' Work Interruption in Wuhan Isolation Wards During the COVID-19 Pandemic.","BACKGROUND Through January 2021, the novel coronavirus (COVID-19) continued to create significant pressure on medical staff who have worked to treat patients with the disease and control its spread. This study aimed to increase understanding of the situation and influencing factors of nurses' work interruption in Wuhan's isolation ward during the COVID-19 pandemic. MATERIAL AND METHODS A self-designed general situation questionnaire and work interruption questionnaire were used to survey 160 nur","2021","07","02","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","Adult; Beijing; COVID-19; China; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Nurses; Pandemics; Risk Factors; SARS-CoV-2; Surveys and Questionnaires; Workload","Zhou","Xiao-Juan","Department of Geriatrics, Beijing Hospital, National Center of Gerontology",NA
"1877","34181636","10.12659/MSM.929851","Factors Influencing Nurses' Work Interruption in Wuhan Isolation Wards During the COVID-19 Pandemic.","BACKGROUND Through January 2021, the novel coronavirus (COVID-19) continued to create significant pressure on medical staff who have worked to treat patients with the disease and control its spread. This study aimed to increase understanding of the situation and influencing factors of nurses' work interruption in Wuhan's isolation ward during the COVID-19 pandemic. MATERIAL AND METHODS A self-designed general situation questionnaire and work interruption questionnaire were used to survey 160 nur","2021","07","02","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","Adult; Beijing; COVID-19; China; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Nurses; Pandemics; Risk Factors; SARS-CoV-2; Surveys and Questionnaires; Workload","Dang","Yuan-Yuan","Department of Neurosurgery, The Seventh Medical Center, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China (mainland)",NA
"1878","34181636","10.12659/MSM.929851","Factors Influencing Nurses' Work Interruption in Wuhan Isolation Wards During the COVID-19 Pandemic.","BACKGROUND Through January 2021, the novel coronavirus (COVID-19) continued to create significant pressure on medical staff who have worked to treat patients with the disease and control its spread. This study aimed to increase understanding of the situation and influencing factors of nurses' work interruption in Wuhan's isolation ward during the COVID-19 pandemic. MATERIAL AND METHODS A self-designed general situation questionnaire and work interruption questionnaire were used to survey 160 nur","2021","07","02","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","Adult; Beijing; COVID-19; China; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Nurses; Pandemics; Risk Factors; SARS-CoV-2; Surveys and Questionnaires; Workload","Wang","Xia","Nursing Department, Beijing Hospital, National Center of Gerontology",NA
"1879","34181636","10.12659/MSM.929851","Factors Influencing Nurses' Work Interruption in Wuhan Isolation Wards During the COVID-19 Pandemic.","BACKGROUND Through January 2021, the novel coronavirus (COVID-19) continued to create significant pressure on medical staff who have worked to treat patients with the disease and control its spread. This study aimed to increase understanding of the situation and influencing factors of nurses' work interruption in Wuhan's isolation ward during the COVID-19 pandemic. MATERIAL AND METHODS A self-designed general situation questionnaire and work interruption questionnaire were used to survey 160 nur","2021","07","02","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","Adult; Beijing; COVID-19; China; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Nurses; Pandemics; Risk Factors; SARS-CoV-2; Surveys and Questionnaires; Workload","Yang","Wen-Zhang","Department of Geriatrics, Beijing Hospital, National Center of Gerontology",NA
"1880","34181636","10.12659/MSM.929851","Factors Influencing Nurses' Work Interruption in Wuhan Isolation Wards During the COVID-19 Pandemic.","BACKGROUND Through January 2021, the novel coronavirus (COVID-19) continued to create significant pressure on medical staff who have worked to treat patients with the disease and control its spread. This study aimed to increase understanding of the situation and influencing factors of nurses' work interruption in Wuhan's isolation ward during the COVID-19 pandemic. MATERIAL AND METHODS A self-designed general situation questionnaire and work interruption questionnaire were used to survey 160 nur","2021","07","02","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","Adult; Beijing; COVID-19; China; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Nurses; Pandemics; Risk Factors; SARS-CoV-2; Surveys and Questionnaires; Workload","Lu","Wei","Department of Geriatrics, Beijing Hospital, National Center of Gerontology",NA
"1881","34181636","10.12659/MSM.929851","Factors Influencing Nurses' Work Interruption in Wuhan Isolation Wards During the COVID-19 Pandemic.","BACKGROUND Through January 2021, the novel coronavirus (COVID-19) continued to create significant pressure on medical staff who have worked to treat patients with the disease and control its spread. This study aimed to increase understanding of the situation and influencing factors of nurses' work interruption in Wuhan's isolation ward during the COVID-19 pandemic. MATERIAL AND METHODS A self-designed general situation questionnaire and work interruption questionnaire were used to survey 160 nur","2021","07","02","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","Adult; Beijing; COVID-19; China; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Nurses; Pandemics; Risk Factors; SARS-CoV-2; Surveys and Questionnaires; Workload","Zhang","Jian-Hua","Department of Geriatrics, Beijing Hospital, National Center of Gerontology",NA
"1882","34181630","","An EUA for sotrovimab for treatment of COVID-19.",NA,"2021","07","08","Med Lett Drugs Ther","The Medical letter on drugs and therapeutics","COVID-19; adverse effects; bamlanivimab; casirivimab; dosage; efficacy; etesevimab; imdevimab; safety; sotrovimab; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; Drug Approval; Humans; SARS-CoV-2; United States; United States Food and Drug Administration",NA,NA,NA,NA
"1883","34181621","10.1097/PRS.0000000000008060","Plastic Surgery amidst the Pandemic: The New York University Experience at the Epicenter of the COVID-19 Crisis.","The coronavirus disease of 2019 pandemic became a global threat in a matter of weeks, with its future implications yet to be defined. New York City was swiftly declared the epicenter of the pandemic in the United States as case numbers grew exponentially in a matter of days, quickly threatening to overwhelm the capacity of the health care system. This burgeoning crisis led practitioners across specialties to adapt and mobilize rapidly. Plastic surgeons and trainees within the New York University","2021","07","05","Plast Reconstr Surg","Plastic and reconstructive surgery","Academic Medical Centers; COVID-19; Communicable Disease Control; Education, Medical, Graduate; Elective Surgical Procedures; Faculty; Forecasting; Humans; Internship and Residency; New York City; Pandemics; Personnel Staffing and Scheduling; Reconstructive Surgical Procedures; Surgeons; Surgery, Plastic; Surveys and Questionnaires; Uncertainty; Universities","Berman","Zoe P","From the Hansjörg Wyss Department of Plastic Surgery, New York University Langone Health",NA
"1884","34181621","10.1097/PRS.0000000000008060","Plastic Surgery amidst the Pandemic: The New York University Experience at the Epicenter of the COVID-19 Crisis.","The coronavirus disease of 2019 pandemic became a global threat in a matter of weeks, with its future implications yet to be defined. New York City was swiftly declared the epicenter of the pandemic in the United States as case numbers grew exponentially in a matter of days, quickly threatening to overwhelm the capacity of the health care system. This burgeoning crisis led practitioners across specialties to adapt and mobilize rapidly. Plastic surgeons and trainees within the New York University","2021","07","05","Plast Reconstr Surg","Plastic and reconstructive surgery","Academic Medical Centers; COVID-19; Communicable Disease Control; Education, Medical, Graduate; Elective Surgical Procedures; Faculty; Forecasting; Humans; Internship and Residency; New York City; Pandemics; Personnel Staffing and Scheduling; Reconstructive Surgical Procedures; Surgeons; Surgery, Plastic; Surveys and Questionnaires; Uncertainty; Universities","Diep","Gustave K","From the Hansjörg Wyss Department of Plastic Surgery, New York University Langone Health",NA
"1885","34181621","10.1097/PRS.0000000000008060","Plastic Surgery amidst the Pandemic: The New York University Experience at the Epicenter of the COVID-19 Crisis.","The coronavirus disease of 2019 pandemic became a global threat in a matter of weeks, with its future implications yet to be defined. New York City was swiftly declared the epicenter of the pandemic in the United States as case numbers grew exponentially in a matter of days, quickly threatening to overwhelm the capacity of the health care system. This burgeoning crisis led practitioners across specialties to adapt and mobilize rapidly. Plastic surgeons and trainees within the New York University","2021","07","05","Plast Reconstr Surg","Plastic and reconstructive surgery","Academic Medical Centers; COVID-19; Communicable Disease Control; Education, Medical, Graduate; Elective Surgical Procedures; Faculty; Forecasting; Humans; Internship and Residency; New York City; Pandemics; Personnel Staffing and Scheduling; Reconstructive Surgical Procedures; Surgeons; Surgery, Plastic; Surveys and Questionnaires; Uncertainty; Universities","Alfonso","Allyson R","From the Hansjörg Wyss Department of Plastic Surgery, New York University Langone Health",NA
"1886","34181621","10.1097/PRS.0000000000008060","Plastic Surgery amidst the Pandemic: The New York University Experience at the Epicenter of the COVID-19 Crisis.","The coronavirus disease of 2019 pandemic became a global threat in a matter of weeks, with its future implications yet to be defined. New York City was swiftly declared the epicenter of the pandemic in the United States as case numbers grew exponentially in a matter of days, quickly threatening to overwhelm the capacity of the health care system. This burgeoning crisis led practitioners across specialties to adapt and mobilize rapidly. Plastic surgeons and trainees within the New York University","2021","07","05","Plast Reconstr Surg","Plastic and reconstructive surgery","Academic Medical Centers; COVID-19; Communicable Disease Control; Education, Medical, Graduate; Elective Surgical Procedures; Faculty; Forecasting; Humans; Internship and Residency; New York City; Pandemics; Personnel Staffing and Scheduling; Reconstructive Surgical Procedures; Surgeons; Surgery, Plastic; Surveys and Questionnaires; Uncertainty; Universities","Ramly","Elie P","From the Hansjörg Wyss Department of Plastic Surgery, New York University Langone Health",NA
"1887","34181621","10.1097/PRS.0000000000008060","Plastic Surgery amidst the Pandemic: The New York University Experience at the Epicenter of the COVID-19 Crisis.","The coronavirus disease of 2019 pandemic became a global threat in a matter of weeks, with its future implications yet to be defined. New York City was swiftly declared the epicenter of the pandemic in the United States as case numbers grew exponentially in a matter of days, quickly threatening to overwhelm the capacity of the health care system. This burgeoning crisis led practitioners across specialties to adapt and mobilize rapidly. Plastic surgeons and trainees within the New York University","2021","07","05","Plast Reconstr Surg","Plastic and reconstructive surgery","Academic Medical Centers; COVID-19; Communicable Disease Control; Education, Medical, Graduate; Elective Surgical Procedures; Faculty; Forecasting; Humans; Internship and Residency; New York City; Pandemics; Personnel Staffing and Scheduling; Reconstructive Surgical Procedures; Surgeons; Surgery, Plastic; Surveys and Questionnaires; Uncertainty; Universities","Bluebond-Langner","Rachel","From the Hansjörg Wyss Department of Plastic Surgery, New York University Langone Health",NA
"1888","34181621","10.1097/PRS.0000000000008060","Plastic Surgery amidst the Pandemic: The New York University Experience at the Epicenter of the COVID-19 Crisis.","The coronavirus disease of 2019 pandemic became a global threat in a matter of weeks, with its future implications yet to be defined. New York City was swiftly declared the epicenter of the pandemic in the United States as case numbers grew exponentially in a matter of days, quickly threatening to overwhelm the capacity of the health care system. This burgeoning crisis led practitioners across specialties to adapt and mobilize rapidly. Plastic surgeons and trainees within the New York University","2021","07","05","Plast Reconstr Surg","Plastic and reconstructive surgery","Academic Medical Centers; COVID-19; Communicable Disease Control; Education, Medical, Graduate; Elective Surgical Procedures; Faculty; Forecasting; Humans; Internship and Residency; New York City; Pandemics; Personnel Staffing and Scheduling; Reconstructive Surgical Procedures; Surgeons; Surgery, Plastic; Surveys and Questionnaires; Uncertainty; Universities","Bernstein","G Leslie","From the Hansjörg Wyss Department of Plastic Surgery, New York University Langone Health",NA
"1889","34181621","10.1097/PRS.0000000000008060","Plastic Surgery amidst the Pandemic: The New York University Experience at the Epicenter of the COVID-19 Crisis.","The coronavirus disease of 2019 pandemic became a global threat in a matter of weeks, with its future implications yet to be defined. New York City was swiftly declared the epicenter of the pandemic in the United States as case numbers grew exponentially in a matter of days, quickly threatening to overwhelm the capacity of the health care system. This burgeoning crisis led practitioners across specialties to adapt and mobilize rapidly. Plastic surgeons and trainees within the New York University","2021","07","05","Plast Reconstr Surg","Plastic and reconstructive surgery","Academic Medical Centers; COVID-19; Communicable Disease Control; Education, Medical, Graduate; Elective Surgical Procedures; Faculty; Forecasting; Humans; Internship and Residency; New York City; Pandemics; Personnel Staffing and Scheduling; Reconstructive Surgical Procedures; Surgeons; Surgery, Plastic; Surveys and Questionnaires; Uncertainty; Universities","Rodriguez","Eduardo D","From the Hansjörg Wyss Department of Plastic Surgery, New York University Langone Health",NA
"1890","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Reyes-Ruiz","José Manuel","Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (CINVESTAV-IPN), Mexico City, Mexico",NA
"1891","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Campuzano-Vences","Rosa","Laboratorio de Biología Molecular, Laboratorio Estatal de Salud Pública del Estado de México, State of Mexico, Mexico",NA
"1892","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Osuna-Ramos","Juan Fidel","Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (CINVESTAV-IPN), Mexico City, Mexico",NA
"1893","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"De Jesús-González","Luis Adrián","Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (CINVESTAV-IPN), Mexico City, Mexico",NA
"1894","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Pérez-Méndez","María J","Laboratorio de Biología Molecular, Laboratorio Estatal de Salud Pública del Estado de México, State of Mexico, Mexico",NA
"1895","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"González-González","Crescencio","Hospital General Miguel Hidalgo y Costilla Bicentenario, State of Mexico, Mexico",NA
"1896","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Farfan-Morales","Carlos Noe","Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (CINVESTAV-IPN), Mexico City, Mexico",NA
"1897","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Rivas-Tovar","Leticia","Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (CINVESTAV-IPN), Mexico City, Mexico",NA
"1898","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Dávila-González","Eduardo","Laboratorio de Biología Molecular, Laboratorio Estatal de Salud Pública del Estado de México, State of Mexico, Mexico",NA
"1899","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"María Del Ángel","Rosa","Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (CINVESTAV-IPN), Mexico City, Mexico",NA
"1900","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Gutiérrez-Garduño","Aarón P","Departamento de Epidemiología, Jurisdicción Sanitaria Tlanepantla ISEM, State of Mexico, Mexico",NA
"1901","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Villegas-Del Ángel","Enrique","Centro Médico ABC, Mexico City, Mexico",NA
"1902","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Zárate-Segura","Paola","Laboratorio de Medicina Traslacional, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City, Mexico",NA
"1903","34181577","10.4269/ajtmh.21-0177","Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.","The risk of coronavirus disease 2019 (COVID-19) and dengue coinfection is increased in tropical countries; however, the extrapulmonary clinical manifestations have not been fully characterized. We report a 42-year-old woman whose clinical manifestations began with fever, diarrhea, headache, chest pain, myalgia, odynophagia, and arthralgia. Despite mild respiratory symptoms and normal chest computed tomography scan results, she was diagnosed with real-time reverse-transcription polymerase chain r","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Bastida-González","Fernando","Hospital General Miguel Hidalgo y Costilla Bicentenario, State of Mexico, Mexico",NA
"1904","34181576","10.4269/ajtmh.21-0156","Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners.","Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured ","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"McHenry","Megan S","Division of Pediatric Infectious Disease and Global Health and Director of Pediatric Global Health Education within the Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana",NA
"1905","34181576","10.4269/ajtmh.21-0156","Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners.","Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured ","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Tam","Reena P","Division of Pediatric Hospital Medicine, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah",NA
"1906","34181576","10.4269/ajtmh.21-0156","Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners.","Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured ","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Nafiseh","Amira A","Indiana University School of Medicine, Indianapolis, Indiana",NA
"1907","34181576","10.4269/ajtmh.21-0156","Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners.","Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured ","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Etling","Mary Ann","Indiana University School of Medicine, Indianapolis, Indiana",NA
"1908","34181576","10.4269/ajtmh.21-0156","Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners.","Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured ","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Barnes","Adelaide E","Section of Hospital Medicine and Associate Program Director of the Pediatrics Residency Program at The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania",NA
"1909","34181576","10.4269/ajtmh.21-0156","Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners.","Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured ","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Rule","Amy R L","Divisions of Hospital Medicine and Perinatal Institute, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio",NA
"1910","34181576","10.4269/ajtmh.21-0156","Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners.","Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured ","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Crouse","Heather L","Department of Pediatrics at Baylor College of Medicine, Houston, Texas",NA
"1911","34181576","10.4269/ajtmh.21-0156","Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners.","Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured ","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Haq","Heather","Department of Pediatrics at Baylor College of Medicine, Houston, Texas",NA
"1912","34181576","10.4269/ajtmh.21-0156","Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners.","Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured ","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Morris","Lee E","Division of Pediatric Infectious Diseases and Immunology, Department of Pediatrics, Atrium Health Levine Children's Hospital, Charlotte, North Carolina",NA
"1913","34181576","10.4269/ajtmh.21-0156","Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners.","Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured ","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Murray","Brittany L","Departments of Pediatrics and Emergency Medicine at Emory University School of Medicine, Atlanta, Georgia",NA
"1914","34181576","10.4269/ajtmh.21-0156","Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners.","Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured ","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Umphrey","Lisa A","Center for Global Health, Colorado School of Public Health, Denver, Colorado",NA
"1915","34181576","10.4269/ajtmh.21-0156","Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners.","Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured ","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Keating","Elizabeth M","Division of Pediatric Emergency Medicine, Department of Pediatrics, University of Utah, Salt Lake City, Utah",NA
"1916","34181574","10.4269/ajtmh.20-1390","Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing.","Antibody tests can be tools for detecting current or past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 [coronavirus disease 2019 (COVID-19)]) infections. Independent test evaluations are needed to document the performance with different sample sets. We evaluated six lateral flow assays (LFAs) and two laboratory-based tests (EUROIMMUN-SARS-CoV-2 ELISA and Abbott-Architect-SARS-CoV-2-IgG). We tested 210 plasma samples from 89 patients diagnosed with acute COVID-19. These samples wer","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Fischer","Peter U","Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri",NA
"1917","34181574","10.4269/ajtmh.20-1390","Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing.","Antibody tests can be tools for detecting current or past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 [coronavirus disease 2019 (COVID-19)]) infections. Independent test evaluations are needed to document the performance with different sample sets. We evaluated six lateral flow assays (LFAs) and two laboratory-based tests (EUROIMMUN-SARS-CoV-2 ELISA and Abbott-Architect-SARS-CoV-2-IgG). We tested 210 plasma samples from 89 patients diagnosed with acute COVID-19. These samples wer","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Fischer","Kerstin","Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri",NA
"1918","34181574","10.4269/ajtmh.20-1390","Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing.","Antibody tests can be tools for detecting current or past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 [coronavirus disease 2019 (COVID-19)]) infections. Independent test evaluations are needed to document the performance with different sample sets. We evaluated six lateral flow assays (LFAs) and two laboratory-based tests (EUROIMMUN-SARS-CoV-2 ELISA and Abbott-Architect-SARS-CoV-2-IgG). We tested 210 plasma samples from 89 patients diagnosed with acute COVID-19. These samples wer","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Curtis","Kurt C","Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri",NA
"1919","34181574","10.4269/ajtmh.20-1390","Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing.","Antibody tests can be tools for detecting current or past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 [coronavirus disease 2019 (COVID-19)]) infections. Independent test evaluations are needed to document the performance with different sample sets. We evaluated six lateral flow assays (LFAs) and two laboratory-based tests (EUROIMMUN-SARS-CoV-2 ELISA and Abbott-Architect-SARS-CoV-2-IgG). We tested 210 plasma samples from 89 patients diagnosed with acute COVID-19. These samples wer","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Huang","Yuefang","Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri",NA
"1920","34181574","10.4269/ajtmh.20-1390","Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing.","Antibody tests can be tools for detecting current or past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 [coronavirus disease 2019 (COVID-19)]) infections. Independent test evaluations are needed to document the performance with different sample sets. We evaluated six lateral flow assays (LFAs) and two laboratory-based tests (EUROIMMUN-SARS-CoV-2 ELISA and Abbott-Architect-SARS-CoV-2-IgG). We tested 210 plasma samples from 89 patients diagnosed with acute COVID-19. These samples wer","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Fetcho","Nicole","Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri",NA
"1921","34181574","10.4269/ajtmh.20-1390","Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing.","Antibody tests can be tools for detecting current or past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 [coronavirus disease 2019 (COVID-19)]) infections. Independent test evaluations are needed to document the performance with different sample sets. We evaluated six lateral flow assays (LFAs) and two laboratory-based tests (EUROIMMUN-SARS-CoV-2 ELISA and Abbott-Architect-SARS-CoV-2-IgG). We tested 210 plasma samples from 89 patients diagnosed with acute COVID-19. These samples wer","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Goss","Charles W","Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri",NA
"1922","34181574","10.4269/ajtmh.20-1390","Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing.","Antibody tests can be tools for detecting current or past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 [coronavirus disease 2019 (COVID-19)]) infections. Independent test evaluations are needed to document the performance with different sample sets. We evaluated six lateral flow assays (LFAs) and two laboratory-based tests (EUROIMMUN-SARS-CoV-2 ELISA and Abbott-Architect-SARS-CoV-2-IgG). We tested 210 plasma samples from 89 patients diagnosed with acute COVID-19. These samples wer","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Weil","Gary J","Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri",NA
"1923","34181573","10.4269/ajtmh.21-0264","Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa.","As the fight against the coronavirus disease 2019 (COVID-19) pandemic continues, the necessity for wide-scale, global vaccine rollout to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and slow its mutation rate remains unassailable. The COVID-19 Vaccines Global Access (COVAX) initiative's campaign involves a proportional framework to finance and distribute SARS-CoV-2 vaccines in low- and middle-income countries. However, the COVAX framework has critical limitat","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Rogers","Abu Bakarr","School of Medicine, Stanford Medical School, Stanford, California",NA
"1924","34181573","10.4269/ajtmh.21-0264","Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa.","As the fight against the coronavirus disease 2019 (COVID-19) pandemic continues, the necessity for wide-scale, global vaccine rollout to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and slow its mutation rate remains unassailable. The COVID-19 Vaccines Global Access (COVAX) initiative's campaign involves a proportional framework to finance and distribute SARS-CoV-2 vaccines in low- and middle-income countries. However, the COVAX framework has critical limitat","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Barrie","Mohamed Bailor","Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California",NA
"1925","34181573","10.4269/ajtmh.21-0264","Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa.","As the fight against the coronavirus disease 2019 (COVID-19) pandemic continues, the necessity for wide-scale, global vaccine rollout to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and slow its mutation rate remains unassailable. The COVID-19 Vaccines Global Access (COVAX) initiative's campaign involves a proportional framework to finance and distribute SARS-CoV-2 vaccines in low- and middle-income countries. However, the COVAX framework has critical limitat","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Fallah","Mosoka P","U.S. Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia",NA
"1926","34181573","10.4269/ajtmh.21-0264","Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa.","As the fight against the coronavirus disease 2019 (COVID-19) pandemic continues, the necessity for wide-scale, global vaccine rollout to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and slow its mutation rate remains unassailable. The COVID-19 Vaccines Global Access (COVAX) initiative's campaign involves a proportional framework to finance and distribute SARS-CoV-2 vaccines in low- and middle-income countries. However, the COVAX framework has critical limitat","2021","06","28","Am J Trop Med Hyg","The American journal of tropical medicine and hygiene",NA,"Kelly","J Daniel","Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California",NA
"1927","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"García-Reyna","Benjamín","Centro Universitario del Norte, Universidad de Guadalajara, Colotlan, Mexico",NA
"1928","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Castillo-García","Gilberto Daniel","Sindicato Nacional de Trabajadores del Instituto Mexicano del Seguro Social, Sección III, Guadalajara, México",NA
"1929","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Barbosa-Camacho","Francisco José","Unidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, México",NA
"1930","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Cervantes-Cardona","Guillermo Alonso","Departamento de Disciplinas Filosófico, Metodológicas e Instrumentales, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, México",NA
"1931","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Cervantes-Pérez","Enrique","Departamento de Nutrición Clínica, Instituto Nacional de Ciencias Médicas y Nutrición ""Salvador Zubirán"", Ciudad de México, México",NA
"1932","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Esparza-Estrada","Isaac","Unidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, México",NA
"1933","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Brancaccio-Pérez","Irma Valeria","Unidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, México",NA
"1934","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Silva-González","Gabriela","Departamento de Odontología para la Preservación de la Salud, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, México",NA
"1935","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Fuentes-Orozco","Clotilde","Unidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, México",NA
"1936","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Pintor-Belmontes","Kevin Josue","Unidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, México",NA
"1937","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Guzmán-Ramírez","Bertha Georgina","Unidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, México",NA
"1938","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Navarro","Dinorah Rodríguez","Unidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, México",NA
"1939","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Ibarrola-Peña","Juan Carlos","Unidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, México",NA
"1940","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"López","Veronica Alexandra Sánchez","Unidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, México",NA
"1941","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Chejfec-Ciociano","Jonathan Matias","Unidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, México",NA
"1942","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Sapién-Fernández","José Héctor","Unidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, México",NA
"1943","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"González-Ojeda","Alejandro","Unidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, México",NA
"1944","34181508","10.1080/07481187.2021.1936297","Anxiety and COVID-19: Coronavirus Anxiety Scale scores in medical and non-medical personnel in urban hospitals in Guadalajara. A cross-sectional survey study.","The world is facing the worst health crisis in modern history. In addition to general concerns about the effects of COVID-19 on health, hospital personnel are developing numerous mental health conditions. This cross-sectional survey study evaluated the prevalence and severity of anxiety caused by the COVID-19 pandemic using the Coronavirus Anxiety Scale (CAS) in 2136 hospital employees. For the employees who presented scores ranging from 1-20 (n = 1090, 51%), the CAS mean score was 4.22 (","2021","06","28","Death Stud","Death studies",NA,"Cervantes-Guevara","Gabino","Centro Universitario del Norte, Universidad de Guadalajara, Colotlan, Mexico",NA
"1945","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Gaborit","Benjamin","Department of Infectious Disease, Nantes University Hospital, Nantes, France",NA
"1946","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Dailly","Eric","Clinical Pharmacology Department, CHU Nantes, Nantes, France",NA
"1947","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Vanhove","Bernard","Xenothera, Nantes, France",NA
"1948","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Josien","Régis","Laboratoire d'Immunologie, CIMNA, CHU Nantes, Nantes, France",NA
"1949","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Lacombe","Karine","Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, INSERM, AP-HP, Hôpital Saint-Antoine, Service des Maladies Infectieuses et Tropicales, Paris, France",NA
"1950","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Dubee","Vincent","Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire d'Angers, Angers",NA
"1951","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Ferre","Virginie","INSERM CIC1413, Nantes University Hospital and Inserm, Nantes, France",NA
"1952","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Brouard","Sophie","Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, ITUN, CHU Nantes, Nantes, France",NA
"1953","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Ader","Florence","Centre International de Recherche en Infectiologie (CIRI), Inserm 1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, F-69007 Lyon, France",NA
"1954","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Vibet","Marie-Anne","CHU Nantes, Sponsor Department, Nantes, France",NA
"1955","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Le Thuaut","Aurélie","CHU Nantes, Sponsor Department, Nantes, France",NA
"1956","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Danger","Richard","Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, ITUN, CHU Nantes, Nantes, France",NA
"1957","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Flet","Laurent","CHU Nantes, Pharmacy Department, Nantes, France",NA
"1958","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Omnes","Anne","CHU Nantes, Sponsor Department, Nantes, France",NA
"1959","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Berly","Laetitia","CHU Nantes, Sponsor Department, Nantes, France",NA
"1960","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Chiffoleau","Anne","CHU Nantes, Sponsor Department, Nantes, France",NA
"1961","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Jobert","Alexandra","CHU Nantes, Sponsor Department, Nantes, France",NA
"1962","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Duvaux","Odile","Xenothera, Nantes, France",NA
"1963","34181475","10.1128/AAC.01237-21","Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study.","Objective: We assessed the pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2, in COVID-19-related moderate pneumonia. To evaluate the optimal dose and safety of XAV-19 during this first administration to patients with COVID-19-related moderate pneumonia. Methods: In this phase 2a trial, adults with COVID-19-related moderate pneumonia of =10 days duration were randomized to infusion of XAV-19 0.5mg/kg at day 1 and day 5 (gro","2021","06","28","Antimicrob Agents Chemother","Antimicrobial agents and chemotherapy",NA,"Raffi","François","Department of Infectious Disease, Nantes University Hospital, Nantes, France",NA
"1964","34181461","10.1152/ajpendo.00174.2021","Vitamin D and lumisterol novel metabolites can inhibit SARS-COV-2 replication machinery enzymes.","Vitamin D deficiency significantly correlates with the severity of SARS-COV-2 infection. Molecular docking-based virtual screening studies predict that novel vitamin D and related lumisterol hydroxymetabolites are able to bind to the active sites of two SARS-COV-2 transcription machinery enzymes with high affinity. These enzymes are the main protease (M<sup>pro</sup>) and RNA dependent RNA polymerase (RdRP) which play important roles in viral replication and establishing infection. Based on pred","2021","06","28","Am J Physiol Endocrinol Metab","American journal of physiology. Endocrinology and metabolism","COVID-19; RNA-dependent RNA polymerase; SARS-CoV-2 main protease; Vitamin D metabolites; lumisterol","Qayyum","Shariq","Department of Dermatology, University of Alabama at Birmingham, United States",NA
"1965","34181461","10.1152/ajpendo.00174.2021","Vitamin D and lumisterol novel metabolites can inhibit SARS-COV-2 replication machinery enzymes.","Vitamin D deficiency significantly correlates with the severity of SARS-COV-2 infection. Molecular docking-based virtual screening studies predict that novel vitamin D and related lumisterol hydroxymetabolites are able to bind to the active sites of two SARS-COV-2 transcription machinery enzymes with high affinity. These enzymes are the main protease (M<sup>pro</sup>) and RNA dependent RNA polymerase (RdRP) which play important roles in viral replication and establishing infection. Based on pred","2021","06","28","Am J Physiol Endocrinol Metab","American journal of physiology. Endocrinology and metabolism","COVID-19; RNA-dependent RNA polymerase; SARS-CoV-2 main protease; Vitamin D metabolites; lumisterol","Mohammad","Taj","Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India",NA
"1966","34181461","10.1152/ajpendo.00174.2021","Vitamin D and lumisterol novel metabolites can inhibit SARS-COV-2 replication machinery enzymes.","Vitamin D deficiency significantly correlates with the severity of SARS-COV-2 infection. Molecular docking-based virtual screening studies predict that novel vitamin D and related lumisterol hydroxymetabolites are able to bind to the active sites of two SARS-COV-2 transcription machinery enzymes with high affinity. These enzymes are the main protease (M<sup>pro</sup>) and RNA dependent RNA polymerase (RdRP) which play important roles in viral replication and establishing infection. Based on pred","2021","06","28","Am J Physiol Endocrinol Metab","American journal of physiology. Endocrinology and metabolism","COVID-19; RNA-dependent RNA polymerase; SARS-CoV-2 main protease; Vitamin D metabolites; lumisterol","Slominski","Radomir M","Department of Dermatology, University of Alabama at Birmingham, United States",NA
"1967","34181461","10.1152/ajpendo.00174.2021","Vitamin D and lumisterol novel metabolites can inhibit SARS-COV-2 replication machinery enzymes.","Vitamin D deficiency significantly correlates with the severity of SARS-COV-2 infection. Molecular docking-based virtual screening studies predict that novel vitamin D and related lumisterol hydroxymetabolites are able to bind to the active sites of two SARS-COV-2 transcription machinery enzymes with high affinity. These enzymes are the main protease (M<sup>pro</sup>) and RNA dependent RNA polymerase (RdRP) which play important roles in viral replication and establishing infection. Based on pred","2021","06","28","Am J Physiol Endocrinol Metab","American journal of physiology. Endocrinology and metabolism","COVID-19; RNA-dependent RNA polymerase; SARS-CoV-2 main protease; Vitamin D metabolites; lumisterol","Hassan","Imtaiyaz","Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India",NA
"1968","34181461","10.1152/ajpendo.00174.2021","Vitamin D and lumisterol novel metabolites can inhibit SARS-COV-2 replication machinery enzymes.","Vitamin D deficiency significantly correlates with the severity of SARS-COV-2 infection. Molecular docking-based virtual screening studies predict that novel vitamin D and related lumisterol hydroxymetabolites are able to bind to the active sites of two SARS-COV-2 transcription machinery enzymes with high affinity. These enzymes are the main protease (M<sup>pro</sup>) and RNA dependent RNA polymerase (RdRP) which play important roles in viral replication and establishing infection. Based on pred","2021","06","28","Am J Physiol Endocrinol Metab","American journal of physiology. Endocrinology and metabolism","COVID-19; RNA-dependent RNA polymerase; SARS-CoV-2 main protease; Vitamin D metabolites; lumisterol","Tuckey","Robert","School of Molecular Sciences, University of Western Australia, Perth, Australia",NA
"1969","34181461","10.1152/ajpendo.00174.2021","Vitamin D and lumisterol novel metabolites can inhibit SARS-COV-2 replication machinery enzymes.","Vitamin D deficiency significantly correlates with the severity of SARS-COV-2 infection. Molecular docking-based virtual screening studies predict that novel vitamin D and related lumisterol hydroxymetabolites are able to bind to the active sites of two SARS-COV-2 transcription machinery enzymes with high affinity. These enzymes are the main protease (M<sup>pro</sup>) and RNA dependent RNA polymerase (RdRP) which play important roles in viral replication and establishing infection. Based on pred","2021","06","28","Am J Physiol Endocrinol Metab","American journal of physiology. Endocrinology and metabolism","COVID-19; RNA-dependent RNA polymerase; SARS-CoV-2 main protease; Vitamin D metabolites; lumisterol","Raman","Chander","Department of Dermatology, University of Alabama at Birmingham, United States",NA
"1970","34181461","10.1152/ajpendo.00174.2021","Vitamin D and lumisterol novel metabolites can inhibit SARS-COV-2 replication machinery enzymes.","Vitamin D deficiency significantly correlates with the severity of SARS-COV-2 infection. Molecular docking-based virtual screening studies predict that novel vitamin D and related lumisterol hydroxymetabolites are able to bind to the active sites of two SARS-COV-2 transcription machinery enzymes with high affinity. These enzymes are the main protease (M<sup>pro</sup>) and RNA dependent RNA polymerase (RdRP) which play important roles in viral replication and establishing infection. Based on pred","2021","06","28","Am J Physiol Endocrinol Metab","American journal of physiology. Endocrinology and metabolism","COVID-19; RNA-dependent RNA polymerase; SARS-CoV-2 main protease; Vitamin D metabolites; lumisterol","Slominski","Andrzej T","Department of Dermatology, University of Alabama at Birmingham, United States",NA
"1971","34181447","10.7326/G20-0111","Annals Graphic Medicine - See/Draw: A COVID-19 Distraction.",NA,"2021","07","21","Ann Intern Med","Annals of internal medicine",NA,"Doan","William J","Penn State University, University Park, Pennsylvania (W.J",NA
"1972","34181444","10.7326/M21-1269","Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.","Working in an unprecedented time frame, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership developed and launched 9 master protocols between 14 April 2020 and 31 May 2021 to allow for the coordinated and efficient evaluation of multiple investigational therapeutic agents for COVID-19. The ACTIV master protocols were designed with a portfolio approach to serve the following patient populations with COVID-19: mild to moderately ill outpatients, mode","2021","07","10","Ann Intern Med","Annals of internal medicine",NA,"LaVange","Lisa","University of North Carolina, Chapel Hill, North Carolina (L",NA
"1973","34181444","10.7326/M21-1269","Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.","Working in an unprecedented time frame, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership developed and launched 9 master protocols between 14 April 2020 and 31 May 2021 to allow for the coordinated and efficient evaluation of multiple investigational therapeutic agents for COVID-19. The ACTIV master protocols were designed with a portfolio approach to serve the following patient populations with COVID-19: mild to moderately ill outpatients, mode","2021","07","10","Ann Intern Med","Annals of internal medicine",NA,"Adam","Stacey J","Foundation for the National Institutes of Health, North Bethesda, Maryland (S.J",NA
"1974","34181444","10.7326/M21-1269","Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.","Working in an unprecedented time frame, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership developed and launched 9 master protocols between 14 April 2020 and 31 May 2021 to allow for the coordinated and efficient evaluation of multiple investigational therapeutic agents for COVID-19. The ACTIV master protocols were designed with a portfolio approach to serve the following patient populations with COVID-19: mild to moderately ill outpatients, mode","2021","07","10","Ann Intern Med","Annals of internal medicine",NA,"Currier","Judith S","University of California, Los Angeles, Los Angeles, California (J.S",NA
"1975","34181444","10.7326/M21-1269","Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.","Working in an unprecedented time frame, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership developed and launched 9 master protocols between 14 April 2020 and 31 May 2021 to allow for the coordinated and efficient evaluation of multiple investigational therapeutic agents for COVID-19. The ACTIV master protocols were designed with a portfolio approach to serve the following patient populations with COVID-19: mild to moderately ill outpatients, mode","2021","07","10","Ann Intern Med","Annals of internal medicine",NA,"Higgs","Elizabeth S","National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (E.S.H., S.W",NA
"1976","34181444","10.7326/M21-1269","Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.","Working in an unprecedented time frame, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership developed and launched 9 master protocols between 14 April 2020 and 31 May 2021 to allow for the coordinated and efficient evaluation of multiple investigational therapeutic agents for COVID-19. The ACTIV master protocols were designed with a portfolio approach to serve the following patient populations with COVID-19: mild to moderately ill outpatients, mode","2021","07","10","Ann Intern Med","Annals of internal medicine",NA,"Reineck","Lora A","National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland (L.A",NA
"1977","34181444","10.7326/M21-1269","Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.","Working in an unprecedented time frame, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership developed and launched 9 master protocols between 14 April 2020 and 31 May 2021 to allow for the coordinated and efficient evaluation of multiple investigational therapeutic agents for COVID-19. The ACTIV master protocols were designed with a portfolio approach to serve the following patient populations with COVID-19: mild to moderately ill outpatients, mode","2021","07","10","Ann Intern Med","Annals of internal medicine",NA,"Hughes","Eric A","Novartis Pharma, Basel, Switzerland (E.A",NA
"1978","34181444","10.7326/M21-1269","Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.","Working in an unprecedented time frame, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership developed and launched 9 master protocols between 14 April 2020 and 31 May 2021 to allow for the coordinated and efficient evaluation of multiple investigational therapeutic agents for COVID-19. The ACTIV master protocols were designed with a portfolio approach to serve the following patient populations with COVID-19: mild to moderately ill outpatients, mode","2021","07","10","Ann Intern Med","Annals of internal medicine",NA,"Read","Sarah W","National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (E.S.H., S.W",NA
"1979","34181394","10.1021/acsnano.1c04996","Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.","Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital components of the COVID-19 mRNA vaccines, LNPs play a key role in effectively protecting and transporting mRNA to cells. Liposomes, an early version of LNPs, are a versatile nanomedicine delivery platform. A number of liposomal drugs have been approved and applied to medical practice. Subsequent generations of lipid nanocarrier","2021","06","28","ACS Nano","ACS nano","cationic lipid; drug delivery; immunoliposome; lipid nanoparticle; liposome; nanostructured lipid carrier; solid lipid nanoparticle; stealth liposome","Tenchov","Rumiana","CAS, a division of the American Chemical Society, Columbus, Ohio 43210, United States",NA
"1980","34181394","10.1021/acsnano.1c04996","Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.","Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital components of the COVID-19 mRNA vaccines, LNPs play a key role in effectively protecting and transporting mRNA to cells. Liposomes, an early version of LNPs, are a versatile nanomedicine delivery platform. A number of liposomal drugs have been approved and applied to medical practice. Subsequent generations of lipid nanocarrier","2021","06","28","ACS Nano","ACS nano","cationic lipid; drug delivery; immunoliposome; lipid nanoparticle; liposome; nanostructured lipid carrier; solid lipid nanoparticle; stealth liposome","Bird","Robert","CAS, a division of the American Chemical Society, Columbus, Ohio 43210, United States",NA
"1981","34181394","10.1021/acsnano.1c04996","Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.","Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital components of the COVID-19 mRNA vaccines, LNPs play a key role in effectively protecting and transporting mRNA to cells. Liposomes, an early version of LNPs, are a versatile nanomedicine delivery platform. A number of liposomal drugs have been approved and applied to medical practice. Subsequent generations of lipid nanocarrier","2021","06","28","ACS Nano","ACS nano","cationic lipid; drug delivery; immunoliposome; lipid nanoparticle; liposome; nanostructured lipid carrier; solid lipid nanoparticle; stealth liposome","Curtze","Allison E","CAS, a division of the American Chemical Society, Columbus, Ohio 43210, United States",NA
"1982","34181394","10.1021/acsnano.1c04996","Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.","Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital components of the COVID-19 mRNA vaccines, LNPs play a key role in effectively protecting and transporting mRNA to cells. Liposomes, an early version of LNPs, are a versatile nanomedicine delivery platform. A number of liposomal drugs have been approved and applied to medical practice. Subsequent generations of lipid nanocarrier","2021","06","28","ACS Nano","ACS nano","cationic lipid; drug delivery; immunoliposome; lipid nanoparticle; liposome; nanostructured lipid carrier; solid lipid nanoparticle; stealth liposome","Zhou","Qiongqiong","CAS, a division of the American Chemical Society, Columbus, Ohio 43210, United States",NA
"1983","34181385","10.1021/acsnano.1c01188","Two-Dimensional-Material-Based Field-Effect Transistor Biosensor for Detecting COVID-19 Virus (SARS-CoV-2).","The emergence of rapidly expanding infectious diseases such as coronavirus (COVID-19) demands effective biosensors that can promptly detect and recognize the pathogens. Field-effect transistors based on semiconducting two-dimensional (2D) materials (2D-FETs) have been identified as potential candidates for rapid and label-free sensing applications. This is because any perturbation of such atomically thin 2D channels can significantly impact their electronic transport properties. Here, we report ","2021","07","09","ACS Nano","ACS nano","2D materials; COVID-19; SARS-CoV-2 spike protein; biosensors; field-effect transistors","Fathi-Hafshejani","Parvin","Department of Electrical and Computer Engineering, Auburn University, Auburn, Alabama 36849, United States",NA
"1984","34181385","10.1021/acsnano.1c01188","Two-Dimensional-Material-Based Field-Effect Transistor Biosensor for Detecting COVID-19 Virus (SARS-CoV-2).","The emergence of rapidly expanding infectious diseases such as coronavirus (COVID-19) demands effective biosensors that can promptly detect and recognize the pathogens. Field-effect transistors based on semiconducting two-dimensional (2D) materials (2D-FETs) have been identified as potential candidates for rapid and label-free sensing applications. This is because any perturbation of such atomically thin 2D channels can significantly impact their electronic transport properties. Here, we report ","2021","07","09","ACS Nano","ACS nano","2D materials; COVID-19; SARS-CoV-2 spike protein; biosensors; field-effect transistors","Azam","Nurul","Department of Electrical and Computer Engineering, Auburn University, Auburn, Alabama 36849, United States",NA
"1985","34181385","10.1021/acsnano.1c01188","Two-Dimensional-Material-Based Field-Effect Transistor Biosensor for Detecting COVID-19 Virus (SARS-CoV-2).","The emergence of rapidly expanding infectious diseases such as coronavirus (COVID-19) demands effective biosensors that can promptly detect and recognize the pathogens. Field-effect transistors based on semiconducting two-dimensional (2D) materials (2D-FETs) have been identified as potential candidates for rapid and label-free sensing applications. This is because any perturbation of such atomically thin 2D channels can significantly impact their electronic transport properties. Here, we report ","2021","07","09","ACS Nano","ACS nano","2D materials; COVID-19; SARS-CoV-2 spike protein; biosensors; field-effect transistors","Wang","Lu","Department of Physics, Auburn University, Auburn, Alabama 36849, United States",NA
"1986","34181385","10.1021/acsnano.1c01188","Two-Dimensional-Material-Based Field-Effect Transistor Biosensor for Detecting COVID-19 Virus (SARS-CoV-2).","The emergence of rapidly expanding infectious diseases such as coronavirus (COVID-19) demands effective biosensors that can promptly detect and recognize the pathogens. Field-effect transistors based on semiconducting two-dimensional (2D) materials (2D-FETs) have been identified as potential candidates for rapid and label-free sensing applications. This is because any perturbation of such atomically thin 2D channels can significantly impact their electronic transport properties. Here, we report ","2021","07","09","ACS Nano","ACS nano","2D materials; COVID-19; SARS-CoV-2 spike protein; biosensors; field-effect transistors","Kuroda","Marcelo A","Department of Physics, Auburn University, Auburn, Alabama 36849, United States",NA
"1987","34181385","10.1021/acsnano.1c01188","Two-Dimensional-Material-Based Field-Effect Transistor Biosensor for Detecting COVID-19 Virus (SARS-CoV-2).","The emergence of rapidly expanding infectious diseases such as coronavirus (COVID-19) demands effective biosensors that can promptly detect and recognize the pathogens. Field-effect transistors based on semiconducting two-dimensional (2D) materials (2D-FETs) have been identified as potential candidates for rapid and label-free sensing applications. This is because any perturbation of such atomically thin 2D channels can significantly impact their electronic transport properties. Here, we report ","2021","07","09","ACS Nano","ACS nano","2D materials; COVID-19; SARS-CoV-2 spike protein; biosensors; field-effect transistors","Hamilton","Michael C","Department of Electrical and Computer Engineering, Auburn University, Auburn, Alabama 36849, United States",NA
"1988","34181385","10.1021/acsnano.1c01188","Two-Dimensional-Material-Based Field-Effect Transistor Biosensor for Detecting COVID-19 Virus (SARS-CoV-2).","The emergence of rapidly expanding infectious diseases such as coronavirus (COVID-19) demands effective biosensors that can promptly detect and recognize the pathogens. Field-effect transistors based on semiconducting two-dimensional (2D) materials (2D-FETs) have been identified as potential candidates for rapid and label-free sensing applications. This is because any perturbation of such atomically thin 2D channels can significantly impact their electronic transport properties. Here, we report ","2021","07","09","ACS Nano","ACS nano","2D materials; COVID-19; SARS-CoV-2 spike protein; biosensors; field-effect transistors","Hasim","Sahar","Department of Biology, Mercer University, Macon, Georgia 31207, United States",NA
"1989","34181385","10.1021/acsnano.1c01188","Two-Dimensional-Material-Based Field-Effect Transistor Biosensor for Detecting COVID-19 Virus (SARS-CoV-2).","The emergence of rapidly expanding infectious diseases such as coronavirus (COVID-19) demands effective biosensors that can promptly detect and recognize the pathogens. Field-effect transistors based on semiconducting two-dimensional (2D) materials (2D-FETs) have been identified as potential candidates for rapid and label-free sensing applications. This is because any perturbation of such atomically thin 2D channels can significantly impact their electronic transport properties. Here, we report ","2021","07","09","ACS Nano","ACS nano","2D materials; COVID-19; SARS-CoV-2 spike protein; biosensors; field-effect transistors","Mahjouri-Samani","Masoud","Department of Electrical and Computer Engineering, Auburn University, Auburn, Alabama 36849, United States",NA
"1990","34181320","10.31557/APJCP.2021.22.6.1667","Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.","While the coronavirus disease 2019 (COVID-19) pandemic spreads, there is increasing evidence to suggest the elevated risk of SARS-CoV-2 infection and following morbidity and mortality in cancer patients. Serology testing using ELISA proposes major advantages as a diagnostic and preventive tool to control the present SARS-CoV-2 outbreak. This cohort study was to determine the SARS-CoV-2 seroconversion in asymptomatic cancer patients. Patients in all age groups and with any type of cancer who have","2021","07","01","Asian Pac J Cancer Prev","Asian Pacific journal of cancer prevention : APJCP","Asymptomatic; COVID-19; Oncology; SARS-CoV-2; cancer; Adult; Asymptomatic Infections; Breast Neoplasms; COVID-19; COVID-19 Serological Testing; Cohort Studies; Female; Humans; Immunoglobulin G; Immunoglobulin M; Iran; Male; Middle Aged; Neoplasms; SARS-CoV-2; Seroepidemiologic Studies; Uterine Cervical Neoplasms; Uterine Neoplasms","Arab","Maliheh","Department of Gynecology Oncology, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1991","34181320","10.31557/APJCP.2021.22.6.1667","Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.","While the coronavirus disease 2019 (COVID-19) pandemic spreads, there is increasing evidence to suggest the elevated risk of SARS-CoV-2 infection and following morbidity and mortality in cancer patients. Serology testing using ELISA proposes major advantages as a diagnostic and preventive tool to control the present SARS-CoV-2 outbreak. This cohort study was to determine the SARS-CoV-2 seroconversion in asymptomatic cancer patients. Patients in all age groups and with any type of cancer who have","2021","07","01","Asian Pac J Cancer Prev","Asian Pacific journal of cancer prevention : APJCP","Asymptomatic; COVID-19; Oncology; SARS-CoV-2; cancer; Adult; Asymptomatic Infections; Breast Neoplasms; COVID-19; COVID-19 Serological Testing; Cohort Studies; Female; Humans; Immunoglobulin G; Immunoglobulin M; Iran; Male; Middle Aged; Neoplasms; SARS-CoV-2; Seroepidemiologic Studies; Uterine Cervical Neoplasms; Uterine Neoplasms","Noei Teymoordash","Somayyeh","Department of Gynecology Oncology, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1992","34181320","10.31557/APJCP.2021.22.6.1667","Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.","While the coronavirus disease 2019 (COVID-19) pandemic spreads, there is increasing evidence to suggest the elevated risk of SARS-CoV-2 infection and following morbidity and mortality in cancer patients. Serology testing using ELISA proposes major advantages as a diagnostic and preventive tool to control the present SARS-CoV-2 outbreak. This cohort study was to determine the SARS-CoV-2 seroconversion in asymptomatic cancer patients. Patients in all age groups and with any type of cancer who have","2021","07","01","Asian Pac J Cancer Prev","Asian Pacific journal of cancer prevention : APJCP","Asymptomatic; COVID-19; Oncology; SARS-CoV-2; cancer; Adult; Asymptomatic Infections; Breast Neoplasms; COVID-19; COVID-19 Serological Testing; Cohort Studies; Female; Humans; Immunoglobulin G; Immunoglobulin M; Iran; Male; Middle Aged; Neoplasms; SARS-CoV-2; Seroepidemiologic Studies; Uterine Cervical Neoplasms; Uterine Neoplasms","Talayeh","Maryam","Department of Gynecology Oncology, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1993","34181320","10.31557/APJCP.2021.22.6.1667","Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.","While the coronavirus disease 2019 (COVID-19) pandemic spreads, there is increasing evidence to suggest the elevated risk of SARS-CoV-2 infection and following morbidity and mortality in cancer patients. Serology testing using ELISA proposes major advantages as a diagnostic and preventive tool to control the present SARS-CoV-2 outbreak. This cohort study was to determine the SARS-CoV-2 seroconversion in asymptomatic cancer patients. Patients in all age groups and with any type of cancer who have","2021","07","01","Asian Pac J Cancer Prev","Asian Pacific journal of cancer prevention : APJCP","Asymptomatic; COVID-19; Oncology; SARS-CoV-2; cancer; Adult; Asymptomatic Infections; Breast Neoplasms; COVID-19; COVID-19 Serological Testing; Cohort Studies; Female; Humans; Immunoglobulin G; Immunoglobulin M; Iran; Male; Middle Aged; Neoplasms; SARS-CoV-2; Seroepidemiologic Studies; Uterine Cervical Neoplasms; Uterine Neoplasms","Ghavami","Behnaz","Obstetrician &amp",NA
"1994","34181320","10.31557/APJCP.2021.22.6.1667","Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.","While the coronavirus disease 2019 (COVID-19) pandemic spreads, there is increasing evidence to suggest the elevated risk of SARS-CoV-2 infection and following morbidity and mortality in cancer patients. Serology testing using ELISA proposes major advantages as a diagnostic and preventive tool to control the present SARS-CoV-2 outbreak. This cohort study was to determine the SARS-CoV-2 seroconversion in asymptomatic cancer patients. Patients in all age groups and with any type of cancer who have","2021","07","01","Asian Pac J Cancer Prev","Asian Pacific journal of cancer prevention : APJCP","Asymptomatic; COVID-19; Oncology; SARS-CoV-2; cancer; Adult; Asymptomatic Infections; Breast Neoplasms; COVID-19; COVID-19 Serological Testing; Cohort Studies; Female; Humans; Immunoglobulin G; Immunoglobulin M; Iran; Male; Middle Aged; Neoplasms; SARS-CoV-2; Seroepidemiologic Studies; Uterine Cervical Neoplasms; Uterine Neoplasms","Javadi","Abdolreza","Department of Pathology and Laboratory Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1995","34181320","10.31557/APJCP.2021.22.6.1667","Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.","While the coronavirus disease 2019 (COVID-19) pandemic spreads, there is increasing evidence to suggest the elevated risk of SARS-CoV-2 infection and following morbidity and mortality in cancer patients. Serology testing using ELISA proposes major advantages as a diagnostic and preventive tool to control the present SARS-CoV-2 outbreak. This cohort study was to determine the SARS-CoV-2 seroconversion in asymptomatic cancer patients. Patients in all age groups and with any type of cancer who have","2021","07","01","Asian Pac J Cancer Prev","Asian Pacific journal of cancer prevention : APJCP","Asymptomatic; COVID-19; Oncology; SARS-CoV-2; cancer; Adult; Asymptomatic Infections; Breast Neoplasms; COVID-19; COVID-19 Serological Testing; Cohort Studies; Female; Humans; Immunoglobulin G; Immunoglobulin M; Iran; Male; Middle Aged; Neoplasms; SARS-CoV-2; Seroepidemiologic Studies; Uterine Cervical Neoplasms; Uterine Neoplasms","Nouri","Behnaz","Department of Obstetrics and Gynecology, Shohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"1996","34181307","10.1002/1348-9585.12242","Barriers and facilitators of productivity while working from home during pandemic.","This study aims to characterize the working environment, stress levels, and psychological detachment of employees working from home during the COVID-19 pandemic in the Philippines and investigate their relationship to productivity and musculoskeletal symptoms. Structural equation modeling was used to examine the direct effect of workstation characteristics, stress, and musculoskeletal symptoms to productivity and the indirect effect of psychological detachment to productivity. Data were gathered","2021","07","09","J Occup Health","Journal of occupational health","ergonomics; musculoskeletal symptoms; pandemic; productivity; stress; workstation; Adult; COVID-19; Efficiency; Ergonomics; Female; Humans; Male; Musculoskeletal Diseases; Occupational Diseases; Philippines; Surveys and Questionnaires; Teleworking; Workplace; Young Adult","Seva","Rosemary R","Industrial &amp",NA
"1997","34181307","10.1002/1348-9585.12242","Barriers and facilitators of productivity while working from home during pandemic.","This study aims to characterize the working environment, stress levels, and psychological detachment of employees working from home during the COVID-19 pandemic in the Philippines and investigate their relationship to productivity and musculoskeletal symptoms. Structural equation modeling was used to examine the direct effect of workstation characteristics, stress, and musculoskeletal symptoms to productivity and the indirect effect of psychological detachment to productivity. Data were gathered","2021","07","09","J Occup Health","Journal of occupational health","ergonomics; musculoskeletal symptoms; pandemic; productivity; stress; workstation; Adult; COVID-19; Efficiency; Ergonomics; Female; Humans; Male; Musculoskeletal Diseases; Occupational Diseases; Philippines; Surveys and Questionnaires; Teleworking; Workplace; Young Adult","Tejero","Lourdes Marie S","College of Nursing, University of the Philippines Manila (UPM), Manila, Philippines",NA
"1998","34181307","10.1002/1348-9585.12242","Barriers and facilitators of productivity while working from home during pandemic.","This study aims to characterize the working environment, stress levels, and psychological detachment of employees working from home during the COVID-19 pandemic in the Philippines and investigate their relationship to productivity and musculoskeletal symptoms. Structural equation modeling was used to examine the direct effect of workstation characteristics, stress, and musculoskeletal symptoms to productivity and the indirect effect of psychological detachment to productivity. Data were gathered","2021","07","09","J Occup Health","Journal of occupational health","ergonomics; musculoskeletal symptoms; pandemic; productivity; stress; workstation; Adult; COVID-19; Efficiency; Ergonomics; Female; Humans; Male; Musculoskeletal Diseases; Occupational Diseases; Philippines; Surveys and Questionnaires; Teleworking; Workplace; Young Adult","Fadrilan-Camacho","Vivien Fe F","Department of Environmental and Occupational Health, University of the Philippines Manila (UPM), Manila, Philippines",NA
"1999","34181305","10.1111/1753-6405.13135","Risk factors leading to COVID-19 cases in a Sydney restaurant.","To explore the factors associated with the transmission of SARS-CoV-2 to patrons of a restaurant. A retrospective cohort design was undertaken, with spatial examination and genomic sequencing of cases. The cohort included all patrons who attended the restaurant on Saturday 25 July 2020. A case was identified as a person who tested positive to a validated specific Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) nucleic acid test. Associations were tested using chi-squared analysis of","2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; SARS-CoV-2; dining; restaurant; transmission","Capon","Adam","South Eastern Sydney Local Health District, South Eastern Sydney Public Health Unit, New South Wales",NA
"2000","34181305","10.1111/1753-6405.13135","Risk factors leading to COVID-19 cases in a Sydney restaurant.","To explore the factors associated with the transmission of SARS-CoV-2 to patrons of a restaurant. A retrospective cohort design was undertaken, with spatial examination and genomic sequencing of cases. The cohort included all patrons who attended the restaurant on Saturday 25 July 2020. A case was identified as a person who tested positive to a validated specific Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) nucleic acid test. Associations were tested using chi-squared analysis of","2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; SARS-CoV-2; dining; restaurant; transmission","Houston","Jody","South Eastern Sydney Local Health District, South Eastern Sydney Public Health Unit, New South Wales",NA
"2001","34181305","10.1111/1753-6405.13135","Risk factors leading to COVID-19 cases in a Sydney restaurant.","To explore the factors associated with the transmission of SARS-CoV-2 to patrons of a restaurant. A retrospective cohort design was undertaken, with spatial examination and genomic sequencing of cases. The cohort included all patrons who attended the restaurant on Saturday 25 July 2020. A case was identified as a person who tested positive to a validated specific Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) nucleic acid test. Associations were tested using chi-squared analysis of","2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; SARS-CoV-2; dining; restaurant; transmission","Rockett","Rebecca","Westmead Hospital, Centre for Infectious Diseases and Microbiology, Public Health, New South Wales",NA
"2002","34181305","10.1111/1753-6405.13135","Risk factors leading to COVID-19 cases in a Sydney restaurant.","To explore the factors associated with the transmission of SARS-CoV-2 to patrons of a restaurant. A retrospective cohort design was undertaken, with spatial examination and genomic sequencing of cases. The cohort included all patrons who attended the restaurant on Saturday 25 July 2020. A case was identified as a person who tested positive to a validated specific Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) nucleic acid test. Associations were tested using chi-squared analysis of","2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; SARS-CoV-2; dining; restaurant; transmission","Sheppeard","Vicky","South Eastern Sydney Local Health District, South Eastern Sydney Public Health Unit, New South Wales",NA
"2003","34181305","10.1111/1753-6405.13135","Risk factors leading to COVID-19 cases in a Sydney restaurant.","To explore the factors associated with the transmission of SARS-CoV-2 to patrons of a restaurant. A retrospective cohort design was undertaken, with spatial examination and genomic sequencing of cases. The cohort included all patrons who attended the restaurant on Saturday 25 July 2020. A case was identified as a person who tested positive to a validated specific Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) nucleic acid test. Associations were tested using chi-squared analysis of","2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; SARS-CoV-2; dining; restaurant; transmission","Chaverot","Sandra","South Eastern Sydney Local Health District, South Eastern Sydney Public Health Unit, New South Wales",NA
"2004","34181305","10.1111/1753-6405.13135","Risk factors leading to COVID-19 cases in a Sydney restaurant.","To explore the factors associated with the transmission of SARS-CoV-2 to patrons of a restaurant. A retrospective cohort design was undertaken, with spatial examination and genomic sequencing of cases. The cohort included all patrons who attended the restaurant on Saturday 25 July 2020. A case was identified as a person who tested positive to a validated specific Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) nucleic acid test. Associations were tested using chi-squared analysis of","2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; SARS-CoV-2; dining; restaurant; transmission","Arnott","Alicia","Westmead Hospital, Centre for Infectious Diseases and Microbiology, Public Health, New South Wales",NA
"2005","34181305","10.1111/1753-6405.13135","Risk factors leading to COVID-19 cases in a Sydney restaurant.","To explore the factors associated with the transmission of SARS-CoV-2 to patrons of a restaurant. A retrospective cohort design was undertaken, with spatial examination and genomic sequencing of cases. The cohort included all patrons who attended the restaurant on Saturday 25 July 2020. A case was identified as a person who tested positive to a validated specific Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) nucleic acid test. Associations were tested using chi-squared analysis of","2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; SARS-CoV-2; dining; restaurant; transmission","Parashko","Tiana","South Eastern Sydney Local Health District, South Eastern Sydney Public Health Unit, New South Wales",NA
"2006","34181305","10.1111/1753-6405.13135","Risk factors leading to COVID-19 cases in a Sydney restaurant.","To explore the factors associated with the transmission of SARS-CoV-2 to patrons of a restaurant. A retrospective cohort design was undertaken, with spatial examination and genomic sequencing of cases. The cohort included all patrons who attended the restaurant on Saturday 25 July 2020. A case was identified as a person who tested positive to a validated specific Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) nucleic acid test. Associations were tested using chi-squared analysis of","2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health","COVID-19; SARS-CoV-2; dining; restaurant; transmission","Ferson","Mark","South Eastern Sydney Local Health District, South Eastern Sydney Public Health Unit, New South Wales",NA
"2007","34181296","10.1111/1753-6405.13138","Partnership, trust and respect: NSW's response to COVID-19 among Aboriginal people.",NA,"2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health",NA,"Wilson-Matenga","Geraldine","Centre for Aboriginal Health, NSW Ministry of Health, NSW Health",NA
"2008","34181296","10.1111/1753-6405.13138","Partnership, trust and respect: NSW's response to COVID-19 among Aboriginal people.",NA,"2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health",NA,"Campbell","Megan","Centre for Aboriginal Health, NSW Ministry of Health, NSW Health",NA
"2009","34181296","10.1111/1753-6405.13138","Partnership, trust and respect: NSW's response to COVID-19 among Aboriginal people.",NA,"2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health",NA,"Katterl","Rachel","Centre for Aboriginal Health, NSW Ministry of Health, NSW Health",NA
"2010","34181296","10.1111/1753-6405.13138","Partnership, trust and respect: NSW's response to COVID-19 among Aboriginal people.",NA,"2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health",NA,"Ellis","Elizabeth","Centre for Aboriginal Health, NSW Ministry of Health, NSW Health",NA
"2011","34181296","10.1111/1753-6405.13138","Partnership, trust and respect: NSW's response to COVID-19 among Aboriginal people.",NA,"2021","06","28","Aust N Z J Public Health","Australian and New Zealand journal of public health",NA,"Skeen","Robert","Aboriginal Health &amp",NA
"2012","34181289","10.1002/jmv.27150","Measles crisis in Africa amidst the COVID-19 pandemic: Delayed measles vaccine administration may cause a measles outbreak in Africa.",NA,"2021","07","03","J Med Virol","Journal of medical virology",NA,"Uwishema","Olivier","Oli Health Magazine Organization, Research and Education, Kigali, Rwanda",NA
"2013","34181289","10.1002/jmv.27150","Measles crisis in Africa amidst the COVID-19 pandemic: Delayed measles vaccine administration may cause a measles outbreak in Africa.",NA,"2021","07","03","J Med Virol","Journal of medical virology",NA,"Adriano","Lubanga F","Oli Health Magazine Organization, Research and Education, Kigali, Rwanda",NA
"2014","34181289","10.1002/jmv.27150","Measles crisis in Africa amidst the COVID-19 pandemic: Delayed measles vaccine administration may cause a measles outbreak in Africa.",NA,"2021","07","03","J Med Virol","Journal of medical virology",NA,"Torbati","Tania","Department of Neurosurgery, Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona, California, USA",NA
"2015","34181289","10.1002/jmv.27150","Measles crisis in Africa amidst the COVID-19 pandemic: Delayed measles vaccine administration may cause a measles outbreak in Africa.",NA,"2021","07","03","J Med Virol","Journal of medical virology",NA,"Onyeaka","Helen","Department of Chemical Engineering, School of Chemical Engineering, University of Birmingham, Birmingham, UK",NA
"2016","34181279","10.1002/jcla.23835","Pooled testing for SARS-CoV-2 infection in an automated high-throughput platform.","Active detection of SARS-CoV-2 infection through testing is elementary for the control of COVID-19 pandemic. The implementation of large-scale RT-PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. To find out the feasibility of pooled testing in a high-throughput platform. Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two-stage testing algorithm was conducted for 1410 samples individually and then as pooled sa","2021","07","21","J Clin Lab Anal","Journal of clinical laboratory analysis","Cobas 6800; RT-PCR; SARS-CoV-2; high-throughput machine; pooled testing; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Female; High-Throughput Screening Assays; Humans; Male; Middle Aged; SARS-CoV-2; Young Adult","Dash","Girish Chandra","Department of Microbiology, ICMR-Regional Medical Research Centre (Dept. of Health Research, Ministry of Health &amp",NA
"2017","34181279","10.1002/jcla.23835","Pooled testing for SARS-CoV-2 infection in an automated high-throughput platform.","Active detection of SARS-CoV-2 infection through testing is elementary for the control of COVID-19 pandemic. The implementation of large-scale RT-PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. To find out the feasibility of pooled testing in a high-throughput platform. Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two-stage testing algorithm was conducted for 1410 samples individually and then as pooled sa","2021","07","21","J Clin Lab Anal","Journal of clinical laboratory analysis","Cobas 6800; RT-PCR; SARS-CoV-2; high-throughput machine; pooled testing; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Female; High-Throughput Screening Assays; Humans; Male; Middle Aged; SARS-CoV-2; Young Adult","Rout","Usha Kiran","Department of Microbiology, ICMR-Regional Medical Research Centre (Dept. of Health Research, Ministry of Health &amp",NA
"2018","34181279","10.1002/jcla.23835","Pooled testing for SARS-CoV-2 infection in an automated high-throughput platform.","Active detection of SARS-CoV-2 infection through testing is elementary for the control of COVID-19 pandemic. The implementation of large-scale RT-PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. To find out the feasibility of pooled testing in a high-throughput platform. Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two-stage testing algorithm was conducted for 1410 samples individually and then as pooled sa","2021","07","21","J Clin Lab Anal","Journal of clinical laboratory analysis","Cobas 6800; RT-PCR; SARS-CoV-2; high-throughput machine; pooled testing; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Female; High-Throughput Screening Assays; Humans; Male; Middle Aged; SARS-CoV-2; Young Adult","Nanda","Rashmi Ranjan","Department of Microbiology, ICMR-Regional Medical Research Centre (Dept. of Health Research, Ministry of Health &amp",NA
"2019","34181279","10.1002/jcla.23835","Pooled testing for SARS-CoV-2 infection in an automated high-throughput platform.","Active detection of SARS-CoV-2 infection through testing is elementary for the control of COVID-19 pandemic. The implementation of large-scale RT-PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. To find out the feasibility of pooled testing in a high-throughput platform. Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two-stage testing algorithm was conducted for 1410 samples individually and then as pooled sa","2021","07","21","J Clin Lab Anal","Journal of clinical laboratory analysis","Cobas 6800; RT-PCR; SARS-CoV-2; high-throughput machine; pooled testing; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Female; High-Throughput Screening Assays; Humans; Male; Middle Aged; SARS-CoV-2; Young Adult","Parai","Debaprasad","Department of Microbiology, ICMR-Regional Medical Research Centre (Dept. of Health Research, Ministry of Health &amp",NA
"2020","34181279","10.1002/jcla.23835","Pooled testing for SARS-CoV-2 infection in an automated high-throughput platform.","Active detection of SARS-CoV-2 infection through testing is elementary for the control of COVID-19 pandemic. The implementation of large-scale RT-PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. To find out the feasibility of pooled testing in a high-throughput platform. Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two-stage testing algorithm was conducted for 1410 samples individually and then as pooled sa","2021","07","21","J Clin Lab Anal","Journal of clinical laboratory analysis","Cobas 6800; RT-PCR; SARS-CoV-2; high-throughput machine; pooled testing; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Female; High-Throughput Screening Assays; Humans; Male; Middle Aged; SARS-CoV-2; Young Adult","Choudhary","Hari Ram","Department of Microbiology, ICMR-Regional Medical Research Centre (Dept. of Health Research, Ministry of Health &amp",NA
"2021","34181279","10.1002/jcla.23835","Pooled testing for SARS-CoV-2 infection in an automated high-throughput platform.","Active detection of SARS-CoV-2 infection through testing is elementary for the control of COVID-19 pandemic. The implementation of large-scale RT-PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. To find out the feasibility of pooled testing in a high-throughput platform. Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two-stage testing algorithm was conducted for 1410 samples individually and then as pooled sa","2021","07","21","J Clin Lab Anal","Journal of clinical laboratory analysis","Cobas 6800; RT-PCR; SARS-CoV-2; high-throughput machine; pooled testing; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Female; High-Throughput Screening Assays; Humans; Male; Middle Aged; SARS-CoV-2; Young Adult","Kanungo","Srikanta","Department of Microbiology, ICMR-Regional Medical Research Centre (Dept. of Health Research, Ministry of Health &amp",NA
"2022","34181279","10.1002/jcla.23835","Pooled testing for SARS-CoV-2 infection in an automated high-throughput platform.","Active detection of SARS-CoV-2 infection through testing is elementary for the control of COVID-19 pandemic. The implementation of large-scale RT-PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. To find out the feasibility of pooled testing in a high-throughput platform. Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two-stage testing algorithm was conducted for 1410 samples individually and then as pooled sa","2021","07","21","J Clin Lab Anal","Journal of clinical laboratory analysis","Cobas 6800; RT-PCR; SARS-CoV-2; high-throughput machine; pooled testing; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Female; High-Throughput Screening Assays; Humans; Male; Middle Aged; SARS-CoV-2; Young Adult","Palo","Subrata Kumar","Department of Microbiology, ICMR-Regional Medical Research Centre (Dept. of Health Research, Ministry of Health &amp",NA
"2023","34181279","10.1002/jcla.23835","Pooled testing for SARS-CoV-2 infection in an automated high-throughput platform.","Active detection of SARS-CoV-2 infection through testing is elementary for the control of COVID-19 pandemic. The implementation of large-scale RT-PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. To find out the feasibility of pooled testing in a high-throughput platform. Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two-stage testing algorithm was conducted for 1410 samples individually and then as pooled sa","2021","07","21","J Clin Lab Anal","Journal of clinical laboratory analysis","Cobas 6800; RT-PCR; SARS-CoV-2; high-throughput machine; pooled testing; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Female; High-Throughput Screening Assays; Humans; Male; Middle Aged; SARS-CoV-2; Young Adult","Kshatri","Jaya Singh","Department of Microbiology, ICMR-Regional Medical Research Centre (Dept. of Health Research, Ministry of Health &amp",NA
"2024","34181279","10.1002/jcla.23835","Pooled testing for SARS-CoV-2 infection in an automated high-throughput platform.","Active detection of SARS-CoV-2 infection through testing is elementary for the control of COVID-19 pandemic. The implementation of large-scale RT-PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. To find out the feasibility of pooled testing in a high-throughput platform. Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two-stage testing algorithm was conducted for 1410 samples individually and then as pooled sa","2021","07","21","J Clin Lab Anal","Journal of clinical laboratory analysis","Cobas 6800; RT-PCR; SARS-CoV-2; high-throughput machine; pooled testing; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Female; High-Throughput Screening Assays; Humans; Male; Middle Aged; SARS-CoV-2; Young Adult","Turuk","Jyotirmayee","Department of Microbiology, ICMR-Regional Medical Research Centre (Dept. of Health Research, Ministry of Health &amp",NA
"2025","34181279","10.1002/jcla.23835","Pooled testing for SARS-CoV-2 infection in an automated high-throughput platform.","Active detection of SARS-CoV-2 infection through testing is elementary for the control of COVID-19 pandemic. The implementation of large-scale RT-PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. To find out the feasibility of pooled testing in a high-throughput platform. Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two-stage testing algorithm was conducted for 1410 samples individually and then as pooled sa","2021","07","21","J Clin Lab Anal","Journal of clinical laboratory analysis","Cobas 6800; RT-PCR; SARS-CoV-2; high-throughput machine; pooled testing; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Female; High-Throughput Screening Assays; Humans; Male; Middle Aged; SARS-CoV-2; Young Adult","Mishra","Bijaya Kumar","Department of Microbiology, ICMR-Regional Medical Research Centre (Dept. of Health Research, Ministry of Health &amp",NA
"2026","34181279","10.1002/jcla.23835","Pooled testing for SARS-CoV-2 infection in an automated high-throughput platform.","Active detection of SARS-CoV-2 infection through testing is elementary for the control of COVID-19 pandemic. The implementation of large-scale RT-PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. To find out the feasibility of pooled testing in a high-throughput platform. Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two-stage testing algorithm was conducted for 1410 samples individually and then as pooled sa","2021","07","21","J Clin Lab Anal","Journal of clinical laboratory analysis","Cobas 6800; RT-PCR; SARS-CoV-2; high-throughput machine; pooled testing; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Female; High-Throughput Screening Assays; Humans; Male; Middle Aged; SARS-CoV-2; Young Adult","Pati","Sanghamitra","Department of Microbiology, ICMR-Regional Medical Research Centre (Dept. of Health Research, Ministry of Health &amp",NA
"2027","34181279","10.1002/jcla.23835","Pooled testing for SARS-CoV-2 infection in an automated high-throughput platform.","Active detection of SARS-CoV-2 infection through testing is elementary for the control of COVID-19 pandemic. The implementation of large-scale RT-PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. To find out the feasibility of pooled testing in a high-throughput platform. Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two-stage testing algorithm was conducted for 1410 samples individually and then as pooled sa","2021","07","21","J Clin Lab Anal","Journal of clinical laboratory analysis","Cobas 6800; RT-PCR; SARS-CoV-2; high-throughput machine; pooled testing; Adolescent; Adult; Aged; COVID-19; COVID-19 Testing; Child; Female; High-Throughput Screening Assays; Humans; Male; Middle Aged; SARS-CoV-2; Young Adult","Bhattacharya","Debdutta","Department of Microbiology, ICMR-Regional Medical Research Centre (Dept. of Health Research, Ministry of Health &amp",NA
"2028","34181273","10.1111/and.14156","COVID-19 vaccine hesitancy linked to increased internet search queries for side effects on fertility potential in the initial rollout phase following Emergency Use Authorization.","The Emergency Use Authorization (EUA) of the COVID-19 vaccine on December 11, 2020 has been met with hesitancy for uptake with some citing potential impacts on future fertility. We hypothesised that irrespective of sex, fertility-related queries would markedly increase during the 48 days following EUA of the coronavirus vaccine. We sought to objectively identify trends in internet search queries on public concerns regarding COVID-19 vaccine side effects on fertility that might impact vaccine upt","2021","06","28","Andrologia","Andrologia","COVID-19; Google Trends; fertility; infertility; vaccine","Diaz","Parris","David Geffen School of Medicine at UCLA, Los Angeles, CA, USA",NA
"2029","34181273","10.1111/and.14156","COVID-19 vaccine hesitancy linked to increased internet search queries for side effects on fertility potential in the initial rollout phase following Emergency Use Authorization.","The Emergency Use Authorization (EUA) of the COVID-19 vaccine on December 11, 2020 has been met with hesitancy for uptake with some citing potential impacts on future fertility. We hypothesised that irrespective of sex, fertility-related queries would markedly increase during the 48 days following EUA of the coronavirus vaccine. We sought to objectively identify trends in internet search queries on public concerns regarding COVID-19 vaccine side effects on fertility that might impact vaccine upt","2021","06","28","Andrologia","Andrologia","COVID-19; Google Trends; fertility; infertility; vaccine","Reddy","Pritika","Department of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA",NA
"2030","34181273","10.1111/and.14156","COVID-19 vaccine hesitancy linked to increased internet search queries for side effects on fertility potential in the initial rollout phase following Emergency Use Authorization.","The Emergency Use Authorization (EUA) of the COVID-19 vaccine on December 11, 2020 has been met with hesitancy for uptake with some citing potential impacts on future fertility. We hypothesised that irrespective of sex, fertility-related queries would markedly increase during the 48 days following EUA of the coronavirus vaccine. We sought to objectively identify trends in internet search queries on public concerns regarding COVID-19 vaccine side effects on fertility that might impact vaccine upt","2021","06","28","Andrologia","Andrologia","COVID-19; Google Trends; fertility; infertility; vaccine","Ramasahayam","Reshna","Department of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA",NA
"2031","34181273","10.1111/and.14156","COVID-19 vaccine hesitancy linked to increased internet search queries for side effects on fertility potential in the initial rollout phase following Emergency Use Authorization.","The Emergency Use Authorization (EUA) of the COVID-19 vaccine on December 11, 2020 has been met with hesitancy for uptake with some citing potential impacts on future fertility. We hypothesised that irrespective of sex, fertility-related queries would markedly increase during the 48 days following EUA of the coronavirus vaccine. We sought to objectively identify trends in internet search queries on public concerns regarding COVID-19 vaccine side effects on fertility that might impact vaccine upt","2021","06","28","Andrologia","Andrologia","COVID-19; Google Trends; fertility; infertility; vaccine","Kuchakulla","Manish","Department of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA",NA
"2032","34181273","10.1111/and.14156","COVID-19 vaccine hesitancy linked to increased internet search queries for side effects on fertility potential in the initial rollout phase following Emergency Use Authorization.","The Emergency Use Authorization (EUA) of the COVID-19 vaccine on December 11, 2020 has been met with hesitancy for uptake with some citing potential impacts on future fertility. We hypothesised that irrespective of sex, fertility-related queries would markedly increase during the 48 days following EUA of the coronavirus vaccine. We sought to objectively identify trends in internet search queries on public concerns regarding COVID-19 vaccine side effects on fertility that might impact vaccine upt","2021","06","28","Andrologia","Andrologia","COVID-19; Google Trends; fertility; infertility; vaccine","Ramasamy","Ranjith","Department of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA",NA
"2033","34181249","10.1002/aorn.13423","Turning a Crisis Into an Opportunity: Promoting Professional Development Among Perioperative Personnel During a Pandemic.","The perioperative setting is a complex, high-risk working environment. Ensuring adequate staffing with highly competent nurses remains a top priority to sustain safe patient care. However, there are barriers to individual professional advancement in hospitals, including costs and lack of support or time, which can lead to decreased nurse satisfaction. After the mandated cancellation of elective surgery in March 2020 resulting from the coronavirus disease 2019 pandemic, leaders at a medical cente","2021","07","01","AORN J","AORN journal","clinical ladder; continuing education; cross-training; professional development; specialty certification","Robertson","Lori",NA,NA
"2034","34181249","10.1002/aorn.13423","Turning a Crisis Into an Opportunity: Promoting Professional Development Among Perioperative Personnel During a Pandemic.","The perioperative setting is a complex, high-risk working environment. Ensuring adequate staffing with highly competent nurses remains a top priority to sustain safe patient care. However, there are barriers to individual professional advancement in hospitals, including costs and lack of support or time, which can lead to decreased nurse satisfaction. After the mandated cancellation of elective surgery in March 2020 resulting from the coronavirus disease 2019 pandemic, leaders at a medical cente","2021","07","01","AORN J","AORN journal","clinical ladder; continuing education; cross-training; professional development; specialty certification","Finlayson","Susan",NA,NA
"2035","34181249","10.1002/aorn.13423","Turning a Crisis Into an Opportunity: Promoting Professional Development Among Perioperative Personnel During a Pandemic.","The perioperative setting is a complex, high-risk working environment. Ensuring adequate staffing with highly competent nurses remains a top priority to sustain safe patient care. However, there are barriers to individual professional advancement in hospitals, including costs and lack of support or time, which can lead to decreased nurse satisfaction. After the mandated cancellation of elective surgery in March 2020 resulting from the coronavirus disease 2019 pandemic, leaders at a medical cente","2021","07","01","AORN J","AORN journal","clinical ladder; continuing education; cross-training; professional development; specialty certification","Peñaloza","M Tracey",NA,NA
"2036","34181249","10.1002/aorn.13423","Turning a Crisis Into an Opportunity: Promoting Professional Development Among Perioperative Personnel During a Pandemic.","The perioperative setting is a complex, high-risk working environment. Ensuring adequate staffing with highly competent nurses remains a top priority to sustain safe patient care. However, there are barriers to individual professional advancement in hospitals, including costs and lack of support or time, which can lead to decreased nurse satisfaction. After the mandated cancellation of elective surgery in March 2020 resulting from the coronavirus disease 2019 pandemic, leaders at a medical cente","2021","07","01","AORN J","AORN journal","clinical ladder; continuing education; cross-training; professional development; specialty certification","Brull","Stacey",NA,NA
"2037","34181240","","The Utility of Telehealth in the Recovery From the COVID-19 Pandemic.","Telehealth has recently been used more often in an attempt to protect practitioners and patients during the 2019 coronavirus infectious disease (COVID-19) crisis. Despite telehealth's existence, there was no prior need to fully realize its potential. Recently, technological innovations in orthopaedic surgery have assisted in making this modality more useful. However, it is important to continually educate the medical community regarding these technologies and their interplay to improve patient c","2021","07","05","Surg Technol Int","Surgical technology international",NA,"Chen","Zhongming","Northwell Health Orthopaedics, Lenox Hill Hospital, New York, New York",NA
"2038","34181240","","The Utility of Telehealth in the Recovery From the COVID-19 Pandemic.","Telehealth has recently been used more often in an attempt to protect practitioners and patients during the 2019 coronavirus infectious disease (COVID-19) crisis. Despite telehealth's existence, there was no prior need to fully realize its potential. Recently, technological innovations in orthopaedic surgery have assisted in making this modality more useful. However, it is important to continually educate the medical community regarding these technologies and their interplay to improve patient c","2021","07","05","Surg Technol Int","Surgical technology international",NA,"Tarazi","John M","Northwell Health Orthopaedics, Lenox Hill Hospital, New York, New York",NA
"2039","34181240","","The Utility of Telehealth in the Recovery From the COVID-19 Pandemic.","Telehealth has recently been used more often in an attempt to protect practitioners and patients during the 2019 coronavirus infectious disease (COVID-19) crisis. Despite telehealth's existence, there was no prior need to fully realize its potential. Recently, technological innovations in orthopaedic surgery have assisted in making this modality more useful. However, it is important to continually educate the medical community regarding these technologies and their interplay to improve patient c","2021","07","05","Surg Technol Int","Surgical technology international",NA,"Salem","Hytham S","Northwell Health Orthopaedics, Lenox Hill Hospital, New York, New York",NA
"2040","34181240","","The Utility of Telehealth in the Recovery From the COVID-19 Pandemic.","Telehealth has recently been used more often in an attempt to protect practitioners and patients during the 2019 coronavirus infectious disease (COVID-19) crisis. Despite telehealth's existence, there was no prior need to fully realize its potential. Recently, technological innovations in orthopaedic surgery have assisted in making this modality more useful. However, it is important to continually educate the medical community regarding these technologies and their interplay to improve patient c","2021","07","05","Surg Technol Int","Surgical technology international",NA,"Scuderi","Giles R","Northwell Health Orthopaedics, Lenox Hill Hospital, New York, New York",NA
"2041","34181240","","The Utility of Telehealth in the Recovery From the COVID-19 Pandemic.","Telehealth has recently been used more often in an attempt to protect practitioners and patients during the 2019 coronavirus infectious disease (COVID-19) crisis. Despite telehealth's existence, there was no prior need to fully realize its potential. Recently, technological innovations in orthopaedic surgery have assisted in making this modality more useful. However, it is important to continually educate the medical community regarding these technologies and their interplay to improve patient c","2021","07","05","Surg Technol Int","Surgical technology international",NA,"Mont","Michael A","Northwell Health Orthopaedics, Lenox Hill Hospital, New York, New York",NA
"2042","34181216","10.1007/s43678-021-00172-1","Why don't health care workers in France trust the COVID-19 vaccine?",NA,"2021","07","01","CJEM","CJEM","Emergency medicine; Health care workers; SARS-CoV-2; Vaccination","Revue","Eric","Emergency Department and PreHospital EMS (SAMU of Paris) Lariboisière's Hospital, Assistance Publique Hôpitaux de Paris, Paris University, 2 rue Ambroise Paré, 75010, Paris, France. eric.revue@aphp","eric.revue@aphp.fr"
"2043","34181216","10.1007/s43678-021-00172-1","Why don't health care workers in France trust the COVID-19 vaccine?",NA,"2021","07","01","CJEM","CJEM","Emergency medicine; Health care workers; SARS-CoV-2; Vaccination","Eyer","Xavier","Emergency Department and PreHospital EMS (SAMU of Paris) Lariboisière's Hospital, Assistance Publique Hôpitaux de Paris, Paris University, 2 rue Ambroise Paré, 75010, Paris, France",NA
"2044","34181216","10.1007/s43678-021-00172-1","Why don't health care workers in France trust the COVID-19 vaccine?",NA,"2021","07","01","CJEM","CJEM","Emergency medicine; Health care workers; SARS-CoV-2; Vaccination","Chauvin","Anthony","Emergency Department and PreHospital EMS (SAMU of Paris) Lariboisière's Hospital, Assistance Publique Hôpitaux de Paris, Paris University, 2 rue Ambroise Paré, 75010, Paris, France",NA
"2045","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Sattar","Yasar","Icahn School of Medicine at Mount, Sinai Elmhurst Hospital, Queens, NY, USA",NA
"2046","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Mukuntharaj","Pradeeksha","Grant Medical College and Sir JJ Group of Hospitals, Mumbai, India",NA
"2047","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Zghouzi","Mohamed","Detroit Medical Center, DMC Heart Hospital, 311 Mack Ave, Detroit, MI, 48201, USA",NA
"2048","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Suleiman","Abdul-Rahman M","Detroit Medical Center, DMC Heart Hospital, 311 Mack Ave, Detroit, MI, 48201, USA",NA
"2049","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Attique","Hassan","University of Connecticut, Mansfield, CT, USA",NA
"2050","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Ullah","Waqas","Abington Jefferson Health, Abington, PA, USA",NA
"2051","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Sana","Muhammad Khawar","King Edward Medical University, Lahore, Punjab, Pakistan",NA
"2052","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Zaher","Nathan","Detroit Medical Center, DMC Heart Hospital, 311 Mack Ave, Detroit, MI, 48201, USA",NA
"2053","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Mehmood","Maham","Icahn School of Medicine at Mount Sinai BronxCare Health System, Bronx, NY, USA",NA
"2054","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Doshi","Rajkumar P","University of Nevada School of Medicine, Reno, NV, USA",NA
"2055","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Panchal","Ankur","University of Pittsburgh Medical Center, Pittsburgh, PA, USA",NA
"2056","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Mir","Tanveer","Detroit Medical Center, DMC Heart Hospital, 311 Mack Ave, Detroit, MI, 48201, USA",NA
"2057","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Nadeem","Muhammad","University of Kentucky, Lexington, KY, USA",NA
"2058","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Ali","Omar E","Detroit Medical Center, DMC Heart Hospital, 311 Mack Ave, Detroit, MI, 48201, USA",NA
"2059","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Mohamed","Mohamad","Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, UK",NA
"2060","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Bagur","Rodrigo","Western University, London, ON, Canada",NA
"2061","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Elgendy","Islam Y","Weill Cornell Medicine-Qatar, Doha, Qatar",NA
"2062","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Mamas","Mamas A","Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, UK",NA
"2063","34181203","10.1007/s40292-021-00462-w","Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.","The safety of renin-angiotensin-aldosterone system inhibitors (RAASi) among COVID-19 patients has been controversial since the onset of the pandemic. Digital databases were queried to study the safety of RAASi in COVID-19. The primary outcome of interest was mortality. The secondary outcome was seropositivity improvement/viral clearance, clinical manifestation progression, and progression to intensive care units. A random-effect model was used to compute an unadjusted odds ratio (OR). A total of","2021","07","08","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","ACEi; ARB; Angiotensin receptor blocker; Angiotensin-converting enzyme inhibitor; COVID-19; RAASi; Reninangiotensinaldosterone system inhibitors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; COVID-19; Contraindications, Drug; Disease Progression; Female; Host-Pathogen Interactions; Humans; Male; Middle Aged; Observational Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Risk Factors; SARS-CoV-2","Alraies","M Chadi","Detroit Medical Center, DMC Heart Hospital, 311 Mack Ave, Detroit, MI, 48201, USA. alraies@hotmail","alraies@hotmail.com"
"2064","34181186","10.1007/s12015-021-10210-1","Role of Glycoprotein Hemagglutinin-Esterase in COVID-19 Pathophysiology?",NA,"2021","07","01","Stem Cell Rev Rep","Stem cell reviews and reports",NA,"Zandi","Milad","Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Miladzandi416@gmail","Miladzandi416@gmail.com"
"2065","34181186","10.1007/s12015-021-10210-1","Role of Glycoprotein Hemagglutinin-Esterase in COVID-19 Pathophysiology?",NA,"2021","07","01","Stem Cell Rev Rep","Stem cell reviews and reports",NA,"Behboudi","Emad","Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran",NA
"2066","34181186","10.1007/s12015-021-10210-1","Role of Glycoprotein Hemagglutinin-Esterase in COVID-19 Pathophysiology?",NA,"2021","07","01","Stem Cell Rev Rep","Stem cell reviews and reports",NA,"Soltani","Saber","Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran",NA
"2067","34181181","10.1007/s11481-021-10001-y","Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop.","This brief report collects the program and abstracts of the Society on NeuroImmune Pharmacology (SNIP) COVID-19 Virtual Workshop held on April 9, 2021. The workshop consisted of four symposia: Symposium 1: Molecular approaches to COVID-19 pathogenesis and underlying mechanisms; Symposium 2: Therapeutic and vaccine approaches to COVID-19; Symposium 3: Early Career Investigator talks; and Symposium 4: Diversity and Inclusion SNIP Committee (DISC) program: Well-being and reflections. The workshop a","2021","07","01","J Neuroimmune Pharmacol","Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","COVID-19; Diversity and Inclusion; Early career investigators; Neuroimmune pharmacology; SARS-CoV-2; Therapeutics; Vaccines; Well-being","Kumar","Santosh","Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA. ksantosh@uthsc","ksantosh@uthsc.edu"
"2068","34181181","10.1007/s11481-021-10001-y","Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop.","This brief report collects the program and abstracts of the Society on NeuroImmune Pharmacology (SNIP) COVID-19 Virtual Workshop held on April 9, 2021. The workshop consisted of four symposia: Symposium 1: Molecular approaches to COVID-19 pathogenesis and underlying mechanisms; Symposium 2: Therapeutic and vaccine approaches to COVID-19; Symposium 3: Early Career Investigator talks; and Symposium 4: Diversity and Inclusion SNIP Committee (DISC) program: Well-being and reflections. The workshop a","2021","07","01","J Neuroimmune Pharmacol","Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","COVID-19; Diversity and Inclusion; Early career investigators; Neuroimmune pharmacology; SARS-CoV-2; Therapeutics; Vaccines; Well-being","Pendyala","Gurudutt","Department of Anesthesiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA",NA
"2069","34181181","10.1007/s11481-021-10001-y","Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop.","This brief report collects the program and abstracts of the Society on NeuroImmune Pharmacology (SNIP) COVID-19 Virtual Workshop held on April 9, 2021. The workshop consisted of four symposia: Symposium 1: Molecular approaches to COVID-19 pathogenesis and underlying mechanisms; Symposium 2: Therapeutic and vaccine approaches to COVID-19; Symposium 3: Early Career Investigator talks; and Symposium 4: Diversity and Inclusion SNIP Committee (DISC) program: Well-being and reflections. The workshop a","2021","07","01","J Neuroimmune Pharmacol","Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","COVID-19; Diversity and Inclusion; Early career investigators; Neuroimmune pharmacology; SARS-CoV-2; Therapeutics; Vaccines; Well-being","Yelamanchili","Sowmya V","Department of Anesthesiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA",NA
"2070","34181181","10.1007/s11481-021-10001-y","Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop.","This brief report collects the program and abstracts of the Society on NeuroImmune Pharmacology (SNIP) COVID-19 Virtual Workshop held on April 9, 2021. The workshop consisted of four symposia: Symposium 1: Molecular approaches to COVID-19 pathogenesis and underlying mechanisms; Symposium 2: Therapeutic and vaccine approaches to COVID-19; Symposium 3: Early Career Investigator talks; and Symposium 4: Diversity and Inclusion SNIP Committee (DISC) program: Well-being and reflections. The workshop a","2021","07","01","J Neuroimmune Pharmacol","Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","COVID-19; Diversity and Inclusion; Early career investigators; Neuroimmune pharmacology; SARS-CoV-2; Therapeutics; Vaccines; Well-being","Seth","Pankaj","National Brain Research Centre, Gurgaon, Haryana, India",NA
"2071","34181181","10.1007/s11481-021-10001-y","Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop.","This brief report collects the program and abstracts of the Society on NeuroImmune Pharmacology (SNIP) COVID-19 Virtual Workshop held on April 9, 2021. The workshop consisted of four symposia: Symposium 1: Molecular approaches to COVID-19 pathogenesis and underlying mechanisms; Symposium 2: Therapeutic and vaccine approaches to COVID-19; Symposium 3: Early Career Investigator talks; and Symposium 4: Diversity and Inclusion SNIP Committee (DISC) program: Well-being and reflections. The workshop a","2021","07","01","J Neuroimmune Pharmacol","Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","COVID-19; Diversity and Inclusion; Early career investigators; Neuroimmune pharmacology; SARS-CoV-2; Therapeutics; Vaccines; Well-being","Maggirwar","Sanjay","Department of Microbiology, Immunology, and Tropical Medicine, The George Washington School of Medicine and Health Sciences, Washington, DC, USA",NA
"2072","34181181","10.1007/s11481-021-10001-y","Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop.","This brief report collects the program and abstracts of the Society on NeuroImmune Pharmacology (SNIP) COVID-19 Virtual Workshop held on April 9, 2021. The workshop consisted of four symposia: Symposium 1: Molecular approaches to COVID-19 pathogenesis and underlying mechanisms; Symposium 2: Therapeutic and vaccine approaches to COVID-19; Symposium 3: Early Career Investigator talks; and Symposium 4: Diversity and Inclusion SNIP Committee (DISC) program: Well-being and reflections. The workshop a","2021","07","01","J Neuroimmune Pharmacol","Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","COVID-19; Diversity and Inclusion; Early career investigators; Neuroimmune pharmacology; SARS-CoV-2; Therapeutics; Vaccines; Well-being","Bidlack","Jean M","Department of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA",NA
"2073","34181181","10.1007/s11481-021-10001-y","Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop.","This brief report collects the program and abstracts of the Society on NeuroImmune Pharmacology (SNIP) COVID-19 Virtual Workshop held on April 9, 2021. The workshop consisted of four symposia: Symposium 1: Molecular approaches to COVID-19 pathogenesis and underlying mechanisms; Symposium 2: Therapeutic and vaccine approaches to COVID-19; Symposium 3: Early Career Investigator talks; and Symposium 4: Diversity and Inclusion SNIP Committee (DISC) program: Well-being and reflections. The workshop a","2021","07","01","J Neuroimmune Pharmacol","Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","COVID-19; Diversity and Inclusion; Early career investigators; Neuroimmune pharmacology; SARS-CoV-2; Therapeutics; Vaccines; Well-being","Chang","Sulie L","Department of Biological Sciences, Institute of Neuroimmune Pharmacology, Seton Hall University, South Orange, NJ, USA. sulie.chang@shu","sulie.chang@shu.edu"
"2074","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Scheim","Ayden I","Department of Epidemiology and Biostatistics, Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA",NA
"2075","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Sniderman","Ruby","Centre on Drug Policy Evaluation, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1X1, Canada",NA
"2076","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Wang","Ri","MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada",NA
"2077","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Bouck","Zachary","Centre on Drug Policy Evaluation, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1X1, Canada",NA
"2078","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","McLean","Elizabeth","Centre on Drug Policy Evaluation, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1X1, Canada",NA
"2079","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Mason","Kate","South Riverdale Community Health Centre, Toronto, ON, Canada",NA
"2080","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Bardwell","Geoff","Department of Medicine, University of British Columbia, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC, Canada",NA
"2081","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Mitra","Sanjana","British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC, Canada",NA
"2082","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Greenwald","Zoë R","Centre on Drug Policy Evaluation, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1X1, Canada",NA
"2083","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Thavorn","Kednapa","Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada",NA
"2084","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Garber","Gary","Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, 501 Smyth Box, Ottawa, ON, Canada",NA
"2085","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Baral","Stefan D","Department of Epidemiology, John Hopkins University School of Public Health, Baltimore, MD, USA",NA
"2086","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Rourke","Sean B","MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada",NA
"2087","34181179","10.1007/s11524-021-00547-w","The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.","The Ontario Integrated Supervised Injection Services cohort in Toronto, Canada (OiSIS-Toronto) is an open prospective cohort of people who inject drugs (PWID). OiSIS-Toronto was established to evaluate the impacts of supervised consumption services (SCS) integrated within three community health agencies on health status and service use. The cohort includes PWID who do and do not use SCS, recruited via self-referral, snowball sampling, and community/street outreach. From 5 November 2018 to 19 Mar","2021","07","01","J Urban Health","Journal of urban health : bulletin of the New York Academy of Medicine","Addictions; Cohort studies; Health services research; People who inject drugs; Supervised injection","Werb","Dan","Centre on Drug Policy Evaluation, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1X1, Canada. dwerb@health.ucsd","dwerb@health.ucsd.edu"
"2088","34181169","10.1007/s12079-021-00632-4","SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19.","Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has been declared a pandemic by WHO. The clinical manifestation and disease progression in COVID-19 patients varies from minimal symptoms to severe respiratory issues with multiple organ failure. Understanding the mechanism of SARS-CoV-2 interaction with host cells will provide key insights into the effective molecular targets for the development of novel therapeutics. Recent studie","2021","07","01","J Cell Commun Signal","Journal of cell communication and signaling","Acute respiratory distress syndrome; Cytokine storm; Inflammation; Interleukins; Proteinprotein interactions; RASS pathway","Rex","D A B","Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed To Be University), Mangalore, 575018, India",NA
"2089","34181169","10.1007/s12079-021-00632-4","SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19.","Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has been declared a pandemic by WHO. The clinical manifestation and disease progression in COVID-19 patients varies from minimal symptoms to severe respiratory issues with multiple organ failure. Understanding the mechanism of SARS-CoV-2 interaction with host cells will provide key insights into the effective molecular targets for the development of novel therapeutics. Recent studie","2021","07","01","J Cell Commun Signal","Journal of cell communication and signaling","Acute respiratory distress syndrome; Cytokine storm; Inflammation; Interleukins; Proteinprotein interactions; RASS pathway","Dagamajalu","Shobha","Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed To Be University), Mangalore, 575018, India. shobha_d@yenepoya.edu",NA
"2090","34181169","10.1007/s12079-021-00632-4","SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19.","Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has been declared a pandemic by WHO. The clinical manifestation and disease progression in COVID-19 patients varies from minimal symptoms to severe respiratory issues with multiple organ failure. Understanding the mechanism of SARS-CoV-2 interaction with host cells will provide key insights into the effective molecular targets for the development of novel therapeutics. Recent studie","2021","07","01","J Cell Commun Signal","Journal of cell communication and signaling","Acute respiratory distress syndrome; Cytokine storm; Inflammation; Interleukins; Proteinprotein interactions; RASS pathway","Kandasamy","Richard K","Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, 7491, Trondheim, Norway",NA
"2091","34181169","10.1007/s12079-021-00632-4","SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19.","Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has been declared a pandemic by WHO. The clinical manifestation and disease progression in COVID-19 patients varies from minimal symptoms to severe respiratory issues with multiple organ failure. Understanding the mechanism of SARS-CoV-2 interaction with host cells will provide key insights into the effective molecular targets for the development of novel therapeutics. Recent studie","2021","07","01","J Cell Commun Signal","Journal of cell communication and signaling","Acute respiratory distress syndrome; Cytokine storm; Inflammation; Interleukins; Proteinprotein interactions; RASS pathway","Raju","Rajesh","Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed To Be University), Mangalore, 575018, India. rajrrnbt@gmail","rajrrnbt@gmail.com"
"2092","34181169","10.1007/s12079-021-00632-4","SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19.","Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has been declared a pandemic by WHO. The clinical manifestation and disease progression in COVID-19 patients varies from minimal symptoms to severe respiratory issues with multiple organ failure. Understanding the mechanism of SARS-CoV-2 interaction with host cells will provide key insights into the effective molecular targets for the development of novel therapeutics. Recent studie","2021","07","01","J Cell Commun Signal","Journal of cell communication and signaling","Acute respiratory distress syndrome; Cytokine storm; Inflammation; Interleukins; Proteinprotein interactions; RASS pathway","Prasad","T S Keshava","Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed To Be University), Mangalore, 575018, India. keshav@yenepoya.edu","keshav@yenepoya.edu.in"
"2093","34181168","10.1007/s10620-021-07118-8","Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.","To learn from the crisis caused by the coronavirus disease (COVID-19) pandemic and be prepared for future pandemics, it is important to investigate the impact of this period on the wellbeing of patients with inflammatory bowel disease (IBD). To describe the health-related quality of life (HRQoL) and disease control of IBD patients during the first wave of the COVID-19 pandemic in The Netherlands. Between March 17 and July 1, 2020, patients aged 18 years and older with IBD from the Erasmus MC (Ro","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","COVID-19; Disease control; Fatigue; Inflammatory bowel disease; Pandemic; Quality of life","Paulides","Emma","Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. e.paulides@erasmusmc","e.paulides@erasmusmc.nl"
"2094","34181168","10.1007/s10620-021-07118-8","Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.","To learn from the crisis caused by the coronavirus disease (COVID-19) pandemic and be prepared for future pandemics, it is important to investigate the impact of this period on the wellbeing of patients with inflammatory bowel disease (IBD). To describe the health-related quality of life (HRQoL) and disease control of IBD patients during the first wave of the COVID-19 pandemic in The Netherlands. Between March 17 and July 1, 2020, patients aged 18 years and older with IBD from the Erasmus MC (Ro","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","COVID-19; Disease control; Fatigue; Inflammatory bowel disease; Pandemic; Quality of life","Pasma","Annelieke","Department of Rheumatology, Erasmus University Medical Centre, Rotterdam, The Netherlands",NA
"2095","34181168","10.1007/s10620-021-07118-8","Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.","To learn from the crisis caused by the coronavirus disease (COVID-19) pandemic and be prepared for future pandemics, it is important to investigate the impact of this period on the wellbeing of patients with inflammatory bowel disease (IBD). To describe the health-related quality of life (HRQoL) and disease control of IBD patients during the first wave of the COVID-19 pandemic in The Netherlands. Between March 17 and July 1, 2020, patients aged 18 years and older with IBD from the Erasmus MC (Ro","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","COVID-19; Disease control; Fatigue; Inflammatory bowel disease; Pandemic; Quality of life","Erler","Nicole S","Department of Biostatistics, Erasmus University Medical Centre, Rotterdam, The Netherlands",NA
"2096","34181168","10.1007/s10620-021-07118-8","Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.","To learn from the crisis caused by the coronavirus disease (COVID-19) pandemic and be prepared for future pandemics, it is important to investigate the impact of this period on the wellbeing of patients with inflammatory bowel disease (IBD). To describe the health-related quality of life (HRQoL) and disease control of IBD patients during the first wave of the COVID-19 pandemic in The Netherlands. Between March 17 and July 1, 2020, patients aged 18 years and older with IBD from the Erasmus MC (Ro","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","COVID-19; Disease control; Fatigue; Inflammatory bowel disease; Pandemic; Quality of life","van Eijk","Rachel L A","Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands",NA
"2097","34181168","10.1007/s10620-021-07118-8","Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.","To learn from the crisis caused by the coronavirus disease (COVID-19) pandemic and be prepared for future pandemics, it is important to investigate the impact of this period on the wellbeing of patients with inflammatory bowel disease (IBD). To describe the health-related quality of life (HRQoL) and disease control of IBD patients during the first wave of the COVID-19 pandemic in The Netherlands. Between March 17 and July 1, 2020, patients aged 18 years and older with IBD from the Erasmus MC (Ro","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","COVID-19; Disease control; Fatigue; Inflammatory bowel disease; Pandemic; Quality of life","de Vries","Annemarie C","Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands",NA
"2098","34181168","10.1007/s10620-021-07118-8","Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.","To learn from the crisis caused by the coronavirus disease (COVID-19) pandemic and be prepared for future pandemics, it is important to investigate the impact of this period on the wellbeing of patients with inflammatory bowel disease (IBD). To describe the health-related quality of life (HRQoL) and disease control of IBD patients during the first wave of the COVID-19 pandemic in The Netherlands. Between March 17 and July 1, 2020, patients aged 18 years and older with IBD from the Erasmus MC (Ro","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","COVID-19; Disease control; Fatigue; Inflammatory bowel disease; Pandemic; Quality of life","van der Woude","C Janneke","Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands",NA
"2099","34181167","10.1007/s10620-021-07106-y","Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?",NA,"2021","07","01","Dig Dis Sci","Digestive diseases and sciences",NA,"Horst","Sara","Division of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, USA. sara.n.horst@vumc","sara.n.horst@vumc.org"
"2100","34181165","10.1007/s10620-021-07104-0","Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.","Comorbidities increase the risk of coronavirus disease 2019 (COVID-19) hospitalization and mortality. As many comorbidities are common in patients with inflammatory bowel diseases (IBD), we sought to investigate the effects of comorbidities in these patients on infection severity. To evaluate association between individual comorbidities and COVID-19 infection severity among patients with IBD. Data were obtained from SECURE-IBD, an international registry created to evaluate COVID-19 outcomes in p","2021","07","13","Dig Dis Sci","Digestive diseases and sciences","Chronic kidney disease; Chronic obstructive pulmonary disease; Coronavirus disease; Crohns disease; Inflammatory bowel disease; Ulcerative colitis","Parekh","Rajen","Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rajennparekh@gmail","rajennparekh@gmail.com"
"2101","34181165","10.1007/s10620-021-07104-0","Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.","Comorbidities increase the risk of coronavirus disease 2019 (COVID-19) hospitalization and mortality. As many comorbidities are common in patients with inflammatory bowel diseases (IBD), we sought to investigate the effects of comorbidities in these patients on infection severity. To evaluate association between individual comorbidities and COVID-19 infection severity among patients with IBD. Data were obtained from SECURE-IBD, an international registry created to evaluate COVID-19 outcomes in p","2021","07","13","Dig Dis Sci","Digestive diseases and sciences","Chronic kidney disease; Chronic obstructive pulmonary disease; Coronavirus disease; Crohns disease; Inflammatory bowel disease; Ulcerative colitis","Zhang","Xian","Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"2102","34181165","10.1007/s10620-021-07104-0","Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.","Comorbidities increase the risk of coronavirus disease 2019 (COVID-19) hospitalization and mortality. As many comorbidities are common in patients with inflammatory bowel diseases (IBD), we sought to investigate the effects of comorbidities in these patients on infection severity. To evaluate association between individual comorbidities and COVID-19 infection severity among patients with IBD. Data were obtained from SECURE-IBD, an international registry created to evaluate COVID-19 outcomes in p","2021","07","13","Dig Dis Sci","Digestive diseases and sciences","Chronic kidney disease; Chronic obstructive pulmonary disease; Coronavirus disease; Crohns disease; Inflammatory bowel disease; Ulcerative colitis","Ungaro","Ryan C","The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"2103","34181165","10.1007/s10620-021-07104-0","Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.","Comorbidities increase the risk of coronavirus disease 2019 (COVID-19) hospitalization and mortality. As many comorbidities are common in patients with inflammatory bowel diseases (IBD), we sought to investigate the effects of comorbidities in these patients on infection severity. To evaluate association between individual comorbidities and COVID-19 infection severity among patients with IBD. Data were obtained from SECURE-IBD, an international registry created to evaluate COVID-19 outcomes in p","2021","07","13","Dig Dis Sci","Digestive diseases and sciences","Chronic kidney disease; Chronic obstructive pulmonary disease; Coronavirus disease; Crohns disease; Inflammatory bowel disease; Ulcerative colitis","Brenner","Erica J","Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"2104","34181165","10.1007/s10620-021-07104-0","Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.","Comorbidities increase the risk of coronavirus disease 2019 (COVID-19) hospitalization and mortality. As many comorbidities are common in patients with inflammatory bowel diseases (IBD), we sought to investigate the effects of comorbidities in these patients on infection severity. To evaluate association between individual comorbidities and COVID-19 infection severity among patients with IBD. Data were obtained from SECURE-IBD, an international registry created to evaluate COVID-19 outcomes in p","2021","07","13","Dig Dis Sci","Digestive diseases and sciences","Chronic kidney disease; Chronic obstructive pulmonary disease; Coronavirus disease; Crohns disease; Inflammatory bowel disease; Ulcerative colitis","Agrawal","Manasi","The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"2105","34181165","10.1007/s10620-021-07104-0","Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.","Comorbidities increase the risk of coronavirus disease 2019 (COVID-19) hospitalization and mortality. As many comorbidities are common in patients with inflammatory bowel diseases (IBD), we sought to investigate the effects of comorbidities in these patients on infection severity. To evaluate association between individual comorbidities and COVID-19 infection severity among patients with IBD. Data were obtained from SECURE-IBD, an international registry created to evaluate COVID-19 outcomes in p","2021","07","13","Dig Dis Sci","Digestive diseases and sciences","Chronic kidney disease; Chronic obstructive pulmonary disease; Coronavirus disease; Crohns disease; Inflammatory bowel disease; Ulcerative colitis","Colombel","Jean-Frederic","The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"2106","34181165","10.1007/s10620-021-07104-0","Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.","Comorbidities increase the risk of coronavirus disease 2019 (COVID-19) hospitalization and mortality. As many comorbidities are common in patients with inflammatory bowel diseases (IBD), we sought to investigate the effects of comorbidities in these patients on infection severity. To evaluate association between individual comorbidities and COVID-19 infection severity among patients with IBD. Data were obtained from SECURE-IBD, an international registry created to evaluate COVID-19 outcomes in p","2021","07","13","Dig Dis Sci","Digestive diseases and sciences","Chronic kidney disease; Chronic obstructive pulmonary disease; Coronavirus disease; Crohns disease; Inflammatory bowel disease; Ulcerative colitis","Kappelman","Michael D","Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA",NA
"2107","34181158","10.1007/s11356-021-15067-y","Financial development, oil resources, and environmental degradation in pandemic recession: to go down in flames.","The novel coronavirus disease-2019 (COVID-19) is a deadly disease that increases global healthcare sufferings. Further, it affects the financial and natural resource market simultaneously, as both are considered complementary goods. The volatility in the oil prices deteriorates the global financial market to substantiate the ""financial resource (oil) curse"" hypothesis primarily filled with earlier studies. In contrast, this study moved forward and extended the given relationship during the COVID","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 pandemic; Carbon emissions; Financial development; Oil rents; Robust least square regression; Total population","Anser","Muhammad Khalid","School of Public Administration, Xi'an University of Architecture and Technology, Xi'an, 710000, China",NA
"2108","34181158","10.1007/s11356-021-15067-y","Financial development, oil resources, and environmental degradation in pandemic recession: to go down in flames.","The novel coronavirus disease-2019 (COVID-19) is a deadly disease that increases global healthcare sufferings. Further, it affects the financial and natural resource market simultaneously, as both are considered complementary goods. The volatility in the oil prices deteriorates the global financial market to substantiate the ""financial resource (oil) curse"" hypothesis primarily filled with earlier studies. In contrast, this study moved forward and extended the given relationship during the COVID","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 pandemic; Carbon emissions; Financial development; Oil rents; Robust least square regression; Total population","Khan","Muhammad Azhar","Department of Economics, University of Haripur, Khyber Pakhtunkhwa, Haripur, Pakistan",NA
"2109","34181158","10.1007/s11356-021-15067-y","Financial development, oil resources, and environmental degradation in pandemic recession: to go down in flames.","The novel coronavirus disease-2019 (COVID-19) is a deadly disease that increases global healthcare sufferings. Further, it affects the financial and natural resource market simultaneously, as both are considered complementary goods. The volatility in the oil prices deteriorates the global financial market to substantiate the ""financial resource (oil) curse"" hypothesis primarily filled with earlier studies. In contrast, this study moved forward and extended the given relationship during the COVID","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 pandemic; Carbon emissions; Financial development; Oil rents; Robust least square regression; Total population","Zaman","Khalid","Department of Economics, University of Haripur, Khyber Pakhtunkhwa, Haripur, Pakistan. khalid_zaman786@yahoo","zaman786@yahoo.com"
"2110","34181158","10.1007/s11356-021-15067-y","Financial development, oil resources, and environmental degradation in pandemic recession: to go down in flames.","The novel coronavirus disease-2019 (COVID-19) is a deadly disease that increases global healthcare sufferings. Further, it affects the financial and natural resource market simultaneously, as both are considered complementary goods. The volatility in the oil prices deteriorates the global financial market to substantiate the ""financial resource (oil) curse"" hypothesis primarily filled with earlier studies. In contrast, this study moved forward and extended the given relationship during the COVID","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 pandemic; Carbon emissions; Financial development; Oil rents; Robust least square regression; Total population","Nassani","Abdelmohsen A","Department of Management, College of Business Administration, King Saud University, P.O. Box 71115, Riyadh, 11587, Saudi Arabia",NA
"2111","34181158","10.1007/s11356-021-15067-y","Financial development, oil resources, and environmental degradation in pandemic recession: to go down in flames.","The novel coronavirus disease-2019 (COVID-19) is a deadly disease that increases global healthcare sufferings. Further, it affects the financial and natural resource market simultaneously, as both are considered complementary goods. The volatility in the oil prices deteriorates the global financial market to substantiate the ""financial resource (oil) curse"" hypothesis primarily filled with earlier studies. In contrast, this study moved forward and extended the given relationship during the COVID","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 pandemic; Carbon emissions; Financial development; Oil rents; Robust least square regression; Total population","Askar","Sameh E","Department of Statistics and Operations Research, College of Science, King Saud University, P.O. Box 11451, Riyadh, 11587, Saudi Arabia",NA
"2112","34181158","10.1007/s11356-021-15067-y","Financial development, oil resources, and environmental degradation in pandemic recession: to go down in flames.","The novel coronavirus disease-2019 (COVID-19) is a deadly disease that increases global healthcare sufferings. Further, it affects the financial and natural resource market simultaneously, as both are considered complementary goods. The volatility in the oil prices deteriorates the global financial market to substantiate the ""financial resource (oil) curse"" hypothesis primarily filled with earlier studies. In contrast, this study moved forward and extended the given relationship during the COVID","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 pandemic; Carbon emissions; Financial development; Oil rents; Robust least square regression; Total population","Abro","Muhammad Moinuddin Qazi","Department of Management, College of Business Administration, King Saud University, P.O. Box 71115, Riyadh, 11587, Saudi Arabia",NA
"2113","34181158","10.1007/s11356-021-15067-y","Financial development, oil resources, and environmental degradation in pandemic recession: to go down in flames.","The novel coronavirus disease-2019 (COVID-19) is a deadly disease that increases global healthcare sufferings. Further, it affects the financial and natural resource market simultaneously, as both are considered complementary goods. The volatility in the oil prices deteriorates the global financial market to substantiate the ""financial resource (oil) curse"" hypothesis primarily filled with earlier studies. In contrast, this study moved forward and extended the given relationship during the COVID","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 pandemic; Carbon emissions; Financial development; Oil rents; Robust least square regression; Total population","Kabbani","Ahmad","Department of Management, Aleppo University, Aleppo, Syria",NA
"2114","34181156","10.1007/s10995-021-03194-4","Ensuring Racial Equity in Pregnancy Care During the COVID-19 Pandemic and Beyond.","The COVID-19 pandemic provoked sweeping changes in practice to care for pregnant and birthing people, and highlighted inequities that threaten to exacerbate racial disparities in maternal outcomes. Moreover, social distancing measures have made it harder for pregnant people to access support. Prioritizing widespread access to COVID-19 testing and vaccination for pregnant people is critical to ensuring they receive safe and equitable care. Transparency in reporting outcomes including race and pre","2021","07","01","Matern Child Health J","Maternal and child health journal","COVID-19; Health equity; Labor support; Telemedicine","Ojo","Ayotomiwa","Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA. Ayotomiwa_ojo@hms.harvard","ojo@hms.harvard.edu"
"2115","34181156","10.1007/s10995-021-03194-4","Ensuring Racial Equity in Pregnancy Care During the COVID-19 Pandemic and Beyond.","The COVID-19 pandemic provoked sweeping changes in practice to care for pregnant and birthing people, and highlighted inequities that threaten to exacerbate racial disparities in maternal outcomes. Moreover, social distancing measures have made it harder for pregnant people to access support. Prioritizing widespread access to COVID-19 testing and vaccination for pregnant people is critical to ensuring they receive safe and equitable care. Transparency in reporting outcomes including race and pre","2021","07","01","Matern Child Health J","Maternal and child health journal","COVID-19; Health equity; Labor support; Telemedicine","Beckman","Adam L","Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA",NA
"2116","34181156","10.1007/s10995-021-03194-4","Ensuring Racial Equity in Pregnancy Care During the COVID-19 Pandemic and Beyond.","The COVID-19 pandemic provoked sweeping changes in practice to care for pregnant and birthing people, and highlighted inequities that threaten to exacerbate racial disparities in maternal outcomes. Moreover, social distancing measures have made it harder for pregnant people to access support. Prioritizing widespread access to COVID-19 testing and vaccination for pregnant people is critical to ensuring they receive safe and equitable care. Transparency in reporting outcomes including race and pre","2021","07","01","Matern Child Health J","Maternal and child health journal","COVID-19; Health equity; Labor support; Telemedicine","Weiseth","Amber","Ariadne Labs, Brigham &amp",NA
"2117","34181156","10.1007/s10995-021-03194-4","Ensuring Racial Equity in Pregnancy Care During the COVID-19 Pandemic and Beyond.","The COVID-19 pandemic provoked sweeping changes in practice to care for pregnant and birthing people, and highlighted inequities that threaten to exacerbate racial disparities in maternal outcomes. Moreover, social distancing measures have made it harder for pregnant people to access support. Prioritizing widespread access to COVID-19 testing and vaccination for pregnant people is critical to ensuring they receive safe and equitable care. Transparency in reporting outcomes including race and pre","2021","07","01","Matern Child Health J","Maternal and child health journal","COVID-19; Health equity; Labor support; Telemedicine","Shah","Neel","Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA",NA
"2118","34181144","10.1007/s11255-021-02889-5","Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report.",NA,"2021","07","01","Int Urol Nephrol","International urology and nephrology",NA,"Özkan","Gülsüm","Department of Nephrology, School of Medicine, Tekirdag Namik Kemal University, 59000, Tekirdag, Turkey. gulsumozkan78@hotmail","gulsumozkan78@hotmail.com"
"2119","34181144","10.1007/s11255-021-02889-5","Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report.",NA,"2021","07","01","Int Urol Nephrol","International urology and nephrology",NA,"Bayrakçi","N","Department of Nephrology, School of Medicine, Tekirdag Namik Kemal University, 59000, Tekirdag, Turkey",NA
"2120","34181144","10.1007/s11255-021-02889-5","Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report.",NA,"2021","07","01","Int Urol Nephrol","International urology and nephrology",NA,"Karabag","S","Department of Pathology, School of Medicine, Tekirdag Namik Kemal University, Tekirdag, Turkey",NA
"2121","34181144","10.1007/s11255-021-02889-5","Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report.",NA,"2021","07","01","Int Urol Nephrol","International urology and nephrology",NA,"Güzel","E Ç","Department of Family Medicine, School of Medicine, Tekirdag Namik Kemal University, Tekirdag, Turkey",NA
"2122","34181144","10.1007/s11255-021-02889-5","Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report.",NA,"2021","07","01","Int Urol Nephrol","International urology and nephrology",NA,"Ulusoy","S","Department of Nephrology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey",NA
"2123","34181102","10.1007/s11910-021-01130-1","The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This review aims to summarize the incidence, risk factors, possible pathophysiology, and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro-PASC based on the published literature. The National Institutes of Health has noted that PASC is a multi-organ disorder ranging from mild symptoms to an i","2021","07","02","Curr Neurol Neurosci Rep","Current neurology and neuroscience reports","COVID-19; Chronic fatigue syndrome; Long COVID; Myalgic encephalomyelitis; PASC; Post-Acute Sequelae of SARS-CoV-2 infection; Post-COVID syndrome; SARS-CoV-2; Brain; COVID-19; Humans; SARS-CoV-2; United States","Moghimi","Narges","Department of Neurology, School of Medicine, 1 University of New Mexico, MSC10-5620, Albuquerque, NM, 87131, USA",NA
"2124","34181102","10.1007/s11910-021-01130-1","The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This review aims to summarize the incidence, risk factors, possible pathophysiology, and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro-PASC based on the published literature. The National Institutes of Health has noted that PASC is a multi-organ disorder ranging from mild symptoms to an i","2021","07","02","Curr Neurol Neurosci Rep","Current neurology and neuroscience reports","COVID-19; Chronic fatigue syndrome; Long COVID; Myalgic encephalomyelitis; PASC; Post-Acute Sequelae of SARS-CoV-2 infection; Post-COVID syndrome; SARS-CoV-2; Brain; COVID-19; Humans; SARS-CoV-2; United States","Di Napoli","Mario","Neurological Service, SS Annunziata Hospital, Sulmona, L'Aquila, Italy",NA
"2125","34181102","10.1007/s11910-021-01130-1","The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This review aims to summarize the incidence, risk factors, possible pathophysiology, and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro-PASC based on the published literature. The National Institutes of Health has noted that PASC is a multi-organ disorder ranging from mild symptoms to an i","2021","07","02","Curr Neurol Neurosci Rep","Current neurology and neuroscience reports","COVID-19; Chronic fatigue syndrome; Long COVID; Myalgic encephalomyelitis; PASC; Post-Acute Sequelae of SARS-CoV-2 infection; Post-COVID syndrome; SARS-CoV-2; Brain; COVID-19; Humans; SARS-CoV-2; United States","Biller","José","Department of Neurology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA",NA
"2126","34181102","10.1007/s11910-021-01130-1","The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This review aims to summarize the incidence, risk factors, possible pathophysiology, and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro-PASC based on the published literature. The National Institutes of Health has noted that PASC is a multi-organ disorder ranging from mild symptoms to an i","2021","07","02","Curr Neurol Neurosci Rep","Current neurology and neuroscience reports","COVID-19; Chronic fatigue syndrome; Long COVID; Myalgic encephalomyelitis; PASC; Post-Acute Sequelae of SARS-CoV-2 infection; Post-COVID syndrome; SARS-CoV-2; Brain; COVID-19; Humans; SARS-CoV-2; United States","Siegler","James E","Cooper Neurological Institute, Cooper University Health Care, Camden, NJ, 08103, USA",NA
"2127","34181102","10.1007/s11910-021-01130-1","The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This review aims to summarize the incidence, risk factors, possible pathophysiology, and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro-PASC based on the published literature. The National Institutes of Health has noted that PASC is a multi-organ disorder ranging from mild symptoms to an i","2021","07","02","Curr Neurol Neurosci Rep","Current neurology and neuroscience reports","COVID-19; Chronic fatigue syndrome; Long COVID; Myalgic encephalomyelitis; PASC; Post-Acute Sequelae of SARS-CoV-2 infection; Post-COVID syndrome; SARS-CoV-2; Brain; COVID-19; Humans; SARS-CoV-2; United States","Shekhar","Rahul","Department of Medicine, School of Medicine, University of New Mexico, Albuquerque, NM, USA",NA
"2128","34181102","10.1007/s11910-021-01130-1","The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This review aims to summarize the incidence, risk factors, possible pathophysiology, and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro-PASC based on the published literature. The National Institutes of Health has noted that PASC is a multi-organ disorder ranging from mild symptoms to an i","2021","07","02","Curr Neurol Neurosci Rep","Current neurology and neuroscience reports","COVID-19; Chronic fatigue syndrome; Long COVID; Myalgic encephalomyelitis; PASC; Post-Acute Sequelae of SARS-CoV-2 infection; Post-COVID syndrome; SARS-CoV-2; Brain; COVID-19; Humans; SARS-CoV-2; United States","McCullough","Louise D","Department of Neurology, McGovern Medical School, University of Texas Health Sciences Center, Houston, Texas, USA",NA
"2129","34181102","10.1007/s11910-021-01130-1","The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This review aims to summarize the incidence, risk factors, possible pathophysiology, and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro-PASC based on the published literature. The National Institutes of Health has noted that PASC is a multi-organ disorder ranging from mild symptoms to an i","2021","07","02","Curr Neurol Neurosci Rep","Current neurology and neuroscience reports","COVID-19; Chronic fatigue syndrome; Long COVID; Myalgic encephalomyelitis; PASC; Post-Acute Sequelae of SARS-CoV-2 infection; Post-COVID syndrome; SARS-CoV-2; Brain; COVID-19; Humans; SARS-CoV-2; United States","Harkins","Michelle S","Department of Medicine, School of Medicine, University of New Mexico, Albuquerque, NM, USA",NA
"2130","34181102","10.1007/s11910-021-01130-1","The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This review aims to summarize the incidence, risk factors, possible pathophysiology, and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro-PASC based on the published literature. The National Institutes of Health has noted that PASC is a multi-organ disorder ranging from mild symptoms to an i","2021","07","02","Curr Neurol Neurosci Rep","Current neurology and neuroscience reports","COVID-19; Chronic fatigue syndrome; Long COVID; Myalgic encephalomyelitis; PASC; Post-Acute Sequelae of SARS-CoV-2 infection; Post-COVID syndrome; SARS-CoV-2; Brain; COVID-19; Humans; SARS-CoV-2; United States","Hong","Emily","Department of Neurology, School of Medicine, 1 University of New Mexico, MSC10-5620, Albuquerque, NM, 87131, USA",NA
"2131","34181102","10.1007/s11910-021-01130-1","The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This review aims to summarize the incidence, risk factors, possible pathophysiology, and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro-PASC based on the published literature. The National Institutes of Health has noted that PASC is a multi-organ disorder ranging from mild symptoms to an i","2021","07","02","Curr Neurol Neurosci Rep","Current neurology and neuroscience reports","COVID-19; Chronic fatigue syndrome; Long COVID; Myalgic encephalomyelitis; PASC; Post-Acute Sequelae of SARS-CoV-2 infection; Post-COVID syndrome; SARS-CoV-2; Brain; COVID-19; Humans; SARS-CoV-2; United States","Alaouieh","Danielle A","Department of Neurology, School of Medicine, 1 University of New Mexico, MSC10-5620, Albuquerque, NM, 87131, USA",NA
"2132","34181102","10.1007/s11910-021-01130-1","The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This review aims to summarize the incidence, risk factors, possible pathophysiology, and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro-PASC based on the published literature. The National Institutes of Health has noted that PASC is a multi-organ disorder ranging from mild symptoms to an i","2021","07","02","Curr Neurol Neurosci Rep","Current neurology and neuroscience reports","COVID-19; Chronic fatigue syndrome; Long COVID; Myalgic encephalomyelitis; PASC; Post-Acute Sequelae of SARS-CoV-2 infection; Post-COVID syndrome; SARS-CoV-2; Brain; COVID-19; Humans; SARS-CoV-2; United States","Mansueto","Gelsomina","Department of Advanced Medical and Surgical Sciences, University of Campania, Naples, Italy",NA
"2133","34181102","10.1007/s11910-021-01130-1","The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This review aims to summarize the incidence, risk factors, possible pathophysiology, and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro-PASC based on the published literature. The National Institutes of Health has noted that PASC is a multi-organ disorder ranging from mild symptoms to an i","2021","07","02","Curr Neurol Neurosci Rep","Current neurology and neuroscience reports","COVID-19; Chronic fatigue syndrome; Long COVID; Myalgic encephalomyelitis; PASC; Post-Acute Sequelae of SARS-CoV-2 infection; Post-COVID syndrome; SARS-CoV-2; Brain; COVID-19; Humans; SARS-CoV-2; United States","Divani","Afshin A","Department of Neurology, School of Medicine, 1 University of New Mexico, MSC10-5620, Albuquerque, NM, 87131, USA. adivani@gmail","adivani@gmail.com"
"2134","34181082","10.1007/s00592-021-01764-0","Vaccination against COVID-19 infection: the need of evidence for diabetic and obese pregnant women.","The recent availability of vaccines against COVID-19 has sparked national and international debate on the feasibility of administering them to pregnant and lactating women, given that these vaccines have not been tested to assess their safety and efficacy in such women. As concerns the risks of COVID-induced disease, published data show that pregnant women who develop COVID-19 have fewer symptoms than patients who are not pregnant, but they are more likely to need hospitalization in intensive ca","2021","07","01","Acta Diabetol","Acta diabetologica","COVID-19 infection; Diabetes; Obesity; Pregnancy; Vaccine","Lapolla","A","Padova University, Padova, Italy. annunziata.lapolla@unipd","annunziata.lapolla@unipd.it"
"2135","34181082","10.1007/s00592-021-01764-0","Vaccination against COVID-19 infection: the need of evidence for diabetic and obese pregnant women.","The recent availability of vaccines against COVID-19 has sparked national and international debate on the feasibility of administering them to pregnant and lactating women, given that these vaccines have not been tested to assess their safety and efficacy in such women. As concerns the risks of COVID-induced disease, published data show that pregnant women who develop COVID-19 have fewer symptoms than patients who are not pregnant, but they are more likely to need hospitalization in intensive ca","2021","07","01","Acta Diabetol","Acta diabetologica","COVID-19 infection; Diabetes; Obesity; Pregnancy; Vaccine","Dalfrà","M G","Padova University, Padova, Italy",NA
"2136","34181082","10.1007/s00592-021-01764-0","Vaccination against COVID-19 infection: the need of evidence for diabetic and obese pregnant women.","The recent availability of vaccines against COVID-19 has sparked national and international debate on the feasibility of administering them to pregnant and lactating women, given that these vaccines have not been tested to assess their safety and efficacy in such women. As concerns the risks of COVID-induced disease, published data show that pregnant women who develop COVID-19 have fewer symptoms than patients who are not pregnant, but they are more likely to need hospitalization in intensive ca","2021","07","01","Acta Diabetol","Acta diabetologica","COVID-19 infection; Diabetes; Obesity; Pregnancy; Vaccine","Burlina","S","Padova University, Padova, Italy",NA
"2137","34181079","10.1007/s00592-021-01761-3","Letter to the Editor on Type 1 diabetes onset triggered by COVID-19.",NA,"2021","07","01","Acta Diabetol","Acta diabetologica",NA,"Sholihah","Mentari Maratus","Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia",NA
"2138","34181079","10.1007/s00592-021-01761-3","Letter to the Editor on Type 1 diabetes onset triggered by COVID-19.",NA,"2021","07","01","Acta Diabetol","Acta diabetologica",NA,"Kusuma","Taufik Ridwan Hadi","Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia",NA
"2139","34181079","10.1007/s00592-021-01761-3","Letter to the Editor on Type 1 diabetes onset triggered by COVID-19.",NA,"2021","07","01","Acta Diabetol","Acta diabetologica",NA,"Hanif","Muhammad Ifham","Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Bandung, Indonesia. muhammadifhamhanif@gmail","muhammadifhamhanif@gmail.com"
"2140","34181079","10.1007/s00592-021-01761-3","Letter to the Editor on Type 1 diabetes onset triggered by COVID-19.",NA,"2021","07","01","Acta Diabetol","Acta diabetologica",NA,"Prabowo","Nurhasan Agung","Department of Internal Medicine, Universitas Sebelas Maret Hospital, Surakarta, Indonesia",NA
"2141","34181072","10.1007/s00520-021-06333-3","Self-care and clinical management of persons with laryngectomy during COVID-19 pandemic: a narrative review.","To summarize guidelines on self-care and clinical management of persons with laryngectomy during the COVID-19 pandemic. Articles published in electronic databases-PubMed, Scopus, Web of Science, and CINHAL with the compliant keywords-were scouted from December 2019 to November 2020. All original articles, letters to editors, reviews, and consensus statements were reviewed and included. In all, 20 articles that had information pertaining to self-care of persons with laryngectomy or guidelines for","2021","07","01","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","Alaryngeal speakers; COVID-19; Corona Virus; Laryngectomy; SARS-COV-2; Tracheoesophageal speakers","Varghese","Janet Jaison","Department of Speech and Hearing, Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal, 576104, India",NA
"2142","34181072","10.1007/s00520-021-06333-3","Self-care and clinical management of persons with laryngectomy during COVID-19 pandemic: a narrative review.","To summarize guidelines on self-care and clinical management of persons with laryngectomy during the COVID-19 pandemic. Articles published in electronic databases-PubMed, Scopus, Web of Science, and CINHAL with the compliant keywords-were scouted from December 2019 to November 2020. All original articles, letters to editors, reviews, and consensus statements were reviewed and included. In all, 20 articles that had information pertaining to self-care of persons with laryngectomy or guidelines for","2021","07","01","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","Alaryngeal speakers; COVID-19; Corona Virus; Laryngectomy; SARS-COV-2; Tracheoesophageal speakers","Aithal","Venkataraja U","Department of Speech and Hearing, Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal, 576104, India. vrajaithal@manipal","vrajaithal@manipal.edu"
"2143","34181072","10.1007/s00520-021-06333-3","Self-care and clinical management of persons with laryngectomy during COVID-19 pandemic: a narrative review.","To summarize guidelines on self-care and clinical management of persons with laryngectomy during the COVID-19 pandemic. Articles published in electronic databases-PubMed, Scopus, Web of Science, and CINHAL with the compliant keywords-were scouted from December 2019 to November 2020. All original articles, letters to editors, reviews, and consensus statements were reviewed and included. In all, 20 articles that had information pertaining to self-care of persons with laryngectomy or guidelines for","2021","07","01","Support Care Cancer","Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer","Alaryngeal speakers; COVID-19; Corona Virus; Laryngectomy; SARS-COV-2; Tracheoesophageal speakers","Rajashekhar","Bellur","Department of Speech and Hearing, Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal, 576104, India",NA
"2144","34181043","10.1007/s00134-021-06466-3","Differential effects of prone position in COVID-19-related ARDS in low and high recruiters.",NA,"2021","07","01","Intensive Care Med","Intensive care medicine",NA,"Cour","Martin","Service de Médecine Intensive-Réanimation, Hospices Civils de Lyon, Hôpital Edouard Herriot, 5, place d'Arsonval, Cedex 03, 69437, Lyon, France. martin.cour@chu-lyon",NA
"2145","34181043","10.1007/s00134-021-06466-3","Differential effects of prone position in COVID-19-related ARDS in low and high recruiters.",NA,"2021","07","01","Intensive Care Med","Intensive care medicine",NA,"Bussy","David","Service de Médecine Intensive-Réanimation, Hospices Civils de Lyon, Hôpital Edouard Herriot, 5, place d'Arsonval, Cedex 03, 69437, Lyon, France",NA
"2146","34181043","10.1007/s00134-021-06466-3","Differential effects of prone position in COVID-19-related ARDS in low and high recruiters.",NA,"2021","07","01","Intensive Care Med","Intensive care medicine",NA,"Stevic","Neven","Service de Médecine Intensive-Réanimation, Hospices Civils de Lyon, Hôpital Edouard Herriot, 5, place d'Arsonval, Cedex 03, 69437, Lyon, France",NA
"2147","34181043","10.1007/s00134-021-06466-3","Differential effects of prone position in COVID-19-related ARDS in low and high recruiters.",NA,"2021","07","01","Intensive Care Med","Intensive care medicine",NA,"Argaud","Laurent","Service de Médecine Intensive-Réanimation, Hospices Civils de Lyon, Hôpital Edouard Herriot, 5, place d'Arsonval, Cedex 03, 69437, Lyon, France",NA
"2148","34181043","10.1007/s00134-021-06466-3","Differential effects of prone position in COVID-19-related ARDS in low and high recruiters.",NA,"2021","07","01","Intensive Care Med","Intensive care medicine",NA,"Guérin","Claude","Service de Médecine Intensive-Réanimation, Hospices Civils de Lyon, Hôpital Edouard Herriot, 5, place d'Arsonval, Cedex 03, 69437, Lyon, France",NA
"2149","34181023","10.1093/qjmed/hcab176","COVID-19 associated Rhino-orbital Mucormycosis: a Single Centre Experience of Ten Cases.",NA,"2021","06","28","QJM","QJM : monthly journal of the Association of Physicians",NA,"Arjun","Rajalakshmi","Senior Consultant, Infectious Diseases, KIMSHEALTH, Thiruvananthapuram, Kerala, India",NA
"2150","34181023","10.1093/qjmed/hcab176","COVID-19 associated Rhino-orbital Mucormycosis: a Single Centre Experience of Ten Cases.",NA,"2021","06","28","QJM","QJM : monthly journal of the Association of Physicians",NA,"Felix","Vinod","Consultant in Rhinology and Skull Base Surgery, Department of Otorhinolaryngology, KIMSHEALTH, Thiruvananthapuram, Kerala, India",NA
"2151","34181023","10.1093/qjmed/hcab176","COVID-19 associated Rhino-orbital Mucormycosis: a Single Centre Experience of Ten Cases.",NA,"2021","06","28","QJM","QJM : monthly journal of the Association of Physicians",NA,"Niyas","Vettakkara Kandy Muhammed","Associate Consultant, Infectious Diseases, KIMSHEALTH, Thiruvananthapuram, Kerala, India",NA
"2152","34181023","10.1093/qjmed/hcab176","COVID-19 associated Rhino-orbital Mucormycosis: a Single Centre Experience of Ten Cases.",NA,"2021","06","28","QJM","QJM : monthly journal of the Association of Physicians",NA,"Kumar","Madaswamy Achary Suresh","Senior Consultant, ENT and Laryngology, Department of Otorhinolaryngology, KIMSHEALTH, Thiruvananthapuram, Kerala, India",NA
"2153","34181023","10.1093/qjmed/hcab176","COVID-19 associated Rhino-orbital Mucormycosis: a Single Centre Experience of Ten Cases.",NA,"2021","06","28","QJM","QJM : monthly journal of the Association of Physicians",NA,"Krishnan","Ragitha Binu","Consultant in Laryngology, Department of Otorhinolaryngology, KIMSHEALTH, Thiruvananthapuram, Kerala, India",NA
"2154","34181023","10.1093/qjmed/hcab176","COVID-19 associated Rhino-orbital Mucormycosis: a Single Centre Experience of Ten Cases.",NA,"2021","06","28","QJM","QJM : monthly journal of the Association of Physicians",NA,"Mohan","Viji","Senior Registrar, Department of Microbiology, KIMSHEALTH, Thiruvananthapuram, Kerala, India",NA
"2155","34181023","10.1093/qjmed/hcab176","COVID-19 associated Rhino-orbital Mucormycosis: a Single Centre Experience of Ten Cases.",NA,"2021","06","28","QJM","QJM : monthly journal of the Association of Physicians",NA,"Ansar","Aneesa","Senior Registrar, Department of Otorhinolaryngology, KIMSHEALTH, Thiruvananthapuram, Kerala, India",NA
"2156","34181023","10.1093/qjmed/hcab176","COVID-19 associated Rhino-orbital Mucormycosis: a Single Centre Experience of Ten Cases.",NA,"2021","06","28","QJM","QJM : monthly journal of the Association of Physicians",NA,"Gautaam","Shivram","Resident, Department of Otorhinolaryngology, KIMSHEALTH, Thiruvananthapuram, Kerala, India",NA
"2157","34181023","10.1093/qjmed/hcab176","COVID-19 associated Rhino-orbital Mucormycosis: a Single Centre Experience of Ten Cases.",NA,"2021","06","28","QJM","QJM : monthly journal of the Association of Physicians",NA,"Lalitha","Sree","Resident, Department of Otorhinolaryngology, KIMSHEALTH, Thiruvananthapuram, Kerala, India",NA
"2158","34181021","10.1093/ibd/izab150","SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.",NA,"2021","06","28","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID19; IBD; SARS-CoV-2; influenza; vaccination","Walldorf","Jens","Martin Luther University of Halle-Wittenberg, Department of Internal Medicine I, Halle, Germany",NA
"2159","34181021","10.1093/ibd/izab150","SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.",NA,"2021","06","28","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID19; IBD; SARS-CoV-2; influenza; vaccination","von Arnim","Ulrike","Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital, Magdeburg, Germany",NA
"2160","34181021","10.1093/ibd/izab150","SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.",NA,"2021","06","28","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID19; IBD; SARS-CoV-2; influenza; vaccination","Schmelz","Renate","University Hospital Dresden, Department of Internal Medicine I, TU Dresden, Germany",NA
"2161","34181021","10.1093/ibd/izab150","SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.",NA,"2021","06","28","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID19; IBD; SARS-CoV-2; influenza; vaccination","Riesner-Wehner","Anica","Martin Luther University of Halle-Wittenberg, Department of Internal Medicine I, Halle, Germany",NA
"2162","34181021","10.1093/ibd/izab150","SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.",NA,"2021","06","28","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID19; IBD; SARS-CoV-2; influenza; vaccination","Michl","Patrick","Martin Luther University of Halle-Wittenberg, Department of Internal Medicine I, Halle, Germany",NA
"2163","34181021","10.1093/ibd/izab150","SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.",NA,"2021","06","28","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID19; IBD; SARS-CoV-2; influenza; vaccination","Grunert","Philip C","Jena University Hospital, Department of Internal Medicine IV, Jena, Germany",NA
"2164","34181021","10.1093/ibd/izab150","SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.",NA,"2021","06","28","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID19; IBD; SARS-CoV-2; influenza; vaccination","Stallmach","Andreas","Jena University Hospital, Department of Internal Medicine IV, Jena, Germany",NA
"2165","34181021","10.1093/ibd/izab150","SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.",NA,"2021","06","28","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID19; IBD; SARS-CoV-2; influenza; vaccination","Teich","Niels","Internistische Gemeinschaftspraxis für Verdauungs-und Stoffwechselkrankheiten Leipzig und Schkeuditz, Leipzig, Germany",NA
"2166","34181021","10.1093/ibd/izab150","SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.",NA,"2021","06","28","Inflamm Bowel Dis","Inflammatory bowel diseases","COVID19; IBD; SARS-CoV-2; influenza; vaccination","Reuken","Philipp A","Jena University Hospital, Department of Internal Medicine IV, Jena, Germany",NA
"2167","34181016","10.1001/jamanetworkopen.2021.14866","Assessment of Mental Health of High School Students During Social Distancing and Remote Schooling During the COVID-19 Pandemic in Austria.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Adolescent; Austria; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Mental Disorders; Patient Health Questionnaire; Quarantine; Young Adult","Pieh","Christoph","Department for Psychotherapy and Biopsychosocial Health, Danube University, Krems, Austria",NA
"2168","34181016","10.1001/jamanetworkopen.2021.14866","Assessment of Mental Health of High School Students During Social Distancing and Remote Schooling During the COVID-19 Pandemic in Austria.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Adolescent; Austria; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Mental Disorders; Patient Health Questionnaire; Quarantine; Young Adult","Plener","Paul L","Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria",NA
"2169","34181016","10.1001/jamanetworkopen.2021.14866","Assessment of Mental Health of High School Students During Social Distancing and Remote Schooling During the COVID-19 Pandemic in Austria.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Adolescent; Austria; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Mental Disorders; Patient Health Questionnaire; Quarantine; Young Adult","Probst","Thomas","Department for Psychotherapy and Biopsychosocial Health, Danube University, Krems, Austria",NA
"2170","34181016","10.1001/jamanetworkopen.2021.14866","Assessment of Mental Health of High School Students During Social Distancing and Remote Schooling During the COVID-19 Pandemic in Austria.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Adolescent; Austria; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Mental Disorders; Patient Health Questionnaire; Quarantine; Young Adult","Dale","Rachel","Department for Psychotherapy and Biopsychosocial Health, Danube University, Krems, Austria",NA
"2171","34181016","10.1001/jamanetworkopen.2021.14866","Assessment of Mental Health of High School Students During Social Distancing and Remote Schooling During the COVID-19 Pandemic in Austria.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","Adolescent; Austria; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Mental Disorders; Patient Health Questionnaire; Quarantine; Young Adult","Humer","Elke","Department for Psychotherapy and Biopsychosocial Health, Danube University, Krems, Austria",NA
"2172","34181015","10.1001/jamanetworkopen.2021.15973","Trends in Respiratory Virus Infections During the COVID-19 Pandemic in Singapore, 2020.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","COVID-19; Humans; Respiratory Tract Infections; Singapore","Wan","Wei Yee","Department of Microbiology, Singapore General Hospital, Singapore",NA
"2173","34181015","10.1001/jamanetworkopen.2021.15973","Trends in Respiratory Virus Infections During the COVID-19 Pandemic in Singapore, 2020.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","COVID-19; Humans; Respiratory Tract Infections; Singapore","Thoon","Koh Cheng","Infectious Disease Service, Department of Paediatric Medicine, KK Women's and Children's Hospital, Singapore",NA
"2174","34181015","10.1001/jamanetworkopen.2021.15973","Trends in Respiratory Virus Infections During the COVID-19 Pandemic in Singapore, 2020.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","COVID-19; Humans; Respiratory Tract Infections; Singapore","Loo","Liat Hui","Duke-National University of Singapore Graduate Medical School, Singapore",NA
"2175","34181015","10.1001/jamanetworkopen.2021.15973","Trends in Respiratory Virus Infections During the COVID-19 Pandemic in Singapore, 2020.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","COVID-19; Humans; Respiratory Tract Infections; Singapore","Chan","Kian Sing","Department of Molecular Pathology, Singapore General Hospital, Singapore",NA
"2176","34181015","10.1001/jamanetworkopen.2021.15973","Trends in Respiratory Virus Infections During the COVID-19 Pandemic in Singapore, 2020.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","COVID-19; Humans; Respiratory Tract Infections; Singapore","Oon","Lynette L E","Duke-National University of Singapore Graduate Medical School, Singapore",NA
"2177","34181015","10.1001/jamanetworkopen.2021.15973","Trends in Respiratory Virus Infections During the COVID-19 Pandemic in Singapore, 2020.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","COVID-19; Humans; Respiratory Tract Infections; Singapore","Ramasamy","Adaikalavan","Genome Institute of Singapore, Agency for Science, Technology, and Research (A*STAR), Singapore",NA
"2178","34181015","10.1001/jamanetworkopen.2021.15973","Trends in Respiratory Virus Infections During the COVID-19 Pandemic in Singapore, 2020.",NA,"2021","07","05","JAMA Netw Open","JAMA network open","COVID-19; Humans; Respiratory Tract Infections; Singapore","Maiwald","Matthias","Duke-National University of Singapore Graduate Medical School, Singapore",NA
"2179","34181008","10.1093/pm/pnab179","The Relationship between Neighborhood Deprivation and Perceived Changes for Pain-Related Experiences among U.S. Patients with Chronic Low Back Pain during the COVID-19 Pandemic.","Disruptions caused by the COVID-19 pandemic could disproportionately affect the health of vulnerable populations, including patients experiencing persistent health conditions (i.e., chronic pain), along with populations living within deprived, lower socioeconomic areas. The current cross-sectional study characterized relationships between neighborhood deprivation and perceived changes in pain-related experiences during the COVID-19 pandemic (early-September to mid-October 2020) for adult patient","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19 pandemic; Chronic low back pain; Disparities; Neighborhood deprivation; Pain management","Rassu","Fenan S","Department of Physical Medicine and Rehabilitation, The Johns Hopkins University School of Medicine, Baltimore, MD, USA",NA
"2180","34181008","10.1093/pm/pnab179","The Relationship between Neighborhood Deprivation and Perceived Changes for Pain-Related Experiences among U.S. Patients with Chronic Low Back Pain during the COVID-19 Pandemic.","Disruptions caused by the COVID-19 pandemic could disproportionately affect the health of vulnerable populations, including patients experiencing persistent health conditions (i.e., chronic pain), along with populations living within deprived, lower socioeconomic areas. The current cross-sectional study characterized relationships between neighborhood deprivation and perceived changes in pain-related experiences during the COVID-19 pandemic (early-September to mid-October 2020) for adult patient","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19 pandemic; Chronic low back pain; Disparities; Neighborhood deprivation; Pain management","McFadden","Molly","Division of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA",NA
"2181","34181008","10.1093/pm/pnab179","The Relationship between Neighborhood Deprivation and Perceived Changes for Pain-Related Experiences among U.S. Patients with Chronic Low Back Pain during the COVID-19 Pandemic.","Disruptions caused by the COVID-19 pandemic could disproportionately affect the health of vulnerable populations, including patients experiencing persistent health conditions (i.e., chronic pain), along with populations living within deprived, lower socioeconomic areas. The current cross-sectional study characterized relationships between neighborhood deprivation and perceived changes in pain-related experiences during the COVID-19 pandemic (early-September to mid-October 2020) for adult patient","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19 pandemic; Chronic low back pain; Disparities; Neighborhood deprivation; Pain management","Aaron","Rachel V","Department of Physical Medicine and Rehabilitation, The Johns Hopkins University School of Medicine, Baltimore, MD, USA",NA
"2182","34181008","10.1093/pm/pnab179","The Relationship between Neighborhood Deprivation and Perceived Changes for Pain-Related Experiences among U.S. Patients with Chronic Low Back Pain during the COVID-19 Pandemic.","Disruptions caused by the COVID-19 pandemic could disproportionately affect the health of vulnerable populations, including patients experiencing persistent health conditions (i.e., chronic pain), along with populations living within deprived, lower socioeconomic areas. The current cross-sectional study characterized relationships between neighborhood deprivation and perceived changes in pain-related experiences during the COVID-19 pandemic (early-September to mid-October 2020) for adult patient","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19 pandemic; Chronic low back pain; Disparities; Neighborhood deprivation; Pain management","Wegener","Stephen T","Department of Physical Medicine and Rehabilitation, The Johns Hopkins University School of Medicine, Baltimore, MD, USA",NA
"2183","34181008","10.1093/pm/pnab179","The Relationship between Neighborhood Deprivation and Perceived Changes for Pain-Related Experiences among U.S. Patients with Chronic Low Back Pain during the COVID-19 Pandemic.","Disruptions caused by the COVID-19 pandemic could disproportionately affect the health of vulnerable populations, including patients experiencing persistent health conditions (i.e., chronic pain), along with populations living within deprived, lower socioeconomic areas. The current cross-sectional study characterized relationships between neighborhood deprivation and perceived changes in pain-related experiences during the COVID-19 pandemic (early-September to mid-October 2020) for adult patient","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19 pandemic; Chronic low back pain; Disparities; Neighborhood deprivation; Pain management","Ephraim","Patti L","Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"2184","34181008","10.1093/pm/pnab179","The Relationship between Neighborhood Deprivation and Perceived Changes for Pain-Related Experiences among U.S. Patients with Chronic Low Back Pain during the COVID-19 Pandemic.","Disruptions caused by the COVID-19 pandemic could disproportionately affect the health of vulnerable populations, including patients experiencing persistent health conditions (i.e., chronic pain), along with populations living within deprived, lower socioeconomic areas. The current cross-sectional study characterized relationships between neighborhood deprivation and perceived changes in pain-related experiences during the COVID-19 pandemic (early-September to mid-October 2020) for adult patient","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19 pandemic; Chronic low back pain; Disparities; Neighborhood deprivation; Pain management","Lane","Elizabeth","Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, UT, USA",NA
"2185","34181008","10.1093/pm/pnab179","The Relationship between Neighborhood Deprivation and Perceived Changes for Pain-Related Experiences among U.S. Patients with Chronic Low Back Pain during the COVID-19 Pandemic.","Disruptions caused by the COVID-19 pandemic could disproportionately affect the health of vulnerable populations, including patients experiencing persistent health conditions (i.e., chronic pain), along with populations living within deprived, lower socioeconomic areas. The current cross-sectional study characterized relationships between neighborhood deprivation and perceived changes in pain-related experiences during the COVID-19 pandemic (early-September to mid-October 2020) for adult patient","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19 pandemic; Chronic low back pain; Disparities; Neighborhood deprivation; Pain management","Brennan","Gerard","Rehabilitation Services, Intermountain Healthcare, Salt Lake City, UT, USA",NA
"2186","34181008","10.1093/pm/pnab179","The Relationship between Neighborhood Deprivation and Perceived Changes for Pain-Related Experiences among U.S. Patients with Chronic Low Back Pain during the COVID-19 Pandemic.","Disruptions caused by the COVID-19 pandemic could disproportionately affect the health of vulnerable populations, including patients experiencing persistent health conditions (i.e., chronic pain), along with populations living within deprived, lower socioeconomic areas. The current cross-sectional study characterized relationships between neighborhood deprivation and perceived changes in pain-related experiences during the COVID-19 pandemic (early-September to mid-October 2020) for adult patient","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19 pandemic; Chronic low back pain; Disparities; Neighborhood deprivation; Pain management","Minick","Kate I","Rehabilitation Services, Intermountain Healthcare, Salt Lake City, UT, USA",NA
"2187","34181008","10.1093/pm/pnab179","The Relationship between Neighborhood Deprivation and Perceived Changes for Pain-Related Experiences among U.S. Patients with Chronic Low Back Pain during the COVID-19 Pandemic.","Disruptions caused by the COVID-19 pandemic could disproportionately affect the health of vulnerable populations, including patients experiencing persistent health conditions (i.e., chronic pain), along with populations living within deprived, lower socioeconomic areas. The current cross-sectional study characterized relationships between neighborhood deprivation and perceived changes in pain-related experiences during the COVID-19 pandemic (early-September to mid-October 2020) for adult patient","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19 pandemic; Chronic low back pain; Disparities; Neighborhood deprivation; Pain management","Fritz","Julie M","Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, UT, USA",NA
"2188","34181008","10.1093/pm/pnab179","The Relationship between Neighborhood Deprivation and Perceived Changes for Pain-Related Experiences among U.S. Patients with Chronic Low Back Pain during the COVID-19 Pandemic.","Disruptions caused by the COVID-19 pandemic could disproportionately affect the health of vulnerable populations, including patients experiencing persistent health conditions (i.e., chronic pain), along with populations living within deprived, lower socioeconomic areas. The current cross-sectional study characterized relationships between neighborhood deprivation and perceived changes in pain-related experiences during the COVID-19 pandemic (early-September to mid-October 2020) for adult patient","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19 pandemic; Chronic low back pain; Disparities; Neighborhood deprivation; Pain management","Skolasky","Richard L","Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA",NA
"2189","34181002","10.1093/pm/pnab202","MIGRAINE MONITORING IN THE TIME OF COVID-19: TRIGGERS AND PROTECTORS DURING A PANDEMIC.","Aim of the present observational study was to assess the impact of COVID-19 quarantine on migraine and evaluate potential influencing factors. Previous studies reported mixed results regarding clinical outcome during quarantine in patients with migraine. In particular, data from areas strongly affetcted by COVID-19 pandemic are missing. One-hundred and seventy patients, previously assessed at the Headache Centre - ASST Spedali Civili Brescia, underwent a telephonic interview regarding migraine f","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; SARS-CoV-2; chronic migraine; daily hassle; migraine triggers; quarantine","di Cola","Francesca Schiano","Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy",NA
"2190","34181002","10.1093/pm/pnab202","MIGRAINE MONITORING IN THE TIME OF COVID-19: TRIGGERS AND PROTECTORS DURING A PANDEMIC.","Aim of the present observational study was to assess the impact of COVID-19 quarantine on migraine and evaluate potential influencing factors. Previous studies reported mixed results regarding clinical outcome during quarantine in patients with migraine. In particular, data from areas strongly affetcted by COVID-19 pandemic are missing. One-hundred and seventy patients, previously assessed at the Headache Centre - ASST Spedali Civili Brescia, underwent a telephonic interview regarding migraine f","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; SARS-CoV-2; chronic migraine; daily hassle; migraine triggers; quarantine","Caratozzolo","Salvatore","Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy",NA
"2191","34181002","10.1093/pm/pnab202","MIGRAINE MONITORING IN THE TIME OF COVID-19: TRIGGERS AND PROTECTORS DURING A PANDEMIC.","Aim of the present observational study was to assess the impact of COVID-19 quarantine on migraine and evaluate potential influencing factors. Previous studies reported mixed results regarding clinical outcome during quarantine in patients with migraine. In particular, data from areas strongly affetcted by COVID-19 pandemic are missing. One-hundred and seventy patients, previously assessed at the Headache Centre - ASST Spedali Civili Brescia, underwent a telephonic interview regarding migraine f","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; SARS-CoV-2; chronic migraine; daily hassle; migraine triggers; quarantine","Di Cesare","Marco","Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy",NA
"2192","34181002","10.1093/pm/pnab202","MIGRAINE MONITORING IN THE TIME OF COVID-19: TRIGGERS AND PROTECTORS DURING A PANDEMIC.","Aim of the present observational study was to assess the impact of COVID-19 quarantine on migraine and evaluate potential influencing factors. Previous studies reported mixed results regarding clinical outcome during quarantine in patients with migraine. In particular, data from areas strongly affetcted by COVID-19 pandemic are missing. One-hundred and seventy patients, previously assessed at the Headache Centre - ASST Spedali Civili Brescia, underwent a telephonic interview regarding migraine f","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; SARS-CoV-2; chronic migraine; daily hassle; migraine triggers; quarantine","Liberini","Paolo","Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy",NA
"2193","34181002","10.1093/pm/pnab202","MIGRAINE MONITORING IN THE TIME OF COVID-19: TRIGGERS AND PROTECTORS DURING A PANDEMIC.","Aim of the present observational study was to assess the impact of COVID-19 quarantine on migraine and evaluate potential influencing factors. Previous studies reported mixed results regarding clinical outcome during quarantine in patients with migraine. In particular, data from areas strongly affetcted by COVID-19 pandemic are missing. One-hundred and seventy patients, previously assessed at the Headache Centre - ASST Spedali Civili Brescia, underwent a telephonic interview regarding migraine f","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; SARS-CoV-2; chronic migraine; daily hassle; migraine triggers; quarantine","Rao","Renata","Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy",NA
"2194","34181002","10.1093/pm/pnab202","MIGRAINE MONITORING IN THE TIME OF COVID-19: TRIGGERS AND PROTECTORS DURING A PANDEMIC.","Aim of the present observational study was to assess the impact of COVID-19 quarantine on migraine and evaluate potential influencing factors. Previous studies reported mixed results regarding clinical outcome during quarantine in patients with migraine. In particular, data from areas strongly affetcted by COVID-19 pandemic are missing. One-hundred and seventy patients, previously assessed at the Headache Centre - ASST Spedali Civili Brescia, underwent a telephonic interview regarding migraine f","2021","06","28","Pain Med","Pain medicine (Malden, Mass.)","COVID-19; SARS-CoV-2; chronic migraine; daily hassle; migraine triggers; quarantine","Padovani","Alessandro","Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy",NA
"2195","34181001","10.1093/jnci/djab122","Association of the COVID-19 Pandemic with Patterns of Statewide Cancer Services.","The coronavirus disease 2019 (COVID-19) pandemic led to delayed medical care in the US. We examined changes in patterns of cancer diagnosis and surgical treatment between January 1 and December 31 in 2020 and 2019 with real-time electronic pathology report data from population-based Surveillance, Epidemiology, and End Results cancer registries from Georgia and Louisiana. During 2020, there were 29,905 fewer pathology reports than in 2019, representing a 10.2% decline. Declines were observed in a","2021","06","28","J Natl Cancer Inst","Journal of the National Cancer Institute","COVID-19; cancer; neoplasms; pathology","Yabroff","K Robin","Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA",NA
"2196","34181001","10.1093/jnci/djab122","Association of the COVID-19 Pandemic with Patterns of Statewide Cancer Services.","The coronavirus disease 2019 (COVID-19) pandemic led to delayed medical care in the US. We examined changes in patterns of cancer diagnosis and surgical treatment between January 1 and December 31 in 2020 and 2019 with real-time electronic pathology report data from population-based Surveillance, Epidemiology, and End Results cancer registries from Georgia and Louisiana. During 2020, there were 29,905 fewer pathology reports than in 2019, representing a 10.2% decline. Declines were observed in a","2021","06","28","J Natl Cancer Inst","Journal of the National Cancer Institute","COVID-19; cancer; neoplasms; pathology","Wu","Xiao-Cheng","Louisiana State University Health Sciences Center, School of Public Health, New Orleans, LA",NA
"2197","34181001","10.1093/jnci/djab122","Association of the COVID-19 Pandemic with Patterns of Statewide Cancer Services.","The coronavirus disease 2019 (COVID-19) pandemic led to delayed medical care in the US. We examined changes in patterns of cancer diagnosis and surgical treatment between January 1 and December 31 in 2020 and 2019 with real-time electronic pathology report data from population-based Surveillance, Epidemiology, and End Results cancer registries from Georgia and Louisiana. During 2020, there were 29,905 fewer pathology reports than in 2019, representing a 10.2% decline. Declines were observed in a","2021","06","28","J Natl Cancer Inst","Journal of the National Cancer Institute","COVID-19; cancer; neoplasms; pathology","Negoita","Serban","Surveillance Research Program, National Cancer Institute, Rockville, MD",NA
"2198","34181001","10.1093/jnci/djab122","Association of the COVID-19 Pandemic with Patterns of Statewide Cancer Services.","The coronavirus disease 2019 (COVID-19) pandemic led to delayed medical care in the US. We examined changes in patterns of cancer diagnosis and surgical treatment between January 1 and December 31 in 2020 and 2019 with real-time electronic pathology report data from population-based Surveillance, Epidemiology, and End Results cancer registries from Georgia and Louisiana. During 2020, there were 29,905 fewer pathology reports than in 2019, representing a 10.2% decline. Declines were observed in a","2021","06","28","J Natl Cancer Inst","Journal of the National Cancer Institute","COVID-19; cancer; neoplasms; pathology","Stevens","Jennifer","Information Management Services, Inc, Calverton, MD",NA
"2199","34181001","10.1093/jnci/djab122","Association of the COVID-19 Pandemic with Patterns of Statewide Cancer Services.","The coronavirus disease 2019 (COVID-19) pandemic led to delayed medical care in the US. We examined changes in patterns of cancer diagnosis and surgical treatment between January 1 and December 31 in 2020 and 2019 with real-time electronic pathology report data from population-based Surveillance, Epidemiology, and End Results cancer registries from Georgia and Louisiana. During 2020, there were 29,905 fewer pathology reports than in 2019, representing a 10.2% decline. Declines were observed in a","2021","06","28","J Natl Cancer Inst","Journal of the National Cancer Institute","COVID-19; cancer; neoplasms; pathology","Coyle","Linda","Information Management Services, Inc, Calverton, MD",NA
"2200","34181001","10.1093/jnci/djab122","Association of the COVID-19 Pandemic with Patterns of Statewide Cancer Services.","The coronavirus disease 2019 (COVID-19) pandemic led to delayed medical care in the US. We examined changes in patterns of cancer diagnosis and surgical treatment between January 1 and December 31 in 2020 and 2019 with real-time electronic pathology report data from population-based Surveillance, Epidemiology, and End Results cancer registries from Georgia and Louisiana. During 2020, there were 29,905 fewer pathology reports than in 2019, representing a 10.2% decline. Declines were observed in a","2021","06","28","J Natl Cancer Inst","Journal of the National Cancer Institute","COVID-19; cancer; neoplasms; pathology","Zhao","Jingxuan","Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA",NA
"2201","34181001","10.1093/jnci/djab122","Association of the COVID-19 Pandemic with Patterns of Statewide Cancer Services.","The coronavirus disease 2019 (COVID-19) pandemic led to delayed medical care in the US. We examined changes in patterns of cancer diagnosis and surgical treatment between January 1 and December 31 in 2020 and 2019 with real-time electronic pathology report data from population-based Surveillance, Epidemiology, and End Results cancer registries from Georgia and Louisiana. During 2020, there were 29,905 fewer pathology reports than in 2019, representing a 10.2% decline. Declines were observed in a","2021","06","28","J Natl Cancer Inst","Journal of the National Cancer Institute","COVID-19; cancer; neoplasms; pathology","Mumphrey","Brent J","Louisiana State University Health Sciences Center, School of Public Health, New Orleans, LA",NA
"2202","34181001","10.1093/jnci/djab122","Association of the COVID-19 Pandemic with Patterns of Statewide Cancer Services.","The coronavirus disease 2019 (COVID-19) pandemic led to delayed medical care in the US. We examined changes in patterns of cancer diagnosis and surgical treatment between January 1 and December 31 in 2020 and 2019 with real-time electronic pathology report data from population-based Surveillance, Epidemiology, and End Results cancer registries from Georgia and Louisiana. During 2020, there were 29,905 fewer pathology reports than in 2019, representing a 10.2% decline. Declines were observed in a","2021","06","28","J Natl Cancer Inst","Journal of the National Cancer Institute","COVID-19; cancer; neoplasms; pathology","Jemal","Ahmedin","Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA",NA
"2203","34181001","10.1093/jnci/djab122","Association of the COVID-19 Pandemic with Patterns of Statewide Cancer Services.","The coronavirus disease 2019 (COVID-19) pandemic led to delayed medical care in the US. We examined changes in patterns of cancer diagnosis and surgical treatment between January 1 and December 31 in 2020 and 2019 with real-time electronic pathology report data from population-based Surveillance, Epidemiology, and End Results cancer registries from Georgia and Louisiana. During 2020, there were 29,905 fewer pathology reports than in 2019, representing a 10.2% decline. Declines were observed in a","2021","06","28","J Natl Cancer Inst","Journal of the National Cancer Institute","COVID-19; cancer; neoplasms; pathology","Ward","Kevin C","Rollins School of Public Health, Emory University, Atlanta, GA",NA
"2205","34180981","10.1093/eurpub/ckab118","Cumulated burden of Covid-19 in Spain from a Bayesian perspective.","The main goal of this work is to estimate the actual number of cases of Covid-19 in Spain in the period 01-31-2020/06-01-2020 by Autonomous Communities. Based on these estimates, this work allows us to accurately re-estimate the lethality of the disease in Spain, taking into account unreported cases. A hierarchical Bayesian model recently proposed in the literature has been adapted to model the actual number of Covid-19 cases in Spain. The results of this work show that the real load of Covid-19","2021","06","28","Eur J Public Health","European journal of public health","Bayesian methods; Covid-19; infections; public health; underreporting","Moriña","David","Department of Econometrics, Statistics and Applied Economics, Riskcenter-IREA, Universitat de Barcelona (UB), Barcelona, Spain",NA
"2206","34180981","10.1093/eurpub/ckab118","Cumulated burden of Covid-19 in Spain from a Bayesian perspective.","The main goal of this work is to estimate the actual number of cases of Covid-19 in Spain in the period 01-31-2020/06-01-2020 by Autonomous Communities. Based on these estimates, this work allows us to accurately re-estimate the lethality of the disease in Spain, taking into account unreported cases. A hierarchical Bayesian model recently proposed in the literature has been adapted to model the actual number of Covid-19 cases in Spain. The results of this work show that the real load of Covid-19","2021","06","28","Eur J Public Health","European journal of public health","Bayesian methods; Covid-19; infections; public health; underreporting","Fernández-Fontelo","Amanda","Chair of Statistics, School of Business and Economics, Humboldt-Universität zu Berlin, Berlin, Germany",NA
"2207","34180981","10.1093/eurpub/ckab118","Cumulated burden of Covid-19 in Spain from a Bayesian perspective.","The main goal of this work is to estimate the actual number of cases of Covid-19 in Spain in the period 01-31-2020/06-01-2020 by Autonomous Communities. Based on these estimates, this work allows us to accurately re-estimate the lethality of the disease in Spain, taking into account unreported cases. A hierarchical Bayesian model recently proposed in the literature has been adapted to model the actual number of Covid-19 cases in Spain. The results of this work show that the real load of Covid-19","2021","06","28","Eur J Public Health","European journal of public health","Bayesian methods; Covid-19; infections; public health; underreporting","Cabaña","Alejandra","Centre de Recerca Matemàtica (CRM, Barcelona Graduate School of Mathematics (BGSMath), Departament de Matemàtiques, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès, Spain)",NA
"2208","34180981","10.1093/eurpub/ckab118","Cumulated burden of Covid-19 in Spain from a Bayesian perspective.","The main goal of this work is to estimate the actual number of cases of Covid-19 in Spain in the period 01-31-2020/06-01-2020 by Autonomous Communities. Based on these estimates, this work allows us to accurately re-estimate the lethality of the disease in Spain, taking into account unreported cases. A hierarchical Bayesian model recently proposed in the literature has been adapted to model the actual number of Covid-19 cases in Spain. The results of this work show that the real load of Covid-19","2021","06","28","Eur J Public Health","European journal of public health","Bayesian methods; Covid-19; infections; public health; underreporting","Arratia","Argimiro","Department of Computer Science, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain",NA
"2209","34180981","10.1093/eurpub/ckab118","Cumulated burden of Covid-19 in Spain from a Bayesian perspective.","The main goal of this work is to estimate the actual number of cases of Covid-19 in Spain in the period 01-31-2020/06-01-2020 by Autonomous Communities. Based on these estimates, this work allows us to accurately re-estimate the lethality of the disease in Spain, taking into account unreported cases. A hierarchical Bayesian model recently proposed in the literature has been adapted to model the actual number of Covid-19 cases in Spain. The results of this work show that the real load of Covid-19","2021","06","28","Eur J Public Health","European journal of public health","Bayesian methods; Covid-19; infections; public health; underreporting","Ávalos","Gustavo","Department of Computer Science, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain",NA
"2210","34180981","10.1093/eurpub/ckab118","Cumulated burden of Covid-19 in Spain from a Bayesian perspective.","The main goal of this work is to estimate the actual number of cases of Covid-19 in Spain in the period 01-31-2020/06-01-2020 by Autonomous Communities. Based on these estimates, this work allows us to accurately re-estimate the lethality of the disease in Spain, taking into account unreported cases. A hierarchical Bayesian model recently proposed in the literature has been adapted to model the actual number of Covid-19 cases in Spain. The results of this work show that the real load of Covid-19","2021","06","28","Eur J Public Health","European journal of public health","Bayesian methods; Covid-19; infections; public health; underreporting","Puig","Pedro","Centre de Recerca Matemàtica (CRM, Barcelona Graduate School of Mathematics (BGSMath), Departament de Matemàtiques, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès, Spain)",NA
"2211","34180975","10.1001/jamapediatrics.2021.1485","Return to Play After COVID-19 Infection in Children.",NA,"2021","06","28","JAMA Pediatr","JAMA pediatrics",NA,"Thompson","Lindsay A","Department of Pediatrics, University of Florida College of Medicine, Gainesville",NA
"2212","34180975","10.1001/jamapediatrics.2021.1485","Return to Play After COVID-19 Infection in Children.",NA,"2021","06","28","JAMA Pediatr","JAMA pediatrics",NA,"Kelly","Maria N","Department of Pediatrics, University of Florida College of Medicine, Gainesville",NA
"2213","34180960","10.1093/aje/kwab185","COVID-19 Policy Impact Evaluation: A guide to common design issues.","Policy responses to COVID-19, particularly those related to non-pharmaceutical interventions, are unprecedented in scale and scope. However, policy impact evaluations require a complex combination of circumstance, study design, data, statistics, and analysis. Beyond the issues that are faced for any policy, evaluation of COVID-19 policies is complicated by additional challenges related to infectious disease dynamics and a multiplicity of interventions. The methods needed for policy-level impact ","2021","06","28","Am J Epidemiol","American journal of epidemiology","COVID-19; difference-in-differences; impact evaluation; interrupted time-series; non-pharmaceutical interventions; policy","Haber","Noah A","Meta-Research Innovation Center at Stanford University (METRICS), Stanford University, Stanford, CA, USA",NA
"2214","34180960","10.1093/aje/kwab185","COVID-19 Policy Impact Evaluation: A guide to common design issues.","Policy responses to COVID-19, particularly those related to non-pharmaceutical interventions, are unprecedented in scale and scope. However, policy impact evaluations require a complex combination of circumstance, study design, data, statistics, and analysis. Beyond the issues that are faced for any policy, evaluation of COVID-19 policies is complicated by additional challenges related to infectious disease dynamics and a multiplicity of interventions. The methods needed for policy-level impact ","2021","06","28","Am J Epidemiol","American journal of epidemiology","COVID-19; difference-in-differences; impact evaluation; interrupted time-series; non-pharmaceutical interventions; policy","Clarke-Deelder","Emma","Department of Global Health &amp",NA
"2215","34180960","10.1093/aje/kwab185","COVID-19 Policy Impact Evaluation: A guide to common design issues.","Policy responses to COVID-19, particularly those related to non-pharmaceutical interventions, are unprecedented in scale and scope. However, policy impact evaluations require a complex combination of circumstance, study design, data, statistics, and analysis. Beyond the issues that are faced for any policy, evaluation of COVID-19 policies is complicated by additional challenges related to infectious disease dynamics and a multiplicity of interventions. The methods needed for policy-level impact ","2021","06","28","Am J Epidemiol","American journal of epidemiology","COVID-19; difference-in-differences; impact evaluation; interrupted time-series; non-pharmaceutical interventions; policy","Salomon","Joshua A","Department of Medicine, Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford, CA, USA",NA
"2216","34180960","10.1093/aje/kwab185","COVID-19 Policy Impact Evaluation: A guide to common design issues.","Policy responses to COVID-19, particularly those related to non-pharmaceutical interventions, are unprecedented in scale and scope. However, policy impact evaluations require a complex combination of circumstance, study design, data, statistics, and analysis. Beyond the issues that are faced for any policy, evaluation of COVID-19 policies is complicated by additional challenges related to infectious disease dynamics and a multiplicity of interventions. The methods needed for policy-level impact ","2021","06","28","Am J Epidemiol","American journal of epidemiology","COVID-19; difference-in-differences; impact evaluation; interrupted time-series; non-pharmaceutical interventions; policy","Feller","Avi","Goldman School of Public Policy, University of California, Berkeley, CA, USA",NA
"2217","34180960","10.1093/aje/kwab185","COVID-19 Policy Impact Evaluation: A guide to common design issues.","Policy responses to COVID-19, particularly those related to non-pharmaceutical interventions, are unprecedented in scale and scope. However, policy impact evaluations require a complex combination of circumstance, study design, data, statistics, and analysis. Beyond the issues that are faced for any policy, evaluation of COVID-19 policies is complicated by additional challenges related to infectious disease dynamics and a multiplicity of interventions. The methods needed for policy-level impact ","2021","06","28","Am J Epidemiol","American journal of epidemiology","COVID-19; difference-in-differences; impact evaluation; interrupted time-series; non-pharmaceutical interventions; policy","Stuart","Elizabeth A","Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA",NA
"2218","34180913","10.1702/3634.36148","[Cultural meta-analysis 2: the after Covid-19].",". Cultural meta-analysis 2: the after Covid-19. Against the background of the promises-expectations of an ethically and ecologically renewed and resilient world (declared needed to compensate and to avoid the repetition of the pandemic tragedy), the same methodology proposed in the heart of the Covid scenario has been applied: a cultural metanalysis - transversal through and comprehensive of the various points of view which have had ( and seem to have) an important role for a period defined as '","2021","07","08","Assist Inferm Ric","Assistenza infermieristica e ricerca : AIR","COVID-19; Culture; Forecasting; Humans; Meta-Analysis as Topic","Tognoni","Gianni",NA,NA
"2219","34180911","10.1702/3634.36146","[Domestic violence in Val Camonica: survey on the accesses to the emergency deparment in the period post Covid-19].",". Domestic violence in Val Camonica: survey on the accesses to the emergency deparment in the period post Covid-19. The lock-down due to COVID-19 has caused hard times to everybody, but especially for women victim of domestic violence, locked up in their own home with violent partners. To describe how and to what extent the lockdown caused by the first wave of COVID-19 influenced the domestic violence in Val Camonica. Using the informatic system of the Esine Emergency Department, accesses for do","2021","07","08","Assist Inferm Ric","Assistenza infermieristica e ricerca : AIR","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Domestic Violence; Emergency Service, Hospital; Facilities and Services Utilization; Female; Humans; Italy; Male; Middle Aged; Quarantine; Time Factors; Young Adult","Delaidelli","Giada",NA,NA
"2220","34180911","10.1702/3634.36146","[Domestic violence in Val Camonica: survey on the accesses to the emergency deparment in the period post Covid-19].",". Domestic violence in Val Camonica: survey on the accesses to the emergency deparment in the period post Covid-19. The lock-down due to COVID-19 has caused hard times to everybody, but especially for women victim of domestic violence, locked up in their own home with violent partners. To describe how and to what extent the lockdown caused by the first wave of COVID-19 influenced the domestic violence in Val Camonica. Using the informatic system of the Esine Emergency Department, accesses for do","2021","07","08","Assist Inferm Ric","Assistenza infermieristica e ricerca : AIR","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Domestic Violence; Emergency Service, Hospital; Facilities and Services Utilization; Female; Humans; Italy; Male; Middle Aged; Quarantine; Time Factors; Young Adult","Georgiu","Alexandra",NA,NA
"2221","34180868","10.1097/JHQ.0000000000000305","Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.","The COVID-19 pandemic has caused over 1,250,000 deaths worldwide. With limited therapeutic options, proning nonintubated patients emerged as a safe and affordable intervention to manage hypoxemia. A proning protocol to identify and prone eligible patients was implemented. Patients were encouraged to self-prone for 2-3 hours, 3 times daily. Investigators created educational materials for nurses and patients and developed a COVID-19-specific proning order within the electronic health record (EHR).","2021","07","13","J Healthc Qual","Journal for healthcare quality : official publication of the National Association for Healthcare Quality","COVID-19; Humans; Hypoxia; Male; Pandemics; Patient Positioning; Prone Position; Retrospective Studies; SARS-CoV-2","D'Souza","Felicia R",NA,NA
"2222","34180868","10.1097/JHQ.0000000000000305","Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.","The COVID-19 pandemic has caused over 1,250,000 deaths worldwide. With limited therapeutic options, proning nonintubated patients emerged as a safe and affordable intervention to manage hypoxemia. A proning protocol to identify and prone eligible patients was implemented. Patients were encouraged to self-prone for 2-3 hours, 3 times daily. Investigators created educational materials for nurses and patients and developed a COVID-19-specific proning order within the electronic health record (EHR).","2021","07","13","J Healthc Qual","Journal for healthcare quality : official publication of the National Association for Healthcare Quality","COVID-19; Humans; Hypoxia; Male; Pandemics; Patient Positioning; Prone Position; Retrospective Studies; SARS-CoV-2","Murray","John P",NA,NA
"2223","34180868","10.1097/JHQ.0000000000000305","Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.","The COVID-19 pandemic has caused over 1,250,000 deaths worldwide. With limited therapeutic options, proning nonintubated patients emerged as a safe and affordable intervention to manage hypoxemia. A proning protocol to identify and prone eligible patients was implemented. Patients were encouraged to self-prone for 2-3 hours, 3 times daily. Investigators created educational materials for nurses and patients and developed a COVID-19-specific proning order within the electronic health record (EHR).","2021","07","13","J Healthc Qual","Journal for healthcare quality : official publication of the National Association for Healthcare Quality","COVID-19; Humans; Hypoxia; Male; Pandemics; Patient Positioning; Prone Position; Retrospective Studies; SARS-CoV-2","Tummala","Sandeep",NA,NA
"2224","34180868","10.1097/JHQ.0000000000000305","Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.","The COVID-19 pandemic has caused over 1,250,000 deaths worldwide. With limited therapeutic options, proning nonintubated patients emerged as a safe and affordable intervention to manage hypoxemia. A proning protocol to identify and prone eligible patients was implemented. Patients were encouraged to self-prone for 2-3 hours, 3 times daily. Investigators created educational materials for nurses and patients and developed a COVID-19-specific proning order within the electronic health record (EHR).","2021","07","13","J Healthc Qual","Journal for healthcare quality : official publication of the National Association for Healthcare Quality","COVID-19; Humans; Hypoxia; Male; Pandemics; Patient Positioning; Prone Position; Retrospective Studies; SARS-CoV-2","Puello","Frances",NA,NA
"2225","34180868","10.1097/JHQ.0000000000000305","Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.","The COVID-19 pandemic has caused over 1,250,000 deaths worldwide. With limited therapeutic options, proning nonintubated patients emerged as a safe and affordable intervention to manage hypoxemia. A proning protocol to identify and prone eligible patients was implemented. Patients were encouraged to self-prone for 2-3 hours, 3 times daily. Investigators created educational materials for nurses and patients and developed a COVID-19-specific proning order within the electronic health record (EHR).","2021","07","13","J Healthc Qual","Journal for healthcare quality : official publication of the National Association for Healthcare Quality","COVID-19; Humans; Hypoxia; Male; Pandemics; Patient Positioning; Prone Position; Retrospective Studies; SARS-CoV-2","Pavkovich","David S",NA,NA
"2226","34180868","10.1097/JHQ.0000000000000305","Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.","The COVID-19 pandemic has caused over 1,250,000 deaths worldwide. With limited therapeutic options, proning nonintubated patients emerged as a safe and affordable intervention to manage hypoxemia. A proning protocol to identify and prone eligible patients was implemented. Patients were encouraged to self-prone for 2-3 hours, 3 times daily. Investigators created educational materials for nurses and patients and developed a COVID-19-specific proning order within the electronic health record (EHR).","2021","07","13","J Healthc Qual","Journal for healthcare quality : official publication of the National Association for Healthcare Quality","COVID-19; Humans; Hypoxia; Male; Pandemics; Patient Positioning; Prone Position; Retrospective Studies; SARS-CoV-2","Ash","Daniel",NA,NA
"2227","34180868","10.1097/JHQ.0000000000000305","Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.","The COVID-19 pandemic has caused over 1,250,000 deaths worldwide. With limited therapeutic options, proning nonintubated patients emerged as a safe and affordable intervention to manage hypoxemia. A proning protocol to identify and prone eligible patients was implemented. Patients were encouraged to self-prone for 2-3 hours, 3 times daily. Investigators created educational materials for nurses and patients and developed a COVID-19-specific proning order within the electronic health record (EHR).","2021","07","13","J Healthc Qual","Journal for healthcare quality : official publication of the National Association for Healthcare Quality","COVID-19; Humans; Hypoxia; Male; Pandemics; Patient Positioning; Prone Position; Retrospective Studies; SARS-CoV-2","Kelly","Stephanie B H",NA,NA
"2228","34180868","10.1097/JHQ.0000000000000305","Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.","The COVID-19 pandemic has caused over 1,250,000 deaths worldwide. With limited therapeutic options, proning nonintubated patients emerged as a safe and affordable intervention to manage hypoxemia. A proning protocol to identify and prone eligible patients was implemented. Patients were encouraged to self-prone for 2-3 hours, 3 times daily. Investigators created educational materials for nurses and patients and developed a COVID-19-specific proning order within the electronic health record (EHR).","2021","07","13","J Healthc Qual","Journal for healthcare quality : official publication of the National Association for Healthcare Quality","COVID-19; Humans; Hypoxia; Male; Pandemics; Patient Positioning; Prone Position; Retrospective Studies; SARS-CoV-2","Tyker","Albina",NA,NA
"2229","34180868","10.1097/JHQ.0000000000000305","Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.","The COVID-19 pandemic has caused over 1,250,000 deaths worldwide. With limited therapeutic options, proning nonintubated patients emerged as a safe and affordable intervention to manage hypoxemia. A proning protocol to identify and prone eligible patients was implemented. Patients were encouraged to self-prone for 2-3 hours, 3 times daily. Investigators created educational materials for nurses and patients and developed a COVID-19-specific proning order within the electronic health record (EHR).","2021","07","13","J Healthc Qual","Journal for healthcare quality : official publication of the National Association for Healthcare Quality","COVID-19; Humans; Hypoxia; Male; Pandemics; Patient Positioning; Prone Position; Retrospective Studies; SARS-CoV-2","Anderson","Daniela",NA,NA
"2230","34180868","10.1097/JHQ.0000000000000305","Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.","The COVID-19 pandemic has caused over 1,250,000 deaths worldwide. With limited therapeutic options, proning nonintubated patients emerged as a safe and affordable intervention to manage hypoxemia. A proning protocol to identify and prone eligible patients was implemented. Patients were encouraged to self-prone for 2-3 hours, 3 times daily. Investigators created educational materials for nurses and patients and developed a COVID-19-specific proning order within the electronic health record (EHR).","2021","07","13","J Healthc Qual","Journal for healthcare quality : official publication of the National Association for Healthcare Quality","COVID-19; Humans; Hypoxia; Male; Pandemics; Patient Positioning; Prone Position; Retrospective Studies; SARS-CoV-2","Francisco","Mary A",NA,NA
"2231","34180868","10.1097/JHQ.0000000000000305","Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.","The COVID-19 pandemic has caused over 1,250,000 deaths worldwide. With limited therapeutic options, proning nonintubated patients emerged as a safe and affordable intervention to manage hypoxemia. A proning protocol to identify and prone eligible patients was implemented. Patients were encouraged to self-prone for 2-3 hours, 3 times daily. Investigators created educational materials for nurses and patients and developed a COVID-19-specific proning order within the electronic health record (EHR).","2021","07","13","J Healthc Qual","Journal for healthcare quality : official publication of the National Association for Healthcare Quality","COVID-19; Humans; Hypoxia; Male; Pandemics; Patient Positioning; Prone Position; Retrospective Studies; SARS-CoV-2","Pierce","Nicole L",NA,NA
"2232","34180868","10.1097/JHQ.0000000000000305","Implementation and Assessment of a Proning Protocol for Nonintubated Patients With COVID-19.","The COVID-19 pandemic has caused over 1,250,000 deaths worldwide. With limited therapeutic options, proning nonintubated patients emerged as a safe and affordable intervention to manage hypoxemia. A proning protocol to identify and prone eligible patients was implemented. Patients were encouraged to self-prone for 2-3 hours, 3 times daily. Investigators created educational materials for nurses and patients and developed a COVID-19-specific proning order within the electronic health record (EHR).","2021","07","13","J Healthc Qual","Journal for healthcare quality : official publication of the National Association for Healthcare Quality","COVID-19; Humans; Hypoxia; Male; Pandemics; Patient Positioning; Prone Position; Retrospective Studies; SARS-CoV-2","Cerasale","Matthew T",NA,NA
"2233","34180855","10.1370/afm.2705","Learning From COVID-19: System Blindness to Primary Care.",NA,"2021","07","13","Ann Fam Med","Annals of family medicine","COVID-19; COVID-19 Testing; COVID-19 Vaccines; Family Practice; Health Care Rationing; Health Care Reform; Health Services Accessibility; Healthcare Disparities; Humans; Pandemics; Personal Protective Equipment; Physician's Role; Primary Health Care; United States","Newton","Warren P","American Board of Family Medicine, Department of Family Medicine, University of North Carolina","wnewton@theabfm.org"
"2234","34180855","10.1370/afm.2705","Learning From COVID-19: System Blindness to Primary Care.",NA,"2021","07","13","Ann Fam Med","Annals of family medicine","COVID-19; COVID-19 Testing; COVID-19 Vaccines; Family Practice; Health Care Rationing; Health Care Reform; Health Services Accessibility; Healthcare Disparities; Humans; Pandemics; Personal Protective Equipment; Physician's Role; Primary Health Care; United States","Baxley","Elizabeth","American Board of Family Medicine",NA
"2235","34180855","10.1370/afm.2705","Learning From COVID-19: System Blindness to Primary Care.",NA,"2021","07","13","Ann Fam Med","Annals of family medicine","COVID-19; COVID-19 Testing; COVID-19 Vaccines; Family Practice; Health Care Rationing; Health Care Reform; Health Services Accessibility; Healthcare Disparities; Humans; Pandemics; Personal Protective Equipment; Physician's Role; Primary Health Care; United States","Magill","Michael","American Board of Family Medicine, Department of Family and Preventive Medicine, University of Utah",NA
"2236","34180849","10.1370/afm.2655","A Thoughtful Rebirth of Health Care: Lessons From the Pandemic.","In 16 years of practice, I had never seen a patient light a cigarette or pour a glass of wine in front of me. Yet, that occurred at the very onset of the COVID-19 era, a time that has shattered any preconceived notions of what I might experience during a clinical visit. The COVID-19 pandemic has forced many physicians to approach patient care in completely different ways. While many have been providing care in hospitals, many more of us have had to stop seeing patients in person, shift to teleme","2021","07","13","Ann Fam Med","Annals of family medicine","COVID-19 pandemic; coronavirus; delivery of health care; social determinants of health; telemedicine; COVID-19; Family Practice; Health Care Reform; Health Promotion; Health Services Accessibility; Humans; Integrative Medicine; New York; Pandemics; Patient-Centered Care; Physician-Patient Relations; Telemedicine","Rosenbaum","Elena","Department of Family and Community Medicine, Albany Medical College, Albany, New York erosenbaum@communitycare","erosenbaum@communitycare.com"
"2237","34180801","10.3238/arztebl.m2021.0185","Disinfectant Exposures in Children Under Age 6 in Germany During the COVID-19 Pandemic.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Child; Disinfectants; Germany; Humans; Pandemics; SARS-CoV-2","Herrera-Melendez","Ana Lucia",NA,NA
"2238","34180801","10.3238/arztebl.m2021.0185","Disinfectant Exposures in Children Under Age 6 in Germany During the COVID-19 Pandemic.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Child; Disinfectants; Germany; Humans; Pandemics; SARS-CoV-2","Acquarone","Daniela",NA,NA
"2239","34180801","10.3238/arztebl.m2021.0185","Disinfectant Exposures in Children Under Age 6 in Germany During the COVID-19 Pandemic.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Child; Disinfectants; Germany; Humans; Pandemics; SARS-CoV-2","Kreutz","Reinhold",NA,NA
"2240","34180797","10.3238/arztebl.m2021.0219","COVID-19 Reveals Opportunities for Better Care of Stroke Patients.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Delivery of Health Care, Integrated; Humans; SARS-CoV-2; Stroke","Studer","Bettina",NA,NA
"2241","34180797","10.3238/arztebl.m2021.0219","COVID-19 Reveals Opportunities for Better Care of Stroke Patients.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Delivery of Health Care, Integrated; Humans; SARS-CoV-2; Stroke","Roukens","Robin",NA,NA
"2242","34180797","10.3238/arztebl.m2021.0219","COVID-19 Reveals Opportunities for Better Care of Stroke Patients.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Delivery of Health Care, Integrated; Humans; SARS-CoV-2; Stroke","Happe","Svenja",NA,NA
"2243","34180797","10.3238/arztebl.m2021.0219","COVID-19 Reveals Opportunities for Better Care of Stroke Patients.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Delivery of Health Care, Integrated; Humans; SARS-CoV-2; Stroke","Schmidt","Simone B",NA,NA
"2244","34180797","10.3238/arztebl.m2021.0219","COVID-19 Reveals Opportunities for Better Care of Stroke Patients.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Delivery of Health Care, Integrated; Humans; SARS-CoV-2; Stroke","Knecht","Stefan",NA,NA
"2245","34180795","10.3238/arztebl.m2021.0223","Intolerance Reaction After Vaccination Against SARS-CoV-2.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; SARS-CoV-2; Vaccination","Kluwig","David",NA,NA
"2246","34180795","10.3238/arztebl.m2021.0223","Intolerance Reaction After Vaccination Against SARS-CoV-2.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; SARS-CoV-2; Vaccination","Weßollek","Katharina",NA,NA
"2247","34180795","10.3238/arztebl.m2021.0223","Intolerance Reaction After Vaccination Against SARS-CoV-2.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; SARS-CoV-2; Vaccination","Yazdi","Amir",NA,NA
"2248","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Schetelig","Johannes",NA,NA
"2249","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Baldauf","Henning",NA,NA
"2250","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Wendler","Sarah",NA,NA
"2251","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Heidenreich","Falk",NA,NA
"2252","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Real","Ruben",NA,NA
"2253","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Kolditz","Martin",NA,NA
"2254","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Rosner","Andrea",NA,NA
"2255","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Dalpke","Alexander",NA,NA
"2256","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","With","Katja de",NA,NA
"2257","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Lange","Vinzenz",NA,NA
"2258","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Markert","Jan",NA,NA
"2259","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Barth","Ralf",NA,NA
"2260","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Bunzel","Carolin",NA,NA
"2261","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Endert","Dennis",NA,NA
"2262","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Hofmann","Jan A",NA,NA
"2263","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Sauter","Jürgen",NA,NA
"2264","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Bernas","Stefanie N",NA,NA
"2265","34180791","10.3238/arztebl.m2021.0200","Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61.",NA,"2021","07","01","Dtsch Arztebl Int","Deutsches Arzteblatt international","COVID-19; Humans; Risk Factors; SARS-CoV-2","Schmidt","Alexander H",NA,NA
"2266","34180767","10.1080/10428194.2021.1885664","Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.","Patients with hematological malignancies are at risk for poor outcomes when diagnosed with coronavirus disease 2019 (COVID-19). It remains unclear whether cytopenias and specific leukemia subtypes play a role in the clinical course of COVID-19 infection. Here, we report outcomes and their clinical/laboratory predictors for 65 patients with acute and chronic leukemias diagnosed with COVID-19 between 8 March 2020 and 19 May 2020 at Memorial Sloan Kettering Cancer Center in New York City. Most pati","2021","06","28","Leuk Lymphoma","Leukemia &amp; lymphoma","COVID-19; SARS-CoV-2; leukemia","Stahl","Maximilian","Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"2267","34180767","10.1080/10428194.2021.1885664","Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.","Patients with hematological malignancies are at risk for poor outcomes when diagnosed with coronavirus disease 2019 (COVID-19). It remains unclear whether cytopenias and specific leukemia subtypes play a role in the clinical course of COVID-19 infection. Here, we report outcomes and their clinical/laboratory predictors for 65 patients with acute and chronic leukemias diagnosed with COVID-19 between 8 March 2020 and 19 May 2020 at Memorial Sloan Kettering Cancer Center in New York City. Most pati","2021","06","28","Leuk Lymphoma","Leukemia &amp; lymphoma","COVID-19; SARS-CoV-2; leukemia","Narendra","Varun","Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"2268","34180767","10.1080/10428194.2021.1885664","Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.","Patients with hematological malignancies are at risk for poor outcomes when diagnosed with coronavirus disease 2019 (COVID-19). It remains unclear whether cytopenias and specific leukemia subtypes play a role in the clinical course of COVID-19 infection. Here, we report outcomes and their clinical/laboratory predictors for 65 patients with acute and chronic leukemias diagnosed with COVID-19 between 8 March 2020 and 19 May 2020 at Memorial Sloan Kettering Cancer Center in New York City. Most pati","2021","06","28","Leuk Lymphoma","Leukemia &amp; lymphoma","COVID-19; SARS-CoV-2; leukemia","Jee","Justin","Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"2269","34180767","10.1080/10428194.2021.1885664","Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.","Patients with hematological malignancies are at risk for poor outcomes when diagnosed with coronavirus disease 2019 (COVID-19). It remains unclear whether cytopenias and specific leukemia subtypes play a role in the clinical course of COVID-19 infection. Here, we report outcomes and their clinical/laboratory predictors for 65 patients with acute and chronic leukemias diagnosed with COVID-19 between 8 March 2020 and 19 May 2020 at Memorial Sloan Kettering Cancer Center in New York City. Most pati","2021","06","28","Leuk Lymphoma","Leukemia &amp; lymphoma","COVID-19; SARS-CoV-2; leukemia","Derkach","Andriy","Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"2270","34180767","10.1080/10428194.2021.1885664","Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.","Patients with hematological malignancies are at risk for poor outcomes when diagnosed with coronavirus disease 2019 (COVID-19). It remains unclear whether cytopenias and specific leukemia subtypes play a role in the clinical course of COVID-19 infection. Here, we report outcomes and their clinical/laboratory predictors for 65 patients with acute and chronic leukemias diagnosed with COVID-19 between 8 March 2020 and 19 May 2020 at Memorial Sloan Kettering Cancer Center in New York City. Most pati","2021","06","28","Leuk Lymphoma","Leukemia &amp; lymphoma","COVID-19; SARS-CoV-2; leukemia","Maloy","Molly","Department of Health Informatics, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"2271","34180767","10.1080/10428194.2021.1885664","Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.","Patients with hematological malignancies are at risk for poor outcomes when diagnosed with coronavirus disease 2019 (COVID-19). It remains unclear whether cytopenias and specific leukemia subtypes play a role in the clinical course of COVID-19 infection. Here, we report outcomes and their clinical/laboratory predictors for 65 patients with acute and chronic leukemias diagnosed with COVID-19 between 8 March 2020 and 19 May 2020 at Memorial Sloan Kettering Cancer Center in New York City. Most pati","2021","06","28","Leuk Lymphoma","Leukemia &amp; lymphoma","COVID-19; SARS-CoV-2; leukemia","Geyer","Mark B","Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"2272","34180767","10.1080/10428194.2021.1885664","Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.","Patients with hematological malignancies are at risk for poor outcomes when diagnosed with coronavirus disease 2019 (COVID-19). It remains unclear whether cytopenias and specific leukemia subtypes play a role in the clinical course of COVID-19 infection. Here, we report outcomes and their clinical/laboratory predictors for 65 patients with acute and chronic leukemias diagnosed with COVID-19 between 8 March 2020 and 19 May 2020 at Memorial Sloan Kettering Cancer Center in New York City. Most pati","2021","06","28","Leuk Lymphoma","Leukemia &amp; lymphoma","COVID-19; SARS-CoV-2; leukemia","Mato","Anthony R","Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"2273","34180767","10.1080/10428194.2021.1885664","Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.","Patients with hematological malignancies are at risk for poor outcomes when diagnosed with coronavirus disease 2019 (COVID-19). It remains unclear whether cytopenias and specific leukemia subtypes play a role in the clinical course of COVID-19 infection. Here, we report outcomes and their clinical/laboratory predictors for 65 patients with acute and chronic leukemias diagnosed with COVID-19 between 8 March 2020 and 19 May 2020 at Memorial Sloan Kettering Cancer Center in New York City. Most pati","2021","06","28","Leuk Lymphoma","Leukemia &amp; lymphoma","COVID-19; SARS-CoV-2; leukemia","Roeker","Lindsey E","Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"2274","34180767","10.1080/10428194.2021.1885664","Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.","Patients with hematological malignancies are at risk for poor outcomes when diagnosed with coronavirus disease 2019 (COVID-19). It remains unclear whether cytopenias and specific leukemia subtypes play a role in the clinical course of COVID-19 infection. Here, we report outcomes and their clinical/laboratory predictors for 65 patients with acute and chronic leukemias diagnosed with COVID-19 between 8 March 2020 and 19 May 2020 at Memorial Sloan Kettering Cancer Center in New York City. Most pati","2021","06","28","Leuk Lymphoma","Leukemia &amp; lymphoma","COVID-19; SARS-CoV-2; leukemia","Tallman","Martin S","Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"2275","34180767","10.1080/10428194.2021.1885664","Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.","Patients with hematological malignancies are at risk for poor outcomes when diagnosed with coronavirus disease 2019 (COVID-19). It remains unclear whether cytopenias and specific leukemia subtypes play a role in the clinical course of COVID-19 infection. Here, we report outcomes and their clinical/laboratory predictors for 65 patients with acute and chronic leukemias diagnosed with COVID-19 between 8 March 2020 and 19 May 2020 at Memorial Sloan Kettering Cancer Center in New York City. Most pati","2021","06","28","Leuk Lymphoma","Leukemia &amp; lymphoma","COVID-19; SARS-CoV-2; leukemia","Shah","Gunjan L","Department of Medicine, Weill Cornell Medical College, New York, NY, USA",NA
"2276","34180767","10.1080/10428194.2021.1885664","Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.","Patients with hematological malignancies are at risk for poor outcomes when diagnosed with coronavirus disease 2019 (COVID-19). It remains unclear whether cytopenias and specific leukemia subtypes play a role in the clinical course of COVID-19 infection. Here, we report outcomes and their clinical/laboratory predictors for 65 patients with acute and chronic leukemias diagnosed with COVID-19 between 8 March 2020 and 19 May 2020 at Memorial Sloan Kettering Cancer Center in New York City. Most pati","2021","06","28","Leuk Lymphoma","Leukemia &amp; lymphoma","COVID-19; SARS-CoV-2; leukemia","Daniyan","Anthony","Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"2277","34180767","10.1080/10428194.2021.1885664","Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.","Patients with hematological malignancies are at risk for poor outcomes when diagnosed with coronavirus disease 2019 (COVID-19). It remains unclear whether cytopenias and specific leukemia subtypes play a role in the clinical course of COVID-19 infection. Here, we report outcomes and their clinical/laboratory predictors for 65 patients with acute and chronic leukemias diagnosed with COVID-19 between 8 March 2020 and 19 May 2020 at Memorial Sloan Kettering Cancer Center in New York City. Most pati","2021","06","28","Leuk Lymphoma","Leukemia &amp; lymphoma","COVID-19; SARS-CoV-2; leukemia","Goldberg","Aaron D","Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"2278","34180766","10.1080/15412555.2021.1941834","Distancing Measures in COVID-19 Pandemic: Loneliness, More than Physical Isolation, Affects Health Status and Psycho-Cognitive Wellbeing in Elderly Patients with Chronic Obstructive Pulmonary Disease.","Since the outbreak of the SARS-CoV-2 pandemic in 2020, many governments have been imposing confinement and physical distancing measures. No data exist on the effects of lockdowns on the health status of patients affected by chronic pathologies, specifically those with Chronic Obstructive Pulmonary Disease (COPD). Our study aims to establish variations across the psychological and cognitive profile of patients during the isolation period in Italy, in a cohort of patients affected by COPD, between","2021","06","28","COPD","COPD","COPD; COVID-19; Physical distancing; SARS-CoV-2; elderly; frailty; psycho-cognitive wellbeing","Scarlata","Simone","Geriatrics, Unit of Respiratory Pathophysiology, Campus Bio-Medico University and Teaching Hospital, Rome, Italy",NA
"2279","34180766","10.1080/15412555.2021.1941834","Distancing Measures in COVID-19 Pandemic: Loneliness, More than Physical Isolation, Affects Health Status and Psycho-Cognitive Wellbeing in Elderly Patients with Chronic Obstructive Pulmonary Disease.","Since the outbreak of the SARS-CoV-2 pandemic in 2020, many governments have been imposing confinement and physical distancing measures. No data exist on the effects of lockdowns on the health status of patients affected by chronic pathologies, specifically those with Chronic Obstructive Pulmonary Disease (COPD). Our study aims to establish variations across the psychological and cognitive profile of patients during the isolation period in Italy, in a cohort of patients affected by COPD, between","2021","06","28","COPD","COPD","COPD; COVID-19; Physical distancing; SARS-CoV-2; elderly; frailty; psycho-cognitive wellbeing","Cardaci","Vittorio","Pulmonary Rehabilitation, IRCCS San Raffaele Pisana Scientific Institute, Rome, Italy",NA
"2280","34180766","10.1080/15412555.2021.1941834","Distancing Measures in COVID-19 Pandemic: Loneliness, More than Physical Isolation, Affects Health Status and Psycho-Cognitive Wellbeing in Elderly Patients with Chronic Obstructive Pulmonary Disease.","Since the outbreak of the SARS-CoV-2 pandemic in 2020, many governments have been imposing confinement and physical distancing measures. No data exist on the effects of lockdowns on the health status of patients affected by chronic pathologies, specifically those with Chronic Obstructive Pulmonary Disease (COPD). Our study aims to establish variations across the psychological and cognitive profile of patients during the isolation period in Italy, in a cohort of patients affected by COPD, between","2021","06","28","COPD","COPD","COPD; COVID-19; Physical distancing; SARS-CoV-2; elderly; frailty; psycho-cognitive wellbeing","Santangelo","Carmen","Research Unit, Nursing Science, Campus Bio-Medico di Roma University, Rome, Italy",NA
"2281","34180766","10.1080/15412555.2021.1941834","Distancing Measures in COVID-19 Pandemic: Loneliness, More than Physical Isolation, Affects Health Status and Psycho-Cognitive Wellbeing in Elderly Patients with Chronic Obstructive Pulmonary Disease.","Since the outbreak of the SARS-CoV-2 pandemic in 2020, many governments have been imposing confinement and physical distancing measures. No data exist on the effects of lockdowns on the health status of patients affected by chronic pathologies, specifically those with Chronic Obstructive Pulmonary Disease (COPD). Our study aims to establish variations across the psychological and cognitive profile of patients during the isolation period in Italy, in a cohort of patients affected by COPD, between","2021","06","28","COPD","COPD","COPD; COVID-19; Physical distancing; SARS-CoV-2; elderly; frailty; psycho-cognitive wellbeing","Matarese","Maria","Research Unit, Nursing Science, Campus Bio-Medico di Roma University, Rome, Italy",NA
"2282","34180766","10.1080/15412555.2021.1941834","Distancing Measures in COVID-19 Pandemic: Loneliness, More than Physical Isolation, Affects Health Status and Psycho-Cognitive Wellbeing in Elderly Patients with Chronic Obstructive Pulmonary Disease.","Since the outbreak of the SARS-CoV-2 pandemic in 2020, many governments have been imposing confinement and physical distancing measures. No data exist on the effects of lockdowns on the health status of patients affected by chronic pathologies, specifically those with Chronic Obstructive Pulmonary Disease (COPD). Our study aims to establish variations across the psychological and cognitive profile of patients during the isolation period in Italy, in a cohort of patients affected by COPD, between","2021","06","28","COPD","COPD","COPD; COVID-19; Physical distancing; SARS-CoV-2; elderly; frailty; psycho-cognitive wellbeing","Cesari","Matteo","Geriatric Unit, Maugeri Clinical Research Institute (IRCCS), Milan, Italy",NA
"2283","34180766","10.1080/15412555.2021.1941834","Distancing Measures in COVID-19 Pandemic: Loneliness, More than Physical Isolation, Affects Health Status and Psycho-Cognitive Wellbeing in Elderly Patients with Chronic Obstructive Pulmonary Disease.","Since the outbreak of the SARS-CoV-2 pandemic in 2020, many governments have been imposing confinement and physical distancing measures. No data exist on the effects of lockdowns on the health status of patients affected by chronic pathologies, specifically those with Chronic Obstructive Pulmonary Disease (COPD). Our study aims to establish variations across the psychological and cognitive profile of patients during the isolation period in Italy, in a cohort of patients affected by COPD, between","2021","06","28","COPD","COPD","COPD; COVID-19; Physical distancing; SARS-CoV-2; elderly; frailty; psycho-cognitive wellbeing","Antonelli Incalzi","Raffaele","Geriatrics, Unit of Respiratory Pathophysiology, Campus Bio-Medico University and Teaching Hospital, Rome, Italy",NA
"2284","34180719","10.1177/09636897211024942","The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.","The aim of this clinical trial was to control the cytokine storm by administering mesenchymal stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to systematically investigate how the treatment works. Patients with moderate and critical COVID-19 clinical manifestations were separated as Group 1 (moderate cases, n = 10, treated conventionally), Group 2 (critical cases, n = 10, treated conventionally), and Group 3 (critical cases, n = 10,","2021","07","07","Cell Transplant","Cell transplantation","COVID-19; cytokines; growth factors; mesenchymal stem cell; Adult; C-Reactive Protein; COVID-19; Critical Illness; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-8; Leukocyte Common Antigens; Lymphocytes; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome","Adas","G","Department of Surgery, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Health Sciences University, Istanbul, Turkey",NA
"2285","34180719","10.1177/09636897211024942","The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.","The aim of this clinical trial was to control the cytokine storm by administering mesenchymal stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to systematically investigate how the treatment works. Patients with moderate and critical COVID-19 clinical manifestations were separated as Group 1 (moderate cases, n = 10, treated conventionally), Group 2 (critical cases, n = 10, treated conventionally), and Group 3 (critical cases, n = 10,","2021","07","07","Cell Transplant","Cell transplantation","COVID-19; cytokines; growth factors; mesenchymal stem cell; Adult; C-Reactive Protein; COVID-19; Critical Illness; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-8; Leukocyte Common Antigens; Lymphocytes; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome","Cukurova","Z","Department of Anesthesia and Intensive Care, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Health Sciences University, Istanbul, Turkey",NA
"2286","34180719","10.1177/09636897211024942","The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.","The aim of this clinical trial was to control the cytokine storm by administering mesenchymal stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to systematically investigate how the treatment works. Patients with moderate and critical COVID-19 clinical manifestations were separated as Group 1 (moderate cases, n = 10, treated conventionally), Group 2 (critical cases, n = 10, treated conventionally), and Group 3 (critical cases, n = 10,","2021","07","07","Cell Transplant","Cell transplantation","COVID-19; cytokines; growth factors; mesenchymal stem cell; Adult; C-Reactive Protein; COVID-19; Critical Illness; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-8; Leukocyte Common Antigens; Lymphocytes; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome","Yasar","K Kart","Department of Infectious Diseases, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Health Sciences University, Istanbul, Turkey",NA
"2287","34180719","10.1177/09636897211024942","The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.","The aim of this clinical trial was to control the cytokine storm by administering mesenchymal stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to systematically investigate how the treatment works. Patients with moderate and critical COVID-19 clinical manifestations were separated as Group 1 (moderate cases, n = 10, treated conventionally), Group 2 (critical cases, n = 10, treated conventionally), and Group 3 (critical cases, n = 10,","2021","07","07","Cell Transplant","Cell transplantation","COVID-19; cytokines; growth factors; mesenchymal stem cell; Adult; C-Reactive Protein; COVID-19; Critical Illness; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-8; Leukocyte Common Antigens; Lymphocytes; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome","Yilmaz","R","Department of Anesthesia and Intensive Care, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Health Sciences University, Istanbul, Turkey",NA
"2288","34180719","10.1177/09636897211024942","The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.","The aim of this clinical trial was to control the cytokine storm by administering mesenchymal stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to systematically investigate how the treatment works. Patients with moderate and critical COVID-19 clinical manifestations were separated as Group 1 (moderate cases, n = 10, treated conventionally), Group 2 (critical cases, n = 10, treated conventionally), and Group 3 (critical cases, n = 10,","2021","07","07","Cell Transplant","Cell transplantation","COVID-19; cytokines; growth factors; mesenchymal stem cell; Adult; C-Reactive Protein; COVID-19; Critical Illness; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-8; Leukocyte Common Antigens; Lymphocytes; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome","Isiksacan","N","Department of Biochemistry and Immunology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Health Sciences University, Istanbul, Turkey",NA
"2289","34180719","10.1177/09636897211024942","The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.","The aim of this clinical trial was to control the cytokine storm by administering mesenchymal stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to systematically investigate how the treatment works. Patients with moderate and critical COVID-19 clinical manifestations were separated as Group 1 (moderate cases, n = 10, treated conventionally), Group 2 (critical cases, n = 10, treated conventionally), and Group 3 (critical cases, n = 10,","2021","07","07","Cell Transplant","Cell transplantation","COVID-19; cytokines; growth factors; mesenchymal stem cell; Adult; C-Reactive Protein; COVID-19; Critical Illness; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-8; Leukocyte Common Antigens; Lymphocytes; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome","Kasapoglu","P","Department of Biochemistry and Immunology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Health Sciences University, Istanbul, Turkey",NA
"2290","34180719","10.1177/09636897211024942","The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.","The aim of this clinical trial was to control the cytokine storm by administering mesenchymal stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to systematically investigate how the treatment works. Patients with moderate and critical COVID-19 clinical manifestations were separated as Group 1 (moderate cases, n = 10, treated conventionally), Group 2 (critical cases, n = 10, treated conventionally), and Group 3 (critical cases, n = 10,","2021","07","07","Cell Transplant","Cell transplantation","COVID-19; cytokines; growth factors; mesenchymal stem cell; Adult; C-Reactive Protein; COVID-19; Critical Illness; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-8; Leukocyte Common Antigens; Lymphocytes; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome","Yesilbag","Z","Department of Infectious Diseases, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Health Sciences University, Istanbul, Turkey",NA
"2291","34180719","10.1177/09636897211024942","The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.","The aim of this clinical trial was to control the cytokine storm by administering mesenchymal stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to systematically investigate how the treatment works. Patients with moderate and critical COVID-19 clinical manifestations were separated as Group 1 (moderate cases, n = 10, treated conventionally), Group 2 (critical cases, n = 10, treated conventionally), and Group 3 (critical cases, n = 10,","2021","07","07","Cell Transplant","Cell transplantation","COVID-19; cytokines; growth factors; mesenchymal stem cell; Adult; C-Reactive Protein; COVID-19; Critical Illness; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-8; Leukocyte Common Antigens; Lymphocytes; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome","Koyuncu","I D","Istinye University, Faculty of Medicine, Department of Histology &amp",NA
"2292","34180719","10.1177/09636897211024942","The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.","The aim of this clinical trial was to control the cytokine storm by administering mesenchymal stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to systematically investigate how the treatment works. Patients with moderate and critical COVID-19 clinical manifestations were separated as Group 1 (moderate cases, n = 10, treated conventionally), Group 2 (critical cases, n = 10, treated conventionally), and Group 3 (critical cases, n = 10,","2021","07","07","Cell Transplant","Cell transplantation","COVID-19; cytokines; growth factors; mesenchymal stem cell; Adult; C-Reactive Protein; COVID-19; Critical Illness; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-8; Leukocyte Common Antigens; Lymphocytes; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome","Karaoz","E","Liv Hospital, Center for Regenerative Medicine and Stem Cell Manufacturing (Liv Med Cell), Istanbul, Turkey",NA
"2293","34180687","10.1037/tra0001062","Gender implications of the Fear of COVID-19 Scale in the Spanish population: A validation study.","Objective: The aim of this study was to determine the psychometric properties of the Fear of COVID-19 Scale (FCV-19S) for the general Spanish population. Method: A cross-sectional investigation was carried out in several stages. Participants (N = 699) between the ages of 18 and 73 (M = 27.79; SD = 12.68) completed both the FCV-19S and the Hospital, Anxiety, and Depression Scale (HADS). We performed descriptive, exploratory factorial (n = 349), confirmatory (n = 350), ","2021","06","28","Psychol Trauma","Psychological trauma : theory, research, practice and policy",NA,"Sánchez-Teruel","David","Department of Psychology",NA
"2294","34180687","10.1037/tra0001062","Gender implications of the Fear of COVID-19 Scale in the Spanish population: A validation study.","Objective: The aim of this study was to determine the psychometric properties of the Fear of COVID-19 Scale (FCV-19S) for the general Spanish population. Method: A cross-sectional investigation was carried out in several stages. Participants (N = 699) between the ages of 18 and 73 (M = 27.79; SD = 12.68) completed both the FCV-19S and the Hospital, Anxiety, and Depression Scale (HADS). We performed descriptive, exploratory factorial (n = 349), confirmatory (n = 350), ","2021","06","28","Psychol Trauma","Psychological trauma : theory, research, practice and policy",NA,"Robles-Bello","María Auxiliadora","Department of Psychology",NA
"2295","34180687","10.1037/tra0001062","Gender implications of the Fear of COVID-19 Scale in the Spanish population: A validation study.","Objective: The aim of this study was to determine the psychometric properties of the Fear of COVID-19 Scale (FCV-19S) for the general Spanish population. Method: A cross-sectional investigation was carried out in several stages. Participants (N = 699) between the ages of 18 and 73 (M = 27.79; SD = 12.68) completed both the FCV-19S and the Hospital, Anxiety, and Depression Scale (HADS). We performed descriptive, exploratory factorial (n = 349), confirmatory (n = 350), ","2021","06","28","Psychol Trauma","Psychological trauma : theory, research, practice and policy",NA,"Lara-Cabrera","Mariela","Department of Research and Development",NA
"2296","34180687","10.1037/tra0001062","Gender implications of the Fear of COVID-19 Scale in the Spanish population: A validation study.","Objective: The aim of this study was to determine the psychometric properties of the Fear of COVID-19 Scale (FCV-19S) for the general Spanish population. Method: A cross-sectional investigation was carried out in several stages. Participants (N = 699) between the ages of 18 and 73 (M = 27.79; SD = 12.68) completed both the FCV-19S and the Hospital, Anxiety, and Depression Scale (HADS). We performed descriptive, exploratory factorial (n = 349), confirmatory (n = 350), ","2021","06","28","Psychol Trauma","Psychological trauma : theory, research, practice and policy",NA,"Valencia-Naranjo","Nieves","Department of Psychology",NA
"2297","34180678","10.1021/acs.jproteome.1c00206","Genetic Variability of the SARS-CoV-2 Pocketome.","In the absence of effective treatment, COVID-19 is likely to remain a global disease burden. Compounding this threat is the near certainty that novel coronaviruses with pandemic potential will emerge in years to come. Pan-coronavirus drugs-agents active against both SARS-CoV-2 and other coronaviruses-would address both threats. A strategy to develop such broad-spectrum inhibitors is to pharmacologically target binding sites on SARS-CoV-2 proteins that are highly conserved in other known coronavi","2021","07","10","J Proteome Res","Journal of proteome research",NA,"Yazdani","Setayesh","Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada",NA
"2298","34180678","10.1021/acs.jproteome.1c00206","Genetic Variability of the SARS-CoV-2 Pocketome.","In the absence of effective treatment, COVID-19 is likely to remain a global disease burden. Compounding this threat is the near certainty that novel coronaviruses with pandemic potential will emerge in years to come. Pan-coronavirus drugs-agents active against both SARS-CoV-2 and other coronaviruses-would address both threats. A strategy to develop such broad-spectrum inhibitors is to pharmacologically target binding sites on SARS-CoV-2 proteins that are highly conserved in other known coronavi","2021","07","10","J Proteome Res","Journal of proteome research",NA,"De Maio","Nicola","European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton CB10 1SD, United Kingdom",NA
"2299","34180678","10.1021/acs.jproteome.1c00206","Genetic Variability of the SARS-CoV-2 Pocketome.","In the absence of effective treatment, COVID-19 is likely to remain a global disease burden. Compounding this threat is the near certainty that novel coronaviruses with pandemic potential will emerge in years to come. Pan-coronavirus drugs-agents active against both SARS-CoV-2 and other coronaviruses-would address both threats. A strategy to develop such broad-spectrum inhibitors is to pharmacologically target binding sites on SARS-CoV-2 proteins that are highly conserved in other known coronavi","2021","07","10","J Proteome Res","Journal of proteome research",NA,"Ding","Yining","Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada",NA
"2300","34180678","10.1021/acs.jproteome.1c00206","Genetic Variability of the SARS-CoV-2 Pocketome.","In the absence of effective treatment, COVID-19 is likely to remain a global disease burden. Compounding this threat is the near certainty that novel coronaviruses with pandemic potential will emerge in years to come. Pan-coronavirus drugs-agents active against both SARS-CoV-2 and other coronaviruses-would address both threats. A strategy to develop such broad-spectrum inhibitors is to pharmacologically target binding sites on SARS-CoV-2 proteins that are highly conserved in other known coronavi","2021","07","10","J Proteome Res","Journal of proteome research",NA,"Shahani","Vijay","Cyclica, Toronto, Ontario M5J 1A7, Canada",NA
"2301","34180678","10.1021/acs.jproteome.1c00206","Genetic Variability of the SARS-CoV-2 Pocketome.","In the absence of effective treatment, COVID-19 is likely to remain a global disease burden. Compounding this threat is the near certainty that novel coronaviruses with pandemic potential will emerge in years to come. Pan-coronavirus drugs-agents active against both SARS-CoV-2 and other coronaviruses-would address both threats. A strategy to develop such broad-spectrum inhibitors is to pharmacologically target binding sites on SARS-CoV-2 proteins that are highly conserved in other known coronavi","2021","07","10","J Proteome Res","Journal of proteome research",NA,"Goldman","Nick","European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton CB10 1SD, United Kingdom",NA
"2302","34180678","10.1021/acs.jproteome.1c00206","Genetic Variability of the SARS-CoV-2 Pocketome.","In the absence of effective treatment, COVID-19 is likely to remain a global disease burden. Compounding this threat is the near certainty that novel coronaviruses with pandemic potential will emerge in years to come. Pan-coronavirus drugs-agents active against both SARS-CoV-2 and other coronaviruses-would address both threats. A strategy to develop such broad-spectrum inhibitors is to pharmacologically target binding sites on SARS-CoV-2 proteins that are highly conserved in other known coronavi","2021","07","10","J Proteome Res","Journal of proteome research",NA,"Schapira","Matthieu","Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada",NA
"2303","34180655","10.1021/acs.analchem.1c01576","A Semi-Quantitative Isothermal Diagnostic Assay Utilizing Competitive Amplification.","Quantitative diagnostics that are rapid, inexpensive, sensitive, robust, and field-deployable are needed to contain the spread of infectious diseases and inform treatment strategies. While current gold-standard techniques are highly sensitive and quantitative, they are slow and require expensive equipment. Conversely, current rapid field-deployable assays available provide essentially binary information about the presence of the target analyte, not a quantitative measure of concentration. Here, ","2021","07","19","Anal Chem","Analytical chemistry","COVID-19; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Recombinases; SARS-CoV-2; Sensitivity and Specificity","Mancuso","Christopher P","Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, United States",NA
"2304","34180655","10.1021/acs.analchem.1c01576","A Semi-Quantitative Isothermal Diagnostic Assay Utilizing Competitive Amplification.","Quantitative diagnostics that are rapid, inexpensive, sensitive, robust, and field-deployable are needed to contain the spread of infectious diseases and inform treatment strategies. While current gold-standard techniques are highly sensitive and quantitative, they are slow and require expensive equipment. Conversely, current rapid field-deployable assays available provide essentially binary information about the presence of the target analyte, not a quantitative measure of concentration. Here, ","2021","07","19","Anal Chem","Analytical chemistry","COVID-19; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Recombinases; SARS-CoV-2; Sensitivity and Specificity","Lu","Zhi-Xiang","Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, United States",NA
"2305","34180655","10.1021/acs.analchem.1c01576","A Semi-Quantitative Isothermal Diagnostic Assay Utilizing Competitive Amplification.","Quantitative diagnostics that are rapid, inexpensive, sensitive, robust, and field-deployable are needed to contain the spread of infectious diseases and inform treatment strategies. While current gold-standard techniques are highly sensitive and quantitative, they are slow and require expensive equipment. Conversely, current rapid field-deployable assays available provide essentially binary information about the presence of the target analyte, not a quantitative measure of concentration. Here, ","2021","07","19","Anal Chem","Analytical chemistry","COVID-19; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Recombinases; SARS-CoV-2; Sensitivity and Specificity","Qian","Jason","Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, United States",NA
"2306","34180655","10.1021/acs.analchem.1c01576","A Semi-Quantitative Isothermal Diagnostic Assay Utilizing Competitive Amplification.","Quantitative diagnostics that are rapid, inexpensive, sensitive, robust, and field-deployable are needed to contain the spread of infectious diseases and inform treatment strategies. While current gold-standard techniques are highly sensitive and quantitative, they are slow and require expensive equipment. Conversely, current rapid field-deployable assays available provide essentially binary information about the presence of the target analyte, not a quantitative measure of concentration. Here, ","2021","07","19","Anal Chem","Analytical chemistry","COVID-19; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Recombinases; SARS-CoV-2; Sensitivity and Specificity","Boswell","Sarah A","Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, United States",NA
"2307","34180655","10.1021/acs.analchem.1c01576","A Semi-Quantitative Isothermal Diagnostic Assay Utilizing Competitive Amplification.","Quantitative diagnostics that are rapid, inexpensive, sensitive, robust, and field-deployable are needed to contain the spread of infectious diseases and inform treatment strategies. While current gold-standard techniques are highly sensitive and quantitative, they are slow and require expensive equipment. Conversely, current rapid field-deployable assays available provide essentially binary information about the presence of the target analyte, not a quantitative measure of concentration. Here, ","2021","07","19","Anal Chem","Analytical chemistry","COVID-19; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Recombinases; SARS-CoV-2; Sensitivity and Specificity","Springer","Michael","Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, United States",NA
"2308","34180638","10.23736/S0026-4806.20.07225-0","Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing.","The aim of this study was the evaluation of the combination of Pycnogenol® (150 mg/day) and Centella asiatica (Centellicum® 3 x 225 mg/day) (PY-CE) for 8 months in subjects with sequelae of idiopathic interstitial pneumonia (IIP). Recently, post-COVID-19 lung disease is emerging with large numbers of patients left with chronic lung conditions. Considering the antifibrotic activity of the combination PY-CE, we also tested this supplementary management in post-COVID-19 lung patients. 19 subjects w","2021","06","28","Minerva Med","Minerva medica",NA,"Cesarone","Maria R","Irvine3 Labs, Department of Medical, Oral and Biotechnological Sciences, Chieti-Pescara University, IAPSS, Pescara, Italy",NA
"2309","34180638","10.23736/S0026-4806.20.07225-0","Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing.","The aim of this study was the evaluation of the combination of Pycnogenol® (150 mg/day) and Centella asiatica (Centellicum® 3 x 225 mg/day) (PY-CE) for 8 months in subjects with sequelae of idiopathic interstitial pneumonia (IIP). Recently, post-COVID-19 lung disease is emerging with large numbers of patients left with chronic lung conditions. Considering the antifibrotic activity of the combination PY-CE, we also tested this supplementary management in post-COVID-19 lung patients. 19 subjects w","2021","06","28","Minerva Med","Minerva medica",NA,"Hu","Shu","Irvine3 Labs, Department of Medical, Oral and Biotechnological Sciences, Chieti-Pescara University, IAPSS, Pescara, Italy",NA
"2310","34180638","10.23736/S0026-4806.20.07225-0","Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing.","The aim of this study was the evaluation of the combination of Pycnogenol® (150 mg/day) and Centella asiatica (Centellicum® 3 x 225 mg/day) (PY-CE) for 8 months in subjects with sequelae of idiopathic interstitial pneumonia (IIP). Recently, post-COVID-19 lung disease is emerging with large numbers of patients left with chronic lung conditions. Considering the antifibrotic activity of the combination PY-CE, we also tested this supplementary management in post-COVID-19 lung patients. 19 subjects w","2021","06","28","Minerva Med","Minerva medica",NA,"Belcaro","Gianni","Irvine3 Labs, Department of Medical, Oral and Biotechnological Sciences, Chieti-Pescara University, IAPSS, Pescara, Italy - cardres@abol","cardres@abol.it"
"2311","34180638","10.23736/S0026-4806.20.07225-0","Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing.","The aim of this study was the evaluation of the combination of Pycnogenol® (150 mg/day) and Centella asiatica (Centellicum® 3 x 225 mg/day) (PY-CE) for 8 months in subjects with sequelae of idiopathic interstitial pneumonia (IIP). Recently, post-COVID-19 lung disease is emerging with large numbers of patients left with chronic lung conditions. Considering the antifibrotic activity of the combination PY-CE, we also tested this supplementary management in post-COVID-19 lung patients. 19 subjects w","2021","06","28","Minerva Med","Minerva medica",NA,"Cornelli","Umberto","Irvine3 Labs, Department of Medical, Oral and Biotechnological Sciences, Chieti-Pescara University, IAPSS, Pescara, Italy",NA
"2312","34180638","10.23736/S0026-4806.20.07225-0","Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing.","The aim of this study was the evaluation of the combination of Pycnogenol® (150 mg/day) and Centella asiatica (Centellicum® 3 x 225 mg/day) (PY-CE) for 8 months in subjects with sequelae of idiopathic interstitial pneumonia (IIP). Recently, post-COVID-19 lung disease is emerging with large numbers of patients left with chronic lung conditions. Considering the antifibrotic activity of the combination PY-CE, we also tested this supplementary management in post-COVID-19 lung patients. 19 subjects w","2021","06","28","Minerva Med","Minerva medica",NA,"Feragalli","Beatrice","Irvine3 Labs, Department of Medical, Oral and Biotechnological Sciences, Chieti-Pescara University, IAPSS, Pescara, Italy",NA
"2313","34180638","10.23736/S0026-4806.20.07225-0","Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing.","The aim of this study was the evaluation of the combination of Pycnogenol® (150 mg/day) and Centella asiatica (Centellicum® 3 x 225 mg/day) (PY-CE) for 8 months in subjects with sequelae of idiopathic interstitial pneumonia (IIP). Recently, post-COVID-19 lung disease is emerging with large numbers of patients left with chronic lung conditions. Considering the antifibrotic activity of the combination PY-CE, we also tested this supplementary management in post-COVID-19 lung patients. 19 subjects w","2021","06","28","Minerva Med","Minerva medica",NA,"Corsi","Marcello","Irvine3 Labs, Department of Medical, Oral and Biotechnological Sciences, Chieti-Pescara University, IAPSS, Pescara, Italy",NA
"2314","34180638","10.23736/S0026-4806.20.07225-0","Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing.","The aim of this study was the evaluation of the combination of Pycnogenol® (150 mg/day) and Centella asiatica (Centellicum® 3 x 225 mg/day) (PY-CE) for 8 months in subjects with sequelae of idiopathic interstitial pneumonia (IIP). Recently, post-COVID-19 lung disease is emerging with large numbers of patients left with chronic lung conditions. Considering the antifibrotic activity of the combination PY-CE, we also tested this supplementary management in post-COVID-19 lung patients. 19 subjects w","2021","06","28","Minerva Med","Minerva medica",NA,"Bombardelli","Ezio","Irvine3 Labs, Department of Medical, Oral and Biotechnological Sciences, Chieti-Pescara University, IAPSS, Pescara, Italy",NA
"2315","34180638","10.23736/S0026-4806.20.07225-0","Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing.","The aim of this study was the evaluation of the combination of Pycnogenol® (150 mg/day) and Centella asiatica (Centellicum® 3 x 225 mg/day) (PY-CE) for 8 months in subjects with sequelae of idiopathic interstitial pneumonia (IIP). Recently, post-COVID-19 lung disease is emerging with large numbers of patients left with chronic lung conditions. Considering the antifibrotic activity of the combination PY-CE, we also tested this supplementary management in post-COVID-19 lung patients. 19 subjects w","2021","06","28","Minerva Med","Minerva medica",NA,"Cotellese","Roberto","Irvine3 Labs, Department of Medical, Oral and Biotechnological Sciences, Chieti-Pescara University, IAPSS, Pescara, Italy",NA
"2316","34180638","10.23736/S0026-4806.20.07225-0","Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing.","The aim of this study was the evaluation of the combination of Pycnogenol® (150 mg/day) and Centella asiatica (Centellicum® 3 x 225 mg/day) (PY-CE) for 8 months in subjects with sequelae of idiopathic interstitial pneumonia (IIP). Recently, post-COVID-19 lung disease is emerging with large numbers of patients left with chronic lung conditions. Considering the antifibrotic activity of the combination PY-CE, we also tested this supplementary management in post-COVID-19 lung patients. 19 subjects w","2021","06","28","Minerva Med","Minerva medica",NA,"Hosoi","Morio","Irvine3 Labs, Department of Medical, Oral and Biotechnological Sciences, Chieti-Pescara University, IAPSS, Pescara, Italy",NA
"2317","34180638","10.23736/S0026-4806.20.07225-0","Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing.","The aim of this study was the evaluation of the combination of Pycnogenol® (150 mg/day) and Centella asiatica (Centellicum® 3 x 225 mg/day) (PY-CE) for 8 months in subjects with sequelae of idiopathic interstitial pneumonia (IIP). Recently, post-COVID-19 lung disease is emerging with large numbers of patients left with chronic lung conditions. Considering the antifibrotic activity of the combination PY-CE, we also tested this supplementary management in post-COVID-19 lung patients. 19 subjects w","2021","06","28","Minerva Med","Minerva medica",NA,"Rosenkvist","Lars","Department of Head and Neck Surgery, Sonderborg Hospital, University of South Denmark, Sonderborg, Denmark",NA
"2318","34180617","10.37201/req/085.2021","[Vaccine against COVID-19].","The COVID-19 pandemic has produced a huge health, economic and psychological collapse in our society. Health workers have had to face one of the greatest challenges in history, trying to show the population how to deal with this disease. We have learned that vaccines are the great instrument for the fight against infectious diseases and a large number of them began to appear, not as a product of chance but as a product of the enormous progress experienced in recent years with vaccines against ne","2021","06","28","Rev Esp Quimioter","Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","COVID-19; SARS-CoV-2; effectiveness-safety; vaccines; variants","Picazo","J J","Juan J. Picazo, Catedrático Emérito de Microbiología Médica. Facultad de Medicina. Universidad Complutense de Madrid, Spain. jpicazo@microb","jpicazo@microb.net"
"2319","34180610","10.20452/pamw.16048","Should we supplement zinc in COVID-19 patients? Evidence from meta-analysis.","Preliminary retrospective reports showed that zinc supplementation may decrease mortality in COVID-19 patients, postulating the potential therapeutic efficacy of zinc in the management of the disease. We sought to summarize the studies published to date regarding the antiviral activity of zinc in COVID-19 patients. A meta-analysis was performed to compare the outcomes of hospitalized patients receiving zinc supplementation and those treated with standard care. The primary outcome was survival to","2021","06","28","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Szarpak","Lukasz",NA,NA
"2320","34180610","10.20452/pamw.16048","Should we supplement zinc in COVID-19 patients? Evidence from meta-analysis.","Preliminary retrospective reports showed that zinc supplementation may decrease mortality in COVID-19 patients, postulating the potential therapeutic efficacy of zinc in the management of the disease. We sought to summarize the studies published to date regarding the antiviral activity of zinc in COVID-19 patients. A meta-analysis was performed to compare the outcomes of hospitalized patients receiving zinc supplementation and those treated with standard care. The primary outcome was survival to","2021","06","28","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Pruc","Michal",NA,NA
"2321","34180610","10.20452/pamw.16048","Should we supplement zinc in COVID-19 patients? Evidence from meta-analysis.","Preliminary retrospective reports showed that zinc supplementation may decrease mortality in COVID-19 patients, postulating the potential therapeutic efficacy of zinc in the management of the disease. We sought to summarize the studies published to date regarding the antiviral activity of zinc in COVID-19 patients. A meta-analysis was performed to compare the outcomes of hospitalized patients receiving zinc supplementation and those treated with standard care. The primary outcome was survival to","2021","06","28","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Gasecka","Aleksandra",NA,NA
"2322","34180610","10.20452/pamw.16048","Should we supplement zinc in COVID-19 patients? Evidence from meta-analysis.","Preliminary retrospective reports showed that zinc supplementation may decrease mortality in COVID-19 patients, postulating the potential therapeutic efficacy of zinc in the management of the disease. We sought to summarize the studies published to date regarding the antiviral activity of zinc in COVID-19 patients. A meta-analysis was performed to compare the outcomes of hospitalized patients receiving zinc supplementation and those treated with standard care. The primary outcome was survival to","2021","06","28","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Jaguszewski","Milosz J",NA,NA
"2323","34180610","10.20452/pamw.16048","Should we supplement zinc in COVID-19 patients? Evidence from meta-analysis.","Preliminary retrospective reports showed that zinc supplementation may decrease mortality in COVID-19 patients, postulating the potential therapeutic efficacy of zinc in the management of the disease. We sought to summarize the studies published to date regarding the antiviral activity of zinc in COVID-19 patients. A meta-analysis was performed to compare the outcomes of hospitalized patients receiving zinc supplementation and those treated with standard care. The primary outcome was survival to","2021","06","28","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Michalski","Tomasz",NA,NA
"2324","34180610","10.20452/pamw.16048","Should we supplement zinc in COVID-19 patients? Evidence from meta-analysis.","Preliminary retrospective reports showed that zinc supplementation may decrease mortality in COVID-19 patients, postulating the potential therapeutic efficacy of zinc in the management of the disease. We sought to summarize the studies published to date regarding the antiviral activity of zinc in COVID-19 patients. A meta-analysis was performed to compare the outcomes of hospitalized patients receiving zinc supplementation and those treated with standard care. The primary outcome was survival to","2021","06","28","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Peacock","Frank W",NA,NA
"2325","34180610","10.20452/pamw.16048","Should we supplement zinc in COVID-19 patients? Evidence from meta-analysis.","Preliminary retrospective reports showed that zinc supplementation may decrease mortality in COVID-19 patients, postulating the potential therapeutic efficacy of zinc in the management of the disease. We sought to summarize the studies published to date regarding the antiviral activity of zinc in COVID-19 patients. A meta-analysis was performed to compare the outcomes of hospitalized patients receiving zinc supplementation and those treated with standard care. The primary outcome was survival to","2021","06","28","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Smereka","Jacek",NA,NA
"2326","34180610","10.20452/pamw.16048","Should we supplement zinc in COVID-19 patients? Evidence from meta-analysis.","Preliminary retrospective reports showed that zinc supplementation may decrease mortality in COVID-19 patients, postulating the potential therapeutic efficacy of zinc in the management of the disease. We sought to summarize the studies published to date regarding the antiviral activity of zinc in COVID-19 patients. A meta-analysis was performed to compare the outcomes of hospitalized patients receiving zinc supplementation and those treated with standard care. The primary outcome was survival to","2021","06","28","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Pytkowska","Katarzyna",NA,NA
"2327","34180610","10.20452/pamw.16048","Should we supplement zinc in COVID-19 patients? Evidence from meta-analysis.","Preliminary retrospective reports showed that zinc supplementation may decrease mortality in COVID-19 patients, postulating the potential therapeutic efficacy of zinc in the management of the disease. We sought to summarize the studies published to date regarding the antiviral activity of zinc in COVID-19 patients. A meta-analysis was performed to compare the outcomes of hospitalized patients receiving zinc supplementation and those treated with standard care. The primary outcome was survival to","2021","06","28","Pol Arch Intern Med","Polish archives of internal medicine",NA,"Filipiak","Krzysztof J",NA,NA
"2328","34180608","10.1002/wnan.1735","Biomaterials and nanomaterials for sustained release vaccine delivery.","Vaccines are considered one of the most significant medical advancements in human history, as they have prevented hundreds of millions of deaths since their discovery; however, modern travel permits disease spread at unprecedented rates, and vaccine shortcomings like thermal sensitivity and required booster shots have been made evident by the COVID-19 pandemic. Approaches to overcoming these issues appear promising via the integration of vaccine technology with biomaterials, which offer sustaine","2021","07","19","Wiley Interdiscip Rev Nanomed Nanobiotechnol","Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology","biomaterials; immunology; sustained release; vaccine","Luzuriaga","Michael A","Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA",NA
"2329","34180608","10.1002/wnan.1735","Biomaterials and nanomaterials for sustained release vaccine delivery.","Vaccines are considered one of the most significant medical advancements in human history, as they have prevented hundreds of millions of deaths since their discovery; however, modern travel permits disease spread at unprecedented rates, and vaccine shortcomings like thermal sensitivity and required booster shots have been made evident by the COVID-19 pandemic. Approaches to overcoming these issues appear promising via the integration of vaccine technology with biomaterials, which offer sustaine","2021","07","19","Wiley Interdiscip Rev Nanomed Nanobiotechnol","Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology","biomaterials; immunology; sustained release; vaccine","Shahrivarkevishahi","Arezoo","Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardon, Texas, USA",NA
"2330","34180608","10.1002/wnan.1735","Biomaterials and nanomaterials for sustained release vaccine delivery.","Vaccines are considered one of the most significant medical advancements in human history, as they have prevented hundreds of millions of deaths since their discovery; however, modern travel permits disease spread at unprecedented rates, and vaccine shortcomings like thermal sensitivity and required booster shots have been made evident by the COVID-19 pandemic. Approaches to overcoming these issues appear promising via the integration of vaccine technology with biomaterials, which offer sustaine","2021","07","19","Wiley Interdiscip Rev Nanomed Nanobiotechnol","Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology","biomaterials; immunology; sustained release; vaccine","Herbert","Fabian C","Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardon, Texas, USA",NA
"2331","34180608","10.1002/wnan.1735","Biomaterials and nanomaterials for sustained release vaccine delivery.","Vaccines are considered one of the most significant medical advancements in human history, as they have prevented hundreds of millions of deaths since their discovery; however, modern travel permits disease spread at unprecedented rates, and vaccine shortcomings like thermal sensitivity and required booster shots have been made evident by the COVID-19 pandemic. Approaches to overcoming these issues appear promising via the integration of vaccine technology with biomaterials, which offer sustaine","2021","07","19","Wiley Interdiscip Rev Nanomed Nanobiotechnol","Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology","biomaterials; immunology; sustained release; vaccine","Wijesundara","Yalini H","Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardon, Texas, USA",NA
"2332","34180608","10.1002/wnan.1735","Biomaterials and nanomaterials for sustained release vaccine delivery.","Vaccines are considered one of the most significant medical advancements in human history, as they have prevented hundreds of millions of deaths since their discovery; however, modern travel permits disease spread at unprecedented rates, and vaccine shortcomings like thermal sensitivity and required booster shots have been made evident by the COVID-19 pandemic. Approaches to overcoming these issues appear promising via the integration of vaccine technology with biomaterials, which offer sustaine","2021","07","19","Wiley Interdiscip Rev Nanomed Nanobiotechnol","Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology","biomaterials; immunology; sustained release; vaccine","Gassensmith","Jeremiah J","Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardon, Texas, USA",NA
"2333","34180590","10.1111/tbed.14208","Serological survey of antibodies against SARS-CoV-2 in dogs and cats, Thailand.","Coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome virus type 2 (SARS-CoV-2) is an emerging severe acute respiratory disease affecting global human health. In this study, a large-scale serological survey of antibodies against SARS-CoV-2 in dogs and cats was conducted during the first and second waves of COVID-19 outbreaks in Thailand, from April to December 2020. A total of 3215 serum samples were collected from dogs (n = 2102) and cats (n = 1113) living in Bangko","2021","07","09","Transbound Emerg Dis","Transboundary and emerging diseases","SARS-CoV-2; Thailand; cats; dogs; survey","Udom","Kitikhun","Center of Excellence for Emerging and Re-emerging Infectious Diseases in Animals and One Health Research Cluster, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand",NA
"2334","34180590","10.1111/tbed.14208","Serological survey of antibodies against SARS-CoV-2 in dogs and cats, Thailand.","Coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome virus type 2 (SARS-CoV-2) is an emerging severe acute respiratory disease affecting global human health. In this study, a large-scale serological survey of antibodies against SARS-CoV-2 in dogs and cats was conducted during the first and second waves of COVID-19 outbreaks in Thailand, from April to December 2020. A total of 3215 serum samples were collected from dogs (n = 2102) and cats (n = 1113) living in Bangko","2021","07","09","Transbound Emerg Dis","Transboundary and emerging diseases","SARS-CoV-2; Thailand; cats; dogs; survey","Jairak","Waleemas","Center of Excellence for Emerging and Re-emerging Infectious Diseases in Animals and One Health Research Cluster, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand",NA
"2335","34180590","10.1111/tbed.14208","Serological survey of antibodies against SARS-CoV-2 in dogs and cats, Thailand.","Coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome virus type 2 (SARS-CoV-2) is an emerging severe acute respiratory disease affecting global human health. In this study, a large-scale serological survey of antibodies against SARS-CoV-2 in dogs and cats was conducted during the first and second waves of COVID-19 outbreaks in Thailand, from April to December 2020. A total of 3215 serum samples were collected from dogs (n = 2102) and cats (n = 1113) living in Bangko","2021","07","09","Transbound Emerg Dis","Transboundary and emerging diseases","SARS-CoV-2; Thailand; cats; dogs; survey","Chamsai","Ekkapat","Center of Excellence for Emerging and Re-emerging Infectious Diseases in Animals and One Health Research Cluster, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand",NA
"2336","34180590","10.1111/tbed.14208","Serological survey of antibodies against SARS-CoV-2 in dogs and cats, Thailand.","Coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome virus type 2 (SARS-CoV-2) is an emerging severe acute respiratory disease affecting global human health. In this study, a large-scale serological survey of antibodies against SARS-CoV-2 in dogs and cats was conducted during the first and second waves of COVID-19 outbreaks in Thailand, from April to December 2020. A total of 3215 serum samples were collected from dogs (n = 2102) and cats (n = 1113) living in Bangko","2021","07","09","Transbound Emerg Dis","Transboundary and emerging diseases","SARS-CoV-2; Thailand; cats; dogs; survey","Charoenkul","Kamonpan","Center of Excellence for Emerging and Re-emerging Infectious Diseases in Animals and One Health Research Cluster, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand",NA
"2337","34180590","10.1111/tbed.14208","Serological survey of antibodies against SARS-CoV-2 in dogs and cats, Thailand.","Coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome virus type 2 (SARS-CoV-2) is an emerging severe acute respiratory disease affecting global human health. In this study, a large-scale serological survey of antibodies against SARS-CoV-2 in dogs and cats was conducted during the first and second waves of COVID-19 outbreaks in Thailand, from April to December 2020. A total of 3215 serum samples were collected from dogs (n = 2102) and cats (n = 1113) living in Bangko","2021","07","09","Transbound Emerg Dis","Transboundary and emerging diseases","SARS-CoV-2; Thailand; cats; dogs; survey","Boonyapisitsopa","Supanat","Center of Excellence for Emerging and Re-emerging Infectious Diseases in Animals and One Health Research Cluster, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand",NA
"2338","34180590","10.1111/tbed.14208","Serological survey of antibodies against SARS-CoV-2 in dogs and cats, Thailand.","Coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome virus type 2 (SARS-CoV-2) is an emerging severe acute respiratory disease affecting global human health. In this study, a large-scale serological survey of antibodies against SARS-CoV-2 in dogs and cats was conducted during the first and second waves of COVID-19 outbreaks in Thailand, from April to December 2020. A total of 3215 serum samples were collected from dogs (n = 2102) and cats (n = 1113) living in Bangko","2021","07","09","Transbound Emerg Dis","Transboundary and emerging diseases","SARS-CoV-2; Thailand; cats; dogs; survey","Bunpapong","Napawan","Center of Excellence for Emerging and Re-emerging Infectious Diseases in Animals and One Health Research Cluster, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand",NA
"2339","34180590","10.1111/tbed.14208","Serological survey of antibodies against SARS-CoV-2 in dogs and cats, Thailand.","Coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome virus type 2 (SARS-CoV-2) is an emerging severe acute respiratory disease affecting global human health. In this study, a large-scale serological survey of antibodies against SARS-CoV-2 in dogs and cats was conducted during the first and second waves of COVID-19 outbreaks in Thailand, from April to December 2020. A total of 3215 serum samples were collected from dogs (n = 2102) and cats (n = 1113) living in Bangko","2021","07","09","Transbound Emerg Dis","Transboundary and emerging diseases","SARS-CoV-2; Thailand; cats; dogs; survey","Techakriengkrai","Navapon","Center of Excellence for Emerging and Re-emerging Infectious Diseases in Animals and One Health Research Cluster, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand",NA
"2340","34180590","10.1111/tbed.14208","Serological survey of antibodies against SARS-CoV-2 in dogs and cats, Thailand.","Coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome virus type 2 (SARS-CoV-2) is an emerging severe acute respiratory disease affecting global human health. In this study, a large-scale serological survey of antibodies against SARS-CoV-2 in dogs and cats was conducted during the first and second waves of COVID-19 outbreaks in Thailand, from April to December 2020. A total of 3215 serum samples were collected from dogs (n = 2102) and cats (n = 1113) living in Bangko","2021","07","09","Transbound Emerg Dis","Transboundary and emerging diseases","SARS-CoV-2; Thailand; cats; dogs; survey","Amonsin","Alongkorn","Center of Excellence for Emerging and Re-emerging Infectious Diseases in Animals and One Health Research Cluster, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand",NA
"2341","34180562","10.1002/cbin.11653","miRNAs; a novel strategy for the treatment of COVID-19.","Coronavirus disease 2019 (COVID-19) is the seventh member of the bat severe acute respiratory syndrome family. COVID-19 can fuse their envelopes with the host cell membranes and deliver their genetic material. COVID-19 attacks the respiratory system and stimulates the host inflammatory responses, enhances the recruitment of immune cells, and promotes angiotensin-converting enzyme 2 activities. Patients with confirmed COVID-19 may have experienced fever, dry cough, headache, dyspnea, acute kidney","2021","07","05","Cell Biol Int","Cell biology international","ACE2; COVID-19; antiviral; coronavirus; miRNAs; viral RNA","Ying","Hao","Zhuji People's Hospital of Zhejiang Province, Zhuji Affiliated Hospital of Shaoxing University, Zhuji, China",NA
"2342","34180562","10.1002/cbin.11653","miRNAs; a novel strategy for the treatment of COVID-19.","Coronavirus disease 2019 (COVID-19) is the seventh member of the bat severe acute respiratory syndrome family. COVID-19 can fuse their envelopes with the host cell membranes and deliver their genetic material. COVID-19 attacks the respiratory system and stimulates the host inflammatory responses, enhances the recruitment of immune cells, and promotes angiotensin-converting enzyme 2 activities. Patients with confirmed COVID-19 may have experienced fever, dry cough, headache, dyspnea, acute kidney","2021","07","05","Cell Biol Int","Cell biology international","ACE2; COVID-19; antiviral; coronavirus; miRNAs; viral RNA","Ebrahimi","Mohsen","Neonatal and Children's Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran",NA
"2343","34180562","10.1002/cbin.11653","miRNAs; a novel strategy for the treatment of COVID-19.","Coronavirus disease 2019 (COVID-19) is the seventh member of the bat severe acute respiratory syndrome family. COVID-19 can fuse their envelopes with the host cell membranes and deliver their genetic material. COVID-19 attacks the respiratory system and stimulates the host inflammatory responses, enhances the recruitment of immune cells, and promotes angiotensin-converting enzyme 2 activities. Patients with confirmed COVID-19 may have experienced fever, dry cough, headache, dyspnea, acute kidney","2021","07","05","Cell Biol Int","Cell biology international","ACE2; COVID-19; antiviral; coronavirus; miRNAs; viral RNA","Keivan","Mona","Fertility, Infertility and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran",NA
"2344","34180562","10.1002/cbin.11653","miRNAs; a novel strategy for the treatment of COVID-19.","Coronavirus disease 2019 (COVID-19) is the seventh member of the bat severe acute respiratory syndrome family. COVID-19 can fuse their envelopes with the host cell membranes and deliver their genetic material. COVID-19 attacks the respiratory system and stimulates the host inflammatory responses, enhances the recruitment of immune cells, and promotes angiotensin-converting enzyme 2 activities. Patients with confirmed COVID-19 may have experienced fever, dry cough, headache, dyspnea, acute kidney","2021","07","05","Cell Biol Int","Cell biology international","ACE2; COVID-19; antiviral; coronavirus; miRNAs; viral RNA","Khoshnam","Seyed Esmaeil","Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran",NA
"2345","34180562","10.1002/cbin.11653","miRNAs; a novel strategy for the treatment of COVID-19.","Coronavirus disease 2019 (COVID-19) is the seventh member of the bat severe acute respiratory syndrome family. COVID-19 can fuse their envelopes with the host cell membranes and deliver their genetic material. COVID-19 attacks the respiratory system and stimulates the host inflammatory responses, enhances the recruitment of immune cells, and promotes angiotensin-converting enzyme 2 activities. Patients with confirmed COVID-19 may have experienced fever, dry cough, headache, dyspnea, acute kidney","2021","07","05","Cell Biol Int","Cell biology international","ACE2; COVID-19; antiviral; coronavirus; miRNAs; viral RNA","Salahi","Sarvenaz","Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran",NA
"2346","34180562","10.1002/cbin.11653","miRNAs; a novel strategy for the treatment of COVID-19.","Coronavirus disease 2019 (COVID-19) is the seventh member of the bat severe acute respiratory syndrome family. COVID-19 can fuse their envelopes with the host cell membranes and deliver their genetic material. COVID-19 attacks the respiratory system and stimulates the host inflammatory responses, enhances the recruitment of immune cells, and promotes angiotensin-converting enzyme 2 activities. Patients with confirmed COVID-19 may have experienced fever, dry cough, headache, dyspnea, acute kidney","2021","07","05","Cell Biol Int","Cell biology international","ACE2; COVID-19; antiviral; coronavirus; miRNAs; viral RNA","Farzaneh","Maryam","Fertility, Infertility and Perinatology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran",NA
"2347","34180546","10.1111/all.14991","One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2.","The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evolved into a worldwide pandemic with massive effects on health, quality of life, and economy. Given the short period of time since the outbreak, there are several knowledge gaps on the comparative and zoonotic aspects of this new virus. Within the One Health concept, the current EAACI position paper dwells into the current knowledge on SARS-CoV-2's recepto","2021","07","09","Allergy","Allergy","(reverse) zoonosis; One Health; companion animals and pets; coronavirus; disease transmission","Korath","Anna D J","Comparative Medicine, Interuniversity Messerli Research Institute, University of Veterinary Medicine and Medical University Vienna, Vienna, Austria",NA
"2348","34180546","10.1111/all.14991","One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2.","The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evolved into a worldwide pandemic with massive effects on health, quality of life, and economy. Given the short period of time since the outbreak, there are several knowledge gaps on the comparative and zoonotic aspects of this new virus. Within the One Health concept, the current EAACI position paper dwells into the current knowledge on SARS-CoV-2's recepto","2021","07","09","Allergy","Allergy","(reverse) zoonosis; One Health; companion animals and pets; coronavirus; disease transmission","Janda","Jozef","Faculty of Science, Charles University, Prague, Czech Republic",NA
"2349","34180546","10.1111/all.14991","One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2.","The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evolved into a worldwide pandemic with massive effects on health, quality of life, and economy. Given the short period of time since the outbreak, there are several knowledge gaps on the comparative and zoonotic aspects of this new virus. Within the One Health concept, the current EAACI position paper dwells into the current knowledge on SARS-CoV-2's recepto","2021","07","09","Allergy","Allergy","(reverse) zoonosis; One Health; companion animals and pets; coronavirus; disease transmission","Untersmayr","Eva","Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria",NA
"2350","34180546","10.1111/all.14991","One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2.","The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evolved into a worldwide pandemic with massive effects on health, quality of life, and economy. Given the short period of time since the outbreak, there are several knowledge gaps on the comparative and zoonotic aspects of this new virus. Within the One Health concept, the current EAACI position paper dwells into the current knowledge on SARS-CoV-2's recepto","2021","07","09","Allergy","Allergy","(reverse) zoonosis; One Health; companion animals and pets; coronavirus; disease transmission","Sokolowska","Milena","Swiss Institute of Allergy and Asthma Research (SIAF),, University of Zurich, Zurich, Switzerland",NA
"2351","34180546","10.1111/all.14991","One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2.","The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evolved into a worldwide pandemic with massive effects on health, quality of life, and economy. Given the short period of time since the outbreak, there are several knowledge gaps on the comparative and zoonotic aspects of this new virus. Within the One Health concept, the current EAACI position paper dwells into the current knowledge on SARS-CoV-2's recepto","2021","07","09","Allergy","Allergy","(reverse) zoonosis; One Health; companion animals and pets; coronavirus; disease transmission","Feleszko","Wojciech","Department of Paediatric Allergy and Pulmonology, The Medical University of Warsaw, Warsaw, Poland",NA
"2352","34180546","10.1111/all.14991","One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2.","The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evolved into a worldwide pandemic with massive effects on health, quality of life, and economy. Given the short period of time since the outbreak, there are several knowledge gaps on the comparative and zoonotic aspects of this new virus. Within the One Health concept, the current EAACI position paper dwells into the current knowledge on SARS-CoV-2's recepto","2021","07","09","Allergy","Allergy","(reverse) zoonosis; One Health; companion animals and pets; coronavirus; disease transmission","Agache","Ioana","Transylvania University, Brasov, Romania",NA
"2353","34180546","10.1111/all.14991","One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2.","The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evolved into a worldwide pandemic with massive effects on health, quality of life, and economy. Given the short period of time since the outbreak, there are several knowledge gaps on the comparative and zoonotic aspects of this new virus. Within the One Health concept, the current EAACI position paper dwells into the current knowledge on SARS-CoV-2's recepto","2021","07","09","Allergy","Allergy","(reverse) zoonosis; One Health; companion animals and pets; coronavirus; disease transmission","Adel Seida","Ahmed","Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt",NA
"2354","34180546","10.1111/all.14991","One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2.","The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evolved into a worldwide pandemic with massive effects on health, quality of life, and economy. Given the short period of time since the outbreak, there are several knowledge gaps on the comparative and zoonotic aspects of this new virus. Within the One Health concept, the current EAACI position paper dwells into the current knowledge on SARS-CoV-2's recepto","2021","07","09","Allergy","Allergy","(reverse) zoonosis; One Health; companion animals and pets; coronavirus; disease transmission","Hartmann","Katrin","Medizinische Kleintierklinik, Zentrum für Klinische Tiermedizin, LMU, Munich, Germany",NA
"2355","34180546","10.1111/all.14991","One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2.","The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evolved into a worldwide pandemic with massive effects on health, quality of life, and economy. Given the short period of time since the outbreak, there are several knowledge gaps on the comparative and zoonotic aspects of this new virus. Within the One Health concept, the current EAACI position paper dwells into the current knowledge on SARS-CoV-2's recepto","2021","07","09","Allergy","Allergy","(reverse) zoonosis; One Health; companion animals and pets; coronavirus; disease transmission","Jensen-Jarolim","Erika","Comparative Medicine, Interuniversity Messerli Research Institute, University of Veterinary Medicine and Medical University Vienna, Vienna, Austria",NA
"2356","34180546","10.1111/all.14991","One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2.","The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evolved into a worldwide pandemic with massive effects on health, quality of life, and economy. Given the short period of time since the outbreak, there are several knowledge gaps on the comparative and zoonotic aspects of this new virus. Within the One Health concept, the current EAACI position paper dwells into the current knowledge on SARS-CoV-2's recepto","2021","07","09","Allergy","Allergy","(reverse) zoonosis; One Health; companion animals and pets; coronavirus; disease transmission","Pali-Schöll","Isabella","Comparative Medicine, Interuniversity Messerli Research Institute, University of Veterinary Medicine and Medical University Vienna, Vienna, Austria",NA
"2357","34180452","10.3233/WOR-213512","Interference: COVID-19 and the Impact on Potential and Performance in Healthcare.","COVID-19 has had a significant effect on all aspects of life and occupational performance most recently. This aim of this article was to discuss the concept of interference and the role that interference plays in productivity and potential across healthcare settings. The framework design was the application of Bolea and Atwater's interference framework to probe the COVID-19 pandemic within healthcare organizations. Leadership that focuses on transparency, frequent metric measurement can increase","2021","06","28","Work","Work (Reading, Mass.)","Leadership; communication; occupational therapy; organizational behavior","Sizemore","Leslie M","Theracare, Manchester, KY, USA",NA
"2358","34180452","10.3233/WOR-213512","Interference: COVID-19 and the Impact on Potential and Performance in Healthcare.","COVID-19 has had a significant effect on all aspects of life and occupational performance most recently. This aim of this article was to discuss the concept of interference and the role that interference plays in productivity and potential across healthcare settings. The framework design was the application of Bolea and Atwater's interference framework to probe the COVID-19 pandemic within healthcare organizations. Leadership that focuses on transparency, frequent metric measurement can increase","2021","06","28","Work","Work (Reading, Mass.)","Leadership; communication; occupational therapy; organizational behavior","Peganoff-O'Brien","Shirley","Occupational Science and Occupational Therapy, Eastern Kentucky University, Richmond, KY, USA",NA
"2359","34180452","10.3233/WOR-213512","Interference: COVID-19 and the Impact on Potential and Performance in Healthcare.","COVID-19 has had a significant effect on all aspects of life and occupational performance most recently. This aim of this article was to discuss the concept of interference and the role that interference plays in productivity and potential across healthcare settings. The framework design was the application of Bolea and Atwater's interference framework to probe the COVID-19 pandemic within healthcare organizations. Leadership that focuses on transparency, frequent metric measurement can increase","2021","06","28","Work","Work (Reading, Mass.)","Leadership; communication; occupational therapy; organizational behavior","Skubik-Peplaski","Camille","Occupational Science and Occupational Therapy, Eastern Kentucky University, Richmond, KY, USA",NA
"2360","34180450","10.3233/WOR-210503","New patient access via telehealth in neuromuscular medicine during COVID-19.","The coronavirus disease 2019 (COVID-19) pandemic has changed the face of health care delivery. Health care institutions rapidly transitioned to telehealth to provide care to patients. Prior to the pandemic, telehealth services extended mostly to patients with established diagnoses. Driven by a necessity to provide care to all patients during the pandemic, neurologists started evaluating new patients also via telehealth. To explore opportunities, challenges, and feasibility of telehealth for new ","2021","06","28","Work","Work (Reading, Mass.)","Virtual care; challenges; feasibility; neurology; quality care","Khan","Shaida","Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA",NA
"2361","34180450","10.3233/WOR-210503","New patient access via telehealth in neuromuscular medicine during COVID-19.","The coronavirus disease 2019 (COVID-19) pandemic has changed the face of health care delivery. Health care institutions rapidly transitioned to telehealth to provide care to patients. Prior to the pandemic, telehealth services extended mostly to patients with established diagnoses. Driven by a necessity to provide care to all patients during the pandemic, neurologists started evaluating new patients also via telehealth. To explore opportunities, challenges, and feasibility of telehealth for new ","2021","06","28","Work","Work (Reading, Mass.)","Virtual care; challenges; feasibility; neurology; quality care","Kramer","Alan","Department of Health System Strategy, UT Southwestern Medical Center, Dallas, TX, USA",NA
"2362","34180450","10.3233/WOR-210503","New patient access via telehealth in neuromuscular medicine during COVID-19.","The coronavirus disease 2019 (COVID-19) pandemic has changed the face of health care delivery. Health care institutions rapidly transitioned to telehealth to provide care to patients. Prior to the pandemic, telehealth services extended mostly to patients with established diagnoses. Driven by a necessity to provide care to all patients during the pandemic, neurologists started evaluating new patients also via telehealth. To explore opportunities, challenges, and feasibility of telehealth for new ","2021","06","28","Work","Work (Reading, Mass.)","Virtual care; challenges; feasibility; neurology; quality care","McIver","Johnathan","Department of Health System Strategy, UT Southwestern Medical Center, Dallas, TX, USA",NA
"2363","34180450","10.3233/WOR-210503","New patient access via telehealth in neuromuscular medicine during COVID-19.","The coronavirus disease 2019 (COVID-19) pandemic has changed the face of health care delivery. Health care institutions rapidly transitioned to telehealth to provide care to patients. Prior to the pandemic, telehealth services extended mostly to patients with established diagnoses. Driven by a necessity to provide care to all patients during the pandemic, neurologists started evaluating new patients also via telehealth. To explore opportunities, challenges, and feasibility of telehealth for new ","2021","06","28","Work","Work (Reading, Mass.)","Virtual care; challenges; feasibility; neurology; quality care","Cady","Leah","Department of Health System Strategy, UT Southwestern Medical Center, Dallas, TX, USA",NA
"2364","34180450","10.3233/WOR-210503","New patient access via telehealth in neuromuscular medicine during COVID-19.","The coronavirus disease 2019 (COVID-19) pandemic has changed the face of health care delivery. Health care institutions rapidly transitioned to telehealth to provide care to patients. Prior to the pandemic, telehealth services extended mostly to patients with established diagnoses. Driven by a necessity to provide care to all patients during the pandemic, neurologists started evaluating new patients also via telehealth. To explore opportunities, challenges, and feasibility of telehealth for new ","2021","06","28","Work","Work (Reading, Mass.)","Virtual care; challenges; feasibility; neurology; quality care","Trivedi","Jaya R","Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA",NA
"2365","34180449","10.3233/WOR-210477","Occupational risk factors of contracting COVID-19 among health workers: A systematic review.","With the spread of COVID-19 and the worsening global prevention and control situation, the risk of infection faced by health workers has been unprecedented. It is necessary to fully understand the occupational risks of health workers to protect them and reduce their risk of infection. This study aimed to obtain comprehensive and detailed information on occupational risk factors of infectious diseases for HWs in different dimensions and to propose control strategies for three risk dimensions to p","2021","06","28","Work","Work (Reading, Mass.)","Coronavirus 2; bibliometric analysis; infection control strategies; infection risk factors; occupational safety","Jin","Haizhe","School of Business Administration, Northeastern University, Shenyang, China",NA
"2366","34180449","10.3233/WOR-210477","Occupational risk factors of contracting COVID-19 among health workers: A systematic review.","With the spread of COVID-19 and the worsening global prevention and control situation, the risk of infection faced by health workers has been unprecedented. It is necessary to fully understand the occupational risks of health workers to protect them and reduce their risk of infection. This study aimed to obtain comprehensive and detailed information on occupational risk factors of infectious diseases for HWs in different dimensions and to propose control strategies for three risk dimensions to p","2021","06","28","Work","Work (Reading, Mass.)","Coronavirus 2; bibliometric analysis; infection control strategies; infection risk factors; occupational safety","Chen","Yuxiao","School of Business Administration, Northeastern University, Shenyang, China",NA
"2367","34180449","10.3233/WOR-210477","Occupational risk factors of contracting COVID-19 among health workers: A systematic review.","With the spread of COVID-19 and the worsening global prevention and control situation, the risk of infection faced by health workers has been unprecedented. It is necessary to fully understand the occupational risks of health workers to protect them and reduce their risk of infection. This study aimed to obtain comprehensive and detailed information on occupational risk factors of infectious diseases for HWs in different dimensions and to propose control strategies for three risk dimensions to p","2021","06","28","Work","Work (Reading, Mass.)","Coronavirus 2; bibliometric analysis; infection control strategies; infection risk factors; occupational safety","Fu","Quanwei","Dongguan Kanghua Hospital, Dongguan, China",NA
"2368","34180449","10.3233/WOR-210477","Occupational risk factors of contracting COVID-19 among health workers: A systematic review.","With the spread of COVID-19 and the worsening global prevention and control situation, the risk of infection faced by health workers has been unprecedented. It is necessary to fully understand the occupational risks of health workers to protect them and reduce their risk of infection. This study aimed to obtain comprehensive and detailed information on occupational risk factors of infectious diseases for HWs in different dimensions and to propose control strategies for three risk dimensions to p","2021","06","28","Work","Work (Reading, Mass.)","Coronavirus 2; bibliometric analysis; infection control strategies; infection risk factors; occupational safety","Qu","Qingxing","School of Business Administration, Northeastern University, Shenyang, China",NA
"2369","34180448","10.3233/WOR-210412","Macro ergonomics and health workers during COVID-19 pandemic.",NA,"2021","06","28","Work","Work (Reading, Mass.)","COVID-19; ergonomics; health workers; occupational health","Khajehnasiri","Farahnaz","Department of Community Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran",NA
"2370","34180448","10.3233/WOR-210412","Macro ergonomics and health workers during COVID-19 pandemic.",NA,"2021","06","28","Work","Work (Reading, Mass.)","COVID-19; ergonomics; health workers; occupational health","Zaroushani","Vida","Social Determinants of Health Research Center, Research Institute for Prevention of Non-Communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran",NA
"2371","34180448","10.3233/WOR-210412","Macro ergonomics and health workers during COVID-19 pandemic.",NA,"2021","06","28","Work","Work (Reading, Mass.)","COVID-19; ergonomics; health workers; occupational health","Poursadeqiyan","Mohsen","Department of occupational health Engineering, school of Health, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran",NA
"2372","34180447","10.3233/WOR-210033","Effects of the COVID-19 lockdown on musculoskeletal pain, physical activity, and work environment in Estonian office workers transitioning to working from home.","COVID-19 lockdown caused a sudden change in the work culture and environment. The aim of this study was to evaluate the impact of COVID-19 lockdown caused changes in musculoskeletal pain (MSP), physical activity (PA), workplace properties, and their in-between relationships among office workers. A total of 161 office workers (64.6%female) with a mean age of 38.2±9.5 years participated. The study was conducted as an online form. Baecke Physical Activity Questionnaire, NORDIC Questionnaire, and qu","2021","06","28","Work","Work (Reading, Mass.)","COVID-19; musculoskeletal pain; office workers; physical activity; work environment","Argus","Martin","Institute of Sport Sciences and Physiotherapy, University of Tartu, Estonia",NA
"2373","34180447","10.3233/WOR-210033","Effects of the COVID-19 lockdown on musculoskeletal pain, physical activity, and work environment in Estonian office workers transitioning to working from home.","COVID-19 lockdown caused a sudden change in the work culture and environment. The aim of this study was to evaluate the impact of COVID-19 lockdown caused changes in musculoskeletal pain (MSP), physical activity (PA), workplace properties, and their in-between relationships among office workers. A total of 161 office workers (64.6%female) with a mean age of 38.2±9.5 years participated. The study was conducted as an online form. Baecke Physical Activity Questionnaire, NORDIC Questionnaire, and qu","2021","06","28","Work","Work (Reading, Mass.)","COVID-19; musculoskeletal pain; office workers; physical activity; work environment","Pääsuke","Mati","Institute of Sport Sciences and Physiotherapy, University of Tartu, Estonia",NA
"2374","34180446","10.3233/WOR-205253","The impact of the COVID-19 pandemic on resident physicians: A cross-sectional study.","COVID-19 presents a threat to the mental health of the medical staff working with COVID-19 patients. To investigate the impact of working during the COVID-19 pandemic on resident physicians. The study was conducted via anonymous online survey and included resident physicians. The survey contained questions about sociodemographic information, general job satisfaction during the COVID-19 pandemic, and the impact of the COVID-19 pandemic on their personal lives. This study included a response from ","2021","06","28","Work","Work (Reading, Mass.)","Internship; residency; surveys and questionnaires","Barac","Anja","Department of Internal Medicine, General Hospital Dubrovnik, Roka Misetica, Dubrovnik, Croatia",NA
"2375","34180446","10.3233/WOR-205253","The impact of the COVID-19 pandemic on resident physicians: A cross-sectional study.","COVID-19 presents a threat to the mental health of the medical staff working with COVID-19 patients. To investigate the impact of working during the COVID-19 pandemic on resident physicians. The study was conducted via anonymous online survey and included resident physicians. The survey contained questions about sociodemographic information, general job satisfaction during the COVID-19 pandemic, and the impact of the COVID-19 pandemic on their personal lives. This study included a response from ","2021","06","28","Work","Work (Reading, Mass.)","Internship; residency; surveys and questionnaires","Krnjaic","Paola","Department of Pediatrics, General Hospital Dubrovnik, Roka Misetica, Dubrovnik, Croatia",NA
"2376","34180446","10.3233/WOR-205253","The impact of the COVID-19 pandemic on resident physicians: A cross-sectional study.","COVID-19 presents a threat to the mental health of the medical staff working with COVID-19 patients. To investigate the impact of working during the COVID-19 pandemic on resident physicians. The study was conducted via anonymous online survey and included resident physicians. The survey contained questions about sociodemographic information, general job satisfaction during the COVID-19 pandemic, and the impact of the COVID-19 pandemic on their personal lives. This study included a response from ","2021","06","28","Work","Work (Reading, Mass.)","Internship; residency; surveys and questionnaires","Vujnovic","Nikola","Trauma and Orthopaedic Department, General Hospital Dubrovnik, Roka Misetica, Dubrovnik, Croatia",NA
"2377","34180446","10.3233/WOR-205253","The impact of the COVID-19 pandemic on resident physicians: A cross-sectional study.","COVID-19 presents a threat to the mental health of the medical staff working with COVID-19 patients. To investigate the impact of working during the COVID-19 pandemic on resident physicians. The study was conducted via anonymous online survey and included resident physicians. The survey contained questions about sociodemographic information, general job satisfaction during the COVID-19 pandemic, and the impact of the COVID-19 pandemic on their personal lives. This study included a response from ","2021","06","28","Work","Work (Reading, Mass.)","Internship; residency; surveys and questionnaires","Matas","Nino","Department of Internal Medicine, General Hospital Dubrovnik, Roka Misetica, Dubrovnik, Croatia",NA
"2378","34180446","10.3233/WOR-205253","The impact of the COVID-19 pandemic on resident physicians: A cross-sectional study.","COVID-19 presents a threat to the mental health of the medical staff working with COVID-19 patients. To investigate the impact of working during the COVID-19 pandemic on resident physicians. The study was conducted via anonymous online survey and included resident physicians. The survey contained questions about sociodemographic information, general job satisfaction during the COVID-19 pandemic, and the impact of the COVID-19 pandemic on their personal lives. This study included a response from ","2021","06","28","Work","Work (Reading, Mass.)","Internship; residency; surveys and questionnaires","Runjic","Edita","Department of Pediatrics, General Hospital Dubrovnik, Roka Misetica, Dubrovnik, Croatia",NA
"2379","34180446","10.3233/WOR-205253","The impact of the COVID-19 pandemic on resident physicians: A cross-sectional study.","COVID-19 presents a threat to the mental health of the medical staff working with COVID-19 patients. To investigate the impact of working during the COVID-19 pandemic on resident physicians. The study was conducted via anonymous online survey and included resident physicians. The survey contained questions about sociodemographic information, general job satisfaction during the COVID-19 pandemic, and the impact of the COVID-19 pandemic on their personal lives. This study included a response from ","2021","06","28","Work","Work (Reading, Mass.)","Internship; residency; surveys and questionnaires","Rogoznica","Marija","Department of Rheumatology, Rehabilitation and Physical Medicine, Hospital for Medical Rehabilitation of Hearth and Lung Diseases and Rheumatism ""Thalassotherapia Opatija"" Ul. Marsala Tita, Opatija, Croatia",NA
"2380","34180446","10.3233/WOR-205253","The impact of the COVID-19 pandemic on resident physicians: A cross-sectional study.","COVID-19 presents a threat to the mental health of the medical staff working with COVID-19 patients. To investigate the impact of working during the COVID-19 pandemic on resident physicians. The study was conducted via anonymous online survey and included resident physicians. The survey contained questions about sociodemographic information, general job satisfaction during the COVID-19 pandemic, and the impact of the COVID-19 pandemic on their personal lives. This study included a response from ","2021","06","28","Work","Work (Reading, Mass.)","Internship; residency; surveys and questionnaires","Markic","Josko","Department of Pediatrics, University Hospital of Split, Spinciceva, Split, Croatia",NA
"2381","34180446","10.3233/WOR-205253","The impact of the COVID-19 pandemic on resident physicians: A cross-sectional study.","COVID-19 presents a threat to the mental health of the medical staff working with COVID-19 patients. To investigate the impact of working during the COVID-19 pandemic on resident physicians. The study was conducted via anonymous online survey and included resident physicians. The survey contained questions about sociodemographic information, general job satisfaction during the COVID-19 pandemic, and the impact of the COVID-19 pandemic on their personal lives. This study included a response from ","2021","06","28","Work","Work (Reading, Mass.)","Internship; residency; surveys and questionnaires","Jelicic Kadic","Antonia","Department of Pediatrics, University Hospital of Split, Spinciceva, Split, Croatia",NA
"2382","34180445","10.3233/WOR-205101","Relationship between work-related ocular events, facial injuries and associated factors amongst dental professionals during COVID-19.","In dental settings, COVID-19 can be transmitted directly from patients to dentists through small droplets, saliva splashes, blood, and other body fluids liberated as a result of dental procedures. To determine the prevalence of ocular and facial injuries in dental professionals and to investigate factors in dental practice contributing to ocular injuries. An analytical cross-sectional study was performed in public and private sector universities. The study had 301 participants including final ye","2021","06","28","Work","Work (Reading, Mass.)","Dental settings; aerosols; dentists; injury; ocular; saliva","Anzar","Wajiha","Dow International Dental College, Dow University of Health Sciences Karachi, Pakistan",NA
"2383","34180445","10.3233/WOR-205101","Relationship between work-related ocular events, facial injuries and associated factors amongst dental professionals during COVID-19.","In dental settings, COVID-19 can be transmitted directly from patients to dentists through small droplets, saliva splashes, blood, and other body fluids liberated as a result of dental procedures. To determine the prevalence of ocular and facial injuries in dental professionals and to investigate factors in dental practice contributing to ocular injuries. An analytical cross-sectional study was performed in public and private sector universities. The study had 301 participants including final ye","2021","06","28","Work","Work (Reading, Mass.)","Dental settings; aerosols; dentists; injury; ocular; saliva","Afaq","Ashar","Dow International Dental College, Dow University of Health Sciences Karachi, Pakistan",NA
"2384","34180445","10.3233/WOR-205101","Relationship between work-related ocular events, facial injuries and associated factors amongst dental professionals during COVID-19.","In dental settings, COVID-19 can be transmitted directly from patients to dentists through small droplets, saliva splashes, blood, and other body fluids liberated as a result of dental procedures. To determine the prevalence of ocular and facial injuries in dental professionals and to investigate factors in dental practice contributing to ocular injuries. An analytical cross-sectional study was performed in public and private sector universities. The study had 301 participants including final ye","2021","06","28","Work","Work (Reading, Mass.)","Dental settings; aerosols; dentists; injury; ocular; saliva","Baig","Qaiser Ali","Dow International Dental College, Dow University of Health Sciences Karachi, Pakistan",NA
"2385","34180445","10.3233/WOR-205101","Relationship between work-related ocular events, facial injuries and associated factors amongst dental professionals during COVID-19.","In dental settings, COVID-19 can be transmitted directly from patients to dentists through small droplets, saliva splashes, blood, and other body fluids liberated as a result of dental procedures. To determine the prevalence of ocular and facial injuries in dental professionals and to investigate factors in dental practice contributing to ocular injuries. An analytical cross-sectional study was performed in public and private sector universities. The study had 301 participants including final ye","2021","06","28","Work","Work (Reading, Mass.)","Dental settings; aerosols; dentists; injury; ocular; saliva","Mohamed","Osama Y","Department of Pharmacology, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"2386","34180445","10.3233/WOR-205101","Relationship between work-related ocular events, facial injuries and associated factors amongst dental professionals during COVID-19.","In dental settings, COVID-19 can be transmitted directly from patients to dentists through small droplets, saliva splashes, blood, and other body fluids liberated as a result of dental procedures. To determine the prevalence of ocular and facial injuries in dental professionals and to investigate factors in dental practice contributing to ocular injuries. An analytical cross-sectional study was performed in public and private sector universities. The study had 301 participants including final ye","2021","06","28","Work","Work (Reading, Mass.)","Dental settings; aerosols; dentists; injury; ocular; saliva","Bukhari","Ishfaq A","Department of Pharmacology, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"2387","34180445","10.3233/WOR-205101","Relationship between work-related ocular events, facial injuries and associated factors amongst dental professionals during COVID-19.","In dental settings, COVID-19 can be transmitted directly from patients to dentists through small droplets, saliva splashes, blood, and other body fluids liberated as a result of dental procedures. To determine the prevalence of ocular and facial injuries in dental professionals and to investigate factors in dental practice contributing to ocular injuries. An analytical cross-sectional study was performed in public and private sector universities. The study had 301 participants including final ye","2021","06","28","Work","Work (Reading, Mass.)","Dental settings; aerosols; dentists; injury; ocular; saliva","Vohra","Fahim","Department of Prosthetic Dental Science, College of Dentistry, King Saud University, Riyadh, Saudi Arabia",NA
"2388","34180390","10.1017/S1047951121002547","Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine.","Two adolescent males presented within 3 days after the first and second dose of the BNT162b2 vaccine with chest pain. Elevated troponin levels, ST segment elevation, and enhancement of the myocardium in cardiac MRI suggested myocarditis. Left ventricular function remained normal, symptoms resolved, and patients were discharged in 4 days. BNT162b2 vaccine may be associated with self-limited myocarditis in youth.","2021","06","28","Cardiol Young","Cardiology in the young","COVID-19; ST segment elevation; myocarditis; troponin; vaccine","Park","Jihyun","Department of Pediatrics, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA",NA
"2389","34180390","10.1017/S1047951121002547","Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine.","Two adolescent males presented within 3 days after the first and second dose of the BNT162b2 vaccine with chest pain. Elevated troponin levels, ST segment elevation, and enhancement of the myocardium in cardiac MRI suggested myocarditis. Left ventricular function remained normal, symptoms resolved, and patients were discharged in 4 days. BNT162b2 vaccine may be associated with self-limited myocarditis in youth.","2021","06","28","Cardiol Young","Cardiology in the young","COVID-19; ST segment elevation; myocarditis; troponin; vaccine","Brekke","Dona R","Department of Pediatrics, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA",NA
"2390","34180390","10.1017/S1047951121002547","Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine.","Two adolescent males presented within 3 days after the first and second dose of the BNT162b2 vaccine with chest pain. Elevated troponin levels, ST segment elevation, and enhancement of the myocardium in cardiac MRI suggested myocarditis. Left ventricular function remained normal, symptoms resolved, and patients were discharged in 4 days. BNT162b2 vaccine may be associated with self-limited myocarditis in youth.","2021","06","28","Cardiol Young","Cardiology in the young","COVID-19; ST segment elevation; myocarditis; troponin; vaccine","Bratincsak","Andras","Department of Pediatrics, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA",NA
"2391","34180381","10.1017/S0950268821001370","RE: George <i>et al.</i> 'High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?'",NA,"2021","07","13","Epidemiol Infect","Epidemiology and infection","COVID-19; Humans; India; Pandemics; Poverty Areas; SARS-CoV-2; Seroepidemiologic Studies","Cardenas","Victor M","Department of Epidemiology, Fay W. Boozman College of Public Health University of Arkansas for Medical Sciences, 4301 W. Markham #820, Little Rock, 72205, Arkansas, USA",NA
"2392","34180374","10.1080/07391102.2021.1938230","The novel tetrahydropyrimidine derivative as inhibitor of SARS CoV-2: synthesis, modeling and molecular docking analysis.","N-(1,3-Benzothiazol-2-yl)-N-(1,4,5,6-tetrahydro-1H-pyrimidine-2-yl) amine was synthesized and characterized by elemental analysis, FT-IR, NMR and X-ray single crystal diffraction. The compound structure belongs to the triclinic system with the P-1 space group with unit cell parameters a = 11.9290(4), b = 13.2547(4) and c = 15.3904(5) Å. Hirhsfeld surface analysis is performed to revealintermolecular interactions with these interactions. The molecular structure, vibrational s","2021","06","28","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","ADMET; DFT/B3LYP; Drug-likeness; SARS-CoV-2; Tetrahydropyrimidine","Karagoz Genç","Zuhal","Metallurgy and Materials Engineering, Engineering Faculty, Adiyaman University, Adiyaman, Turkey",NA
"2393","34180374","10.1080/07391102.2021.1938230","The novel tetrahydropyrimidine derivative as inhibitor of SARS CoV-2: synthesis, modeling and molecular docking analysis.","N-(1,3-Benzothiazol-2-yl)-N-(1,4,5,6-tetrahydro-1H-pyrimidine-2-yl) amine was synthesized and characterized by elemental analysis, FT-IR, NMR and X-ray single crystal diffraction. The compound structure belongs to the triclinic system with the P-1 space group with unit cell parameters a = 11.9290(4), b = 13.2547(4) and c = 15.3904(5) Å. Hirhsfeld surface analysis is performed to revealintermolecular interactions with these interactions. The molecular structure, vibrational s","2021","06","28","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","ADMET; DFT/B3LYP; Drug-likeness; SARS-CoV-2; Tetrahydropyrimidine","Genç","Murat","Chemistry Department, Science and Arts Faculty, Adiyaman University, Adiyaman, Turkey",NA
"2394","34180374","10.1080/07391102.2021.1938230","The novel tetrahydropyrimidine derivative as inhibitor of SARS CoV-2: synthesis, modeling and molecular docking analysis.","N-(1,3-Benzothiazol-2-yl)-N-(1,4,5,6-tetrahydro-1H-pyrimidine-2-yl) amine was synthesized and characterized by elemental analysis, FT-IR, NMR and X-ray single crystal diffraction. The compound structure belongs to the triclinic system with the P-1 space group with unit cell parameters a = 11.9290(4), b = 13.2547(4) and c = 15.3904(5) Å. Hirhsfeld surface analysis is performed to revealintermolecular interactions with these interactions. The molecular structure, vibrational s","2021","06","28","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","ADMET; DFT/B3LYP; Drug-likeness; SARS-CoV-2; Tetrahydropyrimidine","Çosut","Bünyemin","Chemistry Department, Faculty of Science, Gebze Technical University, Gebze, Kocaeli, Turkey",NA
"2395","34180374","10.1080/07391102.2021.1938230","The novel tetrahydropyrimidine derivative as inhibitor of SARS CoV-2: synthesis, modeling and molecular docking analysis.","N-(1,3-Benzothiazol-2-yl)-N-(1,4,5,6-tetrahydro-1H-pyrimidine-2-yl) amine was synthesized and characterized by elemental analysis, FT-IR, NMR and X-ray single crystal diffraction. The compound structure belongs to the triclinic system with the P-1 space group with unit cell parameters a = 11.9290(4), b = 13.2547(4) and c = 15.3904(5) Å. Hirhsfeld surface analysis is performed to revealintermolecular interactions with these interactions. The molecular structure, vibrational s","2021","06","28","J Biomol Struct Dyn","Journal of biomolecular structure &amp; dynamics","ADMET; DFT/B3LYP; Drug-likeness; SARS-CoV-2; Tetrahydropyrimidine","Turgut","Mehmet","Pediatric Department, Adiyaman University, Training and Research Hospital, Adiyaman, Turkey",NA
"2396","34180347","10.1080/14760584.2021.1949293","COVID-19 vaccines: concerns beyond protective efficacy and safety.","Several vaccine candidates have been developed using different platforms, including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus-like particles, peptide-based, recombinant proteins, live attenuated, and inactivated virus modalities. Although many of these vaccines are undergoing pre-clinical trials, several large clinical trials investigating the clinical efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines have produced promising findings. I","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","COVID-19; cellular immunity; protective efficacy; safety; sars-cov-2; vaccination willingness; vaccine; variants of concern","Lai","Chih-Cheng","Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan",NA
"2397","34180347","10.1080/14760584.2021.1949293","COVID-19 vaccines: concerns beyond protective efficacy and safety.","Several vaccine candidates have been developed using different platforms, including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus-like particles, peptide-based, recombinant proteins, live attenuated, and inactivated virus modalities. Although many of these vaccines are undergoing pre-clinical trials, several large clinical trials investigating the clinical efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines have produced promising findings. I","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","COVID-19; cellular immunity; protective efficacy; safety; sars-cov-2; vaccination willingness; vaccine; variants of concern","Chen","I-Tzu","Department of Pharmacy, National Taiwan University Cancer Center, Taipei, Taiwan",NA
"2398","34180347","10.1080/14760584.2021.1949293","COVID-19 vaccines: concerns beyond protective efficacy and safety.","Several vaccine candidates have been developed using different platforms, including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus-like particles, peptide-based, recombinant proteins, live attenuated, and inactivated virus modalities. Although many of these vaccines are undergoing pre-clinical trials, several large clinical trials investigating the clinical efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines have produced promising findings. I","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","COVID-19; cellular immunity; protective efficacy; safety; sars-cov-2; vaccination willingness; vaccine; variants of concern","Chao","Chien-Ming","Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan",NA
"2399","34180347","10.1080/14760584.2021.1949293","COVID-19 vaccines: concerns beyond protective efficacy and safety.","Several vaccine candidates have been developed using different platforms, including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus-like particles, peptide-based, recombinant proteins, live attenuated, and inactivated virus modalities. Although many of these vaccines are undergoing pre-clinical trials, several large clinical trials investigating the clinical efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines have produced promising findings. I","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","COVID-19; cellular immunity; protective efficacy; safety; sars-cov-2; vaccination willingness; vaccine; variants of concern","Lee","Ping-Ing","Department of Pediatrics, National Taiwan University Children's Hospital and National Taiwan University College of Medicine, Taipei, Taiwan",NA
"2400","34180347","10.1080/14760584.2021.1949293","COVID-19 vaccines: concerns beyond protective efficacy and safety.","Several vaccine candidates have been developed using different platforms, including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus-like particles, peptide-based, recombinant proteins, live attenuated, and inactivated virus modalities. Although many of these vaccines are undergoing pre-clinical trials, several large clinical trials investigating the clinical efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines have produced promising findings. I","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","COVID-19; cellular immunity; protective efficacy; safety; sars-cov-2; vaccination willingness; vaccine; variants of concern","Ko","Wen-Chien","Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan",NA
"2401","34180347","10.1080/14760584.2021.1949293","COVID-19 vaccines: concerns beyond protective efficacy and safety.","Several vaccine candidates have been developed using different platforms, including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus-like particles, peptide-based, recombinant proteins, live attenuated, and inactivated virus modalities. Although many of these vaccines are undergoing pre-clinical trials, several large clinical trials investigating the clinical efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines have produced promising findings. I","2021","07","05","Expert Rev Vaccines","Expert review of vaccines","COVID-19; cellular immunity; protective efficacy; safety; sars-cov-2; vaccination willingness; vaccine; variants of concern","Hsueh","Po-Ren","Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan",NA
"2402","34180345","10.1080/21548331.2021.1949170","Stethoscope - An essential diagnostic tool or a relic of the past?","Rene Laennec came up with the idea of a stethoscope in 1816 to avoid the embarrassment of performing immediate auscultation on women. Soon many doctors around the world started using this tool because of its increased accuracy and ease of use. Stethoscopes hold great significance in the medical community. However, is the importance placed on stethoscopes justified today? We now have devices like portable ultrasound machines that make it much easier to visualize the body. These devices offset the","2021","07","02","Hosp Pract (1995)","Hospital practice (1995)","COVID-19; Stethoscope; physical examination","Qamar","Shahraz","Mayo Clinic, Rochester, MN, USA",NA
"2403","34180345","10.1080/21548331.2021.1949170","Stethoscope - An essential diagnostic tool or a relic of the past?","Rene Laennec came up with the idea of a stethoscope in 1816 to avoid the embarrassment of performing immediate auscultation on women. Soon many doctors around the world started using this tool because of its increased accuracy and ease of use. Stethoscopes hold great significance in the medical community. However, is the importance placed on stethoscopes justified today? We now have devices like portable ultrasound machines that make it much easier to visualize the body. These devices offset the","2021","07","02","Hosp Pract (1995)","Hospital practice (1995)","COVID-19; Stethoscope; physical examination","Tekin","Aysun","Mayo Clinic, Rochester, MN, USA",NA
"2404","34180345","10.1080/21548331.2021.1949170","Stethoscope - An essential diagnostic tool or a relic of the past?","Rene Laennec came up with the idea of a stethoscope in 1816 to avoid the embarrassment of performing immediate auscultation on women. Soon many doctors around the world started using this tool because of its increased accuracy and ease of use. Stethoscopes hold great significance in the medical community. However, is the importance placed on stethoscopes justified today? We now have devices like portable ultrasound machines that make it much easier to visualize the body. These devices offset the","2021","07","02","Hosp Pract (1995)","Hospital practice (1995)","COVID-19; Stethoscope; physical examination","Taweesedt","Pahnwat Tonya","Corpus Christi Medical Center, Corpus Christi, TX, USA",NA
"2405","34180345","10.1080/21548331.2021.1949170","Stethoscope - An essential diagnostic tool or a relic of the past?","Rene Laennec came up with the idea of a stethoscope in 1816 to avoid the embarrassment of performing immediate auscultation on women. Soon many doctors around the world started using this tool because of its increased accuracy and ease of use. Stethoscopes hold great significance in the medical community. However, is the importance placed on stethoscopes justified today? We now have devices like portable ultrasound machines that make it much easier to visualize the body. These devices offset the","2021","07","02","Hosp Pract (1995)","Hospital practice (1995)","COVID-19; Stethoscope; physical examination","Varon","Joseph","United Memorial Medical Center, Houston, TX, USA",NA
"2406","34180345","10.1080/21548331.2021.1949170","Stethoscope - An essential diagnostic tool or a relic of the past?","Rene Laennec came up with the idea of a stethoscope in 1816 to avoid the embarrassment of performing immediate auscultation on women. Soon many doctors around the world started using this tool because of its increased accuracy and ease of use. Stethoscopes hold great significance in the medical community. However, is the importance placed on stethoscopes justified today? We now have devices like portable ultrasound machines that make it much easier to visualize the body. These devices offset the","2021","07","02","Hosp Pract (1995)","Hospital practice (1995)","COVID-19; Stethoscope; physical examination","Kashyap","Rahul","Mayo Clinic, Rochester, MN, USA",NA
"2407","34180345","10.1080/21548331.2021.1949170","Stethoscope - An essential diagnostic tool or a relic of the past?","Rene Laennec came up with the idea of a stethoscope in 1816 to avoid the embarrassment of performing immediate auscultation on women. Soon many doctors around the world started using this tool because of its increased accuracy and ease of use. Stethoscopes hold great significance in the medical community. However, is the importance placed on stethoscopes justified today? We now have devices like portable ultrasound machines that make it much easier to visualize the body. These devices offset the","2021","07","02","Hosp Pract (1995)","Hospital practice (1995)","COVID-19; Stethoscope; physical examination","Surani","Salim","Texas A&amp",NA
"2408","34180318","10.1080/08870446.2021.1942875","COVID-19-Related anxieties and parenting stress among first-time mothers and fathers in their first year of parenthood.","The changes accompanying the transition to parenthood, joined by the fears aroused by the COVID-19 pandemic, may lead to high levels of parental anxieties and stress, particularly among parents of young infants. This study, conducted in the midst of the crisis, explores the level of COVID-19-related anxieties and parenting stress of Israeli parents in their first year of parenthood. First-time mothers (n = 469) and fathers (n = 137), aged 21-50, completed self-report questionnaires in April, 202","2021","06","28","Psychol Health","Psychology &amp; health","COVID-19; anxiety; parenting stress; transition to parenthood","Ben-Yaakov","Ofir","The Louis and Gabi Weisfeld School of Social Work, Bar-Ilan University, Ramat Gan, Israel",NA
"2409","34180318","10.1080/08870446.2021.1942875","COVID-19-Related anxieties and parenting stress among first-time mothers and fathers in their first year of parenthood.","The changes accompanying the transition to parenthood, joined by the fears aroused by the COVID-19 pandemic, may lead to high levels of parental anxieties and stress, particularly among parents of young infants. This study, conducted in the midst of the crisis, explores the level of COVID-19-related anxieties and parenting stress of Israeli parents in their first year of parenthood. First-time mothers (n = 469) and fathers (n = 137), aged 21-50, completed self-report questionnaires in April, 202","2021","06","28","Psychol Health","Psychology &amp; health","COVID-19; anxiety; parenting stress; transition to parenthood","Ben-Ari","Orit Taubman","The Louis and Gabi Weisfeld School of Social Work, Bar-Ilan University, Ramat Gan, Israel",NA
"2410","34180295","10.1177/13591053211025596","Does the attribution of responsibilities modify the relationship between coping styles and mental health? A survey of Chinese adults during the COVID-19 pandemic.","The COVID-19 pandemic is associated with Posttraumatic Stress Symptoms (PTSS) and self-reported Posttraumatic Growth (PTG) in the general population. This study used linear regressions for analyses, based on an online survey conducted during the COVID-19 lockdown among 2441 Chinese adults in February 2020. The results showed negative coping and attributing responsibilities to individuals were associated with more PTSS, while both positive and negative coping, as well as attributing responsibilit","2021","07","10","J Health Psychol","Journal of health psychology","COVID-19; PTG; PTSS; attribution of responsibilities; coping styles","Fu","Mingqi","Wuhan University, P.R. China",NA
"2411","34180295","10.1177/13591053211025596","Does the attribution of responsibilities modify the relationship between coping styles and mental health? A survey of Chinese adults during the COVID-19 pandemic.","The COVID-19 pandemic is associated with Posttraumatic Stress Symptoms (PTSS) and self-reported Posttraumatic Growth (PTG) in the general population. This study used linear regressions for analyses, based on an online survey conducted during the COVID-19 lockdown among 2441 Chinese adults in February 2020. The results showed negative coping and attributing responsibilities to individuals were associated with more PTSS, while both positive and negative coping, as well as attributing responsibilit","2021","07","10","J Health Psychol","Journal of health psychology","COVID-19; PTG; PTSS; attribution of responsibilities; coping styles","Huang","Ning","Huazhong University of Science and Technology, P.R. China",NA
"2412","34180295","10.1177/13591053211025596","Does the attribution of responsibilities modify the relationship between coping styles and mental health? A survey of Chinese adults during the COVID-19 pandemic.","The COVID-19 pandemic is associated with Posttraumatic Stress Symptoms (PTSS) and self-reported Posttraumatic Growth (PTG) in the general population. This study used linear regressions for analyses, based on an online survey conducted during the COVID-19 lockdown among 2441 Chinese adults in February 2020. The results showed negative coping and attributing responsibilities to individuals were associated with more PTSS, while both positive and negative coping, as well as attributing responsibilit","2021","07","10","J Health Psychol","Journal of health psychology","COVID-19; PTG; PTSS; attribution of responsibilities; coping styles","Hall","Brian J","New York University Shanghai, China",NA
"2413","34180295","10.1177/13591053211025596","Does the attribution of responsibilities modify the relationship between coping styles and mental health? A survey of Chinese adults during the COVID-19 pandemic.","The COVID-19 pandemic is associated with Posttraumatic Stress Symptoms (PTSS) and self-reported Posttraumatic Growth (PTG) in the general population. This study used linear regressions for analyses, based on an online survey conducted during the COVID-19 lockdown among 2441 Chinese adults in February 2020. The results showed negative coping and attributing responsibilities to individuals were associated with more PTSS, while both positive and negative coping, as well as attributing responsibilit","2021","07","10","J Health Psychol","Journal of health psychology","COVID-19; PTG; PTSS; attribution of responsibilities; coping styles","Shi","Qiaoxin","Peking University, P.R. China",NA
"2414","34180295","10.1177/13591053211025596","Does the attribution of responsibilities modify the relationship between coping styles and mental health? A survey of Chinese adults during the COVID-19 pandemic.","The COVID-19 pandemic is associated with Posttraumatic Stress Symptoms (PTSS) and self-reported Posttraumatic Growth (PTG) in the general population. This study used linear regressions for analyses, based on an online survey conducted during the COVID-19 lockdown among 2441 Chinese adults in February 2020. The results showed negative coping and attributing responsibilities to individuals were associated with more PTSS, while both positive and negative coping, as well as attributing responsibilit","2021","07","10","J Health Psychol","Journal of health psychology","COVID-19; PTG; PTSS; attribution of responsibilities; coping styles","Shahid","Muhammad","World Health Organization, Pakistan",NA
"2415","34180295","10.1177/13591053211025596","Does the attribution of responsibilities modify the relationship between coping styles and mental health? A survey of Chinese adults during the COVID-19 pandemic.","The COVID-19 pandemic is associated with Posttraumatic Stress Symptoms (PTSS) and self-reported Posttraumatic Growth (PTG) in the general population. This study used linear regressions for analyses, based on an online survey conducted during the COVID-19 lockdown among 2441 Chinese adults in February 2020. The results showed negative coping and attributing responsibilities to individuals were associated with more PTSS, while both positive and negative coping, as well as attributing responsibilit","2021","07","10","J Health Psychol","Journal of health psychology","COVID-19; PTG; PTSS; attribution of responsibilities; coping styles","Guo","Jing","Peking University, P.R. China",NA
"2416","34180276","10.1177/01461672211023652","Beliefs About COVID-19 in Canada, the United Kingdom, and the United States: A Novel Test of Political Polarization and Motivated Reasoning.","What are the psychological consequences of the increasingly politicized nature of the COVID-19 pandemic in the United States relative to similar Western countries? In a two-wave study completed early (March) and later (December) in the pandemic, we found that polarization was greater in the United States (N = 1,339) than in Canada (N = 644) and the United Kingdom. (N = 1,283). Political conservatism in the United States was strongly associated with engaging in weaker mitigat","2021","06","28","Pers Soc Psychol Bull","Personality &amp; social psychology bulletin","COVID-19; attitudes; cognitive reflection; motivated reasoning; political polarization","Pennycook","Gordon","University of Regina, Saskatchewan, Canada",NA
"2417","34180276","10.1177/01461672211023652","Beliefs About COVID-19 in Canada, the United Kingdom, and the United States: A Novel Test of Political Polarization and Motivated Reasoning.","What are the psychological consequences of the increasingly politicized nature of the COVID-19 pandemic in the United States relative to similar Western countries? In a two-wave study completed early (March) and later (December) in the pandemic, we found that polarization was greater in the United States (N = 1,339) than in Canada (N = 644) and the United Kingdom. (N = 1,283). Political conservatism in the United States was strongly associated with engaging in weaker mitigat","2021","06","28","Pers Soc Psychol Bull","Personality &amp; social psychology bulletin","COVID-19; attitudes; cognitive reflection; motivated reasoning; political polarization","McPhetres","Jonathon","Durham University, Durham, UK",NA
"2418","34180276","10.1177/01461672211023652","Beliefs About COVID-19 in Canada, the United Kingdom, and the United States: A Novel Test of Political Polarization and Motivated Reasoning.","What are the psychological consequences of the increasingly politicized nature of the COVID-19 pandemic in the United States relative to similar Western countries? In a two-wave study completed early (March) and later (December) in the pandemic, we found that polarization was greater in the United States (N = 1,339) than in Canada (N = 644) and the United Kingdom. (N = 1,283). Political conservatism in the United States was strongly associated with engaging in weaker mitigat","2021","06","28","Pers Soc Psychol Bull","Personality &amp; social psychology bulletin","COVID-19; attitudes; cognitive reflection; motivated reasoning; political polarization","Bago","Bence","University of Toulouse Capitole, France",NA
"2419","34180276","10.1177/01461672211023652","Beliefs About COVID-19 in Canada, the United Kingdom, and the United States: A Novel Test of Political Polarization and Motivated Reasoning.","What are the psychological consequences of the increasingly politicized nature of the COVID-19 pandemic in the United States relative to similar Western countries? In a two-wave study completed early (March) and later (December) in the pandemic, we found that polarization was greater in the United States (N = 1,339) than in Canada (N = 644) and the United Kingdom. (N = 1,283). Political conservatism in the United States was strongly associated with engaging in weaker mitigat","2021","06","28","Pers Soc Psychol Bull","Personality &amp; social psychology bulletin","COVID-19; attitudes; cognitive reflection; motivated reasoning; political polarization","Rand","David G","Massachusetts Institute of Technology, Cambridge, USA",NA
"2420","34180274","10.1177/10600280211028882","Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.","Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agents. The balance of controlling inflammation without increasing the risk of secondary infection is difficult. At present, dexamethasone 6 mg is the standard of care in COVID-19 hypoxia; whether this is the ideal choice of steroid or dosage remains to be proven. T","2021","07","07","Ann Pharmacother","The Annals of pharmacotherapy","adult respiratory distress syndrome; corticosteroids; interleukins; medication therapy management; respiratory infections","Brosnahan","Shari B","New York University Langone Health, NY, USA",NA
"2421","34180274","10.1177/10600280211028882","Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.","Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agents. The balance of controlling inflammation without increasing the risk of secondary infection is difficult. At present, dexamethasone 6 mg is the standard of care in COVID-19 hypoxia; whether this is the ideal choice of steroid or dosage remains to be proven. T","2021","07","07","Ann Pharmacother","The Annals of pharmacotherapy","adult respiratory distress syndrome; corticosteroids; interleukins; medication therapy management; respiratory infections","Chen","Xian Jie Cindy","New York University Langone Hospital - Long Island, NY, USA",NA
"2422","34180274","10.1177/10600280211028882","Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.","Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agents. The balance of controlling inflammation without increasing the risk of secondary infection is difficult. At present, dexamethasone 6 mg is the standard of care in COVID-19 hypoxia; whether this is the ideal choice of steroid or dosage remains to be proven. T","2021","07","07","Ann Pharmacother","The Annals of pharmacotherapy","adult respiratory distress syndrome; corticosteroids; interleukins; medication therapy management; respiratory infections","Chung","Juri","New York University Langone Hospital - Long Island, NY, USA",NA
"2423","34180274","10.1177/10600280211028882","Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.","Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agents. The balance of controlling inflammation without increasing the risk of secondary infection is difficult. At present, dexamethasone 6 mg is the standard of care in COVID-19 hypoxia; whether this is the ideal choice of steroid or dosage remains to be proven. T","2021","07","07","Ann Pharmacother","The Annals of pharmacotherapy","adult respiratory distress syndrome; corticosteroids; interleukins; medication therapy management; respiratory infections","Altshuler","Diana","New York University Langone Health, NY, USA",NA
"2424","34180274","10.1177/10600280211028882","Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.","Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agents. The balance of controlling inflammation without increasing the risk of secondary infection is difficult. At present, dexamethasone 6 mg is the standard of care in COVID-19 hypoxia; whether this is the ideal choice of steroid or dosage remains to be proven. T","2021","07","07","Ann Pharmacother","The Annals of pharmacotherapy","adult respiratory distress syndrome; corticosteroids; interleukins; medication therapy management; respiratory infections","Islam","Shahidul","New York University Langone Hospital - Long Island, NY, USA",NA
"2425","34180274","10.1177/10600280211028882","Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.","Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agents. The balance of controlling inflammation without increasing the risk of secondary infection is difficult. At present, dexamethasone 6 mg is the standard of care in COVID-19 hypoxia; whether this is the ideal choice of steroid or dosage remains to be proven. T","2021","07","07","Ann Pharmacother","The Annals of pharmacotherapy","adult respiratory distress syndrome; corticosteroids; interleukins; medication therapy management; respiratory infections","Thomas","Sarun V","New York University Langone Hospital - Long Island, NY, USA",NA
"2426","34180274","10.1177/10600280211028882","Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.","Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agents. The balance of controlling inflammation without increasing the risk of secondary infection is difficult. At present, dexamethasone 6 mg is the standard of care in COVID-19 hypoxia; whether this is the ideal choice of steroid or dosage remains to be proven. T","2021","07","07","Ann Pharmacother","The Annals of pharmacotherapy","adult respiratory distress syndrome; corticosteroids; interleukins; medication therapy management; respiratory infections","Winner","Megan D","New York University Langone Hospital - Long Island, NY, USA",NA
"2427","34180274","10.1177/10600280211028882","Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.","Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agents. The balance of controlling inflammation without increasing the risk of secondary infection is difficult. At present, dexamethasone 6 mg is the standard of care in COVID-19 hypoxia; whether this is the ideal choice of steroid or dosage remains to be proven. T","2021","07","07","Ann Pharmacother","The Annals of pharmacotherapy","adult respiratory distress syndrome; corticosteroids; interleukins; medication therapy management; respiratory infections","Greco","Allison A","New York University Langone Health, NY, USA",NA
"2428","34180274","10.1177/10600280211028882","Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.","Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agents. The balance of controlling inflammation without increasing the risk of secondary infection is difficult. At present, dexamethasone 6 mg is the standard of care in COVID-19 hypoxia; whether this is the ideal choice of steroid or dosage remains to be proven. T","2021","07","07","Ann Pharmacother","The Annals of pharmacotherapy","adult respiratory distress syndrome; corticosteroids; interleukins; medication therapy management; respiratory infections","Divers","Jasmin","New York University Langone Hospital - Long Island, NY, USA",NA
"2429","34180274","10.1177/10600280211028882","Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.","Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agents. The balance of controlling inflammation without increasing the risk of secondary infection is difficult. At present, dexamethasone 6 mg is the standard of care in COVID-19 hypoxia; whether this is the ideal choice of steroid or dosage remains to be proven. T","2021","07","07","Ann Pharmacother","The Annals of pharmacotherapy","adult respiratory distress syndrome; corticosteroids; interleukins; medication therapy management; respiratory infections","Spiegler","Peter","New York University Langone Hospital - Long Island, NY, USA",NA
"2430","34180274","10.1177/10600280211028882","Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.","Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agents. The balance of controlling inflammation without increasing the risk of secondary infection is difficult. At present, dexamethasone 6 mg is the standard of care in COVID-19 hypoxia; whether this is the ideal choice of steroid or dosage remains to be proven. T","2021","07","07","Ann Pharmacother","The Annals of pharmacotherapy","adult respiratory distress syndrome; corticosteroids; interleukins; medication therapy management; respiratory infections","Sterman","Daniel H","New York University Langone Health, NY, USA",NA
"2431","34180274","10.1177/10600280211028882","Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.","Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agents. The balance of controlling inflammation without increasing the risk of secondary infection is difficult. At present, dexamethasone 6 mg is the standard of care in COVID-19 hypoxia; whether this is the ideal choice of steroid or dosage remains to be proven. T","2021","07","07","Ann Pharmacother","The Annals of pharmacotherapy","adult respiratory distress syndrome; corticosteroids; interleukins; medication therapy management; respiratory infections","Parnia","Sam","New York University Langone Health, NY, USA",NA
"2432","34180269","10.1177/00033197211026044","Diagnostic and Prognostic Value of Serum Endocan Levels in Patients With COVID-19.","We aimed to evaluate whether there was a relationship between endocan (human endothelial cell-specific molecule-1) levels and disease prognosis in patients who presented to the emergency department with coronavirus disease 2019 (COVID-19). A total of 60 patients with COVID-19 who were hospitalized from the emergency department to clinical wards and a control group consisting of healthy adult individuals (n = 28), were included in the study. The majority (93.3%) of the patients were discharged af","2021","06","28","Angiology","Angiology","COVID-19; clinical outcome; endocan","Görgün","Selim","Department of Microbiology, Samsun Education and Research Hospital, Samsun, Turkey",NA
"2433","34180269","10.1177/00033197211026044","Diagnostic and Prognostic Value of Serum Endocan Levels in Patients With COVID-19.","We aimed to evaluate whether there was a relationship between endocan (human endothelial cell-specific molecule-1) levels and disease prognosis in patients who presented to the emergency department with coronavirus disease 2019 (COVID-19). A total of 60 patients with COVID-19 who were hospitalized from the emergency department to clinical wards and a control group consisting of healthy adult individuals (n = 28), were included in the study. The majority (93.3%) of the patients were discharged af","2021","06","28","Angiology","Angiology","COVID-19; clinical outcome; endocan","Cindoruk","Sener","Department of Emergency Medicine, Samsun Education and Research Hospital, Samsun, Turkey",NA
"2434","34180269","10.1177/00033197211026044","Diagnostic and Prognostic Value of Serum Endocan Levels in Patients With COVID-19.","We aimed to evaluate whether there was a relationship between endocan (human endothelial cell-specific molecule-1) levels and disease prognosis in patients who presented to the emergency department with coronavirus disease 2019 (COVID-19). A total of 60 patients with COVID-19 who were hospitalized from the emergency department to clinical wards and a control group consisting of healthy adult individuals (n = 28), were included in the study. The majority (93.3%) of the patients were discharged af","2021","06","28","Angiology","Angiology","COVID-19; clinical outcome; endocan","Özgen","Emre","Merzifon State Hospital, Emergency Medicine, Amasya, Turkey",NA
"2435","34180269","10.1177/00033197211026044","Diagnostic and Prognostic Value of Serum Endocan Levels in Patients With COVID-19.","We aimed to evaluate whether there was a relationship between endocan (human endothelial cell-specific molecule-1) levels and disease prognosis in patients who presented to the emergency department with coronavirus disease 2019 (COVID-19). A total of 60 patients with COVID-19 who were hospitalized from the emergency department to clinical wards and a control group consisting of healthy adult individuals (n = 28), were included in the study. The majority (93.3%) of the patients were discharged af","2021","06","28","Angiology","Angiology","COVID-19; clinical outcome; endocan","Yadigaroglu","Metin","Department of Emergency Medicine, Samsun University, Samsun, Turkey",NA
"2436","34180269","10.1177/00033197211026044","Diagnostic and Prognostic Value of Serum Endocan Levels in Patients With COVID-19.","We aimed to evaluate whether there was a relationship between endocan (human endothelial cell-specific molecule-1) levels and disease prognosis in patients who presented to the emergency department with coronavirus disease 2019 (COVID-19). A total of 60 patients with COVID-19 who were hospitalized from the emergency department to clinical wards and a control group consisting of healthy adult individuals (n = 28), were included in the study. The majority (93.3%) of the patients were discharged af","2021","06","28","Angiology","Angiology","COVID-19; clinical outcome; endocan","Demir","Mehmet Tevfik","Department of Emergency Medicine, Samsun Education and Research Hospital, Samsun, Turkey",NA
"2437","34180269","10.1177/00033197211026044","Diagnostic and Prognostic Value of Serum Endocan Levels in Patients With COVID-19.","We aimed to evaluate whether there was a relationship between endocan (human endothelial cell-specific molecule-1) levels and disease prognosis in patients who presented to the emergency department with coronavirus disease 2019 (COVID-19). A total of 60 patients with COVID-19 who were hospitalized from the emergency department to clinical wards and a control group consisting of healthy adult individuals (n = 28), were included in the study. The majority (93.3%) of the patients were discharged af","2021","06","28","Angiology","Angiology","COVID-19; clinical outcome; endocan","Yücel","Murat","Department of Emergency Medicine, Sakarya University, Sakarya, Turkey",NA
"2438","34180269","10.1177/00033197211026044","Diagnostic and Prognostic Value of Serum Endocan Levels in Patients With COVID-19.","We aimed to evaluate whether there was a relationship between endocan (human endothelial cell-specific molecule-1) levels and disease prognosis in patients who presented to the emergency department with coronavirus disease 2019 (COVID-19). A total of 60 patients with COVID-19 who were hospitalized from the emergency department to clinical wards and a control group consisting of healthy adult individuals (n = 28), were included in the study. The majority (93.3%) of the patients were discharged af","2021","06","28","Angiology","Angiology","COVID-19; clinical outcome; endocan","Akpinar","Çetin Kürsad","Department of Neurology, Samsun Education and Research Hospital, Samsun, Turkey",NA
"2439","34180269","10.1177/00033197211026044","Diagnostic and Prognostic Value of Serum Endocan Levels in Patients With COVID-19.","We aimed to evaluate whether there was a relationship between endocan (human endothelial cell-specific molecule-1) levels and disease prognosis in patients who presented to the emergency department with coronavirus disease 2019 (COVID-19). A total of 60 patients with COVID-19 who were hospitalized from the emergency department to clinical wards and a control group consisting of healthy adult individuals (n = 28), were included in the study. The majority (93.3%) of the patients were discharged af","2021","06","28","Angiology","Angiology","COVID-19; clinical outcome; endocan","Güzel","Murat","Department of Emergency Medicine, Samsun Education and Research Hospital, Samsun, Turkey",NA
"2440","34180262","10.1177/11206721211028037","Challenges of personal protective equipment use among ophthalmologists during the COVID-19 pandemic: A multicenter international study.","To explore the possible challenges and difficulties of using Personal Protective Equipment (PPE) in ophthalmic practice during the Coronavirus disease 2019 (COVID-19) pandemic. This is a multicenter, international survey among practicing ophthalmologists across different countries. The survey was conducted from September 9th to October 24th, 2020. It included a total of 23 questions that navigated through the currently adopted recommendations in different clinical situations. The survey also ass","2021","07","16","Eur J Ophthalmol","European journal of ophthalmology","COVID-19 pandemic; challenges of PPE; face shields; practice of ophthalmologists; proper PPE in ophthalmology; protective goggles","Ashour","Doaa Maamoun","Department of Ophthalmology, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"2441","34180262","10.1177/11206721211028037","Challenges of personal protective equipment use among ophthalmologists during the COVID-19 pandemic: A multicenter international study.","To explore the possible challenges and difficulties of using Personal Protective Equipment (PPE) in ophthalmic practice during the Coronavirus disease 2019 (COVID-19) pandemic. This is a multicenter, international survey among practicing ophthalmologists across different countries. The survey was conducted from September 9th to October 24th, 2020. It included a total of 23 questions that navigated through the currently adopted recommendations in different clinical situations. The survey also ass","2021","07","16","Eur J Ophthalmol","European journal of ophthalmology","COVID-19 pandemic; challenges of PPE; face shields; practice of ophthalmologists; proper PPE in ophthalmology; protective goggles","Elkitkat","Rania Serag","Department of Ophthalmology, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"2442","34180262","10.1177/11206721211028037","Challenges of personal protective equipment use among ophthalmologists during the COVID-19 pandemic: A multicenter international study.","To explore the possible challenges and difficulties of using Personal Protective Equipment (PPE) in ophthalmic practice during the Coronavirus disease 2019 (COVID-19) pandemic. This is a multicenter, international survey among practicing ophthalmologists across different countries. The survey was conducted from September 9th to October 24th, 2020. It included a total of 23 questions that navigated through the currently adopted recommendations in different clinical situations. The survey also ass","2021","07","16","Eur J Ophthalmol","European journal of ophthalmology","COVID-19 pandemic; challenges of PPE; face shields; practice of ophthalmologists; proper PPE in ophthalmology; protective goggles","Gabr","Hesham","Department of Ophthalmology, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"2443","34180262","10.1177/11206721211028037","Challenges of personal protective equipment use among ophthalmologists during the COVID-19 pandemic: A multicenter international study.","To explore the possible challenges and difficulties of using Personal Protective Equipment (PPE) in ophthalmic practice during the Coronavirus disease 2019 (COVID-19) pandemic. This is a multicenter, international survey among practicing ophthalmologists across different countries. The survey was conducted from September 9th to October 24th, 2020. It included a total of 23 questions that navigated through the currently adopted recommendations in different clinical situations. The survey also ass","2021","07","16","Eur J Ophthalmol","European journal of ophthalmology","COVID-19 pandemic; challenges of PPE; face shields; practice of ophthalmologists; proper PPE in ophthalmology; protective goggles","Yosef","Mostafa","Department of Community, Environmental and Occupational Medicine, Ain Shams University, Cairo, Egypt",NA
"2444","34180262","10.1177/11206721211028037","Challenges of personal protective equipment use among ophthalmologists during the COVID-19 pandemic: A multicenter international study.","To explore the possible challenges and difficulties of using Personal Protective Equipment (PPE) in ophthalmic practice during the Coronavirus disease 2019 (COVID-19) pandemic. This is a multicenter, international survey among practicing ophthalmologists across different countries. The survey was conducted from September 9th to October 24th, 2020. It included a total of 23 questions that navigated through the currently adopted recommendations in different clinical situations. The survey also ass","2021","07","16","Eur J Ophthalmol","European journal of ophthalmology","COVID-19 pandemic; challenges of PPE; face shields; practice of ophthalmologists; proper PPE in ophthalmology; protective goggles","Singh Grewal","Dilraj","Department of Ophthalmology, Duke University, Durham, NC, USA",NA
"2445","34180262","10.1177/11206721211028037","Challenges of personal protective equipment use among ophthalmologists during the COVID-19 pandemic: A multicenter international study.","To explore the possible challenges and difficulties of using Personal Protective Equipment (PPE) in ophthalmic practice during the Coronavirus disease 2019 (COVID-19) pandemic. This is a multicenter, international survey among practicing ophthalmologists across different countries. The survey was conducted from September 9th to October 24th, 2020. It included a total of 23 questions that navigated through the currently adopted recommendations in different clinical situations. The survey also ass","2021","07","16","Eur J Ophthalmol","European journal of ophthalmology","COVID-19 pandemic; challenges of PPE; face shields; practice of ophthalmologists; proper PPE in ophthalmology; protective goggles","Saleh","Mohamed Ibrahim","Department of Ophthalmology, Faculty of Medicine, Ain Shams University, Cairo, Egypt",NA
"2446","34180259","10.1177/00031348211029878","Shifting the American College of Surgeons Clinical Congress to 100% Virtual Format During the COVID-19 Pandemic, Is It Better for Knowledge Dissemination?",NA,"2021","06","28","Am Surg","The American surgeon",NA,"Newsome","Kevin","Department of Surgery, Division of Trauma and Surgical Critical Care, 14506Kendall Regional Medical Center, Miami, FL, USA",NA
"2447","34180259","10.1177/00031348211029878","Shifting the American College of Surgeons Clinical Congress to 100% Virtual Format During the COVID-19 Pandemic, Is It Better for Knowledge Dissemination?",NA,"2021","06","28","Am Surg","The American surgeon",NA,"McKenny","Mark","Department of Surgery, Division of Trauma and Surgical Critical Care, 14506Kendall Regional Medical Center, Miami, FL, USA",NA
"2448","34180259","10.1177/00031348211029878","Shifting the American College of Surgeons Clinical Congress to 100% Virtual Format During the COVID-19 Pandemic, Is It Better for Knowledge Dissemination?",NA,"2021","06","28","Am Surg","The American surgeon",NA,"Elkbuli","Adel","Department of Surgery, Division of Trauma and Surgical Critical Care, 14506Kendall Regional Medical Center, Miami, FL, USA",NA
"2449","34180248","10.1177/00048674211025710","The impact of social unrest and pandemic on mental health of young people in Hong Kong: The transdiagnostic role of event-based rumination.","Co-occurring population-level events, such as social unrest and coronavirus disease 2019, are observed in many societies today. Few studies have explored their combined mental health effects on young people. While self-focused rumination has been suggested to be a key mechanism underlying depression, the role of event-based rumination in mediating the impact of population stressors has yet to be elucidated. Data were collected from 6988 young people in a large-scale community online survey in Ho","2021","06","28","Aust N Z J Psychiatry","The Australian and New Zealand journal of psychiatry","Post-traumatic stress disorder; depression; rumination; social unrest; youth mental health","Wong","Stephanie My","Department of Psychiatry, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong",NA
"2450","34180248","10.1177/00048674211025710","The impact of social unrest and pandemic on mental health of young people in Hong Kong: The transdiagnostic role of event-based rumination.","Co-occurring population-level events, such as social unrest and coronavirus disease 2019, are observed in many societies today. Few studies have explored their combined mental health effects on young people. While self-focused rumination has been suggested to be a key mechanism underlying depression, the role of event-based rumination in mediating the impact of population stressors has yet to be elucidated. Data were collected from 6988 young people in a large-scale community online survey in Ho","2021","06","28","Aust N Z J Psychiatry","The Australian and New Zealand journal of psychiatry","Post-traumatic stress disorder; depression; rumination; social unrest; youth mental health","Hui","Christy Lm","Department of Psychiatry, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong",NA
"2451","34180248","10.1177/00048674211025710","The impact of social unrest and pandemic on mental health of young people in Hong Kong: The transdiagnostic role of event-based rumination.","Co-occurring population-level events, such as social unrest and coronavirus disease 2019, are observed in many societies today. Few studies have explored their combined mental health effects on young people. While self-focused rumination has been suggested to be a key mechanism underlying depression, the role of event-based rumination in mediating the impact of population stressors has yet to be elucidated. Data were collected from 6988 young people in a large-scale community online survey in Ho","2021","06","28","Aust N Z J Psychiatry","The Australian and New Zealand journal of psychiatry","Post-traumatic stress disorder; depression; rumination; social unrest; youth mental health","Suen","Yi Nam","Department of Psychiatry, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong",NA
"2452","34180248","10.1177/00048674211025710","The impact of social unrest and pandemic on mental health of young people in Hong Kong: The transdiagnostic role of event-based rumination.","Co-occurring population-level events, such as social unrest and coronavirus disease 2019, are observed in many societies today. Few studies have explored their combined mental health effects on young people. While self-focused rumination has been suggested to be a key mechanism underlying depression, the role of event-based rumination in mediating the impact of population stressors has yet to be elucidated. Data were collected from 6988 young people in a large-scale community online survey in Ho","2021","06","28","Aust N Z J Psychiatry","The Australian and New Zealand journal of psychiatry","Post-traumatic stress disorder; depression; rumination; social unrest; youth mental health","Wong","Corine Sm","Department of Psychiatry, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong",NA
"2453","34180248","10.1177/00048674211025710","The impact of social unrest and pandemic on mental health of young people in Hong Kong: The transdiagnostic role of event-based rumination.","Co-occurring population-level events, such as social unrest and coronavirus disease 2019, are observed in many societies today. Few studies have explored their combined mental health effects on young people. While self-focused rumination has been suggested to be a key mechanism underlying depression, the role of event-based rumination in mediating the impact of population stressors has yet to be elucidated. Data were collected from 6988 young people in a large-scale community online survey in Ho","2021","06","28","Aust N Z J Psychiatry","The Australian and New Zealand journal of psychiatry","Post-traumatic stress disorder; depression; rumination; social unrest; youth mental health","Chan","Sherry Kw","Department of Psychiatry, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong",NA
"2454","34180248","10.1177/00048674211025710","The impact of social unrest and pandemic on mental health of young people in Hong Kong: The transdiagnostic role of event-based rumination.","Co-occurring population-level events, such as social unrest and coronavirus disease 2019, are observed in many societies today. Few studies have explored their combined mental health effects on young people. While self-focused rumination has been suggested to be a key mechanism underlying depression, the role of event-based rumination in mediating the impact of population stressors has yet to be elucidated. Data were collected from 6988 young people in a large-scale community online survey in Ho","2021","06","28","Aust N Z J Psychiatry","The Australian and New Zealand journal of psychiatry","Post-traumatic stress disorder; depression; rumination; social unrest; youth mental health","Lee","Edwin Hm","Department of Psychiatry, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong",NA
"2455","34180248","10.1177/00048674211025710","The impact of social unrest and pandemic on mental health of young people in Hong Kong: The transdiagnostic role of event-based rumination.","Co-occurring population-level events, such as social unrest and coronavirus disease 2019, are observed in many societies today. Few studies have explored their combined mental health effects on young people. While self-focused rumination has been suggested to be a key mechanism underlying depression, the role of event-based rumination in mediating the impact of population stressors has yet to be elucidated. Data were collected from 6988 young people in a large-scale community online survey in Ho","2021","06","28","Aust N Z J Psychiatry","The Australian and New Zealand journal of psychiatry","Post-traumatic stress disorder; depression; rumination; social unrest; youth mental health","Chang","Wing Chung","Department of Psychiatry, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong",NA
"2456","34180248","10.1177/00048674211025710","The impact of social unrest and pandemic on mental health of young people in Hong Kong: The transdiagnostic role of event-based rumination.","Co-occurring population-level events, such as social unrest and coronavirus disease 2019, are observed in many societies today. Few studies have explored their combined mental health effects on young people. While self-focused rumination has been suggested to be a key mechanism underlying depression, the role of event-based rumination in mediating the impact of population stressors has yet to be elucidated. Data were collected from 6988 young people in a large-scale community online survey in Ho","2021","06","28","Aust N Z J Psychiatry","The Australian and New Zealand journal of psychiatry","Post-traumatic stress disorder; depression; rumination; social unrest; youth mental health","Chen","Eric Yh","Department of Psychiatry, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong",NA
"2457","34180223","10.1021/acsami.1c04412","Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus.","Influenza A viruses (IAV) and SARS-CoV-2 can spread via liquid droplets and aerosols. Face masks and other personal protective equipment (PPE) can act as barriers that prevent the spread of these viruses. However, IAV and SARS-CoV-2 are stable for hours on various materials, which makes frequent and correct disposal of these PPE important. Metal ions embedded into PPE may inactivate respiratory viruses, but confounding factors such as adsorption of viruses make measuring and optimizing the inact","2021","07","13","ACS Appl Mater Interfaces","ACS applied materials &amp; interfaces","absorption; coronavirus; face mask; influenza; zinc; Adsorption; Animals; Chlorocebus aethiops; Cotton Fiber; Dogs; HEK293 Cells; Humans; Influenza A virus; Ions; Madin Darby Canine Kidney Cells; Nylons; Polypropylenes; SARS-CoV-2; Textiles; Vero Cells; Viral Load; Virus Inactivation; Zinc; Zinc Oxide","Gopal","Vikram","Ascend Performance Materials, 1010 Travis Street, Suite 900, Houston, Texas 77002, United States",NA
"2458","34180223","10.1021/acsami.1c04412","Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus.","Influenza A viruses (IAV) and SARS-CoV-2 can spread via liquid droplets and aerosols. Face masks and other personal protective equipment (PPE) can act as barriers that prevent the spread of these viruses. However, IAV and SARS-CoV-2 are stable for hours on various materials, which makes frequent and correct disposal of these PPE important. Metal ions embedded into PPE may inactivate respiratory viruses, but confounding factors such as adsorption of viruses make measuring and optimizing the inact","2021","07","13","ACS Appl Mater Interfaces","ACS applied materials &amp; interfaces","absorption; coronavirus; face mask; influenza; zinc; Adsorption; Animals; Chlorocebus aethiops; Cotton Fiber; Dogs; HEK293 Cells; Humans; Influenza A virus; Ions; Madin Darby Canine Kidney Cells; Nylons; Polypropylenes; SARS-CoV-2; Textiles; Vero Cells; Viral Load; Virus Inactivation; Zinc; Zinc Oxide","Nilsson-Payant","Benjamin E","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States",NA
"2459","34180223","10.1021/acsami.1c04412","Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus.","Influenza A viruses (IAV) and SARS-CoV-2 can spread via liquid droplets and aerosols. Face masks and other personal protective equipment (PPE) can act as barriers that prevent the spread of these viruses. However, IAV and SARS-CoV-2 are stable for hours on various materials, which makes frequent and correct disposal of these PPE important. Metal ions embedded into PPE may inactivate respiratory viruses, but confounding factors such as adsorption of viruses make measuring and optimizing the inact","2021","07","13","ACS Appl Mater Interfaces","ACS applied materials &amp; interfaces","absorption; coronavirus; face mask; influenza; zinc; Adsorption; Animals; Chlorocebus aethiops; Cotton Fiber; Dogs; HEK293 Cells; Humans; Influenza A virus; Ions; Madin Darby Canine Kidney Cells; Nylons; Polypropylenes; SARS-CoV-2; Textiles; Vero Cells; Viral Load; Virus Inactivation; Zinc; Zinc Oxide","French","Hollie","Division of Virology, Department of Pathology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge CB2 2QQ, U",NA
"2460","34180223","10.1021/acsami.1c04412","Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus.","Influenza A viruses (IAV) and SARS-CoV-2 can spread via liquid droplets and aerosols. Face masks and other personal protective equipment (PPE) can act as barriers that prevent the spread of these viruses. However, IAV and SARS-CoV-2 are stable for hours on various materials, which makes frequent and correct disposal of these PPE important. Metal ions embedded into PPE may inactivate respiratory viruses, but confounding factors such as adsorption of viruses make measuring and optimizing the inact","2021","07","13","ACS Appl Mater Interfaces","ACS applied materials &amp; interfaces","absorption; coronavirus; face mask; influenza; zinc; Adsorption; Animals; Chlorocebus aethiops; Cotton Fiber; Dogs; HEK293 Cells; Humans; Influenza A virus; Ions; Madin Darby Canine Kidney Cells; Nylons; Polypropylenes; SARS-CoV-2; Textiles; Vero Cells; Viral Load; Virus Inactivation; Zinc; Zinc Oxide","Siegers","Jurre Y","Department of Viroscience, Erasmus University Medical Centre, Rotterdam 3015 GD, the Netherlands",NA
"2461","34180223","10.1021/acsami.1c04412","Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus.","Influenza A viruses (IAV) and SARS-CoV-2 can spread via liquid droplets and aerosols. Face masks and other personal protective equipment (PPE) can act as barriers that prevent the spread of these viruses. However, IAV and SARS-CoV-2 are stable for hours on various materials, which makes frequent and correct disposal of these PPE important. Metal ions embedded into PPE may inactivate respiratory viruses, but confounding factors such as adsorption of viruses make measuring and optimizing the inact","2021","07","13","ACS Appl Mater Interfaces","ACS applied materials &amp; interfaces","absorption; coronavirus; face mask; influenza; zinc; Adsorption; Animals; Chlorocebus aethiops; Cotton Fiber; Dogs; HEK293 Cells; Humans; Influenza A virus; Ions; Madin Darby Canine Kidney Cells; Nylons; Polypropylenes; SARS-CoV-2; Textiles; Vero Cells; Viral Load; Virus Inactivation; Zinc; Zinc Oxide","Yung","Wai-Shing","Ascend Performance Materials, 1010 Travis Street, Suite 900, Houston, Texas 77002, United States",NA
"2462","34180223","10.1021/acsami.1c04412","Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus.","Influenza A viruses (IAV) and SARS-CoV-2 can spread via liquid droplets and aerosols. Face masks and other personal protective equipment (PPE) can act as barriers that prevent the spread of these viruses. However, IAV and SARS-CoV-2 are stable for hours on various materials, which makes frequent and correct disposal of these PPE important. Metal ions embedded into PPE may inactivate respiratory viruses, but confounding factors such as adsorption of viruses make measuring and optimizing the inact","2021","07","13","ACS Appl Mater Interfaces","ACS applied materials &amp; interfaces","absorption; coronavirus; face mask; influenza; zinc; Adsorption; Animals; Chlorocebus aethiops; Cotton Fiber; Dogs; HEK293 Cells; Humans; Influenza A virus; Ions; Madin Darby Canine Kidney Cells; Nylons; Polypropylenes; SARS-CoV-2; Textiles; Vero Cells; Viral Load; Virus Inactivation; Zinc; Zinc Oxide","Hardwick","Matthew","ResInnova Laboratories, 8807 Colesville Rd, 3rd Floor, Silver Spring, Maryland 20910, United States",NA
"2463","34180223","10.1021/acsami.1c04412","Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus.","Influenza A viruses (IAV) and SARS-CoV-2 can spread via liquid droplets and aerosols. Face masks and other personal protective equipment (PPE) can act as barriers that prevent the spread of these viruses. However, IAV and SARS-CoV-2 are stable for hours on various materials, which makes frequent and correct disposal of these PPE important. Metal ions embedded into PPE may inactivate respiratory viruses, but confounding factors such as adsorption of viruses make measuring and optimizing the inact","2021","07","13","ACS Appl Mater Interfaces","ACS applied materials &amp; interfaces","absorption; coronavirus; face mask; influenza; zinc; Adsorption; Animals; Chlorocebus aethiops; Cotton Fiber; Dogs; HEK293 Cells; Humans; Influenza A virus; Ions; Madin Darby Canine Kidney Cells; Nylons; Polypropylenes; SARS-CoV-2; Textiles; Vero Cells; Viral Load; Virus Inactivation; Zinc; Zinc Oxide","Te Velthuis","Aartjan J W","Division of Virology, Department of Pathology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge CB2 2QQ, U",NA
"2464","34180216","","First Episode Psychosis during COVID-19 Pandemic: A Case Series.","Neuropsychiatric events are often associated with viral pandemics. The unexpected turn of events the world over since the onset of the coronavirus pandemic may serve as stressors which can trigger or worsen mental disorders particularly psychosis. There is little or no reports about acute psychosis on the background of this current global pandemic particularly in the African context. The aim of this article describes a case series of acute schizophrenia-like disorder with COVID-19 related psycho","2021","06","29","West Afr J Med","West African journal of medicine","Acute and transient psychosis; COVID-19; First-episode psychosis; Pandemic; Stressors; COVID-19; Humans; Nigeria; Pandemics; Psychotic Disorders; SARS-CoV-2","Oloniniyi","I O","Department of Mental Health, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria",NA
"2465","34180216","","First Episode Psychosis during COVID-19 Pandemic: A Case Series.","Neuropsychiatric events are often associated with viral pandemics. The unexpected turn of events the world over since the onset of the coronavirus pandemic may serve as stressors which can trigger or worsen mental disorders particularly psychosis. There is little or no reports about acute psychosis on the background of this current global pandemic particularly in the African context. The aim of this article describes a case series of acute schizophrenia-like disorder with COVID-19 related psycho","2021","06","29","West Afr J Med","West African journal of medicine","Acute and transient psychosis; COVID-19; First-episode psychosis; Pandemic; Stressors; COVID-19; Humans; Nigeria; Pandemics; Psychotic Disorders; SARS-CoV-2","Ibigbami","O I","Department of Mental Health, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria",NA
"2466","34180216","","First Episode Psychosis during COVID-19 Pandemic: A Case Series.","Neuropsychiatric events are often associated with viral pandemics. The unexpected turn of events the world over since the onset of the coronavirus pandemic may serve as stressors which can trigger or worsen mental disorders particularly psychosis. There is little or no reports about acute psychosis on the background of this current global pandemic particularly in the African context. The aim of this article describes a case series of acute schizophrenia-like disorder with COVID-19 related psycho","2021","06","29","West Afr J Med","West African journal of medicine","Acute and transient psychosis; COVID-19; First-episode psychosis; Pandemic; Stressors; COVID-19; Humans; Nigeria; Pandemics; Psychotic Disorders; SARS-CoV-2","Amiola","A","Department of Mental Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria",NA
"2467","34180216","","First Episode Psychosis during COVID-19 Pandemic: A Case Series.","Neuropsychiatric events are often associated with viral pandemics. The unexpected turn of events the world over since the onset of the coronavirus pandemic may serve as stressors which can trigger or worsen mental disorders particularly psychosis. There is little or no reports about acute psychosis on the background of this current global pandemic particularly in the African context. The aim of this article describes a case series of acute schizophrenia-like disorder with COVID-19 related psycho","2021","06","29","West Afr J Med","West African journal of medicine","Acute and transient psychosis; COVID-19; First-episode psychosis; Pandemic; Stressors; COVID-19; Humans; Nigeria; Pandemics; Psychotic Disorders; SARS-CoV-2","Esan","O A","Department of Mental Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria",NA
"2468","34180216","","First Episode Psychosis during COVID-19 Pandemic: A Case Series.","Neuropsychiatric events are often associated with viral pandemics. The unexpected turn of events the world over since the onset of the coronavirus pandemic may serve as stressors which can trigger or worsen mental disorders particularly psychosis. There is little or no reports about acute psychosis on the background of this current global pandemic particularly in the African context. The aim of this article describes a case series of acute schizophrenia-like disorder with COVID-19 related psycho","2021","06","29","West Afr J Med","West African journal of medicine","Acute and transient psychosis; COVID-19; First-episode psychosis; Pandemic; Stressors; COVID-19; Humans; Nigeria; Pandemics; Psychotic Disorders; SARS-CoV-2","Esan","O O","Department of Mental Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria",NA
"2469","34180164","10.12200/j.issn.1003-0034.2021.06.002","[Reliability of three dimensional CT measurement of glenoid track in patients with recurrent anterior dislocation of shoulder].","To evaluate the reliability and repeatability of three-dimensional (3D)-CT measurement of glenoid track. Glenoid and Hill-Sachs bone defects in 60 patients with recurrent anterior dislocation of the unilateral shoulder were evaluated by 3D-CT and analyzed by three independent observers(shoulder orthopedists) according to the Di Giacomo method. These injuries were classified to formulate a surgical protocol. All the patients were repeatedly measured 1 week later. Intraclass correlation coefficien","2021","06","29","Zhongguo Gu Shang","Zhongguo gu shang = China journal of orthopaedics and traumatology","Glenoid track; Imaging, three-dimensional; Shoulder dislocation; Shoulder joint; Humans; Joint Instability; Reproducibility of Results; Shoulder; Shoulder Dislocation; Shoulder Joint; Tomography, X-Ray Computed","Dai","Fei","Department of Upper Limb, Sichuan Provincial Orthopaedic Hospital, Chengdu 610041, Sichuan, China",NA
"2470","34180164","10.12200/j.issn.1003-0034.2021.06.002","[Reliability of three dimensional CT measurement of glenoid track in patients with recurrent anterior dislocation of shoulder].","To evaluate the reliability and repeatability of three-dimensional (3D)-CT measurement of glenoid track. Glenoid and Hill-Sachs bone defects in 60 patients with recurrent anterior dislocation of the unilateral shoulder were evaluated by 3D-CT and analyzed by three independent observers(shoulder orthopedists) according to the Di Giacomo method. These injuries were classified to formulate a surgical protocol. All the patients were repeatedly measured 1 week later. Intraclass correlation coefficien","2021","06","29","Zhongguo Gu Shang","Zhongguo gu shang = China journal of orthopaedics and traumatology","Glenoid track; Imaging, three-dimensional; Shoulder dislocation; Shoulder joint; Humans; Joint Instability; Reproducibility of Results; Shoulder; Shoulder Dislocation; Shoulder Joint; Tomography, X-Ray Computed","Yang","Jin-Song","Department of Upper Limb, Sichuan Provincial Orthopaedic Hospital, Chengdu 610041, Sichuan, China",NA
"2471","34180164","10.12200/j.issn.1003-0034.2021.06.002","[Reliability of three dimensional CT measurement of glenoid track in patients with recurrent anterior dislocation of shoulder].","To evaluate the reliability and repeatability of three-dimensional (3D)-CT measurement of glenoid track. Glenoid and Hill-Sachs bone defects in 60 patients with recurrent anterior dislocation of the unilateral shoulder were evaluated by 3D-CT and analyzed by three independent observers(shoulder orthopedists) according to the Di Giacomo method. These injuries were classified to formulate a surgical protocol. All the patients were repeatedly measured 1 week later. Intraclass correlation coefficien","2021","06","29","Zhongguo Gu Shang","Zhongguo gu shang = China journal of orthopaedics and traumatology","Glenoid track; Imaging, three-dimensional; Shoulder dislocation; Shoulder joint; Humans; Joint Instability; Reproducibility of Results; Shoulder; Shoulder Dislocation; Shoulder Joint; Tomography, X-Ray Computed","Zhang","Qing","Department of Upper Limb, Sichuan Provincial Orthopaedic Hospital, Chengdu 610041, Sichuan, China",NA
"2472","34180164","10.12200/j.issn.1003-0034.2021.06.002","[Reliability of three dimensional CT measurement of glenoid track in patients with recurrent anterior dislocation of shoulder].","To evaluate the reliability and repeatability of three-dimensional (3D)-CT measurement of glenoid track. Glenoid and Hill-Sachs bone defects in 60 patients with recurrent anterior dislocation of the unilateral shoulder were evaluated by 3D-CT and analyzed by three independent observers(shoulder orthopedists) according to the Di Giacomo method. These injuries were classified to formulate a surgical protocol. All the patients were repeatedly measured 1 week later. Intraclass correlation coefficien","2021","06","29","Zhongguo Gu Shang","Zhongguo gu shang = China journal of orthopaedics and traumatology","Glenoid track; Imaging, three-dimensional; Shoulder dislocation; Shoulder joint; Humans; Joint Instability; Reproducibility of Results; Shoulder; Shoulder Dislocation; Shoulder Joint; Tomography, X-Ray Computed","Chen","Jun-Rong","Department of Upper Limb, Sichuan Provincial Orthopaedic Hospital, Chengdu 610041, Sichuan, China",NA
"2473","34180164","10.12200/j.issn.1003-0034.2021.06.002","[Reliability of three dimensional CT measurement of glenoid track in patients with recurrent anterior dislocation of shoulder].","To evaluate the reliability and repeatability of three-dimensional (3D)-CT measurement of glenoid track. Glenoid and Hill-Sachs bone defects in 60 patients with recurrent anterior dislocation of the unilateral shoulder were evaluated by 3D-CT and analyzed by three independent observers(shoulder orthopedists) according to the Di Giacomo method. These injuries were classified to formulate a surgical protocol. All the patients were repeatedly measured 1 week later. Intraclass correlation coefficien","2021","06","29","Zhongguo Gu Shang","Zhongguo gu shang = China journal of orthopaedics and traumatology","Glenoid track; Imaging, three-dimensional; Shoulder dislocation; Shoulder joint; Humans; Joint Instability; Reproducibility of Results; Shoulder; Shoulder Dislocation; Shoulder Joint; Tomography, X-Ray Computed","Xiang","Ming","Department of Upper Limb, Sichuan Provincial Orthopaedic Hospital, Chengdu 610041, Sichuan, China",NA
"2474","34180156","10.1002/art.41906","A Decade of Jakinibs: what have we learned and what may be the future.","The discovery of cytokines and their role in immune and inflammatory disease led to the development a plethora of targeted biologic therapies. Later, efforts to understand mechanisms of cytokine signal transduction led to the discovery of Janus kinases (JAKs), which themselves were quickly identified as therapeutic targets. It has been a decade since the first JAK inhibitors (jakinibs) were approved and now there are nine jakinibs approved for treatment of rheumatologic, dermatologic, hematologi","2021","06","28","Arthritis Rheumatol","Arthritis &amp; rheumatology (Hoboken, N.J.)","Autoimmunity; COVID-19; Cytokines; Inflammation; JAK; Kinase Inhibitors","Liu","Christine","Translational Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA",NA
"2475","34180156","10.1002/art.41906","A Decade of Jakinibs: what have we learned and what may be the future.","The discovery of cytokines and their role in immune and inflammatory disease led to the development a plethora of targeted biologic therapies. Later, efforts to understand mechanisms of cytokine signal transduction led to the discovery of Janus kinases (JAKs), which themselves were quickly identified as therapeutic targets. It has been a decade since the first JAK inhibitors (jakinibs) were approved and now there are nine jakinibs approved for treatment of rheumatologic, dermatologic, hematologi","2021","06","28","Arthritis Rheumatol","Arthritis &amp; rheumatology (Hoboken, N.J.)","Autoimmunity; COVID-19; Cytokines; Inflammation; JAK; Kinase Inhibitors","Kieltyka","Jacqueline","Translational Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA",NA
"2476","34180156","10.1002/art.41906","A Decade of Jakinibs: what have we learned and what may be the future.","The discovery of cytokines and their role in immune and inflammatory disease led to the development a plethora of targeted biologic therapies. Later, efforts to understand mechanisms of cytokine signal transduction led to the discovery of Janus kinases (JAKs), which themselves were quickly identified as therapeutic targets. It has been a decade since the first JAK inhibitors (jakinibs) were approved and now there are nine jakinibs approved for treatment of rheumatologic, dermatologic, hematologi","2021","06","28","Arthritis Rheumatol","Arthritis &amp; rheumatology (Hoboken, N.J.)","Autoimmunity; COVID-19; Cytokines; Inflammation; JAK; Kinase Inhibitors","Fleischmann","Roy","Metroplex Clinical Research Center, University of Texas, Southwestern Medical Center",NA
"2477","34180156","10.1002/art.41906","A Decade of Jakinibs: what have we learned and what may be the future.","The discovery of cytokines and their role in immune and inflammatory disease led to the development a plethora of targeted biologic therapies. Later, efforts to understand mechanisms of cytokine signal transduction led to the discovery of Janus kinases (JAKs), which themselves were quickly identified as therapeutic targets. It has been a decade since the first JAK inhibitors (jakinibs) were approved and now there are nine jakinibs approved for treatment of rheumatologic, dermatologic, hematologi","2021","06","28","Arthritis Rheumatol","Arthritis &amp; rheumatology (Hoboken, N.J.)","Autoimmunity; COVID-19; Cytokines; Inflammation; JAK; Kinase Inhibitors","Gadina","Massimo","Translational Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA",NA
"2478","34180156","10.1002/art.41906","A Decade of Jakinibs: what have we learned and what may be the future.","The discovery of cytokines and their role in immune and inflammatory disease led to the development a plethora of targeted biologic therapies. Later, efforts to understand mechanisms of cytokine signal transduction led to the discovery of Janus kinases (JAKs), which themselves were quickly identified as therapeutic targets. It has been a decade since the first JAK inhibitors (jakinibs) were approved and now there are nine jakinibs approved for treatment of rheumatologic, dermatologic, hematologi","2021","06","28","Arthritis Rheumatol","Arthritis &amp; rheumatology (Hoboken, N.J.)","Autoimmunity; COVID-19; Cytokines; Inflammation; JAK; Kinase Inhibitors","O'Shea","John J","Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA",NA
"2479","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Mahajan","Amita","Department of Pediatrics Oncology and Hematology, Indraprastha Apollo Hospital, Delhi, India",NA
"2480","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Arora","Ramandeep Singh","Department of Pediatric Oncology, Max Super Specialty Hospital, Saket, Delhi, India",NA
"2481","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Sahi","Puneet Kaur","Department of Pediatrics, Maulana Azad Medical College and Lok Nayak Hospital, Delhi, India",NA
"2482","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Gomber","Sunil","Department of Pediatric, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India",NA
"2483","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Radhakrishnan","Nita","Department of Paediatric Hemato-Oncology, Super Speciality Paediatric Hospital and Post Graduate Teaching Institute, Noida, Uttar Pradesh, India",NA
"2484","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Bagchi","Basab","Department of Medical Oncology &amp",NA
"2485","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Jain","Prachi","Department of Pediatric Oncology, Max Super Specialty Hospital, Vaishali, Delhi, India",NA
"2486","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Kumar","Arvind","Department of Hemato-Oncologist, Buddha Cancer Centre, Patna, Bihar, India",NA
"2487","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Singh","Avinash","Department of Hemato-Oncology, Paras HMRI Hospital, Patna, Bihar, India",NA
"2488","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Gupta","Haresh","Department of Medical Projects and Social Support Program, Cankids Kidscan, Delhi, India",NA
"2489","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Sharma","Sonal","Department of Medical Projects and Social Support Program, Cankids Kidscan, Delhi, India",NA
"2490","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Ahamad","Nasim","Department of Medical Projects and Social Support Program, Cankids Kidscan, Delhi, India",NA
"2491","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Bagai","Poonam","Department of Medical Projects and Social Support Program, Cankids Kidscan, Delhi, India",NA
"2492","34180154","10.1002/cnr2.1486","Shared care for children with cancer in India through social and healthcare partnerships during the COVID-19 pandemic.","The COVID pandemic posed a challenge for the tertiary centers to continue treatment. Some tertiary centers were designated as COVID-only hospitals, making it difficult for existing childhood cancer patients to continue their treatment at those centres. The need for shared care in childhood cancer was perceived by Cankids and its partnering childhood cancer-treating centers in North and East India. We aim to show how Cankids upscaled its shared care model to ensure that COVID designated hospitals","2021","06","28","Cancer Rep (Hoboken)","Cancer reports (Hoboken, N.J.)","COVID-19; childhood cancer; non-government organization; shared care","Kumar","Arvind","Department of Medical Projects and Social Support Program, Cankids Kidscan, Delhi, India",NA
"2493","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Altay","Ozlem","Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, SE-100 44, Sweden",NA
"2494","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Arif","Muhammad","Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, SE-100 44, Sweden",NA
"2495","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Li","Xiangyu","Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, SE-100 44, Sweden",NA
"2496","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Yang","Hong","Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, SE-100 44, Sweden",NA
"2497","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Aydin","Mehtap","Department of Infectious Diseases, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, 34766, Turkey",NA
"2498","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Alkurt","Gizem","Genomic Laboratory (GLAB), Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, 34766, Turkey",NA
"2499","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Kim","Woonghee","Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, SE-100 44, Sweden",NA
"2500","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Akyol","Dogukan","Genomic Laboratory (GLAB), Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, 34766, Turkey",NA
"2501","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Zhang","Cheng","Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, SE-100 44, Sweden",NA
"2502","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Dinler-Doganay","Gizem","Department of Molecular Biology and Genetics, Istanbul Technical University, Istanbul, 34469, Turkey",NA
"2503","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Turkez","Hasan","Department of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum, 25240, Turkey",NA
"2504","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Shoaie","Saeed","Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, SE-100 44, Sweden",NA
"2505","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Nielsen","Jens","Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, SE-41296, Sweden",NA
"2506","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Borén","Jan","Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital Gothenburg, Gothenburg, SE-41345, Sweden",NA
"2507","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Olmuscelik","Oktay","Department of Internal Medicine, Istanbul Medipol University, Bagcilar, Istanbul, 34214, Turkey",NA
"2508","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Doganay","Levent","Department of Gastroenterology, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, 34766, Turkey",NA
"2509","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Uhlén","Mathias","Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, SE-100 44, Sweden",NA
"2510","34180141","10.1002/advs.202101222","Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.","COVID-19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD<sup>+</sup> ) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutathione and NAD+ precursors can restore metabolic function and thus aid the recovery of COVID-19 patients. CMAs include l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tar","2021","06","28","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","COVID-19; combined metabolic activators; metabolomics; omics data; proteomics","Mardinoglu","Adil","Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, SE-100 44, Sweden",NA
"2511","34180130","10.1002/pbc.29191","Varicella-Zoster virus reactivation following SARS-CoV-2 immunization in two patients with leukemia.",NA,"2021","06","28","Pediatr Blood Cancer","Pediatric blood &amp; cancer",NA,"Foster","Catherine E","Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA",NA
"2512","34180130","10.1002/pbc.29191","Varicella-Zoster virus reactivation following SARS-CoV-2 immunization in two patients with leukemia.",NA,"2021","06","28","Pediatr Blood Cancer","Pediatric blood &amp; cancer",NA,"Penella","Ana Del Valle","Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA",NA
"2513","34180130","10.1002/pbc.29191","Varicella-Zoster virus reactivation following SARS-CoV-2 immunization in two patients with leukemia.",NA,"2021","06","28","Pediatr Blood Cancer","Pediatric blood &amp; cancer",NA,"Davis","Andrea L","Department of Infection Control and Prevention, Texas Children's Hospital, Houston, Texas, USA",NA
"2514","34180130","10.1002/pbc.29191","Varicella-Zoster virus reactivation following SARS-CoV-2 immunization in two patients with leukemia.",NA,"2021","06","28","Pediatr Blood Cancer","Pediatric blood &amp; cancer",NA,"Arrington","Amy S","Section of Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA",NA
"2515","34180130","10.1002/pbc.29191","Varicella-Zoster virus reactivation following SARS-CoV-2 immunization in two patients with leukemia.",NA,"2021","06","28","Pediatr Blood Cancer","Pediatric blood &amp; cancer",NA,"Campbell","Judith","Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA",NA
"2516","34180130","10.1002/pbc.29191","Varicella-Zoster virus reactivation following SARS-CoV-2 immunization in two patients with leukemia.",NA,"2021","06","28","Pediatr Blood Cancer","Pediatric blood &amp; cancer",NA,"Palazzi","Debra L","Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA",NA
"2517","34180108","10.1111/psyg.12719","One size does not fit all: individual differences in attachment style and fear of COVID-19 in hospitalized elderly patients.",NA,"2021","07","05","Psychogeriatrics","Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society",NA,"Leonardi","Gloria","Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy",NA
"2518","34180108","10.1111/psyg.12719","One size does not fit all: individual differences in attachment style and fear of COVID-19 in hospitalized elderly patients.",NA,"2021","07","05","Psychogeriatrics","Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society",NA,"Colonnello","Valentina","Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy",NA
"2519","34180108","10.1111/psyg.12719","One size does not fit all: individual differences in attachment style and fear of COVID-19 in hospitalized elderly patients.",NA,"2021","07","05","Psychogeriatrics","Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society",NA,"Farinelli","Marina","Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy",NA
"2520","34180108","10.1111/psyg.12719","One size does not fit all: individual differences in attachment style and fear of COVID-19 in hospitalized elderly patients.",NA,"2021","07","05","Psychogeriatrics","Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society",NA,"Bertoletti","Erik","Santa Viola Hospital, Colibrì Consortium, Bologna, Italy",NA
"2521","34180108","10.1111/psyg.12719","One size does not fit all: individual differences in attachment style and fear of COVID-19 in hospitalized elderly patients.",NA,"2021","07","05","Psychogeriatrics","Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society",NA,"Russo","Paolo Maria","Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy",NA
"2522","34180106","10.1111/resp.14109","The 1918 influenza and COVID-19 pandemics: The effect of age on outcomes.",NA,"2021","06","28","Respirology","Respirology (Carlton, Vic.)","COVID-19; inflammation; influenza","King","Paul T","Monash Lung, Sleep, Allergy and Immunology, Monash Medical Centre, Melbourne, Victoria, Australia",NA
"2523","34180106","10.1111/resp.14109","The 1918 influenza and COVID-19 pandemics: The effect of age on outcomes.",NA,"2021","06","28","Respirology","Respirology (Carlton, Vic.)","COVID-19; inflammation; influenza","Londrigan","Sarah L","Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute, Melbourne, Victoria, Australia",NA
"2524","34180102","10.1111/hsc.13399","Psychosocial care experiences of patients with COVID-19 at home in Iran: A qualitative study.","Due to the onset peak of COVID-19, as well as a shortage of human resources, physical environment, protective and medical equipment in hospitals, many patients with mild to moderate symptoms of COVID-19 are pushed to home care. This condition not only raises public health concerns but also causes a number of psychosocial problems. Therefore, this study intends to examine the psychosocial experiences of patients with COVID-19 after passing the crisis stage. A qualitative study with a conventional","2021","06","28","Health Soc Care Community","Health &amp; social care in the community","COVID-19; experiences; home care; psychosocial care","Akbarbegloo","Masumeh","Pediatric Nursing Department, Faculty of Nursing, Khoy University of Medical Sciences, Khoy, Iran",NA
"2525","34180102","10.1111/hsc.13399","Psychosocial care experiences of patients with COVID-19 at home in Iran: A qualitative study.","Due to the onset peak of COVID-19, as well as a shortage of human resources, physical environment, protective and medical equipment in hospitals, many patients with mild to moderate symptoms of COVID-19 are pushed to home care. This condition not only raises public health concerns but also causes a number of psychosocial problems. Therefore, this study intends to examine the psychosocial experiences of patients with COVID-19 after passing the crisis stage. A qualitative study with a conventional","2021","06","28","Health Soc Care Community","Health &amp; social care in the community","COVID-19; experiences; home care; psychosocial care","Sanaeefar","Mahnaz","Pediatric Nursing Department, Faculty of Nursing, Khoy University of Medical Sciences, Khoy, Iran",NA
"2526","34180102","10.1111/hsc.13399","Psychosocial care experiences of patients with COVID-19 at home in Iran: A qualitative study.","Due to the onset peak of COVID-19, as well as a shortage of human resources, physical environment, protective and medical equipment in hospitals, many patients with mild to moderate symptoms of COVID-19 are pushed to home care. This condition not only raises public health concerns but also causes a number of psychosocial problems. Therefore, this study intends to examine the psychosocial experiences of patients with COVID-19 after passing the crisis stage. A qualitative study with a conventional","2021","06","28","Health Soc Care Community","Health &amp; social care in the community","COVID-19; experiences; home care; psychosocial care","Majid","Purabdollah","Nursing and Midwifery College, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"2527","34180102","10.1111/hsc.13399","Psychosocial care experiences of patients with COVID-19 at home in Iran: A qualitative study.","Due to the onset peak of COVID-19, as well as a shortage of human resources, physical environment, protective and medical equipment in hospitals, many patients with mild to moderate symptoms of COVID-19 are pushed to home care. This condition not only raises public health concerns but also causes a number of psychosocial problems. Therefore, this study intends to examine the psychosocial experiences of patients with COVID-19 after passing the crisis stage. A qualitative study with a conventional","2021","06","28","Health Soc Care Community","Health &amp; social care in the community","COVID-19; experiences; home care; psychosocial care","Mohammadzadeh","Mehdi","Department of Biology, Faculty of Sciences, Urmia University, Urmia, Iran",NA
"2528","34180087","10.1111/birt.12569","Australian women's experiences of receiving maternity care during the COVID-19 pandemic: A cross-sectional national survey.","The COVID-19 pandemic has led to multiple changes in maternity services worldwide. Systems rapidly adapted to meet public health requirements aimed at preventing transmission of SARS-CoV-2, including quarantine procedures, travel restrictions, border closures, physical distancing and ""stay-at-home"" orders. Although these changes have impacted all stakeholders in maternity services, arguably the women at the center of this care have been most affected. This study aimed to explore women's experien","2021","06","28","Birth","Birth (Berkeley, Calif.)","COVID-19; maternity care; midwifery; obstetrics; women's health","Wilson","Alyce N","Maternal, Child and Adolescent Health Program, Burnet Institute, Melbourne, Vic., Australia",NA
"2529","34180087","10.1111/birt.12569","Australian women's experiences of receiving maternity care during the COVID-19 pandemic: A cross-sectional national survey.","The COVID-19 pandemic has led to multiple changes in maternity services worldwide. Systems rapidly adapted to meet public health requirements aimed at preventing transmission of SARS-CoV-2, including quarantine procedures, travel restrictions, border closures, physical distancing and ""stay-at-home"" orders. Although these changes have impacted all stakeholders in maternity services, arguably the women at the center of this care have been most affected. This study aimed to explore women's experien","2021","06","28","Birth","Birth (Berkeley, Calif.)","COVID-19; maternity care; midwifery; obstetrics; women's health","Sweet","Linda","School of Nursing and Midwifery, Deakin University, Melbourne, Vic., Australia",NA
"2530","34180087","10.1111/birt.12569","Australian women's experiences of receiving maternity care during the COVID-19 pandemic: A cross-sectional national survey.","The COVID-19 pandemic has led to multiple changes in maternity services worldwide. Systems rapidly adapted to meet public health requirements aimed at preventing transmission of SARS-CoV-2, including quarantine procedures, travel restrictions, border closures, physical distancing and ""stay-at-home"" orders. Although these changes have impacted all stakeholders in maternity services, arguably the women at the center of this care have been most affected. This study aimed to explore women's experien","2021","06","28","Birth","Birth (Berkeley, Calif.)","COVID-19; maternity care; midwifery; obstetrics; women's health","Vasilevski","Vidanka","School of Nursing and Midwifery, Deakin University, Melbourne, Vic., Australia",NA
"2531","34180087","10.1111/birt.12569","Australian women's experiences of receiving maternity care during the COVID-19 pandemic: A cross-sectional national survey.","The COVID-19 pandemic has led to multiple changes in maternity services worldwide. Systems rapidly adapted to meet public health requirements aimed at preventing transmission of SARS-CoV-2, including quarantine procedures, travel restrictions, border closures, physical distancing and ""stay-at-home"" orders. Although these changes have impacted all stakeholders in maternity services, arguably the women at the center of this care have been most affected. This study aimed to explore women's experien","2021","06","28","Birth","Birth (Berkeley, Calif.)","COVID-19; maternity care; midwifery; obstetrics; women's health","Hauck","Yvonne","School of Nursing, Midwifery and Paramedic Medicine, Curtin University, Perth, WA, Australia",NA
"2532","34180087","10.1111/birt.12569","Australian women's experiences of receiving maternity care during the COVID-19 pandemic: A cross-sectional national survey.","The COVID-19 pandemic has led to multiple changes in maternity services worldwide. Systems rapidly adapted to meet public health requirements aimed at preventing transmission of SARS-CoV-2, including quarantine procedures, travel restrictions, border closures, physical distancing and ""stay-at-home"" orders. Although these changes have impacted all stakeholders in maternity services, arguably the women at the center of this care have been most affected. This study aimed to explore women's experien","2021","06","28","Birth","Birth (Berkeley, Calif.)","COVID-19; maternity care; midwifery; obstetrics; women's health","Wynter","Karen","School of Nursing and Midwifery, Deakin University, Melbourne, Vic., Australia",NA
"2533","34180087","10.1111/birt.12569","Australian women's experiences of receiving maternity care during the COVID-19 pandemic: A cross-sectional national survey.","The COVID-19 pandemic has led to multiple changes in maternity services worldwide. Systems rapidly adapted to meet public health requirements aimed at preventing transmission of SARS-CoV-2, including quarantine procedures, travel restrictions, border closures, physical distancing and ""stay-at-home"" orders. Although these changes have impacted all stakeholders in maternity services, arguably the women at the center of this care have been most affected. This study aimed to explore women's experien","2021","06","28","Birth","Birth (Berkeley, Calif.)","COVID-19; maternity care; midwifery; obstetrics; women's health","Kuliukas","Lesley","School of Nursing, Midwifery and Paramedic Medicine, Curtin University, Perth, WA, Australia",NA
"2534","34180087","10.1111/birt.12569","Australian women's experiences of receiving maternity care during the COVID-19 pandemic: A cross-sectional national survey.","The COVID-19 pandemic has led to multiple changes in maternity services worldwide. Systems rapidly adapted to meet public health requirements aimed at preventing transmission of SARS-CoV-2, including quarantine procedures, travel restrictions, border closures, physical distancing and ""stay-at-home"" orders. Although these changes have impacted all stakeholders in maternity services, arguably the women at the center of this care have been most affected. This study aimed to explore women's experien","2021","06","28","Birth","Birth (Berkeley, Calif.)","COVID-19; maternity care; midwifery; obstetrics; women's health","Szabo","Rebecca A","Royal Women's Hospital, Parkville, Vic., Australia",NA
"2535","34180087","10.1111/birt.12569","Australian women's experiences of receiving maternity care during the COVID-19 pandemic: A cross-sectional national survey.","The COVID-19 pandemic has led to multiple changes in maternity services worldwide. Systems rapidly adapted to meet public health requirements aimed at preventing transmission of SARS-CoV-2, including quarantine procedures, travel restrictions, border closures, physical distancing and ""stay-at-home"" orders. Although these changes have impacted all stakeholders in maternity services, arguably the women at the center of this care have been most affected. This study aimed to explore women's experien","2021","06","28","Birth","Birth (Berkeley, Calif.)","COVID-19; maternity care; midwifery; obstetrics; women's health","Homer","Caroline S E","Maternal, Child and Adolescent Health Program, Burnet Institute, Melbourne, Vic., Australia",NA
"2536","34180087","10.1111/birt.12569","Australian women's experiences of receiving maternity care during the COVID-19 pandemic: A cross-sectional national survey.","The COVID-19 pandemic has led to multiple changes in maternity services worldwide. Systems rapidly adapted to meet public health requirements aimed at preventing transmission of SARS-CoV-2, including quarantine procedures, travel restrictions, border closures, physical distancing and ""stay-at-home"" orders. Although these changes have impacted all stakeholders in maternity services, arguably the women at the center of this care have been most affected. This study aimed to explore women's experien","2021","06","28","Birth","Birth (Berkeley, Calif.)","COVID-19; maternity care; midwifery; obstetrics; women's health","Bradfield","Zoe","School of Nursing, Midwifery and Paramedic Medicine, Curtin University, Perth, WA, Australia",NA
"2537","34180072","10.1111/bioe.12889","Justifying the risks of COVID-19 challenge trials: The analogy with organ donation.","In the beginning of the COVID pandemic, researchers and bioethicists called for human challenge trials to hasten the development of a vaccine for COVID. However, the fact that we lacked a specific, highly effective treatment for COVID led many to argue that a COVID challenge trial would be unethical and we ought to pursue traditional phase III testing instead. These ethical objections to challenge trials may have slowed the progress of a COVID vaccine, so it is important to evaluate their merit.","2021","06","28","Bioethics","Bioethics","COVID-19; clinical trials; human challenge trials; organ donation; research ethics","Jayaram","Athmeya","Institute for Practical Ethics, University of California San Diego, La Jolla, California, USA",NA
"2538","34180072","10.1111/bioe.12889","Justifying the risks of COVID-19 challenge trials: The analogy with organ donation.","In the beginning of the COVID pandemic, researchers and bioethicists called for human challenge trials to hasten the development of a vaccine for COVID. However, the fact that we lacked a specific, highly effective treatment for COVID led many to argue that a COVID challenge trial would be unethical and we ought to pursue traditional phase III testing instead. These ethical objections to challenge trials may have slowed the progress of a COVID vaccine, so it is important to evaluate their merit.","2021","06","28","Bioethics","Bioethics","COVID-19; clinical trials; human challenge trials; organ donation; research ethics","Sparks","Jacob","Philosophy Department, California Polytechnic State University, San Luis Obispo, California, USA",NA
"2539","34180072","10.1111/bioe.12889","Justifying the risks of COVID-19 challenge trials: The analogy with organ donation.","In the beginning of the COVID pandemic, researchers and bioethicists called for human challenge trials to hasten the development of a vaccine for COVID. However, the fact that we lacked a specific, highly effective treatment for COVID led many to argue that a COVID challenge trial would be unethical and we ought to pursue traditional phase III testing instead. These ethical objections to challenge trials may have slowed the progress of a COVID vaccine, so it is important to evaluate their merit.","2021","06","28","Bioethics","Bioethics","COVID-19; clinical trials; human challenge trials; organ donation; research ethics","Callies","Daniel","Health Ethics Center, University of California, Los Angeles, Los Angeles, California, USA",NA
"2540","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Láinez-Andrés","J M","Hospital Clínico Universitario de Valencia, 46010 Valencia, España",NA
"2541","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Ashina","M","Rigshospitalet Glostrup, Glostrup, Dinamarca",NA
"2542","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Belvís","R","Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, España",NA
"2543","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Díaz-Insa","S","Hospital Universitario La Fe, Valencia, España",NA
"2544","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Ezpeleta","D","Hospital Universitario Quirón Salud Madrid, Pozuelo de Alarcón, España",NA
"2545","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","García-Azorín","D","Hospital Universitario Clínico de Valladolid, Valladolid, España",NA
"2546","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","González-Oria","C","Hospital Universitario Virgen del Rocío, Sevilla, España",NA
"2547","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Guerrero","A L","Hospital Universitario Clínico de Valladolid, Valladolid, España",NA
"2548","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Guillém","A","Hospital General Universitario Gregorio Marañón, Madrid, España",NA
"2549","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Holle-Lee","D","University Hospital Essen, Essen, Alemania",NA
"2550","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Huerta-Villanueva","M","Hospital Universitario de Viladecans, Viladecans, España",NA
"2551","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Irimia","P","Clínica Universitaria de Navarra, 31008 Pamplona, España",NA
"2552","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Leira","R","Hospital Clínico Universitario de Santiago de Compostela, A Coruña, España",NA
"2553","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Pascual","J","Hospital Universitario Marqués de Valdecilla, Santander, España",NA
"2554","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Porta-Etessam","J","Hospital Clínico San Carlos, 28040 Madrid, España",NA
"2555","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Pozo-Rosich","P","Hospital Universitari Vall d'Hebron, 08035 Barcelona, España",NA
"2556","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Rodríguez-Vico","J S","Hospital Universitario Fundación Jiménez Díaz, Madrid, España",NA
"2557","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Sánchez Del Río","M","Clínica Universitaria de Navarra, Madrid, España",NA
"2558","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Santos-Lasaosa","S","Hospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, España",NA
"2559","34180043","10.33588/rn.72s02.2021155","1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.","After the European Headache Federation (EHF) Congress, renowned Spanish neurologists specialised in migraine presented the most significant latest developments in research in this field at the Post-EHF Meeting. The main data presented concerning the treatment of chronic and episodic migraine were addressed, with attention paid more specifically to those related to preventive treatments and real-life experience in the management of the disease. An important review was carried out of the new thera","2021","07","15","Rev Neurol","Revista de neurologia","Antibodies, Monoclonal; Congresses as Topic; Europe; Humans; Migraine Disorders; Practice Guidelines as Topic","Silberstein","S","Jefferson University Hospital, Philadelphia, EE",NA
"2560","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Fleuren","Lucas M","Department of Intensive Care Medicine, Amsterdam UMC, Amsterdam, The Netherlands. l.fleuren@amsterdamumc","l.fleuren@amsterdamumc.nl"
"2561","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Tonutti","Michele","Pacmed, Amsterdam, The Netherlands",NA
"2562","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","de Bruin","Daan P","Pacmed, Amsterdam, The Netherlands",NA
"2563","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Lalisang","Robbert C A","Pacmed, Amsterdam, The Netherlands",NA
"2564","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Dam","Tariq A","Department of Intensive Care Medicine, Amsterdam UMC, Amsterdam, The Netherlands",NA
"2565","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Gommers","Diederik","Department of Intensive Care, Erasmus Medical Center, Rotterdam, The Netherlands",NA
"2566","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Cremer","Olaf L","Intensive Care, UMC Utrecht, Utrecht, The Netherlands",NA
"2567","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Bosman","Rob J","ICU, OLVG, Amsterdam, The Netherlands",NA
"2568","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Vonk","Sebastiaan J J","Pacmed, Amsterdam, The Netherlands",NA
"2569","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Fornasa","Mattia","Pacmed, Amsterdam, The Netherlands",NA
"2570","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Machado","Tomas","Pacmed, Amsterdam, The Netherlands",NA
"2571","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","van der Meer","Nardo J M","Intensive Care, Amphia Ziekenhuis, Breda en Oosterhout, The Netherlands",NA
"2572","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Rigter","Sander","Department of Anesthesiology and Intensive Care, St. Antonius Hospital, Nieuwegein, The Netherlands",NA
"2573","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Wils","Evert-Jan","Department of Intensive Care, Franciscus Gasthuis &amp",NA
"2574","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Frenzel","Tim","Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands",NA
"2575","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Dongelmans","Dave A","Department of Intensive Care Medicine, Amsterdam UMC, Amsterdam, The Netherlands",NA
"2576","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","de Jong","Remko","Intensive Care, Bovenij Ziekenhuis, Amsterdam, The Netherlands",NA
"2577","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Peters","Marco","Intensive Care, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands",NA
"2578","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Kamps","Marlijn J A","Intensive Care, Catharina Ziekenhuis Eindhoven, Eindhoven, The Netherlands",NA
"2579","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Ramnarain","Dharmanand","Intensive Care, ETZ Tilburg, Tilburg, The Netherlands",NA
"2580","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Nowitzky","Ralph","Intensive Care, Haga Ziekenhuis, Den Haag, The Netherlands",NA
"2581","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Nooteboom","Fleur G C A","Intensive Care, Laurentius Ziekenhuis, Roermond, The Netherlands",NA
"2582","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","de Ruijter","Wouter","Intensive Care, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands",NA
"2583","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Urlings-Strop","Louise C","Intensive Care, Reinier de Graaf Gasthuis, Delft, The Netherlands",NA
"2584","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Smit","Ellen G M","Intensive Care, Spaarne Gasthuis, Haarlem en Hoofddorp, The Netherlands",NA
"2585","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Mehagnoul-Schipper","D Jannet","Intensive Care, VieCuri Medisch Centrum, Venlo, The Netherlands",NA
"2586","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Dormans","Tom","Intensive Care, Zuyderland MC, Heerlen, The Netherlands",NA
"2587","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","de Jager","Cornelis P C","Department of Intensive Care, Jeroen Bosch Ziekenhuis, Den Bosch, The Netherlands",NA
"2588","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Hendriks","Stefaan H A","Intensive Care, Albert Schweitzerziekenhuis, Dordrecht, The Netherlands",NA
"2589","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Oostdijk","Evelien","ICU, Maasstad Ziekenhuis Rotterdam, Rotterdam, The Netherlands",NA
"2590","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Reidinga","Auke C","ICU, SEH, BWC, Martiniziekenhuis, Groningen, The Netherlands",NA
"2591","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Festen-Spanjer","Barbara","Intensive Care, Ziekenhuis Gelderse Vallei, Ede, The Netherlands",NA
"2592","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Brunnekreef","Gert","Department of Intensive Care, Ziekenhuisgroep Twente, Almelo, The Netherlands",NA
"2593","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Cornet","Alexander D","Department of Intensive Care, Medisch Spectrum Twente, Enschede, The Netherlands",NA
"2594","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","van den Tempel","Walter","Department of Intensive Care, Ikazia Ziekenhuis Rotterdam, Rotterdam, The Netherlands",NA
"2595","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Boelens","Age D","Anesthesiology, Antonius Ziekenhuis Sneek, Sneek, The Netherlands",NA
"2596","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Koetsier","Peter","Intensive Care, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands",NA
"2597","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Lens","Judith","ICU, IJsselland Ziekenhuis, Capelle aan den IJssel, The Netherlands",NA
"2598","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Achterberg","Sefanja","ICU, Haaglanden Medisch Centrum, Den Haag, The Netherlands",NA
"2599","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Faber","Harald J","ICU, WZA, Assen, The Netherlands",NA
"2600","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Karakus","A","Department of Intensive Care, Diakonessenhuis Hospital, Utrecht, The Netherlands",NA
"2601","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Beukema","Menno","Department of Intensive Care, Streekziekenhuis Koningin Beatrix, Winterswijk, The Netherlands",NA
"2602","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Entjes","Robert","Department of Intensive Care, Admiraal De Ruyter Ziekenhuis, Goes, The Netherlands",NA
"2603","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","de Jong","Paul","Department of Anesthesia and Intensive Care, Slingeland Ziekenhuis, Doetinchem, The Netherlands",NA
"2604","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Houwert","Taco","Pacmed, Amsterdam, The Netherlands",NA
"2605","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Hovenkamp","Hidde","Pacmed, Amsterdam, The Netherlands",NA
"2606","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Noorduijn Londono","Roberto","Pacmed, Amsterdam, The Netherlands",NA
"2607","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Quintarelli","Davide","Pacmed, Amsterdam, The Netherlands",NA
"2608","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Scholtemeijer","Martijn G","Pacmed, Amsterdam, The Netherlands",NA
"2609","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","de Beer","Aletta A","Pacmed, Amsterdam, The Netherlands",NA
"2610","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Cinà","Giovanni","Pacmed, Amsterdam, The Netherlands",NA
"2611","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Beudel","Martijn","Department of Neurology, Amsterdam UMC, Universiteit Van Amsterdam, Amsterdam, The Netherlands",NA
"2612","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","de Keizer","Nicolet F","Department of Clinical Informatics, Amsterdam UMC, Amsterdam, The Netherlands",NA
"2613","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Hoogendoorn","Mark","Quantitative Data Analytics Group, Department of Computer Science, Faculty of Science, VU University, Amsterdam, The Netherlands",NA
"2614","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Girbes","Armand R J","Department of Intensive Care Medicine, Amsterdam UMC, Amsterdam, The Netherlands",NA
"2615","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Herter","Willem E","Pacmed, Amsterdam, The Netherlands",NA
"2616","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Elbers","Paul W G","Department of Intensive Care Medicine, Amsterdam UMC, Amsterdam, The Netherlands",NA
"2617","34180025","10.1186/s40635-021-00397-5","Risk factors for adverse outcomes during mechanical ventilation of 1152 COVID-19 patients: a multicenter machine learning study with highly granular data from the Dutch Data Warehouse.","The identification of risk factors for adverse outcomes and prolonged intensive care unit (ICU) stay in COVID-19 patients is essential for prognostication, determining treatment intensity, and resource allocation. Previous studies have determined risk factors on admission only, and included a limited number of predictors. Therefore, using data from the highly granular and multicenter Dutch Data Warehouse, we developed machine learning models to identify risk factors for ICU mortality, ventilator","2021","07","01","Intensive Care Med Exp","Intensive care medicine experimental","COVID-19; Machine learning; Mortality prediction; Risk factors","Thoral","Patrick J","Department of Intensive Care Medicine, Amsterdam UMC, Amsterdam, The Netherlands",NA
"2618","34179996","10.1093/pubmed/fdab248","The impact of pre-existing conditions and perceived health status on mental health during the COVID-19 pandemic.","Patients with pre-existing conditions and poor health status are vulnerable for adverse health sequalae during the COVID-19 pandemic. We investigated the association of pre-existing medical conditions and self-perceived health status with the risk of mental health complications during the COVID-19 pandemic. In October-December, 2020, 1036 respondents completed online survey that included assessment of pre-existing conditions, self-perceived health status, depressive (Patient Health Questionnaire","2021","06","28","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; anxiety; depression; pre-existing conditions; stress","Buneviciene","Inesa","Vytautas Magnus University, Department of Public Communications, Kaunas 44248, Lithuania",NA
"2619","34179996","10.1093/pubmed/fdab248","The impact of pre-existing conditions and perceived health status on mental health during the COVID-19 pandemic.","Patients with pre-existing conditions and poor health status are vulnerable for adverse health sequalae during the COVID-19 pandemic. We investigated the association of pre-existing medical conditions and self-perceived health status with the risk of mental health complications during the COVID-19 pandemic. In October-December, 2020, 1036 respondents completed online survey that included assessment of pre-existing conditions, self-perceived health status, depressive (Patient Health Questionnaire","2021","06","28","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; anxiety; depression; pre-existing conditions; stress","Bunevicius","Romas","ProIT, Vilnius 09312, Lithuania",NA
"2620","34179996","10.1093/pubmed/fdab248","The impact of pre-existing conditions and perceived health status on mental health during the COVID-19 pandemic.","Patients with pre-existing conditions and poor health status are vulnerable for adverse health sequalae during the COVID-19 pandemic. We investigated the association of pre-existing medical conditions and self-perceived health status with the risk of mental health complications during the COVID-19 pandemic. In October-December, 2020, 1036 respondents completed online survey that included assessment of pre-existing conditions, self-perceived health status, depressive (Patient Health Questionnaire","2021","06","28","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; anxiety; depression; pre-existing conditions; stress","Bagdonas","Sarunas","ProIT, Vilnius 09312, Lithuania",NA
"2621","34179996","10.1093/pubmed/fdab248","The impact of pre-existing conditions and perceived health status on mental health during the COVID-19 pandemic.","Patients with pre-existing conditions and poor health status are vulnerable for adverse health sequalae during the COVID-19 pandemic. We investigated the association of pre-existing medical conditions and self-perceived health status with the risk of mental health complications during the COVID-19 pandemic. In October-December, 2020, 1036 respondents completed online survey that included assessment of pre-existing conditions, self-perceived health status, depressive (Patient Health Questionnaire","2021","06","28","J Public Health (Oxf)","Journal of public health (Oxford, England)","COVID-19; anxiety; depression; pre-existing conditions; stress","Bunevicius","Adomas","Cura Te Ipsum, Garliava 53274, Lithuania",NA
"2622","34179989","10.1093/eurjpc/zwab116","Cardiovascular rehabilitation in the COVID-19 era: 'a phoenix arising from the ashes?'",NA,"2021","06","28","Eur J Prev Cardiol","European journal of preventive cardiology",NA,"Laoutaris","Ioannis D","Onassis Cardiac Surgery Center, 356 Sygrou Boulevard, Athens 176 74, Greece",NA
"2623","34179989","10.1093/eurjpc/zwab116","Cardiovascular rehabilitation in the COVID-19 era: 'a phoenix arising from the ashes?'",NA,"2021","06","28","Eur J Prev Cardiol","European journal of preventive cardiology",NA,"Dritsas","Athanasios","Onassis Cardiac Surgery Center, 356 Sygrou Boulevard, Athens 176 74, Greece",NA
"2624","34179989","10.1093/eurjpc/zwab116","Cardiovascular rehabilitation in the COVID-19 era: 'a phoenix arising from the ashes?'",NA,"2021","06","28","Eur J Prev Cardiol","European journal of preventive cardiology",NA,"Adamopoulos","Stamatis","Onassis Cardiac Surgery Center, 356 Sygrou Boulevard, Athens 176 74, Greece",NA
"2625","34179987","10.1093/pubmed/fdab213","Are schools drivers of COVID-19 infections-an analysis of outbreaks in Colorado, USA in 2020.","The impact of school closures/reopening on transmission of SARS-CoV-2 in the wider community remains contested. Outbreak data from Colorado, USA (2020), alongside data on implemented public health measures were analyzed. There were three waves (n = 3169 outbreaks; 61 650 individuals). The first was led by healthcare settings, the second leisure/entertainment and the third workplaces followed by other settings where the trajectory was equally distributed amongst essential workplaces, non-essentia","2021","06","28","J Public Health (Oxf)","Journal of public health (Oxford, England)","children; health protection; public health","Lakha","F","Communicable Diseases Policy and Research Group, Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK",NA
"2626","34179987","10.1093/pubmed/fdab213","Are schools drivers of COVID-19 infections-an analysis of outbreaks in Colorado, USA in 2020.","The impact of school closures/reopening on transmission of SARS-CoV-2 in the wider community remains contested. Outbreak data from Colorado, USA (2020), alongside data on implemented public health measures were analyzed. There were three waves (n = 3169 outbreaks; 61 650 individuals). The first was led by healthcare settings, the second leisure/entertainment and the third workplaces followed by other settings where the trajectory was equally distributed amongst essential workplaces, non-essentia","2021","06","28","J Public Health (Oxf)","Journal of public health (Oxford, England)","children; health protection; public health","King","A","Independent Researcher, London, UK",NA
"2627","34179987","10.1093/pubmed/fdab213","Are schools drivers of COVID-19 infections-an analysis of outbreaks in Colorado, USA in 2020.","The impact of school closures/reopening on transmission of SARS-CoV-2 in the wider community remains contested. Outbreak data from Colorado, USA (2020), alongside data on implemented public health measures were analyzed. There were three waves (n = 3169 outbreaks; 61 650 individuals). The first was led by healthcare settings, the second leisure/entertainment and the third workplaces followed by other settings where the trajectory was equally distributed amongst essential workplaces, non-essentia","2021","06","28","J Public Health (Oxf)","Journal of public health (Oxford, England)","children; health protection; public health","Swinkels","K","Independent Researcher, Toronto, Canada",NA
"2628","34179987","10.1093/pubmed/fdab213","Are schools drivers of COVID-19 infections-an analysis of outbreaks in Colorado, USA in 2020.","The impact of school closures/reopening on transmission of SARS-CoV-2 in the wider community remains contested. Outbreak data from Colorado, USA (2020), alongside data on implemented public health measures were analyzed. There were three waves (n = 3169 outbreaks; 61 650 individuals). The first was led by healthcare settings, the second leisure/entertainment and the third workplaces followed by other settings where the trajectory was equally distributed amongst essential workplaces, non-essentia","2021","06","28","J Public Health (Oxf)","Journal of public health (Oxford, England)","children; health protection; public health","Lee","A C K","School of Health and Related Research, University of Sheffield, Sheffield, S1 4DA, UK",NA
"2629","34179978","10.1093/ije/dyab128","The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standards.",NA,"2021","06","28","Int J Epidemiol","International journal of epidemiology","COVID-19; SARS-CoV-2; epidemiological literacy; epidemiology; health literacy; infodemic; plain language; protective personal behaviours; vaccination; vaccine hesitancy","Smith","Meredith Y","International Network for Epidemiology in Policy, Albany, NY, USA",NA
"2630","34179978","10.1093/ije/dyab128","The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standards.",NA,"2021","06","28","Int J Epidemiol","International journal of epidemiology","COVID-19; SARS-CoV-2; epidemiological literacy; epidemiology; health literacy; infodemic; plain language; protective personal behaviours; vaccination; vaccine hesitancy","Bahri","Priya","International Network for Epidemiology in Policy, Albany, NY, USA",NA
"2631","34179978","10.1093/ije/dyab128","The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standards.",NA,"2021","06","28","Int J Epidemiol","International journal of epidemiology","COVID-19; SARS-CoV-2; epidemiological literacy; epidemiology; health literacy; infodemic; plain language; protective personal behaviours; vaccination; vaccine hesitancy","Gaudino","James A","International Network for Epidemiology in Policy, Albany, NY, USA",NA
"2632","34179978","10.1093/ije/dyab128","The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standards.",NA,"2021","06","28","Int J Epidemiol","International journal of epidemiology","COVID-19; SARS-CoV-2; epidemiological literacy; epidemiology; health literacy; infodemic; plain language; protective personal behaviours; vaccination; vaccine hesitancy","Moreira","Rafael S","International Network for Epidemiology in Policy, Albany, NY, USA",NA
"2633","34179978","10.1093/ije/dyab128","The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standards.",NA,"2021","06","28","Int J Epidemiol","International journal of epidemiology","COVID-19; SARS-CoV-2; epidemiological literacy; epidemiology; health literacy; infodemic; plain language; protective personal behaviours; vaccination; vaccine hesitancy","Danyluk","Gregory M","International Network for Epidemiology in Policy, Albany, NY, USA",NA
"2634","34179978","10.1093/ije/dyab128","The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standards.",NA,"2021","06","28","Int J Epidemiol","International journal of epidemiology","COVID-19; SARS-CoV-2; epidemiological literacy; epidemiology; health literacy; infodemic; plain language; protective personal behaviours; vaccination; vaccine hesitancy","Palevsky","Sheila L","International Network for Epidemiology in Policy, Albany, NY, USA",NA
"2635","34179962","10.1093/eurheartj/ehab409","Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre.",NA,"2021","06","28","Eur Heart J","European heart journal",NA,"Lunardi","Mattia","Department of Cardiology, Saolta Group, Galway University Hospital, Health Service Executive and National University of Ireland Galway (NUIG), Galway H91 TK33, Ireland",NA
"2636","34179962","10.1093/eurheartj/ehab409","Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre.",NA,"2021","06","28","Eur Heart J","European heart journal",NA,"Mylotte","Darren","Department of Cardiology, Saolta Group, Galway University Hospital, Health Service Executive and National University of Ireland Galway (NUIG), Galway H91 TK33, Ireland",NA
"2637","34179962","10.1093/eurheartj/ehab409","Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre.",NA,"2021","06","28","Eur Heart J","European heart journal",NA,"Wijns","William","The Lambe Institute for Translational Medicine and CURAM, National University of Ireland Galway (NUIG), Galway H91 TK33, Ireland",NA
"2638","34179962","10.1093/eurheartj/ehab409","Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre.",NA,"2021","06","28","Eur Heart J","European heart journal",NA,"Onuma","Yoshinobu","CORRIB Corelab, National University of Ireland Galway (NUIG), Galway H91 TK33, Ireland",NA
"2639","34179962","10.1093/eurheartj/ehab409","Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre.",NA,"2021","06","28","Eur Heart J","European heart journal",NA,"Soliman","Osama","CORRIB Corelab, National University of Ireland Galway (NUIG), Galway H91 TK33, Ireland",NA
"2640","34179962","10.1093/eurheartj/ehab409","Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre.",NA,"2021","06","28","Eur Heart J","European heart journal",NA,"Serruys","Patrick W","CORRIB Corelab, National University of Ireland Galway (NUIG), Galway H91 TK33, Ireland",NA
"2641","34179962","10.1093/eurheartj/ehab409","Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre.",NA,"2021","06","28","Eur Heart J","European heart journal",NA,"Sharif","Faisal","Department of Cardiology, Saolta Group, Galway University Hospital, Health Service Executive and National University of Ireland Galway (NUIG), Galway H91 TK33, Ireland",NA
"2642","34179939","10.1007/s12603-021-1635-1","Letter to the Editor: COVID-19 Pandemic Control Measures: Impact on Social Frailty and Health Outcomes in Non-Frail Community-Dwelling Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Pek","K","Kalene Pek, Tan Tock Seng Hospital, Singapore, kalene_sl_pek@ttsh.com","pek@ttsh.com.sg"
"2643","34179939","10.1007/s12603-021-1635-1","Letter to the Editor: COVID-19 Pandemic Control Measures: Impact on Social Frailty and Health Outcomes in Non-Frail Community-Dwelling Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Tan","C N","Kalene Pek, Tan Tock Seng Hospital, Singapore, kalene_sl_pek@ttsh.com",NA
"2644","34179939","10.1007/s12603-021-1635-1","Letter to the Editor: COVID-19 Pandemic Control Measures: Impact on Social Frailty and Health Outcomes in Non-Frail Community-Dwelling Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Yew","S","Kalene Pek, Tan Tock Seng Hospital, Singapore, kalene_sl_pek@ttsh.com",NA
"2645","34179939","10.1007/s12603-021-1635-1","Letter to the Editor: COVID-19 Pandemic Control Measures: Impact on Social Frailty and Health Outcomes in Non-Frail Community-Dwelling Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Yeo","A","Kalene Pek, Tan Tock Seng Hospital, Singapore, kalene_sl_pek@ttsh.com",NA
"2646","34179939","10.1007/s12603-021-1635-1","Letter to the Editor: COVID-19 Pandemic Control Measures: Impact on Social Frailty and Health Outcomes in Non-Frail Community-Dwelling Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Lim","J P","Kalene Pek, Tan Tock Seng Hospital, Singapore, kalene_sl_pek@ttsh.com",NA
"2647","34179939","10.1007/s12603-021-1635-1","Letter to the Editor: COVID-19 Pandemic Control Measures: Impact on Social Frailty and Health Outcomes in Non-Frail Community-Dwelling Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Chew","J","Kalene Pek, Tan Tock Seng Hospital, Singapore, kalene_sl_pek@ttsh.com",NA
"2648","34179939","10.1007/s12603-021-1635-1","Letter to the Editor: COVID-19 Pandemic Control Measures: Impact on Social Frailty and Health Outcomes in Non-Frail Community-Dwelling Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Lim","W S","Kalene Pek, Tan Tock Seng Hospital, Singapore, kalene_sl_pek@ttsh.com",NA
"2649","34179929","10.1007/s12603-021-1634-2","The Influence of the COVID-19 Pandemic on Physical Activity and New Incidence of Frailty among Initially Non-Frail Older Adults in Japan: A Follow-Up Online Survey.","The objective of this study was to investigate the influence of the COVID-19 pandemic on physical activity (PA) and the incidence of frailty among initially non-frail older adults in Japan. A follow-up online survey. Among the 1,600 baseline online survey participants, 388 adults were already frail, and 275 older adults did not respond to the follow-up survey. Thus, the final number of participants in this study was 937 (follow-up rate: 77.3%). We assessed the total PA time at four time points a","2021","06","30","J Nutr Health Aging","The journal of nutrition, health &amp; aging","COVID-19; frailty; living alone; physical activity; social inactivity; Aged; Aged, 80 and over; COVID-19; Disabled Persons; Exercise; Female; Follow-Up Studies; Frail Elderly; Frailty; Health Surveys; Humans; Incidence; Independent Living; Internet; Japan; Male; Pandemics; SARS-CoV-2; Sedentary Behavior; Social Isolation","Yamada","M","Minoru Yamada, Faculty of Human Sciences, University of Tsukuba, 3-29-1 Otsuka, Bunkyo-ku, Tokyo 112-0012, Japan, Tel: +81-3-3942-6863, Fax: +81-3-3942-6895, E-mail address: m-yamada@human.tsukuba.ac","yamada@human.tsukuba.ac.jp"
"2650","34179929","10.1007/s12603-021-1634-2","The Influence of the COVID-19 Pandemic on Physical Activity and New Incidence of Frailty among Initially Non-Frail Older Adults in Japan: A Follow-Up Online Survey.","The objective of this study was to investigate the influence of the COVID-19 pandemic on physical activity (PA) and the incidence of frailty among initially non-frail older adults in Japan. A follow-up online survey. Among the 1,600 baseline online survey participants, 388 adults were already frail, and 275 older adults did not respond to the follow-up survey. Thus, the final number of participants in this study was 937 (follow-up rate: 77.3%). We assessed the total PA time at four time points a","2021","06","30","J Nutr Health Aging","The journal of nutrition, health &amp; aging","COVID-19; frailty; living alone; physical activity; social inactivity; Aged; Aged, 80 and over; COVID-19; Disabled Persons; Exercise; Female; Follow-Up Studies; Frail Elderly; Frailty; Health Surveys; Humans; Incidence; Independent Living; Internet; Japan; Male; Pandemics; SARS-CoV-2; Sedentary Behavior; Social Isolation","Kimura","Y","Minoru Yamada, Faculty of Human Sciences, University of Tsukuba, 3-29-1 Otsuka, Bunkyo-ku, Tokyo 112-0012, Japan, Tel: +81-3-3942-6863, Fax: +81-3-3942-6895, E-mail address: m-yamada@human.tsukuba.ac",NA
"2651","34179929","10.1007/s12603-021-1634-2","The Influence of the COVID-19 Pandemic on Physical Activity and New Incidence of Frailty among Initially Non-Frail Older Adults in Japan: A Follow-Up Online Survey.","The objective of this study was to investigate the influence of the COVID-19 pandemic on physical activity (PA) and the incidence of frailty among initially non-frail older adults in Japan. A follow-up online survey. Among the 1,600 baseline online survey participants, 388 adults were already frail, and 275 older adults did not respond to the follow-up survey. Thus, the final number of participants in this study was 937 (follow-up rate: 77.3%). We assessed the total PA time at four time points a","2021","06","30","J Nutr Health Aging","The journal of nutrition, health &amp; aging","COVID-19; frailty; living alone; physical activity; social inactivity; Aged; Aged, 80 and over; COVID-19; Disabled Persons; Exercise; Female; Follow-Up Studies; Frail Elderly; Frailty; Health Surveys; Humans; Incidence; Independent Living; Internet; Japan; Male; Pandemics; SARS-CoV-2; Sedentary Behavior; Social Isolation","Ishiyama","D","Minoru Yamada, Faculty of Human Sciences, University of Tsukuba, 3-29-1 Otsuka, Bunkyo-ku, Tokyo 112-0012, Japan, Tel: +81-3-3942-6863, Fax: +81-3-3942-6895, E-mail address: m-yamada@human.tsukuba.ac",NA
"2652","34179929","10.1007/s12603-021-1634-2","The Influence of the COVID-19 Pandemic on Physical Activity and New Incidence of Frailty among Initially Non-Frail Older Adults in Japan: A Follow-Up Online Survey.","The objective of this study was to investigate the influence of the COVID-19 pandemic on physical activity (PA) and the incidence of frailty among initially non-frail older adults in Japan. A follow-up online survey. Among the 1,600 baseline online survey participants, 388 adults were already frail, and 275 older adults did not respond to the follow-up survey. Thus, the final number of participants in this study was 937 (follow-up rate: 77.3%). We assessed the total PA time at four time points a","2021","06","30","J Nutr Health Aging","The journal of nutrition, health &amp; aging","COVID-19; frailty; living alone; physical activity; social inactivity; Aged; Aged, 80 and over; COVID-19; Disabled Persons; Exercise; Female; Follow-Up Studies; Frail Elderly; Frailty; Health Surveys; Humans; Incidence; Independent Living; Internet; Japan; Male; Pandemics; SARS-CoV-2; Sedentary Behavior; Social Isolation","Otobe","Y","Minoru Yamada, Faculty of Human Sciences, University of Tsukuba, 3-29-1 Otsuka, Bunkyo-ku, Tokyo 112-0012, Japan, Tel: +81-3-3942-6863, Fax: +81-3-3942-6895, E-mail address: m-yamada@human.tsukuba.ac",NA
"2653","34179929","10.1007/s12603-021-1634-2","The Influence of the COVID-19 Pandemic on Physical Activity and New Incidence of Frailty among Initially Non-Frail Older Adults in Japan: A Follow-Up Online Survey.","The objective of this study was to investigate the influence of the COVID-19 pandemic on physical activity (PA) and the incidence of frailty among initially non-frail older adults in Japan. A follow-up online survey. Among the 1,600 baseline online survey participants, 388 adults were already frail, and 275 older adults did not respond to the follow-up survey. Thus, the final number of participants in this study was 937 (follow-up rate: 77.3%). We assessed the total PA time at four time points a","2021","06","30","J Nutr Health Aging","The journal of nutrition, health &amp; aging","COVID-19; frailty; living alone; physical activity; social inactivity; Aged; Aged, 80 and over; COVID-19; Disabled Persons; Exercise; Female; Follow-Up Studies; Frail Elderly; Frailty; Health Surveys; Humans; Incidence; Independent Living; Internet; Japan; Male; Pandemics; SARS-CoV-2; Sedentary Behavior; Social Isolation","Suzuki","M","Minoru Yamada, Faculty of Human Sciences, University of Tsukuba, 3-29-1 Otsuka, Bunkyo-ku, Tokyo 112-0012, Japan, Tel: +81-3-3942-6863, Fax: +81-3-3942-6895, E-mail address: m-yamada@human.tsukuba.ac",NA
"2654","34179929","10.1007/s12603-021-1634-2","The Influence of the COVID-19 Pandemic on Physical Activity and New Incidence of Frailty among Initially Non-Frail Older Adults in Japan: A Follow-Up Online Survey.","The objective of this study was to investigate the influence of the COVID-19 pandemic on physical activity (PA) and the incidence of frailty among initially non-frail older adults in Japan. A follow-up online survey. Among the 1,600 baseline online survey participants, 388 adults were already frail, and 275 older adults did not respond to the follow-up survey. Thus, the final number of participants in this study was 937 (follow-up rate: 77.3%). We assessed the total PA time at four time points a","2021","06","30","J Nutr Health Aging","The journal of nutrition, health &amp; aging","COVID-19; frailty; living alone; physical activity; social inactivity; Aged; Aged, 80 and over; COVID-19; Disabled Persons; Exercise; Female; Follow-Up Studies; Frail Elderly; Frailty; Health Surveys; Humans; Incidence; Independent Living; Internet; Japan; Male; Pandemics; SARS-CoV-2; Sedentary Behavior; Social Isolation","Koyama","S","Minoru Yamada, Faculty of Human Sciences, University of Tsukuba, 3-29-1 Otsuka, Bunkyo-ku, Tokyo 112-0012, Japan, Tel: +81-3-3942-6863, Fax: +81-3-3942-6895, E-mail address: m-yamada@human.tsukuba.ac",NA
"2655","34179929","10.1007/s12603-021-1634-2","The Influence of the COVID-19 Pandemic on Physical Activity and New Incidence of Frailty among Initially Non-Frail Older Adults in Japan: A Follow-Up Online Survey.","The objective of this study was to investigate the influence of the COVID-19 pandemic on physical activity (PA) and the incidence of frailty among initially non-frail older adults in Japan. A follow-up online survey. Among the 1,600 baseline online survey participants, 388 adults were already frail, and 275 older adults did not respond to the follow-up survey. Thus, the final number of participants in this study was 937 (follow-up rate: 77.3%). We assessed the total PA time at four time points a","2021","06","30","J Nutr Health Aging","The journal of nutrition, health &amp; aging","COVID-19; frailty; living alone; physical activity; social inactivity; Aged; Aged, 80 and over; COVID-19; Disabled Persons; Exercise; Female; Follow-Up Studies; Frail Elderly; Frailty; Health Surveys; Humans; Incidence; Independent Living; Internet; Japan; Male; Pandemics; SARS-CoV-2; Sedentary Behavior; Social Isolation","Kikuchi","T","Minoru Yamada, Faculty of Human Sciences, University of Tsukuba, 3-29-1 Otsuka, Bunkyo-ku, Tokyo 112-0012, Japan, Tel: +81-3-3942-6863, Fax: +81-3-3942-6895, E-mail address: m-yamada@human.tsukuba.ac",NA
"2656","34179929","10.1007/s12603-021-1634-2","The Influence of the COVID-19 Pandemic on Physical Activity and New Incidence of Frailty among Initially Non-Frail Older Adults in Japan: A Follow-Up Online Survey.","The objective of this study was to investigate the influence of the COVID-19 pandemic on physical activity (PA) and the incidence of frailty among initially non-frail older adults in Japan. A follow-up online survey. Among the 1,600 baseline online survey participants, 388 adults were already frail, and 275 older adults did not respond to the follow-up survey. Thus, the final number of participants in this study was 937 (follow-up rate: 77.3%). We assessed the total PA time at four time points a","2021","06","30","J Nutr Health Aging","The journal of nutrition, health &amp; aging","COVID-19; frailty; living alone; physical activity; social inactivity; Aged; Aged, 80 and over; COVID-19; Disabled Persons; Exercise; Female; Follow-Up Studies; Frail Elderly; Frailty; Health Surveys; Humans; Incidence; Independent Living; Internet; Japan; Male; Pandemics; SARS-CoV-2; Sedentary Behavior; Social Isolation","Kusumi","H","Minoru Yamada, Faculty of Human Sciences, University of Tsukuba, 3-29-1 Otsuka, Bunkyo-ku, Tokyo 112-0012, Japan, Tel: +81-3-3942-6863, Fax: +81-3-3942-6895, E-mail address: m-yamada@human.tsukuba.ac",NA
"2657","34179929","10.1007/s12603-021-1634-2","The Influence of the COVID-19 Pandemic on Physical Activity and New Incidence of Frailty among Initially Non-Frail Older Adults in Japan: A Follow-Up Online Survey.","The objective of this study was to investigate the influence of the COVID-19 pandemic on physical activity (PA) and the incidence of frailty among initially non-frail older adults in Japan. A follow-up online survey. Among the 1,600 baseline online survey participants, 388 adults were already frail, and 275 older adults did not respond to the follow-up survey. Thus, the final number of participants in this study was 937 (follow-up rate: 77.3%). We assessed the total PA time at four time points a","2021","06","30","J Nutr Health Aging","The journal of nutrition, health &amp; aging","COVID-19; frailty; living alone; physical activity; social inactivity; Aged; Aged, 80 and over; COVID-19; Disabled Persons; Exercise; Female; Follow-Up Studies; Frail Elderly; Frailty; Health Surveys; Humans; Incidence; Independent Living; Internet; Japan; Male; Pandemics; SARS-CoV-2; Sedentary Behavior; Social Isolation","Arai","H","Minoru Yamada, Faculty of Human Sciences, University of Tsukuba, 3-29-1 Otsuka, Bunkyo-ku, Tokyo 112-0012, Japan, Tel: +81-3-3942-6863, Fax: +81-3-3942-6895, E-mail address: m-yamada@human.tsukuba.ac",NA
"2658","34179924","10.1007/s12603-021-1596-4","Feasibility and Effect of Implementing Physical Activity Program Implementation during Covid-19 in Hospitalized Positive Covid-19 Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Andre","L","Andre Laurine, Gérontopôle, CHU Toulouse, F-31400 Toulouse, France",NA
"2659","34179924","10.1007/s12603-021-1596-4","Feasibility and Effect of Implementing Physical Activity Program Implementation during Covid-19 in Hospitalized Positive Covid-19 Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Rolland","Y","Andre Laurine, Gérontopôle, CHU Toulouse, F-31400 Toulouse, France",NA
"2660","34179924","10.1007/s12603-021-1596-4","Feasibility and Effect of Implementing Physical Activity Program Implementation during Covid-19 in Hospitalized Positive Covid-19 Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Gerard","S","Andre Laurine, Gérontopôle, CHU Toulouse, F-31400 Toulouse, France",NA
"2661","34179924","10.1007/s12603-021-1596-4","Feasibility and Effect of Implementing Physical Activity Program Implementation during Covid-19 in Hospitalized Positive Covid-19 Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Kergoat","M-J","Andre Laurine, Gérontopôle, CHU Toulouse, F-31400 Toulouse, France",NA
"2662","34179924","10.1007/s12603-021-1596-4","Feasibility and Effect of Implementing Physical Activity Program Implementation during Covid-19 in Hospitalized Positive Covid-19 Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Peyrusqué","E","Andre Laurine, Gérontopôle, CHU Toulouse, F-31400 Toulouse, France",NA
"2663","34179924","10.1007/s12603-021-1596-4","Feasibility and Effect of Implementing Physical Activity Program Implementation during Covid-19 in Hospitalized Positive Covid-19 Older Adults.",NA,"2021","07","01","J Nutr Health Aging","The journal of nutrition, health &amp; aging",NA,"Aubertin-Leheudre","M","Andre Laurine, Gérontopôle, CHU Toulouse, F-31400 Toulouse, France",NA
"2664","34179893","","mTOR: A possible therapeutic target against SARS-CoV-2 infection.",NA,"2021","07","10","Arch Stem Cell Ther","Archives of stem cell and therapy",NA,"Khan","Nabab","Department of Biomedical Sciences, University of North Dakota, School of Medicine and Health Sciences, Grand Forks, North Dakota 58203, USA",NA
"2665","34179878","10.1002/emp2.12451","Advancing emergency department-initiated buprenorphine.","Opioids are the main driver of drug overdose deaths in the United States, and there has been a marked increase in opioid-related overdoses during the COVID-19 public health emergency. Many emergency departments (EDs) across the country are implementing ED-initiated buprenorphine programs, and this is a method to address and prevent opioid overdoses. Resources are available to overcome barriers and take action.","2021","06","29","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","ED-initiated buprenorphine; medication for opioid use disorder; opioid use disorder; treatment engagement","Huntley","Kristen","Center for the Clinical Trials Network The National Institute on Drug Abuse Bethesda Maryland USA",NA
"2666","34179878","10.1002/emp2.12451","Advancing emergency department-initiated buprenorphine.","Opioids are the main driver of drug overdose deaths in the United States, and there has been a marked increase in opioid-related overdoses during the COVID-19 public health emergency. Many emergency departments (EDs) across the country are implementing ED-initiated buprenorphine programs, and this is a method to address and prevent opioid overdoses. Resources are available to overcome barriers and take action.","2021","06","29","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","ED-initiated buprenorphine; medication for opioid use disorder; opioid use disorder; treatment engagement","Einstein","Emily","Office of Science Policy and Communications The National Institute on Drug Abuse Bethesda Maryland USA",NA
"2667","34179878","10.1002/emp2.12451","Advancing emergency department-initiated buprenorphine.","Opioids are the main driver of drug overdose deaths in the United States, and there has been a marked increase in opioid-related overdoses during the COVID-19 public health emergency. Many emergency departments (EDs) across the country are implementing ED-initiated buprenorphine programs, and this is a method to address and prevent opioid overdoses. Resources are available to overcome barriers and take action.","2021","06","29","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","ED-initiated buprenorphine; medication for opioid use disorder; opioid use disorder; treatment engagement","Postma","Terri","Center for Medicare Centers for Medicare &amp",NA
"2668","34179878","10.1002/emp2.12451","Advancing emergency department-initiated buprenorphine.","Opioids are the main driver of drug overdose deaths in the United States, and there has been a marked increase in opioid-related overdoses during the COVID-19 public health emergency. Many emergency departments (EDs) across the country are implementing ED-initiated buprenorphine programs, and this is a method to address and prevent opioid overdoses. Resources are available to overcome barriers and take action.","2021","06","29","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","ED-initiated buprenorphine; medication for opioid use disorder; opioid use disorder; treatment engagement","Thomas","Anita","Center for Clinical Standards and Quality Centers for Medicare &amp",NA
"2669","34179878","10.1002/emp2.12451","Advancing emergency department-initiated buprenorphine.","Opioids are the main driver of drug overdose deaths in the United States, and there has been a marked increase in opioid-related overdoses during the COVID-19 public health emergency. Many emergency departments (EDs) across the country are implementing ED-initiated buprenorphine programs, and this is a method to address and prevent opioid overdoses. Resources are available to overcome barriers and take action.","2021","06","29","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","ED-initiated buprenorphine; medication for opioid use disorder; opioid use disorder; treatment engagement","Ling","Shari","Center for Clinical Standards and Quality Centers for Medicare &amp",NA
"2670","34179878","10.1002/emp2.12451","Advancing emergency department-initiated buprenorphine.","Opioids are the main driver of drug overdose deaths in the United States, and there has been a marked increase in opioid-related overdoses during the COVID-19 public health emergency. Many emergency departments (EDs) across the country are implementing ED-initiated buprenorphine programs, and this is a method to address and prevent opioid overdoses. Resources are available to overcome barriers and take action.","2021","06","29","J Am Coll Emerg Physicians Open","Journal of the American College of Emergency Physicians open","ED-initiated buprenorphine; medication for opioid use disorder; opioid use disorder; treatment engagement","Compton","Wilson","Office of the Director The National Institute on Drug Abuse Bethesda Maryland USA",NA
"2671","34179864","10.1016/j.jadr.2021.100182","Coronavirus (COVID-19) outbreak: Addictive social media use, depression, anxiety and stress in quarantine - an exploratory study in Germany and Lithuania.","To slow down the spread of the COVID-19 pandemic, governments of many countries introduced various behavioral measures starting March 2020. The measures included domestic quarantine (not leaving home) for infected or potentially infected people. Due to the need for social distancing, online activity increased in spring 2020. This could foster the risk for addictive social media use (SMU). The present study investigated tendencies of addictive SMU and their relationship with depression, anxiety a","2021","07","16","J Affect Disord Rep","Journal of affective disorders reports","Addictive social media use; COVID-19; Depression, Anxiety, Stress; Germany; Lithuania; Quarantine","Brailovskaia","Julia","Mental Health Research and Treatment Center, Department of Clinical Psychology and Psychotherapy, Ruhr-Universität Bochum, Germany",NA
"2672","34179864","10.1016/j.jadr.2021.100182","Coronavirus (COVID-19) outbreak: Addictive social media use, depression, anxiety and stress in quarantine - an exploratory study in Germany and Lithuania.","To slow down the spread of the COVID-19 pandemic, governments of many countries introduced various behavioral measures starting March 2020. The measures included domestic quarantine (not leaving home) for infected or potentially infected people. Due to the need for social distancing, online activity increased in spring 2020. This could foster the risk for addictive social media use (SMU). The present study investigated tendencies of addictive SMU and their relationship with depression, anxiety a","2021","07","16","J Affect Disord Rep","Journal of affective disorders reports","Addictive social media use; COVID-19; Depression, Anxiety, Stress; Germany; Lithuania; Quarantine","Truskauskaite-Kuneviciene","Inga","Center for Psychotraumatology, Institute of Psychology, Vilnius University, Vilnius, Lithuania, Ciurlionio 29-203, 03100, Vilnius, Lithuania",NA
"2673","34179864","10.1016/j.jadr.2021.100182","Coronavirus (COVID-19) outbreak: Addictive social media use, depression, anxiety and stress in quarantine - an exploratory study in Germany and Lithuania.","To slow down the spread of the COVID-19 pandemic, governments of many countries introduced various behavioral measures starting March 2020. The measures included domestic quarantine (not leaving home) for infected or potentially infected people. Due to the need for social distancing, online activity increased in spring 2020. This could foster the risk for addictive social media use (SMU). The present study investigated tendencies of addictive SMU and their relationship with depression, anxiety a","2021","07","16","J Affect Disord Rep","Journal of affective disorders reports","Addictive social media use; COVID-19; Depression, Anxiety, Stress; Germany; Lithuania; Quarantine","Margraf","Jürgen","Mental Health Research and Treatment Center, Department of Clinical Psychology and Psychotherapy, Ruhr-Universität Bochum, Germany",NA
"2674","34179864","10.1016/j.jadr.2021.100182","Coronavirus (COVID-19) outbreak: Addictive social media use, depression, anxiety and stress in quarantine - an exploratory study in Germany and Lithuania.","To slow down the spread of the COVID-19 pandemic, governments of many countries introduced various behavioral measures starting March 2020. The measures included domestic quarantine (not leaving home) for infected or potentially infected people. Due to the need for social distancing, online activity increased in spring 2020. This could foster the risk for addictive social media use (SMU). The present study investigated tendencies of addictive SMU and their relationship with depression, anxiety a","2021","07","16","J Affect Disord Rep","Journal of affective disorders reports","Addictive social media use; COVID-19; Depression, Anxiety, Stress; Germany; Lithuania; Quarantine","Kazlauskas","Evaldas","Center for Psychotraumatology, Institute of Psychology, Vilnius University, Vilnius, Lithuania, Ciurlionio 29-203, 03100, Vilnius, Lithuania",NA
"2675","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Yang","Limin","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing 100101, China",NA
"2676","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Tian","Deyu","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing 100101, China",NA
"2677","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Han","Jian-Bao","Kunming National High-Level Biosafety Research Center for Nonhuman Primates, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650107, China",NA
"2678","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Fan","Wenhui","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing 100101, China",NA
"2679","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Zhang","Yuan","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing 100101, China",NA
"2680","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Li","Yunlong","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing 100101, China",NA
"2681","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Sun","Wenqiang","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing 100101, China",NA
"2682","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Wei","Yanqiu","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing 100101, China",NA
"2683","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Tian","Xiaodong","University of Chinese Academy of Sciences, Beijing 101408, China",NA
"2684","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Yu","Dan-Dan","Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China",NA
"2685","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Feng","Xiao-Li","Kunming National High-Level Biosafety Research Center for Nonhuman Primates, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650107, China",NA
"2686","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Cheng","Gong","Institute of Infectious Diseases, Shenzhen Bay Laboratory, Shenzhen 518000, China",NA
"2687","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Bi","Yuhai","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing 100101, China",NA
"2688","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Zheng","Yong-Tang","Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China",NA
"2689","34179862","10.1016/j.xinn.2021.100140","A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.","A safe and effective vaccine is critical to combat the COVID-19 pandemic. Here, we developed a trimeric SARS-CoV-2 receptor-binding domain (RBD) subunit vaccine candidate that simulates the natural structure of the spike (S) trimer glycoprotein. Immunization with the RBD trimer-induced robust humoral and cellular immune responses, and a high level of neutralizing antibodies was maintained for at least 4.5 months. Moreover, the antibodies that were produced in response to the vaccine effectively ","2021","07","09","Innovation (N Y)","Innovation (New York, N.Y.)","COVID-19; NHPs; RBD; SARS-CoV-2; subunit vaccine; variants","Liu","Wenjun","CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early Warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing 100101, China",NA
"2690","34179861","10.1016/j.xinn.2021.100138","Climate change, environmental factors, and COVID-19: Current evidence and urgent actions.",NA,"2021","07","06","Innovation (N Y)","Innovation (New York, N.Y.)",NA,"Ma","Runmei","China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China",NA
"2691","34179861","10.1016/j.xinn.2021.100138","Climate change, environmental factors, and COVID-19: Current evidence and urgent actions.",NA,"2021","07","06","Innovation (N Y)","Innovation (New York, N.Y.)",NA,"Du","Peng","China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China",NA
"2692","34179861","10.1016/j.xinn.2021.100138","Climate change, environmental factors, and COVID-19: Current evidence and urgent actions.",NA,"2021","07","06","Innovation (N Y)","Innovation (New York, N.Y.)",NA,"Li","Tiantian","China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China",NA
"2693","34179860","10.1016/j.lanwpc.2021.100184","The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: A case study in Hong Kong.","Many countries/regions implemented strict border measures (e.g., 14-day quarantines) as a blanket policy to prevent COVID-19 importations, while proposed ""travel bubbles"" as an alternative to reduce the impact of border controls. We aim to examine the differential importation risks with departure origins and post-arrival controls. We developed a Bayesian framework to model disease progress of COVID-19 and the effectiveness of travel measures and inferred the origin-specific disease prevalence am","2021","06","29","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Yang","Bingyi","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"2694","34179860","10.1016/j.lanwpc.2021.100184","The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: A case study in Hong Kong.","Many countries/regions implemented strict border measures (e.g., 14-day quarantines) as a blanket policy to prevent COVID-19 importations, while proposed ""travel bubbles"" as an alternative to reduce the impact of border controls. We aim to examine the differential importation risks with departure origins and post-arrival controls. We developed a Bayesian framework to model disease progress of COVID-19 and the effectiveness of travel measures and inferred the origin-specific disease prevalence am","2021","06","29","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Tsang","Tim K","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"2695","34179860","10.1016/j.lanwpc.2021.100184","The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: A case study in Hong Kong.","Many countries/regions implemented strict border measures (e.g., 14-day quarantines) as a blanket policy to prevent COVID-19 importations, while proposed ""travel bubbles"" as an alternative to reduce the impact of border controls. We aim to examine the differential importation risks with departure origins and post-arrival controls. We developed a Bayesian framework to model disease progress of COVID-19 and the effectiveness of travel measures and inferred the origin-specific disease prevalence am","2021","06","29","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Wong","Jessica Y","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"2696","34179860","10.1016/j.lanwpc.2021.100184","The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: A case study in Hong Kong.","Many countries/regions implemented strict border measures (e.g., 14-day quarantines) as a blanket policy to prevent COVID-19 importations, while proposed ""travel bubbles"" as an alternative to reduce the impact of border controls. We aim to examine the differential importation risks with departure origins and post-arrival controls. We developed a Bayesian framework to model disease progress of COVID-19 and the effectiveness of travel measures and inferred the origin-specific disease prevalence am","2021","06","29","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"He","Yinan","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"2697","34179860","10.1016/j.lanwpc.2021.100184","The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: A case study in Hong Kong.","Many countries/regions implemented strict border measures (e.g., 14-day quarantines) as a blanket policy to prevent COVID-19 importations, while proposed ""travel bubbles"" as an alternative to reduce the impact of border controls. We aim to examine the differential importation risks with departure origins and post-arrival controls. We developed a Bayesian framework to model disease progress of COVID-19 and the effectiveness of travel measures and inferred the origin-specific disease prevalence am","2021","06","29","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Gao","Huizhi","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"2698","34179860","10.1016/j.lanwpc.2021.100184","The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: A case study in Hong Kong.","Many countries/regions implemented strict border measures (e.g., 14-day quarantines) as a blanket policy to prevent COVID-19 importations, while proposed ""travel bubbles"" as an alternative to reduce the impact of border controls. We aim to examine the differential importation risks with departure origins and post-arrival controls. We developed a Bayesian framework to model disease progress of COVID-19 and the effectiveness of travel measures and inferred the origin-specific disease prevalence am","2021","06","29","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Ho","Faith","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"2699","34179860","10.1016/j.lanwpc.2021.100184","The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: A case study in Hong Kong.","Many countries/regions implemented strict border measures (e.g., 14-day quarantines) as a blanket policy to prevent COVID-19 importations, while proposed ""travel bubbles"" as an alternative to reduce the impact of border controls. We aim to examine the differential importation risks with departure origins and post-arrival controls. We developed a Bayesian framework to model disease progress of COVID-19 and the effectiveness of travel measures and inferred the origin-specific disease prevalence am","2021","06","29","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Lau","Eric H Y","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"2700","34179860","10.1016/j.lanwpc.2021.100184","The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: A case study in Hong Kong.","Many countries/regions implemented strict border measures (e.g., 14-day quarantines) as a blanket policy to prevent COVID-19 importations, while proposed ""travel bubbles"" as an alternative to reduce the impact of border controls. We aim to examine the differential importation risks with departure origins and post-arrival controls. We developed a Bayesian framework to model disease progress of COVID-19 and the effectiveness of travel measures and inferred the origin-specific disease prevalence am","2021","06","29","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Wu","Peng","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"2701","34179860","10.1016/j.lanwpc.2021.100184","The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: A case study in Hong Kong.","Many countries/regions implemented strict border measures (e.g., 14-day quarantines) as a blanket policy to prevent COVID-19 importations, while proposed ""travel bubbles"" as an alternative to reduce the impact of border controls. We aim to examine the differential importation risks with departure origins and post-arrival controls. We developed a Bayesian framework to model disease progress of COVID-19 and the effectiveness of travel measures and inferred the origin-specific disease prevalence am","2021","06","29","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Sullivan","Sheena G","WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, and Doherty Department, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",NA
"2702","34179860","10.1016/j.lanwpc.2021.100184","The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: A case study in Hong Kong.","Many countries/regions implemented strict border measures (e.g., 14-day quarantines) as a blanket policy to prevent COVID-19 importations, while proposed ""travel bubbles"" as an alternative to reduce the impact of border controls. We aim to examine the differential importation risks with departure origins and post-arrival controls. We developed a Bayesian framework to model disease progress of COVID-19 and the effectiveness of travel measures and inferred the origin-specific disease prevalence am","2021","06","29","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Cowling","Benjamin J","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China",NA
"2703","34179859","10.1016/j.puhip.2021.100153","Mucormycosis or black fungus is a new fright in India during covid-19 pandemic: Associated risk factors and actionable items.",NA,"2021","06","29","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Antibiotics; Black fungus; Covid-19 pandemic; Mucormycosis; Steroids","Moona","Amena Ahmed","Department of Pharmacy, University of Asia Pacific, 74/A Green Road, Farmgate, Dhaka, 1215, Bangladesh",NA
"2704","34179859","10.1016/j.puhip.2021.100153","Mucormycosis or black fungus is a new fright in India during covid-19 pandemic: Associated risk factors and actionable items.",NA,"2021","06","29","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Antibiotics; Black fungus; Covid-19 pandemic; Mucormycosis; Steroids","Islam","Md Rabiul","Department of Pharmacy, University of Asia Pacific, 74/A Green Road, Farmgate, Dhaka, 1215, Bangladesh",NA
"2705","34179858","10.1016/j.puhip.2021.100154","SARS-CoV-2 rapid serological tests for field-based healthcare workers in homeless communities: A mixed-methods exploratory analysis.","The high risk of SARS-CoV-2 transmission in homeless communities requires adapted prevention strategies for field-based healthcare workers (HCWs). Rapid serological tests (RSTs) could be an invaluable tool for HCWs to control COVID-19 transmission. This study assesses the benefits of RSTs for HCWs in Marseille, France. Mixed-methods exploratory analysis. A mixed-methods approach was used, combining quantitative and qualitative data, to prospectively analyse acceptability of RSTs, prevalence of S","2021","07","02","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Behaviour; Covid-19; Healthcare workers; Perception of risk; Prevention; Public health; Rapid serological test; Testing","Mosnier","Emilie","Department of Clinical Research and Innovation, Support Unit for Clinical Research and Economic Evaluation, Assistance Publique - Hôpitaux de Marseille, F-13385, Marseille, France",NA
"2706","34179858","10.1016/j.puhip.2021.100154","SARS-CoV-2 rapid serological tests for field-based healthcare workers in homeless communities: A mixed-methods exploratory analysis.","The high risk of SARS-CoV-2 transmission in homeless communities requires adapted prevention strategies for field-based healthcare workers (HCWs). Rapid serological tests (RSTs) could be an invaluable tool for HCWs to control COVID-19 transmission. This study assesses the benefits of RSTs for HCWs in Marseille, France. Mixed-methods exploratory analysis. A mixed-methods approach was used, combining quantitative and qualitative data, to prospectively analyse acceptability of RSTs, prevalence of S","2021","07","02","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Behaviour; Covid-19; Healthcare workers; Perception of risk; Prevention; Public health; Rapid serological test; Testing","Nevissas","Olivia","Department of Clinical Research and Innovation, Support Unit for Clinical Research and Economic Evaluation, Assistance Publique - Hôpitaux de Marseille, F-13385, Marseille, France",NA
"2707","34179858","10.1016/j.puhip.2021.100154","SARS-CoV-2 rapid serological tests for field-based healthcare workers in homeless communities: A mixed-methods exploratory analysis.","The high risk of SARS-CoV-2 transmission in homeless communities requires adapted prevention strategies for field-based healthcare workers (HCWs). Rapid serological tests (RSTs) could be an invaluable tool for HCWs to control COVID-19 transmission. This study assesses the benefits of RSTs for HCWs in Marseille, France. Mixed-methods exploratory analysis. A mixed-methods approach was used, combining quantitative and qualitative data, to prospectively analyse acceptability of RSTs, prevalence of S","2021","07","02","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Behaviour; Covid-19; Healthcare workers; Perception of risk; Prevention; Public health; Rapid serological test; Testing","Loubière","Sandrine","Department of Clinical Research and Innovation, Support Unit for Clinical Research and Economic Evaluation, Assistance Publique - Hôpitaux de Marseille, F-13385, Marseille, France",NA
"2708","34179858","10.1016/j.puhip.2021.100154","SARS-CoV-2 rapid serological tests for field-based healthcare workers in homeless communities: A mixed-methods exploratory analysis.","The high risk of SARS-CoV-2 transmission in homeless communities requires adapted prevention strategies for field-based healthcare workers (HCWs). Rapid serological tests (RSTs) could be an invaluable tool for HCWs to control COVID-19 transmission. This study assesses the benefits of RSTs for HCWs in Marseille, France. Mixed-methods exploratory analysis. A mixed-methods approach was used, combining quantitative and qualitative data, to prospectively analyse acceptability of RSTs, prevalence of S","2021","07","02","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Behaviour; Covid-19; Healthcare workers; Perception of risk; Prevention; Public health; Rapid serological test; Testing","Mosnier","Marine","Medecins Du Monde - Doctors of the World, F-13003, Marseille, France",NA
"2709","34179858","10.1016/j.puhip.2021.100154","SARS-CoV-2 rapid serological tests for field-based healthcare workers in homeless communities: A mixed-methods exploratory analysis.","The high risk of SARS-CoV-2 transmission in homeless communities requires adapted prevention strategies for field-based healthcare workers (HCWs). Rapid serological tests (RSTs) could be an invaluable tool for HCWs to control COVID-19 transmission. This study assesses the benefits of RSTs for HCWs in Marseille, France. Mixed-methods exploratory analysis. A mixed-methods approach was used, combining quantitative and qualitative data, to prospectively analyse acceptability of RSTs, prevalence of S","2021","07","02","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Behaviour; Covid-19; Healthcare workers; Perception of risk; Prevention; Public health; Rapid serological test; Testing","Bosetti","Thomas","Medecins Du Monde - Doctors of the World, F-13003, Marseille, France",NA
"2710","34179858","10.1016/j.puhip.2021.100154","SARS-CoV-2 rapid serological tests for field-based healthcare workers in homeless communities: A mixed-methods exploratory analysis.","The high risk of SARS-CoV-2 transmission in homeless communities requires adapted prevention strategies for field-based healthcare workers (HCWs). Rapid serological tests (RSTs) could be an invaluable tool for HCWs to control COVID-19 transmission. This study assesses the benefits of RSTs for HCWs in Marseille, France. Mixed-methods exploratory analysis. A mixed-methods approach was used, combining quantitative and qualitative data, to prospectively analyse acceptability of RSTs, prevalence of S","2021","07","02","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Behaviour; Covid-19; Healthcare workers; Perception of risk; Prevention; Public health; Rapid serological test; Testing","Bottero","Julie","Infectious Disease Department, Groupe Hospitalier « Hôpitaux Universitaires Paris Seine-St-Denis » (GH HUPSSD), 93 000 Bobigny, France",NA
"2711","34179858","10.1016/j.puhip.2021.100154","SARS-CoV-2 rapid serological tests for field-based healthcare workers in homeless communities: A mixed-methods exploratory analysis.","The high risk of SARS-CoV-2 transmission in homeless communities requires adapted prevention strategies for field-based healthcare workers (HCWs). Rapid serological tests (RSTs) could be an invaluable tool for HCWs to control COVID-19 transmission. This study assesses the benefits of RSTs for HCWs in Marseille, France. Mixed-methods exploratory analysis. A mixed-methods approach was used, combining quantitative and qualitative data, to prospectively analyse acceptability of RSTs, prevalence of S","2021","07","02","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Behaviour; Covid-19; Healthcare workers; Perception of risk; Prevention; Public health; Rapid serological test; Testing","Roux","Perrine","Aix-Marseille University, INSERM, IRD, SESSTIM, Sciences Economiques &amp",NA
"2712","34179858","10.1016/j.puhip.2021.100154","SARS-CoV-2 rapid serological tests for field-based healthcare workers in homeless communities: A mixed-methods exploratory analysis.","The high risk of SARS-CoV-2 transmission in homeless communities requires adapted prevention strategies for field-based healthcare workers (HCWs). Rapid serological tests (RSTs) could be an invaluable tool for HCWs to control COVID-19 transmission. This study assesses the benefits of RSTs for HCWs in Marseille, France. Mixed-methods exploratory analysis. A mixed-methods approach was used, combining quantitative and qualitative data, to prospectively analyse acceptability of RSTs, prevalence of S","2021","07","02","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Behaviour; Covid-19; Healthcare workers; Perception of risk; Prevention; Public health; Rapid serological test; Testing","Monfardini","Elisabetta","Aix-Marseille University, School of Medicine - La Timone Medical Campus, EA 3279: CEReSS - Health Service Research and Quality of Life Center, F-13005, Marseille, France",NA
"2713","34179858","10.1016/j.puhip.2021.100154","SARS-CoV-2 rapid serological tests for field-based healthcare workers in homeless communities: A mixed-methods exploratory analysis.","The high risk of SARS-CoV-2 transmission in homeless communities requires adapted prevention strategies for field-based healthcare workers (HCWs). Rapid serological tests (RSTs) could be an invaluable tool for HCWs to control COVID-19 transmission. This study assesses the benefits of RSTs for HCWs in Marseille, France. Mixed-methods exploratory analysis. A mixed-methods approach was used, combining quantitative and qualitative data, to prospectively analyse acceptability of RSTs, prevalence of S","2021","07","02","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Behaviour; Covid-19; Healthcare workers; Perception of risk; Prevention; Public health; Rapid serological test; Testing","Tinland","Aurélie","Aix-Marseille University, School of Medicine - La Timone Medical Campus, EA 3279: CEReSS - Health Service Research and Quality of Life Center, F-13005, Marseille, France",NA
"2714","34179857","10.1016/S2666-5247(21)00126-9","Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism.",NA,"2021","06","29","Lancet Microbe","The Lancet. Microbe",NA,"Otu","Akaninyene","Department of Internal Medicine, College of Medical Sciences, University of Calabar, Calabar 1115, Nigeria",NA
"2715","34179857","10.1016/S2666-5247(21)00126-9","Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism.",NA,"2021","06","29","Lancet Microbe","The Lancet. Microbe",NA,"Osifo-Dawodu","Egbe","Anadach Consulting Group, College Park, MD, USA",NA
"2716","34179857","10.1016/S2666-5247(21)00126-9","Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism.",NA,"2021","06","29","Lancet Microbe","The Lancet. Microbe",NA,"Atuhebwe","Phionah","World Health Organization's Regional Office for Africa, Brazzaville, Republic of the Congo",NA
"2717","34179857","10.1016/S2666-5247(21)00126-9","Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism.",NA,"2021","06","29","Lancet Microbe","The Lancet. Microbe",NA,"Agogo","Emmanuel","Resolve to Save Lives, Abuja, Nigeria",NA
"2718","34179857","10.1016/S2666-5247(21)00126-9","Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism.",NA,"2021","06","29","Lancet Microbe","The Lancet. Microbe",NA,"Ebenso","Bassey","Nuffield Centre for International Health and Development, Leeds Institute for Health Sciences, University of Leeds, Leeds, UK",NA
"2719","34179856","10.1016/j.ibmed.2021.100037","A novel data augmentation approach for mask detection using deep transfer learning.","At the onset of 2020, the world saw the rise and spread of a global pandemic named COVID-19 which caused numerous deaths and affected millions of people around the world. Due to its highly contagious nature, this disease spread across the world within a short span of time. It forced almost all the nations to implement strict social distancing rules along with use of face masks to reduce the risk of getting infected. While the virus is still on loose, markets and business firms have reopened to k","2021","06","29","Intell Based Med","Intelligence-based medicine","COVID-19; Deep transfer learning; Mask detection; Object detection; Pre-processing; Safety in public places; YOLOv3","Prusty","Manas Ranjan","Centre for Cyber Physical Systems, Vellore Institute of Technology, Chennai, 600127, India",NA
"2720","34179856","10.1016/j.ibmed.2021.100037","A novel data augmentation approach for mask detection using deep transfer learning.","At the onset of 2020, the world saw the rise and spread of a global pandemic named COVID-19 which caused numerous deaths and affected millions of people around the world. Due to its highly contagious nature, this disease spread across the world within a short span of time. It forced almost all the nations to implement strict social distancing rules along with use of face masks to reduce the risk of getting infected. While the virus is still on loose, markets and business firms have reopened to k","2021","06","29","Intell Based Med","Intelligence-based medicine","COVID-19; Deep transfer learning; Mask detection; Object detection; Pre-processing; Safety in public places; YOLOv3","Tripathi","Vaibhav","School of Electronics Engineering, Vellore Institute of Technology, Chennai, 600127, India",NA
"2721","34179856","10.1016/j.ibmed.2021.100037","A novel data augmentation approach for mask detection using deep transfer learning.","At the onset of 2020, the world saw the rise and spread of a global pandemic named COVID-19 which caused numerous deaths and affected millions of people around the world. Due to its highly contagious nature, this disease spread across the world within a short span of time. It forced almost all the nations to implement strict social distancing rules along with use of face masks to reduce the risk of getting infected. While the virus is still on loose, markets and business firms have reopened to k","2021","06","29","Intell Based Med","Intelligence-based medicine","COVID-19; Deep transfer learning; Mask detection; Object detection; Pre-processing; Safety in public places; YOLOv3","Dubey","Anmol","School of Computer Science and Engineering, Vellore Institute of Technology, Chennai, 600127, India",NA
"2722","34179855","10.1016/j.ibmed.2021.100036","A critical analysis of COVID-19 research literature: Text mining approach.","Among the stakeholders of COVID-19 research, clinicians particularly experience difficulty keeping up with the deluge of SARS-CoV-2 literature while performing their much needed clinical duties. By revealing major topics, this study proposes a text-mining approach as an alternative to navigating large volumes of COVID-19 literature. We obtained 85,268 references from the NIH COVID-19 Portfolio as of November 21. After the exclusion based on inadequate abstracts, 65,262 articles remained in the f","2021","06","29","Intell Based Med","Intelligence-based medicine","COVID-19; Natural language processing; SARS COV-2; Text mining; Topic modeling","Zengul","Ferhat D","Department of Health Services Administration, The University of Alabama at Birmingham, USA",NA
"2723","34179855","10.1016/j.ibmed.2021.100036","A critical analysis of COVID-19 research literature: Text mining approach.","Among the stakeholders of COVID-19 research, clinicians particularly experience difficulty keeping up with the deluge of SARS-CoV-2 literature while performing their much needed clinical duties. By revealing major topics, this study proposes a text-mining approach as an alternative to navigating large volumes of COVID-19 literature. We obtained 85,268 references from the NIH COVID-19 Portfolio as of November 21. After the exclusion based on inadequate abstracts, 65,262 articles remained in the f","2021","06","29","Intell Based Med","Intelligence-based medicine","COVID-19; Natural language processing; SARS COV-2; Text mining; Topic modeling","Zengul","Ayse G","Department of Nutrition, The University of Alabama at Birmingham, USA",NA
"2724","34179855","10.1016/j.ibmed.2021.100036","A critical analysis of COVID-19 research literature: Text mining approach.","Among the stakeholders of COVID-19 research, clinicians particularly experience difficulty keeping up with the deluge of SARS-CoV-2 literature while performing their much needed clinical duties. By revealing major topics, this study proposes a text-mining approach as an alternative to navigating large volumes of COVID-19 literature. We obtained 85,268 references from the NIH COVID-19 Portfolio as of November 21. After the exclusion based on inadequate abstracts, 65,262 articles remained in the f","2021","06","29","Intell Based Med","Intelligence-based medicine","COVID-19; Natural language processing; SARS COV-2; Text mining; Topic modeling","Mugavero","Michael J","Department of Medicine, Division of Infectious Diseases, The University of Alabama at Birmingham, USA",NA
"2725","34179855","10.1016/j.ibmed.2021.100036","A critical analysis of COVID-19 research literature: Text mining approach.","Among the stakeholders of COVID-19 research, clinicians particularly experience difficulty keeping up with the deluge of SARS-CoV-2 literature while performing their much needed clinical duties. By revealing major topics, this study proposes a text-mining approach as an alternative to navigating large volumes of COVID-19 literature. We obtained 85,268 references from the NIH COVID-19 Portfolio as of November 21. After the exclusion based on inadequate abstracts, 65,262 articles remained in the f","2021","06","29","Intell Based Med","Intelligence-based medicine","COVID-19; Natural language processing; SARS COV-2; Text mining; Topic modeling","Oner","Nurettin","Department of Health Services Administration, The University of Alabama at Birmingham, USA",NA
"2726","34179855","10.1016/j.ibmed.2021.100036","A critical analysis of COVID-19 research literature: Text mining approach.","Among the stakeholders of COVID-19 research, clinicians particularly experience difficulty keeping up with the deluge of SARS-CoV-2 literature while performing their much needed clinical duties. By revealing major topics, this study proposes a text-mining approach as an alternative to navigating large volumes of COVID-19 literature. We obtained 85,268 references from the NIH COVID-19 Portfolio as of November 21. After the exclusion based on inadequate abstracts, 65,262 articles remained in the f","2021","06","29","Intell Based Med","Intelligence-based medicine","COVID-19; Natural language processing; SARS COV-2; Text mining; Topic modeling","Ozaydin","Bunyamin","Department of Health Services Administration, The University of Alabama at Birmingham, USA",NA
"2727","34179855","10.1016/j.ibmed.2021.100036","A critical analysis of COVID-19 research literature: Text mining approach.","Among the stakeholders of COVID-19 research, clinicians particularly experience difficulty keeping up with the deluge of SARS-CoV-2 literature while performing their much needed clinical duties. By revealing major topics, this study proposes a text-mining approach as an alternative to navigating large volumes of COVID-19 literature. We obtained 85,268 references from the NIH COVID-19 Portfolio as of November 21. After the exclusion based on inadequate abstracts, 65,262 articles remained in the f","2021","06","29","Intell Based Med","Intelligence-based medicine","COVID-19; Natural language processing; SARS COV-2; Text mining; Topic modeling","Delen","Dursun","Department of Management Science, School of Business, Ibn Haldun University, Istanbul, Turkey",NA
"2728","34179855","10.1016/j.ibmed.2021.100036","A critical analysis of COVID-19 research literature: Text mining approach.","Among the stakeholders of COVID-19 research, clinicians particularly experience difficulty keeping up with the deluge of SARS-CoV-2 literature while performing their much needed clinical duties. By revealing major topics, this study proposes a text-mining approach as an alternative to navigating large volumes of COVID-19 literature. We obtained 85,268 references from the NIH COVID-19 Portfolio as of November 21. After the exclusion based on inadequate abstracts, 65,262 articles remained in the f","2021","06","29","Intell Based Med","Intelligence-based medicine","COVID-19; Natural language processing; SARS COV-2; Text mining; Topic modeling","Willig","James H","Department of Medicine, Division of Infectious Diseases, The University of Alabama at Birmingham, USA",NA
"2729","34179855","10.1016/j.ibmed.2021.100036","A critical analysis of COVID-19 research literature: Text mining approach.","Among the stakeholders of COVID-19 research, clinicians particularly experience difficulty keeping up with the deluge of SARS-CoV-2 literature while performing their much needed clinical duties. By revealing major topics, this study proposes a text-mining approach as an alternative to navigating large volumes of COVID-19 literature. We obtained 85,268 references from the NIH COVID-19 Portfolio as of November 21. After the exclusion based on inadequate abstracts, 65,262 articles remained in the f","2021","06","29","Intell Based Med","Intelligence-based medicine","COVID-19; Natural language processing; SARS COV-2; Text mining; Topic modeling","Kennedy","Kierstin C","UAB Hospital Medicine, University of Alabama at Birmingham, USA",NA
"2730","34179855","10.1016/j.ibmed.2021.100036","A critical analysis of COVID-19 research literature: Text mining approach.","Among the stakeholders of COVID-19 research, clinicians particularly experience difficulty keeping up with the deluge of SARS-CoV-2 literature while performing their much needed clinical duties. By revealing major topics, this study proposes a text-mining approach as an alternative to navigating large volumes of COVID-19 literature. We obtained 85,268 references from the NIH COVID-19 Portfolio as of November 21. After the exclusion based on inadequate abstracts, 65,262 articles remained in the f","2021","06","29","Intell Based Med","Intelligence-based medicine","COVID-19; Natural language processing; SARS COV-2; Text mining; Topic modeling","Cimino","James","Department of Medicine, The University of Alabama at Birmingham, USA",NA
"2731","34179854","10.1016/j.hroo.2020.05.004","Electrophysiology and COVID-19: An era of new potential.",NA,"2021","06","29","Heart Rhythm O2","Heart rhythm O2",NA,"Gleva","Marye J","Washington University School of Medicine, St. Louis, Missouri",NA
"2732","34179839","10.1016/j.xjon.2021.06.009","Commentary: Cardiac care during the coronavirus disease 2019 pandemic: Competing constraints.",NA,"2021","06","29","JTCVS Open","JTCVS open",NA,"Reardon","Michael J","Department of Cardiovascular Surgery, Houston Methodist Hospital, Houston, Tex",NA
"2733","34179835","10.1016/j.xpro.2021.100671","A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients.","One of the key public health strategies in coronavirus 2019 disease (COVID-19) management is the early detection of infected individuals to limit the transmission. As a result, serological assays have been developed to complement PCR-based assays. Here, we report the development of a flow cytometry-based assay to detect antibodies against full-length SARS-CoV-2 Spike protein (S protein) in COVID-19 patients. The assay is time-efficient and sensitive, being able to capture the wider repertoire of","2021","06","28","STAR Protoc","STAR protocols",NA,"Goh","Yun Shan","Infectious Diseases Laboratories (ID Labs), Agency for Science, Technology and Research (ASTAR), Immunos, Biopolis, Singapore 138648, Singapore",NA
"2734","34179835","10.1016/j.xpro.2021.100671","A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients.","One of the key public health strategies in coronavirus 2019 disease (COVID-19) management is the early detection of infected individuals to limit the transmission. As a result, serological assays have been developed to complement PCR-based assays. Here, we report the development of a flow cytometry-based assay to detect antibodies against full-length SARS-CoV-2 Spike protein (S protein) in COVID-19 patients. The assay is time-efficient and sensitive, being able to capture the wider repertoire of","2021","06","28","STAR Protoc","STAR protocols",NA,"Ng","Lisa F P","Infectious Diseases Laboratories (ID Labs), Agency for Science, Technology and Research (ASTAR), Immunos, Biopolis, Singapore 138648, Singapore",NA
"2735","34179835","10.1016/j.xpro.2021.100671","A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients.","One of the key public health strategies in coronavirus 2019 disease (COVID-19) management is the early detection of infected individuals to limit the transmission. As a result, serological assays have been developed to complement PCR-based assays. Here, we report the development of a flow cytometry-based assay to detect antibodies against full-length SARS-CoV-2 Spike protein (S protein) in COVID-19 patients. The assay is time-efficient and sensitive, being able to capture the wider repertoire of","2021","06","28","STAR Protoc","STAR protocols",NA,"Renia","Laurent","Infectious Diseases Laboratories (ID Labs), Agency for Science, Technology and Research (ASTAR), Immunos, Biopolis, Singapore 138648, Singapore",NA
"2736","34179834","10.1016/j.jaccas.2021.05.003","Multiple Etiologies to Myocardial Injury in COVID-19.","In patients with acute myocardial injury secondary to coronavirus disease-2019 (COVID-19), cardiovascular magnetic resonance imaging can identify the underlying pathology. We highlight a case of acute myocardial injury secondary to COVID-19, which demonstrated both epicardial vessel thrombosis and the recently described phenomenon of microvascular thrombosis. (Level of Difficulty: Advanced.).","2021","06","29","JACC Case Rep","JACC. Case reports","CMR, cardiac magnetic resonance imaging; COVID-19, coronavirus-2019; cardiac magnetic resonance; myocardial infarction; thrombosis","Gorecka","Miroslawa","Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom",NA
"2737","34179834","10.1016/j.jaccas.2021.05.003","Multiple Etiologies to Myocardial Injury in COVID-19.","In patients with acute myocardial injury secondary to coronavirus disease-2019 (COVID-19), cardiovascular magnetic resonance imaging can identify the underlying pathology. We highlight a case of acute myocardial injury secondary to COVID-19, which demonstrated both epicardial vessel thrombosis and the recently described phenomenon of microvascular thrombosis. (Level of Difficulty: Advanced.).","2021","06","29","JACC Case Rep","JACC. Case reports","CMR, cardiac magnetic resonance imaging; COVID-19, coronavirus-2019; cardiac magnetic resonance; myocardial infarction; thrombosis","Thirunavukarasu","Sharmaine","Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom",NA
"2738","34179834","10.1016/j.jaccas.2021.05.003","Multiple Etiologies to Myocardial Injury in COVID-19.","In patients with acute myocardial injury secondary to coronavirus disease-2019 (COVID-19), cardiovascular magnetic resonance imaging can identify the underlying pathology. We highlight a case of acute myocardial injury secondary to COVID-19, which demonstrated both epicardial vessel thrombosis and the recently described phenomenon of microvascular thrombosis. (Level of Difficulty: Advanced.).","2021","06","29","JACC Case Rep","JACC. Case reports","CMR, cardiac magnetic resonance imaging; COVID-19, coronavirus-2019; cardiac magnetic resonance; myocardial infarction; thrombosis","Levelt","Eylem","Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom",NA
"2739","34179834","10.1016/j.jaccas.2021.05.003","Multiple Etiologies to Myocardial Injury in COVID-19.","In patients with acute myocardial injury secondary to coronavirus disease-2019 (COVID-19), cardiovascular magnetic resonance imaging can identify the underlying pathology. We highlight a case of acute myocardial injury secondary to COVID-19, which demonstrated both epicardial vessel thrombosis and the recently described phenomenon of microvascular thrombosis. (Level of Difficulty: Advanced.).","2021","06","29","JACC Case Rep","JACC. Case reports","CMR, cardiac magnetic resonance imaging; COVID-19, coronavirus-2019; cardiac magnetic resonance; myocardial infarction; thrombosis","Greenwood","John P","Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom",NA
"2740","34179833","10.1016/S2665-9913(21)00213-7","First data on COVID-19 morbidity and mortality in patients with rheumatic disease from South Korea.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Schreiber","Karen","Danish Hospital for Rheumatic Diseases, University of Southern Denmark, Sønderborg 6400, Denmark",NA
"2741","34179833","10.1016/S2665-9913(21)00213-7","First data on COVID-19 morbidity and mortality in patients with rheumatic disease from South Korea.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Hendricks","Oliver","Danish Hospital for Rheumatic Diseases, University of Southern Denmark, Sønderborg 6400, Denmark",NA
"2742","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Shin","Youn Ho","Department of Pediatrics, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, South Korea",NA
"2743","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Shin","Jae Il","Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea",NA
"2744","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Moon","Sung Yong","Department of Data Science, Sejong University College of Software Convergence, Seoul, South Korea",NA
"2745","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Jin","Hyun Young","Department of Data Science, Sejong University College of Software Convergence, Seoul, South Korea",NA
"2746","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Kim","So Young","Department of Otorhinolaryngology-Head &amp",NA
"2747","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Yang","Jee Myung","Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea",NA
"2748","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Cho","Seong Ho","Division of Allergy-Immunology, University of South Florida Morsani College of Medicine, Tampa, FL, USA",NA
"2749","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Kim","Sungeun","Yonsei University College of Medicine, Seoul, South Korea",NA
"2750","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Lee","Minho","Yonsei University College of Medicine, Seoul, South Korea",NA
"2751","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Park","Youngjoo","Yonsei University College of Medicine, Seoul, South Korea",NA
"2752","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Kim","Min Seo","Korea University College of Medicine, Seoul, South Korea",NA
"2753","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Won","Hong-Hee","Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea",NA
"2754","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Hong","Sung Hwi","Yonsei University College of Medicine, Seoul, South Korea",NA
"2755","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Kronbichler","Andreas","Department of Internal Medicine IV (Nephrology and Hypertension), Medical University of Innsbruck, Innsbruck, Austria",NA
"2756","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Koyanagi","Ai","Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, Barcelona, Spain",NA
"2757","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Jacob","Louis","Research and Development Unit, Parc Sanitari Sant Joan de Déu, CIBERSAM, Barcelona, Spain",NA
"2758","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Smith","Lee","The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, UK",NA
"2759","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Lee","Keum Hwa","Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea",NA
"2760","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Suh","Dong In","Department of Pediatrics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea",NA
"2761","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Lee","Seung Won","Department of Data Science, Sejong University College of Software Convergence, Seoul, South Korea",NA
"2762","34179832","10.1016/S2665-9913(21)00151-X","Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.","Real-world evidence on the association between autoimmune inflammatory rheumatic diseases, therapies related to these diseases, and COVID-19 outcomes are inconsistent. We aimed to investigate the potential association between autoimmune inflammatory rheumatic diseases and COVID-19 early in the COVID-19 pandemic. We did an exposure-driven, propensity score-matched study using a South Korean nationwide cohort linked to general health examination records. We analysed all South Korean patients aged ","2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Yon","Dong Keon","Department of Pediatrics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea",NA
"2763","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Boekel","Laura","Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, 1056 AB Amsterdam, Netherlands",NA
"2764","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Kummer","Laura Y","Department of Neurology and Neurophysiology, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands",NA
"2765","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"van Dam","Koos P J","Department of Neurology and Neurophysiology, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands",NA
"2766","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Hooijberg","Femke","Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, 1056 AB Amsterdam, Netherlands",NA
"2767","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"van Kempen","Zoé","Department of Neurology, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands",NA
"2768","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Vogelzang","Erik H","Department of Medical Microbiology and Infection Control, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands",NA
"2769","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Wieske","Luuk","Department of Neurology and Neurophysiology, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands",NA
"2770","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Eftimov","Filip","Department of Neurology and Neurophysiology, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands",NA
"2771","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"van Vollenhoven","Ronald","Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, 1056 AB Amsterdam, Netherlands",NA
"2772","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Kuijpers","Taco W","Department of Pediatric Immunology, Rheumatology and Infectious Disease, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands",NA
"2773","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"van Ham","S Marieke","Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, Amsterdam, Netherlands",NA
"2774","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Tas","Sander W","Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, 1056 AB Amsterdam, Netherlands",NA
"2775","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Killestein","Joep","Department of Neurology, University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands",NA
"2776","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Boers","Maarten","Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, 1056 AB Amsterdam, Netherlands",NA
"2777","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Nurmohamed","Mike T","Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, 1056 AB Amsterdam, Netherlands",NA
"2778","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Rispens","Theo","Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, Amsterdam, Netherlands",NA
"2779","34179831","10.1016/S2665-9913(21)00181-8","Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.",NA,"2021","06","29","Lancet Rheumatol","The Lancet. Rheumatology",NA,"Wolbink","Gertjan","Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, 1056 AB Amsterdam, Netherlands",NA
"2780","34179827","10.1007/s42979-021-00746-x","CoviChain: A Blockchain Based Framework for Nonrepudiable Contact Tracing in Healthcare Cyber-Physical Systems During Pandemic Outbreaks.","With the world facing the new virus SARS-CoV-2, many countries have introduced instant Internet applications to identify people carrying the infection. Internet-of-Medical-Things (IoMT) have proven useful in collecting medical data as well in tracing an individual carrying the virus. The data collected or traced belongs to an individual and should be revealed to themselves and hospital providers, but not to any third-party unauthorized agencies. In this paper we use an off-chain distributed stor","2021","06","28","SN Comput Sci","SN computer science","Blockchain; COVID-19; Contract tracing; Data privacy; Data provenance; Healthcare cyber-physical system (H-CPS); Internet-of-Medical-Things (IoMT)","Vangipuram","Sukrutha L T","Department of Computer Science and Engineering, University of North Texas, Denton, TX, USA",NA
"2781","34179827","10.1007/s42979-021-00746-x","CoviChain: A Blockchain Based Framework for Nonrepudiable Contact Tracing in Healthcare Cyber-Physical Systems During Pandemic Outbreaks.","With the world facing the new virus SARS-CoV-2, many countries have introduced instant Internet applications to identify people carrying the infection. Internet-of-Medical-Things (IoMT) have proven useful in collecting medical data as well in tracing an individual carrying the virus. The data collected or traced belongs to an individual and should be revealed to themselves and hospital providers, but not to any third-party unauthorized agencies. In this paper we use an off-chain distributed stor","2021","06","28","SN Comput Sci","SN computer science","Blockchain; COVID-19; Contract tracing; Data privacy; Data provenance; Healthcare cyber-physical system (H-CPS); Internet-of-Medical-Things (IoMT)","Mohanty","Saraju P","Department of Computer Science and Engineering, University of North Texas, Denton, TX, USA",NA
"2782","34179827","10.1007/s42979-021-00746-x","CoviChain: A Blockchain Based Framework for Nonrepudiable Contact Tracing in Healthcare Cyber-Physical Systems During Pandemic Outbreaks.","With the world facing the new virus SARS-CoV-2, many countries have introduced instant Internet applications to identify people carrying the infection. Internet-of-Medical-Things (IoMT) have proven useful in collecting medical data as well in tracing an individual carrying the virus. The data collected or traced belongs to an individual and should be revealed to themselves and hospital providers, but not to any third-party unauthorized agencies. In this paper we use an off-chain distributed stor","2021","06","28","SN Comput Sci","SN computer science","Blockchain; COVID-19; Contract tracing; Data privacy; Data provenance; Healthcare cyber-physical system (H-CPS); Internet-of-Medical-Things (IoMT)","Kougianos","Elias","Department of Electrical Engineering, University of North Texas, Denton, TX, USA",NA
"2783","34179769","10.3389/frai.2021.684609","Insights Into Co-Morbidity and Other Risk Factors Related to COVID-19 Within Ontario, Canada.","The worldwide rapid spread of the severe acute respiratory syndrome coronavirus 2 has affected millions of individuals and caused unprecedented medical challenges by putting healthcare services under high pressure. Given the global increase in number of cases and mortalities due to the current COVID-19 pandemic, it is critical to identify predictive features that assist identification of individuals most at-risk of COVID-19 mortality and thus, enable planning for effective usage of medical resou","2021","06","29","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; SHAP (shapley additive explanation); XGBoost (extreme gradient boosting); artificial intelligence; co-morbidity; mortality","Snider","Brett","University of Guelph, Guelph, ON, Canada",NA
"2784","34179769","10.3389/frai.2021.684609","Insights Into Co-Morbidity and Other Risk Factors Related to COVID-19 Within Ontario, Canada.","The worldwide rapid spread of the severe acute respiratory syndrome coronavirus 2 has affected millions of individuals and caused unprecedented medical challenges by putting healthcare services under high pressure. Given the global increase in number of cases and mortalities due to the current COVID-19 pandemic, it is critical to identify predictive features that assist identification of individuals most at-risk of COVID-19 mortality and thus, enable planning for effective usage of medical resou","2021","06","29","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; SHAP (shapley additive explanation); XGBoost (extreme gradient boosting); artificial intelligence; co-morbidity; mortality","Patel","Bhumi","University of Guelph, Guelph, ON, Canada",NA
"2785","34179769","10.3389/frai.2021.684609","Insights Into Co-Morbidity and Other Risk Factors Related to COVID-19 Within Ontario, Canada.","The worldwide rapid spread of the severe acute respiratory syndrome coronavirus 2 has affected millions of individuals and caused unprecedented medical challenges by putting healthcare services under high pressure. Given the global increase in number of cases and mortalities due to the current COVID-19 pandemic, it is critical to identify predictive features that assist identification of individuals most at-risk of COVID-19 mortality and thus, enable planning for effective usage of medical resou","2021","06","29","Front Artif Intell","Frontiers in artificial intelligence","COVID-19; SHAP (shapley additive explanation); XGBoost (extreme gradient boosting); artificial intelligence; co-morbidity; mortality","McBean","Edward","University of Guelph, Guelph, ON, Canada",NA
"2786","34179747","10.1016/j.bsheal.2021.06.003","A short report of Biosafety and Biobanking: current understanding and knowledge gaps.","Infectious disease outbreaks, such as 'Coronavirus Disease 2019' (COVID-19), can constitute major global health threats with far-reaching consequences. As outbreaks develop, the international scientific community must provide high-quality scientific research-ready biological samples to solve the existing clinical and epidemiological questions to better combat the pandemic. Such examples are provided by dedicated biobank facilities, the latter collecting increasingly high volumes of biological sa","2021","07","24","Biosaf Health","Biosafety and health","Biobank; Biological safety; Biosafety; Data safety; Safety regulations","Roux","Julie","World Health Organization, International Agency for Research on Cancer, Lyon, France",NA
"2787","34179747","10.1016/j.bsheal.2021.06.003","A short report of Biosafety and Biobanking: current understanding and knowledge gaps.","Infectious disease outbreaks, such as 'Coronavirus Disease 2019' (COVID-19), can constitute major global health threats with far-reaching consequences. As outbreaks develop, the international scientific community must provide high-quality scientific research-ready biological samples to solve the existing clinical and epidemiological questions to better combat the pandemic. Such examples are provided by dedicated biobank facilities, the latter collecting increasingly high volumes of biological sa","2021","07","24","Biosaf Health","Biosafety and health","Biobank; Biological safety; Biosafety; Data safety; Safety regulations","Zeghidi","Maissa","World Health Organization, International Agency for Research on Cancer, Lyon, France",NA
"2788","34179747","10.1016/j.bsheal.2021.06.003","A short report of Biosafety and Biobanking: current understanding and knowledge gaps.","Infectious disease outbreaks, such as 'Coronavirus Disease 2019' (COVID-19), can constitute major global health threats with far-reaching consequences. As outbreaks develop, the international scientific community must provide high-quality scientific research-ready biological samples to solve the existing clinical and epidemiological questions to better combat the pandemic. Such examples are provided by dedicated biobank facilities, the latter collecting increasingly high volumes of biological sa","2021","07","24","Biosaf Health","Biosafety and health","Biobank; Biological safety; Biosafety; Data safety; Safety regulations","Villar","Stephanie","World Health Organization, International Agency for Research on Cancer, Lyon, France",NA
"2789","34179747","10.1016/j.bsheal.2021.06.003","A short report of Biosafety and Biobanking: current understanding and knowledge gaps.","Infectious disease outbreaks, such as 'Coronavirus Disease 2019' (COVID-19), can constitute major global health threats with far-reaching consequences. As outbreaks develop, the international scientific community must provide high-quality scientific research-ready biological samples to solve the existing clinical and epidemiological questions to better combat the pandemic. Such examples are provided by dedicated biobank facilities, the latter collecting increasingly high volumes of biological sa","2021","07","24","Biosaf Health","Biosafety and health","Biobank; Biological safety; Biosafety; Data safety; Safety regulations","Kozlakidis","Zisis","World Health Organization, International Agency for Research on Cancer, Lyon, France",NA
"2790","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Wang","C-G","Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis, No. 08-03, 138634, Singapore",NA
"2791","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Li","Z","Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis, No. 08-03, 138634, Singapore",NA
"2792","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Liu","S","Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis, No. 08-03, 138634, Singapore",NA
"2793","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Ng","C T","Environmental Health Institute, National Environment Agency (NEA), 11 Biopolis Way No.06-05/08 Helios Block, 138667, Singapore",NA
"2794","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Marzuki","M","A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, 138648, Singapore",NA
"2795","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Jeslyn Wong","P S","Environmental Health Institute, National Environment Agency (NEA), 11 Biopolis Way No.06-05/08 Helios Block, 138667, Singapore",NA
"2796","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Tan","B","A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, 138648, Singapore",NA
"2797","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Lee","A","A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, 138648, Singapore",NA
"2798","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Hui Lim","C F","A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, 138648, Singapore",NA
"2799","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Bifani","P","A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, 138648, Singapore",NA
"2800","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Fang","Z","Environmental Health Institute, National Environment Agency (NEA), 11 Biopolis Way No.06-05/08 Helios Block, 138667, Singapore",NA
"2801","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Ching Wong","J C","Environmental Health Institute, National Environment Agency (NEA), 11 Biopolis Way No.06-05/08 Helios Block, 138667, Singapore",NA
"2802","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Setoh","Y X","Environmental Health Institute, National Environment Agency (NEA), 11 Biopolis Way No.06-05/08 Helios Block, 138667, Singapore",NA
"2803","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Yang","Y Y","Institute of Bioengineering and Bioimaging, Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, Nanos, 138669, Singapore",NA
"2804","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Mun","C H","DSO National Laboratories, 12 Science Park Dr, 118225, Singapore",NA
"2805","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Fiona Phua","S Z","DSO National Laboratories, 12 Science Park Dr, 118225, Singapore",NA
"2806","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Lim","W Q","DSO National Laboratories, 12 Science Park Dr, 118225, Singapore",NA
"2807","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Lin","L","ST Engineering Aerospace Engines Pte Ltd, 501 Airport Rd, 539931, Singapore",NA
"2808","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Cook","A R","Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, 117549, Singapore",NA
"2809","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Tanoto","H","Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis, No. 08-03, 138634, Singapore",NA
"2810","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Ng","L-C","Environmental Health Institute, National Environment Agency (NEA), 11 Biopolis Way No.06-05/08 Helios Block, 138667, Singapore",NA
"2811","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Singhal","A","A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, 138648, Singapore",NA
"2812","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Leong","Y W","Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis, No. 08-03, 138634, Singapore",NA
"2813","34179746","10.1016/j.mtadv.2021.100148","N95 respirator decontamination: a study in reusability.","The coronavirus disease 2019 (COVID-19) pandemic had caused a severe depletion of the worldwide supply of N95 respirators. The development of methods to effectively decontaminate N95 respirators while maintaining their integrity is crucial for respirator regeneration and reuse. In this study, we systematically evaluated five respirator decontamination methods using vaporized hydrogen peroxide (VHP) or ultraviolet (254 nm wavelength, UVC) radiation. Through testing the bioburden, filtration, flui","2021","06","29","Mater Today Adv","Materials today. Advances","COVID-19; Decontamination; N95; Respirator; Reuse; SARS-CoV-2; UV; Vaporized hydrogen peroxide (VHP)","Loh","X J","Institute of Materials Research and Engineering (IMRE), Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis, No. 08-03, 138634, Singapore",NA
"2814","34179744","10.1016/j.metop.2021.100101","Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story.","The recognition of the rare but serious and potentially lethal complication of vaccine induced thrombotic thrombocytopenia (VITT) raised concerns regarding the safety of COVID-19 vaccines and led to the reconsideration of vaccination strategies in many countries. Following the description of VITT among recipients of adenoviral vector ChAdOx1 vaccine, a review of similar cases after Ad26.COV2·S vaccination gave rise to the question whether this entity may constitute a potential class effect of al","2021","07","02","Metabol Open","Metabolism open","Adenoviral vector; Adenovirus; CAR, Coxsackie-adenovirus receptor; CDC, Centers for Disease Control and Prevention; COVID-19; COVID-19, Coronavirus disease 2019; CVST, cerebellar sinus thrombosis; FDA, Food and Drug Administration; HIT, Heparin-induced thrombocytopenia; ICU, Intensive Care Unit; IVIG, Intravenous immunoglobulin; LMWH, low molecular weight heparin; PF4, Platelet factor 4; PLT, Platelet; PRAC, Pharmacovigilance Risk Assessment Committee; PT, prothrombin time; SARS-CoV-2; SARS-Cov-2, severe acute respiratory syndrome coronavirus 2; SVT, splanchnic vein thrombosis; TTS, thrombosis-thrombocytopenia-syndrome; VCAM-1, vascular cell adhesion molecule 1; VIPIT, vaccine-induced prothrombotic immune thrombocytopenia; VITT, vaccine induced thrombotic thrombocytopenia; Vaccine; Vaccine induced thrombotic thrombocytopenia; aPTT, activated partial thromboplastin time; <U+0395><U+039C><U+0391>, European Medicines Agency","Tsilingiris","Dimitrios","First Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, 17 St Thomas Street, 11527, Athens, Greece",NA
"2815","34179744","10.1016/j.metop.2021.100101","Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story.","The recognition of the rare but serious and potentially lethal complication of vaccine induced thrombotic thrombocytopenia (VITT) raised concerns regarding the safety of COVID-19 vaccines and led to the reconsideration of vaccination strategies in many countries. Following the description of VITT among recipients of adenoviral vector ChAdOx1 vaccine, a review of similar cases after Ad26.COV2·S vaccination gave rise to the question whether this entity may constitute a potential class effect of al","2021","07","02","Metabol Open","Metabolism open","Adenoviral vector; Adenovirus; CAR, Coxsackie-adenovirus receptor; CDC, Centers for Disease Control and Prevention; COVID-19; COVID-19, Coronavirus disease 2019; CVST, cerebellar sinus thrombosis; FDA, Food and Drug Administration; HIT, Heparin-induced thrombocytopenia; ICU, Intensive Care Unit; IVIG, Intravenous immunoglobulin; LMWH, low molecular weight heparin; PF4, Platelet factor 4; PLT, Platelet; PRAC, Pharmacovigilance Risk Assessment Committee; PT, prothrombin time; SARS-CoV-2; SARS-Cov-2, severe acute respiratory syndrome coronavirus 2; SVT, splanchnic vein thrombosis; TTS, thrombosis-thrombocytopenia-syndrome; VCAM-1, vascular cell adhesion molecule 1; VIPIT, vaccine-induced prothrombotic immune thrombocytopenia; VITT, vaccine induced thrombotic thrombocytopenia; Vaccine; Vaccine induced thrombotic thrombocytopenia; aPTT, activated partial thromboplastin time; <U+0395><U+039C><U+0391>, European Medicines Agency","Vallianou","Natalia G","First Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou Str, 10676, Athens, Greece",NA
"2816","34179744","10.1016/j.metop.2021.100101","Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story.","The recognition of the rare but serious and potentially lethal complication of vaccine induced thrombotic thrombocytopenia (VITT) raised concerns regarding the safety of COVID-19 vaccines and led to the reconsideration of vaccination strategies in many countries. Following the description of VITT among recipients of adenoviral vector ChAdOx1 vaccine, a review of similar cases after Ad26.COV2·S vaccination gave rise to the question whether this entity may constitute a potential class effect of al","2021","07","02","Metabol Open","Metabolism open","Adenoviral vector; Adenovirus; CAR, Coxsackie-adenovirus receptor; CDC, Centers for Disease Control and Prevention; COVID-19; COVID-19, Coronavirus disease 2019; CVST, cerebellar sinus thrombosis; FDA, Food and Drug Administration; HIT, Heparin-induced thrombocytopenia; ICU, Intensive Care Unit; IVIG, Intravenous immunoglobulin; LMWH, low molecular weight heparin; PF4, Platelet factor 4; PLT, Platelet; PRAC, Pharmacovigilance Risk Assessment Committee; PT, prothrombin time; SARS-CoV-2; SARS-Cov-2, severe acute respiratory syndrome coronavirus 2; SVT, splanchnic vein thrombosis; TTS, thrombosis-thrombocytopenia-syndrome; VCAM-1, vascular cell adhesion molecule 1; VIPIT, vaccine-induced prothrombotic immune thrombocytopenia; VITT, vaccine induced thrombotic thrombocytopenia; Vaccine; Vaccine induced thrombotic thrombocytopenia; aPTT, activated partial thromboplastin time; <U+0395><U+039C><U+0391>, European Medicines Agency","Karampela","Irene","Second Department of Critical Care, Attikon General University Hospital, Medical School, National and Kapodistrian University of Athens, 1 Rimini St, Haidari, 12462, Athens, Greece",NA
"2817","34179744","10.1016/j.metop.2021.100101","Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story.","The recognition of the rare but serious and potentially lethal complication of vaccine induced thrombotic thrombocytopenia (VITT) raised concerns regarding the safety of COVID-19 vaccines and led to the reconsideration of vaccination strategies in many countries. Following the description of VITT among recipients of adenoviral vector ChAdOx1 vaccine, a review of similar cases after Ad26.COV2·S vaccination gave rise to the question whether this entity may constitute a potential class effect of al","2021","07","02","Metabol Open","Metabolism open","Adenoviral vector; Adenovirus; CAR, Coxsackie-adenovirus receptor; CDC, Centers for Disease Control and Prevention; COVID-19; COVID-19, Coronavirus disease 2019; CVST, cerebellar sinus thrombosis; FDA, Food and Drug Administration; HIT, Heparin-induced thrombocytopenia; ICU, Intensive Care Unit; IVIG, Intravenous immunoglobulin; LMWH, low molecular weight heparin; PF4, Platelet factor 4; PLT, Platelet; PRAC, Pharmacovigilance Risk Assessment Committee; PT, prothrombin time; SARS-CoV-2; SARS-Cov-2, severe acute respiratory syndrome coronavirus 2; SVT, splanchnic vein thrombosis; TTS, thrombosis-thrombocytopenia-syndrome; VCAM-1, vascular cell adhesion molecule 1; VIPIT, vaccine-induced prothrombotic immune thrombocytopenia; VITT, vaccine induced thrombotic thrombocytopenia; Vaccine; Vaccine induced thrombotic thrombocytopenia; aPTT, activated partial thromboplastin time; <U+0395><U+039C><U+0391>, European Medicines Agency","Dalamaga","Maria","Department of Biological Chemistry, School of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias, 11527 Athens, Greece",NA
"2818","34179743","10.1016/j.jtauto.2021.100108","Autoimmune diseases - New insights into a troublesome field.","Recent updates in the diagnosis and management of chronic inflammatory conditions can be brought together to better understand autoimmune diseases (ADs). With organ-specific or organ-limited and systemic ADs, physicians often are faced with a dilemma when making a diagnosis and may feel a kind of embarrassment when a more distinct nosological entity cannot be found. ADs often overlap with other diseases and good diagnostic procedures for ADs only become evidence-based when refined histopathologi","2021","06","29","J Transl Autoimmun","Journal of translational autoimmunity","Biosimilars I; Complement; Cytokine; Innate immunity; Monoclonal antibodies","Lung","Thomas","Center for Laboratory Medicine Dr Risch, Vaduz, Liechtenstein",NA
"2819","34179743","10.1016/j.jtauto.2021.100108","Autoimmune diseases - New insights into a troublesome field.","Recent updates in the diagnosis and management of chronic inflammatory conditions can be brought together to better understand autoimmune diseases (ADs). With organ-specific or organ-limited and systemic ADs, physicians often are faced with a dilemma when making a diagnosis and may feel a kind of embarrassment when a more distinct nosological entity cannot be found. ADs often overlap with other diseases and good diagnostic procedures for ADs only become evidence-based when refined histopathologi","2021","06","29","J Transl Autoimmun","Journal of translational autoimmunity","Biosimilars I; Complement; Cytokine; Innate immunity; Monoclonal antibodies","Sakem","Benjamin","Center for Laboratory Medicine Dr Risch, Vaduz, Liechtenstein",NA
"2820","34179743","10.1016/j.jtauto.2021.100108","Autoimmune diseases - New insights into a troublesome field.","Recent updates in the diagnosis and management of chronic inflammatory conditions can be brought together to better understand autoimmune diseases (ADs). With organ-specific or organ-limited and systemic ADs, physicians often are faced with a dilemma when making a diagnosis and may feel a kind of embarrassment when a more distinct nosological entity cannot be found. ADs often overlap with other diseases and good diagnostic procedures for ADs only become evidence-based when refined histopathologi","2021","06","29","J Transl Autoimmun","Journal of translational autoimmunity","Biosimilars I; Complement; Cytokine; Innate immunity; Monoclonal antibodies","Hemmerle","Andreas","Center for Laboratory Medicine Dr Risch, Vaduz, Liechtenstein",NA
"2821","34179743","10.1016/j.jtauto.2021.100108","Autoimmune diseases - New insights into a troublesome field.","Recent updates in the diagnosis and management of chronic inflammatory conditions can be brought together to better understand autoimmune diseases (ADs). With organ-specific or organ-limited and systemic ADs, physicians often are faced with a dilemma when making a diagnosis and may feel a kind of embarrassment when a more distinct nosological entity cannot be found. ADs often overlap with other diseases and good diagnostic procedures for ADs only become evidence-based when refined histopathologi","2021","06","29","J Transl Autoimmun","Journal of translational autoimmunity","Biosimilars I; Complement; Cytokine; Innate immunity; Monoclonal antibodies","Nydegger","Michèle","Institute of Anesthesiology and Intensive Care Medicine, Triemli City Hospital, Zurich, Switzerland",NA
"2822","34179743","10.1016/j.jtauto.2021.100108","Autoimmune diseases - New insights into a troublesome field.","Recent updates in the diagnosis and management of chronic inflammatory conditions can be brought together to better understand autoimmune diseases (ADs). With organ-specific or organ-limited and systemic ADs, physicians often are faced with a dilemma when making a diagnosis and may feel a kind of embarrassment when a more distinct nosological entity cannot be found. ADs often overlap with other diseases and good diagnostic procedures for ADs only become evidence-based when refined histopathologi","2021","06","29","J Transl Autoimmun","Journal of translational autoimmunity","Biosimilars I; Complement; Cytokine; Innate immunity; Monoclonal antibodies","Risch","Martin","Center for Laboratory Medicine Dr Risch, Vaduz, Liechtenstein",NA
"2823","34179743","10.1016/j.jtauto.2021.100108","Autoimmune diseases - New insights into a troublesome field.","Recent updates in the diagnosis and management of chronic inflammatory conditions can be brought together to better understand autoimmune diseases (ADs). With organ-specific or organ-limited and systemic ADs, physicians often are faced with a dilemma when making a diagnosis and may feel a kind of embarrassment when a more distinct nosological entity cannot be found. ADs often overlap with other diseases and good diagnostic procedures for ADs only become evidence-based when refined histopathologi","2021","06","29","J Transl Autoimmun","Journal of translational autoimmunity","Biosimilars I; Complement; Cytokine; Innate immunity; Monoclonal antibodies","Risch","Lorenz","Center for Laboratory Medicine Dr Risch, Vaduz, Liechtenstein",NA
"2824","34179743","10.1016/j.jtauto.2021.100108","Autoimmune diseases - New insights into a troublesome field.","Recent updates in the diagnosis and management of chronic inflammatory conditions can be brought together to better understand autoimmune diseases (ADs). With organ-specific or organ-limited and systemic ADs, physicians often are faced with a dilemma when making a diagnosis and may feel a kind of embarrassment when a more distinct nosological entity cannot be found. ADs often overlap with other diseases and good diagnostic procedures for ADs only become evidence-based when refined histopathologi","2021","06","29","J Transl Autoimmun","Journal of translational autoimmunity","Biosimilars I; Complement; Cytokine; Innate immunity; Monoclonal antibodies","Nydegger","Urs","Center for Laboratory Medicine Dr Risch, Vaduz, Liechtenstein",NA
"2825","34179737","10.1016/j.eclinm.2021.100967","Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease 19 (COVID-19), a respiratory infection that, starting from December 2019, has spread around the world in a few months, becoming a pandemic. The lack of initial knowledge on its management has led to a great effort in developing vaccines and in finding therapeutic weapons capable of improving the clinical outcome of the affected patients. In particular, the possible role of vitamin D s","2021","06","29","EClinicalMedicine","EClinicalMedicine","25-hydroxy-cholecalciferol; COVID-19; COVID-19 severity; SARS-CoV-2; Vitamin D; Vitamin D deficiency","Crafa","Andrea","Department of Clinical and Experimental Medicine, University of Catania, via S. Sofia 78, Catania 95123, Italy",NA
"2826","34179737","10.1016/j.eclinm.2021.100967","Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease 19 (COVID-19), a respiratory infection that, starting from December 2019, has spread around the world in a few months, becoming a pandemic. The lack of initial knowledge on its management has led to a great effort in developing vaccines and in finding therapeutic weapons capable of improving the clinical outcome of the affected patients. In particular, the possible role of vitamin D s","2021","06","29","EClinicalMedicine","EClinicalMedicine","25-hydroxy-cholecalciferol; COVID-19; COVID-19 severity; SARS-CoV-2; Vitamin D; Vitamin D deficiency","Cannarella","Rossella","Department of Clinical and Experimental Medicine, University of Catania, via S. Sofia 78, Catania 95123, Italy",NA
"2827","34179737","10.1016/j.eclinm.2021.100967","Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease 19 (COVID-19), a respiratory infection that, starting from December 2019, has spread around the world in a few months, becoming a pandemic. The lack of initial knowledge on its management has led to a great effort in developing vaccines and in finding therapeutic weapons capable of improving the clinical outcome of the affected patients. In particular, the possible role of vitamin D s","2021","06","29","EClinicalMedicine","EClinicalMedicine","25-hydroxy-cholecalciferol; COVID-19; COVID-19 severity; SARS-CoV-2; Vitamin D; Vitamin D deficiency","Condorelli","Rosita A","Department of Clinical and Experimental Medicine, University of Catania, via S. Sofia 78, Catania 95123, Italy",NA
"2828","34179737","10.1016/j.eclinm.2021.100967","Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease 19 (COVID-19), a respiratory infection that, starting from December 2019, has spread around the world in a few months, becoming a pandemic. The lack of initial knowledge on its management has led to a great effort in developing vaccines and in finding therapeutic weapons capable of improving the clinical outcome of the affected patients. In particular, the possible role of vitamin D s","2021","06","29","EClinicalMedicine","EClinicalMedicine","25-hydroxy-cholecalciferol; COVID-19; COVID-19 severity; SARS-CoV-2; Vitamin D; Vitamin D deficiency","Mongioì","Laura M","Department of Clinical and Experimental Medicine, University of Catania, via S. Sofia 78, Catania 95123, Italy",NA
"2829","34179737","10.1016/j.eclinm.2021.100967","Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease 19 (COVID-19), a respiratory infection that, starting from December 2019, has spread around the world in a few months, becoming a pandemic. The lack of initial knowledge on its management has led to a great effort in developing vaccines and in finding therapeutic weapons capable of improving the clinical outcome of the affected patients. In particular, the possible role of vitamin D s","2021","06","29","EClinicalMedicine","EClinicalMedicine","25-hydroxy-cholecalciferol; COVID-19; COVID-19 severity; SARS-CoV-2; Vitamin D; Vitamin D deficiency","Barbagallo","Federica","Department of Clinical and Experimental Medicine, University of Catania, via S. Sofia 78, Catania 95123, Italy",NA
"2830","34179737","10.1016/j.eclinm.2021.100967","Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease 19 (COVID-19), a respiratory infection that, starting from December 2019, has spread around the world in a few months, becoming a pandemic. The lack of initial knowledge on its management has led to a great effort in developing vaccines and in finding therapeutic weapons capable of improving the clinical outcome of the affected patients. In particular, the possible role of vitamin D s","2021","06","29","EClinicalMedicine","EClinicalMedicine","25-hydroxy-cholecalciferol; COVID-19; COVID-19 severity; SARS-CoV-2; Vitamin D; Vitamin D deficiency","Aversa","Antonio","Department of Experimental and Clinical Medicine, University ""Magna Græcia"", Catanzaro, Italy",NA
"2831","34179737","10.1016/j.eclinm.2021.100967","Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease 19 (COVID-19), a respiratory infection that, starting from December 2019, has spread around the world in a few months, becoming a pandemic. The lack of initial knowledge on its management has led to a great effort in developing vaccines and in finding therapeutic weapons capable of improving the clinical outcome of the affected patients. In particular, the possible role of vitamin D s","2021","06","29","EClinicalMedicine","EClinicalMedicine","25-hydroxy-cholecalciferol; COVID-19; COVID-19 severity; SARS-CoV-2; Vitamin D; Vitamin D deficiency","La Vignera","Sandro","Department of Clinical and Experimental Medicine, University of Catania, via S. Sofia 78, Catania 95123, Italy",NA
"2832","34179737","10.1016/j.eclinm.2021.100967","Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease 19 (COVID-19), a respiratory infection that, starting from December 2019, has spread around the world in a few months, becoming a pandemic. The lack of initial knowledge on its management has led to a great effort in developing vaccines and in finding therapeutic weapons capable of improving the clinical outcome of the affected patients. In particular, the possible role of vitamin D s","2021","06","29","EClinicalMedicine","EClinicalMedicine","25-hydroxy-cholecalciferol; COVID-19; COVID-19 severity; SARS-CoV-2; Vitamin D; Vitamin D deficiency","Calogero","Aldo E","Department of Clinical and Experimental Medicine, University of Catania, via S. Sofia 78, Catania 95123, Italy",NA
"2833","34179736","10.1016/j.eclinm.2021.100965","Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review.","the aim of this review was to analyze the implementation and impact of remote home monitoring models (virtual wards) for confirmed or suspected COVID-19 patients, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt. we carried out a rapid systematic review on models led by primary and secondary care across seven countries (US, Australia, Canada, The Netherlands, Ireland, China, UK). The main outcomes included in","2021","06","29","EClinicalMedicine","EClinicalMedicine","COVID-19; Rapid systematic review; Remote home monitoring; SARS-CoV-2; Silent hypoxia; Virtual wards","Vindrola-Padros","Cecilia","Department of Targeted Intervention, University College London (UCL), Charles Bell House, 43-45 Foley Street, London W1W 7TY, United Kingdom",NA
"2834","34179736","10.1016/j.eclinm.2021.100965","Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review.","the aim of this review was to analyze the implementation and impact of remote home monitoring models (virtual wards) for confirmed or suspected COVID-19 patients, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt. we carried out a rapid systematic review on models led by primary and secondary care across seven countries (US, Australia, Canada, The Netherlands, Ireland, China, UK). The main outcomes included in","2021","06","29","EClinicalMedicine","EClinicalMedicine","COVID-19; Rapid systematic review; Remote home monitoring; SARS-CoV-2; Silent hypoxia; Virtual wards","Singh","Kelly E","Health Services Management Centre, School of Social Policy, University of Birmingham, Park House, University of Birmingham, Edgbaston, Birmingham B15 2RT, UK",NA
"2835","34179736","10.1016/j.eclinm.2021.100965","Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review.","the aim of this review was to analyze the implementation and impact of remote home monitoring models (virtual wards) for confirmed or suspected COVID-19 patients, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt. we carried out a rapid systematic review on models led by primary and secondary care across seven countries (US, Australia, Canada, The Netherlands, Ireland, China, UK). The main outcomes included in","2021","06","29","EClinicalMedicine","EClinicalMedicine","COVID-19; Rapid systematic review; Remote home monitoring; SARS-CoV-2; Silent hypoxia; Virtual wards","Sidhu","Manbinder S","Health Services Management Centre, School of Social Policy, University of Birmingham, Park House, University of Birmingham, Edgbaston, Birmingham B15 2RT, UK",NA
"2836","34179736","10.1016/j.eclinm.2021.100965","Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review.","the aim of this review was to analyze the implementation and impact of remote home monitoring models (virtual wards) for confirmed or suspected COVID-19 patients, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt. we carried out a rapid systematic review on models led by primary and secondary care across seven countries (US, Australia, Canada, The Netherlands, Ireland, China, UK). The main outcomes included in","2021","06","29","EClinicalMedicine","EClinicalMedicine","COVID-19; Rapid systematic review; Remote home monitoring; SARS-CoV-2; Silent hypoxia; Virtual wards","Georghiou","Theo","Nuffield Trust, 59 New Cavendish Street, London W1G 7LP, UK",NA
"2837","34179736","10.1016/j.eclinm.2021.100965","Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review.","the aim of this review was to analyze the implementation and impact of remote home monitoring models (virtual wards) for confirmed or suspected COVID-19 patients, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt. we carried out a rapid systematic review on models led by primary and secondary care across seven countries (US, Australia, Canada, The Netherlands, Ireland, China, UK). The main outcomes included in","2021","06","29","EClinicalMedicine","EClinicalMedicine","COVID-19; Rapid systematic review; Remote home monitoring; SARS-CoV-2; Silent hypoxia; Virtual wards","Sherlaw-Johnson","Chris","Nuffield Trust, 59 New Cavendish Street, London W1G 7LP, UK",NA
"2838","34179736","10.1016/j.eclinm.2021.100965","Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review.","the aim of this review was to analyze the implementation and impact of remote home monitoring models (virtual wards) for confirmed or suspected COVID-19 patients, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt. we carried out a rapid systematic review on models led by primary and secondary care across seven countries (US, Australia, Canada, The Netherlands, Ireland, China, UK). The main outcomes included in","2021","06","29","EClinicalMedicine","EClinicalMedicine","COVID-19; Rapid systematic review; Remote home monitoring; SARS-CoV-2; Silent hypoxia; Virtual wards","Tomini","Sonila M","Department of Applied Health Research, University College London, Gower Street London, WC1E 6BT, UK",NA
"2839","34179736","10.1016/j.eclinm.2021.100965","Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review.","the aim of this review was to analyze the implementation and impact of remote home monitoring models (virtual wards) for confirmed or suspected COVID-19 patients, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt. we carried out a rapid systematic review on models led by primary and secondary care across seven countries (US, Australia, Canada, The Netherlands, Ireland, China, UK). The main outcomes included in","2021","06","29","EClinicalMedicine","EClinicalMedicine","COVID-19; Rapid systematic review; Remote home monitoring; SARS-CoV-2; Silent hypoxia; Virtual wards","Inada-Kim","Matthew","Wessex Academic Health and Science Network, National COVID Clinical Reference groups- Primary care, Secondary care, Care homes, National Clinical Lead Deterioration and National Specialist Advisor Sepsis, NHS England and NHS Improvement, McGill ward, Royal Hampshire County Hospital, Romsey Road, Winchester SO21 1QW, UK",NA
"2840","34179736","10.1016/j.eclinm.2021.100965","Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review.","the aim of this review was to analyze the implementation and impact of remote home monitoring models (virtual wards) for confirmed or suspected COVID-19 patients, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt. we carried out a rapid systematic review on models led by primary and secondary care across seven countries (US, Australia, Canada, The Netherlands, Ireland, China, UK). The main outcomes included in","2021","06","29","EClinicalMedicine","EClinicalMedicine","COVID-19; Rapid systematic review; Remote home monitoring; SARS-CoV-2; Silent hypoxia; Virtual wards","Kirkham","Karen","Integrated Care System Clinical Lead, NHSE/I Senior Medical Advisor Primary Care Transformation, Dorset CCG, Vespasian House, Barrack Rd, Dorchester DT1 7TG, UK",NA
"2841","34179736","10.1016/j.eclinm.2021.100965","Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review.","the aim of this review was to analyze the implementation and impact of remote home monitoring models (virtual wards) for confirmed or suspected COVID-19 patients, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt. we carried out a rapid systematic review on models led by primary and secondary care across seven countries (US, Australia, Canada, The Netherlands, Ireland, China, UK). The main outcomes included in","2021","06","29","EClinicalMedicine","EClinicalMedicine","COVID-19; Rapid systematic review; Remote home monitoring; SARS-CoV-2; Silent hypoxia; Virtual wards","Streetly","Allison","Department of Population Health Sciences Faculty of Life Sciences and Medicine King's College London SE1 1UL, UK",NA
"2842","34179736","10.1016/j.eclinm.2021.100965","Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review.","the aim of this review was to analyze the implementation and impact of remote home monitoring models (virtual wards) for confirmed or suspected COVID-19 patients, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt. we carried out a rapid systematic review on models led by primary and secondary care across seven countries (US, Australia, Canada, The Netherlands, Ireland, China, UK). The main outcomes included in","2021","06","29","EClinicalMedicine","EClinicalMedicine","COVID-19; Rapid systematic review; Remote home monitoring; SARS-CoV-2; Silent hypoxia; Virtual wards","Cohen","Nathan","University College London, UK",NA
"2843","34179736","10.1016/j.eclinm.2021.100965","Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review.","the aim of this review was to analyze the implementation and impact of remote home monitoring models (virtual wards) for confirmed or suspected COVID-19 patients, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt. we carried out a rapid systematic review on models led by primary and secondary care across seven countries (US, Australia, Canada, The Netherlands, Ireland, China, UK). The main outcomes included in","2021","06","29","EClinicalMedicine","EClinicalMedicine","COVID-19; Rapid systematic review; Remote home monitoring; SARS-CoV-2; Silent hypoxia; Virtual wards","Fulop","Naomi J","Department of Applied Health Research, University College London, Gower Street London, WC1E 6BT, UK",NA
"2844","34179735","10.1016/j.biteb.2021.100737","Capacity of existing wastewater treatment plants to treat SARS-CoV-2. A review.","Water is one of many viral transmission routes, and the presence of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) in wastewater has brought attention to its treatment. SARS CoV-2 primarily transmits in the air but the persistence of the virus in the water possibly can serve as a secondary source even though current studies do not show this. In this paper, an evaluation of the current literature with regards to the treatment of SARS-CoV-2 in wastewater treatment plant (WWTP) efflu","2021","06","29","Bioresour Technol Rep","Bioresource technology reports","Disinfection; Inactivation; SARS-CoV-2; Treatment; Virus detection; Wastewater","Saba","Beenish","Department of Food, Agricultural and Biological Engineering, The Ohio State University, 590 Woody Hayes Drive, Columbus, OH 43210, USA",NA
"2845","34179735","10.1016/j.biteb.2021.100737","Capacity of existing wastewater treatment plants to treat SARS-CoV-2. A review.","Water is one of many viral transmission routes, and the presence of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) in wastewater has brought attention to its treatment. SARS CoV-2 primarily transmits in the air but the persistence of the virus in the water possibly can serve as a secondary source even though current studies do not show this. In this paper, an evaluation of the current literature with regards to the treatment of SARS-CoV-2 in wastewater treatment plant (WWTP) efflu","2021","06","29","Bioresour Technol Rep","Bioresource technology reports","Disinfection; Inactivation; SARS-CoV-2; Treatment; Virus detection; Wastewater","Hasan","Shadi W","Center for Membranes and Advanced Water Technology (CMAT), Department of Chemical Engineering, Khalifa University of Science and Technology, P.O. Box 127788, Abu Dhabi, United Arab Emirates",NA
"2846","34179735","10.1016/j.biteb.2021.100737","Capacity of existing wastewater treatment plants to treat SARS-CoV-2. A review.","Water is one of many viral transmission routes, and the presence of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) in wastewater has brought attention to its treatment. SARS CoV-2 primarily transmits in the air but the persistence of the virus in the water possibly can serve as a secondary source even though current studies do not show this. In this paper, an evaluation of the current literature with regards to the treatment of SARS-CoV-2 in wastewater treatment plant (WWTP) efflu","2021","06","29","Bioresour Technol Rep","Bioresource technology reports","Disinfection; Inactivation; SARS-CoV-2; Treatment; Virus detection; Wastewater","Kjellerup","Birthe V","Department of Civil and Environmental Engineering, University of Maryland at College Park, College Park, MD, USA",NA
"2847","34179735","10.1016/j.biteb.2021.100737","Capacity of existing wastewater treatment plants to treat SARS-CoV-2. A review.","Water is one of many viral transmission routes, and the presence of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) in wastewater has brought attention to its treatment. SARS CoV-2 primarily transmits in the air but the persistence of the virus in the water possibly can serve as a secondary source even though current studies do not show this. In this paper, an evaluation of the current literature with regards to the treatment of SARS-CoV-2 in wastewater treatment plant (WWTP) efflu","2021","06","29","Bioresour Technol Rep","Bioresource technology reports","Disinfection; Inactivation; SARS-CoV-2; Treatment; Virus detection; Wastewater","Christy","Ann D","Department of Food, Agricultural and Biological Engineering, The Ohio State University, 590 Woody Hayes Drive, Columbus, OH 43210, USA",NA
"2848","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Woo","Marcel S","Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2849","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Haag","Friedrich","Department of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2850","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Nierhaus","Axel","Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2851","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Jarczak","Dominik","Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2852","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Roedl","Kevin","Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2853","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Mayer","Christina","Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2854","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Brehm","Thomas T","I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2855","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","van der Meirschen","Marc","I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2856","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Hennigs","Annette","I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2857","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Christopeit","Maximilian","Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2858","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Fiedler","Walter","Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, II. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2859","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Karagiannis","Panagiotis","Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, II. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2860","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Burdelski","Christoph","Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2861","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Schultze","Alexander","Department of Emergency Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2862","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Huber","Samuel","I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2863","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Addo","Marylyn M","I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2864","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Schmiedel","Stefan","I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2865","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Friese","Manuel A","Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2866","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Kluge","Stefan","Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2867","34179733","10.1016/j.isci.2021.102752","Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.","COVID-19 is a respiratory tract infection that can affect multiple organ systems. Predicting the severity and clinical outcome of individual patients is a major unmet clinical need that remains challenging due to intra- and inter-patient variability. Here, we longitudinally profiled and integrated more than 150 clinical, laboratory, and immunological parameters of 173 patients with mild to fatal COVID-19. Using systems biology, we detected progressive dysregulation of multiple parameters indicat","2021","07","03","iScience","iScience","Immunology; Virology; systems biology","Schulze Zur Wiesch","Julian","I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany",NA
"2868","34179732","10.1016/j.isci.2021.102738","Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution.","Severe COVID-19 is accompanied by rampant immune dysregulation in the lung and periphery, with immune cells of both compartments contributing to systemic distress. The extent to which immune cells of the lung and blood enter similar or distinct pathological states during severe disease remains unknown. Here, we leveraged 96 publicly available single-cell RNA sequencing datasets to elucidate common and compartment-specific features of severe to critical COVID-19 at the levels of transcript expres","2021","07","06","iScience","iScience","Complex system biology; Immunology; Pathophysiology; Transcriptomics","Overholt","Kalon J","Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA",NA
"2869","34179732","10.1016/j.isci.2021.102738","Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution.","Severe COVID-19 is accompanied by rampant immune dysregulation in the lung and periphery, with immune cells of both compartments contributing to systemic distress. The extent to which immune cells of the lung and blood enter similar or distinct pathological states during severe disease remains unknown. Here, we leveraged 96 publicly available single-cell RNA sequencing datasets to elucidate common and compartment-specific features of severe to critical COVID-19 at the levels of transcript expres","2021","07","06","iScience","iScience","Complex system biology; Immunology; Pathophysiology; Transcriptomics","Krog","Jonathan R","Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA",NA
"2870","34179732","10.1016/j.isci.2021.102738","Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution.","Severe COVID-19 is accompanied by rampant immune dysregulation in the lung and periphery, with immune cells of both compartments contributing to systemic distress. The extent to which immune cells of the lung and blood enter similar or distinct pathological states during severe disease remains unknown. Here, we leveraged 96 publicly available single-cell RNA sequencing datasets to elucidate common and compartment-specific features of severe to critical COVID-19 at the levels of transcript expres","2021","07","06","iScience","iScience","Complex system biology; Immunology; Pathophysiology; Transcriptomics","Zanoni","Ivan","Harvard Medical School, Boston Children's Hospital, Division of Immunology, Boston, MA, USA",NA
"2871","34179732","10.1016/j.isci.2021.102738","Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution.","Severe COVID-19 is accompanied by rampant immune dysregulation in the lung and periphery, with immune cells of both compartments contributing to systemic distress. The extent to which immune cells of the lung and blood enter similar or distinct pathological states during severe disease remains unknown. Here, we leveraged 96 publicly available single-cell RNA sequencing datasets to elucidate common and compartment-specific features of severe to critical COVID-19 at the levels of transcript expres","2021","07","06","iScience","iScience","Complex system biology; Immunology; Pathophysiology; Transcriptomics","Bryson","Bryan D","Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA",NA
"2872","34179713","10.1002/ped4.12277","Family integrated care: Supporting parents as primary caregivers in the neonatal intensive care unit.","Family integrated care (FICare) is a collaborative model of neonatal care which aims to address the negative impacts of the neonatal intensive care unit (NICU) environment by involving parents as equal partners, minimizing separation, and supporting parent-infant closeness. FICare incorporates psychological, educational, communication, and environmental strategies to support parents to cope with the NICU environment and to prepare them to be able to emotionally, cognitively, and physically care ","2021","06","29","Pediatr Investig","Pediatric investigation","Caregivers; Family integrated care; Neonatal intensive care; Parent-child","Waddington","Chandra","Faculty of Nursing University of Toronto Canada",NA
"2873","34179713","10.1002/ped4.12277","Family integrated care: Supporting parents as primary caregivers in the neonatal intensive care unit.","Family integrated care (FICare) is a collaborative model of neonatal care which aims to address the negative impacts of the neonatal intensive care unit (NICU) environment by involving parents as equal partners, minimizing separation, and supporting parent-infant closeness. FICare incorporates psychological, educational, communication, and environmental strategies to support parents to cope with the NICU environment and to prepare them to be able to emotionally, cognitively, and physically care ","2021","06","29","Pediatr Investig","Pediatric investigation","Caregivers; Family integrated care; Neonatal intensive care; Parent-child","van Veenendaal","Nicole R","OLVG Amsterdam the Netherlands",NA
"2874","34179713","10.1002/ped4.12277","Family integrated care: Supporting parents as primary caregivers in the neonatal intensive care unit.","Family integrated care (FICare) is a collaborative model of neonatal care which aims to address the negative impacts of the neonatal intensive care unit (NICU) environment by involving parents as equal partners, minimizing separation, and supporting parent-infant closeness. FICare incorporates psychological, educational, communication, and environmental strategies to support parents to cope with the NICU environment and to prepare them to be able to emotionally, cognitively, and physically care ","2021","06","29","Pediatr Investig","Pediatric investigation","Caregivers; Family integrated care; Neonatal intensive care; Parent-child","O'Brien","Karel","Mount Sinai Hospital Toronto Canada",NA
"2875","34179713","10.1002/ped4.12277","Family integrated care: Supporting parents as primary caregivers in the neonatal intensive care unit.","Family integrated care (FICare) is a collaborative model of neonatal care which aims to address the negative impacts of the neonatal intensive care unit (NICU) environment by involving parents as equal partners, minimizing separation, and supporting parent-infant closeness. FICare incorporates psychological, educational, communication, and environmental strategies to support parents to cope with the NICU environment and to prepare them to be able to emotionally, cognitively, and physically care ","2021","06","29","Pediatr Investig","Pediatric investigation","Caregivers; Family integrated care; Neonatal intensive care; Parent-child","Patel","Neil","Royal Hospital for Children Glasgow UK",NA
"2876","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Saunders","Jamie","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2877","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Curto-Garcia","Natalia","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2878","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Sriskandarajah","Priya","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2879","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"O'Sullivan","Jennifer","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2880","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Woodley","Claire","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2881","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Asirvatham","Susan","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2882","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Campbell-Drew","Marion","MPN Voice, c/o Guy's and St Thomas' Charity, London, United Kingdom",NA
"2883","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Mathias","Jonathan","MPN Voice, c/o Guy's and St Thomas' Charity, London, United Kingdom",NA
"2884","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Ellis","Tim","MPN Voice, c/o Guy's and St Thomas' Charity, London, United Kingdom",NA
"2885","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Baker","Nona","MPN Voice, c/o Guy's and St Thomas' Charity, London, United Kingdom",NA
"2886","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Radia","Deepti H","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2887","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Ali","Sahra","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2888","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Kordasti","Shahram","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2889","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Harrington","Patrick","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2890","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"de Lavallade","Hugues","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2891","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"McLornan","Donal P","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2892","34179698","10.1097/HS9.0000000000000609","Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.","Supplemental Digital Content is available in the text.","2021","06","29","Hemasphere","HemaSphere",NA,"Harrison","Claire N","Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",NA
"2893","34179695","10.1007/s42399-021-00992-3","Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19.","Advanced SARS-CoV-2 infections not uncommonly associate with the occurrence of silent or manifest thrombotic events which may be found as focal or systemic disease. Given the potential complexity of COVID-19 illnesses, a multifactorial causation is likely, but several studies have focused on infection-induced coagulopathy. Procoagulant states are commonly found in association with the finding of antiphospholipid antibodies. The correlation of the latter with thrombosis and/or clinical severity r","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","Antiphospholipid; COVID-19; Coronavirus; Thrombosis; Vaccine","Cimolai","Nevio","Faculty of Medicine, The University of British Columbia, Vancouver, BC Canada",NA
"2894","34179694","10.1007/s42399-021-00998-x","SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.","We describe a case of a previous healthy 20-year-old male athlete who presented with an atypical clinical profile with multiorgan involvement within five weeks after confirmed SARS-CoV-2 infection, suggestive for multisystem inflammatory syndrome (MIS); MIS is a rare, potentially life-threatening complication associated with SARS-CoV-2. MIS shares similar clinical features compatible with several overlapping lifethreatening hyperinflammatory syndromes, such as incomplete Kawasaki Disease (KD) an","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; Glucocorticoids; Heart failure; Immunoglobulins; Multisystem inflammatory syndrome","Bulut","Haldun","Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands",NA
"2895","34179694","10.1007/s42399-021-00998-x","SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.","We describe a case of a previous healthy 20-year-old male athlete who presented with an atypical clinical profile with multiorgan involvement within five weeks after confirmed SARS-CoV-2 infection, suggestive for multisystem inflammatory syndrome (MIS); MIS is a rare, potentially life-threatening complication associated with SARS-CoV-2. MIS shares similar clinical features compatible with several overlapping lifethreatening hyperinflammatory syndromes, such as incomplete Kawasaki Disease (KD) an","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; Glucocorticoids; Heart failure; Immunoglobulins; Multisystem inflammatory syndrome","Herbers","Alexandra H E","Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands",NA
"2896","34179694","10.1007/s42399-021-00998-x","SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.","We describe a case of a previous healthy 20-year-old male athlete who presented with an atypical clinical profile with multiorgan involvement within five weeks after confirmed SARS-CoV-2 infection, suggestive for multisystem inflammatory syndrome (MIS); MIS is a rare, potentially life-threatening complication associated with SARS-CoV-2. MIS shares similar clinical features compatible with several overlapping lifethreatening hyperinflammatory syndromes, such as incomplete Kawasaki Disease (KD) an","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; Glucocorticoids; Heart failure; Immunoglobulins; Multisystem inflammatory syndrome","Hageman","Ilse M G","Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands",NA
"2897","34179694","10.1007/s42399-021-00998-x","SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.","We describe a case of a previous healthy 20-year-old male athlete who presented with an atypical clinical profile with multiorgan involvement within five weeks after confirmed SARS-CoV-2 infection, suggestive for multisystem inflammatory syndrome (MIS); MIS is a rare, potentially life-threatening complication associated with SARS-CoV-2. MIS shares similar clinical features compatible with several overlapping lifethreatening hyperinflammatory syndromes, such as incomplete Kawasaki Disease (KD) an","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; Glucocorticoids; Heart failure; Immunoglobulins; Multisystem inflammatory syndrome","Netten","Paetrick M","Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands",NA
"2898","34179694","10.1007/s42399-021-00998-x","SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.","We describe a case of a previous healthy 20-year-old male athlete who presented with an atypical clinical profile with multiorgan involvement within five weeks after confirmed SARS-CoV-2 infection, suggestive for multisystem inflammatory syndrome (MIS); MIS is a rare, potentially life-threatening complication associated with SARS-CoV-2. MIS shares similar clinical features compatible with several overlapping lifethreatening hyperinflammatory syndromes, such as incomplete Kawasaki Disease (KD) an","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; Glucocorticoids; Heart failure; Immunoglobulins; Multisystem inflammatory syndrome","de Jonge","Hendrik J M","Department of Gastroenterology and Hepatology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands",NA
"2899","34179694","10.1007/s42399-021-00998-x","SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.","We describe a case of a previous healthy 20-year-old male athlete who presented with an atypical clinical profile with multiorgan involvement within five weeks after confirmed SARS-CoV-2 infection, suggestive for multisystem inflammatory syndrome (MIS); MIS is a rare, potentially life-threatening complication associated with SARS-CoV-2. MIS shares similar clinical features compatible with several overlapping lifethreatening hyperinflammatory syndromes, such as incomplete Kawasaki Disease (KD) an","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; Glucocorticoids; Heart failure; Immunoglobulins; Multisystem inflammatory syndrome","Joustra","Robert","Department of Cardiology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands",NA
"2900","34179694","10.1007/s42399-021-00998-x","SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.","We describe a case of a previous healthy 20-year-old male athlete who presented with an atypical clinical profile with multiorgan involvement within five weeks after confirmed SARS-CoV-2 infection, suggestive for multisystem inflammatory syndrome (MIS); MIS is a rare, potentially life-threatening complication associated with SARS-CoV-2. MIS shares similar clinical features compatible with several overlapping lifethreatening hyperinflammatory syndromes, such as incomplete Kawasaki Disease (KD) an","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; Glucocorticoids; Heart failure; Immunoglobulins; Multisystem inflammatory syndrome","van de Veerdonk","Frank L","Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands",NA
"2901","34179694","10.1007/s42399-021-00998-x","SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.","We describe a case of a previous healthy 20-year-old male athlete who presented with an atypical clinical profile with multiorgan involvement within five weeks after confirmed SARS-CoV-2 infection, suggestive for multisystem inflammatory syndrome (MIS); MIS is a rare, potentially life-threatening complication associated with SARS-CoV-2. MIS shares similar clinical features compatible with several overlapping lifethreatening hyperinflammatory syndromes, such as incomplete Kawasaki Disease (KD) an","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; Glucocorticoids; Heart failure; Immunoglobulins; Multisystem inflammatory syndrome","de Jager","Cornelis P C","Department of Intensive Care Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands",NA
"2902","34179693","10.1007/s42399-021-00996-z","A Study on the Safety of Percutaneous Tracheostomy in Patients with Severe Acute Respiratory Syndrome Novel Corona Virus 2 (SARS-nCoV2) Infection: A Single-Center Observational Cohort Study in a CoVID Intensive Care Unit.","We studied the safety of percutaneous dilatational tracheostomy (PCDT) in severe acute respiratory syndrome novel coronavirus 2 (SARS-nCoV2). From 01 March 20 to 30 November 2020, 1635 required hospital admission of which 145 (9%) required intensive (ICU) care. The primary outcomes are mortality and secondary outcomes were duration of invasive mechanical ventilation (IMV), length of stay (LOS) in ICU and hospital, and days required for decannulation. Out of the 145 (9%), 107 (73.7%) were males (","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","ARDS; COVID-19; Percutaneous tracheostomy","Mylavarapu","Krishna Kumar","Department of Anaesthesiology &amp",NA
"2903","34179693","10.1007/s42399-021-00996-z","A Study on the Safety of Percutaneous Tracheostomy in Patients with Severe Acute Respiratory Syndrome Novel Corona Virus 2 (SARS-nCoV2) Infection: A Single-Center Observational Cohort Study in a CoVID Intensive Care Unit.","We studied the safety of percutaneous dilatational tracheostomy (PCDT) in severe acute respiratory syndrome novel coronavirus 2 (SARS-nCoV2). From 01 March 20 to 30 November 2020, 1635 required hospital admission of which 145 (9%) required intensive (ICU) care. The primary outcomes are mortality and secondary outcomes were duration of invasive mechanical ventilation (IMV), length of stay (LOS) in ICU and hospital, and days required for decannulation. Out of the 145 (9%), 107 (73.7%) were males (","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","ARDS; COVID-19; Percutaneous tracheostomy","Joshi","Aditya","Department of Anaesthesiology &amp",NA
"2904","34179693","10.1007/s42399-021-00996-z","A Study on the Safety of Percutaneous Tracheostomy in Patients with Severe Acute Respiratory Syndrome Novel Corona Virus 2 (SARS-nCoV2) Infection: A Single-Center Observational Cohort Study in a CoVID Intensive Care Unit.","We studied the safety of percutaneous dilatational tracheostomy (PCDT) in severe acute respiratory syndrome novel coronavirus 2 (SARS-nCoV2). From 01 March 20 to 30 November 2020, 1635 required hospital admission of which 145 (9%) required intensive (ICU) care. The primary outcomes are mortality and secondary outcomes were duration of invasive mechanical ventilation (IMV), length of stay (LOS) in ICU and hospital, and days required for decannulation. Out of the 145 (9%), 107 (73.7%) were males (","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","ARDS; COVID-19; Percutaneous tracheostomy","Nair","Ranjith","Department of Internal medicine, Command Hospital (EC), Kolkata, 700027 India",NA
"2905","34179693","10.1007/s42399-021-00996-z","A Study on the Safety of Percutaneous Tracheostomy in Patients with Severe Acute Respiratory Syndrome Novel Corona Virus 2 (SARS-nCoV2) Infection: A Single-Center Observational Cohort Study in a CoVID Intensive Care Unit.","We studied the safety of percutaneous dilatational tracheostomy (PCDT) in severe acute respiratory syndrome novel coronavirus 2 (SARS-nCoV2). From 01 March 20 to 30 November 2020, 1635 required hospital admission of which 145 (9%) required intensive (ICU) care. The primary outcomes are mortality and secondary outcomes were duration of invasive mechanical ventilation (IMV), length of stay (LOS) in ICU and hospital, and days required for decannulation. Out of the 145 (9%), 107 (73.7%) were males (","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","ARDS; COVID-19; Percutaneous tracheostomy","Setlur","Rangraj","Department of Anaesthesiology &amp",NA
"2906","34179693","10.1007/s42399-021-00996-z","A Study on the Safety of Percutaneous Tracheostomy in Patients with Severe Acute Respiratory Syndrome Novel Corona Virus 2 (SARS-nCoV2) Infection: A Single-Center Observational Cohort Study in a CoVID Intensive Care Unit.","We studied the safety of percutaneous dilatational tracheostomy (PCDT) in severe acute respiratory syndrome novel coronavirus 2 (SARS-nCoV2). From 01 March 20 to 30 November 2020, 1635 required hospital admission of which 145 (9%) required intensive (ICU) care. The primary outcomes are mortality and secondary outcomes were duration of invasive mechanical ventilation (IMV), length of stay (LOS) in ICU and hospital, and days required for decannulation. Out of the 145 (9%), 107 (73.7%) were males (","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","ARDS; COVID-19; Percutaneous tracheostomy","Kapoor","Rajan","Department of Internal medicine, Command Hospital (EC), Kolkata, 700027 India",NA
"2907","34179692","10.1007/s42399-021-00997-y","Modified National Early Warning Score as Early Predictor of Outcome in COVID-19 Pandemic.","COVID-19 represented an important challenge to the Italian healthcare system (IHCS). Our main aim was to obtain evidence to support the use of modified national early warning score (m-NEWS) as an interdisciplinary, common, and universal scoring scale to quickly recognize patients with a risk of clinical deterioration before admission and during hospitalization. As a secondary goal, we tried to find a score threshold that can trigger patients' immediate medical review as a part of an optimal tria","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; EWS; Respiratory failure; Score","Tagliabue","Fabio","ASST Bergamo Est, P.O. Pesenti Fenaroli, General Surgery Unit, Alzano Lombardo, Bergamo, Italy",NA
"2908","34179692","10.1007/s42399-021-00997-y","Modified National Early Warning Score as Early Predictor of Outcome in COVID-19 Pandemic.","COVID-19 represented an important challenge to the Italian healthcare system (IHCS). Our main aim was to obtain evidence to support the use of modified national early warning score (m-NEWS) as an interdisciplinary, common, and universal scoring scale to quickly recognize patients with a risk of clinical deterioration before admission and during hospitalization. As a secondary goal, we tried to find a score threshold that can trigger patients' immediate medical review as a part of an optimal tria","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; EWS; Respiratory failure; Score","Schena","Daniele","ASST Bergamo Est, P.O. Pesenti Fenaroli, Orthopaedics and Traumatology Unit, Alzano Lombardo, Bergamo, Italy",NA
"2909","34179692","10.1007/s42399-021-00997-y","Modified National Early Warning Score as Early Predictor of Outcome in COVID-19 Pandemic.","COVID-19 represented an important challenge to the Italian healthcare system (IHCS). Our main aim was to obtain evidence to support the use of modified national early warning score (m-NEWS) as an interdisciplinary, common, and universal scoring scale to quickly recognize patients with a risk of clinical deterioration before admission and during hospitalization. As a secondary goal, we tried to find a score threshold that can trigger patients' immediate medical review as a part of an optimal tria","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; EWS; Respiratory failure; Score","Galassi","Luca","ASST Bergamo Est, P.O. Pesenti Fenaroli, General Surgery Unit, Alzano Lombardo, Bergamo, Italy",NA
"2910","34179692","10.1007/s42399-021-00997-y","Modified National Early Warning Score as Early Predictor of Outcome in COVID-19 Pandemic.","COVID-19 represented an important challenge to the Italian healthcare system (IHCS). Our main aim was to obtain evidence to support the use of modified national early warning score (m-NEWS) as an interdisciplinary, common, and universal scoring scale to quickly recognize patients with a risk of clinical deterioration before admission and during hospitalization. As a secondary goal, we tried to find a score threshold that can trigger patients' immediate medical review as a part of an optimal tria","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; EWS; Respiratory failure; Score","Magni","Matteo","ASST Bergamo Est, P.O. Pesenti Fenaroli, General Surgery Unit, Alzano Lombardo, Bergamo, Italy",NA
"2911","34179692","10.1007/s42399-021-00997-y","Modified National Early Warning Score as Early Predictor of Outcome in COVID-19 Pandemic.","COVID-19 represented an important challenge to the Italian healthcare system (IHCS). Our main aim was to obtain evidence to support the use of modified national early warning score (m-NEWS) as an interdisciplinary, common, and universal scoring scale to quickly recognize patients with a risk of clinical deterioration before admission and during hospitalization. As a secondary goal, we tried to find a score threshold that can trigger patients' immediate medical review as a part of an optimal tria","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; EWS; Respiratory failure; Score","Guerrazzi","Guglielmo","University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy",NA
"2912","34179692","10.1007/s42399-021-00997-y","Modified National Early Warning Score as Early Predictor of Outcome in COVID-19 Pandemic.","COVID-19 represented an important challenge to the Italian healthcare system (IHCS). Our main aim was to obtain evidence to support the use of modified national early warning score (m-NEWS) as an interdisciplinary, common, and universal scoring scale to quickly recognize patients with a risk of clinical deterioration before admission and during hospitalization. As a secondary goal, we tried to find a score threshold that can trigger patients' immediate medical review as a part of an optimal tria","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; EWS; Respiratory failure; Score","Acerbis","Andrea","ASST Bergamo Est, P.O. Pesenti Fenaroli, General Surgery Unit, Alzano Lombardo, Bergamo, Italy",NA
"2913","34179692","10.1007/s42399-021-00997-y","Modified National Early Warning Score as Early Predictor of Outcome in COVID-19 Pandemic.","COVID-19 represented an important challenge to the Italian healthcare system (IHCS). Our main aim was to obtain evidence to support the use of modified national early warning score (m-NEWS) as an interdisciplinary, common, and universal scoring scale to quickly recognize patients with a risk of clinical deterioration before admission and during hospitalization. As a secondary goal, we tried to find a score threshold that can trigger patients' immediate medical review as a part of an optimal tria","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; EWS; Respiratory failure; Score","Rinallo","Christina","ASST Bergamo Est, P.O. Pesenti Fenaroli, Orthopaedics and Traumatology Unit, Alzano Lombardo, Bergamo, Italy",NA
"2914","34179692","10.1007/s42399-021-00997-y","Modified National Early Warning Score as Early Predictor of Outcome in COVID-19 Pandemic.","COVID-19 represented an important challenge to the Italian healthcare system (IHCS). Our main aim was to obtain evidence to support the use of modified national early warning score (m-NEWS) as an interdisciplinary, common, and universal scoring scale to quickly recognize patients with a risk of clinical deterioration before admission and during hospitalization. As a secondary goal, we tried to find a score threshold that can trigger patients' immediate medical review as a part of an optimal tria","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; EWS; Respiratory failure; Score","Longhi","Daniel","Polytechnic University of Milan, Piazza Leonardo da Vinci, 32, 20133 Milan, Italy",NA
"2915","34179692","10.1007/s42399-021-00997-y","Modified National Early Warning Score as Early Predictor of Outcome in COVID-19 Pandemic.","COVID-19 represented an important challenge to the Italian healthcare system (IHCS). Our main aim was to obtain evidence to support the use of modified national early warning score (m-NEWS) as an interdisciplinary, common, and universal scoring scale to quickly recognize patients with a risk of clinical deterioration before admission and during hospitalization. As a secondary goal, we tried to find a score threshold that can trigger patients' immediate medical review as a part of an optimal tria","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; EWS; Respiratory failure; Score","Ronzani","Alberto","VTT Technical Research Centre of Finland Ltd., 02150 Espoo, Finland",NA
"2916","34179692","10.1007/s42399-021-00997-y","Modified National Early Warning Score as Early Predictor of Outcome in COVID-19 Pandemic.","COVID-19 represented an important challenge to the Italian healthcare system (IHCS). Our main aim was to obtain evidence to support the use of modified national early warning score (m-NEWS) as an interdisciplinary, common, and universal scoring scale to quickly recognize patients with a risk of clinical deterioration before admission and during hospitalization. As a secondary goal, we tried to find a score threshold that can trigger patients' immediate medical review as a part of an optimal tria","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19; EWS; Respiratory failure; Score","Mariani","Pierpaolo","ASST Bergamo Est, P.O. Pesenti Fenaroli, General Surgery Unit, Alzano Lombardo, Bergamo, Italy",NA
"2917","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Portale","Grazia","Emergency Medicine Unit, Madre Giuseppina Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy",NA
"2918","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Ciolina","Federica","Radiology Unit, Madre Giuseppina Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy",NA
"2919","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Arcari","Luca","Covid-Cardiology Unit, Madre Giuseppina Vannini Hospital, Rome, Italy",NA
"2920","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Giraldi","Gianluca Di Lazzaro","Emergency Medicine Unit, Madre Giuseppina Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy",NA
"2921","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Danti","Massimiliano","Radiology Unit, Madre Giuseppina Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy",NA
"2922","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Pietropaolo","Lorenzo","Emergency Medicine Unit, Madre Giuseppina Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy",NA
"2923","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Camastra","Giovanni","Covid-Cardiology Unit, Madre Giuseppina Vannini Hospital, Rome, Italy",NA
"2924","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Cordischi","Chiara","Emergency Medicine Unit, Madre Giuseppina Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy",NA
"2925","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Urbani","Laura","Emergency Medicine Unit, Madre Giuseppina Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy",NA
"2926","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Proietti","Lidia","Emergency Medicine Unit, Madre Giuseppina Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy",NA
"2927","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Cacciotti","Luca","Covid-Cardiology Unit, Madre Giuseppina Vannini Hospital, Rome, Italy",NA
"2928","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Santini","Claudio","Internal Medicine Department, Madre Giuseppina Vannini Hospital, Rome, Italy",NA
"2929","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Melandri","Serena","Internal Medicine Department, Madre Giuseppina Vannini Hospital, Rome, Italy",NA
"2930","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Ansalone","Gerardo","Covid-Cardiology Unit, Madre Giuseppina Vannini Hospital, Rome, Italy",NA
"2931","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Sbarbati","Stefano","Covid-Cardiology Unit, Madre Giuseppina Vannini Hospital, Rome, Italy",NA
"2932","34179691","10.1007/s42399-021-00986-1","Lung Ultrasound in COVID-19: Clinical Correlates and Comparison with Chest Computed Tomography.","Lung ultrasound (LUS) and chest computed tomography (chest CT) are largely employed to evaluate coronavirus disease 2019 (COVID-19) pneumonia. We investigated semi-quantitative LUS and CT scoring in hospitalized COVID-19 patients. LUS and chest CT were performed within 24 h upon admission. Both were analyzed according to semi-quantitative scoring systems. Subgroups were identified according to median LUS score. Patients within higher LUS score group were older (79 vs 60 years, p&lt;0.001), had h","2021","06","29","SN Compr Clin Med","SN comprehensive clinical medicine","COVID-19 pneumonia; Chest CT; Lung ultrasound; Scoring system","Sighieri","Cinzia","Emergency Medicine Unit, Madre Giuseppina Vannini Hospital, Via di Acqua Bullicante 4, 00177 Rome, Italy",NA
